{"TEXT1": "CYP3A4 @DRUG$ increased plasma concentrations @DRUG$ subjects poor metabolizers CLINICAL PHARMACOLOGY Variability Metabolism", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d765.s0.p0", "DRUGA": ["Ketoconazole", "drug", "19-30"], "DRUGB": ["tolterodine", "drug", "135-145"]}
{"TEXT1": "patients receiving @DRUG$ potent CYP3A4 inhibitors @DRUG$ itraconazole macrolide antibiotics erythromycin cyclosporine vinblastine recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p0", "DRUGA": ["ketoconazole", "drug", "23-34"], "DRUGB": ["azole antifungals", "group", "84-100"]}
{"TEXT1": "patients receiving @DRUG$ potent CYP3A4 inhibitors azole antifungals @DRUG$ macrolide antibiotics erythromycin cyclosporine vinblastine recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p1", "DRUGA": ["ketoconazole", "drug", "23-34"], "DRUGB": ["itraconazole", "drug", "107-118"]}
{"TEXT1": "patients receiving @DRUG$ potent CYP3A4 inhibitors azole antifungals itraconazole macrolide antibiotics erythromycin cyclosporine vinblastine recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p2", "DRUGA": ["ketoconazole", "drug", "23-34"], "DRUGB": ["miconazole", "drug", "121-130"]}
{"TEXT1": "patients receiving @DRUG$ potent CYP3A4 inhibitors azole antifungals itraconazole @DRUG$ erythromycin cyclosporine vinblastine recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p3", "DRUGA": ["ketoconazole", "drug", "23-34"], "DRUGB": ["macrolide antibiotics", "group", "136-156"]}
{"TEXT1": "patients receiving @DRUG$ potent CYP3A4 inhibitors azole antifungals itraconazole macrolide antibiotics @DRUG$ cyclosporine vinblastine recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p4", "DRUGA": ["ketoconazole", "drug", "23-34"], "DRUGB": ["erythromycin", "drug", "163-174"]}
{"TEXT1": "patients receiving @DRUG$ potent CYP3A4 inhibitors azole antifungals itraconazole macrolide antibiotics erythromycin cyclosporine vinblastine recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p5", "DRUGA": ["ketoconazole", "drug", "23-34"], "DRUGB": ["clarithromycin", "drug", "177-190"]}
{"TEXT1": "patients receiving @DRUG$ potent CYP3A4 inhibitors azole antifungals itraconazole macrolide antibiotics erythromycin @DRUG$ vinblastine recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p6", "DRUGA": ["ketoconazole", "drug", "23-34"], "DRUGB": ["cyclosporine", "drug", "196-207"]}
{"TEXT1": "patients receiving @DRUG$ potent CYP3A4 inhibitors azole antifungals itraconazole macrolide antibiotics erythromycin cyclosporine @DRUG$ recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p7", "DRUGA": ["ketoconazole", "drug", "23-34"], "DRUGB": ["vinblastine", "drug", "212-222"]}
{"TEXT1": "patients receiving @DRUG$ potent CYP3A4 inhibitors azole antifungals itraconazole macrolide antibiotics erythromycin cyclosporine vinblastine recommended dose @DRUG$ 2 mg daily", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d765.s1.p8", "DRUGA": ["ketoconazole", "drug", "23-34"], "DRUGB": ["DETROL LA", "brand", "249-257"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors @DRUG$ @DRUG$ macrolide antibiotics erythromycin cyclosporine vinblastine recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p9", "DRUGA": ["azole antifungals", "group", "84-100"], "DRUGB": ["itraconazole", "drug", "107-118"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors @DRUG$ itraconazole macrolide antibiotics erythromycin cyclosporine vinblastine recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p10", "DRUGA": ["azole antifungals", "group", "84-100"], "DRUGB": ["miconazole", "drug", "121-130"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors @DRUG$ itraconazole @DRUG$ erythromycin cyclosporine vinblastine recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p11", "DRUGA": ["azole antifungals", "group", "84-100"], "DRUGB": ["macrolide antibiotics", "group", "136-156"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors @DRUG$ itraconazole macrolide antibiotics @DRUG$ cyclosporine vinblastine recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p12", "DRUGA": ["azole antifungals", "group", "84-100"], "DRUGB": ["erythromycin", "drug", "163-174"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors @DRUG$ itraconazole macrolide antibiotics erythromycin cyclosporine vinblastine recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p13", "DRUGA": ["azole antifungals", "group", "84-100"], "DRUGB": ["clarithromycin", "drug", "177-190"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors @DRUG$ itraconazole macrolide antibiotics erythromycin @DRUG$ vinblastine recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p14", "DRUGA": ["azole antifungals", "group", "84-100"], "DRUGB": ["cyclosporine", "drug", "196-207"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors @DRUG$ itraconazole macrolide antibiotics erythromycin cyclosporine @DRUG$ recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p15", "DRUGA": ["azole antifungals", "group", "84-100"], "DRUGB": ["vinblastine", "drug", "212-222"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors @DRUG$ itraconazole macrolide antibiotics erythromycin cyclosporine vinblastine recommended dose @DRUG$ 2 mg daily", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d765.s1.p16", "DRUGA": ["azole antifungals", "group", "84-100"], "DRUGB": ["DETROL LA", "brand", "249-257"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors azole antifungals @DRUG$ macrolide antibiotics erythromycin cyclosporine vinblastine recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p17", "DRUGA": ["itraconazole", "drug", "107-118"], "DRUGB": ["miconazole", "drug", "121-130"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors azole antifungals @DRUG$ @DRUG$ erythromycin cyclosporine vinblastine recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p18", "DRUGA": ["itraconazole", "drug", "107-118"], "DRUGB": ["macrolide antibiotics", "group", "136-156"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors azole antifungals @DRUG$ macrolide antibiotics @DRUG$ cyclosporine vinblastine recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p19", "DRUGA": ["itraconazole", "drug", "107-118"], "DRUGB": ["erythromycin", "drug", "163-174"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors azole antifungals @DRUG$ macrolide antibiotics erythromycin cyclosporine vinblastine recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p20", "DRUGA": ["itraconazole", "drug", "107-118"], "DRUGB": ["clarithromycin", "drug", "177-190"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors azole antifungals @DRUG$ macrolide antibiotics erythromycin @DRUG$ vinblastine recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p21", "DRUGA": ["itraconazole", "drug", "107-118"], "DRUGB": ["cyclosporine", "drug", "196-207"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors azole antifungals @DRUG$ macrolide antibiotics erythromycin cyclosporine @DRUG$ recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p22", "DRUGA": ["itraconazole", "drug", "107-118"], "DRUGB": ["vinblastine", "drug", "212-222"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors azole antifungals @DRUG$ macrolide antibiotics erythromycin cyclosporine vinblastine recommended dose @DRUG$ 2 mg daily", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d765.s1.p23", "DRUGA": ["itraconazole", "drug", "107-118"], "DRUGB": ["DETROL LA", "brand", "249-257"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors azole antifungals itraconazole @DRUG$ erythromycin cyclosporine vinblastine recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p24", "DRUGA": ["miconazole", "drug", "121-130"], "DRUGB": ["macrolide antibiotics", "group", "136-156"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors azole antifungals itraconazole macrolide antibiotics @DRUG$ cyclosporine vinblastine recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p25", "DRUGA": ["miconazole", "drug", "121-130"], "DRUGB": ["erythromycin", "drug", "163-174"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors azole antifungals itraconazole macrolide antibiotics erythromycin cyclosporine vinblastine recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p26", "DRUGA": ["miconazole", "drug", "121-130"], "DRUGB": ["clarithromycin", "drug", "177-190"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors azole antifungals itraconazole macrolide antibiotics erythromycin @DRUG$ vinblastine recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p27", "DRUGA": ["miconazole", "drug", "121-130"], "DRUGB": ["cyclosporine", "drug", "196-207"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors azole antifungals itraconazole macrolide antibiotics erythromycin cyclosporine @DRUG$ recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p28", "DRUGA": ["miconazole", "drug", "121-130"], "DRUGB": ["vinblastine", "drug", "212-222"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors azole antifungals itraconazole macrolide antibiotics erythromycin cyclosporine vinblastine recommended dose @DRUG$ 2 mg daily", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d765.s1.p29", "DRUGA": ["miconazole", "drug", "121-130"], "DRUGB": ["DETROL LA", "brand", "249-257"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors azole antifungals itraconazole @DRUG$ @DRUG$ cyclosporine vinblastine recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p30", "DRUGA": ["macrolide antibiotics", "group", "136-156"], "DRUGB": ["erythromycin", "drug", "163-174"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors azole antifungals itraconazole @DRUG$ erythromycin cyclosporine vinblastine recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p31", "DRUGA": ["macrolide antibiotics", "group", "136-156"], "DRUGB": ["clarithromycin", "drug", "177-190"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors azole antifungals itraconazole @DRUG$ erythromycin @DRUG$ vinblastine recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p32", "DRUGA": ["macrolide antibiotics", "group", "136-156"], "DRUGB": ["cyclosporine", "drug", "196-207"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors azole antifungals itraconazole @DRUG$ erythromycin cyclosporine @DRUG$ recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p33", "DRUGA": ["macrolide antibiotics", "group", "136-156"], "DRUGB": ["vinblastine", "drug", "212-222"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors azole antifungals itraconazole @DRUG$ erythromycin cyclosporine vinblastine recommended dose @DRUG$ 2 mg daily", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d765.s1.p34", "DRUGA": ["macrolide antibiotics", "group", "136-156"], "DRUGB": ["DETROL LA", "brand", "249-257"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors azole antifungals itraconazole macrolide antibiotics @DRUG$ cyclosporine vinblastine recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p35", "DRUGA": ["erythromycin", "drug", "163-174"], "DRUGB": ["clarithromycin", "drug", "177-190"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors azole antifungals itraconazole macrolide antibiotics @DRUG$ @DRUG$ vinblastine recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p36", "DRUGA": ["erythromycin", "drug", "163-174"], "DRUGB": ["cyclosporine", "drug", "196-207"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors azole antifungals itraconazole macrolide antibiotics @DRUG$ cyclosporine @DRUG$ recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p37", "DRUGA": ["erythromycin", "drug", "163-174"], "DRUGB": ["vinblastine", "drug", "212-222"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors azole antifungals itraconazole macrolide antibiotics @DRUG$ cyclosporine vinblastine recommended dose @DRUG$ 2 mg daily", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d765.s1.p38", "DRUGA": ["erythromycin", "drug", "163-174"], "DRUGB": ["DETROL LA", "brand", "249-257"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors azole antifungals itraconazole macrolide antibiotics erythromycin @DRUG$ vinblastine recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p39", "DRUGA": ["clarithromycin", "drug", "177-190"], "DRUGB": ["cyclosporine", "drug", "196-207"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors azole antifungals itraconazole macrolide antibiotics erythromycin cyclosporine @DRUG$ recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p40", "DRUGA": ["clarithromycin", "drug", "177-190"], "DRUGB": ["vinblastine", "drug", "212-222"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors azole antifungals itraconazole macrolide antibiotics erythromycin cyclosporine vinblastine recommended dose @DRUG$ 2 mg daily", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d765.s1.p41", "DRUGA": ["clarithromycin", "drug", "177-190"], "DRUGB": ["DETROL LA", "brand", "249-257"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors azole antifungals itraconazole macrolide antibiotics erythromycin @DRUG$ @DRUG$ recommended dose DETROL LA 2 mg daily", "LBL": "0", "ID": "DDI-DrugBank.d765.s1.p42", "DRUGA": ["cyclosporine", "drug", "196-207"], "DRUGB": ["vinblastine", "drug", "212-222"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors azole antifungals itraconazole macrolide antibiotics erythromycin @DRUG$ vinblastine recommended dose @DRUG$ 2 mg daily", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d765.s1.p43", "DRUGA": ["cyclosporine", "drug", "196-207"], "DRUGB": ["DETROL LA", "brand", "249-257"]}
{"TEXT1": "patients receiving ketoconazole potent CYP3A4 inhibitors azole antifungals itraconazole macrolide antibiotics erythromycin cyclosporine @DRUG$ recommended dose @DRUG$ 2 mg daily", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d765.s1.p44", "DRUGA": ["vinblastine", "drug", "212-222"], "DRUGB": ["DETROL LA", "brand", "249-257"]}
{"TEXT1": "Potential @DRUG$ to Affect Drugs @DRUG$ not expected cause important pharmacokinetic interactions drugs metabolized cytochrome P450 isozymes", "LBL": "0", "ID": "DDI-DrugBank.d670.s0.p0", "DRUGA": ["INVEGA", "brand", "14-19"], "DRUGB": ["Paliperidone", "drug", "46-57"]}
{"TEXT1": "Given primary CNS effects @DRUG$ @DRUG$ used with caution alcohol", "LBL": "0", "ID": "DDI-DrugBank.d670.s6.p0", "DRUGA": ["paliperidone", "drug", "33-44"], "DRUGB": ["INVEGA", "brand", "47-52"]}
{"TEXT1": "Given primary CNS effects @DRUG$ INVEGA used with caution @DRUG$ alcohol", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d670.s6.p1", "DRUGA": ["paliperidone", "drug", "33-44"], "DRUGB": ["centrally acting drugs", "group", "111-132"]}
{"TEXT1": "Given primary CNS effects @DRUG$ INVEGA used with caution @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d670.s6.p2", "DRUGA": ["paliperidone", "drug", "33-44"], "DRUGB": ["alcohol", "drug", "138-144"]}
{"TEXT1": "Given primary CNS effects paliperidone @DRUG$ used with caution @DRUG$ alcohol", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d670.s6.p3", "DRUGA": ["INVEGA", "brand", "47-52"], "DRUGB": ["centrally acting drugs", "group", "111-132"]}
{"TEXT1": "Given primary CNS effects paliperidone @DRUG$ used with caution @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d670.s6.p4", "DRUGA": ["INVEGA", "brand", "47-52"], "DRUGB": ["alcohol", "drug", "138-144"]}
{"TEXT1": "Given primary CNS effects paliperidone INVEGA used with caution @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d670.s6.p5", "DRUGA": ["centrally acting drugs", "group", "111-132"], "DRUGB": ["alcohol", "drug", "138-144"]}
{"TEXT1": "@DRUG$ effect @DRUG$ dopamine agonists", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d670.s7.p0", "DRUGA": ["Paliperidone", "drug", "0-11"], "DRUGB": ["levodopa", "drug", "42-49"]}
{"TEXT1": "@DRUG$ effect levodopa @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d670.s7.p1", "DRUGA": ["Paliperidone", "drug", "0-11"], "DRUGB": ["dopamine agonists", "group", "61-77"]}
{"TEXT1": "Paliperidone effect @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d670.s7.p2", "DRUGA": ["levodopa", "drug", "42-49"], "DRUGB": ["dopamine agonists", "group", "61-77"]}
{"TEXT1": "Potential Drugs to Affect @DRUG$ @DRUG$ not substrate CYP1A2 CYP2C19 so interaction inhibitors inducers isozymes unlikely", "LBL": "0", "ID": "DDI-DrugBank.d670.s9.p0", "DRUGA": ["INVEGA", "brand", "36-41"], "DRUGB": ["Paliperidone", "drug", "46-57"]}
{"TEXT1": "concomitant use of @DRUG$ @DRUG$ agents dry mouth constipation somnolence anticholinergic effects increase frequency severity", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d784.s0.p0", "DRUGA": ["oxybutynin", "drug", "23-32"], "DRUGB": ["anticholinergic drugs", "group", "45-65"]}
{"TEXT1": "Mean @DRUG$ plasma concentrations approximately fold higher @DRUG$ administered ketoconazole potent CYP3A4 inhibitor", "LBL": "0", "ID": "DDI-DrugBank.d784.s3.p0", "DRUGA": ["oxybutynin chloride", "drug", "5-23"], "DRUGB": ["DITROPAN XL", "brand", "85-95"]}
{"TEXT1": "Mean @DRUG$ plasma concentrations approximately fold higher DITROPAN XL administered @DRUG$ potent CYP3A4 inhibitor", "LBL": "0", "ID": "DDI-DrugBank.d784.s3.p1", "DRUGA": ["oxybutynin chloride", "drug", "5-23"], "DRUGB": ["ketoconazole", "drug", "119-130"]}
{"TEXT1": "Mean oxybutynin chloride plasma concentrations approximately fold higher @DRUG$ administered @DRUG$ potent CYP3A4 inhibitor", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d784.s3.p2", "DRUGA": ["DITROPAN XL", "brand", "85-95"], "DRUGB": ["ketoconazole", "drug", "119-130"]}
{"TEXT1": "inhibitors cytochrome P450 3A4 enzyme system @DRUG$ @DRUG$ macrolide antibiotics erythromycin alter oxybutynin mean pharmacokinetic parameters Cmax", "LBL": "0", "ID": "DDI-DrugBank.d784.s4.p0", "DRUGA": ["antimycotic agents", "group", "67-84"], "DRUGB": ["itraconazole", "drug", "93-104"]}
{"TEXT1": "inhibitors cytochrome P450 3A4 enzyme system @DRUG$ itraconazole macrolide antibiotics erythromycin alter oxybutynin mean pharmacokinetic parameters Cmax", "LBL": "0", "ID": "DDI-DrugBank.d784.s4.p1", "DRUGA": ["antimycotic agents", "group", "67-84"], "DRUGB": ["miconazole", "drug", "110-119"]}
{"TEXT1": "inhibitors cytochrome P450 3A4 enzyme system @DRUG$ itraconazole @DRUG$ erythromycin alter oxybutynin mean pharmacokinetic parameters Cmax", "LBL": "0", "ID": "DDI-DrugBank.d784.s4.p2", "DRUGA": ["antimycotic agents", "group", "67-84"], "DRUGB": ["macrolide antibiotics", "group", "125-145"]}
{"TEXT1": "inhibitors cytochrome P450 3A4 enzyme system @DRUG$ itraconazole macrolide antibiotics @DRUG$ alter oxybutynin mean pharmacokinetic parameters Cmax", "LBL": "0", "ID": "DDI-DrugBank.d784.s4.p3", "DRUGA": ["antimycotic agents", "group", "67-84"], "DRUGB": ["erythromycin", "drug", "154-165"]}
{"TEXT1": "inhibitors cytochrome P450 3A4 enzyme system @DRUG$ itraconazole macrolide antibiotics erythromycin alter oxybutynin mean pharmacokinetic parameters Cmax", "LBL": "0", "ID": "DDI-DrugBank.d784.s4.p4", "DRUGA": ["antimycotic agents", "group", "67-84"], "DRUGB": ["clarithromycin", "drug", "171-184"]}
{"TEXT1": "inhibitors cytochrome P450 3A4 enzyme system @DRUG$ itraconazole macrolide antibiotics erythromycin alter @DRUG$ mean pharmacokinetic parameters Cmax", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d784.s4.p5", "DRUGA": ["antimycotic agents", "group", "67-84"], "DRUGB": ["oxybutynin", "drug", "198-207"]}
{"TEXT1": "inhibitors cytochrome P450 3A4 enzyme system agents @DRUG$ macrolide antibiotics erythromycin alter oxybutynin mean pharmacokinetic parameters Cmax", "LBL": "0", "ID": "DDI-DrugBank.d784.s4.p6", "DRUGA": ["itraconazole", "drug", "93-104"], "DRUGB": ["miconazole", "drug", "110-119"]}
{"TEXT1": "inhibitors cytochrome P450 3A4 enzyme system agents @DRUG$ @DRUG$ erythromycin alter oxybutynin mean pharmacokinetic parameters Cmax", "LBL": "0", "ID": "DDI-DrugBank.d784.s4.p7", "DRUGA": ["itraconazole", "drug", "93-104"], "DRUGB": ["macrolide antibiotics", "group", "125-145"]}
{"TEXT1": "inhibitors cytochrome P450 3A4 enzyme system agents @DRUG$ macrolide antibiotics @DRUG$ alter oxybutynin mean pharmacokinetic parameters Cmax", "LBL": "0", "ID": "DDI-DrugBank.d784.s4.p8", "DRUGA": ["itraconazole", "drug", "93-104"], "DRUGB": ["erythromycin", "drug", "154-165"]}
{"TEXT1": "inhibitors cytochrome P450 3A4 enzyme system agents @DRUG$ macrolide antibiotics erythromycin alter oxybutynin mean pharmacokinetic parameters Cmax", "LBL": "0", "ID": "DDI-DrugBank.d784.s4.p9", "DRUGA": ["itraconazole", "drug", "93-104"], "DRUGB": ["clarithromycin", "drug", "171-184"]}
{"TEXT1": "inhibitors cytochrome P450 3A4 enzyme system agents @DRUG$ macrolide antibiotics erythromycin alter @DRUG$ mean pharmacokinetic parameters Cmax", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d784.s4.p10", "DRUGA": ["itraconazole", "drug", "93-104"], "DRUGB": ["oxybutynin", "drug", "198-207"]}
{"TEXT1": "inhibitors cytochrome P450 3A4 enzyme system agents itraconazole @DRUG$ erythromycin alter oxybutynin mean pharmacokinetic parameters Cmax", "LBL": "0", "ID": "DDI-DrugBank.d784.s4.p11", "DRUGA": ["miconazole", "drug", "110-119"], "DRUGB": ["macrolide antibiotics", "group", "125-145"]}
{"TEXT1": "inhibitors cytochrome P450 3A4 enzyme system agents itraconazole macrolide antibiotics @DRUG$ alter oxybutynin mean pharmacokinetic parameters Cmax", "LBL": "0", "ID": "DDI-DrugBank.d784.s4.p12", "DRUGA": ["miconazole", "drug", "110-119"], "DRUGB": ["erythromycin", "drug", "154-165"]}
{"TEXT1": "inhibitors cytochrome P450 3A4 enzyme system agents itraconazole macrolide antibiotics erythromycin alter oxybutynin mean pharmacokinetic parameters Cmax", "LBL": "0", "ID": "DDI-DrugBank.d784.s4.p13", "DRUGA": ["miconazole", "drug", "110-119"], "DRUGB": ["clarithromycin", "drug", "171-184"]}
{"TEXT1": "inhibitors cytochrome P450 3A4 enzyme system agents itraconazole macrolide antibiotics erythromycin alter @DRUG$ mean pharmacokinetic parameters Cmax", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d784.s4.p14", "DRUGA": ["miconazole", "drug", "110-119"], "DRUGB": ["oxybutynin", "drug", "198-207"]}
{"TEXT1": "inhibitors cytochrome P450 3A4 enzyme system agents itraconazole @DRUG$ @DRUG$ alter oxybutynin mean pharmacokinetic parameters Cmax", "LBL": "0", "ID": "DDI-DrugBank.d784.s4.p15", "DRUGA": ["macrolide antibiotics", "group", "125-145"], "DRUGB": ["erythromycin", "drug", "154-165"]}
{"TEXT1": "inhibitors cytochrome P450 3A4 enzyme system agents itraconazole @DRUG$ erythromycin alter oxybutynin mean pharmacokinetic parameters Cmax", "LBL": "0", "ID": "DDI-DrugBank.d784.s4.p16", "DRUGA": ["macrolide antibiotics", "group", "125-145"], "DRUGB": ["clarithromycin", "drug", "171-184"]}
{"TEXT1": "inhibitors cytochrome P450 3A4 enzyme system agents itraconazole @DRUG$ erythromycin alter @DRUG$ mean pharmacokinetic parameters Cmax", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d784.s4.p17", "DRUGA": ["macrolide antibiotics", "group", "125-145"], "DRUGB": ["oxybutynin", "drug", "198-207"]}
{"TEXT1": "inhibitors cytochrome P450 3A4 enzyme system agents itraconazole macrolide antibiotics @DRUG$ alter oxybutynin mean pharmacokinetic parameters Cmax", "LBL": "0", "ID": "DDI-DrugBank.d784.s4.p18", "DRUGA": ["erythromycin", "drug", "154-165"], "DRUGB": ["clarithromycin", "drug", "171-184"]}
{"TEXT1": "inhibitors cytochrome P450 3A4 enzyme system agents itraconazole macrolide antibiotics @DRUG$ alter @DRUG$ mean pharmacokinetic parameters Cmax", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d784.s4.p19", "DRUGA": ["erythromycin", "drug", "154-165"], "DRUGB": ["oxybutynin", "drug", "198-207"]}
{"TEXT1": "inhibitors cytochrome P450 3A4 enzyme system agents itraconazole macrolide antibiotics erythromycin alter @DRUG$ mean pharmacokinetic parameters Cmax", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d784.s4.p20", "DRUGA": ["clarithromycin", "drug", "171-184"], "DRUGB": ["oxybutynin", "drug", "198-207"]}
{"TEXT1": "Concurrent ingestion @DRUG$ mL @DRUG$ containing not affect exposure oxybutynin desethyloxybutynin", "LBL": "0", "ID": "DDI-DrugBank.d784.s7.p0", "DRUGA": ["antacid", "group", "24-30"], "DRUGB": ["antacid", "group", "42-48"]}
{"TEXT1": "Concurrent ingestion @DRUG$ mL antacid containing @DRUG$ magnesium hydroxide not affect exposure oxybutynin desethyloxybutynin", "LBL": "0", "ID": "DDI-DrugBank.d784.s7.p1", "DRUGA": ["antacid", "group", "24-30"], "DRUGB": ["aluminum hydroxide", "drug", "61-78"]}
{"TEXT1": "Concurrent ingestion @DRUG$ mL antacid aluminum hydroxide containing @DRUG$ not affect exposure oxybutynin desethyloxybutynin", "LBL": "0", "ID": "DDI-DrugBank.d784.s7.p2", "DRUGA": ["antacid", "group", "24-30"], "DRUGB": ["magnesium hydroxide", "drug", "81-99"]}
{"TEXT1": "Concurrent ingestion @DRUG$ mL antacid aluminum hydroxide containing not affect exposure oxybutynin desethyloxybutynin", "LBL": "0", "ID": "DDI-DrugBank.d784.s7.p3", "DRUGA": ["antacid", "group", "24-30"], "DRUGB": ["simethicone", "drug", "106-116"]}
{"TEXT1": "Concurrent ingestion @DRUG$ mL antacid aluminum hydroxide containing not affect exposure @DRUG$ desethyloxybutynin", "LBL": "0", "ID": "DDI-DrugBank.d784.s7.p4", "DRUGA": ["antacid", "group", "24-30"], "DRUGB": ["oxybutynin", "drug", "164-173"]}
{"TEXT1": "Concurrent ingestion @DRUG$ mL antacid aluminum hydroxide containing not affect exposure oxybutynin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d784.s7.p5", "DRUGA": ["antacid", "group", "24-30"], "DRUGB": ["desethyloxybutynin", "drug_n", "178-195"]}
{"TEXT1": "Concurrent ingestion antacid mL @DRUG$ containing @DRUG$ magnesium hydroxide not affect exposure oxybutynin desethyloxybutynin", "LBL": "0", "ID": "DDI-DrugBank.d784.s7.p6", "DRUGA": ["antacid", "group", "42-48"], "DRUGB": ["aluminum hydroxide", "drug", "61-78"]}
{"TEXT1": "Concurrent ingestion antacid mL @DRUG$ containing @DRUG$ not affect exposure oxybutynin desethyloxybutynin", "LBL": "0", "ID": "DDI-DrugBank.d784.s7.p7", "DRUGA": ["antacid", "group", "42-48"], "DRUGB": ["magnesium hydroxide", "drug", "81-99"]}
{"TEXT1": "Concurrent ingestion antacid mL @DRUG$ containing not affect exposure oxybutynin desethyloxybutynin", "LBL": "0", "ID": "DDI-DrugBank.d784.s7.p8", "DRUGA": ["antacid", "group", "42-48"], "DRUGB": ["simethicone", "drug", "106-116"]}
{"TEXT1": "Concurrent ingestion antacid mL @DRUG$ containing not affect exposure @DRUG$ desethyloxybutynin", "LBL": "0", "ID": "DDI-DrugBank.d784.s7.p9", "DRUGA": ["antacid", "group", "42-48"], "DRUGB": ["oxybutynin", "drug", "164-173"]}
{"TEXT1": "Concurrent ingestion antacid mL @DRUG$ containing not affect exposure oxybutynin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d784.s7.p10", "DRUGA": ["antacid", "group", "42-48"], "DRUGB": ["desethyloxybutynin", "drug_n", "178-195"]}
{"TEXT1": "Concurrent ingestion antacid mL containing @DRUG$ @DRUG$ not affect exposure oxybutynin desethyloxybutynin", "LBL": "0", "ID": "DDI-DrugBank.d784.s7.p11", "DRUGA": ["aluminum hydroxide", "drug", "61-78"], "DRUGB": ["magnesium hydroxide", "drug", "81-99"]}
{"TEXT1": "Concurrent ingestion antacid mL containing @DRUG$ magnesium hydroxide not affect exposure oxybutynin desethyloxybutynin", "LBL": "0", "ID": "DDI-DrugBank.d784.s7.p12", "DRUGA": ["aluminum hydroxide", "drug", "61-78"], "DRUGB": ["simethicone", "drug", "106-116"]}
{"TEXT1": "Concurrent ingestion antacid mL containing @DRUG$ magnesium hydroxide not affect exposure @DRUG$ desethyloxybutynin", "LBL": "0", "ID": "DDI-DrugBank.d784.s7.p13", "DRUGA": ["aluminum hydroxide", "drug", "61-78"], "DRUGB": ["oxybutynin", "drug", "164-173"]}
{"TEXT1": "Concurrent ingestion antacid mL containing @DRUG$ magnesium hydroxide not affect exposure oxybutynin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d784.s7.p14", "DRUGA": ["aluminum hydroxide", "drug", "61-78"], "DRUGB": ["desethyloxybutynin", "drug_n", "178-195"]}
{"TEXT1": "Concurrent ingestion antacid mL containing @DRUG$ not affect exposure oxybutynin desethyloxybutynin", "LBL": "0", "ID": "DDI-DrugBank.d784.s7.p15", "DRUGA": ["magnesium hydroxide", "drug", "81-99"], "DRUGB": ["simethicone", "drug", "106-116"]}
{"TEXT1": "Concurrent ingestion antacid mL containing @DRUG$ not affect exposure @DRUG$ desethyloxybutynin", "LBL": "0", "ID": "DDI-DrugBank.d784.s7.p16", "DRUGA": ["magnesium hydroxide", "drug", "81-99"], "DRUGB": ["oxybutynin", "drug", "164-173"]}
{"TEXT1": "Concurrent ingestion antacid mL containing @DRUG$ not affect exposure oxybutynin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d784.s7.p17", "DRUGA": ["magnesium hydroxide", "drug", "81-99"], "DRUGB": ["desethyloxybutynin", "drug_n", "178-195"]}
{"TEXT1": "Concurrent ingestion antacid mL containing not affect exposure @DRUG$ desethyloxybutynin", "LBL": "0", "ID": "DDI-DrugBank.d784.s7.p18", "DRUGA": ["simethicone", "drug", "106-116"], "DRUGB": ["oxybutynin", "drug", "164-173"]}
{"TEXT1": "Concurrent ingestion antacid mL containing not affect exposure oxybutynin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d784.s7.p19", "DRUGA": ["simethicone", "drug", "106-116"], "DRUGB": ["desethyloxybutynin", "drug_n", "178-195"]}
{"TEXT1": "Concurrent ingestion antacid mL containing not affect exposure @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d784.s7.p20", "DRUGA": ["oxybutynin", "drug", "164-173"], "DRUGB": ["desethyloxybutynin", "drug_n", "178-195"]}
{"TEXT1": "@DRUG$ reported to accelerate metabolism @DRUG$ mechanism hepatic enzyme microsomal enzyme induction leading increase dosage requirements warfarin", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d717.s0.p0", "DRUGA": ["Mitotane", "drug", "0-7"], "DRUGB": ["warfarin", "drug", "59-66"]}
{"TEXT1": "@DRUG$ reported to accelerate metabolism warfarin mechanism hepatic enzyme microsomal enzyme induction leading increase dosage requirements @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d717.s0.p1", "DRUGA": ["Mitotane", "drug", "0-7"], "DRUGB": ["warfarin", "drug", "175-182"]}
{"TEXT1": "Mitotane reported to accelerate metabolism @DRUG$ mechanism hepatic enzyme microsomal enzyme induction leading increase dosage requirements @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d717.s0.p2", "DRUGA": ["warfarin", "drug", "59-66"], "DRUGB": ["warfarin", "drug", "175-182"]}
{"TEXT1": "physicians monitor patients change @DRUG$ dosage requirements administering @DRUG$ coumarin anticoagulants type", "LBL": "0", "ID": "DDI-DrugBank.d717.s1.p0", "DRUGA": ["anticoagulant", "group", "70-82"], "DRUGB": ["Mitotane", "drug", "123-130"]}
{"TEXT1": "physicians monitor patients change @DRUG$ dosage requirements administering Mitotane @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d717.s1.p1", "DRUGA": ["anticoagulant", "group", "70-82"], "DRUGB": ["coumarin-type anticoagulants", "group", "147-174"]}
{"TEXT1": "physicians monitor patients change anticoagulant dosage requirements administering @DRUG$ @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d717.s1.p2", "DRUGA": ["Mitotane", "drug", "123-130"], "DRUGB": ["coumarin-type anticoagulants", "group", "147-174"]}
{"TEXT1": "Concomitant administration @DRUG$ @DRUG$ associated with erythema histamine flushing anaphylactoid reactions", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d669.s0.p0", "DRUGA": ["vancomycin", "drug", "30-39"], "DRUGB": ["anesthetic agents", "group", "45-61"]}
{"TEXT1": "Concurrent sequential systemic topical use of neurotoxic nephrotoxic drugs @DRUG$ @DRUG$ bacitracin polymyxin B colistin viomycin cisplatin indicated careful monitoring", "LBL": "0", "ID": "DDI-DrugBank.d669.s1.p0", "DRUGA": ["amphotericin B", "drug", "119-132"], "DRUGB": ["aminoglycosides", "group", "135-149"]}
{"TEXT1": "Concurrent sequential systemic topical use of neurotoxic nephrotoxic drugs @DRUG$ aminoglycosides @DRUG$ polymyxin B colistin viomycin cisplatin indicated careful monitoring", "LBL": "0", "ID": "DDI-DrugBank.d669.s1.p1", "DRUGA": ["amphotericin B", "drug", "119-132"], "DRUGB": ["bacitracin", "drug", "152-161"]}
{"TEXT1": "Concurrent sequential systemic topical use of neurotoxic nephrotoxic drugs @DRUG$ aminoglycosides bacitracin @DRUG$ colistin viomycin cisplatin indicated careful monitoring", "LBL": "0", "ID": "DDI-DrugBank.d669.s1.p2", "DRUGA": ["amphotericin B", "drug", "119-132"], "DRUGB": ["polymyxin B", "drug", "164-174"]}
{"TEXT1": "Concurrent sequential systemic topical use of neurotoxic nephrotoxic drugs @DRUG$ aminoglycosides bacitracin polymyxin B @DRUG$ viomycin cisplatin indicated careful monitoring", "LBL": "0", "ID": "DDI-DrugBank.d669.s1.p3", "DRUGA": ["amphotericin B", "drug", "119-132"], "DRUGB": ["colistin", "drug", "177-184"]}
{"TEXT1": "Concurrent sequential systemic topical use of neurotoxic nephrotoxic drugs @DRUG$ aminoglycosides bacitracin polymyxin B colistin @DRUG$ cisplatin indicated careful monitoring", "LBL": "0", "ID": "DDI-DrugBank.d669.s1.p4", "DRUGA": ["amphotericin B", "drug", "119-132"], "DRUGB": ["viomycin", "drug", "187-194"]}
{"TEXT1": "Concurrent sequential systemic topical use of neurotoxic nephrotoxic drugs @DRUG$ aminoglycosides bacitracin polymyxin B colistin viomycin @DRUG$ indicated careful monitoring", "LBL": "0", "ID": "DDI-DrugBank.d669.s1.p5", "DRUGA": ["amphotericin B", "drug", "119-132"], "DRUGB": ["cisplatin", "drug", "200-208"]}
{"TEXT1": "Concurrent sequential systemic topical use of neurotoxic nephrotoxic drugs amphotericin B @DRUG$ @DRUG$ colistin viomycin cisplatin indicated careful monitoring", "LBL": "0", "ID": "DDI-DrugBank.d669.s1.p6", "DRUGA": ["aminoglycosides", "group", "135-149"], "DRUGB": ["bacitracin", "drug", "152-161"]}
{"TEXT1": "Concurrent sequential systemic topical use of neurotoxic nephrotoxic drugs amphotericin B @DRUG$ bacitracin @DRUG$ colistin viomycin cisplatin indicated careful monitoring", "LBL": "0", "ID": "DDI-DrugBank.d669.s1.p7", "DRUGA": ["aminoglycosides", "group", "135-149"], "DRUGB": ["polymyxin B", "drug", "164-174"]}
{"TEXT1": "Concurrent sequential systemic topical use of neurotoxic nephrotoxic drugs amphotericin B @DRUG$ bacitracin @DRUG$ viomycin cisplatin indicated careful monitoring", "LBL": "0", "ID": "DDI-DrugBank.d669.s1.p8", "DRUGA": ["aminoglycosides", "group", "135-149"], "DRUGB": ["colistin", "drug", "177-184"]}
{"TEXT1": "Concurrent sequential systemic topical use of neurotoxic nephrotoxic drugs amphotericin B @DRUG$ bacitracin colistin @DRUG$ cisplatin indicated careful monitoring", "LBL": "0", "ID": "DDI-DrugBank.d669.s1.p9", "DRUGA": ["aminoglycosides", "group", "135-149"], "DRUGB": ["viomycin", "drug", "187-194"]}
{"TEXT1": "Concurrent sequential systemic topical use of neurotoxic nephrotoxic drugs amphotericin B @DRUG$ bacitracin colistin viomycin @DRUG$ indicated careful monitoring", "LBL": "0", "ID": "DDI-DrugBank.d669.s1.p10", "DRUGA": ["aminoglycosides", "group", "135-149"], "DRUGB": ["cisplatin", "drug", "200-208"]}
{"TEXT1": "Concurrent sequential systemic topical use of neurotoxic nephrotoxic drugs amphotericin B aminoglycosides @DRUG$ @DRUG$ colistin viomycin cisplatin indicated careful monitoring", "LBL": "0", "ID": "DDI-DrugBank.d669.s1.p11", "DRUGA": ["bacitracin", "drug", "152-161"], "DRUGB": ["polymyxin B", "drug", "164-174"]}
{"TEXT1": "Concurrent sequential systemic topical use of neurotoxic nephrotoxic drugs amphotericin B aminoglycosides @DRUG$ @DRUG$ viomycin cisplatin indicated careful monitoring", "LBL": "0", "ID": "DDI-DrugBank.d669.s1.p12", "DRUGA": ["bacitracin", "drug", "152-161"], "DRUGB": ["colistin", "drug", "177-184"]}
{"TEXT1": "Concurrent sequential systemic topical use of neurotoxic nephrotoxic drugs amphotericin B aminoglycosides @DRUG$ colistin @DRUG$ cisplatin indicated careful monitoring", "LBL": "0", "ID": "DDI-DrugBank.d669.s1.p13", "DRUGA": ["bacitracin", "drug", "152-161"], "DRUGB": ["viomycin", "drug", "187-194"]}
{"TEXT1": "Concurrent sequential systemic topical use of neurotoxic nephrotoxic drugs amphotericin B aminoglycosides @DRUG$ colistin viomycin @DRUG$ indicated careful monitoring", "LBL": "0", "ID": "DDI-DrugBank.d669.s1.p14", "DRUGA": ["bacitracin", "drug", "152-161"], "DRUGB": ["cisplatin", "drug", "200-208"]}
{"TEXT1": "Concurrent sequential systemic topical use of neurotoxic nephrotoxic drugs amphotericin B aminoglycosides bacitracin @DRUG$ @DRUG$ viomycin cisplatin indicated careful monitoring", "LBL": "0", "ID": "DDI-DrugBank.d669.s1.p15", "DRUGA": ["polymyxin B", "drug", "164-174"], "DRUGB": ["colistin", "drug", "177-184"]}
{"TEXT1": "Concurrent sequential systemic topical use of neurotoxic nephrotoxic drugs amphotericin B aminoglycosides bacitracin @DRUG$ colistin @DRUG$ cisplatin indicated careful monitoring", "LBL": "0", "ID": "DDI-DrugBank.d669.s1.p16", "DRUGA": ["polymyxin B", "drug", "164-174"], "DRUGB": ["viomycin", "drug", "187-194"]}
{"TEXT1": "Concurrent sequential systemic topical use of neurotoxic nephrotoxic drugs amphotericin B aminoglycosides bacitracin @DRUG$ colistin viomycin @DRUG$ indicated careful monitoring", "LBL": "0", "ID": "DDI-DrugBank.d669.s1.p17", "DRUGA": ["polymyxin B", "drug", "164-174"], "DRUGB": ["cisplatin", "drug", "200-208"]}
{"TEXT1": "Concurrent sequential systemic topical use of neurotoxic nephrotoxic drugs amphotericin B aminoglycosides bacitracin @DRUG$ @DRUG$ cisplatin indicated careful monitoring", "LBL": "0", "ID": "DDI-DrugBank.d669.s1.p18", "DRUGA": ["colistin", "drug", "177-184"], "DRUGB": ["viomycin", "drug", "187-194"]}
{"TEXT1": "Concurrent sequential systemic topical use of neurotoxic nephrotoxic drugs amphotericin B aminoglycosides bacitracin @DRUG$ viomycin @DRUG$ indicated careful monitoring", "LBL": "0", "ID": "DDI-DrugBank.d669.s1.p19", "DRUGA": ["colistin", "drug", "177-184"], "DRUGB": ["cisplatin", "drug", "200-208"]}
{"TEXT1": "Concurrent sequential systemic topical use of neurotoxic nephrotoxic drugs amphotericin B aminoglycosides bacitracin colistin @DRUG$ @DRUG$ indicated careful monitoring", "LBL": "0", "ID": "DDI-DrugBank.d669.s1.p20", "DRUGA": ["viomycin", "drug", "187-194"], "DRUGB": ["cisplatin", "drug", "200-208"]}
{"TEXT1": "Coadministration @DRUG$ @DRUG$ resulted increased plasma concentrations ranitidine bismuth trough 14 hydroxy clarithromycin", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d590.s0.p0", "DRUGA": ["TRITEC", "brand", "20-25"], "DRUGB": ["clarithromycin", "drug", "32-45"]}
{"TEXT1": "Coadministration @DRUG$ clarithromycin resulted increased plasma concentrations @DRUG$ bismuth trough", "LBL": "0", "ID": "DDI-DrugBank.d590.s0.p1", "DRUGA": ["TRITEC", "brand", "20-25"], "DRUGB": ["ranitidine", "drug", "76-85"]}
{"TEXT1": "Coadministration @DRUG$ clarithromycin resulted increased plasma concentrations ranitidine bismuth trough @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d590.s0.p2", "DRUGA": ["TRITEC", "brand", "20-25"], "DRUGB": ["14- hydroxy- clarithromycin", "drug_n", "177-203"]}
{"TEXT1": "Coadministration TRITEC @DRUG$ resulted increased plasma concentrations @DRUG$ bismuth trough 14 hydroxy clarithromycin", "LBL": "0", "ID": "DDI-DrugBank.d590.s0.p3", "DRUGA": ["clarithromycin", "drug", "32-45"], "DRUGB": ["ranitidine", "drug", "76-85"]}
{"TEXT1": "Coadministration TRITEC @DRUG$ resulted increased plasma concentrations ranitidine bismuth trough @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d590.s0.p4", "DRUGA": ["clarithromycin", "drug", "32-45"], "DRUGB": ["14- hydroxy- clarithromycin", "drug_n", "177-203"]}
{"TEXT1": "Coadministration TRITEC clarithromycin resulted increased plasma concentrations @DRUG$ bismuth trough @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d590.s0.p5", "DRUGA": ["ranitidine", "drug", "76-85"], "DRUGB": ["14- hydroxy- clarithromycin", "drug_n", "177-203"]}
{"TEXT1": "Coadministration @DRUG$ results slight decrease rate @DRUG$ absorption", "LBL": "0", "ID": "DDI-DrugBank.d590.s1.p0", "DRUGA": ["aspirin", "brand", "22-28"], "DRUGB": ["salicylate", "group", "74-83"]}
{"TEXT1": "Coadministration high dose @DRUG$ results decrease plasma concentrations @DRUG$ bismuth TRITEC", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d590.s2.p0", "DRUGA": ["antacid", "group", "37-43"], "DRUGB": ["ranitidine", "drug", "109-118"]}
{"TEXT1": "Coadministration high dose @DRUG$ results decrease plasma concentrations ranitidine bismuth @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d590.s2.p1", "DRUGA": ["antacid", "group", "37-43"], "DRUGB": ["TRITEC", "brand", "175-180"]}
{"TEXT1": "Coadministration high dose antacid results decrease plasma concentrations @DRUG$ bismuth @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d590.s2.p2", "DRUGA": ["ranitidine", "drug", "109-118"], "DRUGB": ["TRITEC", "brand", "175-180"]}
{"TEXT1": "information drug interactions associated with @DRUG$ refer @DRUG$ package insert", "LBL": "0", "ID": "DDI-DrugBank.d590.s4.p0", "DRUGA": ["ranitidine", "drug", "53-62"], "DRUGB": ["ZANTAC", "brand", "78-83"]}
{"TEXT1": "include @DRUG$ @DRUG$ oral inhaled steroids", "LBL": "0", "ID": "DDI-DrugBank.d702.s1.p0", "DRUGA": ["sympathomimetic bronchodilators", "group", "14-44"], "DRUGB": ["methylxanthines", "group", "47-61"]}
{"TEXT1": "include @DRUG$ methylxanthines oral inhaled @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d702.s1.p1", "DRUGA": ["sympathomimetic bronchodilators", "group", "14-44"], "DRUGB": ["steroids", "group", "85-92"]}
{"TEXT1": "include sympathomimetic bronchodilators @DRUG$ oral inhaled @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d702.s1.p2", "DRUGA": ["methylxanthines", "group", "47-61"], "DRUGB": ["steroids", "group", "85-92"]}
{"TEXT1": "co administration @DRUG$ @DRUG$ containing not studied recommended", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d702.s2.p0", "DRUGA": ["SPIRIVA", "brand", "36-42"], "DRUGB": ["anticholinergic", "group", "55-69"]}
{"TEXT1": "co administration @DRUG$ anticholinergic drugs containing not studied recommended", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d702.s2.p1", "DRUGA": ["SPIRIVA", "brand", "36-42"], "DRUGB": ["ipratropium", "drug", "97-107"]}
{"TEXT1": "co administration SPIRIVA @DRUG$ containing not studied recommended", "LBL": "0", "ID": "DDI-DrugBank.d702.s2.p2", "DRUGA": ["anticholinergic", "group", "55-69"], "DRUGB": ["ipratropium", "drug", "97-107"]}
{"TEXT1": "Prothrombin time suitable anticoagulation test monitored @DRUG$ administered @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d642.s0.p0", "DRUGA": ["tigecycline", "drug", "79-89"], "DRUGB": ["warfarin", "drug", "112-119"]}
{"TEXT1": "Concurrent use of @DRUG$ @DRUG$ less effective", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d642.s1.p0", "DRUGA": ["antibacterial drugs", "group", "18-36"], "DRUGB": ["contraceptives", "group", "48-61"]}
{"TEXT1": "Concurrent use of @DRUG$ oral contraceptives @DRUG$ less effective", "LBL": "0", "ID": "DDI-DrugBank.d642.s1.p1", "DRUGA": ["antibacterial drugs", "group", "18-36"], "DRUGB": ["contraceptives", "group", "79-92"]}
{"TEXT1": "Concurrent use of antibacterial drugs @DRUG$ @DRUG$ less effective", "LBL": "0", "ID": "DDI-DrugBank.d642.s1.p2", "DRUGA": ["contraceptives", "group", "48-61"], "DRUGB": ["contraceptives", "group", "79-92"]}
{"TEXT1": "@DRUG$ enhance sedative effects @DRUG$ including alcohol barbiturates hypnotics narcotic analgesics sedatives tranquillisers", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d615.s0.p0", "DRUGA": ["Triprolidine", "drug", "0-11"], "DRUGB": ["central nervous system depressants", "group", "49-82"]}
{"TEXT1": "@DRUG$ enhance sedative effects central nervous system depressants including @DRUG$ barbiturates hypnotics narcotic analgesics sedatives tranquillisers", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d615.s0.p1", "DRUGA": ["Triprolidine", "drug", "0-11"], "DRUGB": ["alcohol", "drug", "94-100"]}
{"TEXT1": "@DRUG$ enhance sedative effects central nervous system depressants including alcohol @DRUG$ hypnotics narcotic analgesics sedatives tranquillisers", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d615.s0.p2", "DRUGA": ["Triprolidine", "drug", "0-11"], "DRUGB": ["barbiturates", "group", "103-114"]}
{"TEXT1": "@DRUG$ enhance sedative effects central nervous system depressants including alcohol barbiturates @DRUG$ narcotic analgesics sedatives tranquillisers", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d615.s0.p3", "DRUGA": ["Triprolidine", "drug", "0-11"], "DRUGB": ["hypnotics", "group", "117-125"]}
{"TEXT1": "@DRUG$ enhance sedative effects central nervous system depressants including alcohol barbiturates hypnotics @DRUG$ sedatives tranquillisers", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d615.s0.p4", "DRUGA": ["Triprolidine", "drug", "0-11"], "DRUGB": ["narcotic analgesics", "group", "128-146"]}
{"TEXT1": "@DRUG$ enhance sedative effects central nervous system depressants including alcohol barbiturates hypnotics narcotic analgesics @DRUG$ tranquillisers", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d615.s0.p5", "DRUGA": ["Triprolidine", "drug", "0-11"], "DRUGB": ["sedatives", "group", "149-157"]}
{"TEXT1": "@DRUG$ enhance sedative effects central nervous system depressants including alcohol barbiturates hypnotics narcotic analgesics sedatives @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d615.s0.p6", "DRUGA": ["Triprolidine", "drug", "0-11"], "DRUGB": ["tranquillisers", "group", "164-177"]}
{"TEXT1": "Triprolidine enhance sedative effects @DRUG$ including @DRUG$ barbiturates hypnotics narcotic analgesics sedatives tranquillisers", "LBL": "0", "ID": "DDI-DrugBank.d615.s0.p7", "DRUGA": ["central nervous system depressants", "group", "49-82"], "DRUGB": ["alcohol", "drug", "94-100"]}
{"TEXT1": "Triprolidine enhance sedative effects @DRUG$ including alcohol @DRUG$ hypnotics narcotic analgesics sedatives tranquillisers", "LBL": "0", "ID": "DDI-DrugBank.d615.s0.p8", "DRUGA": ["central nervous system depressants", "group", "49-82"], "DRUGB": ["barbiturates", "group", "103-114"]}
{"TEXT1": "Triprolidine enhance sedative effects @DRUG$ including alcohol barbiturates @DRUG$ narcotic analgesics sedatives tranquillisers", "LBL": "0", "ID": "DDI-DrugBank.d615.s0.p9", "DRUGA": ["central nervous system depressants", "group", "49-82"], "DRUGB": ["hypnotics", "group", "117-125"]}
{"TEXT1": "Triprolidine enhance sedative effects @DRUG$ including alcohol barbiturates hypnotics @DRUG$ sedatives tranquillisers", "LBL": "0", "ID": "DDI-DrugBank.d615.s0.p10", "DRUGA": ["central nervous system depressants", "group", "49-82"], "DRUGB": ["narcotic analgesics", "group", "128-146"]}
{"TEXT1": "Triprolidine enhance sedative effects @DRUG$ including alcohol barbiturates hypnotics narcotic analgesics @DRUG$ tranquillisers", "LBL": "0", "ID": "DDI-DrugBank.d615.s0.p11", "DRUGA": ["central nervous system depressants", "group", "49-82"], "DRUGB": ["sedatives", "group", "149-157"]}
{"TEXT1": "Triprolidine enhance sedative effects @DRUG$ including alcohol barbiturates hypnotics narcotic analgesics sedatives @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d615.s0.p12", "DRUGA": ["central nervous system depressants", "group", "49-82"], "DRUGB": ["tranquillisers", "group", "164-177"]}
{"TEXT1": "Triprolidine enhance sedative effects central nervous system depressants including @DRUG$ @DRUG$ hypnotics narcotic analgesics sedatives tranquillisers", "LBL": "0", "ID": "DDI-DrugBank.d615.s0.p13", "DRUGA": ["alcohol", "drug", "94-100"], "DRUGB": ["barbiturates", "group", "103-114"]}
{"TEXT1": "Triprolidine enhance sedative effects central nervous system depressants including @DRUG$ barbiturates @DRUG$ narcotic analgesics sedatives tranquillisers", "LBL": "0", "ID": "DDI-DrugBank.d615.s0.p14", "DRUGA": ["alcohol", "drug", "94-100"], "DRUGB": ["hypnotics", "group", "117-125"]}
{"TEXT1": "Triprolidine enhance sedative effects central nervous system depressants including @DRUG$ barbiturates hypnotics @DRUG$ sedatives tranquillisers", "LBL": "0", "ID": "DDI-DrugBank.d615.s0.p15", "DRUGA": ["alcohol", "drug", "94-100"], "DRUGB": ["narcotic analgesics", "group", "128-146"]}
{"TEXT1": "Triprolidine enhance sedative effects central nervous system depressants including @DRUG$ barbiturates hypnotics narcotic analgesics @DRUG$ tranquillisers", "LBL": "0", "ID": "DDI-DrugBank.d615.s0.p16", "DRUGA": ["alcohol", "drug", "94-100"], "DRUGB": ["sedatives", "group", "149-157"]}
{"TEXT1": "Triprolidine enhance sedative effects central nervous system depressants including @DRUG$ barbiturates hypnotics narcotic analgesics sedatives @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d615.s0.p17", "DRUGA": ["alcohol", "drug", "94-100"], "DRUGB": ["tranquillisers", "group", "164-177"]}
{"TEXT1": "Triprolidine enhance sedative effects central nervous system depressants including alcohol @DRUG$ @DRUG$ narcotic analgesics sedatives tranquillisers", "LBL": "0", "ID": "DDI-DrugBank.d615.s0.p18", "DRUGA": ["barbiturates", "group", "103-114"], "DRUGB": ["hypnotics", "group", "117-125"]}
{"TEXT1": "Triprolidine enhance sedative effects central nervous system depressants including alcohol @DRUG$ hypnotics @DRUG$ sedatives tranquillisers", "LBL": "0", "ID": "DDI-DrugBank.d615.s0.p19", "DRUGA": ["barbiturates", "group", "103-114"], "DRUGB": ["narcotic analgesics", "group", "128-146"]}
{"TEXT1": "Triprolidine enhance sedative effects central nervous system depressants including alcohol @DRUG$ hypnotics narcotic analgesics @DRUG$ tranquillisers", "LBL": "0", "ID": "DDI-DrugBank.d615.s0.p20", "DRUGA": ["barbiturates", "group", "103-114"], "DRUGB": ["sedatives", "group", "149-157"]}
{"TEXT1": "Triprolidine enhance sedative effects central nervous system depressants including alcohol @DRUG$ hypnotics narcotic analgesics sedatives @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d615.s0.p21", "DRUGA": ["barbiturates", "group", "103-114"], "DRUGB": ["tranquillisers", "group", "164-177"]}
{"TEXT1": "Triprolidine enhance sedative effects central nervous system depressants including alcohol barbiturates @DRUG$ @DRUG$ sedatives tranquillisers", "LBL": "0", "ID": "DDI-DrugBank.d615.s0.p22", "DRUGA": ["hypnotics", "group", "117-125"], "DRUGB": ["narcotic analgesics", "group", "128-146"]}
{"TEXT1": "Triprolidine enhance sedative effects central nervous system depressants including alcohol barbiturates @DRUG$ narcotic analgesics @DRUG$ tranquillisers", "LBL": "0", "ID": "DDI-DrugBank.d615.s0.p23", "DRUGA": ["hypnotics", "group", "117-125"], "DRUGB": ["sedatives", "group", "149-157"]}
{"TEXT1": "Triprolidine enhance sedative effects central nervous system depressants including alcohol barbiturates @DRUG$ narcotic analgesics sedatives @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d615.s0.p24", "DRUGA": ["hypnotics", "group", "117-125"], "DRUGB": ["tranquillisers", "group", "164-177"]}
{"TEXT1": "Triprolidine enhance sedative effects central nervous system depressants including alcohol barbiturates hypnotics @DRUG$ @DRUG$ tranquillisers", "LBL": "0", "ID": "DDI-DrugBank.d615.s0.p25", "DRUGA": ["narcotic analgesics", "group", "128-146"], "DRUGB": ["sedatives", "group", "149-157"]}
{"TEXT1": "Triprolidine enhance sedative effects central nervous system depressants including alcohol barbiturates hypnotics @DRUG$ sedatives @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d615.s0.p26", "DRUGA": ["narcotic analgesics", "group", "128-146"], "DRUGB": ["tranquillisers", "group", "164-177"]}
{"TEXT1": "Triprolidine enhance sedative effects central nervous system depressants including alcohol barbiturates hypnotics narcotic analgesics @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d615.s0.p27", "DRUGA": ["sedatives", "group", "149-157"], "DRUGB": ["tranquillisers", "group", "164-177"]}
{"TEXT1": "@DRUG$ @DRUG$ tricyclic antidepressants enhanced concomitant administration triprolidine", "LBL": "0", "ID": "DDI-DrugBank.d615.s1.p0", "DRUGA": ["anticholinergic drugs", "group", "15-35"], "DRUGB": ["atropine", "drug", "46-53"]}
{"TEXT1": "@DRUG$ atropine @DRUG$ enhanced concomitant administration triprolidine", "LBL": "0", "ID": "DDI-DrugBank.d615.s1.p1", "DRUGA": ["anticholinergic drugs", "group", "15-35"], "DRUGB": ["tricyclic antidepressants", "group", "59-83"]}
{"TEXT1": "@DRUG$ atropine tricyclic antidepressants enhanced concomitant administration @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d615.s1.p2", "DRUGA": ["anticholinergic drugs", "group", "15-35"], "DRUGB": ["triprolidine", "drug", "138-149"]}
{"TEXT1": "anticholinergic @DRUG$ @DRUG$ enhanced concomitant administration triprolidine", "LBL": "0", "ID": "DDI-DrugBank.d615.s1.p3", "DRUGA": ["atropine", "drug", "46-53"], "DRUGB": ["tricyclic antidepressants", "group", "59-83"]}
{"TEXT1": "anticholinergic @DRUG$ tricyclic antidepressants enhanced concomitant administration @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d615.s1.p4", "DRUGA": ["atropine", "drug", "46-53"], "DRUGB": ["triprolidine", "drug", "138-149"]}
{"TEXT1": "anticholinergic atropine @DRUG$ enhanced concomitant administration @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d615.s1.p5", "DRUGA": ["tricyclic antidepressants", "group", "59-83"], "DRUGB": ["triprolidine", "drug", "138-149"]}
{"TEXT1": "CYP @DRUG$ rare reports of serious adverse events connection coadministration certain ergot alkaloid drugs dihydroergotamine potent inhibitors vasospasm leading cerebral ischemia extremities", "LBL": "0", "ID": "DDI-DrugBank.d675.s0.p0", "DRUGA": ["Macrolide Antibiotics", "group", "25-45"], "DRUGB": ["Protease Inhibitors", "group", "51-69"]}
{"TEXT1": "CYP @DRUG$ rare reports of serious adverse events connection coadministration certain @DRUG$ dihydroergotamine potent inhibitors vasospasm leading cerebral ischemia extremities", "LBL": "0", "ID": "DDI-DrugBank.d675.s0.p1", "DRUGA": ["Macrolide Antibiotics", "group", "25-45"], "DRUGB": ["ergot alkaloid drugs", "group", "178-197"]}
{"TEXT1": "CYP @DRUG$ rare reports of serious adverse events connection coadministration certain ergot alkaloid drugs @DRUG$ potent inhibitors vasospasm leading cerebral ischemia extremities", "LBL": "0", "ID": "DDI-DrugBank.d675.s0.p2", "DRUGA": ["Macrolide Antibiotics", "group", "25-45"], "DRUGB": ["dihydroergotamine", "drug", "205-221"]}
{"TEXT1": "CYP @DRUG$ rare reports of serious adverse events connection coadministration certain ergot alkaloid drugs dihydroergotamine potent inhibitors vasospasm leading cerebral ischemia extremities", "LBL": "0", "ID": "DDI-DrugBank.d675.s0.p3", "DRUGA": ["Macrolide Antibiotics", "group", "25-45"], "DRUGB": ["ergotamine", "drug", "227-236"]}
{"TEXT1": "CYP Macrolide Antibiotics rare reports of serious adverse events connection coadministration certain @DRUG$ dihydroergotamine potent inhibitors vasospasm leading cerebral ischemia extremities", "LBL": "0", "ID": "DDI-DrugBank.d675.s0.p4", "DRUGA": ["Protease Inhibitors", "group", "51-69"], "DRUGB": ["ergot alkaloid drugs", "group", "178-197"]}
{"TEXT1": "CYP Macrolide Antibiotics rare reports of serious adverse events connection coadministration certain ergot alkaloid drugs @DRUG$ potent inhibitors vasospasm leading cerebral ischemia extremities", "LBL": "0", "ID": "DDI-DrugBank.d675.s0.p5", "DRUGA": ["Protease Inhibitors", "group", "51-69"], "DRUGB": ["dihydroergotamine", "drug", "205-221"]}
{"TEXT1": "CYP Macrolide Antibiotics rare reports of serious adverse events connection coadministration certain ergot alkaloid drugs dihydroergotamine potent inhibitors vasospasm leading cerebral ischemia extremities", "LBL": "0", "ID": "DDI-DrugBank.d675.s0.p6", "DRUGA": ["Protease Inhibitors", "group", "51-69"], "DRUGB": ["ergotamine", "drug", "227-236"]}
{"TEXT1": "CYP Macrolide Antibiotics rare reports of serious adverse events connection coadministration certain @DRUG$ @DRUG$ potent inhibitors vasospasm leading cerebral ischemia extremities", "LBL": "0", "ID": "DDI-DrugBank.d675.s0.p7", "DRUGA": ["ergot alkaloid drugs", "group", "178-197"], "DRUGB": ["dihydroergotamine", "drug", "205-221"]}
{"TEXT1": "CYP Macrolide Antibiotics rare reports of serious adverse events connection coadministration certain @DRUG$ dihydroergotamine potent inhibitors vasospasm leading cerebral ischemia extremities", "LBL": "0", "ID": "DDI-DrugBank.d675.s0.p8", "DRUGA": ["ergot alkaloid drugs", "group", "178-197"], "DRUGB": ["ergotamine", "drug", "227-236"]}
{"TEXT1": "CYP Macrolide Antibiotics rare reports of serious adverse events connection coadministration certain ergot alkaloid drugs @DRUG$ potent inhibitors vasospasm leading cerebral ischemia extremities", "LBL": "0", "ID": "DDI-DrugBank.d675.s0.p9", "DRUGA": ["dihydroergotamine", "drug", "205-221"], "DRUGB": ["ergotamine", "drug", "227-236"]}
{"TEXT1": "Examples potent CYP inhibitors include @DRUG$ @DRUG$ troleandomycin HIV protease ritonavir indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p0", "DRUGA": ["macrolide antibiotics", "group", "63-83"], "DRUGB": ["erythromycin", "drug", "92-103"]}
{"TEXT1": "Examples potent CYP inhibitors include @DRUG$ erythromycin @DRUG$ HIV protease ritonavir indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p1", "DRUGA": ["macrolide antibiotics", "group", "63-83"], "DRUGB": ["troleandomycin", "drug", "106-119"]}
{"TEXT1": "Examples potent CYP inhibitors include @DRUG$ erythromycin troleandomycin HIV protease ritonavir indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p2", "DRUGA": ["macrolide antibiotics", "group", "63-83"], "DRUGB": ["clarithromycin", "drug", "122-135"]}
{"TEXT1": "Examples potent CYP inhibitors include @DRUG$ erythromycin troleandomycin @DRUG$ ritonavir indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p3", "DRUGA": ["macrolide antibiotics", "group", "63-83"], "DRUGB": ["HIV protease inhibitors", "group", "139-150;177-186"]}
{"TEXT1": "Examples potent CYP inhibitors include @DRUG$ erythromycin troleandomycin HIV protease @DRUG$ ritonavir indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p4", "DRUGA": ["macrolide antibiotics", "group", "63-83"], "DRUGB": ["reverse transcriptase inhibitors", "group", "155-186"]}
{"TEXT1": "Examples potent CYP inhibitors include @DRUG$ erythromycin troleandomycin HIV protease @DRUG$ indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p5", "DRUGA": ["macrolide antibiotics", "group", "63-83"], "DRUGB": ["ritonavir", "drug", "195-203"]}
{"TEXT1": "Examples potent CYP inhibitors include @DRUG$ erythromycin troleandomycin HIV protease ritonavir @DRUG$ nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p6", "DRUGA": ["macrolide antibiotics", "group", "63-83"], "DRUGB": ["indinavir", "drug", "206-214"]}
{"TEXT1": "Examples potent CYP inhibitors include @DRUG$ erythromycin troleandomycin HIV protease ritonavir indinavir @DRUG$ azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p7", "DRUGA": ["macrolide antibiotics", "group", "63-83"], "DRUGB": ["nelfinavir", "drug", "217-226"]}
{"TEXT1": "Examples potent CYP inhibitors include @DRUG$ erythromycin troleandomycin HIV protease ritonavir indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p8", "DRUGA": ["macrolide antibiotics", "group", "63-83"], "DRUGB": ["delavirdine", "drug", "229-239"]}
{"TEXT1": "Examples potent CYP inhibitors include @DRUG$ erythromycin troleandomycin HIV protease ritonavir indinavir nelfinavir @DRUG$ ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p9", "DRUGA": ["macrolide antibiotics", "group", "63-83"], "DRUGB": ["azole antifungals", "group", "245-261"]}
{"TEXT1": "Examples potent CYP inhibitors include @DRUG$ erythromycin troleandomycin HIV protease ritonavir indinavir nelfinavir azole antifungals @DRUG$ itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p10", "DRUGA": ["macrolide antibiotics", "group", "63-83"], "DRUGB": ["ketoconazole", "drug", "270-281"]}
{"TEXT1": "Examples potent CYP inhibitors include @DRUG$ erythromycin troleandomycin HIV protease ritonavir indinavir nelfinavir azole antifungals ketoconazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p11", "DRUGA": ["macrolide antibiotics", "group", "63-83"], "DRUGB": ["itraconazole", "drug", "284-295"]}
{"TEXT1": "Examples potent CYP inhibitors include @DRUG$ erythromycin troleandomycin HIV protease ritonavir indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p12", "DRUGA": ["macrolide antibiotics", "group", "63-83"], "DRUGB": ["voriconazole", "drug", "298-309"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics @DRUG$ @DRUG$ HIV protease ritonavir indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p13", "DRUGA": ["erythromycin", "drug", "92-103"], "DRUGB": ["troleandomycin", "drug", "106-119"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics @DRUG$ troleandomycin HIV protease ritonavir indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p14", "DRUGA": ["erythromycin", "drug", "92-103"], "DRUGB": ["clarithromycin", "drug", "122-135"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics @DRUG$ troleandomycin @DRUG$ ritonavir indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p15", "DRUGA": ["erythromycin", "drug", "92-103"], "DRUGB": ["HIV protease inhibitors", "group", "139-150;177-186"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics @DRUG$ troleandomycin HIV protease @DRUG$ ritonavir indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p16", "DRUGA": ["erythromycin", "drug", "92-103"], "DRUGB": ["reverse transcriptase inhibitors", "group", "155-186"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics @DRUG$ troleandomycin HIV protease @DRUG$ indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p17", "DRUGA": ["erythromycin", "drug", "92-103"], "DRUGB": ["ritonavir", "drug", "195-203"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics @DRUG$ troleandomycin HIV protease ritonavir @DRUG$ nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p18", "DRUGA": ["erythromycin", "drug", "92-103"], "DRUGB": ["indinavir", "drug", "206-214"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics @DRUG$ troleandomycin HIV protease ritonavir indinavir @DRUG$ azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p19", "DRUGA": ["erythromycin", "drug", "92-103"], "DRUGB": ["nelfinavir", "drug", "217-226"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics @DRUG$ troleandomycin HIV protease ritonavir indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p20", "DRUGA": ["erythromycin", "drug", "92-103"], "DRUGB": ["delavirdine", "drug", "229-239"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics @DRUG$ troleandomycin HIV protease ritonavir indinavir nelfinavir @DRUG$ ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p21", "DRUGA": ["erythromycin", "drug", "92-103"], "DRUGB": ["azole antifungals", "group", "245-261"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics @DRUG$ troleandomycin HIV protease ritonavir indinavir nelfinavir azole antifungals @DRUG$ itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p22", "DRUGA": ["erythromycin", "drug", "92-103"], "DRUGB": ["ketoconazole", "drug", "270-281"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics @DRUG$ troleandomycin HIV protease ritonavir indinavir nelfinavir azole antifungals ketoconazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p23", "DRUGA": ["erythromycin", "drug", "92-103"], "DRUGB": ["itraconazole", "drug", "284-295"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics @DRUG$ troleandomycin HIV protease ritonavir indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p24", "DRUGA": ["erythromycin", "drug", "92-103"], "DRUGB": ["voriconazole", "drug", "298-309"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin @DRUG$ HIV protease ritonavir indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p25", "DRUGA": ["troleandomycin", "drug", "106-119"], "DRUGB": ["clarithromycin", "drug", "122-135"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin @DRUG$ @DRUG$ ritonavir indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p26", "DRUGA": ["troleandomycin", "drug", "106-119"], "DRUGB": ["HIV protease inhibitors", "group", "139-150;177-186"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin @DRUG$ HIV protease @DRUG$ ritonavir indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p27", "DRUGA": ["troleandomycin", "drug", "106-119"], "DRUGB": ["reverse transcriptase inhibitors", "group", "155-186"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin @DRUG$ HIV protease @DRUG$ indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p28", "DRUGA": ["troleandomycin", "drug", "106-119"], "DRUGB": ["ritonavir", "drug", "195-203"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin @DRUG$ HIV protease ritonavir @DRUG$ nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p29", "DRUGA": ["troleandomycin", "drug", "106-119"], "DRUGB": ["indinavir", "drug", "206-214"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin @DRUG$ HIV protease ritonavir indinavir @DRUG$ azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p30", "DRUGA": ["troleandomycin", "drug", "106-119"], "DRUGB": ["nelfinavir", "drug", "217-226"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin @DRUG$ HIV protease ritonavir indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p31", "DRUGA": ["troleandomycin", "drug", "106-119"], "DRUGB": ["delavirdine", "drug", "229-239"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin @DRUG$ HIV protease ritonavir indinavir nelfinavir @DRUG$ ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p32", "DRUGA": ["troleandomycin", "drug", "106-119"], "DRUGB": ["azole antifungals", "group", "245-261"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin @DRUG$ HIV protease ritonavir indinavir nelfinavir azole antifungals @DRUG$ itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p33", "DRUGA": ["troleandomycin", "drug", "106-119"], "DRUGB": ["ketoconazole", "drug", "270-281"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin @DRUG$ HIV protease ritonavir indinavir nelfinavir azole antifungals ketoconazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p34", "DRUGA": ["troleandomycin", "drug", "106-119"], "DRUGB": ["itraconazole", "drug", "284-295"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin @DRUG$ HIV protease ritonavir indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p35", "DRUGA": ["troleandomycin", "drug", "106-119"], "DRUGB": ["voriconazole", "drug", "298-309"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin @DRUG$ ritonavir indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p36", "DRUGA": ["clarithromycin", "drug", "122-135"], "DRUGB": ["HIV protease inhibitors", "group", "139-150;177-186"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease @DRUG$ ritonavir indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p37", "DRUGA": ["clarithromycin", "drug", "122-135"], "DRUGB": ["reverse transcriptase inhibitors", "group", "155-186"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease @DRUG$ indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p38", "DRUGA": ["clarithromycin", "drug", "122-135"], "DRUGB": ["ritonavir", "drug", "195-203"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease ritonavir @DRUG$ nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p39", "DRUGA": ["clarithromycin", "drug", "122-135"], "DRUGB": ["indinavir", "drug", "206-214"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease ritonavir indinavir @DRUG$ azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p40", "DRUGA": ["clarithromycin", "drug", "122-135"], "DRUGB": ["nelfinavir", "drug", "217-226"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease ritonavir indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p41", "DRUGA": ["clarithromycin", "drug", "122-135"], "DRUGB": ["delavirdine", "drug", "229-239"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease ritonavir indinavir nelfinavir @DRUG$ ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p42", "DRUGA": ["clarithromycin", "drug", "122-135"], "DRUGB": ["azole antifungals", "group", "245-261"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease ritonavir indinavir nelfinavir azole antifungals @DRUG$ itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p43", "DRUGA": ["clarithromycin", "drug", "122-135"], "DRUGB": ["ketoconazole", "drug", "270-281"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease ritonavir indinavir nelfinavir azole antifungals ketoconazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p44", "DRUGA": ["clarithromycin", "drug", "122-135"], "DRUGB": ["itraconazole", "drug", "284-295"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease ritonavir indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p45", "DRUGA": ["clarithromycin", "drug", "122-135"], "DRUGB": ["voriconazole", "drug", "298-309"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin ritonavir indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p46", "DRUGA": ["HIV protease inhibitors", "group", "139-150;177-186"], "DRUGB": ["reverse transcriptase inhibitors", "group", "155-186"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin @DRUG$ @DRUG$ indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p47", "DRUGA": ["HIV protease inhibitors", "group", "139-150;177-186"], "DRUGB": ["ritonavir", "drug", "195-203"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin @DRUG$ ritonavir @DRUG$ nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p48", "DRUGA": ["HIV protease inhibitors", "group", "139-150;177-186"], "DRUGB": ["indinavir", "drug", "206-214"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin @DRUG$ ritonavir indinavir @DRUG$ azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p49", "DRUGA": ["HIV protease inhibitors", "group", "139-150;177-186"], "DRUGB": ["nelfinavir", "drug", "217-226"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin @DRUG$ ritonavir indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p50", "DRUGA": ["HIV protease inhibitors", "group", "139-150;177-186"], "DRUGB": ["delavirdine", "drug", "229-239"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin @DRUG$ ritonavir indinavir nelfinavir @DRUG$ ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p51", "DRUGA": ["HIV protease inhibitors", "group", "139-150;177-186"], "DRUGB": ["azole antifungals", "group", "245-261"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin @DRUG$ ritonavir indinavir nelfinavir azole antifungals @DRUG$ itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p52", "DRUGA": ["HIV protease inhibitors", "group", "139-150;177-186"], "DRUGB": ["ketoconazole", "drug", "270-281"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin @DRUG$ ritonavir indinavir nelfinavir azole antifungals ketoconazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p53", "DRUGA": ["HIV protease inhibitors", "group", "139-150;177-186"], "DRUGB": ["itraconazole", "drug", "284-295"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin @DRUG$ ritonavir indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p54", "DRUGA": ["HIV protease inhibitors", "group", "139-150;177-186"], "DRUGB": ["voriconazole", "drug", "298-309"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease @DRUG$ @DRUG$ indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p55", "DRUGA": ["reverse transcriptase inhibitors", "group", "155-186"], "DRUGB": ["ritonavir", "drug", "195-203"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease @DRUG$ ritonavir @DRUG$ nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p56", "DRUGA": ["reverse transcriptase inhibitors", "group", "155-186"], "DRUGB": ["indinavir", "drug", "206-214"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease @DRUG$ ritonavir indinavir @DRUG$ azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p57", "DRUGA": ["reverse transcriptase inhibitors", "group", "155-186"], "DRUGB": ["nelfinavir", "drug", "217-226"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease @DRUG$ ritonavir indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p58", "DRUGA": ["reverse transcriptase inhibitors", "group", "155-186"], "DRUGB": ["delavirdine", "drug", "229-239"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease @DRUG$ ritonavir indinavir nelfinavir @DRUG$ ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p59", "DRUGA": ["reverse transcriptase inhibitors", "group", "155-186"], "DRUGB": ["azole antifungals", "group", "245-261"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease @DRUG$ ritonavir indinavir nelfinavir azole antifungals @DRUG$ itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p60", "DRUGA": ["reverse transcriptase inhibitors", "group", "155-186"], "DRUGB": ["ketoconazole", "drug", "270-281"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease @DRUG$ ritonavir indinavir nelfinavir azole antifungals ketoconazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p61", "DRUGA": ["reverse transcriptase inhibitors", "group", "155-186"], "DRUGB": ["itraconazole", "drug", "284-295"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease @DRUG$ ritonavir indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p62", "DRUGA": ["reverse transcriptase inhibitors", "group", "155-186"], "DRUGB": ["voriconazole", "drug", "298-309"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease @DRUG$ @DRUG$ nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p63", "DRUGA": ["ritonavir", "drug", "195-203"], "DRUGB": ["indinavir", "drug", "206-214"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease @DRUG$ indinavir @DRUG$ azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p64", "DRUGA": ["ritonavir", "drug", "195-203"], "DRUGB": ["nelfinavir", "drug", "217-226"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease @DRUG$ indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p65", "DRUGA": ["ritonavir", "drug", "195-203"], "DRUGB": ["delavirdine", "drug", "229-239"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease @DRUG$ indinavir nelfinavir @DRUG$ ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p66", "DRUGA": ["ritonavir", "drug", "195-203"], "DRUGB": ["azole antifungals", "group", "245-261"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease @DRUG$ indinavir nelfinavir azole antifungals @DRUG$ itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p67", "DRUGA": ["ritonavir", "drug", "195-203"], "DRUGB": ["ketoconazole", "drug", "270-281"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease @DRUG$ indinavir nelfinavir azole antifungals ketoconazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p68", "DRUGA": ["ritonavir", "drug", "195-203"], "DRUGB": ["itraconazole", "drug", "284-295"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease @DRUG$ indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p69", "DRUGA": ["ritonavir", "drug", "195-203"], "DRUGB": ["voriconazole", "drug", "298-309"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease ritonavir @DRUG$ @DRUG$ azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p70", "DRUGA": ["indinavir", "drug", "206-214"], "DRUGB": ["nelfinavir", "drug", "217-226"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease ritonavir @DRUG$ nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p71", "DRUGA": ["indinavir", "drug", "206-214"], "DRUGB": ["delavirdine", "drug", "229-239"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease ritonavir @DRUG$ nelfinavir @DRUG$ ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p72", "DRUGA": ["indinavir", "drug", "206-214"], "DRUGB": ["azole antifungals", "group", "245-261"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease ritonavir @DRUG$ nelfinavir azole antifungals @DRUG$ itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p73", "DRUGA": ["indinavir", "drug", "206-214"], "DRUGB": ["ketoconazole", "drug", "270-281"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease ritonavir @DRUG$ nelfinavir azole antifungals ketoconazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p74", "DRUGA": ["indinavir", "drug", "206-214"], "DRUGB": ["itraconazole", "drug", "284-295"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease ritonavir @DRUG$ nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p75", "DRUGA": ["indinavir", "drug", "206-214"], "DRUGB": ["voriconazole", "drug", "298-309"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease ritonavir indinavir @DRUG$ azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p76", "DRUGA": ["nelfinavir", "drug", "217-226"], "DRUGB": ["delavirdine", "drug", "229-239"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease ritonavir indinavir @DRUG$ @DRUG$ ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p77", "DRUGA": ["nelfinavir", "drug", "217-226"], "DRUGB": ["azole antifungals", "group", "245-261"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease ritonavir indinavir @DRUG$ azole antifungals @DRUG$ itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p78", "DRUGA": ["nelfinavir", "drug", "217-226"], "DRUGB": ["ketoconazole", "drug", "270-281"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease ritonavir indinavir @DRUG$ azole antifungals ketoconazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p79", "DRUGA": ["nelfinavir", "drug", "217-226"], "DRUGB": ["itraconazole", "drug", "284-295"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease ritonavir indinavir @DRUG$ azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p80", "DRUGA": ["nelfinavir", "drug", "217-226"], "DRUGB": ["voriconazole", "drug", "298-309"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease ritonavir indinavir nelfinavir @DRUG$ ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p81", "DRUGA": ["delavirdine", "drug", "229-239"], "DRUGB": ["azole antifungals", "group", "245-261"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease ritonavir indinavir nelfinavir azole antifungals @DRUG$ itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p82", "DRUGA": ["delavirdine", "drug", "229-239"], "DRUGB": ["ketoconazole", "drug", "270-281"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease ritonavir indinavir nelfinavir azole antifungals ketoconazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p83", "DRUGA": ["delavirdine", "drug", "229-239"], "DRUGB": ["itraconazole", "drug", "284-295"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease ritonavir indinavir nelfinavir azole antifungals ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p84", "DRUGA": ["delavirdine", "drug", "229-239"], "DRUGB": ["voriconazole", "drug", "298-309"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease ritonavir indinavir nelfinavir @DRUG$ @DRUG$ itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p85", "DRUGA": ["azole antifungals", "group", "245-261"], "DRUGB": ["ketoconazole", "drug", "270-281"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease ritonavir indinavir nelfinavir @DRUG$ ketoconazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p86", "DRUGA": ["azole antifungals", "group", "245-261"], "DRUGB": ["itraconazole", "drug", "284-295"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease ritonavir indinavir nelfinavir @DRUG$ ketoconazole itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p87", "DRUGA": ["azole antifungals", "group", "245-261"], "DRUGB": ["voriconazole", "drug", "298-309"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease ritonavir indinavir nelfinavir azole antifungals @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p88", "DRUGA": ["ketoconazole", "drug", "270-281"], "DRUGB": ["itraconazole", "drug", "284-295"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease ritonavir indinavir nelfinavir azole antifungals @DRUG$ itraconazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p89", "DRUGA": ["ketoconazole", "drug", "270-281"], "DRUGB": ["voriconazole", "drug", "298-309"]}
{"TEXT1": "Examples potent CYP inhibitors include macrolide antibiotics erythromycin troleandomycin HIV protease ritonavir indinavir nelfinavir azole antifungals ketoconazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d675.s2.p90", "DRUGA": ["itraconazole", "drug", "284-295"], "DRUGB": ["voriconazole", "drug", "298-309"]}
{"TEXT1": "potent inhibitors include @DRUG$ @DRUG$ fluconazole grapefruit juice fluoxetine fluvoxamine zileuton clotrimazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s4.p0", "DRUGA": ["saquinavir", "drug", "31-40"], "DRUGB": ["nefazodone", "drug", "43-52"]}
{"TEXT1": "potent inhibitors include @DRUG$ nefazodone @DRUG$ grapefruit juice fluoxetine fluvoxamine zileuton clotrimazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s4.p1", "DRUGA": ["saquinavir", "drug", "31-40"], "DRUGB": ["fluconazole", "drug", "55-65"]}
{"TEXT1": "potent inhibitors include @DRUG$ nefazodone fluconazole grapefruit juice @DRUG$ fluvoxamine zileuton clotrimazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s4.p2", "DRUGA": ["saquinavir", "drug", "31-40"], "DRUGB": ["fluoxetine", "drug", "86-95"]}
{"TEXT1": "potent inhibitors include @DRUG$ nefazodone fluconazole grapefruit juice fluoxetine @DRUG$ zileuton clotrimazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s4.p3", "DRUGA": ["saquinavir", "drug", "31-40"], "DRUGB": ["fluvoxamine", "drug", "98-108"]}
{"TEXT1": "potent inhibitors include @DRUG$ nefazodone fluconazole grapefruit juice fluoxetine fluvoxamine @DRUG$ clotrimazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s4.p4", "DRUGA": ["saquinavir", "drug", "31-40"], "DRUGB": ["zileuton", "drug", "111-118"]}
{"TEXT1": "potent inhibitors include @DRUG$ nefazodone fluconazole grapefruit juice fluoxetine fluvoxamine zileuton @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d675.s4.p5", "DRUGA": ["saquinavir", "drug", "31-40"], "DRUGB": ["clotrimazole", "drug", "125-136"]}
{"TEXT1": "potent inhibitors include saquinavir @DRUG$ @DRUG$ grapefruit juice fluoxetine fluvoxamine zileuton clotrimazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s4.p6", "DRUGA": ["nefazodone", "drug", "43-52"], "DRUGB": ["fluconazole", "drug", "55-65"]}
{"TEXT1": "potent inhibitors include saquinavir @DRUG$ fluconazole grapefruit juice @DRUG$ fluvoxamine zileuton clotrimazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s4.p7", "DRUGA": ["nefazodone", "drug", "43-52"], "DRUGB": ["fluoxetine", "drug", "86-95"]}
{"TEXT1": "potent inhibitors include saquinavir @DRUG$ fluconazole grapefruit juice fluoxetine @DRUG$ zileuton clotrimazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s4.p8", "DRUGA": ["nefazodone", "drug", "43-52"], "DRUGB": ["fluvoxamine", "drug", "98-108"]}
{"TEXT1": "potent inhibitors include saquinavir @DRUG$ fluconazole grapefruit juice fluoxetine fluvoxamine @DRUG$ clotrimazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s4.p9", "DRUGA": ["nefazodone", "drug", "43-52"], "DRUGB": ["zileuton", "drug", "111-118"]}
{"TEXT1": "potent inhibitors include saquinavir @DRUG$ fluconazole grapefruit juice fluoxetine fluvoxamine zileuton @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d675.s4.p10", "DRUGA": ["nefazodone", "drug", "43-52"], "DRUGB": ["clotrimazole", "drug", "125-136"]}
{"TEXT1": "potent inhibitors include saquinavir nefazodone @DRUG$ grapefruit juice @DRUG$ fluvoxamine zileuton clotrimazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s4.p11", "DRUGA": ["fluconazole", "drug", "55-65"], "DRUGB": ["fluoxetine", "drug", "86-95"]}
{"TEXT1": "potent inhibitors include saquinavir nefazodone @DRUG$ grapefruit juice fluoxetine @DRUG$ zileuton clotrimazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s4.p12", "DRUGA": ["fluconazole", "drug", "55-65"], "DRUGB": ["fluvoxamine", "drug", "98-108"]}
{"TEXT1": "potent inhibitors include saquinavir nefazodone @DRUG$ grapefruit juice fluoxetine fluvoxamine @DRUG$ clotrimazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s4.p13", "DRUGA": ["fluconazole", "drug", "55-65"], "DRUGB": ["zileuton", "drug", "111-118"]}
{"TEXT1": "potent inhibitors include saquinavir nefazodone @DRUG$ grapefruit juice fluoxetine fluvoxamine zileuton @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d675.s4.p14", "DRUGA": ["fluconazole", "drug", "55-65"], "DRUGB": ["clotrimazole", "drug", "125-136"]}
{"TEXT1": "potent inhibitors include saquinavir nefazodone fluconazole grapefruit juice @DRUG$ @DRUG$ zileuton clotrimazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s4.p15", "DRUGA": ["fluoxetine", "drug", "86-95"], "DRUGB": ["fluvoxamine", "drug", "98-108"]}
{"TEXT1": "potent inhibitors include saquinavir nefazodone fluconazole grapefruit juice @DRUG$ fluvoxamine @DRUG$ clotrimazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s4.p16", "DRUGA": ["fluoxetine", "drug", "86-95"], "DRUGB": ["zileuton", "drug", "111-118"]}
{"TEXT1": "potent inhibitors include saquinavir nefazodone fluconazole grapefruit juice @DRUG$ fluvoxamine zileuton @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d675.s4.p17", "DRUGA": ["fluoxetine", "drug", "86-95"], "DRUGB": ["clotrimazole", "drug", "125-136"]}
{"TEXT1": "potent inhibitors include saquinavir nefazodone fluconazole grapefruit juice fluoxetine @DRUG$ @DRUG$ clotrimazole", "LBL": "0", "ID": "DDI-DrugBank.d675.s4.p18", "DRUGA": ["fluvoxamine", "drug", "98-108"], "DRUGB": ["zileuton", "drug", "111-118"]}
{"TEXT1": "potent inhibitors include saquinavir nefazodone fluconazole grapefruit juice fluoxetine @DRUG$ zileuton @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d675.s4.p19", "DRUGA": ["fluvoxamine", "drug", "98-108"], "DRUGB": ["clotrimazole", "drug", "125-136"]}
{"TEXT1": "potent inhibitors include saquinavir nefazodone fluconazole grapefruit juice fluoxetine fluvoxamine @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d675.s4.p20", "DRUGA": ["zileuton", "drug", "111-118"], "DRUGB": ["clotrimazole", "drug", "125-136"]}
{"TEXT1": "exercised @DRUG$ used vasoconstrictors ergot alkaloids", "LBL": "0", "ID": "DDI-DrugBank.d675.s7.p0", "DRUGA": ["Methergine", "brand", "33-42"], "DRUGB": ["methylergonovine maleate", "drug", "48-71"]}
{"TEXT1": "exercised @DRUG$ used @DRUG$ ergot alkaloids", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d675.s7.p1", "DRUGA": ["Methergine", "brand", "33-42"], "DRUGB": ["vasoconstrictors", "group", "106-121"]}
{"TEXT1": "exercised @DRUG$ used vasoconstrictors @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d675.s7.p2", "DRUGA": ["Methergine", "brand", "33-42"], "DRUGB": ["ergot alkaloids", "group", "126-140"]}
{"TEXT1": "exercised Methergine used @DRUG$ ergot alkaloids", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d675.s7.p3", "DRUGA": ["methylergonovine maleate", "drug", "48-71"], "DRUGB": ["vasoconstrictors", "group", "106-121"]}
{"TEXT1": "exercised Methergine used vasoconstrictors @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d675.s7.p4", "DRUGA": ["methylergonovine maleate", "drug", "48-71"], "DRUGB": ["ergot alkaloids", "group", "126-140"]}
{"TEXT1": "exercised Methergine used @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d675.s7.p5", "DRUGA": ["vasoconstrictors", "group", "106-121"], "DRUGB": ["ergot alkaloids", "group", "126-140"]}
{"TEXT1": "@DRUG$ metabolized P450 enzyme system drugs induce inhibit elicit important alter @DRUG$ plasma concentrations", "LBL": "0", "ID": "DDI-DrugBank.d766.s0.p0", "DRUGA": ["trimetrexate", "drug", "6-17"], "DRUGB": ["trimetrexate", "drug", "184-195"]}
{"TEXT1": "Agents @DRUG$ AIDS patients indications elicit activity include @DRUG$ rifampin rifabutin ketoconazole fluconazole", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d766.s1.p0", "DRUGA": ["trimetrexate", "drug", "41-52"], "DRUGB": ["erythromycin", "drug", "133-144"]}
{"TEXT1": "Agents @DRUG$ AIDS patients indications elicit activity include erythromycin @DRUG$ rifabutin ketoconazole fluconazole", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d766.s1.p1", "DRUGA": ["trimetrexate", "drug", "41-52"], "DRUGB": ["rifampin", "drug", "147-154"]}
{"TEXT1": "Agents @DRUG$ AIDS patients indications elicit activity include erythromycin rifampin @DRUG$ ketoconazole fluconazole", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d766.s1.p2", "DRUGA": ["trimetrexate", "drug", "41-52"], "DRUGB": ["rifabutin", "drug", "157-165"]}
{"TEXT1": "Agents @DRUG$ AIDS patients indications elicit activity include erythromycin rifampin rifabutin @DRUG$ fluconazole", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d766.s1.p3", "DRUGA": ["trimetrexate", "drug", "41-52"], "DRUGB": ["ketoconazole", "drug", "168-179"]}
{"TEXT1": "Agents @DRUG$ AIDS patients indications elicit activity include erythromycin rifampin rifabutin ketoconazole @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d766.s1.p4", "DRUGA": ["trimetrexate", "drug", "41-52"], "DRUGB": ["fluconazole", "drug", "186-196"]}
{"TEXT1": "Agents trimetrexate AIDS patients indications elicit activity include @DRUG$ @DRUG$ rifabutin ketoconazole fluconazole", "LBL": "0", "ID": "DDI-DrugBank.d766.s1.p5", "DRUGA": ["erythromycin", "drug", "133-144"], "DRUGB": ["rifampin", "drug", "147-154"]}
{"TEXT1": "Agents trimetrexate AIDS patients indications elicit activity include @DRUG$ rifampin @DRUG$ ketoconazole fluconazole", "LBL": "0", "ID": "DDI-DrugBank.d766.s1.p6", "DRUGA": ["erythromycin", "drug", "133-144"], "DRUGB": ["rifabutin", "drug", "157-165"]}
{"TEXT1": "Agents trimetrexate AIDS patients indications elicit activity include @DRUG$ rifampin rifabutin @DRUG$ fluconazole", "LBL": "0", "ID": "DDI-DrugBank.d766.s1.p7", "DRUGA": ["erythromycin", "drug", "133-144"], "DRUGB": ["ketoconazole", "drug", "168-179"]}
{"TEXT1": "Agents trimetrexate AIDS patients indications elicit activity include @DRUG$ rifampin rifabutin ketoconazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d766.s1.p8", "DRUGA": ["erythromycin", "drug", "133-144"], "DRUGB": ["fluconazole", "drug", "186-196"]}
{"TEXT1": "Agents trimetrexate AIDS patients indications elicit activity include erythromycin @DRUG$ @DRUG$ ketoconazole fluconazole", "LBL": "0", "ID": "DDI-DrugBank.d766.s1.p9", "DRUGA": ["rifampin", "drug", "147-154"], "DRUGB": ["rifabutin", "drug", "157-165"]}
{"TEXT1": "Agents trimetrexate AIDS patients indications elicit activity include erythromycin @DRUG$ rifabutin @DRUG$ fluconazole", "LBL": "0", "ID": "DDI-DrugBank.d766.s1.p10", "DRUGA": ["rifampin", "drug", "147-154"], "DRUGB": ["ketoconazole", "drug", "168-179"]}
{"TEXT1": "Agents trimetrexate AIDS patients indications elicit activity include erythromycin @DRUG$ rifabutin ketoconazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d766.s1.p11", "DRUGA": ["rifampin", "drug", "147-154"], "DRUGB": ["fluconazole", "drug", "186-196"]}
{"TEXT1": "Agents trimetrexate AIDS patients indications elicit activity include erythromycin rifampin @DRUG$ @DRUG$ fluconazole", "LBL": "0", "ID": "DDI-DrugBank.d766.s1.p12", "DRUGA": ["rifabutin", "drug", "157-165"], "DRUGB": ["ketoconazole", "drug", "168-179"]}
{"TEXT1": "Agents trimetrexate AIDS patients indications elicit activity include erythromycin rifampin @DRUG$ ketoconazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d766.s1.p13", "DRUGA": ["rifabutin", "drug", "157-165"], "DRUGB": ["fluconazole", "drug", "186-196"]}
{"TEXT1": "Agents trimetrexate AIDS patients indications elicit activity include erythromycin rifampin rifabutin @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d766.s1.p14", "DRUGA": ["ketoconazole", "drug", "168-179"], "DRUGB": ["fluconazole", "drug", "186-196"]}
{"TEXT1": "In vitro perfusion of liver isolated rat shown @DRUG$ caused significant reduction @DRUG$ metabolism acetaminophen altered relative concentration trimetrexate metabolites possibly sulfate", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d766.s2.p0", "DRUGA": ["cimetidine", "drug", "56-65"], "DRUGB": ["trimetrexate", "drug", "101-112"]}
{"TEXT1": "In vitro perfusion of liver isolated rat shown @DRUG$ caused significant reduction trimetrexate metabolism @DRUG$ altered relative concentration metabolites possibly sulfate", "LBL": "0", "ID": "DDI-DrugBank.d766.s2.p1", "DRUGA": ["cimetidine", "drug", "56-65"], "DRUGB": ["acetaminophen", "drug", "134-146"]}
{"TEXT1": "In vitro perfusion of liver isolated rat shown cimetidine caused significant reduction @DRUG$ metabolism @DRUG$ altered relative concentration trimetrexate metabolites possibly sulfate", "LBL": "0", "ID": "DDI-DrugBank.d766.s2.p2", "DRUGA": ["trimetrexate", "drug", "101-112"], "DRUGB": ["acetaminophen", "drug", "134-146"]}
{"TEXT1": "Based in vitro model rat liver nitrogen @DRUG$ ketoconazole potent non competitive inhibitors trimetrexate metabolism", "LBL": "0", "ID": "DDI-DrugBank.d766.s3.p0", "DRUGA": ["imidazole drugs", "group", "59-73"], "DRUGB": ["clotrimazole", "drug", "76-87"]}
{"TEXT1": "Based in vitro model rat liver nitrogen @DRUG$ @DRUG$ potent non competitive inhibitors trimetrexate metabolism", "LBL": "0", "ID": "DDI-DrugBank.d766.s3.p1", "DRUGA": ["imidazole drugs", "group", "59-73"], "DRUGB": ["ketoconazole", "drug", "90-101"]}
{"TEXT1": "Based in vitro model rat liver nitrogen @DRUG$ ketoconazole potent non competitive inhibitors trimetrexate metabolism", "LBL": "0", "ID": "DDI-DrugBank.d766.s3.p2", "DRUGA": ["imidazole drugs", "group", "59-73"], "DRUGB": ["miconazole", "drug", "104-113"]}
{"TEXT1": "Based in vitro model rat liver nitrogen @DRUG$ ketoconazole potent non competitive inhibitors @DRUG$ metabolism", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d766.s3.p3", "DRUGA": ["imidazole drugs", "group", "59-73"], "DRUGB": ["trimetrexate", "drug", "159-170"]}
{"TEXT1": "Based in vitro model rat liver nitrogen imidazole drugs @DRUG$ potent non competitive inhibitors trimetrexate metabolism", "LBL": "0", "ID": "DDI-DrugBank.d766.s3.p4", "DRUGA": ["clotrimazole", "drug", "76-87"], "DRUGB": ["ketoconazole", "drug", "90-101"]}
{"TEXT1": "Based in vitro model rat liver nitrogen imidazole drugs ketoconazole potent non competitive inhibitors trimetrexate metabolism", "LBL": "0", "ID": "DDI-DrugBank.d766.s3.p5", "DRUGA": ["clotrimazole", "drug", "76-87"], "DRUGB": ["miconazole", "drug", "104-113"]}
{"TEXT1": "Based in vitro model rat liver nitrogen imidazole drugs ketoconazole potent non competitive inhibitors @DRUG$ metabolism", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d766.s3.p6", "DRUGA": ["clotrimazole", "drug", "76-87"], "DRUGB": ["trimetrexate", "drug", "159-170"]}
{"TEXT1": "Based in vitro model rat liver nitrogen imidazole drugs @DRUG$ potent non competitive inhibitors trimetrexate metabolism", "LBL": "0", "ID": "DDI-DrugBank.d766.s3.p7", "DRUGA": ["ketoconazole", "drug", "90-101"], "DRUGB": ["miconazole", "drug", "104-113"]}
{"TEXT1": "Based in vitro model rat liver nitrogen imidazole drugs @DRUG$ potent non competitive inhibitors @DRUG$ metabolism", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d766.s3.p8", "DRUGA": ["ketoconazole", "drug", "90-101"], "DRUGB": ["trimetrexate", "drug", "159-170"]}
{"TEXT1": "Based in vitro model rat liver nitrogen imidazole drugs ketoconazole potent non competitive inhibitors @DRUG$ metabolism", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d766.s3.p9", "DRUGA": ["miconazole", "drug", "104-113"], "DRUGB": ["trimetrexate", "drug", "159-170"]}
{"TEXT1": "@DRUG$ studied background @DRUG$ heparin", "LBL": "0", "ID": "DDI-DrugBank.d751.s0.p0", "DRUGA": ["AGGRASTAT", "brand", "0-8"], "DRUGB": ["aspirin", "brand", "46-52"]}
{"TEXT1": "@DRUG$ studied background aspirin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d751.s0.p1", "DRUGA": ["AGGRASTAT", "brand", "0-8"], "DRUGB": ["heparin", "drug", "58-64"]}
{"TEXT1": "AGGRASTAT studied background @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d751.s0.p2", "DRUGA": ["aspirin", "brand", "46-52"], "DRUGB": ["heparin", "drug", "58-64"]}
{"TEXT1": "use of @DRUG$ combination @DRUG$ aspirin increase bleeding compared heparin alone", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d751.s1.p0", "DRUGA": ["AGGRASTAT", "brand", "11-19"], "DRUGB": ["heparin", "drug", "42-48"]}
{"TEXT1": "use of @DRUG$ combination heparin @DRUG$ increase bleeding compared aspirin alone", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d751.s1.p1", "DRUGA": ["AGGRASTAT", "brand", "11-19"], "DRUGB": ["aspirin", "brand", "54-60"]}
{"TEXT1": "use of @DRUG$ combination heparin aspirin increase bleeding compared @DRUG$ alone", "LBL": "0", "ID": "DDI-DrugBank.d751.s1.p2", "DRUGA": ["AGGRASTAT", "brand", "11-19"], "DRUGB": ["heparin", "drug", "124-130"]}
{"TEXT1": "use of @DRUG$ combination heparin aspirin increase bleeding compared @DRUG$ alone", "LBL": "0", "ID": "DDI-DrugBank.d751.s1.p3", "DRUGA": ["AGGRASTAT", "brand", "11-19"], "DRUGB": ["aspirin", "drug", "136-142"]}
{"TEXT1": "use of AGGRASTAT combination @DRUG$ @DRUG$ increase bleeding compared heparin aspirin alone", "LBL": "0", "ID": "DDI-DrugBank.d751.s1.p4", "DRUGA": ["heparin", "drug", "42-48"], "DRUGB": ["aspirin", "brand", "54-60"]}
{"TEXT1": "use of AGGRASTAT combination @DRUG$ aspirin increase bleeding compared @DRUG$ alone", "LBL": "0", "ID": "DDI-DrugBank.d751.s1.p5", "DRUGA": ["heparin", "drug", "42-48"], "DRUGB": ["heparin", "drug", "124-130"]}
{"TEXT1": "use of AGGRASTAT combination @DRUG$ aspirin increase bleeding compared heparin @DRUG$ alone", "LBL": "0", "ID": "DDI-DrugBank.d751.s1.p6", "DRUGA": ["heparin", "drug", "42-48"], "DRUGB": ["aspirin", "drug", "136-142"]}
{"TEXT1": "use of AGGRASTAT combination heparin @DRUG$ increase bleeding compared @DRUG$ aspirin alone", "LBL": "0", "ID": "DDI-DrugBank.d751.s1.p7", "DRUGA": ["aspirin", "brand", "54-60"], "DRUGB": ["heparin", "drug", "124-130"]}
{"TEXT1": "use of AGGRASTAT combination heparin @DRUG$ increase bleeding compared @DRUG$ alone", "LBL": "0", "ID": "DDI-DrugBank.d751.s1.p8", "DRUGA": ["aspirin", "brand", "54-60"], "DRUGB": ["aspirin", "drug", "136-142"]}
{"TEXT1": "use of AGGRASTAT combination heparin aspirin increase bleeding compared @DRUG$ @DRUG$ alone", "LBL": "0", "ID": "DDI-DrugBank.d751.s1.p9", "DRUGA": ["heparin", "drug", "124-130"], "DRUGB": ["aspirin", "drug", "136-142"]}
{"TEXT1": "patients Paget's Disease prior @DRUG$ use appears to resorptive response @DRUG$ nasal spray", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d770.s4.p0", "DRUGA": ["diphosphonate", "group", "48-60"], "DRUGB": ["Calcitonin (salmon)", "drug", "116-134"]}
{"TEXT1": "To CNS depression possible potentiation @DRUG$ @DRUG$ narcotics hypotensive agents phenothiazines used with caution", "LBL": "0", "ID": "DDI-DrugBank.d676.s0.p0", "DRUGA": ["barbiturates", "group", "54-65"], "DRUGB": ["antihistamines", "group", "68-81"]}
{"TEXT1": "To CNS depression possible potentiation @DRUG$ antihistamines @DRUG$ hypotensive agents phenothiazines used with caution", "LBL": "0", "ID": "DDI-DrugBank.d676.s0.p1", "DRUGA": ["barbiturates", "group", "54-65"], "DRUGB": ["narcotics", "group", "84-92"]}
{"TEXT1": "To CNS depression possible potentiation @DRUG$ antihistamines narcotics @DRUG$ phenothiazines used with caution", "LBL": "0", "ID": "DDI-DrugBank.d676.s0.p2", "DRUGA": ["barbiturates", "group", "54-65"], "DRUGB": ["hypotensive agents", "group", "95-112"]}
{"TEXT1": "To CNS depression possible potentiation @DRUG$ antihistamines narcotics hypotensive agents @DRUG$ used with caution", "LBL": "0", "ID": "DDI-DrugBank.d676.s0.p3", "DRUGA": ["barbiturates", "group", "54-65"], "DRUGB": ["phenothiazines", "group", "117-130"]}
{"TEXT1": "To CNS depression possible potentiation barbiturates @DRUG$ @DRUG$ hypotensive agents phenothiazines used with caution", "LBL": "0", "ID": "DDI-DrugBank.d676.s0.p4", "DRUGA": ["antihistamines", "group", "68-81"], "DRUGB": ["narcotics", "group", "84-92"]}
{"TEXT1": "To CNS depression possible potentiation barbiturates @DRUG$ narcotics @DRUG$ phenothiazines used with caution", "LBL": "0", "ID": "DDI-DrugBank.d676.s0.p5", "DRUGA": ["antihistamines", "group", "68-81"], "DRUGB": ["hypotensive agents", "group", "95-112"]}
{"TEXT1": "To CNS depression possible potentiation barbiturates @DRUG$ narcotics hypotensive agents @DRUG$ used with caution", "LBL": "0", "ID": "DDI-DrugBank.d676.s0.p6", "DRUGA": ["antihistamines", "group", "68-81"], "DRUGB": ["phenothiazines", "group", "117-130"]}
{"TEXT1": "To CNS depression possible potentiation barbiturates antihistamines @DRUG$ @DRUG$ phenothiazines used with caution", "LBL": "0", "ID": "DDI-DrugBank.d676.s0.p7", "DRUGA": ["narcotics", "group", "84-92"], "DRUGB": ["hypotensive agents", "group", "95-112"]}
{"TEXT1": "To CNS depression possible potentiation barbiturates antihistamines @DRUG$ hypotensive agents @DRUG$ used with caution", "LBL": "0", "ID": "DDI-DrugBank.d676.s0.p8", "DRUGA": ["narcotics", "group", "84-92"], "DRUGB": ["phenothiazines", "group", "117-130"]}
{"TEXT1": "To CNS depression possible potentiation barbiturates antihistamines narcotics @DRUG$ @DRUG$ used with caution", "LBL": "0", "ID": "DDI-DrugBank.d676.s0.p9", "DRUGA": ["hypotensive agents", "group", "95-112"], "DRUGB": ["phenothiazines", "group", "117-130"]}
{"TEXT1": "@DRUG$ exhibits monoamine oxidase activity inhibitory @DRUG$ tricyclic antidepressant drugs amitriptyline HCl foods known high tyramine content wine yogurt cheese bananas", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d676.s2.p0", "DRUGA": ["Matulane", "brand", "8-15"], "DRUGB": ["sympathomimetic drugs", "group", "70-90"]}
{"TEXT1": "@DRUG$ exhibits monoamine oxidase activity inhibitory sympathomimetic drugs @DRUG$ amitriptyline HCl foods known high tyramine content wine yogurt cheese bananas", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d676.s2.p1", "DRUGA": ["Matulane", "brand", "8-15"], "DRUGB": ["tricyclic antidepressant", "group", "93-116"]}
{"TEXT1": "@DRUG$ exhibits monoamine oxidase activity inhibitory sympathomimetic drugs @DRUG$ foods known high tyramine content wine yogurt cheese bananas", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d676.s2.p2", "DRUGA": ["Matulane", "brand", "8-15"], "DRUGB": ["amitriptyline HCl", "drug", "131-147"]}
{"TEXT1": "@DRUG$ exhibits monoamine oxidase activity inhibitory sympathomimetic drugs amitriptyline HCl foods known high tyramine content wine yogurt cheese bananas", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d676.s2.p3", "DRUGA": ["Matulane", "brand", "8-15"], "DRUGB": ["imipramine HCl", "drug", "150-163"]}
{"TEXT1": "@DRUG$ exhibits monoamine oxidase activity inhibitory sympathomimetic drugs amitriptyline HCl foods known high @DRUG$ content wine yogurt cheese bananas", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d676.s2.p4", "DRUGA": ["Matulane", "brand", "8-15"], "DRUGB": ["tyramine", "drug_n", "208-215"]}
{"TEXT1": "Matulane exhibits monoamine oxidase activity inhibitory @DRUG$ @DRUG$ drugs amitriptyline HCl foods known high tyramine content wine yogurt cheese bananas", "LBL": "0", "ID": "DDI-DrugBank.d676.s2.p5", "DRUGA": ["sympathomimetic drugs", "group", "70-90"], "DRUGB": ["tricyclic antidepressant", "group", "93-116"]}
{"TEXT1": "Matulane exhibits monoamine oxidase activity inhibitory @DRUG$ tricyclic antidepressant drugs @DRUG$ foods known high tyramine content wine yogurt cheese bananas", "LBL": "0", "ID": "DDI-DrugBank.d676.s2.p6", "DRUGA": ["sympathomimetic drugs", "group", "70-90"], "DRUGB": ["amitriptyline HCl", "drug", "131-147"]}
{"TEXT1": "Matulane exhibits monoamine oxidase activity inhibitory @DRUG$ tricyclic antidepressant drugs amitriptyline HCl foods known high tyramine content wine yogurt cheese bananas", "LBL": "0", "ID": "DDI-DrugBank.d676.s2.p7", "DRUGA": ["sympathomimetic drugs", "group", "70-90"], "DRUGB": ["imipramine HCl", "drug", "150-163"]}
{"TEXT1": "Matulane exhibits monoamine oxidase activity inhibitory @DRUG$ tricyclic antidepressant drugs amitriptyline HCl foods known high @DRUG$ content wine yogurt cheese bananas", "LBL": "0", "ID": "DDI-DrugBank.d676.s2.p8", "DRUGA": ["sympathomimetic drugs", "group", "70-90"], "DRUGB": ["tyramine", "drug_n", "208-215"]}
{"TEXT1": "Matulane exhibits monoamine oxidase activity inhibitory sympathomimetic drugs @DRUG$ @DRUG$ foods known high tyramine content wine yogurt cheese bananas", "LBL": "0", "ID": "DDI-DrugBank.d676.s2.p9", "DRUGA": ["tricyclic antidepressant", "group", "93-116"], "DRUGB": ["amitriptyline HCl", "drug", "131-147"]}
{"TEXT1": "Matulane exhibits monoamine oxidase activity inhibitory sympathomimetic drugs @DRUG$ amitriptyline HCl foods known high tyramine content wine yogurt cheese bananas", "LBL": "0", "ID": "DDI-DrugBank.d676.s2.p10", "DRUGA": ["tricyclic antidepressant", "group", "93-116"], "DRUGB": ["imipramine HCl", "drug", "150-163"]}
{"TEXT1": "Matulane exhibits monoamine oxidase activity inhibitory sympathomimetic drugs @DRUG$ amitriptyline HCl foods known high @DRUG$ content wine yogurt cheese bananas", "LBL": "0", "ID": "DDI-DrugBank.d676.s2.p11", "DRUGA": ["tricyclic antidepressant", "group", "93-116"], "DRUGB": ["tyramine", "drug_n", "208-215"]}
{"TEXT1": "Matulane exhibits monoamine oxidase activity inhibitory sympathomimetic drugs @DRUG$ foods known high tyramine content wine yogurt cheese bananas", "LBL": "0", "ID": "DDI-DrugBank.d676.s2.p12", "DRUGA": ["amitriptyline HCl", "drug", "131-147"], "DRUGB": ["imipramine HCl", "drug", "150-163"]}
{"TEXT1": "Matulane exhibits monoamine oxidase activity inhibitory sympathomimetic drugs @DRUG$ foods known high @DRUG$ content wine yogurt cheese bananas", "LBL": "0", "ID": "DDI-DrugBank.d676.s2.p13", "DRUGA": ["amitriptyline HCl", "drug", "131-147"], "DRUGB": ["tyramine", "drug_n", "208-215"]}
{"TEXT1": "Matulane exhibits monoamine oxidase activity inhibitory sympathomimetic drugs amitriptyline HCl foods known high @DRUG$ content wine yogurt cheese bananas", "LBL": "0", "ID": "DDI-DrugBank.d676.s2.p14", "DRUGA": ["imipramine HCl", "drug", "150-163"], "DRUGB": ["tyramine", "drug_n", "208-215"]}
{"TEXT1": "cross @DRUG$ radiotherapy @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d676.s4.p0", "DRUGA": ["chemotherapeutic agents", "group", "31-53"], "DRUGB": ["steroids", "group", "72-79"]}
{"TEXT1": "patients receiving @DRUG$ @DRUG$ more frequent monitoring neutrophil counts", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d581.s2.p0", "DRUGA": ["lithium", "drug", "19-25"], "DRUGB": ["Neulasta", "brand", "31-38"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential @DRUG$ @DRUG$ cyclosporine tacrolimus prednisolone sirolimus nifedipine fluconazole ritonavir rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p0", "DRUGA": ["MYCAMINE", "brand", "140-147"], "DRUGB": ["mycophenolate mofetil", "drug", "153-173"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential @DRUG$ mycophenolate mofetil @DRUG$ tacrolimus prednisolone sirolimus nifedipine fluconazole ritonavir rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p1", "DRUGA": ["MYCAMINE", "brand", "140-147"], "DRUGB": ["cyclosporine", "drug", "176-187"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential @DRUG$ mycophenolate mofetil cyclosporine @DRUG$ prednisolone sirolimus nifedipine fluconazole ritonavir rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p2", "DRUGA": ["MYCAMINE", "brand", "140-147"], "DRUGB": ["tacrolimus", "drug", "190-199"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential @DRUG$ mycophenolate mofetil cyclosporine tacrolimus @DRUG$ sirolimus nifedipine fluconazole ritonavir rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p3", "DRUGA": ["MYCAMINE", "brand", "140-147"], "DRUGB": ["prednisolone", "drug", "202-213"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential @DRUG$ mycophenolate mofetil cyclosporine tacrolimus prednisolone @DRUG$ nifedipine fluconazole ritonavir rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p4", "DRUGA": ["MYCAMINE", "brand", "140-147"], "DRUGB": ["sirolimus", "drug", "216-224"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential @DRUG$ mycophenolate mofetil cyclosporine tacrolimus prednisolone sirolimus @DRUG$ fluconazole ritonavir rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p5", "DRUGA": ["MYCAMINE", "brand", "140-147"], "DRUGB": ["nifedipine", "drug", "227-236"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential @DRUG$ mycophenolate mofetil cyclosporine tacrolimus prednisolone sirolimus nifedipine @DRUG$ ritonavir rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p6", "DRUGA": ["MYCAMINE", "brand", "140-147"], "DRUGB": ["fluconazole", "drug", "239-249"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential @DRUG$ mycophenolate mofetil cyclosporine tacrolimus prednisolone sirolimus nifedipine fluconazole @DRUG$ rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p7", "DRUGA": ["MYCAMINE", "brand", "140-147"], "DRUGB": ["ritonavir", "drug", "252-260"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential @DRUG$ mycophenolate mofetil cyclosporine tacrolimus prednisolone sirolimus nifedipine fluconazole ritonavir @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p8", "DRUGA": ["MYCAMINE", "brand", "140-147"], "DRUGB": ["rifampin", "drug", "267-274"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE @DRUG$ @DRUG$ tacrolimus prednisolone sirolimus nifedipine fluconazole ritonavir rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p9", "DRUGA": ["mycophenolate mofetil", "drug", "153-173"], "DRUGB": ["cyclosporine", "drug", "176-187"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE @DRUG$ cyclosporine @DRUG$ prednisolone sirolimus nifedipine fluconazole ritonavir rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p10", "DRUGA": ["mycophenolate mofetil", "drug", "153-173"], "DRUGB": ["tacrolimus", "drug", "190-199"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE @DRUG$ cyclosporine tacrolimus @DRUG$ sirolimus nifedipine fluconazole ritonavir rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p11", "DRUGA": ["mycophenolate mofetil", "drug", "153-173"], "DRUGB": ["prednisolone", "drug", "202-213"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE @DRUG$ cyclosporine tacrolimus prednisolone @DRUG$ nifedipine fluconazole ritonavir rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p12", "DRUGA": ["mycophenolate mofetil", "drug", "153-173"], "DRUGB": ["sirolimus", "drug", "216-224"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE @DRUG$ cyclosporine tacrolimus prednisolone sirolimus @DRUG$ fluconazole ritonavir rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p13", "DRUGA": ["mycophenolate mofetil", "drug", "153-173"], "DRUGB": ["nifedipine", "drug", "227-236"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE @DRUG$ cyclosporine tacrolimus prednisolone sirolimus nifedipine @DRUG$ ritonavir rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p14", "DRUGA": ["mycophenolate mofetil", "drug", "153-173"], "DRUGB": ["fluconazole", "drug", "239-249"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE @DRUG$ cyclosporine tacrolimus prednisolone sirolimus nifedipine fluconazole @DRUG$ rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p15", "DRUGA": ["mycophenolate mofetil", "drug", "153-173"], "DRUGB": ["ritonavir", "drug", "252-260"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE @DRUG$ cyclosporine tacrolimus prednisolone sirolimus nifedipine fluconazole ritonavir @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p16", "DRUGA": ["mycophenolate mofetil", "drug", "153-173"], "DRUGB": ["rifampin", "drug", "267-274"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE mycophenolate mofetil @DRUG$ @DRUG$ prednisolone sirolimus nifedipine fluconazole ritonavir rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p17", "DRUGA": ["cyclosporine", "drug", "176-187"], "DRUGB": ["tacrolimus", "drug", "190-199"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE mycophenolate mofetil @DRUG$ tacrolimus @DRUG$ sirolimus nifedipine fluconazole ritonavir rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p18", "DRUGA": ["cyclosporine", "drug", "176-187"], "DRUGB": ["prednisolone", "drug", "202-213"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE mycophenolate mofetil @DRUG$ tacrolimus prednisolone @DRUG$ nifedipine fluconazole ritonavir rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p19", "DRUGA": ["cyclosporine", "drug", "176-187"], "DRUGB": ["sirolimus", "drug", "216-224"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE mycophenolate mofetil @DRUG$ tacrolimus prednisolone sirolimus @DRUG$ fluconazole ritonavir rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p20", "DRUGA": ["cyclosporine", "drug", "176-187"], "DRUGB": ["nifedipine", "drug", "227-236"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE mycophenolate mofetil @DRUG$ tacrolimus prednisolone sirolimus nifedipine @DRUG$ ritonavir rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p21", "DRUGA": ["cyclosporine", "drug", "176-187"], "DRUGB": ["fluconazole", "drug", "239-249"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE mycophenolate mofetil @DRUG$ tacrolimus prednisolone sirolimus nifedipine fluconazole @DRUG$ rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p22", "DRUGA": ["cyclosporine", "drug", "176-187"], "DRUGB": ["ritonavir", "drug", "252-260"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE mycophenolate mofetil @DRUG$ tacrolimus prednisolone sirolimus nifedipine fluconazole ritonavir @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p23", "DRUGA": ["cyclosporine", "drug", "176-187"], "DRUGB": ["rifampin", "drug", "267-274"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE mycophenolate mofetil cyclosporine @DRUG$ @DRUG$ sirolimus nifedipine fluconazole ritonavir rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p24", "DRUGA": ["tacrolimus", "drug", "190-199"], "DRUGB": ["prednisolone", "drug", "202-213"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE mycophenolate mofetil cyclosporine @DRUG$ prednisolone @DRUG$ nifedipine fluconazole ritonavir rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p25", "DRUGA": ["tacrolimus", "drug", "190-199"], "DRUGB": ["sirolimus", "drug", "216-224"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE mycophenolate mofetil cyclosporine @DRUG$ prednisolone sirolimus @DRUG$ fluconazole ritonavir rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p26", "DRUGA": ["tacrolimus", "drug", "190-199"], "DRUGB": ["nifedipine", "drug", "227-236"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE mycophenolate mofetil cyclosporine @DRUG$ prednisolone sirolimus nifedipine @DRUG$ ritonavir rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p27", "DRUGA": ["tacrolimus", "drug", "190-199"], "DRUGB": ["fluconazole", "drug", "239-249"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE mycophenolate mofetil cyclosporine @DRUG$ prednisolone sirolimus nifedipine fluconazole @DRUG$ rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p28", "DRUGA": ["tacrolimus", "drug", "190-199"], "DRUGB": ["ritonavir", "drug", "252-260"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE mycophenolate mofetil cyclosporine @DRUG$ prednisolone sirolimus nifedipine fluconazole ritonavir @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p29", "DRUGA": ["tacrolimus", "drug", "190-199"], "DRUGB": ["rifampin", "drug", "267-274"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE mycophenolate mofetil cyclosporine tacrolimus @DRUG$ @DRUG$ nifedipine fluconazole ritonavir rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p30", "DRUGA": ["prednisolone", "drug", "202-213"], "DRUGB": ["sirolimus", "drug", "216-224"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE mycophenolate mofetil cyclosporine tacrolimus @DRUG$ sirolimus @DRUG$ fluconazole ritonavir rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p31", "DRUGA": ["prednisolone", "drug", "202-213"], "DRUGB": ["nifedipine", "drug", "227-236"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE mycophenolate mofetil cyclosporine tacrolimus @DRUG$ sirolimus nifedipine @DRUG$ ritonavir rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p32", "DRUGA": ["prednisolone", "drug", "202-213"], "DRUGB": ["fluconazole", "drug", "239-249"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE mycophenolate mofetil cyclosporine tacrolimus @DRUG$ sirolimus nifedipine fluconazole @DRUG$ rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p33", "DRUGA": ["prednisolone", "drug", "202-213"], "DRUGB": ["ritonavir", "drug", "252-260"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE mycophenolate mofetil cyclosporine tacrolimus @DRUG$ sirolimus nifedipine fluconazole ritonavir @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p34", "DRUGA": ["prednisolone", "drug", "202-213"], "DRUGB": ["rifampin", "drug", "267-274"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE mycophenolate mofetil cyclosporine tacrolimus prednisolone @DRUG$ @DRUG$ fluconazole ritonavir rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p35", "DRUGA": ["sirolimus", "drug", "216-224"], "DRUGB": ["nifedipine", "drug", "227-236"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE mycophenolate mofetil cyclosporine tacrolimus prednisolone @DRUG$ nifedipine @DRUG$ ritonavir rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p36", "DRUGA": ["sirolimus", "drug", "216-224"], "DRUGB": ["fluconazole", "drug", "239-249"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE mycophenolate mofetil cyclosporine tacrolimus prednisolone @DRUG$ nifedipine fluconazole @DRUG$ rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p37", "DRUGA": ["sirolimus", "drug", "216-224"], "DRUGB": ["ritonavir", "drug", "252-260"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE mycophenolate mofetil cyclosporine tacrolimus prednisolone @DRUG$ nifedipine fluconazole ritonavir @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p38", "DRUGA": ["sirolimus", "drug", "216-224"], "DRUGB": ["rifampin", "drug", "267-274"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE mycophenolate mofetil cyclosporine tacrolimus prednisolone sirolimus @DRUG$ @DRUG$ ritonavir rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p39", "DRUGA": ["nifedipine", "drug", "227-236"], "DRUGB": ["fluconazole", "drug", "239-249"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE mycophenolate mofetil cyclosporine tacrolimus prednisolone sirolimus @DRUG$ fluconazole @DRUG$ rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p40", "DRUGA": ["nifedipine", "drug", "227-236"], "DRUGB": ["ritonavir", "drug", "252-260"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE mycophenolate mofetil cyclosporine tacrolimus prednisolone sirolimus @DRUG$ fluconazole ritonavir @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p41", "DRUGA": ["nifedipine", "drug", "227-236"], "DRUGB": ["rifampin", "drug", "267-274"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE mycophenolate mofetil cyclosporine tacrolimus prednisolone sirolimus nifedipine @DRUG$ @DRUG$ rifampin", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p42", "DRUGA": ["fluconazole", "drug", "239-249"], "DRUGB": ["ritonavir", "drug", "252-260"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE mycophenolate mofetil cyclosporine tacrolimus prednisolone sirolimus nifedipine @DRUG$ ritonavir @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p43", "DRUGA": ["fluconazole", "drug", "239-249"], "DRUGB": ["rifampin", "drug", "267-274"]}
{"TEXT1": "total interaction conducted healthy volunteers to evaluate potential MYCAMINE mycophenolate mofetil cyclosporine tacrolimus prednisolone sirolimus nifedipine fluconazole @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d735.s0.p44", "DRUGA": ["ritonavir", "drug", "252-260"], "DRUGB": ["rifampin", "drug", "267-274"]}
{"TEXT1": "no effect single dose multiple doses @DRUG$ @DRUG$ cyclosporine tacrolimus prednisolone fluconazole pharmacokinetics", "LBL": "0", "ID": "DDI-DrugBank.d735.s2.p0", "DRUGA": ["MYCAMINE", "brand", "58-65"], "DRUGB": ["mycophenolate mofetil", "drug", "70-90"]}
{"TEXT1": "no effect single dose multiple doses @DRUG$ mycophenolate mofetil @DRUG$ tacrolimus prednisolone fluconazole pharmacokinetics", "LBL": "0", "ID": "DDI-DrugBank.d735.s2.p1", "DRUGA": ["MYCAMINE", "brand", "58-65"], "DRUGB": ["cyclosporine", "drug", "93-104"]}
{"TEXT1": "no effect single dose multiple doses @DRUG$ mycophenolate mofetil cyclosporine @DRUG$ prednisolone fluconazole pharmacokinetics", "LBL": "0", "ID": "DDI-DrugBank.d735.s2.p2", "DRUGA": ["MYCAMINE", "brand", "58-65"], "DRUGB": ["tacrolimus", "drug", "107-116"]}
{"TEXT1": "no effect single dose multiple doses @DRUG$ mycophenolate mofetil cyclosporine tacrolimus @DRUG$ fluconazole pharmacokinetics", "LBL": "0", "ID": "DDI-DrugBank.d735.s2.p3", "DRUGA": ["MYCAMINE", "brand", "58-65"], "DRUGB": ["prednisolone", "drug", "119-130"]}
{"TEXT1": "no effect single dose multiple doses @DRUG$ mycophenolate mofetil cyclosporine tacrolimus prednisolone @DRUG$ pharmacokinetics", "LBL": "0", "ID": "DDI-DrugBank.d735.s2.p4", "DRUGA": ["MYCAMINE", "brand", "58-65"], "DRUGB": ["fluconazole", "drug", "137-147"]}
{"TEXT1": "no effect single dose multiple doses MYCAMINE @DRUG$ @DRUG$ tacrolimus prednisolone fluconazole pharmacokinetics", "LBL": "0", "ID": "DDI-DrugBank.d735.s2.p5", "DRUGA": ["mycophenolate mofetil", "drug", "70-90"], "DRUGB": ["cyclosporine", "drug", "93-104"]}
{"TEXT1": "no effect single dose multiple doses MYCAMINE @DRUG$ cyclosporine @DRUG$ prednisolone fluconazole pharmacokinetics", "LBL": "0", "ID": "DDI-DrugBank.d735.s2.p6", "DRUGA": ["mycophenolate mofetil", "drug", "70-90"], "DRUGB": ["tacrolimus", "drug", "107-116"]}
{"TEXT1": "no effect single dose multiple doses MYCAMINE @DRUG$ cyclosporine tacrolimus @DRUG$ fluconazole pharmacokinetics", "LBL": "0", "ID": "DDI-DrugBank.d735.s2.p7", "DRUGA": ["mycophenolate mofetil", "drug", "70-90"], "DRUGB": ["prednisolone", "drug", "119-130"]}
{"TEXT1": "no effect single dose multiple doses MYCAMINE @DRUG$ cyclosporine tacrolimus prednisolone @DRUG$ pharmacokinetics", "LBL": "0", "ID": "DDI-DrugBank.d735.s2.p8", "DRUGA": ["mycophenolate mofetil", "drug", "70-90"], "DRUGB": ["fluconazole", "drug", "137-147"]}
{"TEXT1": "no effect single dose multiple doses MYCAMINE mycophenolate mofetil @DRUG$ @DRUG$ prednisolone fluconazole pharmacokinetics", "LBL": "0", "ID": "DDI-DrugBank.d735.s2.p9", "DRUGA": ["cyclosporine", "drug", "93-104"], "DRUGB": ["tacrolimus", "drug", "107-116"]}
{"TEXT1": "no effect single dose multiple doses MYCAMINE mycophenolate mofetil @DRUG$ tacrolimus @DRUG$ fluconazole pharmacokinetics", "LBL": "0", "ID": "DDI-DrugBank.d735.s2.p10", "DRUGA": ["cyclosporine", "drug", "93-104"], "DRUGB": ["prednisolone", "drug", "119-130"]}
{"TEXT1": "no effect single dose multiple doses MYCAMINE mycophenolate mofetil @DRUG$ tacrolimus prednisolone @DRUG$ pharmacokinetics", "LBL": "0", "ID": "DDI-DrugBank.d735.s2.p11", "DRUGA": ["cyclosporine", "drug", "93-104"], "DRUGB": ["fluconazole", "drug", "137-147"]}
{"TEXT1": "no effect single dose multiple doses MYCAMINE mycophenolate mofetil cyclosporine @DRUG$ @DRUG$ fluconazole pharmacokinetics", "LBL": "0", "ID": "DDI-DrugBank.d735.s2.p12", "DRUGA": ["tacrolimus", "drug", "107-116"], "DRUGB": ["prednisolone", "drug", "119-130"]}
{"TEXT1": "no effect single dose multiple doses MYCAMINE mycophenolate mofetil cyclosporine @DRUG$ prednisolone @DRUG$ pharmacokinetics", "LBL": "0", "ID": "DDI-DrugBank.d735.s2.p13", "DRUGA": ["tacrolimus", "drug", "107-116"], "DRUGB": ["fluconazole", "drug", "137-147"]}
{"TEXT1": "no effect single dose multiple doses MYCAMINE mycophenolate mofetil cyclosporine tacrolimus @DRUG$ @DRUG$ pharmacokinetics", "LBL": "0", "ID": "DDI-DrugBank.d735.s2.p14", "DRUGA": ["prednisolone", "drug", "119-130"], "DRUGB": ["fluconazole", "drug", "137-147"]}
{"TEXT1": "@DRUG$ AUC increased no effect Cmax presence @DRUG$ compared sirolimus alone", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d735.s3.p0", "DRUGA": ["Sirolimus", "drug", "0-8"], "DRUGB": ["MYCAMINE", "brand", "90-97"]}
{"TEXT1": "@DRUG$ AUC increased no effect Cmax presence MYCAMINE compared @DRUG$ alone", "LBL": "0", "ID": "DDI-DrugBank.d735.s3.p1", "DRUGA": ["Sirolimus", "drug", "0-8"], "DRUGB": ["sirolimus", "drug", "113-121"]}
{"TEXT1": "AUC increased no effect Cmax presence @DRUG$ compared @DRUG$ alone", "LBL": "0", "ID": "DDI-DrugBank.d735.s3.p2", "DRUGA": ["MYCAMINE", "brand", "90-97"], "DRUGB": ["sirolimus", "drug", "113-121"]}
{"TEXT1": "@DRUG$ AUC Cmax increased presence @DRUG$ compared nifedipine alone", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d735.s4.p0", "DRUGA": ["Nifedipine", "drug", "0-9"], "DRUGB": ["MYCAMINE", "brand", "101-108"]}
{"TEXT1": "@DRUG$ AUC Cmax increased presence MYCAMINE compared @DRUG$ alone", "LBL": "0", "ID": "DDI-DrugBank.d735.s4.p1", "DRUGA": ["Nifedipine", "drug", "0-9"], "DRUGB": ["nifedipine", "drug", "124-133"]}
{"TEXT1": "AUC Cmax increased presence @DRUG$ compared @DRUG$ alone", "LBL": "0", "ID": "DDI-DrugBank.d735.s4.p2", "DRUGA": ["MYCAMINE", "brand", "101-108"], "DRUGB": ["nifedipine", "drug", "124-133"]}
{"TEXT1": "Patients receiving @DRUG$ @DRUG$ combination MYCAMINE monitored sirolimus nifedipine toxicity dosage reduced", "LBL": "0", "ID": "DDI-DrugBank.d735.s5.p0", "DRUGA": ["sirolimus", "drug", "19-27"], "DRUGB": ["nifedipine", "drug", "32-41"]}
{"TEXT1": "Patients receiving @DRUG$ nifedipine combination @DRUG$ monitored sirolimus toxicity dosage reduced", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d735.s5.p1", "DRUGA": ["sirolimus", "drug", "19-27"], "DRUGB": ["MYCAMINE", "brand", "63-70"]}
{"TEXT1": "Patients receiving @DRUG$ nifedipine combination MYCAMINE monitored @DRUG$ toxicity sirolimus dosage reduced", "LBL": "0", "ID": "DDI-DrugBank.d735.s5.p2", "DRUGA": ["sirolimus", "drug", "19-27"], "DRUGB": ["sirolimus", "drug", "96-104"]}
{"TEXT1": "Patients receiving @DRUG$ nifedipine combination MYCAMINE monitored sirolimus @DRUG$ toxicity dosage reduced", "LBL": "0", "ID": "DDI-DrugBank.d735.s5.p3", "DRUGA": ["sirolimus", "drug", "19-27"], "DRUGB": ["nifedipine", "drug", "109-118"]}
{"TEXT1": "Patients receiving @DRUG$ nifedipine combination MYCAMINE monitored sirolimus toxicity @DRUG$ dosage reduced", "LBL": "0", "ID": "DDI-DrugBank.d735.s5.p4", "DRUGA": ["sirolimus", "drug", "19-27"], "DRUGB": ["sirolimus", "drug", "133-141"]}
{"TEXT1": "Patients receiving @DRUG$ nifedipine combination MYCAMINE monitored sirolimus toxicity @DRUG$ dosage reduced", "LBL": "0", "ID": "DDI-DrugBank.d735.s5.p5", "DRUGA": ["sirolimus", "drug", "19-27"], "DRUGB": ["nifedipine", "drug", "146-155"]}
{"TEXT1": "Patients receiving sirolimus @DRUG$ combination @DRUG$ monitored nifedipine toxicity dosage reduced", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d735.s5.p6", "DRUGA": ["nifedipine", "drug", "32-41"], "DRUGB": ["MYCAMINE", "brand", "63-70"]}
{"TEXT1": "Patients receiving sirolimus @DRUG$ combination MYCAMINE monitored @DRUG$ nifedipine toxicity dosage reduced", "LBL": "0", "ID": "DDI-DrugBank.d735.s5.p7", "DRUGA": ["nifedipine", "drug", "32-41"], "DRUGB": ["sirolimus", "drug", "96-104"]}
{"TEXT1": "Patients receiving sirolimus @DRUG$ combination MYCAMINE monitored @DRUG$ toxicity nifedipine dosage reduced", "LBL": "0", "ID": "DDI-DrugBank.d735.s5.p8", "DRUGA": ["nifedipine", "drug", "32-41"], "DRUGB": ["nifedipine", "drug", "109-118"]}
{"TEXT1": "Patients receiving sirolimus @DRUG$ combination MYCAMINE monitored nifedipine toxicity @DRUG$ dosage reduced", "LBL": "0", "ID": "DDI-DrugBank.d735.s5.p9", "DRUGA": ["nifedipine", "drug", "32-41"], "DRUGB": ["sirolimus", "drug", "133-141"]}
{"TEXT1": "Patients receiving sirolimus @DRUG$ combination MYCAMINE monitored nifedipine toxicity @DRUG$ dosage reduced", "LBL": "0", "ID": "DDI-DrugBank.d735.s5.p10", "DRUGA": ["nifedipine", "drug", "32-41"], "DRUGB": ["nifedipine", "drug", "146-155"]}
{"TEXT1": "Patients receiving sirolimus nifedipine combination @DRUG$ monitored @DRUG$ toxicity dosage reduced", "LBL": "0", "ID": "DDI-DrugBank.d735.s5.p11", "DRUGA": ["MYCAMINE", "brand", "63-70"], "DRUGB": ["sirolimus", "drug", "96-104"]}
{"TEXT1": "Patients receiving sirolimus nifedipine combination @DRUG$ monitored @DRUG$ toxicity dosage reduced", "LBL": "0", "ID": "DDI-DrugBank.d735.s5.p12", "DRUGA": ["MYCAMINE", "brand", "63-70"], "DRUGB": ["nifedipine", "drug", "109-118"]}
{"TEXT1": "Patients receiving sirolimus nifedipine combination @DRUG$ monitored toxicity @DRUG$ dosage reduced", "LBL": "0", "ID": "DDI-DrugBank.d735.s5.p13", "DRUGA": ["MYCAMINE", "brand", "63-70"], "DRUGB": ["sirolimus", "drug", "133-141"]}
{"TEXT1": "Patients receiving sirolimus nifedipine combination @DRUG$ monitored toxicity @DRUG$ dosage reduced", "LBL": "0", "ID": "DDI-DrugBank.d735.s5.p14", "DRUGA": ["MYCAMINE", "brand", "63-70"], "DRUGB": ["nifedipine", "drug", "146-155"]}
{"TEXT1": "Patients receiving sirolimus nifedipine combination MYCAMINE monitored @DRUG$ @DRUG$ toxicity dosage reduced", "LBL": "0", "ID": "DDI-DrugBank.d735.s5.p15", "DRUGA": ["sirolimus", "drug", "96-104"], "DRUGB": ["nifedipine", "drug", "109-118"]}
{"TEXT1": "Patients receiving sirolimus nifedipine combination MYCAMINE monitored @DRUG$ toxicity @DRUG$ dosage reduced", "LBL": "0", "ID": "DDI-DrugBank.d735.s5.p16", "DRUGA": ["sirolimus", "drug", "96-104"], "DRUGB": ["sirolimus", "drug", "133-141"]}
{"TEXT1": "Patients receiving sirolimus nifedipine combination MYCAMINE monitored @DRUG$ toxicity @DRUG$ dosage reduced", "LBL": "0", "ID": "DDI-DrugBank.d735.s5.p17", "DRUGA": ["sirolimus", "drug", "96-104"], "DRUGB": ["nifedipine", "drug", "146-155"]}
{"TEXT1": "Patients receiving sirolimus nifedipine combination MYCAMINE monitored @DRUG$ toxicity @DRUG$ dosage reduced", "LBL": "0", "ID": "DDI-DrugBank.d735.s5.p18", "DRUGA": ["nifedipine", "drug", "109-118"], "DRUGB": ["sirolimus", "drug", "133-141"]}
{"TEXT1": "Patients receiving sirolimus nifedipine combination MYCAMINE monitored @DRUG$ toxicity @DRUG$ dosage reduced", "LBL": "0", "ID": "DDI-DrugBank.d735.s5.p19", "DRUGA": ["nifedipine", "drug", "109-118"], "DRUGB": ["nifedipine", "drug", "146-155"]}
{"TEXT1": "Patients receiving sirolimus nifedipine combination MYCAMINE monitored toxicity @DRUG$ @DRUG$ dosage reduced", "LBL": "0", "ID": "DDI-DrugBank.d735.s5.p20", "DRUGA": ["sirolimus", "drug", "133-141"], "DRUGB": ["nifedipine", "drug", "146-155"]}
{"TEXT1": "Dosages administered @DRUG$ reduced approximately half @DRUG$ therapeutic actions opioids", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d756.s0.p0", "DRUGA": ["opioids", "group", "38-44"], "DRUGB": ["levomepromazine", "drug", "95-109"]}
{"TEXT1": "Dosages administered @DRUG$ reduced approximately half levomepromazine therapeutic actions @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d756.s0.p1", "DRUGA": ["opioids", "group", "38-44"], "DRUGB": ["opioids", "group", "165-171"]}
{"TEXT1": "Dosages administered opioids reduced approximately half @DRUG$ therapeutic actions @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d756.s0.p2", "DRUGA": ["levomepromazine", "drug", "95-109"], "DRUGB": ["opioids", "group", "165-171"]}
{"TEXT1": "Combination @DRUG$ increased risk seizures", "LBL": "0", "ID": "DDI-DrugBank.d756.s1.p0", "DRUGA": ["tramadol", "drug", "17-24"], "DRUGB": ["Ultram", "brand", "27-32"]}
{"TEXT1": "Additive sedative effects confusional states @DRUG$ given @DRUG$ barbiturates", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d756.s2.p0", "DRUGA": ["levomepromazine", "drug", "63-77"], "DRUGB": ["benzodiazepines", "group", "93-107"]}
{"TEXT1": "Additive sedative effects confusional states @DRUG$ given benzodiazepines @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d756.s2.p1", "DRUGA": ["levomepromazine", "drug", "63-77"], "DRUGB": ["barbiturates", "group", "112-123"]}
{"TEXT1": "Additive sedative effects confusional states levomepromazine given @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d756.s2.p2", "DRUGA": ["benzodiazepines", "group", "93-107"], "DRUGB": ["barbiturates", "group", "112-123"]}
{"TEXT1": "Exert combining @DRUG$ @DRUG$ elderly delirium high fever severe obstipation ileus glaucoma", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d756.s4.p0", "DRUGA": ["levomepromazine", "drug", "38-52"], "DRUGB": ["anticholinergic drugs", "group", "65-85"]}
{"TEXT1": "Exert combining @DRUG$ anticholinergic drugs elderly delirium high fever severe obstipation ileus glaucoma", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d756.s4.p1", "DRUGA": ["levomepromazine", "drug", "38-52"], "DRUGB": ["tricyclic antidepressants", "group", "88-112"]}
{"TEXT1": "Exert combining @DRUG$ anticholinergic drugs elderly delirium high fever severe obstipation ileus glaucoma", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d756.s4.p2", "DRUGA": ["levomepromazine", "drug", "38-52"], "DRUGB": ["antiparkinsonian-agents", "group", "118-140"]}
{"TEXT1": "Exert combining levomepromazine @DRUG$ elderly delirium high fever severe obstipation ileus glaucoma", "LBL": "0", "ID": "DDI-DrugBank.d756.s4.p3", "DRUGA": ["anticholinergic drugs", "group", "65-85"], "DRUGB": ["tricyclic antidepressants", "group", "88-112"]}
{"TEXT1": "Exert combining levomepromazine @DRUG$ elderly delirium high fever severe obstipation ileus glaucoma", "LBL": "0", "ID": "DDI-DrugBank.d756.s4.p4", "DRUGA": ["anticholinergic drugs", "group", "65-85"], "DRUGB": ["antiparkinsonian-agents", "group", "118-140"]}
{"TEXT1": "Exert combining levomepromazine anticholinergic drugs elderly delirium high fever severe obstipation ileus glaucoma", "LBL": "0", "ID": "DDI-DrugBank.d756.s4.p5", "DRUGA": ["tricyclic antidepressants", "group", "88-112"], "DRUGB": ["antiparkinsonian-agents", "group", "118-140"]}
{"TEXT1": "@DRUG$ type specific actions levomepromazine", "LBL": "0", "ID": "DDI-DrugBank.d756.s7.p0", "DRUGA": ["Caffeine", "drug", "0-7"], "DRUGB": ["ephedrine", "drug", "35-43"]}
{"TEXT1": "@DRUG$ type specific actions levomepromazine", "LBL": "0", "ID": "DDI-DrugBank.d756.s7.p1", "DRUGA": ["Caffeine", "drug", "0-7"], "DRUGB": ["amphetamine", "drug", "45-55"]}
{"TEXT1": "@DRUG$ type specific actions @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d756.s7.p2", "DRUGA": ["Caffeine", "drug", "0-7"], "DRUGB": ["levomepromazine", "drug", "101-115"]}
{"TEXT1": "Caffeine type specific actions levomepromazine", "LBL": "0", "ID": "DDI-DrugBank.d756.s7.p3", "DRUGA": ["ephedrine", "drug", "35-43"], "DRUGB": ["amphetamine", "drug", "45-55"]}
{"TEXT1": "Caffeine type specific actions @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d756.s7.p4", "DRUGA": ["ephedrine", "drug", "35-43"], "DRUGB": ["levomepromazine", "drug", "101-115"]}
{"TEXT1": "Caffeine type specific actions @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d756.s7.p5", "DRUGA": ["amphetamine", "drug", "45-55"], "DRUGB": ["levomepromazine", "drug", "101-115"]}
{"TEXT1": "@DRUG$ mixture three administered following succinylcholine tracheal intubation interaction @DRUG$ not studied", "LBL": "0", "ID": "DDI-DrugBank.d775.s0.p0", "DRUGA": ["MIVACRON", "brand", "9-16"], "DRUGB": ["MIVACRON", "brand", "165-172"]}
{"TEXT1": "@DRUG$ mixture three administered following succinylcholine tracheal intubation interaction MIVACRON @DRUG$ not studied", "LBL": "0", "ID": "DDI-DrugBank.d775.s0.p1", "DRUGA": ["MIVACRON", "brand", "9-16"], "DRUGB": ["succinylcholine", "drug", "178-192"]}
{"TEXT1": "MIVACRON mixture three administered following succinylcholine tracheal intubation interaction @DRUG$ @DRUG$ not studied", "LBL": "0", "ID": "DDI-DrugBank.d775.s0.p2", "DRUGA": ["MIVACRON", "brand", "165-172"], "DRUGB": ["succinylcholine", "drug", "178-192"]}
{"TEXT1": "Prior administration @DRUG$ effects @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d775.s1.p0", "DRUGA": ["succinylcholine", "drug", "24-38"], "DRUGB": ["nondepolarizing agents", "group", "93-114"]}
{"TEXT1": "Evidence spontaneous recovery @DRUG$ observed administration @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d775.s2.p0", "DRUGA": ["succinylcholine", "drug", "38-52"], "DRUGB": ["MIVACRON", "brand", "102-109"]}
{"TEXT1": "use of @DRUG$ @DRUG$ to attenuate side effects succinylcholine not studied", "LBL": "0", "ID": "DDI-DrugBank.d775.s3.p0", "DRUGA": ["MIVACRON", "brand", "11-18"], "DRUGB": ["succinylcholine", "drug", "27-41"]}
{"TEXT1": "use of @DRUG$ succinylcholine to attenuate side effects @DRUG$ not studied", "LBL": "0", "ID": "DDI-DrugBank.d775.s3.p1", "DRUGA": ["MIVACRON", "brand", "11-18"], "DRUGB": ["succinylcholine", "drug", "84-98"]}
{"TEXT1": "use of MIVACRON @DRUG$ to attenuate side effects @DRUG$ not studied", "LBL": "0", "ID": "DDI-DrugBank.d775.s3.p2", "DRUGA": ["succinylcholine", "drug", "27-41"], "DRUGB": ["succinylcholine", "drug", "84-98"]}
{"TEXT1": "no clinical data use of @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s4.p0", "DRUGA": ["MIVACRON", "brand", "41-48"], "DRUGB": ["nondepolarizing neuromuscular blocking agents", "group", "61-105"]}
{"TEXT1": "@DRUG$ @DRUG$ to 1 M", "LBL": "0", "ID": "DDI-DrugBank.d775.s5.p0", "DRUGA": ["Isoflurane", "drug", "0-9"], "DRUGB": ["enflurane", "drug", "15-23"]}
{"TEXT1": "@DRUG$ enflurane to 1 M", "LBL": "0", "ID": "DDI-DrugBank.d775.s5.p1", "DRUGA": ["Isoflurane", "drug", "0-9"], "DRUGB": ["nitrous oxide", "drug", "44-56"]}
{"TEXT1": "@DRUG$ enflurane to 1 M", "LBL": "0", "ID": "DDI-DrugBank.d775.s5.p2", "DRUGA": ["Isoflurane", "drug", "0-9"], "DRUGB": ["oxygen", "drug", "58-63"]}
{"TEXT1": "Isoflurane @DRUG$ to 1 M", "LBL": "0", "ID": "DDI-DrugBank.d775.s5.p3", "DRUGA": ["enflurane", "drug", "15-23"], "DRUGB": ["nitrous oxide", "drug", "44-56"]}
{"TEXT1": "Isoflurane @DRUG$ to 1 M", "LBL": "0", "ID": "DDI-DrugBank.d775.s5.p4", "DRUGA": ["enflurane", "drug", "15-23"], "DRUGB": ["oxygen", "drug", "58-63"]}
{"TEXT1": "Isoflurane enflurane to 1 M", "LBL": "0", "ID": "DDI-DrugBank.d775.s5.p5", "DRUGA": ["nitrous oxide", "drug", "44-56"], "DRUGB": ["oxygen", "drug", "58-63"]}
{"TEXT1": "greater potentiation neuromuscular blocking neuromuscular effects blocking effects @DRUG$ expected higher concentrations @DRUG$ isoflurane", "LBL": "0", "ID": "DDI-DrugBank.d775.s8.p0", "DRUGA": ["MIVACRON", "brand", "64-71"], "DRUGB": ["enflurane", "drug", "119-127"]}
{"TEXT1": "greater potentiation neuromuscular blocking neuromuscular effects blocking effects @DRUG$ expected higher concentrations enflurane @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s8.p1", "DRUGA": ["MIVACRON", "brand", "64-71"], "DRUGB": ["isoflurane", "drug", "132-141"]}
{"TEXT1": "greater potentiation neuromuscular blocking neuromuscular effects blocking effects MIVACRON expected higher concentrations @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s8.p2", "DRUGA": ["enflurane", "drug", "119-127"], "DRUGB": ["isoflurane", "drug", "132-141"]}
{"TEXT1": "drugs enhance action @DRUG$ @DRUG$ include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p0", "DRUGA": ["nondepolarizing agents", "drug", "67-88"], "DRUGB": ["MIVACRON", "brand", "98-105"]}
{"TEXT1": "drugs enhance action @DRUG$ MIVACRON include certain @DRUG$ aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d775.s10.p1", "DRUGA": ["nondepolarizing agents", "drug", "67-88"], "DRUGB": ["antibiotics", "group", "123-133"]}
{"TEXT1": "drugs enhance action @DRUG$ MIVACRON include certain antibiotics @DRUG$ tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d775.s10.p2", "DRUGA": ["nondepolarizing agents", "drug", "67-88"], "DRUGB": ["aminoglycosides", "group", "142-156"]}
{"TEXT1": "drugs enhance action @DRUG$ MIVACRON include certain antibiotics aminoglycosides @DRUG$ bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d775.s10.p3", "DRUGA": ["nondepolarizing agents", "drug", "67-88"], "DRUGB": ["tetracyclines", "group", "159-171"]}
{"TEXT1": "drugs enhance action @DRUG$ MIVACRON include certain antibiotics aminoglycosides tetracyclines @DRUG$ polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d775.s10.p4", "DRUGA": ["nondepolarizing agents", "drug", "67-88"], "DRUGB": ["bacitracin", "drug", "174-183"]}
{"TEXT1": "drugs enhance action @DRUG$ MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin @DRUG$ lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d775.s10.p5", "DRUGA": ["nondepolarizing agents", "drug", "67-88"], "DRUGB": ["polymyxins", "group", "186-195"]}
{"TEXT1": "drugs enhance action @DRUG$ MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins @DRUG$ clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d775.s10.p6", "DRUGA": ["nondepolarizing agents", "drug", "67-88"], "DRUGB": ["lincomycin", "drug", "198-207"]}
{"TEXT1": "drugs enhance action @DRUG$ MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin @DRUG$ colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d775.s10.p7", "DRUGA": ["nondepolarizing agents", "drug", "67-88"], "DRUGB": ["clindamycin", "drug", "210-220"]}
{"TEXT1": "drugs enhance action @DRUG$ MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin @DRUG$ sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d775.s10.p8", "DRUGA": ["nondepolarizing agents", "drug", "67-88"], "DRUGB": ["colistin", "drug", "223-230"]}
{"TEXT1": "drugs enhance action @DRUG$ MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d775.s10.p9", "DRUGA": ["nondepolarizing agents", "drug", "67-88"], "DRUGB": ["sodium colistimethate", "drug", "237-257"]}
{"TEXT1": "drugs enhance action @DRUG$ MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium @DRUG$ lithium local anesthetics procainamide quinidine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d775.s10.p10", "DRUGA": ["nondepolarizing agents", "drug", "67-88"], "DRUGB": ["magnesium", "group", "261-269"]}
{"TEXT1": "drugs enhance action @DRUG$ MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts @DRUG$ local anesthetics procainamide quinidine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d775.s10.p11", "DRUGA": ["nondepolarizing agents", "drug", "67-88"], "DRUGB": ["lithium", "drug", "278-284"]}
{"TEXT1": "drugs enhance action @DRUG$ MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium @DRUG$ procainamide quinidine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d775.s10.p12", "DRUGA": ["nondepolarizing agents", "drug", "67-88"], "DRUGB": ["anesthetics", "group", "293-303"]}
{"TEXT1": "drugs enhance action @DRUG$ MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics @DRUG$ quinidine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d775.s10.p13", "DRUGA": ["nondepolarizing agents", "drug", "67-88"], "DRUGB": ["procainamide", "drug", "306-317"]}
{"TEXT1": "drugs enhance action @DRUG$ MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide @DRUG$", "LBL": "DDI-int", "ID": "DDI-DrugBank.d775.s10.p14", "DRUGA": ["nondepolarizing agents", "drug", "67-88"], "DRUGB": ["quinidine", "drug", "324-332"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action @DRUG$ include certain @DRUG$ aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d775.s10.p15", "DRUGA": ["MIVACRON", "brand", "98-105"], "DRUGB": ["antibiotics", "group", "123-133"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action @DRUG$ include certain antibiotics @DRUG$ tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d775.s10.p16", "DRUGA": ["MIVACRON", "brand", "98-105"], "DRUGB": ["aminoglycosides", "group", "142-156"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action @DRUG$ include certain antibiotics aminoglycosides @DRUG$ bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d775.s10.p17", "DRUGA": ["MIVACRON", "brand", "98-105"], "DRUGB": ["tetracyclines", "group", "159-171"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action @DRUG$ include certain antibiotics aminoglycosides tetracyclines @DRUG$ polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d775.s10.p18", "DRUGA": ["MIVACRON", "brand", "98-105"], "DRUGB": ["bacitracin", "drug", "174-183"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action @DRUG$ include certain antibiotics aminoglycosides tetracyclines bacitracin @DRUG$ lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d775.s10.p19", "DRUGA": ["MIVACRON", "brand", "98-105"], "DRUGB": ["polymyxins", "group", "186-195"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action @DRUG$ include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins @DRUG$ clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d775.s10.p20", "DRUGA": ["MIVACRON", "brand", "98-105"], "DRUGB": ["lincomycin", "drug", "198-207"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action @DRUG$ include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin @DRUG$ colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d775.s10.p21", "DRUGA": ["MIVACRON", "brand", "98-105"], "DRUGB": ["clindamycin", "drug", "210-220"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action @DRUG$ include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin @DRUG$ sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d775.s10.p22", "DRUGA": ["MIVACRON", "brand", "98-105"], "DRUGB": ["colistin", "drug", "223-230"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action @DRUG$ include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d775.s10.p23", "DRUGA": ["MIVACRON", "brand", "98-105"], "DRUGB": ["sodium colistimethate", "drug", "237-257"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action @DRUG$ include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium @DRUG$ lithium local anesthetics procainamide quinidine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d775.s10.p24", "DRUGA": ["MIVACRON", "brand", "98-105"], "DRUGB": ["magnesium", "group", "261-269"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action @DRUG$ include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts @DRUG$ local anesthetics procainamide quinidine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d775.s10.p25", "DRUGA": ["MIVACRON", "brand", "98-105"], "DRUGB": ["lithium", "drug", "278-284"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action @DRUG$ include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium @DRUG$ procainamide quinidine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d775.s10.p26", "DRUGA": ["MIVACRON", "brand", "98-105"], "DRUGB": ["anesthetics", "group", "293-303"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action @DRUG$ include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics @DRUG$ quinidine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d775.s10.p27", "DRUGA": ["MIVACRON", "brand", "98-105"], "DRUGB": ["procainamide", "drug", "306-317"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action @DRUG$ include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide @DRUG$", "LBL": "DDI-int", "ID": "DDI-DrugBank.d775.s10.p28", "DRUGA": ["MIVACRON", "brand", "98-105"], "DRUGB": ["quinidine", "drug", "324-332"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain @DRUG$ @DRUG$ tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p29", "DRUGA": ["antibiotics", "group", "123-133"], "DRUGB": ["aminoglycosides", "group", "142-156"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain @DRUG$ aminoglycosides @DRUG$ bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p30", "DRUGA": ["antibiotics", "group", "123-133"], "DRUGB": ["tetracyclines", "group", "159-171"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain @DRUG$ aminoglycosides tetracyclines @DRUG$ polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p31", "DRUGA": ["antibiotics", "group", "123-133"], "DRUGB": ["bacitracin", "drug", "174-183"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain @DRUG$ aminoglycosides tetracyclines bacitracin @DRUG$ lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p32", "DRUGA": ["antibiotics", "group", "123-133"], "DRUGB": ["polymyxins", "group", "186-195"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain @DRUG$ aminoglycosides tetracyclines bacitracin polymyxins @DRUG$ clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p33", "DRUGA": ["antibiotics", "group", "123-133"], "DRUGB": ["lincomycin", "drug", "198-207"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain @DRUG$ aminoglycosides tetracyclines bacitracin polymyxins lincomycin @DRUG$ colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p34", "DRUGA": ["antibiotics", "group", "123-133"], "DRUGB": ["clindamycin", "drug", "210-220"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain @DRUG$ aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin @DRUG$ sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p35", "DRUGA": ["antibiotics", "group", "123-133"], "DRUGB": ["colistin", "drug", "223-230"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain @DRUG$ aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p36", "DRUGA": ["antibiotics", "group", "123-133"], "DRUGB": ["sodium colistimethate", "drug", "237-257"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain @DRUG$ aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium @DRUG$ lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p37", "DRUGA": ["antibiotics", "group", "123-133"], "DRUGB": ["magnesium", "group", "261-269"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain @DRUG$ aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts @DRUG$ local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p38", "DRUGA": ["antibiotics", "group", "123-133"], "DRUGB": ["lithium", "drug", "278-284"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain @DRUG$ aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium @DRUG$ procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p39", "DRUGA": ["antibiotics", "group", "123-133"], "DRUGB": ["anesthetics", "group", "293-303"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain @DRUG$ aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics @DRUG$ quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p40", "DRUGA": ["antibiotics", "group", "123-133"], "DRUGB": ["procainamide", "drug", "306-317"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain @DRUG$ aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p41", "DRUGA": ["antibiotics", "group", "123-133"], "DRUGB": ["quinidine", "drug", "324-332"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics @DRUG$ @DRUG$ bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p42", "DRUGA": ["aminoglycosides", "group", "142-156"], "DRUGB": ["tetracyclines", "group", "159-171"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics @DRUG$ tetracyclines @DRUG$ polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p43", "DRUGA": ["aminoglycosides", "group", "142-156"], "DRUGB": ["bacitracin", "drug", "174-183"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics @DRUG$ tetracyclines bacitracin @DRUG$ lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p44", "DRUGA": ["aminoglycosides", "group", "142-156"], "DRUGB": ["polymyxins", "group", "186-195"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics @DRUG$ tetracyclines bacitracin polymyxins @DRUG$ clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p45", "DRUGA": ["aminoglycosides", "group", "142-156"], "DRUGB": ["lincomycin", "drug", "198-207"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics @DRUG$ tetracyclines bacitracin polymyxins lincomycin @DRUG$ colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p46", "DRUGA": ["aminoglycosides", "group", "142-156"], "DRUGB": ["clindamycin", "drug", "210-220"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics @DRUG$ tetracyclines bacitracin polymyxins lincomycin clindamycin @DRUG$ sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p47", "DRUGA": ["aminoglycosides", "group", "142-156"], "DRUGB": ["colistin", "drug", "223-230"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics @DRUG$ tetracyclines bacitracin polymyxins lincomycin clindamycin colistin magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p48", "DRUGA": ["aminoglycosides", "group", "142-156"], "DRUGB": ["sodium colistimethate", "drug", "237-257"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics @DRUG$ tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium @DRUG$ lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p49", "DRUGA": ["aminoglycosides", "group", "142-156"], "DRUGB": ["magnesium", "group", "261-269"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics @DRUG$ tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts @DRUG$ local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p50", "DRUGA": ["aminoglycosides", "group", "142-156"], "DRUGB": ["lithium", "drug", "278-284"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics @DRUG$ tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium @DRUG$ procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p51", "DRUGA": ["aminoglycosides", "group", "142-156"], "DRUGB": ["anesthetics", "group", "293-303"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics @DRUG$ tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics @DRUG$ quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p52", "DRUGA": ["aminoglycosides", "group", "142-156"], "DRUGB": ["procainamide", "drug", "306-317"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics @DRUG$ tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p53", "DRUGA": ["aminoglycosides", "group", "142-156"], "DRUGB": ["quinidine", "drug", "324-332"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides @DRUG$ @DRUG$ polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p54", "DRUGA": ["tetracyclines", "group", "159-171"], "DRUGB": ["bacitracin", "drug", "174-183"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides @DRUG$ bacitracin @DRUG$ lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p55", "DRUGA": ["tetracyclines", "group", "159-171"], "DRUGB": ["polymyxins", "group", "186-195"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides @DRUG$ bacitracin polymyxins @DRUG$ clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p56", "DRUGA": ["tetracyclines", "group", "159-171"], "DRUGB": ["lincomycin", "drug", "198-207"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides @DRUG$ bacitracin polymyxins lincomycin @DRUG$ colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p57", "DRUGA": ["tetracyclines", "group", "159-171"], "DRUGB": ["clindamycin", "drug", "210-220"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides @DRUG$ bacitracin polymyxins lincomycin clindamycin @DRUG$ sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p58", "DRUGA": ["tetracyclines", "group", "159-171"], "DRUGB": ["colistin", "drug", "223-230"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides @DRUG$ bacitracin polymyxins lincomycin clindamycin colistin magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p59", "DRUGA": ["tetracyclines", "group", "159-171"], "DRUGB": ["sodium colistimethate", "drug", "237-257"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides @DRUG$ bacitracin polymyxins lincomycin clindamycin colistin sodium @DRUG$ lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p60", "DRUGA": ["tetracyclines", "group", "159-171"], "DRUGB": ["magnesium", "group", "261-269"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides @DRUG$ bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts @DRUG$ local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p61", "DRUGA": ["tetracyclines", "group", "159-171"], "DRUGB": ["lithium", "drug", "278-284"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides @DRUG$ bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium @DRUG$ procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p62", "DRUGA": ["tetracyclines", "group", "159-171"], "DRUGB": ["anesthetics", "group", "293-303"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides @DRUG$ bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics @DRUG$ quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p63", "DRUGA": ["tetracyclines", "group", "159-171"], "DRUGB": ["procainamide", "drug", "306-317"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides @DRUG$ bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p64", "DRUGA": ["tetracyclines", "group", "159-171"], "DRUGB": ["quinidine", "drug", "324-332"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines @DRUG$ @DRUG$ lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p65", "DRUGA": ["bacitracin", "drug", "174-183"], "DRUGB": ["polymyxins", "group", "186-195"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines @DRUG$ polymyxins @DRUG$ clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p66", "DRUGA": ["bacitracin", "drug", "174-183"], "DRUGB": ["lincomycin", "drug", "198-207"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines @DRUG$ polymyxins lincomycin @DRUG$ colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p67", "DRUGA": ["bacitracin", "drug", "174-183"], "DRUGB": ["clindamycin", "drug", "210-220"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines @DRUG$ polymyxins lincomycin clindamycin @DRUG$ sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p68", "DRUGA": ["bacitracin", "drug", "174-183"], "DRUGB": ["colistin", "drug", "223-230"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines @DRUG$ polymyxins lincomycin clindamycin colistin magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p69", "DRUGA": ["bacitracin", "drug", "174-183"], "DRUGB": ["sodium colistimethate", "drug", "237-257"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines @DRUG$ polymyxins lincomycin clindamycin colistin sodium @DRUG$ lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p70", "DRUGA": ["bacitracin", "drug", "174-183"], "DRUGB": ["magnesium", "group", "261-269"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines @DRUG$ polymyxins lincomycin clindamycin colistin sodium magnesium salts @DRUG$ local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p71", "DRUGA": ["bacitracin", "drug", "174-183"], "DRUGB": ["lithium", "drug", "278-284"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines @DRUG$ polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium @DRUG$ procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p72", "DRUGA": ["bacitracin", "drug", "174-183"], "DRUGB": ["anesthetics", "group", "293-303"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines @DRUG$ polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics @DRUG$ quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p73", "DRUGA": ["bacitracin", "drug", "174-183"], "DRUGB": ["procainamide", "drug", "306-317"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines @DRUG$ polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p74", "DRUGA": ["bacitracin", "drug", "174-183"], "DRUGB": ["quinidine", "drug", "324-332"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin @DRUG$ @DRUG$ clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p75", "DRUGA": ["polymyxins", "group", "186-195"], "DRUGB": ["lincomycin", "drug", "198-207"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin @DRUG$ lincomycin @DRUG$ colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p76", "DRUGA": ["polymyxins", "group", "186-195"], "DRUGB": ["clindamycin", "drug", "210-220"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin @DRUG$ lincomycin clindamycin @DRUG$ sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p77", "DRUGA": ["polymyxins", "group", "186-195"], "DRUGB": ["colistin", "drug", "223-230"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin @DRUG$ lincomycin clindamycin colistin magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p78", "DRUGA": ["polymyxins", "group", "186-195"], "DRUGB": ["sodium colistimethate", "drug", "237-257"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin @DRUG$ lincomycin clindamycin colistin sodium @DRUG$ lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p79", "DRUGA": ["polymyxins", "group", "186-195"], "DRUGB": ["magnesium", "group", "261-269"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin @DRUG$ lincomycin clindamycin colistin sodium magnesium salts @DRUG$ local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p80", "DRUGA": ["polymyxins", "group", "186-195"], "DRUGB": ["lithium", "drug", "278-284"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin @DRUG$ lincomycin clindamycin colistin sodium magnesium salts lithium @DRUG$ procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p81", "DRUGA": ["polymyxins", "group", "186-195"], "DRUGB": ["anesthetics", "group", "293-303"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin @DRUG$ lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics @DRUG$ quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p82", "DRUGA": ["polymyxins", "group", "186-195"], "DRUGB": ["procainamide", "drug", "306-317"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin @DRUG$ lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p83", "DRUGA": ["polymyxins", "group", "186-195"], "DRUGB": ["quinidine", "drug", "324-332"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins @DRUG$ @DRUG$ colistin sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p84", "DRUGA": ["lincomycin", "drug", "198-207"], "DRUGB": ["clindamycin", "drug", "210-220"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins @DRUG$ clindamycin @DRUG$ sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p85", "DRUGA": ["lincomycin", "drug", "198-207"], "DRUGB": ["colistin", "drug", "223-230"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins @DRUG$ clindamycin colistin magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p86", "DRUGA": ["lincomycin", "drug", "198-207"], "DRUGB": ["sodium colistimethate", "drug", "237-257"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins @DRUG$ clindamycin colistin sodium @DRUG$ lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p87", "DRUGA": ["lincomycin", "drug", "198-207"], "DRUGB": ["magnesium", "group", "261-269"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins @DRUG$ clindamycin colistin sodium magnesium salts @DRUG$ local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p88", "DRUGA": ["lincomycin", "drug", "198-207"], "DRUGB": ["lithium", "drug", "278-284"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins @DRUG$ clindamycin colistin sodium magnesium salts lithium @DRUG$ procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p89", "DRUGA": ["lincomycin", "drug", "198-207"], "DRUGB": ["anesthetics", "group", "293-303"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins @DRUG$ clindamycin colistin sodium magnesium salts lithium local anesthetics @DRUG$ quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p90", "DRUGA": ["lincomycin", "drug", "198-207"], "DRUGB": ["procainamide", "drug", "306-317"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins @DRUG$ clindamycin colistin sodium magnesium salts lithium local anesthetics procainamide @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p91", "DRUGA": ["lincomycin", "drug", "198-207"], "DRUGB": ["quinidine", "drug", "324-332"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin @DRUG$ @DRUG$ sodium magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p92", "DRUGA": ["clindamycin", "drug", "210-220"], "DRUGB": ["colistin", "drug", "223-230"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin @DRUG$ colistin magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p93", "DRUGA": ["clindamycin", "drug", "210-220"], "DRUGB": ["sodium colistimethate", "drug", "237-257"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin @DRUG$ colistin sodium @DRUG$ lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p94", "DRUGA": ["clindamycin", "drug", "210-220"], "DRUGB": ["magnesium", "group", "261-269"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin @DRUG$ colistin sodium magnesium salts @DRUG$ local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p95", "DRUGA": ["clindamycin", "drug", "210-220"], "DRUGB": ["lithium", "drug", "278-284"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin @DRUG$ colistin sodium magnesium salts lithium @DRUG$ procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p96", "DRUGA": ["clindamycin", "drug", "210-220"], "DRUGB": ["anesthetics", "group", "293-303"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin @DRUG$ colistin sodium magnesium salts lithium local anesthetics @DRUG$ quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p97", "DRUGA": ["clindamycin", "drug", "210-220"], "DRUGB": ["procainamide", "drug", "306-317"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin @DRUG$ colistin sodium magnesium salts lithium local anesthetics procainamide @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p98", "DRUGA": ["clindamycin", "drug", "210-220"], "DRUGB": ["quinidine", "drug", "324-332"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin @DRUG$ magnesium salts lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p99", "DRUGA": ["colistin", "drug", "223-230"], "DRUGB": ["sodium colistimethate", "drug", "237-257"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin @DRUG$ sodium @DRUG$ lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p100", "DRUGA": ["colistin", "drug", "223-230"], "DRUGB": ["magnesium", "group", "261-269"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin @DRUG$ sodium magnesium salts @DRUG$ local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p101", "DRUGA": ["colistin", "drug", "223-230"], "DRUGB": ["lithium", "drug", "278-284"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin @DRUG$ sodium magnesium salts lithium @DRUG$ procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p102", "DRUGA": ["colistin", "drug", "223-230"], "DRUGB": ["anesthetics", "group", "293-303"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin @DRUG$ sodium magnesium salts lithium local anesthetics @DRUG$ quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p103", "DRUGA": ["colistin", "drug", "223-230"], "DRUGB": ["procainamide", "drug", "306-317"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin @DRUG$ sodium magnesium salts lithium local anesthetics procainamide @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p104", "DRUGA": ["colistin", "drug", "223-230"], "DRUGB": ["quinidine", "drug", "324-332"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin @DRUG$ lithium local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p105", "DRUGA": ["sodium colistimethate", "drug", "237-257"], "DRUGB": ["magnesium", "group", "261-269"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin magnesium salts @DRUG$ local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p106", "DRUGA": ["sodium colistimethate", "drug", "237-257"], "DRUGB": ["lithium", "drug", "278-284"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin magnesium salts lithium @DRUG$ procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p107", "DRUGA": ["sodium colistimethate", "drug", "237-257"], "DRUGB": ["anesthetics", "group", "293-303"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin magnesium salts lithium local anesthetics @DRUG$ quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p108", "DRUGA": ["sodium colistimethate", "drug", "237-257"], "DRUGB": ["procainamide", "drug", "306-317"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin magnesium salts lithium local anesthetics procainamide @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p109", "DRUGA": ["sodium colistimethate", "drug", "237-257"], "DRUGB": ["quinidine", "drug", "324-332"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium @DRUG$ @DRUG$ local anesthetics procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p110", "DRUGA": ["magnesium", "group", "261-269"], "DRUGB": ["lithium", "drug", "278-284"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium @DRUG$ lithium @DRUG$ procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p111", "DRUGA": ["magnesium", "group", "261-269"], "DRUGB": ["anesthetics", "group", "293-303"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium @DRUG$ lithium local anesthetics @DRUG$ quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p112", "DRUGA": ["magnesium", "group", "261-269"], "DRUGB": ["procainamide", "drug", "306-317"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium @DRUG$ lithium local anesthetics procainamide @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p113", "DRUGA": ["magnesium", "group", "261-269"], "DRUGB": ["quinidine", "drug", "324-332"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts @DRUG$ @DRUG$ procainamide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p114", "DRUGA": ["lithium", "drug", "278-284"], "DRUGB": ["anesthetics", "group", "293-303"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts @DRUG$ local anesthetics @DRUG$ quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p115", "DRUGA": ["lithium", "drug", "278-284"], "DRUGB": ["procainamide", "drug", "306-317"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts @DRUG$ local anesthetics procainamide @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p116", "DRUGA": ["lithium", "drug", "278-284"], "DRUGB": ["quinidine", "drug", "324-332"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium @DRUG$ @DRUG$ quinidine", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p117", "DRUGA": ["anesthetics", "group", "293-303"], "DRUGB": ["procainamide", "drug", "306-317"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium @DRUG$ procainamide @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p118", "DRUGA": ["anesthetics", "group", "293-303"], "DRUGB": ["quinidine", "drug", "324-332"]}
{"TEXT1": "drugs enhance neuromuscular blocking nondepolarizing agents action MIVACRON include certain antibiotics aminoglycosides tetracyclines bacitracin polymyxins lincomycin clindamycin colistin sodium magnesium salts lithium local anesthetics @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s10.p119", "DRUGA": ["procainamide", "drug", "306-317"], "DRUGB": ["quinidine", "drug", "324-332"]}
{"TEXT1": "neuromuscular blocking neuromuscular effect @DRUG$ enhanced drugs plasma cholinesterase activity administered @DRUG$ glucocorticoids certain inhibit Resistance to action patients phenytoin carbamazepine", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d775.s11.p0", "DRUGA": ["MIVACRON", "brand", "37-44"], "DRUGB": ["contraceptives", "group", "151-164"]}
{"TEXT1": "neuromuscular blocking neuromuscular effect @DRUG$ enhanced drugs plasma cholinesterase activity administered oral contraceptives @DRUG$ certain inhibit Resistance to action patients phenytoin carbamazepine", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d775.s11.p1", "DRUGA": ["MIVACRON", "brand", "37-44"], "DRUGB": ["glucocorticoids", "group", "167-181"]}
{"TEXT1": "neuromuscular blocking neuromuscular effect @DRUG$ enhanced drugs plasma cholinesterase activity administered oral contraceptives glucocorticoids certain inhibit Resistance to action patients phenytoin carbamazepine", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d775.s11.p2", "DRUGA": ["MIVACRON", "brand", "37-44"], "DRUGB": ["monoamine oxidase inhibitors", "group", "195-222"]}
{"TEXT1": "neuromuscular blocking neuromuscular effect @DRUG$ enhanced drugs plasma cholinesterase activity administered oral contraceptives glucocorticoids certain inhibit Resistance to action @DRUG$ patients phenytoin carbamazepine", "LBL": "0", "ID": "DDI-DrugBank.d775.s11.p3", "DRUGA": ["MIVACRON", "brand", "37-44"], "DRUGB": ["neuromuscular blocking agents", "group", "354-382"]}
{"TEXT1": "neuromuscular blocking neuromuscular effect @DRUG$ enhanced drugs plasma cholinesterase activity administered oral contraceptives glucocorticoids certain inhibit Resistance to action patients @DRUG$ carbamazepine", "LBL": "0", "ID": "DDI-DrugBank.d775.s11.p4", "DRUGA": ["MIVACRON", "brand", "37-44"], "DRUGB": ["phenytoin", "drug", "443-451"]}
{"TEXT1": "neuromuscular blocking neuromuscular effect @DRUG$ enhanced drugs plasma cholinesterase activity administered oral contraceptives glucocorticoids certain inhibit Resistance to action patients phenytoin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s11.p5", "DRUGA": ["MIVACRON", "brand", "37-44"], "DRUGB": ["carbamazepine", "drug", "456-468"]}
{"TEXT1": "neuromuscular blocking neuromuscular effect MIVACRON enhanced drugs plasma cholinesterase activity administered @DRUG$ @DRUG$ certain inhibit Resistance to action patients phenytoin carbamazepine", "LBL": "0", "ID": "DDI-DrugBank.d775.s11.p6", "DRUGA": ["contraceptives", "group", "151-164"], "DRUGB": ["glucocorticoids", "group", "167-181"]}
{"TEXT1": "neuromuscular blocking neuromuscular effect MIVACRON enhanced drugs plasma cholinesterase activity administered @DRUG$ glucocorticoids certain inhibit Resistance to action patients phenytoin carbamazepine", "LBL": "0", "ID": "DDI-DrugBank.d775.s11.p7", "DRUGA": ["contraceptives", "group", "151-164"], "DRUGB": ["monoamine oxidase inhibitors", "group", "195-222"]}
{"TEXT1": "neuromuscular blocking neuromuscular effect MIVACRON enhanced drugs plasma cholinesterase activity administered @DRUG$ glucocorticoids certain inhibit Resistance to action @DRUG$ patients phenytoin carbamazepine", "LBL": "0", "ID": "DDI-DrugBank.d775.s11.p8", "DRUGA": ["contraceptives", "group", "151-164"], "DRUGB": ["neuromuscular blocking agents", "group", "354-382"]}
{"TEXT1": "neuromuscular blocking neuromuscular effect MIVACRON enhanced drugs plasma cholinesterase activity administered @DRUG$ glucocorticoids certain inhibit Resistance to action patients @DRUG$ carbamazepine", "LBL": "0", "ID": "DDI-DrugBank.d775.s11.p9", "DRUGA": ["contraceptives", "group", "151-164"], "DRUGB": ["phenytoin", "drug", "443-451"]}
{"TEXT1": "neuromuscular blocking neuromuscular effect MIVACRON enhanced drugs plasma cholinesterase activity administered @DRUG$ glucocorticoids certain inhibit Resistance to action patients phenytoin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s11.p10", "DRUGA": ["contraceptives", "group", "151-164"], "DRUGB": ["carbamazepine", "drug", "456-468"]}
{"TEXT1": "neuromuscular blocking neuromuscular effect MIVACRON enhanced drugs plasma cholinesterase activity administered oral contraceptives @DRUG$ certain inhibit Resistance to action patients phenytoin carbamazepine", "LBL": "0", "ID": "DDI-DrugBank.d775.s11.p11", "DRUGA": ["glucocorticoids", "group", "167-181"], "DRUGB": ["monoamine oxidase inhibitors", "group", "195-222"]}
{"TEXT1": "neuromuscular blocking neuromuscular effect MIVACRON enhanced drugs plasma cholinesterase activity administered oral contraceptives @DRUG$ certain inhibit Resistance to action @DRUG$ patients phenytoin carbamazepine", "LBL": "0", "ID": "DDI-DrugBank.d775.s11.p12", "DRUGA": ["glucocorticoids", "group", "167-181"], "DRUGB": ["neuromuscular blocking agents", "group", "354-382"]}
{"TEXT1": "neuromuscular blocking neuromuscular effect MIVACRON enhanced drugs plasma cholinesterase activity administered oral contraceptives @DRUG$ certain inhibit Resistance to action patients @DRUG$ carbamazepine", "LBL": "0", "ID": "DDI-DrugBank.d775.s11.p13", "DRUGA": ["glucocorticoids", "group", "167-181"], "DRUGB": ["phenytoin", "drug", "443-451"]}
{"TEXT1": "neuromuscular blocking neuromuscular effect MIVACRON enhanced drugs plasma cholinesterase activity administered oral contraceptives @DRUG$ certain inhibit Resistance to action patients phenytoin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s11.p14", "DRUGA": ["glucocorticoids", "group", "167-181"], "DRUGB": ["carbamazepine", "drug", "456-468"]}
{"TEXT1": "neuromuscular blocking neuromuscular effect MIVACRON enhanced drugs plasma cholinesterase activity administered oral contraceptives glucocorticoids certain inhibit Resistance to action @DRUG$ patients phenytoin carbamazepine", "LBL": "0", "ID": "DDI-DrugBank.d775.s11.p15", "DRUGA": ["monoamine oxidase inhibitors", "group", "195-222"], "DRUGB": ["neuromuscular blocking agents", "group", "354-382"]}
{"TEXT1": "neuromuscular blocking neuromuscular effect MIVACRON enhanced drugs plasma cholinesterase activity administered oral contraceptives glucocorticoids certain inhibit Resistance to action patients @DRUG$ carbamazepine", "LBL": "0", "ID": "DDI-DrugBank.d775.s11.p16", "DRUGA": ["monoamine oxidase inhibitors", "group", "195-222"], "DRUGB": ["phenytoin", "drug", "443-451"]}
{"TEXT1": "neuromuscular blocking neuromuscular effect MIVACRON enhanced drugs plasma cholinesterase activity administered oral contraceptives glucocorticoids certain inhibit Resistance to action patients phenytoin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s11.p17", "DRUGA": ["monoamine oxidase inhibitors", "group", "195-222"], "DRUGB": ["carbamazepine", "drug", "456-468"]}
{"TEXT1": "neuromuscular blocking neuromuscular effect MIVACRON enhanced drugs plasma cholinesterase activity administered oral contraceptives glucocorticoids certain inhibit Resistance to action @DRUG$ patients @DRUG$ carbamazepine", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d775.s11.p18", "DRUGA": ["neuromuscular blocking agents", "group", "354-382"], "DRUGB": ["phenytoin", "drug", "443-451"]}
{"TEXT1": "neuromuscular blocking neuromuscular effect MIVACRON enhanced drugs plasma cholinesterase activity administered oral contraceptives glucocorticoids certain inhibit Resistance to action @DRUG$ patients phenytoin @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d775.s11.p19", "DRUGA": ["neuromuscular blocking agents", "group", "354-382"], "DRUGB": ["carbamazepine", "drug", "456-468"]}
{"TEXT1": "neuromuscular blocking neuromuscular effect MIVACRON enhanced drugs plasma cholinesterase activity administered oral contraceptives glucocorticoids certain inhibit Resistance to action patients @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s11.p20", "DRUGA": ["phenytoin", "drug", "443-451"], "DRUGB": ["carbamazepine", "drug", "456-468"]}
{"TEXT1": "effects chronic @DRUG$ @DRUG$ therapy action MIVACRON unknown slightly shorter durations neuromuscular block anticipated infusion rate requirements higher", "LBL": "0", "ID": "DDI-DrugBank.d775.s12.p0", "DRUGA": ["phenytoin", "drug", "29-37"], "DRUGB": ["carbamazepine", "drug", "42-54"]}
{"TEXT1": "effects chronic @DRUG$ carbamazepine therapy action @DRUG$ unknown slightly shorter durations neuromuscular block anticipated infusion rate requirements higher", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d775.s12.p1", "DRUGA": ["phenytoin", "drug", "29-37"], "DRUGB": ["MIVACRON", "brand", "81-88"]}
{"TEXT1": "effects chronic phenytoin @DRUG$ therapy action @DRUG$ unknown slightly shorter durations neuromuscular block anticipated infusion rate requirements higher", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d775.s12.p2", "DRUGA": ["carbamazepine", "drug", "42-54"], "DRUGB": ["MIVACRON", "brand", "81-88"]}
{"TEXT1": "drug interactions birth control pills control @DRUG$ medicines angina pain to seizures @DRUG$ carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B bacitracin local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p0", "DRUGA": ["corticosteroids", "group", "53-67"], "DRUGB": ["phenytoin", "drug", "176-184"]}
{"TEXT1": "drug interactions birth control pills control @DRUG$ medicines angina pain to seizures phenytoin @DRUG$ certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B bacitracin local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p1", "DRUGA": ["corticosteroids", "group", "53-67"], "DRUGB": ["carbamazepine", "drug", "189-201"]}
{"TEXT1": "drug interactions birth control pills control @DRUG$ medicines angina pain to seizures phenytoin carbamazepine certain @DRUG$ given injection cisplatin edrophonium neostigmine polymyxin B bacitracin local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p2", "DRUGA": ["corticosteroids", "group", "53-67"], "DRUGB": ["antibiotics", "group", "213-223"]}
{"TEXT1": "drug interactions birth control pills control @DRUG$ medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection @DRUG$ edrophonium neostigmine polymyxin B bacitracin local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p3", "DRUGA": ["corticosteroids", "group", "53-67"], "DRUGB": ["cisplatin", "drug", "246-254"]}
{"TEXT1": "drug interactions birth control pills control @DRUG$ medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin @DRUG$ neostigmine polymyxin B bacitracin local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p4", "DRUGA": ["corticosteroids", "group", "53-67"], "DRUGB": ["edrophonium", "drug", "258-268"]}
{"TEXT1": "drug interactions birth control pills control @DRUG$ medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium @DRUG$ polymyxin B bacitracin local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p5", "DRUGA": ["corticosteroids", "group", "53-67"], "DRUGB": ["neostigmine", "drug", "272-282"]}
{"TEXT1": "drug interactions birth control pills control @DRUG$ medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine @DRUG$ bacitracin local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p6", "DRUGA": ["corticosteroids", "group", "53-67"], "DRUGB": ["polymyxin B", "drug", "286-296"]}
{"TEXT1": "drug interactions birth control pills control @DRUG$ medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B @DRUG$ local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p7", "DRUGA": ["corticosteroids", "group", "53-67"], "DRUGB": ["bacitracin", "drug", "301-310"]}
{"TEXT1": "drug interactions birth control pills control @DRUG$ medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B bacitracin @DRUG$ procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p8", "DRUGA": ["corticosteroids", "group", "53-67"], "DRUGB": ["anesthetics", "group", "320-330"]}
{"TEXT1": "drug interactions birth control pills control @DRUG$ medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B bacitracin local anesthetics general @DRUG$ succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p9", "DRUGA": ["corticosteroids", "group", "53-67"], "DRUGB": ["procaine", "drug", "340-347"]}
{"TEXT1": "drug interactions birth control pills control @DRUG$ medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B bacitracin local anesthetics procaine @DRUG$ succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p10", "DRUGA": ["corticosteroids", "group", "53-67"], "DRUGB": ["anesthetics", "group", "359-369"]}
{"TEXT1": "drug interactions birth control pills control @DRUG$ medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B bacitracin local anesthetics procaine @DRUG$ muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p11", "DRUGA": ["corticosteroids", "group", "53-67"], "DRUGB": ["succinylcholine", "drug", "373-387"]}
{"TEXT1": "drug interactions birth control pills control @DRUG$ medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B bacitracin local anesthetics procaine succinylcholine @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p12", "DRUGA": ["corticosteroids", "group", "53-67"], "DRUGB": ["muscle relaxants", "group", "398-413"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures @DRUG$ @DRUG$ certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B bacitracin local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p13", "DRUGA": ["phenytoin", "drug", "176-184"], "DRUGB": ["carbamazepine", "drug", "189-201"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures @DRUG$ carbamazepine certain @DRUG$ given injection cisplatin edrophonium neostigmine polymyxin B bacitracin local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p14", "DRUGA": ["phenytoin", "drug", "176-184"], "DRUGB": ["antibiotics", "group", "213-223"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures @DRUG$ carbamazepine certain antibiotics given injection @DRUG$ edrophonium neostigmine polymyxin B bacitracin local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p15", "DRUGA": ["phenytoin", "drug", "176-184"], "DRUGB": ["cisplatin", "drug", "246-254"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures @DRUG$ carbamazepine certain antibiotics given injection cisplatin @DRUG$ neostigmine polymyxin B bacitracin local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p16", "DRUGA": ["phenytoin", "drug", "176-184"], "DRUGB": ["edrophonium", "drug", "258-268"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures @DRUG$ carbamazepine certain antibiotics given injection cisplatin edrophonium @DRUG$ polymyxin B bacitracin local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p17", "DRUGA": ["phenytoin", "drug", "176-184"], "DRUGB": ["neostigmine", "drug", "272-282"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures @DRUG$ carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine @DRUG$ bacitracin local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p18", "DRUGA": ["phenytoin", "drug", "176-184"], "DRUGB": ["polymyxin B", "drug", "286-296"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures @DRUG$ carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B @DRUG$ local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p19", "DRUGA": ["phenytoin", "drug", "176-184"], "DRUGB": ["bacitracin", "drug", "301-310"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures @DRUG$ carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B bacitracin @DRUG$ procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p20", "DRUGA": ["phenytoin", "drug", "176-184"], "DRUGB": ["anesthetics", "group", "320-330"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures @DRUG$ carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B bacitracin local anesthetics general @DRUG$ succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p21", "DRUGA": ["phenytoin", "drug", "176-184"], "DRUGB": ["procaine", "drug", "340-347"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures @DRUG$ carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B bacitracin local anesthetics procaine @DRUG$ succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p22", "DRUGA": ["phenytoin", "drug", "176-184"], "DRUGB": ["anesthetics", "group", "359-369"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures @DRUG$ carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B bacitracin local anesthetics procaine @DRUG$ muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p23", "DRUGA": ["phenytoin", "drug", "176-184"], "DRUGB": ["succinylcholine", "drug", "373-387"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures @DRUG$ carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B bacitracin local anesthetics procaine succinylcholine @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p24", "DRUGA": ["phenytoin", "drug", "176-184"], "DRUGB": ["muscle relaxants", "group", "398-413"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin @DRUG$ certain @DRUG$ given injection cisplatin edrophonium neostigmine polymyxin B bacitracin local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p25", "DRUGA": ["carbamazepine", "drug", "189-201"], "DRUGB": ["antibiotics", "group", "213-223"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin @DRUG$ certain antibiotics given injection @DRUG$ edrophonium neostigmine polymyxin B bacitracin local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p26", "DRUGA": ["carbamazepine", "drug", "189-201"], "DRUGB": ["cisplatin", "drug", "246-254"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin @DRUG$ certain antibiotics given injection cisplatin @DRUG$ neostigmine polymyxin B bacitracin local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p27", "DRUGA": ["carbamazepine", "drug", "189-201"], "DRUGB": ["edrophonium", "drug", "258-268"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin @DRUG$ certain antibiotics given injection cisplatin edrophonium @DRUG$ polymyxin B bacitracin local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p28", "DRUGA": ["carbamazepine", "drug", "189-201"], "DRUGB": ["neostigmine", "drug", "272-282"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin @DRUG$ certain antibiotics given injection cisplatin edrophonium neostigmine @DRUG$ bacitracin local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p29", "DRUGA": ["carbamazepine", "drug", "189-201"], "DRUGB": ["polymyxin B", "drug", "286-296"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin @DRUG$ certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B @DRUG$ local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p30", "DRUGA": ["carbamazepine", "drug", "189-201"], "DRUGB": ["bacitracin", "drug", "301-310"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin @DRUG$ certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B bacitracin @DRUG$ procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p31", "DRUGA": ["carbamazepine", "drug", "189-201"], "DRUGB": ["anesthetics", "group", "320-330"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin @DRUG$ certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B bacitracin local anesthetics general @DRUG$ succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p32", "DRUGA": ["carbamazepine", "drug", "189-201"], "DRUGB": ["procaine", "drug", "340-347"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin @DRUG$ certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B bacitracin local anesthetics procaine @DRUG$ succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p33", "DRUGA": ["carbamazepine", "drug", "189-201"], "DRUGB": ["anesthetics", "group", "359-369"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin @DRUG$ certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B bacitracin local anesthetics procaine @DRUG$ muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p34", "DRUGA": ["carbamazepine", "drug", "189-201"], "DRUGB": ["succinylcholine", "drug", "373-387"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin @DRUG$ certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B bacitracin local anesthetics procaine succinylcholine @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p35", "DRUGA": ["carbamazepine", "drug", "189-201"], "DRUGB": ["muscle relaxants", "group", "398-413"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain @DRUG$ given injection @DRUG$ edrophonium neostigmine polymyxin B bacitracin local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p36", "DRUGA": ["antibiotics", "group", "213-223"], "DRUGB": ["cisplatin", "drug", "246-254"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain @DRUG$ given injection cisplatin @DRUG$ neostigmine polymyxin B bacitracin local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p37", "DRUGA": ["antibiotics", "group", "213-223"], "DRUGB": ["edrophonium", "drug", "258-268"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain @DRUG$ given injection cisplatin edrophonium @DRUG$ polymyxin B bacitracin local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p38", "DRUGA": ["antibiotics", "group", "213-223"], "DRUGB": ["neostigmine", "drug", "272-282"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain @DRUG$ given injection cisplatin edrophonium neostigmine @DRUG$ bacitracin local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p39", "DRUGA": ["antibiotics", "group", "213-223"], "DRUGB": ["polymyxin B", "drug", "286-296"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain @DRUG$ given injection cisplatin edrophonium neostigmine polymyxin B @DRUG$ local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p40", "DRUGA": ["antibiotics", "group", "213-223"], "DRUGB": ["bacitracin", "drug", "301-310"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain @DRUG$ given injection cisplatin edrophonium neostigmine polymyxin B bacitracin @DRUG$ procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p41", "DRUGA": ["antibiotics", "group", "213-223"], "DRUGB": ["anesthetics", "group", "320-330"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain @DRUG$ given injection cisplatin edrophonium neostigmine polymyxin B bacitracin local anesthetics general @DRUG$ succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p42", "DRUGA": ["antibiotics", "group", "213-223"], "DRUGB": ["procaine", "drug", "340-347"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain @DRUG$ given injection cisplatin edrophonium neostigmine polymyxin B bacitracin local anesthetics procaine @DRUG$ succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p43", "DRUGA": ["antibiotics", "group", "213-223"], "DRUGB": ["anesthetics", "group", "359-369"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain @DRUG$ given injection cisplatin edrophonium neostigmine polymyxin B bacitracin local anesthetics procaine @DRUG$ muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p44", "DRUGA": ["antibiotics", "group", "213-223"], "DRUGB": ["succinylcholine", "drug", "373-387"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain @DRUG$ given injection cisplatin edrophonium neostigmine polymyxin B bacitracin local anesthetics procaine succinylcholine @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p45", "DRUGA": ["antibiotics", "group", "213-223"], "DRUGB": ["muscle relaxants", "group", "398-413"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection @DRUG$ @DRUG$ neostigmine polymyxin B bacitracin local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p46", "DRUGA": ["cisplatin", "drug", "246-254"], "DRUGB": ["edrophonium", "drug", "258-268"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection @DRUG$ edrophonium @DRUG$ polymyxin B bacitracin local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p47", "DRUGA": ["cisplatin", "drug", "246-254"], "DRUGB": ["neostigmine", "drug", "272-282"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection @DRUG$ edrophonium neostigmine @DRUG$ bacitracin local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p48", "DRUGA": ["cisplatin", "drug", "246-254"], "DRUGB": ["polymyxin B", "drug", "286-296"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection @DRUG$ edrophonium neostigmine polymyxin B @DRUG$ local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p49", "DRUGA": ["cisplatin", "drug", "246-254"], "DRUGB": ["bacitracin", "drug", "301-310"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection @DRUG$ edrophonium neostigmine polymyxin B bacitracin @DRUG$ procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p50", "DRUGA": ["cisplatin", "drug", "246-254"], "DRUGB": ["anesthetics", "group", "320-330"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection @DRUG$ edrophonium neostigmine polymyxin B bacitracin local anesthetics general @DRUG$ succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p51", "DRUGA": ["cisplatin", "drug", "246-254"], "DRUGB": ["procaine", "drug", "340-347"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection @DRUG$ edrophonium neostigmine polymyxin B bacitracin local anesthetics procaine @DRUG$ succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p52", "DRUGA": ["cisplatin", "drug", "246-254"], "DRUGB": ["anesthetics", "group", "359-369"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection @DRUG$ edrophonium neostigmine polymyxin B bacitracin local anesthetics procaine @DRUG$ muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p53", "DRUGA": ["cisplatin", "drug", "246-254"], "DRUGB": ["succinylcholine", "drug", "373-387"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection @DRUG$ edrophonium neostigmine polymyxin B bacitracin local anesthetics procaine succinylcholine @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p54", "DRUGA": ["cisplatin", "drug", "246-254"], "DRUGB": ["muscle relaxants", "group", "398-413"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin @DRUG$ @DRUG$ polymyxin B bacitracin local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p55", "DRUGA": ["edrophonium", "drug", "258-268"], "DRUGB": ["neostigmine", "drug", "272-282"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin @DRUG$ neostigmine @DRUG$ bacitracin local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p56", "DRUGA": ["edrophonium", "drug", "258-268"], "DRUGB": ["polymyxin B", "drug", "286-296"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin @DRUG$ neostigmine polymyxin B @DRUG$ local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p57", "DRUGA": ["edrophonium", "drug", "258-268"], "DRUGB": ["bacitracin", "drug", "301-310"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin @DRUG$ neostigmine polymyxin B bacitracin @DRUG$ procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p58", "DRUGA": ["edrophonium", "drug", "258-268"], "DRUGB": ["anesthetics", "group", "320-330"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin @DRUG$ neostigmine polymyxin B bacitracin local anesthetics general @DRUG$ succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p59", "DRUGA": ["edrophonium", "drug", "258-268"], "DRUGB": ["procaine", "drug", "340-347"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin @DRUG$ neostigmine polymyxin B bacitracin local anesthetics procaine @DRUG$ succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p60", "DRUGA": ["edrophonium", "drug", "258-268"], "DRUGB": ["anesthetics", "group", "359-369"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin @DRUG$ neostigmine polymyxin B bacitracin local anesthetics procaine @DRUG$ muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p61", "DRUGA": ["edrophonium", "drug", "258-268"], "DRUGB": ["succinylcholine", "drug", "373-387"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin @DRUG$ neostigmine polymyxin B bacitracin local anesthetics procaine succinylcholine @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p62", "DRUGA": ["edrophonium", "drug", "258-268"], "DRUGB": ["muscle relaxants", "group", "398-413"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium @DRUG$ @DRUG$ bacitracin local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p63", "DRUGA": ["neostigmine", "drug", "272-282"], "DRUGB": ["polymyxin B", "drug", "286-296"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium @DRUG$ polymyxin B @DRUG$ local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p64", "DRUGA": ["neostigmine", "drug", "272-282"], "DRUGB": ["bacitracin", "drug", "301-310"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium @DRUG$ polymyxin B bacitracin @DRUG$ procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p65", "DRUGA": ["neostigmine", "drug", "272-282"], "DRUGB": ["anesthetics", "group", "320-330"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium @DRUG$ polymyxin B bacitracin local anesthetics general @DRUG$ succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p66", "DRUGA": ["neostigmine", "drug", "272-282"], "DRUGB": ["procaine", "drug", "340-347"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium @DRUG$ polymyxin B bacitracin local anesthetics procaine @DRUG$ succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p67", "DRUGA": ["neostigmine", "drug", "272-282"], "DRUGB": ["anesthetics", "group", "359-369"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium @DRUG$ polymyxin B bacitracin local anesthetics procaine @DRUG$ muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p68", "DRUGA": ["neostigmine", "drug", "272-282"], "DRUGB": ["succinylcholine", "drug", "373-387"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium @DRUG$ polymyxin B bacitracin local anesthetics procaine succinylcholine @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p69", "DRUGA": ["neostigmine", "drug", "272-282"], "DRUGB": ["muscle relaxants", "group", "398-413"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine @DRUG$ @DRUG$ local anesthetics procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p70", "DRUGA": ["polymyxin B", "drug", "286-296"], "DRUGB": ["bacitracin", "drug", "301-310"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine @DRUG$ bacitracin @DRUG$ procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p71", "DRUGA": ["polymyxin B", "drug", "286-296"], "DRUGB": ["anesthetics", "group", "320-330"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine @DRUG$ bacitracin local anesthetics general @DRUG$ succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p72", "DRUGA": ["polymyxin B", "drug", "286-296"], "DRUGB": ["procaine", "drug", "340-347"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine @DRUG$ bacitracin local anesthetics procaine @DRUG$ succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p73", "DRUGA": ["polymyxin B", "drug", "286-296"], "DRUGB": ["anesthetics", "group", "359-369"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine @DRUG$ bacitracin local anesthetics procaine @DRUG$ muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p74", "DRUGA": ["polymyxin B", "drug", "286-296"], "DRUGB": ["succinylcholine", "drug", "373-387"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine @DRUG$ bacitracin local anesthetics procaine succinylcholine @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p75", "DRUGA": ["polymyxin B", "drug", "286-296"], "DRUGB": ["muscle relaxants", "group", "398-413"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B @DRUG$ @DRUG$ procaine succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p76", "DRUGA": ["bacitracin", "drug", "301-310"], "DRUGB": ["anesthetics", "group", "320-330"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B @DRUG$ local anesthetics general @DRUG$ succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p77", "DRUGA": ["bacitracin", "drug", "301-310"], "DRUGB": ["procaine", "drug", "340-347"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B @DRUG$ local anesthetics procaine @DRUG$ succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p78", "DRUGA": ["bacitracin", "drug", "301-310"], "DRUGB": ["anesthetics", "group", "359-369"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B @DRUG$ local anesthetics procaine @DRUG$ muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p79", "DRUGA": ["bacitracin", "drug", "301-310"], "DRUGB": ["succinylcholine", "drug", "373-387"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B @DRUG$ local anesthetics procaine succinylcholine @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p80", "DRUGA": ["bacitracin", "drug", "301-310"], "DRUGB": ["muscle relaxants", "group", "398-413"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B bacitracin @DRUG$ @DRUG$ succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p81", "DRUGA": ["anesthetics", "group", "320-330"], "DRUGB": ["procaine", "drug", "340-347"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B bacitracin @DRUG$ procaine @DRUG$ succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p82", "DRUGA": ["anesthetics", "group", "320-330"], "DRUGB": ["anesthetics", "group", "359-369"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B bacitracin @DRUG$ procaine @DRUG$ muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p83", "DRUGA": ["anesthetics", "group", "320-330"], "DRUGB": ["succinylcholine", "drug", "373-387"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B bacitracin @DRUG$ procaine succinylcholine @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p84", "DRUGA": ["anesthetics", "group", "320-330"], "DRUGB": ["muscle relaxants", "group", "398-413"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B bacitracin local anesthetics general @DRUG$ @DRUG$ succinylcholine muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p85", "DRUGA": ["procaine", "drug", "340-347"], "DRUGB": ["anesthetics", "group", "359-369"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B bacitracin local anesthetics general @DRUG$ @DRUG$ muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p86", "DRUGA": ["procaine", "drug", "340-347"], "DRUGB": ["succinylcholine", "drug", "373-387"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B bacitracin local anesthetics general @DRUG$ succinylcholine @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p87", "DRUGA": ["procaine", "drug", "340-347"], "DRUGB": ["muscle relaxants", "group", "398-413"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B bacitracin local anesthetics procaine @DRUG$ @DRUG$ muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p88", "DRUGA": ["anesthetics", "group", "359-369"], "DRUGB": ["succinylcholine", "drug", "373-387"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B bacitracin local anesthetics procaine @DRUG$ succinylcholine @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p89", "DRUGA": ["anesthetics", "group", "359-369"], "DRUGB": ["muscle relaxants", "group", "398-413"]}
{"TEXT1": "drug interactions birth control pills control corticosteroids medicines angina pain to seizures phenytoin carbamazepine certain antibiotics given injection cisplatin edrophonium neostigmine polymyxin B bacitracin local anesthetics procaine @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d775.s13.p90", "DRUGA": ["succinylcholine", "drug", "373-387"], "DRUGB": ["muscle relaxants", "group", "398-413"]}
{"TEXT1": "not 5 mg daily dose @DRUG$ administered therapeutic doses @DRUG$ potent CYP3A4 inhibitors", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d738.s0.p0", "DRUGA": ["VESIcare", "brand", "35-42"], "DRUGB": ["ketoconazole", "drug", "88-99"]}
{"TEXT1": "Patients Congenital Acquired QT Prolongation study effect @DRUG$ 76 healthy women appeared less @DRUG$ 10 mg 30 times maximum recommended solifenacin not large positive control moxifloxacin therapeutic dose", "LBL": "0", "ID": "DDI-DrugBank.d738.s1.p0", "DRUGA": ["solifenacin", "drug", "81-91"], "DRUGB": ["solifenacin", "drug", "177-187"]}
{"TEXT1": "Patients Congenital Acquired QT Prolongation study effect @DRUG$ 76 healthy women appeared less solifenacin 10 mg 30 times maximum recommended @DRUG$ not large positive control moxifloxacin therapeutic dose", "LBL": "0", "ID": "DDI-DrugBank.d738.s1.p1", "DRUGA": ["solifenacin", "drug", "81-91"], "DRUGB": ["solifenacin", "drug", "273-283"]}
{"TEXT1": "Patients Congenital Acquired QT Prolongation study effect @DRUG$ 76 healthy women appeared less solifenacin 10 mg 30 times maximum recommended not large positive control @DRUG$ therapeutic dose", "LBL": "0", "ID": "DDI-DrugBank.d738.s1.p2", "DRUGA": ["solifenacin", "drug", "81-91"], "DRUGB": ["moxifloxacin", "drug", "347-358"]}
{"TEXT1": "Patients Congenital Acquired QT Prolongation study effect solifenacin 76 healthy women appeared less @DRUG$ 10 mg 30 times maximum recommended @DRUG$ not large positive control moxifloxacin therapeutic dose", "LBL": "0", "ID": "DDI-DrugBank.d738.s1.p3", "DRUGA": ["solifenacin", "drug", "177-187"], "DRUGB": ["solifenacin", "drug", "273-283"]}
{"TEXT1": "Patients Congenital Acquired QT Prolongation study effect solifenacin 76 healthy women appeared less @DRUG$ 10 mg 30 times maximum recommended not large positive control @DRUG$ therapeutic dose", "LBL": "0", "ID": "DDI-DrugBank.d738.s1.p4", "DRUGA": ["solifenacin", "drug", "177-187"], "DRUGB": ["moxifloxacin", "drug", "347-358"]}
{"TEXT1": "Patients Congenital Acquired QT Prolongation study effect solifenacin 76 healthy women appeared less 10 mg 30 times maximum recommended @DRUG$ not large positive control @DRUG$ therapeutic dose", "LBL": "0", "ID": "DDI-DrugBank.d738.s1.p5", "DRUGA": ["solifenacin", "drug", "273-283"], "DRUGB": ["moxifloxacin", "drug", "347-358"]}
{"TEXT1": "Interaction @DRUG$ not cause orthostatic hypotension administration patients receiving guanethidine result profound effects", "LBL": "0", "ID": "DDI-DrugBank.d573.s0.p0", "DRUGA": ["Guanethidine", "drug", "17-28"], "DRUGB": ["minoxidil", "drug", "40-48"]}
{"TEXT1": "Interaction minoxidil not cause orthostatic hypotension administration patients receiving @DRUG$ result profound effects", "LBL": "0", "ID": "DDI-DrugBank.d573.s0.p1", "DRUGA": ["Guanethidine", "drug", "17-28"], "DRUGB": ["guanethidine", "drug", "146-157"]}
{"TEXT1": "Interaction @DRUG$ not cause orthostatic hypotension administration patients receiving @DRUG$ result profound effects", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d573.s0.p2", "DRUGA": ["minoxidil", "drug", "40-48"], "DRUGB": ["guanethidine", "drug", "146-157"]}
{"TEXT1": "possible @DRUG$ discontinued well @DRUG$ begun", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d573.s1.p0", "DRUGA": ["guanethidine", "drug", "19-30"], "DRUGB": ["minoxidil", "drug", "67-75"]}
{"TEXT1": "@DRUG$ appeared to increase clearance @DRUG$ results not conclusive small number subjects studied patients took variable doses Cerezyme", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d695.s0.p0", "DRUGA": ["ZAVESCA", "brand", "27-33"], "DRUGB": ["Cerezyme", "brand", "76-83"]}
{"TEXT1": "@DRUG$ appeared to increase clearance Cerezyme results not conclusive small number subjects studied patients took variable doses @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d695.s0.p1", "DRUGA": ["ZAVESCA", "brand", "27-33"], "DRUGB": ["Cerezyme", "brand", "218-225"]}
{"TEXT1": "ZAVESCA appeared to increase clearance @DRUG$ results not conclusive small number subjects studied patients took variable doses @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d695.s0.p2", "DRUGA": ["Cerezyme", "brand", "76-83"], "DRUGB": ["Cerezyme", "brand", "218-225"]}
{"TEXT1": "Combination @DRUG$ ZAVESCA not indicated", "LBL": "0", "ID": "DDI-DrugBank.d695.s1.p0", "DRUGA": ["Cerezyme", "brand", "25-32"], "DRUGB": ["imiglucerase", "drug", "38-49"]}
{"TEXT1": "Combination @DRUG$ @DRUG$ not indicated", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d695.s1.p1", "DRUGA": ["Cerezyme", "brand", "25-32"], "DRUGB": ["ZAVESCA", "brand", "56-62"]}
{"TEXT1": "Combination Cerezyme @DRUG$ not indicated", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d695.s1.p2", "DRUGA": ["imiglucerase", "drug", "38-49"], "DRUGB": ["ZAVESCA", "brand", "56-62"]}
{"TEXT1": "@DRUG$ administered @DRUG$ decrease serum concentrations", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d623.s1.p0", "DRUGA": ["Aminoglutethimide", "drug", "0-16"], "DRUGB": ["depo-subQ provera 104", "brand", "50-70"]}
{"TEXT1": "@DRUG$ administered decrease serum concentrations @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d623.s1.p1", "DRUGA": ["Aminoglutethimide", "drug", "0-16"], "DRUGB": ["MPA", "drug", "127-129"]}
{"TEXT1": "Aminoglutethimide administered @DRUG$ decrease serum concentrations @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d623.s1.p2", "DRUGA": ["depo-subQ provera 104", "brand", "50-70"], "DRUGB": ["MPA", "drug", "127-129"]}
{"TEXT1": "Hypokalemia concomitant @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d736.s1.p0", "DRUGA": ["steroids", "group", "50-57"], "DRUGB": ["ACTH", "drug", "62-65"]}
{"TEXT1": "@DRUG$ decrease arterial responsiveness @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d736.s3.p0", "DRUGA": ["Thiazides", "group", "0-8"], "DRUGB": ["norepinephrine", "drug", "50-63"]}
{"TEXT1": "@DRUG$ increase responsiveness @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d736.s5.p0", "DRUGA": ["Thiazide drugs", "group", "0-13"], "DRUGB": ["tubocurarine", "drug", "50-61"]}
{"TEXT1": "@DRUG$ reduced @DRUG$ increasing risk lithium toxicity", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d736.s6.p0", "DRUGA": ["Lithium", "drug", "0-6"], "DRUGB": ["thiazides", "group", "38-46"]}
{"TEXT1": "@DRUG$ reduced thiazides increasing risk @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d736.s6.p1", "DRUGA": ["Lithium", "drug", "0-6"], "DRUGB": ["lithium", "drug", "72-78"]}
{"TEXT1": "Lithium renal clearance reduced @DRUG$ increasing risk @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d736.s6.p2", "DRUGA": ["thiazides", "group", "38-46"], "DRUGB": ["lithium", "drug", "72-78"]}
{"TEXT1": "@DRUG$ add action @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d736.s7.p0", "DRUGA": ["Thiazides", "group", "0-8"], "DRUGB": ["antihypertensive drugs", "group", "55-76"]}
{"TEXT1": "Potentiation occurs", "LBL": "0", "ID": "DDI-DrugBank.d736.s8.p0", "DRUGA": ["ganglionic adrenergic blocking drugs", "group", "25-34;50-74"], "DRUGB": ["peripheral adrenergic blocking drugs", "group", "39-74"]}
{"TEXT1": "Patients @DRUG$ started recently occasionally experience excessive reduction blood pressure initiation ACEON Tablets therapy", "LBL": "0", "ID": "DDI-DrugBank.d781.s0.p0", "DRUGA": ["Diuretics", "group", "0-8"], "DRUGB": ["diuretics", "group", "23-31"]}
{"TEXT1": "Patients diuretics started recently occasionally experience excessive reduction blood pressure initiation @DRUG$ Tablets therapy", "LBL": "0", "ID": "DDI-DrugBank.d781.s0.p1", "DRUGA": ["Diuretics", "group", "0-8"], "DRUGB": ["ACEON", "brand", "162-166"]}
{"TEXT1": "Patients @DRUG$ started recently occasionally experience excessive reduction blood pressure initiation @DRUG$ Tablets therapy", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d781.s0.p2", "DRUGA": ["diuretics", "group", "23-31"], "DRUGB": ["ACEON", "brand", "162-166"]}
{"TEXT1": "possibility hypotensive effects discontinuing @DRUG$ increasing salt intake prior to treatment initiation @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d781.s1.p0", "DRUGA": ["diuretic", "group", "84-91"], "DRUGB": ["perindopril", "drug", "161-171"]}
{"TEXT1": "@DRUG$ interrupted close supervision medical provided first dose @DRUG$ Tablets two hours blood pressure stabilized hour", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d781.s2.p0", "DRUGA": ["diuretics", "group", "3-11"], "DRUGB": ["ACEON", "brand", "104-108"]}
{"TEXT1": "rate extent @DRUG$ absorption elimination not affected concomitant @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d781.s3.p0", "DRUGA": ["perindopril", "drug", "23-33"], "DRUGB": ["diuretics", "group", "94-102"]}
{"TEXT1": "bioavailability @DRUG$ reduced @DRUG$ associated with decrease plasma ACE inhibition", "LBL": "0", "ID": "DDI-DrugBank.d781.s4.p0", "DRUGA": ["perindoprilat", "drug_n", "23-35"], "DRUGB": ["diuretics", "group", "52-60"]}
{"TEXT1": "@DRUG$ ACEON Tablets increase serum potassium potential to decrease aldosterone production", "LBL": "0", "ID": "DDI-DrugBank.d781.s5.p0", "DRUGA": ["Potassium", "drug", "0-8"], "DRUGB": ["Potassium-Sparing Diuretics", "group", "26-52"]}
{"TEXT1": "@DRUG$ @DRUG$ Tablets increase serum potassium potential to decrease aldosterone production", "LBL": "0", "ID": "DDI-DrugBank.d781.s5.p1", "DRUGA": ["Potassium", "drug", "0-8"], "DRUGB": ["ACEON", "brand", "55-59"]}
{"TEXT1": "Potassium Supplements @DRUG$ Tablets increase serum potassium potential to decrease aldosterone production", "LBL": "0", "ID": "DDI-DrugBank.d781.s5.p2", "DRUGA": ["Potassium-Sparing Diuretics", "group", "26-52"], "DRUGB": ["ACEON", "brand", "55-59"]}
{"TEXT1": "Use of @DRUG$ amiloride triamterene potassium supplements drugs capable increasing heparin cyclosporine increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d781.s6.p0", "DRUGA": ["potassium-sparing diuretics", "group", "7-33"], "DRUGB": ["spironolactone", "drug", "36-49"]}
{"TEXT1": "Use of @DRUG$ @DRUG$ triamterene potassium supplements drugs capable increasing heparin cyclosporine increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d781.s6.p1", "DRUGA": ["potassium-sparing diuretics", "group", "7-33"], "DRUGB": ["amiloride", "drug", "52-60"]}
{"TEXT1": "Use of @DRUG$ amiloride @DRUG$ potassium supplements drugs capable increasing heparin cyclosporine increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d781.s6.p2", "DRUGA": ["potassium-sparing diuretics", "group", "7-33"], "DRUGB": ["triamterene", "drug", "63-73"]}
{"TEXT1": "Use of @DRUG$ amiloride triamterene @DRUG$ drugs capable increasing serum potassium heparin cyclosporine increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d781.s6.p3", "DRUGA": ["potassium-sparing diuretics", "group", "7-33"], "DRUGB": ["potassium", "drug", "88-96"]}
{"TEXT1": "Use of @DRUG$ amiloride triamterene potassium supplements drugs capable increasing heparin cyclosporine increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d781.s6.p4", "DRUGA": ["potassium-sparing diuretics", "group", "7-33"], "DRUGB": ["indomethacin", "drug", "164-175"]}
{"TEXT1": "Use of @DRUG$ amiloride triamterene potassium supplements drugs capable increasing @DRUG$ cyclosporine increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d781.s6.p5", "DRUGA": ["potassium-sparing diuretics", "group", "7-33"], "DRUGB": ["heparin", "drug", "178-184"]}
{"TEXT1": "Use of @DRUG$ amiloride triamterene potassium supplements drugs capable increasing heparin @DRUG$ increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d781.s6.p6", "DRUGA": ["potassium-sparing diuretics", "group", "7-33"], "DRUGB": ["cyclosporine", "drug", "187-198"]}
{"TEXT1": "Use of @DRUG$ triamterene drugs capable increasing heparin cyclosporine increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d781.s6.p7", "DRUGA": ["spironolactone", "drug", "36-49"], "DRUGB": ["amiloride", "drug", "52-60"]}
{"TEXT1": "Use of amiloride @DRUG$ drugs capable increasing heparin cyclosporine increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d781.s6.p8", "DRUGA": ["spironolactone", "drug", "36-49"], "DRUGB": ["triamterene", "drug", "63-73"]}
{"TEXT1": "Use of amiloride triamterene @DRUG$ drugs capable increasing heparin cyclosporine increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d781.s6.p9", "DRUGA": ["spironolactone", "drug", "36-49"], "DRUGB": ["potassium", "drug", "88-96"]}
{"TEXT1": "Use of amiloride triamterene drugs capable increasing heparin cyclosporine increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d781.s6.p10", "DRUGA": ["spironolactone", "drug", "36-49"], "DRUGB": ["indomethacin", "drug", "164-175"]}
{"TEXT1": "Use of amiloride triamterene drugs capable increasing @DRUG$ cyclosporine increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d781.s6.p11", "DRUGA": ["spironolactone", "drug", "36-49"], "DRUGB": ["heparin", "drug", "178-184"]}
{"TEXT1": "Use of amiloride triamterene drugs capable increasing heparin @DRUG$ increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d781.s6.p12", "DRUGA": ["spironolactone", "drug", "36-49"], "DRUGB": ["cyclosporine", "drug", "187-198"]}
{"TEXT1": "Use of @DRUG$ @DRUG$ drugs capable increasing heparin cyclosporine increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d781.s6.p13", "DRUGA": ["amiloride", "drug", "52-60"], "DRUGB": ["triamterene", "drug", "63-73"]}
{"TEXT1": "Use of @DRUG$ triamterene @DRUG$ drugs capable increasing heparin cyclosporine increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d781.s6.p14", "DRUGA": ["amiloride", "drug", "52-60"], "DRUGB": ["potassium", "drug", "88-96"]}
{"TEXT1": "Use of @DRUG$ triamterene drugs capable increasing heparin cyclosporine increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d781.s6.p15", "DRUGA": ["amiloride", "drug", "52-60"], "DRUGB": ["indomethacin", "drug", "164-175"]}
{"TEXT1": "Use of @DRUG$ triamterene drugs capable increasing @DRUG$ cyclosporine increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d781.s6.p16", "DRUGA": ["amiloride", "drug", "52-60"], "DRUGB": ["heparin", "drug", "178-184"]}
{"TEXT1": "Use of @DRUG$ triamterene drugs capable increasing heparin @DRUG$ increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d781.s6.p17", "DRUGA": ["amiloride", "drug", "52-60"], "DRUGB": ["cyclosporine", "drug", "187-198"]}
{"TEXT1": "Use of amiloride @DRUG$ @DRUG$ drugs capable increasing heparin cyclosporine increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d781.s6.p18", "DRUGA": ["triamterene", "drug", "63-73"], "DRUGB": ["potassium", "drug", "88-96"]}
{"TEXT1": "Use of amiloride @DRUG$ drugs capable increasing heparin cyclosporine increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d781.s6.p19", "DRUGA": ["triamterene", "drug", "63-73"], "DRUGB": ["indomethacin", "drug", "164-175"]}
{"TEXT1": "Use of amiloride @DRUG$ drugs capable increasing @DRUG$ cyclosporine increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d781.s6.p20", "DRUGA": ["triamterene", "drug", "63-73"], "DRUGB": ["heparin", "drug", "178-184"]}
{"TEXT1": "Use of amiloride @DRUG$ drugs capable increasing heparin @DRUG$ increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d781.s6.p21", "DRUGA": ["triamterene", "drug", "63-73"], "DRUGB": ["cyclosporine", "drug", "187-198"]}
{"TEXT1": "Use of amiloride triamterene @DRUG$ drugs capable increasing heparin cyclosporine increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d781.s6.p22", "DRUGA": ["potassium", "drug", "88-96"], "DRUGB": ["indomethacin", "drug", "164-175"]}
{"TEXT1": "Use of amiloride triamterene @DRUG$ drugs capable increasing @DRUG$ cyclosporine increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d781.s6.p23", "DRUGA": ["potassium", "drug", "88-96"], "DRUGB": ["heparin", "drug", "178-184"]}
{"TEXT1": "Use of amiloride triamterene @DRUG$ drugs capable increasing heparin @DRUG$ increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d781.s6.p24", "DRUGA": ["potassium", "drug", "88-96"], "DRUGB": ["cyclosporine", "drug", "187-198"]}
{"TEXT1": "Use of amiloride triamterene drugs capable increasing @DRUG$ cyclosporine increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d781.s6.p25", "DRUGA": ["indomethacin", "drug", "164-175"], "DRUGB": ["heparin", "drug", "178-184"]}
{"TEXT1": "Use of amiloride triamterene drugs capable increasing heparin @DRUG$ increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d781.s6.p26", "DRUGA": ["indomethacin", "drug", "164-175"], "DRUGB": ["cyclosporine", "drug", "187-198"]}
{"TEXT1": "Use of amiloride triamterene drugs capable increasing @DRUG$ @DRUG$ increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d781.s6.p27", "DRUGA": ["heparin", "drug", "178-184"], "DRUGB": ["cyclosporine", "drug", "187-198"]}
{"TEXT1": "Increased serum @DRUG$ symptoms lithium toxicity reported patients receiving concomitant ACE inhibitor therapy", "LBL": "0", "ID": "DDI-DrugBank.d781.s8.p0", "DRUGA": ["Lithium", "drug", "0-6"], "DRUGB": ["lithium", "drug", "25-31"]}
{"TEXT1": "Increased serum lithium symptoms @DRUG$ reported patients receiving concomitant ACE inhibitor therapy", "LBL": "0", "ID": "DDI-DrugBank.d781.s8.p1", "DRUGA": ["Lithium", "drug", "0-6"], "DRUGB": ["lithium", "drug", "49-55"]}
{"TEXT1": "Increased serum lithium symptoms reported patients receiving concomitant @DRUG$ ACE inhibitor therapy", "LBL": "0", "ID": "DDI-DrugBank.d781.s8.p2", "DRUGA": ["Lithium", "drug", "0-6"], "DRUGB": ["lithium", "drug", "119-125"]}
{"TEXT1": "Increased serum @DRUG$ symptoms @DRUG$ reported patients receiving concomitant lithium ACE inhibitor therapy", "LBL": "0", "ID": "DDI-DrugBank.d781.s8.p3", "DRUGA": ["lithium", "drug", "25-31"], "DRUGB": ["lithium", "drug", "49-55"]}
{"TEXT1": "Increased serum @DRUG$ symptoms lithium toxicity reported patients receiving concomitant @DRUG$ ACE inhibitor therapy", "LBL": "0", "ID": "DDI-DrugBank.d781.s8.p4", "DRUGA": ["lithium", "drug", "25-31"], "DRUGB": ["lithium", "drug", "119-125"]}
{"TEXT1": "Increased serum lithium symptoms @DRUG$ reported patients receiving concomitant @DRUG$ ACE inhibitor therapy", "LBL": "0", "ID": "DDI-DrugBank.d781.s8.p5", "DRUGA": ["lithium", "drug", "49-55"], "DRUGB": ["lithium", "drug", "119-125"]}
{"TEXT1": "Use of @DRUG$ further increase risk @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d781.s10.p0", "DRUGA": ["diuretic", "group", "9-16"], "DRUGB": ["lithium", "drug", "51-57"]}
{"TEXT1": "controlled pharmacokinetic study shown no effect @DRUG$ ACEON Tablets digoxin not excluded", "LBL": "0", "ID": "DDI-DrugBank.d781.s11.p0", "DRUGA": ["Digoxin", "drug", "0-6"], "DRUGB": ["digoxin", "drug", "74-80"]}
{"TEXT1": "controlled pharmacokinetic study shown no effect digoxin @DRUG$ Tablets not excluded", "LBL": "0", "ID": "DDI-DrugBank.d781.s11.p1", "DRUGA": ["Digoxin", "drug", "0-6"], "DRUGB": ["ACEON", "brand", "122-126"]}
{"TEXT1": "controlled pharmacokinetic study shown no effect digoxin ACEON Tablets @DRUG$ not excluded", "LBL": "0", "ID": "DDI-DrugBank.d781.s11.p2", "DRUGA": ["Digoxin", "drug", "0-6"], "DRUGB": ["digoxin", "drug", "157-163"]}
{"TEXT1": "controlled pharmacokinetic study shown no effect digoxin ACEON Tablets not excluded", "LBL": "0", "ID": "DDI-DrugBank.d781.s11.p3", "DRUGA": ["Digoxin", "drug", "0-6"], "DRUGB": ["perindopril", "drug", "196-206"]}
{"TEXT1": "controlled pharmacokinetic study shown no effect digoxin ACEON Tablets not excluded", "LBL": "0", "ID": "DDI-DrugBank.d781.s11.p4", "DRUGA": ["Digoxin", "drug", "0-6"], "DRUGB": ["perindoprilat", "drug_n", "208-220"]}
{"TEXT1": "controlled pharmacokinetic study shown no effect @DRUG$ @DRUG$ Tablets digoxin not excluded", "LBL": "0", "ID": "DDI-DrugBank.d781.s11.p5", "DRUGA": ["digoxin", "drug", "74-80"], "DRUGB": ["ACEON", "brand", "122-126"]}
{"TEXT1": "controlled pharmacokinetic study shown no effect @DRUG$ ACEON Tablets @DRUG$ not excluded", "LBL": "0", "ID": "DDI-DrugBank.d781.s11.p6", "DRUGA": ["digoxin", "drug", "74-80"], "DRUGB": ["digoxin", "drug", "157-163"]}
{"TEXT1": "controlled pharmacokinetic study shown no effect @DRUG$ ACEON Tablets digoxin not excluded", "LBL": "0", "ID": "DDI-DrugBank.d781.s11.p7", "DRUGA": ["digoxin", "drug", "74-80"], "DRUGB": ["perindopril", "drug", "196-206"]}
{"TEXT1": "controlled pharmacokinetic study shown no effect @DRUG$ ACEON Tablets digoxin not excluded", "LBL": "0", "ID": "DDI-DrugBank.d781.s11.p8", "DRUGA": ["digoxin", "drug", "74-80"], "DRUGB": ["perindoprilat", "drug_n", "208-220"]}
{"TEXT1": "controlled pharmacokinetic study shown no effect digoxin @DRUG$ Tablets @DRUG$ not excluded", "LBL": "0", "ID": "DDI-DrugBank.d781.s11.p9", "DRUGA": ["ACEON", "brand", "122-126"], "DRUGB": ["digoxin", "drug", "157-163"]}
{"TEXT1": "controlled pharmacokinetic study shown no effect digoxin @DRUG$ Tablets not excluded", "LBL": "0", "ID": "DDI-DrugBank.d781.s11.p10", "DRUGA": ["ACEON", "brand", "122-126"], "DRUGB": ["perindopril", "drug", "196-206"]}
{"TEXT1": "controlled pharmacokinetic study shown no effect digoxin @DRUG$ Tablets not excluded", "LBL": "0", "ID": "DDI-DrugBank.d781.s11.p11", "DRUGA": ["ACEON", "brand", "122-126"], "DRUGB": ["perindoprilat", "drug_n", "208-220"]}
{"TEXT1": "controlled pharmacokinetic study shown no effect digoxin ACEON Tablets @DRUG$ not excluded", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d781.s11.p12", "DRUGA": ["digoxin", "drug", "157-163"], "DRUGB": ["perindopril", "drug", "196-206"]}
{"TEXT1": "controlled pharmacokinetic study shown no effect digoxin ACEON Tablets @DRUG$ not excluded", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d781.s11.p13", "DRUGA": ["digoxin", "drug", "157-163"], "DRUGB": ["perindoprilat", "drug_n", "208-220"]}
{"TEXT1": "controlled pharmacokinetic study shown no effect digoxin ACEON Tablets not excluded", "LBL": "0", "ID": "DDI-DrugBank.d781.s11.p14", "DRUGA": ["perindopril", "drug", "196-206"], "DRUGB": ["perindoprilat", "drug_n", "208-220"]}
{"TEXT1": "Animal data suggested possibility interaction @DRUG$ gentamicin", "LBL": "0", "ID": "DDI-DrugBank.d781.s12.p0", "DRUGA": ["Gentamicin", "drug", "0-9"], "DRUGB": ["perindopril", "drug", "78-88"]}
{"TEXT1": "Animal data suggested possibility interaction perindopril @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d781.s12.p1", "DRUGA": ["Gentamicin", "drug", "0-9"], "DRUGB": ["gentamicin", "drug", "94-103"]}
{"TEXT1": "Animal data suggested possibility interaction @DRUG$ @DRUG$", "LBL": "DDI-int", "ID": "DDI-DrugBank.d781.s12.p2", "DRUGA": ["perindopril", "drug", "78-88"], "DRUGB": ["gentamicin", "drug", "94-103"]}
{"TEXT1": "Oral administration @DRUG$ Tablets food not lower rate extent @DRUG$ absorption relative to fasted state", "LBL": "0", "ID": "DDI-DrugBank.d781.s15.p0", "DRUGA": ["ACEON", "brand", "41-45"], "DRUGB": ["perindopril", "drug", "119-129"]}
{"TEXT1": "extent biotransformation @DRUG$ active metabolite @DRUG$ approximately resulting in reduction plasma ACE inhibition curve probably", "LBL": "0", "ID": "DDI-DrugBank.d781.s16.p0", "DRUGA": ["perindopril", "drug", "44-54"], "DRUGB": ["perindoprilat", "drug_n", "82-94"]}
{"TEXT1": "Concurrent use of @DRUG$ @DRUG$ increase CNS depressant effects methyprylon medications", "LBL": "0", "ID": "DDI-DrugBank.d600.s1.p0", "DRUGA": ["alcohol", "drug", "18-24"], "DRUGB": ["CNS depression-producing drugs", "group", "36-65"]}
{"TEXT1": "Concurrent use of @DRUG$ CNS depression drugs increase effects @DRUG$ medications", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d600.s1.p1", "DRUGA": ["alcohol", "drug", "18-24"], "DRUGB": ["methyprylon", "drug", "110-120"]}
{"TEXT1": "Concurrent use of alcohol @DRUG$ increase CNS depressant effects @DRUG$ medications", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d600.s1.p2", "DRUGA": ["CNS depression-producing drugs", "group", "36-65"], "DRUGB": ["methyprylon", "drug", "110-120"]}
{"TEXT1": "@DRUG$ decreases oral clearance @DRUG$ about", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d687.s0.p0", "DRUGA": ["valproic acid", "drug", "18-30"], "DRUGB": ["temozolomide", "drug", "60-71"]}
{"TEXT1": "study different drugs tested relevant concentrations @DRUG$ @DRUG$ sulfamethizole displaced bound teniposide fresh human serum small significant extent", "LBL": "0", "ID": "DDI-DrugBank.d575.s0.p0", "DRUGA": ["tolbutamide", "drug", "95-105"], "DRUGB": ["sodium salicylate", "drug", "108-124"]}
{"TEXT1": "study different drugs tested relevant concentrations @DRUG$ sodium salicylate @DRUG$ displaced bound teniposide fresh human serum small significant extent", "LBL": "0", "ID": "DDI-DrugBank.d575.s0.p1", "DRUGA": ["tolbutamide", "drug", "95-105"], "DRUGB": ["sulfamethizole", "drug", "130-143"]}
{"TEXT1": "study different drugs tested relevant concentrations @DRUG$ sodium salicylate sulfamethizole displaced bound @DRUG$ fresh human serum small significant extent", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d575.s0.p2", "DRUGA": ["tolbutamide", "drug", "95-105"], "DRUGB": ["teniposide", "drug", "169-178"]}
{"TEXT1": "study different drugs tested relevant concentrations tolbutamide @DRUG$ @DRUG$ displaced bound teniposide fresh human serum small significant extent", "LBL": "0", "ID": "DDI-DrugBank.d575.s0.p3", "DRUGA": ["sodium salicylate", "drug", "108-124"], "DRUGB": ["sulfamethizole", "drug", "130-143"]}
{"TEXT1": "study different drugs tested relevant concentrations tolbutamide @DRUG$ sulfamethizole displaced bound @DRUG$ fresh human serum small significant extent", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d575.s0.p4", "DRUGA": ["sodium salicylate", "drug", "108-124"], "DRUGB": ["teniposide", "drug", "169-178"]}
{"TEXT1": "study different drugs tested relevant concentrations tolbutamide sodium salicylate @DRUG$ displaced bound @DRUG$ fresh human serum small significant extent", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d575.s0.p5", "DRUGA": ["sulfamethizole", "drug", "130-143"], "DRUGB": ["teniposide", "drug", "169-178"]}
{"TEXT1": "used administering @DRUG$ patients receiving agents", "LBL": "0", "ID": "DDI-DrugBank.d575.s2.p0", "DRUGA": ["VUMON", "brand", "51-55"], "DRUGB": ["teniposide", "drug", "58-67"]}
{"TEXT1": "no change plasma kinetics @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d575.s3.p0", "DRUGA": ["teniposide", "drug", "46-55"], "DRUGB": ["methotrexate", "drug", "82-93"]}
{"TEXT1": "increase intracellular @DRUG$ observed presence @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d575.s5.p0", "DRUGA": ["methotrexate", "drug", "39-50"], "DRUGB": ["teniposide", "drug", "93-102"]}
{"TEXT1": "@DRUG$ activity oral @DRUG$ vitamin attributed methimazole", "LBL": "0", "ID": "DDI-DrugBank.d634.s0.p0", "DRUGA": ["Anticoagulants", "group", "0-13"], "DRUGB": ["anticoagulants", "group", "44-57"]}
{"TEXT1": "@DRUG$ activity oral anticoagulants vitamin attributed @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d634.s0.p1", "DRUGA": ["Anticoagulants", "group", "0-13"], "DRUGB": ["methimazole", "drug", "119-129"]}
{"TEXT1": "Anticoagulants activity oral @DRUG$ vitamin attributed @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d634.s0.p2", "DRUGA": ["anticoagulants", "group", "44-57"], "DRUGB": ["methimazole", "drug", "119-129"]}
{"TEXT1": "Serum digitalis levels increased hyperthyroid patients stable @DRUG$ regimen", "LBL": "0", "ID": "DDI-DrugBank.d634.s3.p0", "DRUGA": ["Digitalis glycosides", "group", "0-19"], "DRUGB": ["digitalis glycoside", "group", "101-119"]}
{"TEXT1": "@DRUG$ clearance decrease hyperthyroid patients stable theophylline regimen", "LBL": "0", "ID": "DDI-DrugBank.d634.s5.p0", "DRUGA": ["Theophylline", "drug", "0-11"], "DRUGB": ["Theophylline", "drug", "14-25"]}
{"TEXT1": "clearance decrease hyperthyroid patients stable @DRUG$ regimen", "LBL": "0", "ID": "DDI-DrugBank.d634.s5.p1", "DRUGA": ["Theophylline", "drug", "0-11"], "DRUGB": ["theophylline", "drug", "89-100"]}
{"TEXT1": "@DRUG$ clearance decrease hyperthyroid patients stable @DRUG$ regimen", "LBL": "0", "ID": "DDI-DrugBank.d634.s5.p2", "DRUGA": ["Theophylline", "drug", "14-25"], "DRUGB": ["theophylline", "drug", "89-100"]}
{"TEXT1": "interaction @DRUG$ drugs not studied humans", "LBL": "0", "ID": "DDI-DrugBank.d671.s0.p0", "DRUGA": ["CYLERT", "brand", "19-24"], "DRUGB": ["pemoline", "drug", "27-34"]}
{"TEXT1": "Decreased seizure threshold reported patients receiving @DRUG$ @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d671.s2.p0", "DRUGA": ["CYLERT", "brand", "68-73"], "DRUGB": ["antiepileptic medications", "group", "94-118"]}
{"TEXT1": "@DRUG$ probably loop diuretics given metolazone cause large prolonged losses of fluid electrolytes", "LBL": "0", "ID": "DDI-DrugBank.d588.s0.p0", "DRUGA": ["Diuretics", "group", "0-8"], "DRUGB": ["Furosemide", "drug", "11-20"]}
{"TEXT1": "Furosemide probably @DRUG$ given metolazone cause large prolonged losses of fluid electrolytes", "LBL": "0", "ID": "DDI-DrugBank.d588.s0.p1", "DRUGA": ["Diuretics", "group", "0-8"], "DRUGB": ["loop diuretics", "group", "41-54"]}
{"TEXT1": "Furosemide probably loop diuretics given @DRUG$ cause large prolonged losses of fluid electrolytes", "LBL": "0", "ID": "DDI-DrugBank.d588.s0.p2", "DRUGA": ["Diuretics", "group", "0-8"], "DRUGB": ["metolazone", "drug", "81-90"]}
{"TEXT1": "@DRUG$ probably @DRUG$ given metolazone cause large prolonged losses of fluid electrolytes", "LBL": "0", "ID": "DDI-DrugBank.d588.s0.p3", "DRUGA": ["Furosemide", "drug", "11-20"], "DRUGB": ["loop diuretics", "group", "41-54"]}
{"TEXT1": "@DRUG$ probably loop diuretics given @DRUG$ cause large prolonged losses of fluid electrolytes", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d588.s0.p4", "DRUGA": ["Furosemide", "drug", "11-20"], "DRUGB": ["metolazone", "drug", "81-90"]}
{"TEXT1": "Furosemide probably @DRUG$ given @DRUG$ cause large prolonged losses of fluid electrolytes", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d588.s0.p5", "DRUGA": ["loop diuretics", "group", "41-54"], "DRUGB": ["metolazone", "drug", "81-90"]}
{"TEXT1": "@DRUG$ Tablets used antihypertensive drugs care taken initial therapy", "LBL": "0", "ID": "DDI-DrugBank.d588.s1.p0", "DRUGA": ["Antihypertensives", "group", "6-22"], "DRUGB": ["MYKROX", "brand", "30-35"]}
{"TEXT1": "MYKROX Tablets used @DRUG$ care taken initial therapy", "LBL": "0", "ID": "DDI-DrugBank.d588.s1.p1", "DRUGA": ["Antihypertensives", "group", "6-22"], "DRUGB": ["antihypertensive drugs", "group", "65-86"]}
{"TEXT1": "@DRUG$ Tablets used @DRUG$ care taken initial therapy", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d588.s1.p2", "DRUGA": ["MYKROX", "brand", "30-35"], "DRUGB": ["antihypertensive drugs", "group", "65-86"]}
{"TEXT1": "@DRUG$ @DRUG$ hypotensive effects of drugs volume contraction associated with metolazone therapy", "LBL": "0", "ID": "DDI-DrugBank.d588.s3.p0", "DRUGA": ["Alcohol", "drug", "0-6"], "DRUGB": ["Barbiturates", "group", "9-20"]}
{"TEXT1": "@DRUG$ Barbiturates hypotensive effects of drugs volume contraction associated with metolazone therapy", "LBL": "0", "ID": "DDI-DrugBank.d588.s3.p1", "DRUGA": ["Alcohol", "drug", "0-6"], "DRUGB": ["Narcotics", "group", "27-35"]}
{"TEXT1": "@DRUG$ Barbiturates hypotensive effects of drugs volume contraction associated with @DRUG$ therapy", "LBL": "0", "ID": "DDI-DrugBank.d588.s3.p2", "DRUGA": ["Alcohol", "drug", "0-6"], "DRUGB": ["metolazone", "drug", "150-159"]}
{"TEXT1": "Alcohol @DRUG$ hypotensive effects of drugs volume contraction associated with metolazone therapy", "LBL": "0", "ID": "DDI-DrugBank.d588.s3.p3", "DRUGA": ["Barbiturates", "group", "9-20"], "DRUGB": ["Narcotics", "group", "27-35"]}
{"TEXT1": "Alcohol @DRUG$ hypotensive effects of drugs volume contraction associated with @DRUG$ therapy", "LBL": "0", "ID": "DDI-DrugBank.d588.s3.p4", "DRUGA": ["Barbiturates", "group", "9-20"], "DRUGB": ["metolazone", "drug", "150-159"]}
{"TEXT1": "Alcohol Barbiturates hypotensive effects of drugs volume contraction associated with @DRUG$ therapy", "LBL": "0", "ID": "DDI-DrugBank.d588.s3.p5", "DRUGA": ["Narcotics", "group", "27-35"], "DRUGB": ["metolazone", "drug", "150-159"]}
{"TEXT1": "@DRUG$ induced hypokalemia increase sensitivity myocardium digitalis", "LBL": "0", "ID": "DDI-DrugBank.d588.s4.p0", "DRUGA": ["Digitalis Glycosides", "group", "0-19"], "DRUGB": ["Diuretic", "group", "22-29"]}
{"TEXT1": "Diuretic induced hypokalemia increase sensitivity myocardium @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d588.s4.p1", "DRUGA": ["Digitalis Glycosides", "group", "0-19"], "DRUGB": ["digitalis", "group", "101-109"]}
{"TEXT1": "@DRUG$ induced hypokalemia increase sensitivity myocardium @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d588.s4.p2", "DRUGA": ["Diuretic", "group", "22-29"], "DRUGB": ["digitalis", "group", "101-109"]}
{"TEXT1": "@DRUG$ May increase risk hypokalemia salt water retention", "LBL": "0", "ID": "DDI-DrugBank.d588.s6.p0", "DRUGA": ["Corticosteroids", "group", "0-14"], "DRUGB": ["ACTH", "drug", "19-22"]}
{"TEXT1": "@DRUG$ increase", "LBL": "0", "ID": "DDI-DrugBank.d588.s7.p0", "DRUGA": ["Lithium", "drug", "0-6"], "DRUGB": ["lithium", "drug", "15-21"]}
{"TEXT1": "@DRUG$ induced hypokalemia enhance neuromuscular blocking effects of drugs curariform most serious effect respiratory depression apnea", "LBL": "0", "ID": "DDI-DrugBank.d588.s8.p0", "DRUGA": ["Curariform Drugs", "group", "0-15"], "DRUGB": ["Diuretic", "group", "18-25"]}
{"TEXT1": "Diuretic induced hypokalemia enhance neuromuscular blocking @DRUG$ most serious effect respiratory depression apnea", "LBL": "0", "ID": "DDI-DrugBank.d588.s8.p1", "DRUGA": ["Curariform Drugs", "group", "0-15"], "DRUGB": ["curariform drugs", "group", "93-108"]}
{"TEXT1": "Diuretic induced hypokalemia enhance neuromuscular blocking effects of drugs curariform most serious effect respiratory depression apnea", "LBL": "0", "ID": "DDI-DrugBank.d588.s8.p2", "DRUGA": ["Curariform Drugs", "group", "0-15"], "DRUGB": ["tubocurarine", "drug", "119-130"]}
{"TEXT1": "@DRUG$ induced hypokalemia enhance neuromuscular blocking @DRUG$ most serious effect respiratory depression apnea", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d588.s8.p3", "DRUGA": ["Diuretic", "group", "18-25"], "DRUGB": ["curariform drugs", "group", "93-108"]}
{"TEXT1": "@DRUG$ induced hypokalemia enhance neuromuscular blocking effects of drugs curariform most serious effect respiratory depression apnea", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d588.s8.p4", "DRUGA": ["Diuretic", "group", "18-25"], "DRUGB": ["tubocurarine", "drug", "119-130"]}
{"TEXT1": "Diuretic induced hypokalemia enhance neuromuscular blocking @DRUG$ most serious effect respiratory depression apnea", "LBL": "0", "ID": "DDI-DrugBank.d588.s8.p5", "DRUGA": ["curariform drugs", "group", "93-108"], "DRUGB": ["tubocurarine", "drug", "119-130"]}
{"TEXT1": "@DRUG$ May decrease antihypertensive effects MYKROX Tablets", "LBL": "0", "ID": "DDI-DrugBank.d588.s10.p0", "DRUGA": ["Salicylates", "group", "0-10"], "DRUGB": ["Non-Steroidal Anti-Inflammatory Drugs", "group", "22-58"]}
{"TEXT1": "@DRUG$ May decrease antihypertensive effects @DRUG$ Tablets", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d588.s10.p1", "DRUGA": ["Salicylates", "group", "0-10"], "DRUGB": ["MYKROX", "brand", "106-111"]}
{"TEXT1": "Salicylates May decrease antihypertensive effects @DRUG$ Tablets", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d588.s10.p2", "DRUGA": ["Non-Steroidal Anti-Inflammatory Drugs", "group", "22-58"], "DRUGB": ["MYKROX", "brand", "106-111"]}
{"TEXT1": "@DRUG$ decrease arterial responsiveness to norepinephrine diminution not sufficient effectiveness pressor agent therapeutic use", "LBL": "0", "ID": "DDI-DrugBank.d588.s11.p0", "DRUGA": ["Sympathomimetics", "group", "0-15"], "DRUGB": ["Metolazone", "drug", "18-27"]}
{"TEXT1": "Metolazone decrease arterial responsiveness to @DRUG$ diminution not sufficient effectiveness pressor agent therapeutic use", "LBL": "0", "ID": "DDI-DrugBank.d588.s11.p1", "DRUGA": ["Sympathomimetics", "group", "0-15"], "DRUGB": ["norepinephrine", "drug", "69-82"]}
{"TEXT1": "@DRUG$ decrease arterial responsiveness to @DRUG$ diminution not sufficient effectiveness pressor agent therapeutic use", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d588.s11.p2", "DRUGA": ["Metolazone", "drug", "18-27"], "DRUGB": ["norepinephrine", "drug", "69-82"]}
{"TEXT1": "Efficacy decreased due to urinary effect @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d588.s12.p0", "DRUGA": ["Methenamine", "drug", "0-10"], "DRUGB": ["metolazone", "drug", "75-84"]}
{"TEXT1": "@DRUG$ thiazide diuretics affect hypoprothrombinemic", "LBL": "0", "ID": "DDI-DrugBank.d588.s13.p0", "DRUGA": ["Anticoagulants", "group", "0-13"], "DRUGB": ["Metolazone", "drug", "16-25"]}
{"TEXT1": "Metolazone @DRUG$ affect hypoprothrombinemic", "LBL": "0", "ID": "DDI-DrugBank.d588.s13.p1", "DRUGA": ["Anticoagulants", "group", "0-13"], "DRUGB": ["thiazide-like diuretics", "group", "45-67"]}
{"TEXT1": "Metolazone thiazide diuretics affect hypoprothrombinemic", "LBL": "0", "ID": "DDI-DrugBank.d588.s13.p2", "DRUGA": ["Anticoagulants", "group", "0-13"], "DRUGB": ["anticoagulants", "group", "117-130"]}
{"TEXT1": "@DRUG$ @DRUG$ affect hypoprothrombinemic", "LBL": "0", "ID": "DDI-DrugBank.d588.s13.p3", "DRUGA": ["Metolazone", "drug", "16-25"], "DRUGB": ["thiazide-like diuretics", "group", "45-67"]}
{"TEXT1": "@DRUG$ thiazide diuretics affect hypoprothrombinemic", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d588.s13.p4", "DRUGA": ["Metolazone", "drug", "16-25"], "DRUGB": ["anticoagulants", "group", "117-130"]}
{"TEXT1": "Metolazone @DRUG$ affect hypoprothrombinemic", "LBL": "0", "ID": "DDI-DrugBank.d588.s13.p5", "DRUGA": ["thiazide-like diuretics", "group", "45-67"], "DRUGB": ["anticoagulants", "group", "117-130"]}
{"TEXT1": "following agents increase certain actions @DRUG$ antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs anticholinergic activity", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d585.s0.p0", "DRUGA": ["anticholinergic drugs", "group", "69-89"], "DRUGB": ["amantadine", "drug", "92-101"]}
{"TEXT1": "following agents increase certain actions amantadine @DRUG$ g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs anticholinergic activity", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d585.s0.p1", "DRUGA": ["anticholinergic drugs", "group", "69-89"], "DRUGB": ["antiarrhythmic agents of class I", "group", "104-135"]}
{"TEXT1": "following agents increase certain actions amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs anticholinergic activity", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d585.s0.p2", "DRUGA": ["anticholinergic drugs", "group", "69-89"], "DRUGB": ["quinidine", "drug", "144-152"]}
{"TEXT1": "following agents increase certain actions amantadine antiarrhythmic agents class I g @DRUG$ benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs anticholinergic activity", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d585.s0.p3", "DRUGA": ["anticholinergic drugs", "group", "69-89"], "DRUGB": ["antihistamines", "group", "156-169"]}
{"TEXT1": "following agents increase certain actions amantadine antiarrhythmic agents class I g antihistamines @DRUG$ benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs anticholinergic activity", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d585.s0.p4", "DRUGA": ["anticholinergic drugs", "group", "69-89"], "DRUGB": ["antipsychotic agents", "group", "172-191"]}
{"TEXT1": "following agents increase certain actions amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs anticholinergic activity", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d585.s0.p5", "DRUGA": ["anticholinergic drugs", "group", "69-89"], "DRUGB": ["phenothiazines", "group", "200-213"]}
{"TEXT1": "following agents increase certain actions amantadine antiarrhythmic agents class I g antihistamines @DRUG$ MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs anticholinergic activity", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d585.s0.p6", "DRUGA": ["anticholinergic drugs", "group", "69-89"], "DRUGB": ["benzodiazepines", "group", "217-231"]}
{"TEXT1": "following agents increase certain actions amantadine antiarrhythmic agents class I g antihistamines benzodiazepines @DRUG$ narcotic analgesics nitrates nitrites tricyclic antidepressants drugs anticholinergic activity", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d585.s0.p7", "DRUGA": ["anticholinergic drugs", "group", "69-89"], "DRUGB": ["MAO inhibitors", "group", "234-247"]}
{"TEXT1": "following agents increase certain actions amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors @DRUG$ nitrates nitrites tricyclic antidepressants drugs anticholinergic activity", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d585.s0.p8", "DRUGA": ["anticholinergic drugs", "group", "69-89"], "DRUGB": ["narcotic analgesics", "group", "250-268"]}
{"TEXT1": "following agents increase certain actions amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs anticholinergic activity", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d585.s0.p9", "DRUGA": ["anticholinergic drugs", "group", "69-89"], "DRUGB": ["meperidine", "drug", "277-286"]}
{"TEXT1": "following agents increase certain actions amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics @DRUG$ nitrites tricyclic antidepressants drugs anticholinergic activity", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d585.s0.p10", "DRUGA": ["anticholinergic drugs", "group", "69-89"], "DRUGB": ["nitrates", "group", "290-297"]}
{"TEXT1": "following agents increase certain actions amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates @DRUG$ tricyclic antidepressants drugs anticholinergic activity", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d585.s0.p11", "DRUGA": ["anticholinergic drugs", "group", "69-89"], "DRUGB": ["nitrites", "group", "303-310"]}
{"TEXT1": "following agents increase certain actions amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites @DRUG$ tricyclic antidepressants drugs anticholinergic activity", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d585.s0.p12", "DRUGA": ["anticholinergic drugs", "group", "69-89"], "DRUGB": ["sympathomimetic agents", "group", "313-334"]}
{"TEXT1": "following agents increase certain actions amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites @DRUG$ drugs anticholinergic activity", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d585.s0.p13", "DRUGA": ["anticholinergic drugs", "group", "69-89"], "DRUGB": ["tricyclic antidepressants", "group", "337-361"]}
{"TEXT1": "following agents increase certain actions anticholinergic @DRUG$ @DRUG$ g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p14", "DRUGA": ["amantadine", "drug", "92-101"], "DRUGB": ["antiarrhythmic agents of class I", "group", "104-135"]}
{"TEXT1": "following agents increase certain actions anticholinergic @DRUG$ antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p15", "DRUGA": ["amantadine", "drug", "92-101"], "DRUGB": ["quinidine", "drug", "144-152"]}
{"TEXT1": "following agents increase certain actions anticholinergic @DRUG$ antiarrhythmic agents class I g @DRUG$ benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p16", "DRUGA": ["amantadine", "drug", "92-101"], "DRUGB": ["antihistamines", "group", "156-169"]}
{"TEXT1": "following agents increase certain actions anticholinergic @DRUG$ antiarrhythmic agents class I g antihistamines @DRUG$ benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p17", "DRUGA": ["amantadine", "drug", "92-101"], "DRUGB": ["antipsychotic agents", "group", "172-191"]}
{"TEXT1": "following agents increase certain actions anticholinergic @DRUG$ antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p18", "DRUGA": ["amantadine", "drug", "92-101"], "DRUGB": ["phenothiazines", "group", "200-213"]}
{"TEXT1": "following agents increase certain actions anticholinergic @DRUG$ antiarrhythmic agents class I g antihistamines @DRUG$ MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p19", "DRUGA": ["amantadine", "drug", "92-101"], "DRUGB": ["benzodiazepines", "group", "217-231"]}
{"TEXT1": "following agents increase certain actions anticholinergic @DRUG$ antiarrhythmic agents class I g antihistamines benzodiazepines @DRUG$ narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p20", "DRUGA": ["amantadine", "drug", "92-101"], "DRUGB": ["MAO inhibitors", "group", "234-247"]}
{"TEXT1": "following agents increase certain actions anticholinergic @DRUG$ antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors @DRUG$ nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p21", "DRUGA": ["amantadine", "drug", "92-101"], "DRUGB": ["narcotic analgesics", "group", "250-268"]}
{"TEXT1": "following agents increase certain actions anticholinergic @DRUG$ antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p22", "DRUGA": ["amantadine", "drug", "92-101"], "DRUGB": ["meperidine", "drug", "277-286"]}
{"TEXT1": "following agents increase certain actions anticholinergic @DRUG$ antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics @DRUG$ nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p23", "DRUGA": ["amantadine", "drug", "92-101"], "DRUGB": ["nitrates", "group", "290-297"]}
{"TEXT1": "following agents increase certain actions anticholinergic @DRUG$ antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates @DRUG$ tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p24", "DRUGA": ["amantadine", "drug", "92-101"], "DRUGB": ["nitrites", "group", "303-310"]}
{"TEXT1": "following agents increase certain actions anticholinergic @DRUG$ antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites @DRUG$ tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p25", "DRUGA": ["amantadine", "drug", "92-101"], "DRUGB": ["sympathomimetic agents", "group", "313-334"]}
{"TEXT1": "following agents increase certain actions anticholinergic @DRUG$ antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites @DRUG$ drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p26", "DRUGA": ["amantadine", "drug", "92-101"], "DRUGB": ["tricyclic antidepressants", "group", "337-361"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine @DRUG$ g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p27", "DRUGA": ["antiarrhythmic agents of class I", "group", "104-135"], "DRUGB": ["quinidine", "drug", "144-152"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine @DRUG$ g @DRUG$ benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p28", "DRUGA": ["antiarrhythmic agents of class I", "group", "104-135"], "DRUGB": ["antihistamines", "group", "156-169"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine @DRUG$ g antihistamines @DRUG$ benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p29", "DRUGA": ["antiarrhythmic agents of class I", "group", "104-135"], "DRUGB": ["antipsychotic agents", "group", "172-191"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine @DRUG$ g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p30", "DRUGA": ["antiarrhythmic agents of class I", "group", "104-135"], "DRUGB": ["phenothiazines", "group", "200-213"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine @DRUG$ g antihistamines @DRUG$ MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p31", "DRUGA": ["antiarrhythmic agents of class I", "group", "104-135"], "DRUGB": ["benzodiazepines", "group", "217-231"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine @DRUG$ g antihistamines benzodiazepines @DRUG$ narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p32", "DRUGA": ["antiarrhythmic agents of class I", "group", "104-135"], "DRUGB": ["MAO inhibitors", "group", "234-247"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine @DRUG$ g antihistamines benzodiazepines MAO inhibitors @DRUG$ nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p33", "DRUGA": ["antiarrhythmic agents of class I", "group", "104-135"], "DRUGB": ["narcotic analgesics", "group", "250-268"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine @DRUG$ g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p34", "DRUGA": ["antiarrhythmic agents of class I", "group", "104-135"], "DRUGB": ["meperidine", "drug", "277-286"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine @DRUG$ g antihistamines benzodiazepines MAO inhibitors narcotic analgesics @DRUG$ nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p35", "DRUGA": ["antiarrhythmic agents of class I", "group", "104-135"], "DRUGB": ["nitrates", "group", "290-297"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine @DRUG$ g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates @DRUG$ tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p36", "DRUGA": ["antiarrhythmic agents of class I", "group", "104-135"], "DRUGB": ["nitrites", "group", "303-310"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine @DRUG$ g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites @DRUG$ tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p37", "DRUGA": ["antiarrhythmic agents of class I", "group", "104-135"], "DRUGB": ["sympathomimetic agents", "group", "313-334"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine @DRUG$ g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites @DRUG$ drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p38", "DRUGA": ["antiarrhythmic agents of class I", "group", "104-135"], "DRUGB": ["tricyclic antidepressants", "group", "337-361"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g @DRUG$ benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p39", "DRUGA": ["quinidine", "drug", "144-152"], "DRUGB": ["antihistamines", "group", "156-169"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines @DRUG$ benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p40", "DRUGA": ["quinidine", "drug", "144-152"], "DRUGB": ["antipsychotic agents", "group", "172-191"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p41", "DRUGA": ["quinidine", "drug", "144-152"], "DRUGB": ["phenothiazines", "group", "200-213"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines @DRUG$ MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p42", "DRUGA": ["quinidine", "drug", "144-152"], "DRUGB": ["benzodiazepines", "group", "217-231"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines @DRUG$ narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p43", "DRUGA": ["quinidine", "drug", "144-152"], "DRUGB": ["MAO inhibitors", "group", "234-247"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors @DRUG$ nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p44", "DRUGA": ["quinidine", "drug", "144-152"], "DRUGB": ["narcotic analgesics", "group", "250-268"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p45", "DRUGA": ["quinidine", "drug", "144-152"], "DRUGB": ["meperidine", "drug", "277-286"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics @DRUG$ nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p46", "DRUGA": ["quinidine", "drug", "144-152"], "DRUGB": ["nitrates", "group", "290-297"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates @DRUG$ tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p47", "DRUGA": ["quinidine", "drug", "144-152"], "DRUGB": ["nitrites", "group", "303-310"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites @DRUG$ tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p48", "DRUGA": ["quinidine", "drug", "144-152"], "DRUGB": ["sympathomimetic agents", "group", "313-334"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites @DRUG$ drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p49", "DRUGA": ["quinidine", "drug", "144-152"], "DRUGB": ["tricyclic antidepressants", "group", "337-361"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g @DRUG$ @DRUG$ benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p50", "DRUGA": ["antihistamines", "group", "156-169"], "DRUGB": ["antipsychotic agents", "group", "172-191"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g @DRUG$ benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p51", "DRUGA": ["antihistamines", "group", "156-169"], "DRUGB": ["phenothiazines", "group", "200-213"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g @DRUG$ @DRUG$ MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p52", "DRUGA": ["antihistamines", "group", "156-169"], "DRUGB": ["benzodiazepines", "group", "217-231"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g @DRUG$ benzodiazepines @DRUG$ narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p53", "DRUGA": ["antihistamines", "group", "156-169"], "DRUGB": ["MAO inhibitors", "group", "234-247"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g @DRUG$ benzodiazepines MAO inhibitors @DRUG$ nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p54", "DRUGA": ["antihistamines", "group", "156-169"], "DRUGB": ["narcotic analgesics", "group", "250-268"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g @DRUG$ benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p55", "DRUGA": ["antihistamines", "group", "156-169"], "DRUGB": ["meperidine", "drug", "277-286"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g @DRUG$ benzodiazepines MAO inhibitors narcotic analgesics @DRUG$ nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p56", "DRUGA": ["antihistamines", "group", "156-169"], "DRUGB": ["nitrates", "group", "290-297"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g @DRUG$ benzodiazepines MAO inhibitors narcotic analgesics nitrates @DRUG$ tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p57", "DRUGA": ["antihistamines", "group", "156-169"], "DRUGB": ["nitrites", "group", "303-310"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g @DRUG$ benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites @DRUG$ tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p58", "DRUGA": ["antihistamines", "group", "156-169"], "DRUGB": ["sympathomimetic agents", "group", "313-334"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g @DRUG$ benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites @DRUG$ drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p59", "DRUGA": ["antihistamines", "group", "156-169"], "DRUGB": ["tricyclic antidepressants", "group", "337-361"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines @DRUG$ benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p60", "DRUGA": ["antipsychotic agents", "group", "172-191"], "DRUGB": ["phenothiazines", "group", "200-213"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines @DRUG$ @DRUG$ MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p61", "DRUGA": ["antipsychotic agents", "group", "172-191"], "DRUGB": ["benzodiazepines", "group", "217-231"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines @DRUG$ benzodiazepines @DRUG$ narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p62", "DRUGA": ["antipsychotic agents", "group", "172-191"], "DRUGB": ["MAO inhibitors", "group", "234-247"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines @DRUG$ benzodiazepines MAO inhibitors @DRUG$ nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p63", "DRUGA": ["antipsychotic agents", "group", "172-191"], "DRUGB": ["narcotic analgesics", "group", "250-268"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines @DRUG$ benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p64", "DRUGA": ["antipsychotic agents", "group", "172-191"], "DRUGB": ["meperidine", "drug", "277-286"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines @DRUG$ benzodiazepines MAO inhibitors narcotic analgesics @DRUG$ nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p65", "DRUGA": ["antipsychotic agents", "group", "172-191"], "DRUGB": ["nitrates", "group", "290-297"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines @DRUG$ benzodiazepines MAO inhibitors narcotic analgesics nitrates @DRUG$ tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p66", "DRUGA": ["antipsychotic agents", "group", "172-191"], "DRUGB": ["nitrites", "group", "303-310"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines @DRUG$ benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites @DRUG$ tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p67", "DRUGA": ["antipsychotic agents", "group", "172-191"], "DRUGB": ["sympathomimetic agents", "group", "313-334"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines @DRUG$ benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites @DRUG$ drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p68", "DRUGA": ["antipsychotic agents", "group", "172-191"], "DRUGB": ["tricyclic antidepressants", "group", "337-361"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines @DRUG$ MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p69", "DRUGA": ["phenothiazines", "group", "200-213"], "DRUGB": ["benzodiazepines", "group", "217-231"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines @DRUG$ narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p70", "DRUGA": ["phenothiazines", "group", "200-213"], "DRUGB": ["MAO inhibitors", "group", "234-247"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors @DRUG$ nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p71", "DRUGA": ["phenothiazines", "group", "200-213"], "DRUGB": ["narcotic analgesics", "group", "250-268"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p72", "DRUGA": ["phenothiazines", "group", "200-213"], "DRUGB": ["meperidine", "drug", "277-286"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics @DRUG$ nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p73", "DRUGA": ["phenothiazines", "group", "200-213"], "DRUGB": ["nitrates", "group", "290-297"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates @DRUG$ tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p74", "DRUGA": ["phenothiazines", "group", "200-213"], "DRUGB": ["nitrites", "group", "303-310"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites @DRUG$ tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p75", "DRUGA": ["phenothiazines", "group", "200-213"], "DRUGB": ["sympathomimetic agents", "group", "313-334"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites @DRUG$ drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p76", "DRUGA": ["phenothiazines", "group", "200-213"], "DRUGB": ["tricyclic antidepressants", "group", "337-361"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines @DRUG$ @DRUG$ narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p77", "DRUGA": ["benzodiazepines", "group", "217-231"], "DRUGB": ["MAO inhibitors", "group", "234-247"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines @DRUG$ MAO inhibitors @DRUG$ nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p78", "DRUGA": ["benzodiazepines", "group", "217-231"], "DRUGB": ["narcotic analgesics", "group", "250-268"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines @DRUG$ MAO inhibitors narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p79", "DRUGA": ["benzodiazepines", "group", "217-231"], "DRUGB": ["meperidine", "drug", "277-286"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines @DRUG$ MAO inhibitors narcotic analgesics @DRUG$ nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p80", "DRUGA": ["benzodiazepines", "group", "217-231"], "DRUGB": ["nitrates", "group", "290-297"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines @DRUG$ MAO inhibitors narcotic analgesics nitrates @DRUG$ tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p81", "DRUGA": ["benzodiazepines", "group", "217-231"], "DRUGB": ["nitrites", "group", "303-310"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines @DRUG$ MAO inhibitors narcotic analgesics nitrates nitrites @DRUG$ tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p82", "DRUGA": ["benzodiazepines", "group", "217-231"], "DRUGB": ["sympathomimetic agents", "group", "313-334"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines @DRUG$ MAO inhibitors narcotic analgesics nitrates nitrites @DRUG$ drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p83", "DRUGA": ["benzodiazepines", "group", "217-231"], "DRUGB": ["tricyclic antidepressants", "group", "337-361"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines @DRUG$ @DRUG$ nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p84", "DRUGA": ["MAO inhibitors", "group", "234-247"], "DRUGB": ["narcotic analgesics", "group", "250-268"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines @DRUG$ narcotic analgesics nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p85", "DRUGA": ["MAO inhibitors", "group", "234-247"], "DRUGB": ["meperidine", "drug", "277-286"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines @DRUG$ narcotic analgesics @DRUG$ nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p86", "DRUGA": ["MAO inhibitors", "group", "234-247"], "DRUGB": ["nitrates", "group", "290-297"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines @DRUG$ narcotic analgesics nitrates @DRUG$ tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p87", "DRUGA": ["MAO inhibitors", "group", "234-247"], "DRUGB": ["nitrites", "group", "303-310"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines @DRUG$ narcotic analgesics nitrates nitrites @DRUG$ tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p88", "DRUGA": ["MAO inhibitors", "group", "234-247"], "DRUGB": ["sympathomimetic agents", "group", "313-334"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines @DRUG$ narcotic analgesics nitrates nitrites @DRUG$ drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p89", "DRUGA": ["MAO inhibitors", "group", "234-247"], "DRUGB": ["tricyclic antidepressants", "group", "337-361"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors @DRUG$ nitrates nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p90", "DRUGA": ["narcotic analgesics", "group", "250-268"], "DRUGB": ["meperidine", "drug", "277-286"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors @DRUG$ @DRUG$ nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p91", "DRUGA": ["narcotic analgesics", "group", "250-268"], "DRUGB": ["nitrates", "group", "290-297"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors @DRUG$ nitrates @DRUG$ tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p92", "DRUGA": ["narcotic analgesics", "group", "250-268"], "DRUGB": ["nitrites", "group", "303-310"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors @DRUG$ nitrates nitrites @DRUG$ tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p93", "DRUGA": ["narcotic analgesics", "group", "250-268"], "DRUGB": ["sympathomimetic agents", "group", "313-334"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors @DRUG$ nitrates nitrites @DRUG$ drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p94", "DRUGA": ["narcotic analgesics", "group", "250-268"], "DRUGB": ["tricyclic antidepressants", "group", "337-361"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics @DRUG$ nitrites tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p95", "DRUGA": ["meperidine", "drug", "277-286"], "DRUGB": ["nitrates", "group", "290-297"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates @DRUG$ tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p96", "DRUGA": ["meperidine", "drug", "277-286"], "DRUGB": ["nitrites", "group", "303-310"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites @DRUG$ tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p97", "DRUGA": ["meperidine", "drug", "277-286"], "DRUGB": ["sympathomimetic agents", "group", "313-334"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites @DRUG$ drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p98", "DRUGA": ["meperidine", "drug", "277-286"], "DRUGB": ["tricyclic antidepressants", "group", "337-361"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics @DRUG$ @DRUG$ tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p99", "DRUGA": ["nitrates", "group", "290-297"], "DRUGB": ["nitrites", "group", "303-310"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics @DRUG$ nitrites @DRUG$ tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p100", "DRUGA": ["nitrates", "group", "290-297"], "DRUGB": ["sympathomimetic agents", "group", "313-334"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics @DRUG$ nitrites @DRUG$ drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p101", "DRUGA": ["nitrates", "group", "290-297"], "DRUGB": ["tricyclic antidepressants", "group", "337-361"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates @DRUG$ @DRUG$ tricyclic antidepressants drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p102", "DRUGA": ["nitrites", "group", "303-310"], "DRUGB": ["sympathomimetic agents", "group", "313-334"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates @DRUG$ @DRUG$ drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p103", "DRUGA": ["nitrites", "group", "303-310"], "DRUGB": ["tricyclic antidepressants", "group", "337-361"]}
{"TEXT1": "following agents increase certain actions anticholinergic amantadine antiarrhythmic agents class I g antihistamines benzodiazepines MAO inhibitors narcotic analgesics nitrates nitrites @DRUG$ @DRUG$ drugs activity", "LBL": "0", "ID": "DDI-DrugBank.d585.s0.p104", "DRUGA": ["sympathomimetic agents", "group", "313-334"], "DRUGB": ["tricyclic antidepressants", "group", "337-361"]}
{"TEXT1": "@DRUG$ effects @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d585.s1.p0", "DRUGA": ["Anticholinergics", "group", "0-15"], "DRUGB": ["antiglaucoma agents", "group", "43-61"]}
{"TEXT1": "@DRUG$ increased intraocular pressure hazardous taken agents @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d585.s2.p0", "DRUGA": ["Anticholinergic drugs", "group", "0-20"], "DRUGB": ["corticosteroids", "group", "133-147"]}
{"TEXT1": "@DRUG$ affect gastrointestinal absorption drugs various slowly dissolving dosage forms", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d585.s3.p0", "DRUGA": ["Anticholinergic agents", "group", "0-21"], "DRUGB": ["digoxin", "drug", "122-128"]}
{"TEXT1": "@DRUG$ effects of drugs alter gastrointestinal motility @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d585.s5.p0", "DRUGA": ["Anticholinergic drugs", "group", "0-20"], "DRUGB": ["metoclopramide", "drug", "104-117"]}
{"TEXT1": "@DRUG$ interfere absorption @DRUG$ simultaneous drugs", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d585.s6.p0", "DRUGA": ["antacids", "group", "8-15"], "DRUGB": ["anticholinergic agents", "group", "54-75"]}
{"TEXT1": "@DRUG$ used with caution patients receiving @DRUG$ agents related toxic effects drugs additive", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d591.s0.p0", "DRUGA": ["Ropivacaine", "drug", "0-10"], "DRUGB": ["anesthetics", "group", "74-84"]}
{"TEXT1": "@DRUG$ used with caution patients receiving local anesthetics agents related @DRUG$ toxic effects drugs additive", "LBL": "0", "ID": "DDI-DrugBank.d591.s0.p1", "DRUGA": ["Ropivacaine", "drug", "0-10"], "DRUGB": ["amide-type local anesthetics", "group", "120-147"]}
{"TEXT1": "Ropivacaine used with caution patients receiving @DRUG$ agents related @DRUG$ toxic effects drugs additive", "LBL": "0", "ID": "DDI-DrugBank.d591.s0.p2", "DRUGA": ["anesthetics", "group", "74-84"], "DRUGB": ["amide-type local anesthetics", "group", "120-147"]}
{"TEXT1": "In vivo plasma clearance @DRUG$ reduced coadministration @DRUG$ selective potent CYP1A2 inhibitor", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d591.s2.p0", "DRUGA": ["ropivacaine", "drug", "33-43"], "DRUGB": ["fluvoxamine", "drug", "91-101"]}
{"TEXT1": "strong inhibitors cytochrome @DRUG$ given administration @DRUG$ ropivacaine plasma", "LBL": "DDI-int", "ID": "DDI-DrugBank.d591.s3.p0", "DRUGA": ["fluvoxamine", "drug", "54-64"], "DRUGB": ["Ropivacaine", "drug", "112-122"]}
{"TEXT1": "strong inhibitors cytochrome @DRUG$ given administration @DRUG$ ropivacaine plasma", "LBL": "0", "ID": "DDI-DrugBank.d591.s3.p1", "DRUGA": ["fluvoxamine", "drug", "54-64"], "DRUGB": ["Ropivacaine", "drug", "143-153"]}
{"TEXT1": "strong inhibitors cytochrome @DRUG$ given administration leading increased levels @DRUG$ plasma", "LBL": "0", "ID": "DDI-DrugBank.d591.s3.p2", "DRUGA": ["fluvoxamine", "drug", "54-64"], "DRUGB": ["ropivacaine", "drug", "176-186"]}
{"TEXT1": "strong inhibitors cytochrome fluvoxamine given administration @DRUG$ @DRUG$ ropivacaine plasma", "LBL": "0", "ID": "DDI-DrugBank.d591.s3.p3", "DRUGA": ["Ropivacaine", "drug", "112-122"], "DRUGB": ["Ropivacaine", "drug", "143-153"]}
{"TEXT1": "strong inhibitors cytochrome fluvoxamine given administration @DRUG$ leading increased levels @DRUG$ plasma", "LBL": "0", "ID": "DDI-DrugBank.d591.s3.p4", "DRUGA": ["Ropivacaine", "drug", "112-122"], "DRUGB": ["ropivacaine", "drug", "176-186"]}
{"TEXT1": "strong inhibitors cytochrome fluvoxamine given administration @DRUG$ leading increased levels @DRUG$ plasma", "LBL": "0", "ID": "DDI-DrugBank.d591.s3.p5", "DRUGA": ["Ropivacaine", "drug", "143-153"], "DRUGB": ["ropivacaine", "drug", "176-186"]}
{"TEXT1": "Possible interactions drugs known to metabolized CYP1A2 competitive inhibition @DRUG$ @DRUG$ occur", "LBL": "0", "ID": "DDI-DrugBank.d591.s5.p0", "DRUGA": ["theophylline", "drug", "102-113"], "DRUGB": ["imipramine", "drug", "119-128"]}
{"TEXT1": "Coadministration selective potent inhibitor CYP3A4 @DRUG$ days @DRUG$ infusion administered 1 hour caused reduction in vivo plasma clearance ropivacaine", "LBL": "0", "ID": "DDI-DrugBank.d591.s6.p0", "DRUGA": ["ketoconazole", "drug", "64-75"], "DRUGB": ["ropivacaine", "drug", "105-115"]}
{"TEXT1": "Coadministration selective potent inhibitor CYP3A4 @DRUG$ days ropivacaine infusion administered 1 hour caused reduction in vivo plasma clearance", "LBL": "0", "ID": "DDI-DrugBank.d591.s6.p1", "DRUGA": ["ketoconazole", "drug", "64-75"], "DRUGB": ["ketoconazole", "drug", "152-163"]}
{"TEXT1": "Coadministration selective potent inhibitor CYP3A4 @DRUG$ days ropivacaine infusion administered 1 hour caused reduction in vivo plasma clearance @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d591.s6.p2", "DRUGA": ["ketoconazole", "drug", "64-75"], "DRUGB": ["ropivacaine", "drug", "220-230"]}
{"TEXT1": "Coadministration selective potent inhibitor CYP3A4 ketoconazole days @DRUG$ infusion administered 1 hour caused reduction in vivo plasma clearance ropivacaine", "LBL": "0", "ID": "DDI-DrugBank.d591.s6.p3", "DRUGA": ["ropivacaine", "drug", "105-115"], "DRUGB": ["ketoconazole", "drug", "152-163"]}
{"TEXT1": "Coadministration selective potent inhibitor CYP3A4 ketoconazole days @DRUG$ infusion administered 1 hour caused reduction in vivo plasma clearance @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d591.s6.p4", "DRUGA": ["ropivacaine", "drug", "105-115"], "DRUGB": ["ropivacaine", "drug", "220-230"]}
{"TEXT1": "Coadministration selective potent inhibitor CYP3A4 ketoconazole days ropivacaine infusion administered 1 hour caused reduction in vivo plasma clearance @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d591.s6.p5", "DRUGA": ["ketoconazole", "drug", "152-163"], "DRUGB": ["ropivacaine", "drug", "220-230"]}
{"TEXT1": "elderly patients receiving certain @DRUG$ @DRUG$ increased incidence thrombopenia purpura reported", "LBL": "0", "ID": "DDI-DrugBank.d577.s0.p0", "DRUGA": ["diuretics", "group", "51-59"], "DRUGB": ["thiazides", "group", "72-80"]}
{"TEXT1": "reported @DRUG$ prothrombin time patients receiving @DRUG$ warfarin", "LBL": "0", "ID": "DDI-DrugBank.d577.s1.p0", "DRUGA": ["sulfamethoxazole", "drug", "26-41"], "DRUGB": ["anticoagulant", "group", "110-122"]}
{"TEXT1": "reported @DRUG$ prothrombin time patients receiving anticoagulant @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d577.s1.p1", "DRUGA": ["sulfamethoxazole", "drug", "26-41"], "DRUGB": ["warfarin", "drug", "124-131"]}
{"TEXT1": "reported sulfamethoxazole prothrombin time patients receiving @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d577.s1.p2", "DRUGA": ["anticoagulant", "group", "110-122"], "DRUGB": ["warfarin", "drug", "124-131"]}
{"TEXT1": "@DRUG$ inhibit hepatic metabolism @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d577.s3.p0", "DRUGA": ["Sulfamethoxazole", "drug", "0-15"], "DRUGB": ["phenytoin", "drug", "55-63"]}
{"TEXT1": "dose @DRUG$ slight significant increase @DRUG$ not decrease metabolic clearance rate", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d577.s4.p0", "DRUGA": ["sulfamethoxazole", "drug", "17-32"], "DRUGB": ["phenytoin", "drug", "97-105"]}
{"TEXT1": "@DRUG$ @DRUG$ plasma protein binding sites increasing free methotrexate concentrations", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d577.s6.p0", "DRUGA": ["Sulfonamides", "group", "0-11"], "DRUGB": ["methotrexate", "drug", "31-42"]}
{"TEXT1": "@DRUG$ methotrexate plasma protein binding sites increasing free @DRUG$ concentrations", "LBL": "0", "ID": "DDI-DrugBank.d577.s6.p1", "DRUGA": ["Sulfonamides", "group", "0-11"], "DRUGB": ["methotrexate", "drug", "100-111"]}
{"TEXT1": "Sulfonamides @DRUG$ plasma protein binding sites increasing free @DRUG$ concentrations", "LBL": "0", "ID": "DDI-DrugBank.d577.s6.p2", "DRUGA": ["methotrexate", "drug", "31-42"], "DRUGB": ["methotrexate", "drug", "100-111"]}
{"TEXT1": "usually complete cross resistance @DRUG$ TABLOID brand Thioguanine", "LBL": "0", "ID": "DDI-DrugBank.d722.s0.p0", "DRUGA": ["PURINETHOL", "brand", "51-60"], "DRUGB": ["mercaptopurine", "drug", "63-76"]}
{"TEXT1": "usually complete cross resistance @DRUG$ @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d722.s0.p1", "DRUGA": ["PURINETHOL", "brand", "51-60"], "DRUGB": ["TABLOID", "brand", "83-89"]}
{"TEXT1": "usually complete cross resistance @DRUG$ @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d722.s0.p2", "DRUGA": ["PURINETHOL", "brand", "51-60"], "DRUGB": ["Thioguanine", "drug", "97-107"]}
{"TEXT1": "usually complete cross resistance PURINETHOL @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d722.s0.p3", "DRUGA": ["mercaptopurine", "drug", "63-76"], "DRUGB": ["TABLOID", "brand", "83-89"]}
{"TEXT1": "usually complete cross resistance PURINETHOL @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d722.s0.p4", "DRUGA": ["mercaptopurine", "drug", "63-76"], "DRUGB": ["Thioguanine", "drug", "97-107"]}
{"TEXT1": "usually complete cross resistance PURINETHOL @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d722.s0.p5", "DRUGA": ["TABLOID", "brand", "83-89"], "DRUGB": ["Thioguanine", "drug", "97-107"]}
{"TEXT1": "in vitro evidence @DRUG$ @DRUG$ mesalazine inhibit TPMT enzyme administered patients receiving concurrent therapy thioguanine", "LBL": "0", "ID": "DDI-DrugBank.d722.s1.p0", "DRUGA": ["aminosalicylate derivatives", "group", "35-61"], "DRUGB": ["olsalazine", "drug", "70-79"]}
{"TEXT1": "in vitro evidence @DRUG$ olsalazine @DRUG$ inhibit TPMT enzyme administered patients receiving concurrent therapy thioguanine", "LBL": "0", "ID": "DDI-DrugBank.d722.s1.p1", "DRUGA": ["aminosalicylate derivatives", "group", "35-61"], "DRUGB": ["mesalazine", "drug", "82-91"]}
{"TEXT1": "in vitro evidence @DRUG$ olsalazine mesalazine inhibit TPMT enzyme administered patients receiving concurrent therapy thioguanine", "LBL": "0", "ID": "DDI-DrugBank.d722.s1.p2", "DRUGA": ["aminosalicylate derivatives", "group", "35-61"], "DRUGB": ["sulphasalazine", "drug", "97-110"]}
{"TEXT1": "in vitro evidence @DRUG$ olsalazine mesalazine inhibit TPMT enzyme administered patients receiving concurrent therapy @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d722.s1.p3", "DRUGA": ["aminosalicylate derivatives", "group", "35-61"], "DRUGB": ["thioguanine", "drug", "212-222"]}
{"TEXT1": "in vitro evidence aminosalicylate derivatives @DRUG$ @DRUG$ inhibit TPMT enzyme administered patients receiving concurrent therapy thioguanine", "LBL": "0", "ID": "DDI-DrugBank.d722.s1.p4", "DRUGA": ["olsalazine", "drug", "70-79"], "DRUGB": ["mesalazine", "drug", "82-91"]}
{"TEXT1": "in vitro evidence aminosalicylate derivatives @DRUG$ mesalazine inhibit TPMT enzyme administered patients receiving concurrent therapy thioguanine", "LBL": "0", "ID": "DDI-DrugBank.d722.s1.p5", "DRUGA": ["olsalazine", "drug", "70-79"], "DRUGB": ["sulphasalazine", "drug", "97-110"]}
{"TEXT1": "in vitro evidence aminosalicylate derivatives @DRUG$ mesalazine inhibit TPMT enzyme administered patients receiving concurrent therapy @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d722.s1.p6", "DRUGA": ["olsalazine", "drug", "70-79"], "DRUGB": ["thioguanine", "drug", "212-222"]}
{"TEXT1": "in vitro evidence aminosalicylate derivatives olsalazine @DRUG$ inhibit TPMT enzyme administered patients receiving concurrent therapy thioguanine", "LBL": "0", "ID": "DDI-DrugBank.d722.s1.p7", "DRUGA": ["mesalazine", "drug", "82-91"], "DRUGB": ["sulphasalazine", "drug", "97-110"]}
{"TEXT1": "in vitro evidence aminosalicylate derivatives olsalazine @DRUG$ inhibit TPMT enzyme administered patients receiving concurrent therapy @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d722.s1.p8", "DRUGA": ["mesalazine", "drug", "82-91"], "DRUGB": ["thioguanine", "drug", "212-222"]}
{"TEXT1": "in vitro evidence aminosalicylate derivatives olsalazine mesalazine inhibit TPMT enzyme administered patients receiving concurrent therapy @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d722.s1.p9", "DRUGA": ["sulphasalazine", "drug", "97-110"], "DRUGB": ["thioguanine", "drug", "212-222"]}
{"TEXT1": "@DRUG$ reported to enhance activity @DRUG$ alcohol chlorpromazine reserpine", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d604.s0.p0", "DRUGA": ["Thalidomide", "drug", "0-10"], "DRUGB": ["barbiturates", "group", "66-77"]}
{"TEXT1": "@DRUG$ reported to enhance sedative barbiturates activity @DRUG$ chlorpromazine reserpine", "LBL": "0", "ID": "DDI-DrugBank.d604.s0.p1", "DRUGA": ["Thalidomide", "drug", "0-10"], "DRUGB": ["alcohol", "drug", "80-86"]}
{"TEXT1": "@DRUG$ reported to enhance sedative barbiturates activity alcohol @DRUG$ reserpine", "LBL": "0", "ID": "DDI-DrugBank.d604.s0.p2", "DRUGA": ["Thalidomide", "drug", "0-10"], "DRUGB": ["chlorpromazine", "drug", "89-102"]}
{"TEXT1": "@DRUG$ reported to enhance sedative barbiturates activity alcohol chlorpromazine @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d604.s0.p3", "DRUGA": ["Thalidomide", "drug", "0-10"], "DRUGB": ["reserpine", "drug", "109-117"]}
{"TEXT1": "Thalidomide reported to enhance activity @DRUG$ @DRUG$ chlorpromazine reserpine", "LBL": "0", "ID": "DDI-DrugBank.d604.s0.p4", "DRUGA": ["barbiturates", "group", "66-77"], "DRUGB": ["alcohol", "drug", "80-86"]}
{"TEXT1": "Thalidomide reported to enhance activity @DRUG$ alcohol @DRUG$ reserpine", "LBL": "0", "ID": "DDI-DrugBank.d604.s0.p5", "DRUGA": ["barbiturates", "group", "66-77"], "DRUGB": ["chlorpromazine", "drug", "89-102"]}
{"TEXT1": "Thalidomide reported to enhance activity @DRUG$ alcohol chlorpromazine @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d604.s0.p6", "DRUGA": ["barbiturates", "group", "66-77"], "DRUGB": ["reserpine", "drug", "109-117"]}
{"TEXT1": "Thalidomide reported to enhance sedative barbiturates activity @DRUG$ @DRUG$ reserpine", "LBL": "0", "ID": "DDI-DrugBank.d604.s0.p7", "DRUGA": ["alcohol", "drug", "80-86"], "DRUGB": ["chlorpromazine", "drug", "89-102"]}
{"TEXT1": "Thalidomide reported to enhance sedative barbiturates activity @DRUG$ chlorpromazine @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d604.s0.p8", "DRUGA": ["alcohol", "drug", "80-86"], "DRUGB": ["reserpine", "drug", "109-117"]}
{"TEXT1": "Thalidomide reported to enhance sedative barbiturates activity alcohol @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d604.s0.p9", "DRUGA": ["chlorpromazine", "drug", "89-102"], "DRUGB": ["reserpine", "drug", "109-117"]}
{"TEXT1": "10 healthy women pharmacokinetic profiles @DRUG$ ethinyl estradiol following administration single dose containing norethindrone 75 g studied", "LBL": "0", "ID": "DDI-DrugBank.d604.s2.p0", "DRUGA": ["Contraceptives", "group", "5-18"], "DRUGB": ["norethindrone", "drug", "74-86"]}
{"TEXT1": "10 healthy women pharmacokinetic profiles norethindrone @DRUG$ following administration single dose containing 75 g ethinyl estradiol studied", "LBL": "0", "ID": "DDI-DrugBank.d604.s2.p1", "DRUGA": ["Contraceptives", "group", "5-18"], "DRUGB": ["ethinyl estradiol", "drug", "92-108"]}
{"TEXT1": "10 healthy women pharmacokinetic profiles norethindrone ethinyl estradiol following administration single dose containing @DRUG$ 75 g studied", "LBL": "0", "ID": "DDI-DrugBank.d604.s2.p2", "DRUGA": ["Contraceptives", "group", "5-18"], "DRUGB": ["norethindrone acetate", "drug", "173-193"]}
{"TEXT1": "10 healthy women pharmacokinetic profiles norethindrone ethinyl estradiol following administration single dose containing 75 g @DRUG$ studied", "LBL": "0", "ID": "DDI-DrugBank.d604.s2.p3", "DRUGA": ["Contraceptives", "group", "5-18"], "DRUGB": ["ethinyl estradiol", "drug", "210-226"]}
{"TEXT1": "10 healthy women pharmacokinetic profiles @DRUG$ @DRUG$ following administration single dose containing norethindrone 75 g ethinyl estradiol studied", "LBL": "0", "ID": "DDI-DrugBank.d604.s2.p4", "DRUGA": ["norethindrone", "drug", "74-86"], "DRUGB": ["ethinyl estradiol", "drug", "92-108"]}
{"TEXT1": "10 healthy women pharmacokinetic profiles @DRUG$ ethinyl estradiol following administration single dose containing @DRUG$ 75 g studied", "LBL": "0", "ID": "DDI-DrugBank.d604.s2.p5", "DRUGA": ["norethindrone", "drug", "74-86"], "DRUGB": ["norethindrone acetate", "drug", "173-193"]}
{"TEXT1": "10 healthy women pharmacokinetic profiles @DRUG$ ethinyl estradiol following administration single dose containing norethindrone 75 g @DRUG$ studied", "LBL": "0", "ID": "DDI-DrugBank.d604.s2.p6", "DRUGA": ["norethindrone", "drug", "74-86"], "DRUGB": ["ethinyl estradiol", "drug", "210-226"]}
{"TEXT1": "10 healthy women pharmacokinetic profiles norethindrone @DRUG$ following administration single dose containing @DRUG$ 75 g ethinyl estradiol studied", "LBL": "0", "ID": "DDI-DrugBank.d604.s2.p7", "DRUGA": ["ethinyl estradiol", "drug", "92-108"], "DRUGB": ["norethindrone acetate", "drug", "173-193"]}
{"TEXT1": "10 healthy women pharmacokinetic profiles norethindrone @DRUG$ following administration single dose containing 75 g @DRUG$ studied", "LBL": "0", "ID": "DDI-DrugBank.d604.s2.p8", "DRUGA": ["ethinyl estradiol", "drug", "92-108"], "DRUGB": ["ethinyl estradiol", "drug", "210-226"]}
{"TEXT1": "10 healthy women pharmacokinetic profiles norethindrone ethinyl estradiol following administration single dose containing @DRUG$ 75 g @DRUG$ studied", "LBL": "0", "ID": "DDI-DrugBank.d604.s2.p9", "DRUGA": ["norethindrone acetate", "drug", "173-193"], "DRUGB": ["ethinyl estradiol", "drug", "210-226"]}
{"TEXT1": "Important Non @DRUG$ Interactions Interfere Concomitant use of griseofulvin modafinil penicillins rifampin rifabutin phenytoin carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p0", "DRUGA": ["Thalidomide", "drug", "14-24"], "DRUGB": ["Hormonal Contraceptives", "group", "70-92"]}
{"TEXT1": "Important Non @DRUG$ Interactions Interfere Hormonal Concomitant use of @DRUG$ griseofulvin modafinil penicillins rifampin rifabutin phenytoin carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p1", "DRUGA": ["Thalidomide", "drug", "14-24"], "DRUGB": ["HIV-protease inhibitors", "group", "114-136"]}
{"TEXT1": "Important Non @DRUG$ Interactions Interfere Hormonal Concomitant use of @DRUG$ modafinil penicillins rifampin rifabutin phenytoin carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p2", "DRUGA": ["Thalidomide", "drug", "14-24"], "DRUGB": ["griseofulvin", "drug", "139-150"]}
{"TEXT1": "Important Non @DRUG$ Interactions Interfere Hormonal Concomitant use of griseofulvin @DRUG$ penicillins rifampin rifabutin phenytoin carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p3", "DRUGA": ["Thalidomide", "drug", "14-24"], "DRUGB": ["modafinil", "drug", "153-161"]}
{"TEXT1": "Important Non @DRUG$ Interactions Interfere Hormonal Concomitant use of griseofulvin modafinil @DRUG$ rifampin rifabutin phenytoin carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p4", "DRUGA": ["Thalidomide", "drug", "14-24"], "DRUGB": ["penicillins", "group", "164-174"]}
{"TEXT1": "Important Non @DRUG$ Interactions Interfere Hormonal Concomitant use of griseofulvin modafinil penicillins @DRUG$ rifabutin phenytoin carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p5", "DRUGA": ["Thalidomide", "drug", "14-24"], "DRUGB": ["rifampin", "drug", "177-184"]}
{"TEXT1": "Important Non @DRUG$ Interactions Interfere Hormonal Concomitant use of griseofulvin modafinil penicillins rifampin @DRUG$ phenytoin carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p6", "DRUGA": ["Thalidomide", "drug", "14-24"], "DRUGB": ["rifabutin", "drug", "187-195"]}
{"TEXT1": "Important Non @DRUG$ Interactions Interfere Hormonal Concomitant use of griseofulvin modafinil penicillins rifampin rifabutin @DRUG$ carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p7", "DRUGA": ["Thalidomide", "drug", "14-24"], "DRUGB": ["phenytoin", "drug", "198-206"]}
{"TEXT1": "Important Non @DRUG$ Interactions Interfere Hormonal Concomitant use of griseofulvin modafinil penicillins rifampin rifabutin phenytoin @DRUG$ certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p8", "DRUGA": ["Thalidomide", "drug", "14-24"], "DRUGB": ["carbamazepine", "drug", "209-221"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Concomitant use of @DRUG$ griseofulvin modafinil penicillins rifampin rifabutin phenytoin carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p9", "DRUGA": ["Hormonal Contraceptives", "group", "70-92"], "DRUGB": ["HIV-protease inhibitors", "group", "114-136"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Concomitant use of @DRUG$ modafinil penicillins rifampin rifabutin phenytoin carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p10", "DRUGA": ["Hormonal Contraceptives", "group", "70-92"], "DRUGB": ["griseofulvin", "drug", "139-150"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Concomitant use of griseofulvin @DRUG$ penicillins rifampin rifabutin phenytoin carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p11", "DRUGA": ["Hormonal Contraceptives", "group", "70-92"], "DRUGB": ["modafinil", "drug", "153-161"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Concomitant use of griseofulvin modafinil @DRUG$ rifampin rifabutin phenytoin carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p12", "DRUGA": ["Hormonal Contraceptives", "group", "70-92"], "DRUGB": ["penicillins", "group", "164-174"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Concomitant use of griseofulvin modafinil penicillins @DRUG$ rifabutin phenytoin carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p13", "DRUGA": ["Hormonal Contraceptives", "group", "70-92"], "DRUGB": ["rifampin", "drug", "177-184"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Concomitant use of griseofulvin modafinil penicillins rifampin @DRUG$ phenytoin carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p14", "DRUGA": ["Hormonal Contraceptives", "group", "70-92"], "DRUGB": ["rifabutin", "drug", "187-195"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Concomitant use of griseofulvin modafinil penicillins rifampin rifabutin @DRUG$ carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p15", "DRUGA": ["Hormonal Contraceptives", "group", "70-92"], "DRUGB": ["phenytoin", "drug", "198-206"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Concomitant use of griseofulvin modafinil penicillins rifampin rifabutin phenytoin @DRUG$ certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p16", "DRUGA": ["Hormonal Contraceptives", "group", "70-92"], "DRUGB": ["carbamazepine", "drug", "209-221"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Hormonal Concomitant use of @DRUG$ @DRUG$ modafinil penicillins rifampin rifabutin phenytoin carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p17", "DRUGA": ["HIV-protease inhibitors", "group", "114-136"], "DRUGB": ["griseofulvin", "drug", "139-150"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Hormonal Concomitant use of @DRUG$ griseofulvin @DRUG$ penicillins rifampin rifabutin phenytoin carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p18", "DRUGA": ["HIV-protease inhibitors", "group", "114-136"], "DRUGB": ["modafinil", "drug", "153-161"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Hormonal Concomitant use of @DRUG$ griseofulvin modafinil @DRUG$ rifampin rifabutin phenytoin carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p19", "DRUGA": ["HIV-protease inhibitors", "group", "114-136"], "DRUGB": ["penicillins", "group", "164-174"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Hormonal Concomitant use of @DRUG$ griseofulvin modafinil penicillins @DRUG$ rifabutin phenytoin carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p20", "DRUGA": ["HIV-protease inhibitors", "group", "114-136"], "DRUGB": ["rifampin", "drug", "177-184"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Hormonal Concomitant use of @DRUG$ griseofulvin modafinil penicillins rifampin @DRUG$ phenytoin carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p21", "DRUGA": ["HIV-protease inhibitors", "group", "114-136"], "DRUGB": ["rifabutin", "drug", "187-195"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Hormonal Concomitant use of @DRUG$ griseofulvin modafinil penicillins rifampin rifabutin @DRUG$ carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p22", "DRUGA": ["HIV-protease inhibitors", "group", "114-136"], "DRUGB": ["phenytoin", "drug", "198-206"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Hormonal Concomitant use of @DRUG$ griseofulvin modafinil penicillins rifampin rifabutin phenytoin @DRUG$ certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p23", "DRUGA": ["HIV-protease inhibitors", "group", "114-136"], "DRUGB": ["carbamazepine", "drug", "209-221"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Hormonal Concomitant use of @DRUG$ @DRUG$ penicillins rifampin rifabutin phenytoin carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p24", "DRUGA": ["griseofulvin", "drug", "139-150"], "DRUGB": ["modafinil", "drug", "153-161"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Hormonal Concomitant use of @DRUG$ modafinil @DRUG$ rifampin rifabutin phenytoin carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p25", "DRUGA": ["griseofulvin", "drug", "139-150"], "DRUGB": ["penicillins", "group", "164-174"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Hormonal Concomitant use of @DRUG$ modafinil penicillins @DRUG$ rifabutin phenytoin carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p26", "DRUGA": ["griseofulvin", "drug", "139-150"], "DRUGB": ["rifampin", "drug", "177-184"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Hormonal Concomitant use of @DRUG$ modafinil penicillins rifampin @DRUG$ phenytoin carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p27", "DRUGA": ["griseofulvin", "drug", "139-150"], "DRUGB": ["rifabutin", "drug", "187-195"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Hormonal Concomitant use of @DRUG$ modafinil penicillins rifampin rifabutin @DRUG$ carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p28", "DRUGA": ["griseofulvin", "drug", "139-150"], "DRUGB": ["phenytoin", "drug", "198-206"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Hormonal Concomitant use of @DRUG$ modafinil penicillins rifampin rifabutin phenytoin @DRUG$ certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p29", "DRUGA": ["griseofulvin", "drug", "139-150"], "DRUGB": ["carbamazepine", "drug", "209-221"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Hormonal Concomitant use of griseofulvin @DRUG$ @DRUG$ rifampin rifabutin phenytoin carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p30", "DRUGA": ["modafinil", "drug", "153-161"], "DRUGB": ["penicillins", "group", "164-174"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Hormonal Concomitant use of griseofulvin @DRUG$ penicillins @DRUG$ rifabutin phenytoin carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p31", "DRUGA": ["modafinil", "drug", "153-161"], "DRUGB": ["rifampin", "drug", "177-184"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Hormonal Concomitant use of griseofulvin @DRUG$ penicillins rifampin @DRUG$ phenytoin carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p32", "DRUGA": ["modafinil", "drug", "153-161"], "DRUGB": ["rifabutin", "drug", "187-195"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Hormonal Concomitant use of griseofulvin @DRUG$ penicillins rifampin rifabutin @DRUG$ carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p33", "DRUGA": ["modafinil", "drug", "153-161"], "DRUGB": ["phenytoin", "drug", "198-206"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Hormonal Concomitant use of griseofulvin @DRUG$ penicillins rifampin rifabutin phenytoin @DRUG$ certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p34", "DRUGA": ["modafinil", "drug", "153-161"], "DRUGB": ["carbamazepine", "drug", "209-221"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Hormonal Concomitant use of griseofulvin modafinil @DRUG$ @DRUG$ rifabutin phenytoin carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p35", "DRUGA": ["penicillins", "group", "164-174"], "DRUGB": ["rifampin", "drug", "177-184"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Hormonal Concomitant use of griseofulvin modafinil @DRUG$ rifampin @DRUG$ phenytoin carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p36", "DRUGA": ["penicillins", "group", "164-174"], "DRUGB": ["rifabutin", "drug", "187-195"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Hormonal Concomitant use of griseofulvin modafinil @DRUG$ rifampin rifabutin @DRUG$ carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p37", "DRUGA": ["penicillins", "group", "164-174"], "DRUGB": ["phenytoin", "drug", "198-206"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Hormonal Concomitant use of griseofulvin modafinil @DRUG$ rifampin rifabutin phenytoin @DRUG$ certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p38", "DRUGA": ["penicillins", "group", "164-174"], "DRUGB": ["carbamazepine", "drug", "209-221"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Hormonal Concomitant use of griseofulvin modafinil penicillins @DRUG$ @DRUG$ phenytoin carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p39", "DRUGA": ["rifampin", "drug", "177-184"], "DRUGB": ["rifabutin", "drug", "187-195"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Hormonal Concomitant use of griseofulvin modafinil penicillins @DRUG$ rifabutin @DRUG$ carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p40", "DRUGA": ["rifampin", "drug", "177-184"], "DRUGB": ["phenytoin", "drug", "198-206"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Hormonal Concomitant use of griseofulvin modafinil penicillins @DRUG$ rifabutin phenytoin @DRUG$ certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p41", "DRUGA": ["rifampin", "drug", "177-184"], "DRUGB": ["carbamazepine", "drug", "209-221"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Hormonal Concomitant use of griseofulvin modafinil penicillins rifampin @DRUG$ @DRUG$ carbamazepine certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p42", "DRUGA": ["rifabutin", "drug", "187-195"], "DRUGB": ["phenytoin", "drug", "198-206"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Hormonal Concomitant use of griseofulvin modafinil penicillins rifampin @DRUG$ phenytoin @DRUG$ certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p43", "DRUGA": ["rifabutin", "drug", "187-195"], "DRUGB": ["carbamazepine", "drug", "209-221"]}
{"TEXT1": "Important Non Thalidomide Interactions Interfere Hormonal Concomitant use of griseofulvin modafinil penicillins rifampin rifabutin @DRUG$ @DRUG$ certain herbal supplements St", "LBL": "0", "ID": "DDI-DrugBank.d604.s4.p44", "DRUGA": ["phenytoin", "drug", "198-206"], "DRUGB": ["carbamazepine", "drug", "209-221"]}
{"TEXT1": "@DRUG$ @DRUG$ effectiveness contraception up to one month discontinuation concomitant therapies", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d604.s5.p0", "DRUGA": ["John's Wort", "drug_n", "0-10"], "DRUGB": ["hormonal contraceptive agents", "group", "17-45"]}
{"TEXT1": "Catecholamine depleting drugs additive effect given @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d706.s0.p0", "DRUGA": ["reserpine", "drug", "37-45"], "DRUGB": ["beta-blocking agents", "group", "92-111"]}
{"TEXT1": "effect @DRUG$ additive @DRUG$ including alcohol", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d690.s0.p0", "DRUGA": ["propoxyphene", "drug", "29-40"], "DRUGB": ["CNS depressants", "group", "73-87"]}
{"TEXT1": "effect @DRUG$ additive including @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d690.s0.p1", "DRUGA": ["propoxyphene", "drug", "29-40"], "DRUGB": ["alcohol", "drug", "100-106"]}
{"TEXT1": "effect propoxyphene additive @DRUG$ including @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d690.s0.p2", "DRUGA": ["CNS depressants", "group", "73-87"], "DRUGB": ["alcohol", "drug", "100-106"]}
{"TEXT1": "occurrences reported @DRUG$ administered patients @DRUG$ anticonvulsants warfarin drugs", "LBL": "0", "ID": "DDI-DrugBank.d690.s3.p0", "DRUGA": ["propoxyphene", "drug", "41-52"], "DRUGB": ["antidepressants", "group", "86-100"]}
{"TEXT1": "occurrences reported @DRUG$ administered patients antidepressants @DRUG$ warfarin drugs", "LBL": "0", "ID": "DDI-DrugBank.d690.s3.p1", "DRUGA": ["propoxyphene", "drug", "41-52"], "DRUGB": ["anticonvulsants", "group", "103-117"]}
{"TEXT1": "occurrences reported @DRUG$ administered patients antidepressants anticonvulsants @DRUG$ drugs", "LBL": "0", "ID": "DDI-DrugBank.d690.s3.p2", "DRUGA": ["propoxyphene", "drug", "41-52"], "DRUGB": ["warfarin", "drug", "123-130"]}
{"TEXT1": "occurrences reported propoxyphene administered patients @DRUG$ @DRUG$ warfarin drugs", "LBL": "0", "ID": "DDI-DrugBank.d690.s3.p3", "DRUGA": ["antidepressants", "group", "86-100"], "DRUGB": ["anticonvulsants", "group", "103-117"]}
{"TEXT1": "occurrences reported propoxyphene administered patients @DRUG$ anticonvulsants @DRUG$ drugs", "LBL": "0", "ID": "DDI-DrugBank.d690.s3.p4", "DRUGA": ["antidepressants", "group", "86-100"], "DRUGB": ["warfarin", "drug", "123-130"]}
{"TEXT1": "occurrences reported propoxyphene administered patients antidepressants @DRUG$ @DRUG$ drugs", "LBL": "0", "ID": "DDI-DrugBank.d690.s3.p5", "DRUGA": ["anticonvulsants", "group", "103-117"], "DRUGB": ["warfarin", "drug", "123-130"]}
{"TEXT1": "@DRUG$ Daily Dosed Pharmacokinetic Steady State not cause significant changes kinetics single intravenous @DRUG$ cytochrome P450 1A2", "LBL": "0", "ID": "DDI-DrugBank.d739.s0.p0", "DRUGA": ["Montelukast", "drug", "0-10"], "DRUGB": ["theophylline", "drug", "176-187"]}
{"TEXT1": "not change pharmacokinetic profile @DRUG$ substrate cytochromes P450 2A6 effect single 30 mg dose oral @DRUG$ prothrombin time INR", "LBL": "0", "ID": "DDI-DrugBank.d739.s1.p0", "DRUGA": ["warfarin", "drug", "48-55"], "DRUGB": ["warfarin", "drug", "158-165"]}
{"TEXT1": "not change plasma concentration profile @DRUG$ substrate @DRUG$ carboxylated metabolite QTc interval following terfenadine 60 mg twice daily", "LBL": "0", "ID": "DDI-DrugBank.d739.s3.p0", "DRUGA": ["terfenadine", "drug", "53-63"], "DRUGB": ["fexofenadine", "drug", "105-116"]}
{"TEXT1": "not change plasma concentration profile @DRUG$ substrate fexofenadine carboxylated metabolite QTc interval following @DRUG$ twice daily", "LBL": "0", "ID": "DDI-DrugBank.d739.s3.p1", "DRUGA": ["terfenadine", "drug", "53-63"], "DRUGB": ["terfenadine", "drug", "218-228"]}
{"TEXT1": "not change plasma concentration profile terfenadine substrate @DRUG$ carboxylated metabolite QTc interval following @DRUG$ twice daily", "LBL": "0", "ID": "DDI-DrugBank.d739.s3.p2", "DRUGA": ["fexofenadine", "drug", "105-116"], "DRUGB": ["terfenadine", "drug", "218-228"]}
{"TEXT1": "@DRUG$ 100 Daily Dosed Pharmacokinetic not alter plasma concentrations component @DRUG$ containing 35 mcg", "LBL": "0", "ID": "DDI-DrugBank.d739.s4.p0", "DRUGA": ["Montelukast", "drug", "0-10"], "DRUGB": ["contraceptive", "group", "167-179"]}
{"TEXT1": "@DRUG$ 100 Daily Dosed Pharmacokinetic not alter plasma concentrations component oral contraceptive containing @DRUG$ 35 mcg", "LBL": "0", "ID": "DDI-DrugBank.d739.s4.p1", "DRUGA": ["Montelukast", "drug", "0-10"], "DRUGB": ["norethindrone", "drug", "192-204"]}
{"TEXT1": "@DRUG$ 100 Daily Dosed Pharmacokinetic not alter plasma concentrations component oral contraceptive containing @DRUG$ 35 mcg", "LBL": "0", "ID": "DDI-DrugBank.d739.s4.p2", "DRUGA": ["Montelukast", "drug", "0-10"], "DRUGB": ["estradiol", "drug", "219-227"]}
{"TEXT1": "Montelukast 100 Daily Dosed Pharmacokinetic not alter plasma concentrations component @DRUG$ containing @DRUG$ 35 mcg", "LBL": "0", "ID": "DDI-DrugBank.d739.s4.p3", "DRUGA": ["contraceptive", "group", "167-179"], "DRUGB": ["norethindrone", "drug", "192-204"]}
{"TEXT1": "Montelukast 100 Daily Dosed Pharmacokinetic not alter plasma concentrations component @DRUG$ containing @DRUG$ 35 mcg", "LBL": "0", "ID": "DDI-DrugBank.d739.s4.p4", "DRUGA": ["contraceptive", "group", "167-179"], "DRUGB": ["estradiol", "drug", "219-227"]}
{"TEXT1": "Montelukast 100 Daily Dosed Pharmacokinetic not alter plasma concentrations component oral contraceptive containing @DRUG$ @DRUG$ 35 mcg", "LBL": "0", "ID": "DDI-DrugBank.d739.s4.p5", "DRUGA": ["norethindrone", "drug", "192-204"], "DRUGB": ["estradiol", "drug", "219-227"]}
{"TEXT1": "not cause significant change plasma profiles @DRUG$ @DRUG$ following administration oral administration prednisone oral prednisone intravenous prednisolone", "LBL": "0", "ID": "DDI-DrugBank.d739.s5.p0", "DRUGA": ["prednisone", "drug", "72-81"], "DRUGB": ["prednisolone", "drug", "86-97"]}
{"TEXT1": "not cause significant change plasma profiles @DRUG$ prednisolone following administration oral @DRUG$ intravenous", "LBL": "0", "ID": "DDI-DrugBank.d739.s5.p1", "DRUGA": ["prednisone", "drug", "72-81"], "DRUGB": ["prednisone", "drug", "139-148"]}
{"TEXT1": "not cause significant change plasma profiles @DRUG$ prednisolone following administration oral administration prednisone oral prednisone intravenous @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d739.s5.p2", "DRUGA": ["prednisone", "drug", "72-81"], "DRUGB": ["prednisolone", "drug", "165-176"]}
{"TEXT1": "not cause significant change plasma profiles prednisone @DRUG$ following administration oral @DRUG$ intravenous prednisolone", "LBL": "0", "ID": "DDI-DrugBank.d739.s5.p3", "DRUGA": ["prednisolone", "drug", "86-97"], "DRUGB": ["prednisone", "drug", "139-148"]}
{"TEXT1": "not cause significant change plasma profiles prednisone @DRUG$ following administration oral intravenous @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d739.s5.p4", "DRUGA": ["prednisolone", "drug", "86-97"], "DRUGB": ["prednisolone", "drug", "165-176"]}
{"TEXT1": "not cause significant change plasma profiles prednisone prednisolone following administration oral @DRUG$ intravenous @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d739.s5.p5", "DRUGA": ["prednisone", "drug", "139-148"], "DRUGB": ["prednisolone", "drug", "165-176"]}
{"TEXT1": "@DRUG$ induces hepatic metabolism decreased AUC @DRUG$ approximately following single dose montelukast", "LBL": "0", "ID": "DDI-DrugBank.d739.s6.p0", "DRUGA": ["Phenobarbital", "drug", "0-12"], "DRUGB": ["montelukast", "drug", "70-80"]}
{"TEXT1": "@DRUG$ induces hepatic metabolism decreased AUC montelukast approximately following single dose @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d739.s6.p1", "DRUGA": ["Phenobarbital", "drug", "0-12"], "DRUGB": ["montelukast", "drug", "133-143"]}
{"TEXT1": "Phenobarbital induces hepatic metabolism decreased AUC @DRUG$ approximately following single dose @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d739.s6.p2", "DRUGA": ["montelukast", "drug", "70-80"], "DRUGB": ["montelukast", "drug", "133-143"]}
{"TEXT1": "to employ appropriate clinical monitoring potent cytochrome P450 enzyme inducers @DRUG$ @DRUG$ co administered montelukast", "LBL": "0", "ID": "DDI-DrugBank.d739.s8.p0", "DRUGA": ["phenobarbital", "drug", "112-124"], "DRUGB": ["rifampin", "drug", "129-136"]}
{"TEXT1": "to employ appropriate clinical monitoring potent cytochrome P450 enzyme inducers @DRUG$ rifampin co administered @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d739.s8.p1", "DRUGA": ["phenobarbital", "drug", "112-124"], "DRUGB": ["montelukast", "drug", "164-174"]}
{"TEXT1": "to employ appropriate clinical monitoring potent cytochrome P450 enzyme inducers phenobarbital @DRUG$ co administered @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d739.s8.p2", "DRUGA": ["rifampin", "drug", "129-136"], "DRUGB": ["montelukast", "drug", "164-174"]}
{"TEXT1": "studies recommended clinical dose @DRUG$ not important pharmacokinetics following @DRUG$ prednisone prednisolone oral contraceptives 35 terfenadine digoxin warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p0", "DRUGA": ["montelukast", "drug", "62-72"], "DRUGB": ["theophylline", "drug", "164-175"]}
{"TEXT1": "studies recommended clinical dose @DRUG$ not important pharmacokinetics following theophylline @DRUG$ prednisolone oral contraceptives 35 terfenadine digoxin warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p1", "DRUGA": ["montelukast", "drug", "62-72"], "DRUGB": ["prednisone", "drug", "178-187"]}
{"TEXT1": "studies recommended clinical dose @DRUG$ not important pharmacokinetics following theophylline prednisone @DRUG$ oral contraceptives 35 terfenadine digoxin warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p2", "DRUGA": ["montelukast", "drug", "62-72"], "DRUGB": ["prednisolone", "drug", "190-201"]}
{"TEXT1": "studies recommended clinical dose @DRUG$ not important pharmacokinetics following theophylline prednisone prednisolone @DRUG$ 35 terfenadine digoxin warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p3", "DRUGA": ["montelukast", "drug", "62-72"], "DRUGB": ["contraceptives", "group", "209-222"]}
{"TEXT1": "studies recommended clinical dose @DRUG$ not important pharmacokinetics following theophylline prednisone prednisolone oral contraceptives 35 terfenadine digoxin warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p4", "DRUGA": ["montelukast", "drug", "62-72"], "DRUGB": ["norethindrone", "drug", "225-237"]}
{"TEXT1": "studies recommended clinical dose @DRUG$ not important pharmacokinetics following theophylline prednisone prednisolone oral contraceptives 35 terfenadine digoxin warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p5", "DRUGA": ["montelukast", "drug", "62-72"], "DRUGB": ["ethinyl estradiol", "drug", "244-260"]}
{"TEXT1": "studies recommended clinical dose @DRUG$ not important pharmacokinetics following theophylline prednisone prednisolone oral contraceptives 35 @DRUG$ digoxin warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p6", "DRUGA": ["montelukast", "drug", "62-72"], "DRUGB": ["terfenadine", "drug", "271-281"]}
{"TEXT1": "studies recommended clinical dose @DRUG$ not important pharmacokinetics following theophylline prednisone prednisolone oral contraceptives 35 terfenadine @DRUG$ warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p7", "DRUGA": ["montelukast", "drug", "62-72"], "DRUGB": ["digoxin", "drug", "284-290"]}
{"TEXT1": "studies recommended clinical dose @DRUG$ not important pharmacokinetics following theophylline prednisone prednisolone oral contraceptives 35 terfenadine digoxin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p8", "DRUGA": ["montelukast", "drug", "62-72"], "DRUGB": ["warfarin", "drug", "297-304"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following @DRUG$ @DRUG$ prednisolone oral contraceptives 35 terfenadine digoxin warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p9", "DRUGA": ["theophylline", "drug", "164-175"], "DRUGB": ["prednisone", "drug", "178-187"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following @DRUG$ prednisone @DRUG$ oral contraceptives 35 terfenadine digoxin warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p10", "DRUGA": ["theophylline", "drug", "164-175"], "DRUGB": ["prednisolone", "drug", "190-201"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following @DRUG$ prednisone prednisolone @DRUG$ 35 terfenadine digoxin warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p11", "DRUGA": ["theophylline", "drug", "164-175"], "DRUGB": ["contraceptives", "group", "209-222"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following @DRUG$ prednisone prednisolone oral contraceptives 35 terfenadine digoxin warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p12", "DRUGA": ["theophylline", "drug", "164-175"], "DRUGB": ["norethindrone", "drug", "225-237"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following @DRUG$ prednisone prednisolone oral contraceptives 35 terfenadine digoxin warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p13", "DRUGA": ["theophylline", "drug", "164-175"], "DRUGB": ["ethinyl estradiol", "drug", "244-260"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following @DRUG$ prednisone prednisolone oral contraceptives 35 @DRUG$ digoxin warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p14", "DRUGA": ["theophylline", "drug", "164-175"], "DRUGB": ["terfenadine", "drug", "271-281"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following @DRUG$ prednisone prednisolone oral contraceptives 35 terfenadine @DRUG$ warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p15", "DRUGA": ["theophylline", "drug", "164-175"], "DRUGB": ["digoxin", "drug", "284-290"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following @DRUG$ prednisone prednisolone oral contraceptives 35 terfenadine digoxin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p16", "DRUGA": ["theophylline", "drug", "164-175"], "DRUGB": ["warfarin", "drug", "297-304"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following theophylline @DRUG$ @DRUG$ oral contraceptives 35 terfenadine digoxin warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p17", "DRUGA": ["prednisone", "drug", "178-187"], "DRUGB": ["prednisolone", "drug", "190-201"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following theophylline @DRUG$ prednisolone @DRUG$ 35 terfenadine digoxin warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p18", "DRUGA": ["prednisone", "drug", "178-187"], "DRUGB": ["contraceptives", "group", "209-222"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following theophylline @DRUG$ prednisolone oral contraceptives 35 terfenadine digoxin warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p19", "DRUGA": ["prednisone", "drug", "178-187"], "DRUGB": ["norethindrone", "drug", "225-237"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following theophylline @DRUG$ prednisolone oral contraceptives 35 terfenadine digoxin warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p20", "DRUGA": ["prednisone", "drug", "178-187"], "DRUGB": ["ethinyl estradiol", "drug", "244-260"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following theophylline @DRUG$ prednisolone oral contraceptives 35 @DRUG$ digoxin warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p21", "DRUGA": ["prednisone", "drug", "178-187"], "DRUGB": ["terfenadine", "drug", "271-281"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following theophylline @DRUG$ prednisolone oral contraceptives 35 terfenadine @DRUG$ warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p22", "DRUGA": ["prednisone", "drug", "178-187"], "DRUGB": ["digoxin", "drug", "284-290"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following theophylline @DRUG$ prednisolone oral contraceptives 35 terfenadine digoxin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p23", "DRUGA": ["prednisone", "drug", "178-187"], "DRUGB": ["warfarin", "drug", "297-304"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following theophylline prednisone @DRUG$ @DRUG$ 35 terfenadine digoxin warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p24", "DRUGA": ["prednisolone", "drug", "190-201"], "DRUGB": ["contraceptives", "group", "209-222"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following theophylline prednisone @DRUG$ oral contraceptives 35 terfenadine digoxin warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p25", "DRUGA": ["prednisolone", "drug", "190-201"], "DRUGB": ["norethindrone", "drug", "225-237"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following theophylline prednisone @DRUG$ oral contraceptives 35 terfenadine digoxin warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p26", "DRUGA": ["prednisolone", "drug", "190-201"], "DRUGB": ["ethinyl estradiol", "drug", "244-260"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following theophylline prednisone @DRUG$ oral contraceptives 35 @DRUG$ digoxin warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p27", "DRUGA": ["prednisolone", "drug", "190-201"], "DRUGB": ["terfenadine", "drug", "271-281"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following theophylline prednisone @DRUG$ oral contraceptives 35 terfenadine @DRUG$ warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p28", "DRUGA": ["prednisolone", "drug", "190-201"], "DRUGB": ["digoxin", "drug", "284-290"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following theophylline prednisone @DRUG$ oral contraceptives 35 terfenadine digoxin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p29", "DRUGA": ["prednisolone", "drug", "190-201"], "DRUGB": ["warfarin", "drug", "297-304"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following theophylline prednisone prednisolone @DRUG$ 35 terfenadine digoxin warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p30", "DRUGA": ["contraceptives", "group", "209-222"], "DRUGB": ["norethindrone", "drug", "225-237"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following theophylline prednisone prednisolone @DRUG$ 35 terfenadine digoxin warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p31", "DRUGA": ["contraceptives", "group", "209-222"], "DRUGB": ["ethinyl estradiol", "drug", "244-260"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following theophylline prednisone prednisolone @DRUG$ 35 @DRUG$ digoxin warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p32", "DRUGA": ["contraceptives", "group", "209-222"], "DRUGB": ["terfenadine", "drug", "271-281"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following theophylline prednisone prednisolone @DRUG$ 35 terfenadine @DRUG$ warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p33", "DRUGA": ["contraceptives", "group", "209-222"], "DRUGB": ["digoxin", "drug", "284-290"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following theophylline prednisone prednisolone @DRUG$ 35 terfenadine digoxin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p34", "DRUGA": ["contraceptives", "group", "209-222"], "DRUGB": ["warfarin", "drug", "297-304"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following theophylline prednisone prednisolone oral contraceptives 35 terfenadine digoxin warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p35", "DRUGA": ["norethindrone", "drug", "225-237"], "DRUGB": ["ethinyl estradiol", "drug", "244-260"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following theophylline prednisone prednisolone oral contraceptives 35 @DRUG$ digoxin warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p36", "DRUGA": ["norethindrone", "drug", "225-237"], "DRUGB": ["terfenadine", "drug", "271-281"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following theophylline prednisone prednisolone oral contraceptives 35 terfenadine @DRUG$ warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p37", "DRUGA": ["norethindrone", "drug", "225-237"], "DRUGB": ["digoxin", "drug", "284-290"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following theophylline prednisone prednisolone oral contraceptives 35 terfenadine digoxin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p38", "DRUGA": ["norethindrone", "drug", "225-237"], "DRUGB": ["warfarin", "drug", "297-304"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following theophylline prednisone prednisolone oral contraceptives 35 @DRUG$ digoxin warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p39", "DRUGA": ["ethinyl estradiol", "drug", "244-260"], "DRUGB": ["terfenadine", "drug", "271-281"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following theophylline prednisone prednisolone oral contraceptives 35 terfenadine @DRUG$ warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p40", "DRUGA": ["ethinyl estradiol", "drug", "244-260"], "DRUGB": ["digoxin", "drug", "284-290"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following theophylline prednisone prednisolone oral contraceptives 35 terfenadine digoxin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p41", "DRUGA": ["ethinyl estradiol", "drug", "244-260"], "DRUGB": ["warfarin", "drug", "297-304"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following theophylline prednisone prednisolone oral contraceptives 35 @DRUG$ @DRUG$ warfarin", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p42", "DRUGA": ["terfenadine", "drug", "271-281"], "DRUGB": ["digoxin", "drug", "284-290"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following theophylline prednisone prednisolone oral contraceptives 35 @DRUG$ digoxin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p43", "DRUGA": ["terfenadine", "drug", "271-281"], "DRUGB": ["warfarin", "drug", "297-304"]}
{"TEXT1": "studies recommended clinical dose montelukast not important pharmacokinetics following theophylline prednisone prednisolone oral contraceptives 35 terfenadine @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d739.s10.p44", "DRUGA": ["digoxin", "drug", "284-290"], "DRUGB": ["warfarin", "drug", "297-304"]}
{"TEXT1": "medications included @DRUG$ @DRUG$ benzodiazepines decongestants", "LBL": "0", "ID": "DDI-DrugBank.d739.s12.p0", "DRUGA": ["thyroid hormones", "group", "27-42"], "DRUGB": ["sedative hypnotics", "group", "45-62"]}
{"TEXT1": "medications included @DRUG$ sedative hypnotics @DRUG$ benzodiazepines decongestants", "LBL": "0", "ID": "DDI-DrugBank.d739.s12.p1", "DRUGA": ["thyroid hormones", "group", "27-42"], "DRUGB": ["non-steroidal anti-inflammatory agents", "group", "65-102"]}
{"TEXT1": "medications included @DRUG$ sedative hypnotics @DRUG$ decongestants", "LBL": "0", "ID": "DDI-DrugBank.d739.s12.p2", "DRUGA": ["thyroid hormones", "group", "27-42"], "DRUGB": ["benzodiazepines", "group", "105-119"]}
{"TEXT1": "medications included @DRUG$ sedative hypnotics benzodiazepines @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d739.s12.p3", "DRUGA": ["thyroid hormones", "group", "27-42"], "DRUGB": ["decongestants", "group", "126-138"]}
{"TEXT1": "medications included thyroid hormones @DRUG$ @DRUG$ benzodiazepines decongestants", "LBL": "0", "ID": "DDI-DrugBank.d739.s12.p4", "DRUGA": ["sedative hypnotics", "group", "45-62"], "DRUGB": ["non-steroidal anti-inflammatory agents", "group", "65-102"]}
{"TEXT1": "medications included thyroid hormones @DRUG$ @DRUG$ decongestants", "LBL": "0", "ID": "DDI-DrugBank.d739.s12.p5", "DRUGA": ["sedative hypnotics", "group", "45-62"], "DRUGB": ["benzodiazepines", "group", "105-119"]}
{"TEXT1": "medications included thyroid hormones @DRUG$ benzodiazepines @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d739.s12.p6", "DRUGA": ["sedative hypnotics", "group", "45-62"], "DRUGB": ["decongestants", "group", "126-138"]}
{"TEXT1": "medications included thyroid hormones sedative hypnotics @DRUG$ @DRUG$ decongestants", "LBL": "0", "ID": "DDI-DrugBank.d739.s12.p7", "DRUGA": ["non-steroidal anti-inflammatory agents", "group", "65-102"], "DRUGB": ["benzodiazepines", "group", "105-119"]}
{"TEXT1": "medications included thyroid hormones sedative hypnotics @DRUG$ benzodiazepines @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d739.s12.p8", "DRUGA": ["non-steroidal anti-inflammatory agents", "group", "65-102"], "DRUGB": ["decongestants", "group", "126-138"]}
{"TEXT1": "medications included thyroid hormones sedative hypnotics @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d739.s12.p9", "DRUGA": ["benzodiazepines", "group", "105-119"], "DRUGB": ["decongestants", "group", "126-138"]}
{"TEXT1": "@DRUG$ induces hepatic metabolism decreased AUC @DRUG$ approximately following single dose montelukast", "LBL": "0", "ID": "DDI-DrugBank.d739.s13.p0", "DRUGA": ["Phenobarbital", "drug", "0-12"], "DRUGB": ["montelukast", "drug", "70-80"]}
{"TEXT1": "@DRUG$ induces hepatic metabolism decreased AUC montelukast approximately following single dose @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d739.s13.p1", "DRUGA": ["Phenobarbital", "drug", "0-12"], "DRUGB": ["montelukast", "drug", "133-143"]}
{"TEXT1": "Phenobarbital induces hepatic metabolism decreased AUC @DRUG$ approximately following single dose @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d739.s13.p2", "DRUGA": ["montelukast", "drug", "70-80"], "DRUGB": ["montelukast", "drug", "133-143"]}
{"TEXT1": "to employ appropriate clinical monitoring potent cytochrome P450 enzyme inducers @DRUG$ @DRUG$ co administered montelukast", "LBL": "0", "ID": "DDI-DrugBank.d739.s15.p0", "DRUGA": ["phenobarbital", "drug", "112-124"], "DRUGB": ["rifampin", "drug", "129-136"]}
{"TEXT1": "to employ appropriate clinical monitoring potent cytochrome P450 enzyme inducers @DRUG$ rifampin co administered @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d739.s15.p1", "DRUGA": ["phenobarbital", "drug", "112-124"], "DRUGB": ["montelukast", "drug", "164-174"]}
{"TEXT1": "to employ appropriate clinical monitoring potent cytochrome P450 enzyme inducers phenobarbital @DRUG$ co administered @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d739.s15.p2", "DRUGA": ["rifampin", "drug", "129-136"], "DRUGB": ["montelukast", "drug", "164-174"]}
{"TEXT1": "Carbidopa/Levodopa not pharmacokinetics pramipexole healthy volunteers", "LBL": "0", "ID": "DDI-DrugBank.d737.s0.p0", "DRUGA": ["Carbidopa", "drug", "0-8"], "DRUGB": ["Levodopa", "drug", "10-17"]}
{"TEXT1": "not pharmacokinetics pramipexole healthy volunteers", "LBL": "0", "ID": "DDI-DrugBank.d737.s0.p1", "DRUGA": ["Carbidopa", "drug", "0-8"], "DRUGB": ["Carbidopa", "drug", "20-28"]}
{"TEXT1": "not pharmacokinetics pramipexole healthy volunteers", "LBL": "0", "ID": "DDI-DrugBank.d737.s0.p2", "DRUGA": ["Carbidopa", "drug", "0-8"], "DRUGB": ["Levodopa", "drug", "30-37"]}
{"TEXT1": "Carbidopa/Levodopa not pharmacokinetics @DRUG$ healthy volunteers", "LBL": "0", "ID": "DDI-DrugBank.d737.s0.p3", "DRUGA": ["Carbidopa", "drug", "0-8"], "DRUGB": ["pramipexole", "drug", "82-92"]}
{"TEXT1": "not pharmacokinetics pramipexole healthy volunteers", "LBL": "0", "ID": "DDI-DrugBank.d737.s0.p4", "DRUGA": ["Levodopa", "drug", "10-17"], "DRUGB": ["Carbidopa", "drug", "20-28"]}
{"TEXT1": "not pharmacokinetics pramipexole healthy volunteers", "LBL": "0", "ID": "DDI-DrugBank.d737.s0.p5", "DRUGA": ["Levodopa", "drug", "10-17"], "DRUGB": ["Levodopa", "drug", "30-37"]}
{"TEXT1": "Carbidopa/Levodopa not pharmacokinetics @DRUG$ healthy volunteers", "LBL": "0", "ID": "DDI-DrugBank.d737.s0.p6", "DRUGA": ["Levodopa", "drug", "10-17"], "DRUGB": ["pramipexole", "drug", "82-92"]}
{"TEXT1": "not pharmacokinetics pramipexole healthy volunteers", "LBL": "0", "ID": "DDI-DrugBank.d737.s0.p7", "DRUGA": ["Carbidopa", "drug", "20-28"], "DRUGB": ["Levodopa", "drug", "30-37"]}
{"TEXT1": "not pharmacokinetics @DRUG$ healthy volunteers", "LBL": "0", "ID": "DDI-DrugBank.d737.s0.p8", "DRUGA": ["Carbidopa", "drug", "20-28"], "DRUGB": ["pramipexole", "drug", "82-92"]}
{"TEXT1": "not pharmacokinetics @DRUG$ healthy volunteers", "LBL": "0", "ID": "DDI-DrugBank.d737.s0.p9", "DRUGA": ["Levodopa", "drug", "30-37"], "DRUGB": ["pramipexole", "drug", "82-92"]}
{"TEXT1": "healthy volunteers @DRUG$ not pharmacokinetics pramipexole", "LBL": "0", "ID": "DDI-DrugBank.d737.s2.p0", "DRUGA": ["Selegiline", "drug", "0-9"], "DRUGB": ["selegiline", "drug", "43-52"]}
{"TEXT1": "healthy volunteers selegiline not pharmacokinetics @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d737.s2.p1", "DRUGA": ["Selegiline", "drug", "0-9"], "DRUGB": ["pramipexole", "drug", "96-106"]}
{"TEXT1": "healthy volunteers @DRUG$ not pharmacokinetics @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d737.s2.p2", "DRUGA": ["selegiline", "drug", "43-52"], "DRUGB": ["pramipexole", "drug", "96-106"]}
{"TEXT1": "pharmacokinetic suggests @DRUG$ unlikely to alter oral clearance pramipexole", "LBL": "0", "ID": "DDI-DrugBank.d737.s3.p0", "DRUGA": ["Amantadine", "drug", "0-9"], "DRUGB": ["amantadine", "drug", "62-71"]}
{"TEXT1": "pharmacokinetic suggests amantadine unlikely to alter oral clearance @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d737.s3.p1", "DRUGA": ["Amantadine", "drug", "0-9"], "DRUGB": ["pramipexole", "drug", "116-126"]}
{"TEXT1": "pharmacokinetic suggests @DRUG$ unlikely to alter oral clearance @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d737.s3.p2", "DRUGA": ["amantadine", "drug", "62-71"], "DRUGB": ["pramipexole", "drug", "116-126"]}
{"TEXT1": "@DRUG$ known inhibitor renal tubular secretion organic bases cationic transport system caused increase pramipexole AUC", "LBL": "0", "ID": "DDI-DrugBank.d737.s4.p0", "DRUGA": ["Cimetidine", "drug", "0-9"], "DRUGB": ["Cimetidine", "drug", "12-21"]}
{"TEXT1": "Cimetidine known inhibitor renal tubular secretion organic bases cationic transport system caused increase @DRUG$ AUC", "LBL": "0", "ID": "DDI-DrugBank.d737.s4.p1", "DRUGA": ["Cimetidine", "drug", "0-9"], "DRUGB": ["pramipexole", "drug", "146-156"]}
{"TEXT1": "@DRUG$ known inhibitor renal tubular secretion organic bases cationic transport system caused increase @DRUG$ AUC", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d737.s4.p2", "DRUGA": ["Cimetidine", "drug", "12-21"], "DRUGB": ["pramipexole", "drug", "146-156"]}
{"TEXT1": "@DRUG$ known inhibitor renal tubular secretion organic acids transporter not pramipexole pharmacokinetics", "LBL": "0", "ID": "DDI-DrugBank.d737.s5.p0", "DRUGA": ["Probenecid", "drug", "0-9"], "DRUGB": ["Probenecid", "drug", "12-21"]}
{"TEXT1": "Probenecid known inhibitor renal tubular secretion organic acids transporter not @DRUG$ pharmacokinetics", "LBL": "0", "ID": "DDI-DrugBank.d737.s5.p1", "DRUGA": ["Probenecid", "drug", "0-9"], "DRUGB": ["pramipexole", "drug", "144-154"]}
{"TEXT1": "@DRUG$ known inhibitor renal tubular secretion organic acids transporter not @DRUG$ pharmacokinetics", "LBL": "0", "ID": "DDI-DrugBank.d737.s5.p2", "DRUGA": ["Probenecid", "drug", "12-21"], "DRUGB": ["pramipexole", "drug", "144-154"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system @DRUG$ @DRUG$ diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p0", "DRUGA": ["cimetidine", "drug", "178-187"], "DRUGB": ["ranitidine", "drug", "190-199"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system @DRUG$ ranitidine @DRUG$ triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p1", "DRUGA": ["cimetidine", "drug", "178-187"], "DRUGB": ["diltiazem", "drug", "202-210"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system @DRUG$ ranitidine diltiazem @DRUG$ verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p2", "DRUGA": ["cimetidine", "drug", "178-187"], "DRUGB": ["triamterene", "drug", "213-223"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system @DRUG$ ranitidine diltiazem triamterene @DRUG$ quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p3", "DRUGA": ["cimetidine", "drug", "178-187"], "DRUGB": ["verapamil", "drug", "226-234"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system @DRUG$ ranitidine diltiazem triamterene verapamil @DRUG$ decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p4", "DRUGA": ["cimetidine", "drug", "178-187"], "DRUGB": ["quinidine", "drug", "237-245"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system @DRUG$ ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p5", "DRUGA": ["cimetidine", "drug", "178-187"], "DRUGB": ["quinine", "drug", "252-258"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system @DRUG$ ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance @DRUG$ about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect pramipexole", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d737.s6.p6", "DRUGA": ["cimetidine", "drug", "178-187"], "DRUGB": ["pramipexole", "drug", "293-303"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system @DRUG$ ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about @DRUG$ penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p7", "DRUGA": ["cimetidine", "drug", "178-187"], "DRUGB": ["cephalosporins", "group", "379-392"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system @DRUG$ ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins @DRUG$ indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p8", "DRUGA": ["cimetidine", "drug", "178-187"], "DRUGB": ["penicillins", "group", "395-405"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system @DRUG$ ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins @DRUG$ hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p9", "DRUGA": ["cimetidine", "drug", "178-187"], "DRUGB": ["indomethacin", "drug", "408-419"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system @DRUG$ ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin @DRUG$ likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p10", "DRUGA": ["cimetidine", "drug", "178-187"], "DRUGB": ["hydrochlorothiazide", "drug", "422-440"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system @DRUG$ ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p11", "DRUGA": ["cimetidine", "drug", "178-187"], "DRUGB": ["chlorpropamide", "drug", "447-460"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system @DRUG$ ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p12", "DRUGA": ["cimetidine", "drug", "178-187"], "DRUGB": ["pramipexole", "drug", "521-531"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine @DRUG$ @DRUG$ triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p13", "DRUGA": ["ranitidine", "drug", "190-199"], "DRUGB": ["diltiazem", "drug", "202-210"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine @DRUG$ diltiazem @DRUG$ verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p14", "DRUGA": ["ranitidine", "drug", "190-199"], "DRUGB": ["triamterene", "drug", "213-223"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine @DRUG$ diltiazem triamterene @DRUG$ quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p15", "DRUGA": ["ranitidine", "drug", "190-199"], "DRUGB": ["verapamil", "drug", "226-234"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine @DRUG$ diltiazem triamterene verapamil @DRUG$ decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p16", "DRUGA": ["ranitidine", "drug", "190-199"], "DRUGB": ["quinidine", "drug", "237-245"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine @DRUG$ diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p17", "DRUGA": ["ranitidine", "drug", "190-199"], "DRUGB": ["quinine", "drug", "252-258"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine @DRUG$ diltiazem triamterene verapamil quinidine decreases oral clearance @DRUG$ about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect pramipexole", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d737.s6.p18", "DRUGA": ["ranitidine", "drug", "190-199"], "DRUGB": ["pramipexole", "drug", "293-303"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine @DRUG$ diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about @DRUG$ penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p19", "DRUGA": ["ranitidine", "drug", "190-199"], "DRUGB": ["cephalosporins", "group", "379-392"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine @DRUG$ diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins @DRUG$ indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p20", "DRUGA": ["ranitidine", "drug", "190-199"], "DRUGB": ["penicillins", "group", "395-405"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine @DRUG$ diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins @DRUG$ hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p21", "DRUGA": ["ranitidine", "drug", "190-199"], "DRUGB": ["indomethacin", "drug", "408-419"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine @DRUG$ diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin @DRUG$ likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p22", "DRUGA": ["ranitidine", "drug", "190-199"], "DRUGB": ["hydrochlorothiazide", "drug", "422-440"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine @DRUG$ diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p23", "DRUGA": ["ranitidine", "drug", "190-199"], "DRUGB": ["chlorpropamide", "drug", "447-460"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine @DRUG$ diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p24", "DRUGA": ["ranitidine", "drug", "190-199"], "DRUGB": ["pramipexole", "drug", "521-531"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine @DRUG$ @DRUG$ verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p25", "DRUGA": ["diltiazem", "drug", "202-210"], "DRUGB": ["triamterene", "drug", "213-223"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine @DRUG$ triamterene @DRUG$ quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p26", "DRUGA": ["diltiazem", "drug", "202-210"], "DRUGB": ["verapamil", "drug", "226-234"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine @DRUG$ triamterene verapamil @DRUG$ decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p27", "DRUGA": ["diltiazem", "drug", "202-210"], "DRUGB": ["quinidine", "drug", "237-245"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine @DRUG$ triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p28", "DRUGA": ["diltiazem", "drug", "202-210"], "DRUGB": ["quinine", "drug", "252-258"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine @DRUG$ triamterene verapamil quinidine decreases oral clearance @DRUG$ about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect pramipexole", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d737.s6.p29", "DRUGA": ["diltiazem", "drug", "202-210"], "DRUGB": ["pramipexole", "drug", "293-303"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine @DRUG$ triamterene verapamil quinidine decreases oral clearance pramipexole about @DRUG$ penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p30", "DRUGA": ["diltiazem", "drug", "202-210"], "DRUGB": ["cephalosporins", "group", "379-392"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine @DRUG$ triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins @DRUG$ indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p31", "DRUGA": ["diltiazem", "drug", "202-210"], "DRUGB": ["penicillins", "group", "395-405"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine @DRUG$ triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins @DRUG$ hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p32", "DRUGA": ["diltiazem", "drug", "202-210"], "DRUGB": ["indomethacin", "drug", "408-419"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine @DRUG$ triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin @DRUG$ likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p33", "DRUGA": ["diltiazem", "drug", "202-210"], "DRUGB": ["hydrochlorothiazide", "drug", "422-440"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine @DRUG$ triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p34", "DRUGA": ["diltiazem", "drug", "202-210"], "DRUGB": ["chlorpropamide", "drug", "447-460"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine @DRUG$ triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p35", "DRUGA": ["diltiazem", "drug", "202-210"], "DRUGB": ["pramipexole", "drug", "521-531"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem @DRUG$ @DRUG$ quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p36", "DRUGA": ["triamterene", "drug", "213-223"], "DRUGB": ["verapamil", "drug", "226-234"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem @DRUG$ verapamil @DRUG$ decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p37", "DRUGA": ["triamterene", "drug", "213-223"], "DRUGB": ["quinidine", "drug", "237-245"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem @DRUG$ verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p38", "DRUGA": ["triamterene", "drug", "213-223"], "DRUGB": ["quinine", "drug", "252-258"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem @DRUG$ verapamil quinidine decreases oral clearance @DRUG$ about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect pramipexole", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d737.s6.p39", "DRUGA": ["triamterene", "drug", "213-223"], "DRUGB": ["pramipexole", "drug", "293-303"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem @DRUG$ verapamil quinidine decreases oral clearance pramipexole about @DRUG$ penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p40", "DRUGA": ["triamterene", "drug", "213-223"], "DRUGB": ["cephalosporins", "group", "379-392"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem @DRUG$ verapamil quinidine decreases oral clearance pramipexole about cephalosporins @DRUG$ indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p41", "DRUGA": ["triamterene", "drug", "213-223"], "DRUGB": ["penicillins", "group", "395-405"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem @DRUG$ verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins @DRUG$ hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p42", "DRUGA": ["triamterene", "drug", "213-223"], "DRUGB": ["indomethacin", "drug", "408-419"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem @DRUG$ verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin @DRUG$ likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p43", "DRUGA": ["triamterene", "drug", "213-223"], "DRUGB": ["hydrochlorothiazide", "drug", "422-440"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem @DRUG$ verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p44", "DRUGA": ["triamterene", "drug", "213-223"], "DRUGB": ["chlorpropamide", "drug", "447-460"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem @DRUG$ verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p45", "DRUGA": ["triamterene", "drug", "213-223"], "DRUGB": ["pramipexole", "drug", "521-531"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene @DRUG$ @DRUG$ decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p46", "DRUGA": ["verapamil", "drug", "226-234"], "DRUGB": ["quinidine", "drug", "237-245"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene @DRUG$ quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p47", "DRUGA": ["verapamil", "drug", "226-234"], "DRUGB": ["quinine", "drug", "252-258"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene @DRUG$ quinidine decreases oral clearance @DRUG$ about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect pramipexole", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d737.s6.p48", "DRUGA": ["verapamil", "drug", "226-234"], "DRUGB": ["pramipexole", "drug", "293-303"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene @DRUG$ quinidine decreases oral clearance pramipexole about @DRUG$ penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p49", "DRUGA": ["verapamil", "drug", "226-234"], "DRUGB": ["cephalosporins", "group", "379-392"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene @DRUG$ quinidine decreases oral clearance pramipexole about cephalosporins @DRUG$ indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p50", "DRUGA": ["verapamil", "drug", "226-234"], "DRUGB": ["penicillins", "group", "395-405"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene @DRUG$ quinidine decreases oral clearance pramipexole about cephalosporins penicillins @DRUG$ hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p51", "DRUGA": ["verapamil", "drug", "226-234"], "DRUGB": ["indomethacin", "drug", "408-419"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene @DRUG$ quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin @DRUG$ likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p52", "DRUGA": ["verapamil", "drug", "226-234"], "DRUGB": ["hydrochlorothiazide", "drug", "422-440"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene @DRUG$ quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p53", "DRUGA": ["verapamil", "drug", "226-234"], "DRUGB": ["chlorpropamide", "drug", "447-460"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene @DRUG$ quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p54", "DRUGA": ["verapamil", "drug", "226-234"], "DRUGB": ["pramipexole", "drug", "521-531"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil @DRUG$ decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p55", "DRUGA": ["quinidine", "drug", "237-245"], "DRUGB": ["quinine", "drug", "252-258"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil @DRUG$ decreases oral clearance @DRUG$ about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect pramipexole", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d737.s6.p56", "DRUGA": ["quinidine", "drug", "237-245"], "DRUGB": ["pramipexole", "drug", "293-303"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil @DRUG$ decreases oral clearance pramipexole about @DRUG$ penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p57", "DRUGA": ["quinidine", "drug", "237-245"], "DRUGB": ["cephalosporins", "group", "379-392"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil @DRUG$ decreases oral clearance pramipexole about cephalosporins @DRUG$ indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p58", "DRUGA": ["quinidine", "drug", "237-245"], "DRUGB": ["penicillins", "group", "395-405"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil @DRUG$ decreases oral clearance pramipexole about cephalosporins penicillins @DRUG$ hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p59", "DRUGA": ["quinidine", "drug", "237-245"], "DRUGB": ["indomethacin", "drug", "408-419"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil @DRUG$ decreases oral clearance pramipexole about cephalosporins penicillins indomethacin @DRUG$ likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p60", "DRUGA": ["quinidine", "drug", "237-245"], "DRUGB": ["hydrochlorothiazide", "drug", "422-440"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil @DRUG$ decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p61", "DRUGA": ["quinidine", "drug", "237-245"], "DRUGB": ["chlorpropamide", "drug", "447-460"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil @DRUG$ decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p62", "DRUGA": ["quinidine", "drug", "237-245"], "DRUGB": ["pramipexole", "drug", "521-531"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance @DRUG$ about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect pramipexole", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d737.s6.p63", "DRUGA": ["quinine", "drug", "252-258"], "DRUGB": ["pramipexole", "drug", "293-303"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about @DRUG$ penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p64", "DRUGA": ["quinine", "drug", "252-258"], "DRUGB": ["cephalosporins", "group", "379-392"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins @DRUG$ indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p65", "DRUGA": ["quinine", "drug", "252-258"], "DRUGB": ["penicillins", "group", "395-405"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins @DRUG$ hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p66", "DRUGA": ["quinine", "drug", "252-258"], "DRUGB": ["indomethacin", "drug", "408-419"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin @DRUG$ likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p67", "DRUGA": ["quinine", "drug", "252-258"], "DRUGB": ["hydrochlorothiazide", "drug", "422-440"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p68", "DRUGA": ["quinine", "drug", "252-258"], "DRUGB": ["chlorpropamide", "drug", "447-460"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p69", "DRUGA": ["quinine", "drug", "252-258"], "DRUGB": ["pramipexole", "drug", "521-531"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance @DRUG$ about @DRUG$ penicillins indomethacin hydrochlorothiazide likely to little effect pramipexole", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p70", "DRUGA": ["pramipexole", "drug", "293-303"], "DRUGB": ["cephalosporins", "group", "379-392"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance @DRUG$ about cephalosporins @DRUG$ indomethacin hydrochlorothiazide likely to little effect pramipexole", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p71", "DRUGA": ["pramipexole", "drug", "293-303"], "DRUGB": ["penicillins", "group", "395-405"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance @DRUG$ about cephalosporins penicillins @DRUG$ hydrochlorothiazide likely to little effect pramipexole", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p72", "DRUGA": ["pramipexole", "drug", "293-303"], "DRUGB": ["indomethacin", "drug", "408-419"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance @DRUG$ about cephalosporins penicillins indomethacin @DRUG$ likely to little effect pramipexole", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p73", "DRUGA": ["pramipexole", "drug", "293-303"], "DRUGB": ["hydrochlorothiazide", "drug", "422-440"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance @DRUG$ about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect pramipexole", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p74", "DRUGA": ["pramipexole", "drug", "293-303"], "DRUGB": ["chlorpropamide", "drug", "447-460"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance @DRUG$ about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p75", "DRUGA": ["pramipexole", "drug", "293-303"], "DRUGB": ["pramipexole", "drug", "521-531"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about @DRUG$ @DRUG$ indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p76", "DRUGA": ["cephalosporins", "group", "379-392"], "DRUGB": ["penicillins", "group", "395-405"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about @DRUG$ penicillins @DRUG$ hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p77", "DRUGA": ["cephalosporins", "group", "379-392"], "DRUGB": ["indomethacin", "drug", "408-419"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about @DRUG$ penicillins indomethacin @DRUG$ likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p78", "DRUGA": ["cephalosporins", "group", "379-392"], "DRUGB": ["hydrochlorothiazide", "drug", "422-440"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about @DRUG$ penicillins indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p79", "DRUGA": ["cephalosporins", "group", "379-392"], "DRUGB": ["chlorpropamide", "drug", "447-460"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about @DRUG$ penicillins indomethacin hydrochlorothiazide likely to little effect @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d737.s6.p80", "DRUGA": ["cephalosporins", "group", "379-392"], "DRUGB": ["pramipexole", "drug", "521-531"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins @DRUG$ @DRUG$ hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p81", "DRUGA": ["penicillins", "group", "395-405"], "DRUGB": ["indomethacin", "drug", "408-419"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins @DRUG$ indomethacin @DRUG$ likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p82", "DRUGA": ["penicillins", "group", "395-405"], "DRUGB": ["hydrochlorothiazide", "drug", "422-440"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins @DRUG$ indomethacin hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p83", "DRUGA": ["penicillins", "group", "395-405"], "DRUGB": ["chlorpropamide", "drug", "447-460"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins @DRUG$ indomethacin hydrochlorothiazide likely to little effect @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d737.s6.p84", "DRUGA": ["penicillins", "group", "395-405"], "DRUGB": ["pramipexole", "drug", "521-531"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins @DRUG$ @DRUG$ likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p85", "DRUGA": ["indomethacin", "drug", "408-419"], "DRUGB": ["hydrochlorothiazide", "drug", "422-440"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins @DRUG$ hydrochlorothiazide likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p86", "DRUGA": ["indomethacin", "drug", "408-419"], "DRUGB": ["chlorpropamide", "drug", "447-460"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins @DRUG$ hydrochlorothiazide likely to little effect @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d737.s6.p87", "DRUGA": ["indomethacin", "drug", "408-419"], "DRUGB": ["pramipexole", "drug", "521-531"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin @DRUG$ likely to little effect", "LBL": "0", "ID": "DDI-DrugBank.d737.s6.p88", "DRUGA": ["hydrochlorothiazide", "drug", "422-440"], "DRUGB": ["chlorpropamide", "drug", "447-460"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin @DRUG$ likely to little effect @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d737.s6.p89", "DRUGA": ["hydrochlorothiazide", "drug", "422-440"], "DRUGB": ["pramipexole", "drug", "521-531"]}
{"TEXT1": "drugs eliminated renal pharmacokinetic suggests coadministration secreted cationic transport system cimetidine ranitidine diltiazem triamterene verapamil quinidine decreases oral clearance pramipexole about cephalosporins penicillins indomethacin hydrochlorothiazide likely to little effect @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d737.s6.p90", "DRUGA": ["chlorpropamide", "drug", "447-460"], "DRUGB": ["pramipexole", "drug", "521-531"]}
{"TEXT1": "CYP Inhibitors cytochrome P450 enzymes not expected to affect @DRUG$ elimination @DRUG$ metabolized in vivo", "LBL": "0", "ID": "DDI-DrugBank.d737.s7.p0", "DRUGA": ["pramipexole", "drug", "88-98"], "DRUGB": ["pramipexole", "drug", "120-130"]}
{"TEXT1": "@DRUG$ dopamine agonist possible neuroleptics butyrophenones metoclopramide diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p0", "DRUGA": ["Dopamine antagonists", "group", "0-19"], "DRUGB": ["pramipexole", "drug", "28-38"]}
{"TEXT1": "pramipexole @DRUG$ possible dopamine antagonists neuroleptics butyrophenones metoclopramide diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p1", "DRUGA": ["Dopamine antagonists", "group", "0-19"], "DRUGB": ["dopamine agonist", "group", "45-60"]}
{"TEXT1": "pramipexole dopamine agonist possible @DRUG$ neuroleptics butyrophenones metoclopramide diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p2", "DRUGA": ["Dopamine antagonists", "group", "0-19"], "DRUGB": ["dopamine antagonists", "group", "83-102"]}
{"TEXT1": "pramipexole dopamine agonist possible @DRUG$ butyrophenones metoclopramide diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p3", "DRUGA": ["Dopamine antagonists", "group", "0-19"], "DRUGB": ["neuroleptics", "group", "117-128"]}
{"TEXT1": "pramipexole dopamine agonist possible neuroleptics butyrophenones metoclopramide diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p4", "DRUGA": ["Dopamine antagonists", "group", "0-19"], "DRUGB": ["phenothiazines", "group", "131-144"]}
{"TEXT1": "pramipexole dopamine agonist possible neuroleptics @DRUG$ metoclopramide diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p5", "DRUGA": ["Dopamine antagonists", "group", "0-19"], "DRUGB": ["butyrophenones", "group", "147-160"]}
{"TEXT1": "pramipexole dopamine agonist possible neuroleptics butyrophenones metoclopramide diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p6", "DRUGA": ["Dopamine antagonists", "group", "0-19"], "DRUGB": ["thioxanthenes", "group", "163-175"]}
{"TEXT1": "pramipexole dopamine agonist possible neuroleptics butyrophenones @DRUG$ diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p7", "DRUGA": ["Dopamine antagonists", "group", "0-19"], "DRUGB": ["metoclopramide", "group", "181-194"]}
{"TEXT1": "pramipexole dopamine agonist possible neuroleptics butyrophenones metoclopramide diminish effectiveness @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p8", "DRUGA": ["Dopamine antagonists", "group", "0-19"], "DRUGB": ["MIRAPEX", "brand", "231-237"]}
{"TEXT1": "@DRUG$ @DRUG$ possible dopamine antagonists neuroleptics butyrophenones metoclopramide diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p9", "DRUGA": ["pramipexole", "drug", "28-38"], "DRUGB": ["dopamine agonist", "group", "45-60"]}
{"TEXT1": "@DRUG$ dopamine agonist possible @DRUG$ neuroleptics butyrophenones metoclopramide diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p10", "DRUGA": ["pramipexole", "drug", "28-38"], "DRUGB": ["dopamine antagonists", "group", "83-102"]}
{"TEXT1": "@DRUG$ dopamine agonist possible @DRUG$ butyrophenones metoclopramide diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p11", "DRUGA": ["pramipexole", "drug", "28-38"], "DRUGB": ["neuroleptics", "group", "117-128"]}
{"TEXT1": "@DRUG$ dopamine agonist possible neuroleptics butyrophenones metoclopramide diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p12", "DRUGA": ["pramipexole", "drug", "28-38"], "DRUGB": ["phenothiazines", "group", "131-144"]}
{"TEXT1": "@DRUG$ dopamine agonist possible neuroleptics @DRUG$ metoclopramide diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p13", "DRUGA": ["pramipexole", "drug", "28-38"], "DRUGB": ["butyrophenones", "group", "147-160"]}
{"TEXT1": "@DRUG$ dopamine agonist possible neuroleptics butyrophenones metoclopramide diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p14", "DRUGA": ["pramipexole", "drug", "28-38"], "DRUGB": ["thioxanthenes", "group", "163-175"]}
{"TEXT1": "@DRUG$ dopamine agonist possible neuroleptics butyrophenones @DRUG$ diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p15", "DRUGA": ["pramipexole", "drug", "28-38"], "DRUGB": ["metoclopramide", "group", "181-194"]}
{"TEXT1": "@DRUG$ dopamine agonist possible neuroleptics butyrophenones metoclopramide diminish effectiveness @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p16", "DRUGA": ["pramipexole", "drug", "28-38"], "DRUGB": ["MIRAPEX", "brand", "231-237"]}
{"TEXT1": "pramipexole @DRUG$ possible @DRUG$ neuroleptics butyrophenones metoclopramide diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p17", "DRUGA": ["dopamine agonist", "group", "45-60"], "DRUGB": ["dopamine antagonists", "group", "83-102"]}
{"TEXT1": "pramipexole @DRUG$ possible dopamine antagonists @DRUG$ butyrophenones metoclopramide diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p18", "DRUGA": ["dopamine agonist", "group", "45-60"], "DRUGB": ["neuroleptics", "group", "117-128"]}
{"TEXT1": "pramipexole @DRUG$ possible dopamine antagonists neuroleptics butyrophenones metoclopramide diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p19", "DRUGA": ["dopamine agonist", "group", "45-60"], "DRUGB": ["phenothiazines", "group", "131-144"]}
{"TEXT1": "pramipexole @DRUG$ possible dopamine antagonists neuroleptics @DRUG$ metoclopramide diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p20", "DRUGA": ["dopamine agonist", "group", "45-60"], "DRUGB": ["butyrophenones", "group", "147-160"]}
{"TEXT1": "pramipexole @DRUG$ possible dopamine antagonists neuroleptics butyrophenones metoclopramide diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p21", "DRUGA": ["dopamine agonist", "group", "45-60"], "DRUGB": ["thioxanthenes", "group", "163-175"]}
{"TEXT1": "pramipexole @DRUG$ possible dopamine antagonists neuroleptics butyrophenones @DRUG$ diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p22", "DRUGA": ["dopamine agonist", "group", "45-60"], "DRUGB": ["metoclopramide", "group", "181-194"]}
{"TEXT1": "pramipexole @DRUG$ possible dopamine antagonists neuroleptics butyrophenones metoclopramide diminish effectiveness @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p23", "DRUGA": ["dopamine agonist", "group", "45-60"], "DRUGB": ["MIRAPEX", "brand", "231-237"]}
{"TEXT1": "pramipexole dopamine agonist possible @DRUG$ @DRUG$ butyrophenones metoclopramide diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p24", "DRUGA": ["dopamine antagonists", "group", "83-102"], "DRUGB": ["neuroleptics", "group", "117-128"]}
{"TEXT1": "pramipexole dopamine agonist possible @DRUG$ neuroleptics butyrophenones metoclopramide diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p25", "DRUGA": ["dopamine antagonists", "group", "83-102"], "DRUGB": ["phenothiazines", "group", "131-144"]}
{"TEXT1": "pramipexole dopamine agonist possible @DRUG$ neuroleptics @DRUG$ metoclopramide diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p26", "DRUGA": ["dopamine antagonists", "group", "83-102"], "DRUGB": ["butyrophenones", "group", "147-160"]}
{"TEXT1": "pramipexole dopamine agonist possible @DRUG$ neuroleptics butyrophenones metoclopramide diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p27", "DRUGA": ["dopamine antagonists", "group", "83-102"], "DRUGB": ["thioxanthenes", "group", "163-175"]}
{"TEXT1": "pramipexole dopamine agonist possible @DRUG$ neuroleptics butyrophenones @DRUG$ diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p28", "DRUGA": ["dopamine antagonists", "group", "83-102"], "DRUGB": ["metoclopramide", "group", "181-194"]}
{"TEXT1": "pramipexole dopamine agonist possible @DRUG$ neuroleptics butyrophenones metoclopramide diminish effectiveness @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d737.s10.p29", "DRUGA": ["dopamine antagonists", "group", "83-102"], "DRUGB": ["MIRAPEX", "brand", "231-237"]}
{"TEXT1": "pramipexole dopamine agonist possible @DRUG$ butyrophenones metoclopramide diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p30", "DRUGA": ["neuroleptics", "group", "117-128"], "DRUGB": ["phenothiazines", "group", "131-144"]}
{"TEXT1": "pramipexole dopamine agonist possible @DRUG$ @DRUG$ metoclopramide diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p31", "DRUGA": ["neuroleptics", "group", "117-128"], "DRUGB": ["butyrophenones", "group", "147-160"]}
{"TEXT1": "pramipexole dopamine agonist possible @DRUG$ butyrophenones metoclopramide diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p32", "DRUGA": ["neuroleptics", "group", "117-128"], "DRUGB": ["thioxanthenes", "group", "163-175"]}
{"TEXT1": "pramipexole dopamine agonist possible @DRUG$ butyrophenones @DRUG$ diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p33", "DRUGA": ["neuroleptics", "group", "117-128"], "DRUGB": ["metoclopramide", "group", "181-194"]}
{"TEXT1": "pramipexole dopamine agonist possible @DRUG$ butyrophenones metoclopramide diminish effectiveness @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d737.s10.p34", "DRUGA": ["neuroleptics", "group", "117-128"], "DRUGB": ["MIRAPEX", "brand", "231-237"]}
{"TEXT1": "pramipexole dopamine agonist possible neuroleptics @DRUG$ metoclopramide diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p35", "DRUGA": ["phenothiazines", "group", "131-144"], "DRUGB": ["butyrophenones", "group", "147-160"]}
{"TEXT1": "pramipexole dopamine agonist possible neuroleptics butyrophenones metoclopramide diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p36", "DRUGA": ["phenothiazines", "group", "131-144"], "DRUGB": ["thioxanthenes", "group", "163-175"]}
{"TEXT1": "pramipexole dopamine agonist possible neuroleptics butyrophenones @DRUG$ diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p37", "DRUGA": ["phenothiazines", "group", "131-144"], "DRUGB": ["metoclopramide", "group", "181-194"]}
{"TEXT1": "pramipexole dopamine agonist possible neuroleptics butyrophenones metoclopramide diminish effectiveness @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d737.s10.p38", "DRUGA": ["phenothiazines", "group", "131-144"], "DRUGB": ["MIRAPEX", "brand", "231-237"]}
{"TEXT1": "pramipexole dopamine agonist possible neuroleptics @DRUG$ metoclopramide diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p39", "DRUGA": ["butyrophenones", "group", "147-160"], "DRUGB": ["thioxanthenes", "group", "163-175"]}
{"TEXT1": "pramipexole dopamine agonist possible neuroleptics @DRUG$ @DRUG$ diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p40", "DRUGA": ["butyrophenones", "group", "147-160"], "DRUGB": ["metoclopramide", "group", "181-194"]}
{"TEXT1": "pramipexole dopamine agonist possible neuroleptics @DRUG$ metoclopramide diminish effectiveness @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d737.s10.p41", "DRUGA": ["butyrophenones", "group", "147-160"], "DRUGB": ["MIRAPEX", "brand", "231-237"]}
{"TEXT1": "pramipexole dopamine agonist possible neuroleptics butyrophenones @DRUG$ diminish effectiveness MIRAPEX", "LBL": "0", "ID": "DDI-DrugBank.d737.s10.p42", "DRUGA": ["thioxanthenes", "group", "163-175"], "DRUGB": ["metoclopramide", "group", "181-194"]}
{"TEXT1": "pramipexole dopamine agonist possible neuroleptics butyrophenones metoclopramide diminish effectiveness @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d737.s10.p43", "DRUGA": ["thioxanthenes", "group", "163-175"], "DRUGB": ["MIRAPEX", "brand", "231-237"]}
{"TEXT1": "pramipexole dopamine agonist possible neuroleptics butyrophenones @DRUG$ diminish effectiveness @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d737.s10.p44", "DRUGA": ["metoclopramide", "group", "181-194"], "DRUGB": ["MIRAPEX", "brand", "231-237"]}
{"TEXT1": "Based studies evaluating possible interactions @DRUG$ drugs no dosage adjustment needed concomitant @DRUG$ cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p0", "DRUGA": ["pantoprazole", "drug", "53-64"], "DRUGB": ["theophylline", "drug", "154-165"]}
{"TEXT1": "Based studies evaluating possible interactions @DRUG$ drugs no dosage adjustment needed concomitant theophylline @DRUG$ antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p1", "DRUGA": ["pantoprazole", "drug", "53-64"], "DRUGB": ["cisapride", "drug", "168-176"]}
{"TEXT1": "Based studies evaluating possible interactions @DRUG$ drugs no dosage adjustment needed concomitant theophylline cisapride @DRUG$ caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p2", "DRUGA": ["pantoprazole", "drug", "53-64"], "DRUGB": ["antipyrine", "drug", "179-188"]}
{"TEXT1": "Based studies evaluating possible interactions @DRUG$ drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine @DRUG$ carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p3", "DRUGA": ["pantoprazole", "drug", "53-64"], "DRUGB": ["caffeine", "drug", "191-198"]}
{"TEXT1": "Based studies evaluating possible interactions @DRUG$ drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine @DRUG$ diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p4", "DRUGA": ["pantoprazole", "drug", "53-64"], "DRUGB": ["carbamazepine", "drug", "201-213"]}
{"TEXT1": "Based studies evaluating possible interactions @DRUG$ drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine @DRUG$ active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p5", "DRUGA": ["pantoprazole", "drug", "53-64"], "DRUGB": ["diazepam", "drug", "216-223"]}
{"TEXT1": "Based studies evaluating possible interactions @DRUG$ drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p6", "DRUGA": ["pantoprazole", "drug", "53-64"], "DRUGB": ["desmethyldiazepam", "drug_n", "253-269"]}
{"TEXT1": "Based studies evaluating possible interactions @DRUG$ drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite @DRUG$ naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p7", "DRUGA": ["pantoprazole", "drug", "53-64"], "DRUGB": ["diclofenac", "drug", "273-282"]}
{"TEXT1": "Based studies evaluating possible interactions @DRUG$ drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac @DRUG$ piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p8", "DRUGA": ["pantoprazole", "drug", "53-64"], "DRUGB": ["naproxen", "drug", "285-292"]}
{"TEXT1": "Based studies evaluating possible interactions @DRUG$ drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen @DRUG$ digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p9", "DRUGA": ["pantoprazole", "drug", "53-64"], "DRUGB": ["piroxicam", "drug", "295-303"]}
{"TEXT1": "Based studies evaluating possible interactions @DRUG$ drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam @DRUG$ ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p10", "DRUGA": ["pantoprazole", "drug", "53-64"], "DRUGB": ["digoxin", "drug", "306-312"]}
{"TEXT1": "Based studies evaluating possible interactions @DRUG$ drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin @DRUG$ glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p11", "DRUGA": ["pantoprazole", "drug", "53-64"], "DRUGB": ["ethanol", "drug", "315-321"]}
{"TEXT1": "Based studies evaluating possible interactions @DRUG$ drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol @DRUG$ oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p12", "DRUGA": ["pantoprazole", "drug", "53-64"], "DRUGB": ["glyburide", "drug", "324-332"]}
{"TEXT1": "Based studies evaluating possible interactions @DRUG$ drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide @DRUG$ metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p13", "DRUGA": ["pantoprazole", "drug", "53-64"], "DRUGB": ["contraceptive", "group", "343-355"]}
{"TEXT1": "Based studies evaluating possible interactions @DRUG$ drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p14", "DRUGA": ["pantoprazole", "drug", "53-64"], "DRUGB": ["levonorgestrel", "drug", "358-371"]}
{"TEXT1": "Based studies evaluating possible interactions @DRUG$ drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p15", "DRUGA": ["pantoprazole", "drug", "53-64"], "DRUGB": ["ethinyl estradiol", "drug", "373-389"]}
{"TEXT1": "Based studies evaluating possible interactions @DRUG$ drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive @DRUG$ nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p16", "DRUGA": ["pantoprazole", "drug", "53-64"], "DRUGB": ["metoprolol", "drug", "393-402"]}
{"TEXT1": "Based studies evaluating possible interactions @DRUG$ drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol @DRUG$ phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p17", "DRUGA": ["pantoprazole", "drug", "53-64"], "DRUGB": ["nifedipine", "drug", "405-414"]}
{"TEXT1": "Based studies evaluating possible interactions @DRUG$ drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine @DRUG$ warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p18", "DRUGA": ["pantoprazole", "drug", "53-64"], "DRUGB": ["phenytoin", "drug", "417-425"]}
{"TEXT1": "Based studies evaluating possible interactions @DRUG$ drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin @DRUG$ midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p19", "DRUGA": ["pantoprazole", "drug", "53-64"], "DRUGB": ["warfarin", "drug", "428-435"]}
{"TEXT1": "Based studies evaluating possible interactions @DRUG$ drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin @DRUG$ clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p20", "DRUGA": ["pantoprazole", "drug", "53-64"], "DRUGB": ["midazolam", "drug", "438-446"]}
{"TEXT1": "Based studies evaluating possible interactions @DRUG$ drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam @DRUG$ metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p21", "DRUGA": ["pantoprazole", "drug", "53-64"], "DRUGB": ["clarithromycin", "drug", "449-462"]}
{"TEXT1": "Based studies evaluating possible interactions @DRUG$ drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin @DRUG$ amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p22", "DRUGA": ["pantoprazole", "drug", "53-64"], "DRUGB": ["metronidazole", "drug", "465-477"]}
{"TEXT1": "Based studies evaluating possible interactions @DRUG$ drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p23", "DRUGA": ["pantoprazole", "drug", "53-64"], "DRUGB": ["amoxicillin", "drug", "483-493"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant @DRUG$ @DRUG$ antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p24", "DRUGA": ["theophylline", "drug", "154-165"], "DRUGB": ["cisapride", "drug", "168-176"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant @DRUG$ cisapride @DRUG$ caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p25", "DRUGA": ["theophylline", "drug", "154-165"], "DRUGB": ["antipyrine", "drug", "179-188"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant @DRUG$ cisapride antipyrine @DRUG$ carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p26", "DRUGA": ["theophylline", "drug", "154-165"], "DRUGB": ["caffeine", "drug", "191-198"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant @DRUG$ cisapride antipyrine caffeine @DRUG$ diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p27", "DRUGA": ["theophylline", "drug", "154-165"], "DRUGB": ["carbamazepine", "drug", "201-213"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant @DRUG$ cisapride antipyrine caffeine carbamazepine @DRUG$ active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p28", "DRUGA": ["theophylline", "drug", "154-165"], "DRUGB": ["diazepam", "drug", "216-223"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant @DRUG$ cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p29", "DRUGA": ["theophylline", "drug", "154-165"], "DRUGB": ["desmethyldiazepam", "drug_n", "253-269"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant @DRUG$ cisapride antipyrine caffeine carbamazepine diazepam active metabolite @DRUG$ naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p30", "DRUGA": ["theophylline", "drug", "154-165"], "DRUGB": ["diclofenac", "drug", "273-282"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant @DRUG$ cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac @DRUG$ piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p31", "DRUGA": ["theophylline", "drug", "154-165"], "DRUGB": ["naproxen", "drug", "285-292"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant @DRUG$ cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen @DRUG$ digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p32", "DRUGA": ["theophylline", "drug", "154-165"], "DRUGB": ["piroxicam", "drug", "295-303"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant @DRUG$ cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam @DRUG$ ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p33", "DRUGA": ["theophylline", "drug", "154-165"], "DRUGB": ["digoxin", "drug", "306-312"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant @DRUG$ cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin @DRUG$ glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p34", "DRUGA": ["theophylline", "drug", "154-165"], "DRUGB": ["ethanol", "drug", "315-321"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant @DRUG$ cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol @DRUG$ oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p35", "DRUGA": ["theophylline", "drug", "154-165"], "DRUGB": ["glyburide", "drug", "324-332"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant @DRUG$ cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide @DRUG$ metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p36", "DRUGA": ["theophylline", "drug", "154-165"], "DRUGB": ["contraceptive", "group", "343-355"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant @DRUG$ cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p37", "DRUGA": ["theophylline", "drug", "154-165"], "DRUGB": ["levonorgestrel", "drug", "358-371"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant @DRUG$ cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p38", "DRUGA": ["theophylline", "drug", "154-165"], "DRUGB": ["ethinyl estradiol", "drug", "373-389"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant @DRUG$ cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive @DRUG$ nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p39", "DRUGA": ["theophylline", "drug", "154-165"], "DRUGB": ["metoprolol", "drug", "393-402"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant @DRUG$ cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol @DRUG$ phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p40", "DRUGA": ["theophylline", "drug", "154-165"], "DRUGB": ["nifedipine", "drug", "405-414"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant @DRUG$ cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine @DRUG$ warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p41", "DRUGA": ["theophylline", "drug", "154-165"], "DRUGB": ["phenytoin", "drug", "417-425"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant @DRUG$ cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin @DRUG$ midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p42", "DRUGA": ["theophylline", "drug", "154-165"], "DRUGB": ["warfarin", "drug", "428-435"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant @DRUG$ cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin @DRUG$ clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p43", "DRUGA": ["theophylline", "drug", "154-165"], "DRUGB": ["midazolam", "drug", "438-446"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant @DRUG$ cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam @DRUG$ metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p44", "DRUGA": ["theophylline", "drug", "154-165"], "DRUGB": ["clarithromycin", "drug", "449-462"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant @DRUG$ cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin @DRUG$ amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p45", "DRUGA": ["theophylline", "drug", "154-165"], "DRUGB": ["metronidazole", "drug", "465-477"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant @DRUG$ cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p46", "DRUGA": ["theophylline", "drug", "154-165"], "DRUGB": ["amoxicillin", "drug", "483-493"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline @DRUG$ @DRUG$ caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p47", "DRUGA": ["cisapride", "drug", "168-176"], "DRUGB": ["antipyrine", "drug", "179-188"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline @DRUG$ antipyrine @DRUG$ carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p48", "DRUGA": ["cisapride", "drug", "168-176"], "DRUGB": ["caffeine", "drug", "191-198"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline @DRUG$ antipyrine caffeine @DRUG$ diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p49", "DRUGA": ["cisapride", "drug", "168-176"], "DRUGB": ["carbamazepine", "drug", "201-213"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline @DRUG$ antipyrine caffeine carbamazepine @DRUG$ active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p50", "DRUGA": ["cisapride", "drug", "168-176"], "DRUGB": ["diazepam", "drug", "216-223"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline @DRUG$ antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p51", "DRUGA": ["cisapride", "drug", "168-176"], "DRUGB": ["desmethyldiazepam", "drug_n", "253-269"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline @DRUG$ antipyrine caffeine carbamazepine diazepam active metabolite @DRUG$ naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p52", "DRUGA": ["cisapride", "drug", "168-176"], "DRUGB": ["diclofenac", "drug", "273-282"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline @DRUG$ antipyrine caffeine carbamazepine diazepam active metabolite diclofenac @DRUG$ piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p53", "DRUGA": ["cisapride", "drug", "168-176"], "DRUGB": ["naproxen", "drug", "285-292"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline @DRUG$ antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen @DRUG$ digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p54", "DRUGA": ["cisapride", "drug", "168-176"], "DRUGB": ["piroxicam", "drug", "295-303"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline @DRUG$ antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam @DRUG$ ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p55", "DRUGA": ["cisapride", "drug", "168-176"], "DRUGB": ["digoxin", "drug", "306-312"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline @DRUG$ antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin @DRUG$ glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p56", "DRUGA": ["cisapride", "drug", "168-176"], "DRUGB": ["ethanol", "drug", "315-321"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline @DRUG$ antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol @DRUG$ oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p57", "DRUGA": ["cisapride", "drug", "168-176"], "DRUGB": ["glyburide", "drug", "324-332"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline @DRUG$ antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide @DRUG$ metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p58", "DRUGA": ["cisapride", "drug", "168-176"], "DRUGB": ["contraceptive", "group", "343-355"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline @DRUG$ antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p59", "DRUGA": ["cisapride", "drug", "168-176"], "DRUGB": ["levonorgestrel", "drug", "358-371"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline @DRUG$ antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p60", "DRUGA": ["cisapride", "drug", "168-176"], "DRUGB": ["ethinyl estradiol", "drug", "373-389"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline @DRUG$ antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive @DRUG$ nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p61", "DRUGA": ["cisapride", "drug", "168-176"], "DRUGB": ["metoprolol", "drug", "393-402"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline @DRUG$ antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol @DRUG$ phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p62", "DRUGA": ["cisapride", "drug", "168-176"], "DRUGB": ["nifedipine", "drug", "405-414"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline @DRUG$ antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine @DRUG$ warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p63", "DRUGA": ["cisapride", "drug", "168-176"], "DRUGB": ["phenytoin", "drug", "417-425"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline @DRUG$ antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin @DRUG$ midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p64", "DRUGA": ["cisapride", "drug", "168-176"], "DRUGB": ["warfarin", "drug", "428-435"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline @DRUG$ antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin @DRUG$ clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p65", "DRUGA": ["cisapride", "drug", "168-176"], "DRUGB": ["midazolam", "drug", "438-446"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline @DRUG$ antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam @DRUG$ metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p66", "DRUGA": ["cisapride", "drug", "168-176"], "DRUGB": ["clarithromycin", "drug", "449-462"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline @DRUG$ antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin @DRUG$ amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p67", "DRUGA": ["cisapride", "drug", "168-176"], "DRUGB": ["metronidazole", "drug", "465-477"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline @DRUG$ antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p68", "DRUGA": ["cisapride", "drug", "168-176"], "DRUGB": ["amoxicillin", "drug", "483-493"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride @DRUG$ @DRUG$ carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p69", "DRUGA": ["antipyrine", "drug", "179-188"], "DRUGB": ["caffeine", "drug", "191-198"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride @DRUG$ caffeine @DRUG$ diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p70", "DRUGA": ["antipyrine", "drug", "179-188"], "DRUGB": ["carbamazepine", "drug", "201-213"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride @DRUG$ caffeine carbamazepine @DRUG$ active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p71", "DRUGA": ["antipyrine", "drug", "179-188"], "DRUGB": ["diazepam", "drug", "216-223"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride @DRUG$ caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p72", "DRUGA": ["antipyrine", "drug", "179-188"], "DRUGB": ["desmethyldiazepam", "drug_n", "253-269"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride @DRUG$ caffeine carbamazepine diazepam active metabolite @DRUG$ naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p73", "DRUGA": ["antipyrine", "drug", "179-188"], "DRUGB": ["diclofenac", "drug", "273-282"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride @DRUG$ caffeine carbamazepine diazepam active metabolite diclofenac @DRUG$ piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p74", "DRUGA": ["antipyrine", "drug", "179-188"], "DRUGB": ["naproxen", "drug", "285-292"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride @DRUG$ caffeine carbamazepine diazepam active metabolite diclofenac naproxen @DRUG$ digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p75", "DRUGA": ["antipyrine", "drug", "179-188"], "DRUGB": ["piroxicam", "drug", "295-303"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride @DRUG$ caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam @DRUG$ ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p76", "DRUGA": ["antipyrine", "drug", "179-188"], "DRUGB": ["digoxin", "drug", "306-312"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride @DRUG$ caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin @DRUG$ glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p77", "DRUGA": ["antipyrine", "drug", "179-188"], "DRUGB": ["ethanol", "drug", "315-321"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride @DRUG$ caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol @DRUG$ oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p78", "DRUGA": ["antipyrine", "drug", "179-188"], "DRUGB": ["glyburide", "drug", "324-332"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride @DRUG$ caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide @DRUG$ metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p79", "DRUGA": ["antipyrine", "drug", "179-188"], "DRUGB": ["contraceptive", "group", "343-355"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride @DRUG$ caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p80", "DRUGA": ["antipyrine", "drug", "179-188"], "DRUGB": ["levonorgestrel", "drug", "358-371"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride @DRUG$ caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p81", "DRUGA": ["antipyrine", "drug", "179-188"], "DRUGB": ["ethinyl estradiol", "drug", "373-389"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride @DRUG$ caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive @DRUG$ nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p82", "DRUGA": ["antipyrine", "drug", "179-188"], "DRUGB": ["metoprolol", "drug", "393-402"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride @DRUG$ caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol @DRUG$ phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p83", "DRUGA": ["antipyrine", "drug", "179-188"], "DRUGB": ["nifedipine", "drug", "405-414"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride @DRUG$ caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine @DRUG$ warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p84", "DRUGA": ["antipyrine", "drug", "179-188"], "DRUGB": ["phenytoin", "drug", "417-425"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride @DRUG$ caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin @DRUG$ midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p85", "DRUGA": ["antipyrine", "drug", "179-188"], "DRUGB": ["warfarin", "drug", "428-435"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride @DRUG$ caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin @DRUG$ clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p86", "DRUGA": ["antipyrine", "drug", "179-188"], "DRUGB": ["midazolam", "drug", "438-446"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride @DRUG$ caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam @DRUG$ metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p87", "DRUGA": ["antipyrine", "drug", "179-188"], "DRUGB": ["clarithromycin", "drug", "449-462"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride @DRUG$ caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin @DRUG$ amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p88", "DRUGA": ["antipyrine", "drug", "179-188"], "DRUGB": ["metronidazole", "drug", "465-477"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride @DRUG$ caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p89", "DRUGA": ["antipyrine", "drug", "179-188"], "DRUGB": ["amoxicillin", "drug", "483-493"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine @DRUG$ @DRUG$ diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p90", "DRUGA": ["caffeine", "drug", "191-198"], "DRUGB": ["carbamazepine", "drug", "201-213"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine @DRUG$ carbamazepine @DRUG$ active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p91", "DRUGA": ["caffeine", "drug", "191-198"], "DRUGB": ["diazepam", "drug", "216-223"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine @DRUG$ carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p92", "DRUGA": ["caffeine", "drug", "191-198"], "DRUGB": ["desmethyldiazepam", "drug_n", "253-269"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine @DRUG$ carbamazepine diazepam active metabolite @DRUG$ naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p93", "DRUGA": ["caffeine", "drug", "191-198"], "DRUGB": ["diclofenac", "drug", "273-282"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine @DRUG$ carbamazepine diazepam active metabolite diclofenac @DRUG$ piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p94", "DRUGA": ["caffeine", "drug", "191-198"], "DRUGB": ["naproxen", "drug", "285-292"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine @DRUG$ carbamazepine diazepam active metabolite diclofenac naproxen @DRUG$ digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p95", "DRUGA": ["caffeine", "drug", "191-198"], "DRUGB": ["piroxicam", "drug", "295-303"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine @DRUG$ carbamazepine diazepam active metabolite diclofenac naproxen piroxicam @DRUG$ ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p96", "DRUGA": ["caffeine", "drug", "191-198"], "DRUGB": ["digoxin", "drug", "306-312"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine @DRUG$ carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin @DRUG$ glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p97", "DRUGA": ["caffeine", "drug", "191-198"], "DRUGB": ["ethanol", "drug", "315-321"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine @DRUG$ carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol @DRUG$ oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p98", "DRUGA": ["caffeine", "drug", "191-198"], "DRUGB": ["glyburide", "drug", "324-332"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine @DRUG$ carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide @DRUG$ metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p99", "DRUGA": ["caffeine", "drug", "191-198"], "DRUGB": ["contraceptive", "group", "343-355"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine @DRUG$ carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p100", "DRUGA": ["caffeine", "drug", "191-198"], "DRUGB": ["levonorgestrel", "drug", "358-371"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine @DRUG$ carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p101", "DRUGA": ["caffeine", "drug", "191-198"], "DRUGB": ["ethinyl estradiol", "drug", "373-389"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine @DRUG$ carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive @DRUG$ nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p102", "DRUGA": ["caffeine", "drug", "191-198"], "DRUGB": ["metoprolol", "drug", "393-402"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine @DRUG$ carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol @DRUG$ phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p103", "DRUGA": ["caffeine", "drug", "191-198"], "DRUGB": ["nifedipine", "drug", "405-414"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine @DRUG$ carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine @DRUG$ warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p104", "DRUGA": ["caffeine", "drug", "191-198"], "DRUGB": ["phenytoin", "drug", "417-425"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine @DRUG$ carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin @DRUG$ midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p105", "DRUGA": ["caffeine", "drug", "191-198"], "DRUGB": ["warfarin", "drug", "428-435"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine @DRUG$ carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin @DRUG$ clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p106", "DRUGA": ["caffeine", "drug", "191-198"], "DRUGB": ["midazolam", "drug", "438-446"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine @DRUG$ carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam @DRUG$ metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p107", "DRUGA": ["caffeine", "drug", "191-198"], "DRUGB": ["clarithromycin", "drug", "449-462"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine @DRUG$ carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin @DRUG$ amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p108", "DRUGA": ["caffeine", "drug", "191-198"], "DRUGB": ["metronidazole", "drug", "465-477"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine @DRUG$ carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p109", "DRUGA": ["caffeine", "drug", "191-198"], "DRUGB": ["amoxicillin", "drug", "483-493"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine @DRUG$ @DRUG$ active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p110", "DRUGA": ["carbamazepine", "drug", "201-213"], "DRUGB": ["diazepam", "drug", "216-223"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine @DRUG$ diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p111", "DRUGA": ["carbamazepine", "drug", "201-213"], "DRUGB": ["desmethyldiazepam", "drug_n", "253-269"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine @DRUG$ diazepam active metabolite @DRUG$ naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p112", "DRUGA": ["carbamazepine", "drug", "201-213"], "DRUGB": ["diclofenac", "drug", "273-282"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine @DRUG$ diazepam active metabolite diclofenac @DRUG$ piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p113", "DRUGA": ["carbamazepine", "drug", "201-213"], "DRUGB": ["naproxen", "drug", "285-292"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine @DRUG$ diazepam active metabolite diclofenac naproxen @DRUG$ digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p114", "DRUGA": ["carbamazepine", "drug", "201-213"], "DRUGB": ["piroxicam", "drug", "295-303"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine @DRUG$ diazepam active metabolite diclofenac naproxen piroxicam @DRUG$ ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p115", "DRUGA": ["carbamazepine", "drug", "201-213"], "DRUGB": ["digoxin", "drug", "306-312"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine @DRUG$ diazepam active metabolite diclofenac naproxen piroxicam digoxin @DRUG$ glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p116", "DRUGA": ["carbamazepine", "drug", "201-213"], "DRUGB": ["ethanol", "drug", "315-321"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine @DRUG$ diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol @DRUG$ oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p117", "DRUGA": ["carbamazepine", "drug", "201-213"], "DRUGB": ["glyburide", "drug", "324-332"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine @DRUG$ diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide @DRUG$ metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p118", "DRUGA": ["carbamazepine", "drug", "201-213"], "DRUGB": ["contraceptive", "group", "343-355"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine @DRUG$ diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p119", "DRUGA": ["carbamazepine", "drug", "201-213"], "DRUGB": ["levonorgestrel", "drug", "358-371"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine @DRUG$ diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p120", "DRUGA": ["carbamazepine", "drug", "201-213"], "DRUGB": ["ethinyl estradiol", "drug", "373-389"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine @DRUG$ diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive @DRUG$ nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p121", "DRUGA": ["carbamazepine", "drug", "201-213"], "DRUGB": ["metoprolol", "drug", "393-402"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine @DRUG$ diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol @DRUG$ phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p122", "DRUGA": ["carbamazepine", "drug", "201-213"], "DRUGB": ["nifedipine", "drug", "405-414"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine @DRUG$ diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine @DRUG$ warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p123", "DRUGA": ["carbamazepine", "drug", "201-213"], "DRUGB": ["phenytoin", "drug", "417-425"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine @DRUG$ diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin @DRUG$ midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p124", "DRUGA": ["carbamazepine", "drug", "201-213"], "DRUGB": ["warfarin", "drug", "428-435"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine @DRUG$ diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin @DRUG$ clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p125", "DRUGA": ["carbamazepine", "drug", "201-213"], "DRUGB": ["midazolam", "drug", "438-446"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine @DRUG$ diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam @DRUG$ metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p126", "DRUGA": ["carbamazepine", "drug", "201-213"], "DRUGB": ["clarithromycin", "drug", "449-462"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine @DRUG$ diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin @DRUG$ amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p127", "DRUGA": ["carbamazepine", "drug", "201-213"], "DRUGB": ["metronidazole", "drug", "465-477"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine @DRUG$ diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p128", "DRUGA": ["carbamazepine", "drug", "201-213"], "DRUGB": ["amoxicillin", "drug", "483-493"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine @DRUG$ active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p129", "DRUGA": ["diazepam", "drug", "216-223"], "DRUGB": ["desmethyldiazepam", "drug_n", "253-269"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine @DRUG$ active metabolite @DRUG$ naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p130", "DRUGA": ["diazepam", "drug", "216-223"], "DRUGB": ["diclofenac", "drug", "273-282"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine @DRUG$ active metabolite diclofenac @DRUG$ piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p131", "DRUGA": ["diazepam", "drug", "216-223"], "DRUGB": ["naproxen", "drug", "285-292"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine @DRUG$ active metabolite diclofenac naproxen @DRUG$ digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p132", "DRUGA": ["diazepam", "drug", "216-223"], "DRUGB": ["piroxicam", "drug", "295-303"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine @DRUG$ active metabolite diclofenac naproxen piroxicam @DRUG$ ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p133", "DRUGA": ["diazepam", "drug", "216-223"], "DRUGB": ["digoxin", "drug", "306-312"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine @DRUG$ active metabolite diclofenac naproxen piroxicam digoxin @DRUG$ glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p134", "DRUGA": ["diazepam", "drug", "216-223"], "DRUGB": ["ethanol", "drug", "315-321"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine @DRUG$ active metabolite diclofenac naproxen piroxicam digoxin ethanol @DRUG$ oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p135", "DRUGA": ["diazepam", "drug", "216-223"], "DRUGB": ["glyburide", "drug", "324-332"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine @DRUG$ active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide @DRUG$ metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p136", "DRUGA": ["diazepam", "drug", "216-223"], "DRUGB": ["contraceptive", "group", "343-355"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine @DRUG$ active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p137", "DRUGA": ["diazepam", "drug", "216-223"], "DRUGB": ["levonorgestrel", "drug", "358-371"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine @DRUG$ active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p138", "DRUGA": ["diazepam", "drug", "216-223"], "DRUGB": ["ethinyl estradiol", "drug", "373-389"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine @DRUG$ active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive @DRUG$ nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p139", "DRUGA": ["diazepam", "drug", "216-223"], "DRUGB": ["metoprolol", "drug", "393-402"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine @DRUG$ active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol @DRUG$ phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p140", "DRUGA": ["diazepam", "drug", "216-223"], "DRUGB": ["nifedipine", "drug", "405-414"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine @DRUG$ active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine @DRUG$ warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p141", "DRUGA": ["diazepam", "drug", "216-223"], "DRUGB": ["phenytoin", "drug", "417-425"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine @DRUG$ active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin @DRUG$ midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p142", "DRUGA": ["diazepam", "drug", "216-223"], "DRUGB": ["warfarin", "drug", "428-435"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine @DRUG$ active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin @DRUG$ clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p143", "DRUGA": ["diazepam", "drug", "216-223"], "DRUGB": ["midazolam", "drug", "438-446"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine @DRUG$ active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam @DRUG$ metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p144", "DRUGA": ["diazepam", "drug", "216-223"], "DRUGB": ["clarithromycin", "drug", "449-462"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine @DRUG$ active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin @DRUG$ amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p145", "DRUGA": ["diazepam", "drug", "216-223"], "DRUGB": ["metronidazole", "drug", "465-477"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine @DRUG$ active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p146", "DRUGA": ["diazepam", "drug", "216-223"], "DRUGB": ["amoxicillin", "drug", "483-493"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite @DRUG$ naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p147", "DRUGA": ["desmethyldiazepam", "drug_n", "253-269"], "DRUGB": ["diclofenac", "drug", "273-282"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac @DRUG$ piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p148", "DRUGA": ["desmethyldiazepam", "drug_n", "253-269"], "DRUGB": ["naproxen", "drug", "285-292"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen @DRUG$ digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p149", "DRUGA": ["desmethyldiazepam", "drug_n", "253-269"], "DRUGB": ["piroxicam", "drug", "295-303"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam @DRUG$ ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p150", "DRUGA": ["desmethyldiazepam", "drug_n", "253-269"], "DRUGB": ["digoxin", "drug", "306-312"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin @DRUG$ glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p151", "DRUGA": ["desmethyldiazepam", "drug_n", "253-269"], "DRUGB": ["ethanol", "drug", "315-321"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol @DRUG$ oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p152", "DRUGA": ["desmethyldiazepam", "drug_n", "253-269"], "DRUGB": ["glyburide", "drug", "324-332"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide @DRUG$ metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p153", "DRUGA": ["desmethyldiazepam", "drug_n", "253-269"], "DRUGB": ["contraceptive", "group", "343-355"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p154", "DRUGA": ["desmethyldiazepam", "drug_n", "253-269"], "DRUGB": ["levonorgestrel", "drug", "358-371"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p155", "DRUGA": ["desmethyldiazepam", "drug_n", "253-269"], "DRUGB": ["ethinyl estradiol", "drug", "373-389"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive @DRUG$ nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p156", "DRUGA": ["desmethyldiazepam", "drug_n", "253-269"], "DRUGB": ["metoprolol", "drug", "393-402"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol @DRUG$ phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p157", "DRUGA": ["desmethyldiazepam", "drug_n", "253-269"], "DRUGB": ["nifedipine", "drug", "405-414"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine @DRUG$ warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p158", "DRUGA": ["desmethyldiazepam", "drug_n", "253-269"], "DRUGB": ["phenytoin", "drug", "417-425"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin @DRUG$ midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p159", "DRUGA": ["desmethyldiazepam", "drug_n", "253-269"], "DRUGB": ["warfarin", "drug", "428-435"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin @DRUG$ clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p160", "DRUGA": ["desmethyldiazepam", "drug_n", "253-269"], "DRUGB": ["midazolam", "drug", "438-446"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam @DRUG$ metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p161", "DRUGA": ["desmethyldiazepam", "drug_n", "253-269"], "DRUGB": ["clarithromycin", "drug", "449-462"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin @DRUG$ amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p162", "DRUGA": ["desmethyldiazepam", "drug_n", "253-269"], "DRUGB": ["metronidazole", "drug", "465-477"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p163", "DRUGA": ["desmethyldiazepam", "drug_n", "253-269"], "DRUGB": ["amoxicillin", "drug", "483-493"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite @DRUG$ @DRUG$ piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p164", "DRUGA": ["diclofenac", "drug", "273-282"], "DRUGB": ["naproxen", "drug", "285-292"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite @DRUG$ naproxen @DRUG$ digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p165", "DRUGA": ["diclofenac", "drug", "273-282"], "DRUGB": ["piroxicam", "drug", "295-303"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite @DRUG$ naproxen piroxicam @DRUG$ ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p166", "DRUGA": ["diclofenac", "drug", "273-282"], "DRUGB": ["digoxin", "drug", "306-312"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite @DRUG$ naproxen piroxicam digoxin @DRUG$ glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p167", "DRUGA": ["diclofenac", "drug", "273-282"], "DRUGB": ["ethanol", "drug", "315-321"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite @DRUG$ naproxen piroxicam digoxin ethanol @DRUG$ oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p168", "DRUGA": ["diclofenac", "drug", "273-282"], "DRUGB": ["glyburide", "drug", "324-332"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite @DRUG$ naproxen piroxicam digoxin ethanol glyburide @DRUG$ metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p169", "DRUGA": ["diclofenac", "drug", "273-282"], "DRUGB": ["contraceptive", "group", "343-355"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite @DRUG$ naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p170", "DRUGA": ["diclofenac", "drug", "273-282"], "DRUGB": ["levonorgestrel", "drug", "358-371"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite @DRUG$ naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p171", "DRUGA": ["diclofenac", "drug", "273-282"], "DRUGB": ["ethinyl estradiol", "drug", "373-389"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite @DRUG$ naproxen piroxicam digoxin ethanol glyburide oral contraceptive @DRUG$ nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p172", "DRUGA": ["diclofenac", "drug", "273-282"], "DRUGB": ["metoprolol", "drug", "393-402"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite @DRUG$ naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol @DRUG$ phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p173", "DRUGA": ["diclofenac", "drug", "273-282"], "DRUGB": ["nifedipine", "drug", "405-414"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite @DRUG$ naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine @DRUG$ warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p174", "DRUGA": ["diclofenac", "drug", "273-282"], "DRUGB": ["phenytoin", "drug", "417-425"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite @DRUG$ naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin @DRUG$ midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p175", "DRUGA": ["diclofenac", "drug", "273-282"], "DRUGB": ["warfarin", "drug", "428-435"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite @DRUG$ naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin @DRUG$ clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p176", "DRUGA": ["diclofenac", "drug", "273-282"], "DRUGB": ["midazolam", "drug", "438-446"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite @DRUG$ naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam @DRUG$ metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p177", "DRUGA": ["diclofenac", "drug", "273-282"], "DRUGB": ["clarithromycin", "drug", "449-462"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite @DRUG$ naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin @DRUG$ amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p178", "DRUGA": ["diclofenac", "drug", "273-282"], "DRUGB": ["metronidazole", "drug", "465-477"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite @DRUG$ naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p179", "DRUGA": ["diclofenac", "drug", "273-282"], "DRUGB": ["amoxicillin", "drug", "483-493"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac @DRUG$ @DRUG$ digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p180", "DRUGA": ["naproxen", "drug", "285-292"], "DRUGB": ["piroxicam", "drug", "295-303"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac @DRUG$ piroxicam @DRUG$ ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p181", "DRUGA": ["naproxen", "drug", "285-292"], "DRUGB": ["digoxin", "drug", "306-312"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac @DRUG$ piroxicam digoxin @DRUG$ glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p182", "DRUGA": ["naproxen", "drug", "285-292"], "DRUGB": ["ethanol", "drug", "315-321"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac @DRUG$ piroxicam digoxin ethanol @DRUG$ oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p183", "DRUGA": ["naproxen", "drug", "285-292"], "DRUGB": ["glyburide", "drug", "324-332"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac @DRUG$ piroxicam digoxin ethanol glyburide @DRUG$ metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p184", "DRUGA": ["naproxen", "drug", "285-292"], "DRUGB": ["contraceptive", "group", "343-355"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac @DRUG$ piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p185", "DRUGA": ["naproxen", "drug", "285-292"], "DRUGB": ["levonorgestrel", "drug", "358-371"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac @DRUG$ piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p186", "DRUGA": ["naproxen", "drug", "285-292"], "DRUGB": ["ethinyl estradiol", "drug", "373-389"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac @DRUG$ piroxicam digoxin ethanol glyburide oral contraceptive @DRUG$ nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p187", "DRUGA": ["naproxen", "drug", "285-292"], "DRUGB": ["metoprolol", "drug", "393-402"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac @DRUG$ piroxicam digoxin ethanol glyburide oral contraceptive metoprolol @DRUG$ phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p188", "DRUGA": ["naproxen", "drug", "285-292"], "DRUGB": ["nifedipine", "drug", "405-414"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac @DRUG$ piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine @DRUG$ warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p189", "DRUGA": ["naproxen", "drug", "285-292"], "DRUGB": ["phenytoin", "drug", "417-425"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac @DRUG$ piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin @DRUG$ midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p190", "DRUGA": ["naproxen", "drug", "285-292"], "DRUGB": ["warfarin", "drug", "428-435"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac @DRUG$ piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin @DRUG$ clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p191", "DRUGA": ["naproxen", "drug", "285-292"], "DRUGB": ["midazolam", "drug", "438-446"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac @DRUG$ piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam @DRUG$ metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p192", "DRUGA": ["naproxen", "drug", "285-292"], "DRUGB": ["clarithromycin", "drug", "449-462"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac @DRUG$ piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin @DRUG$ amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p193", "DRUGA": ["naproxen", "drug", "285-292"], "DRUGB": ["metronidazole", "drug", "465-477"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac @DRUG$ piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p194", "DRUGA": ["naproxen", "drug", "285-292"], "DRUGB": ["amoxicillin", "drug", "483-493"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen @DRUG$ @DRUG$ ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p195", "DRUGA": ["piroxicam", "drug", "295-303"], "DRUGB": ["digoxin", "drug", "306-312"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen @DRUG$ digoxin @DRUG$ glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p196", "DRUGA": ["piroxicam", "drug", "295-303"], "DRUGB": ["ethanol", "drug", "315-321"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen @DRUG$ digoxin ethanol @DRUG$ oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p197", "DRUGA": ["piroxicam", "drug", "295-303"], "DRUGB": ["glyburide", "drug", "324-332"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen @DRUG$ digoxin ethanol glyburide @DRUG$ metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p198", "DRUGA": ["piroxicam", "drug", "295-303"], "DRUGB": ["contraceptive", "group", "343-355"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen @DRUG$ digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p199", "DRUGA": ["piroxicam", "drug", "295-303"], "DRUGB": ["levonorgestrel", "drug", "358-371"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen @DRUG$ digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p200", "DRUGA": ["piroxicam", "drug", "295-303"], "DRUGB": ["ethinyl estradiol", "drug", "373-389"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen @DRUG$ digoxin ethanol glyburide oral contraceptive @DRUG$ nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p201", "DRUGA": ["piroxicam", "drug", "295-303"], "DRUGB": ["metoprolol", "drug", "393-402"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen @DRUG$ digoxin ethanol glyburide oral contraceptive metoprolol @DRUG$ phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p202", "DRUGA": ["piroxicam", "drug", "295-303"], "DRUGB": ["nifedipine", "drug", "405-414"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen @DRUG$ digoxin ethanol glyburide oral contraceptive metoprolol nifedipine @DRUG$ warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p203", "DRUGA": ["piroxicam", "drug", "295-303"], "DRUGB": ["phenytoin", "drug", "417-425"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen @DRUG$ digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin @DRUG$ midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p204", "DRUGA": ["piroxicam", "drug", "295-303"], "DRUGB": ["warfarin", "drug", "428-435"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen @DRUG$ digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin @DRUG$ clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p205", "DRUGA": ["piroxicam", "drug", "295-303"], "DRUGB": ["midazolam", "drug", "438-446"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen @DRUG$ digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam @DRUG$ metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p206", "DRUGA": ["piroxicam", "drug", "295-303"], "DRUGB": ["clarithromycin", "drug", "449-462"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen @DRUG$ digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin @DRUG$ amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p207", "DRUGA": ["piroxicam", "drug", "295-303"], "DRUGB": ["metronidazole", "drug", "465-477"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen @DRUG$ digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p208", "DRUGA": ["piroxicam", "drug", "295-303"], "DRUGB": ["amoxicillin", "drug", "483-493"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam @DRUG$ @DRUG$ glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p209", "DRUGA": ["digoxin", "drug", "306-312"], "DRUGB": ["ethanol", "drug", "315-321"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam @DRUG$ ethanol @DRUG$ oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p210", "DRUGA": ["digoxin", "drug", "306-312"], "DRUGB": ["glyburide", "drug", "324-332"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam @DRUG$ ethanol glyburide @DRUG$ metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p211", "DRUGA": ["digoxin", "drug", "306-312"], "DRUGB": ["contraceptive", "group", "343-355"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam @DRUG$ ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p212", "DRUGA": ["digoxin", "drug", "306-312"], "DRUGB": ["levonorgestrel", "drug", "358-371"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam @DRUG$ ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p213", "DRUGA": ["digoxin", "drug", "306-312"], "DRUGB": ["ethinyl estradiol", "drug", "373-389"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam @DRUG$ ethanol glyburide oral contraceptive @DRUG$ nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p214", "DRUGA": ["digoxin", "drug", "306-312"], "DRUGB": ["metoprolol", "drug", "393-402"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam @DRUG$ ethanol glyburide oral contraceptive metoprolol @DRUG$ phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p215", "DRUGA": ["digoxin", "drug", "306-312"], "DRUGB": ["nifedipine", "drug", "405-414"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam @DRUG$ ethanol glyburide oral contraceptive metoprolol nifedipine @DRUG$ warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p216", "DRUGA": ["digoxin", "drug", "306-312"], "DRUGB": ["phenytoin", "drug", "417-425"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam @DRUG$ ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin @DRUG$ midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p217", "DRUGA": ["digoxin", "drug", "306-312"], "DRUGB": ["warfarin", "drug", "428-435"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam @DRUG$ ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin @DRUG$ clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p218", "DRUGA": ["digoxin", "drug", "306-312"], "DRUGB": ["midazolam", "drug", "438-446"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam @DRUG$ ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam @DRUG$ metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p219", "DRUGA": ["digoxin", "drug", "306-312"], "DRUGB": ["clarithromycin", "drug", "449-462"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam @DRUG$ ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin @DRUG$ amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p220", "DRUGA": ["digoxin", "drug", "306-312"], "DRUGB": ["metronidazole", "drug", "465-477"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam @DRUG$ ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p221", "DRUGA": ["digoxin", "drug", "306-312"], "DRUGB": ["amoxicillin", "drug", "483-493"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin @DRUG$ @DRUG$ oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p222", "DRUGA": ["ethanol", "drug", "315-321"], "DRUGB": ["glyburide", "drug", "324-332"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin @DRUG$ glyburide @DRUG$ metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p223", "DRUGA": ["ethanol", "drug", "315-321"], "DRUGB": ["contraceptive", "group", "343-355"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin @DRUG$ glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p224", "DRUGA": ["ethanol", "drug", "315-321"], "DRUGB": ["levonorgestrel", "drug", "358-371"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin @DRUG$ glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p225", "DRUGA": ["ethanol", "drug", "315-321"], "DRUGB": ["ethinyl estradiol", "drug", "373-389"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin @DRUG$ glyburide oral contraceptive @DRUG$ nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p226", "DRUGA": ["ethanol", "drug", "315-321"], "DRUGB": ["metoprolol", "drug", "393-402"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin @DRUG$ glyburide oral contraceptive metoprolol @DRUG$ phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p227", "DRUGA": ["ethanol", "drug", "315-321"], "DRUGB": ["nifedipine", "drug", "405-414"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin @DRUG$ glyburide oral contraceptive metoprolol nifedipine @DRUG$ warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p228", "DRUGA": ["ethanol", "drug", "315-321"], "DRUGB": ["phenytoin", "drug", "417-425"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin @DRUG$ glyburide oral contraceptive metoprolol nifedipine phenytoin @DRUG$ midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p229", "DRUGA": ["ethanol", "drug", "315-321"], "DRUGB": ["warfarin", "drug", "428-435"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin @DRUG$ glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin @DRUG$ clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p230", "DRUGA": ["ethanol", "drug", "315-321"], "DRUGB": ["midazolam", "drug", "438-446"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin @DRUG$ glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam @DRUG$ metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p231", "DRUGA": ["ethanol", "drug", "315-321"], "DRUGB": ["clarithromycin", "drug", "449-462"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin @DRUG$ glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin @DRUG$ amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p232", "DRUGA": ["ethanol", "drug", "315-321"], "DRUGB": ["metronidazole", "drug", "465-477"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin @DRUG$ glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p233", "DRUGA": ["ethanol", "drug", "315-321"], "DRUGB": ["amoxicillin", "drug", "483-493"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol @DRUG$ @DRUG$ metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p234", "DRUGA": ["glyburide", "drug", "324-332"], "DRUGB": ["contraceptive", "group", "343-355"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol @DRUG$ oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p235", "DRUGA": ["glyburide", "drug", "324-332"], "DRUGB": ["levonorgestrel", "drug", "358-371"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol @DRUG$ oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p236", "DRUGA": ["glyburide", "drug", "324-332"], "DRUGB": ["ethinyl estradiol", "drug", "373-389"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol @DRUG$ oral contraceptive @DRUG$ nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p237", "DRUGA": ["glyburide", "drug", "324-332"], "DRUGB": ["metoprolol", "drug", "393-402"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol @DRUG$ oral contraceptive metoprolol @DRUG$ phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p238", "DRUGA": ["glyburide", "drug", "324-332"], "DRUGB": ["nifedipine", "drug", "405-414"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol @DRUG$ oral contraceptive metoprolol nifedipine @DRUG$ warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p239", "DRUGA": ["glyburide", "drug", "324-332"], "DRUGB": ["phenytoin", "drug", "417-425"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol @DRUG$ oral contraceptive metoprolol nifedipine phenytoin @DRUG$ midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p240", "DRUGA": ["glyburide", "drug", "324-332"], "DRUGB": ["warfarin", "drug", "428-435"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol @DRUG$ oral contraceptive metoprolol nifedipine phenytoin warfarin @DRUG$ clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p241", "DRUGA": ["glyburide", "drug", "324-332"], "DRUGB": ["midazolam", "drug", "438-446"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol @DRUG$ oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam @DRUG$ metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p242", "DRUGA": ["glyburide", "drug", "324-332"], "DRUGB": ["clarithromycin", "drug", "449-462"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol @DRUG$ oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin @DRUG$ amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p243", "DRUGA": ["glyburide", "drug", "324-332"], "DRUGB": ["metronidazole", "drug", "465-477"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol @DRUG$ oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p244", "DRUGA": ["glyburide", "drug", "324-332"], "DRUGB": ["amoxicillin", "drug", "483-493"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide @DRUG$ metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p245", "DRUGA": ["contraceptive", "group", "343-355"], "DRUGB": ["levonorgestrel", "drug", "358-371"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide @DRUG$ metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p246", "DRUGA": ["contraceptive", "group", "343-355"], "DRUGB": ["ethinyl estradiol", "drug", "373-389"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide @DRUG$ @DRUG$ nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p247", "DRUGA": ["contraceptive", "group", "343-355"], "DRUGB": ["metoprolol", "drug", "393-402"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide @DRUG$ metoprolol @DRUG$ phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p248", "DRUGA": ["contraceptive", "group", "343-355"], "DRUGB": ["nifedipine", "drug", "405-414"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide @DRUG$ metoprolol nifedipine @DRUG$ warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p249", "DRUGA": ["contraceptive", "group", "343-355"], "DRUGB": ["phenytoin", "drug", "417-425"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide @DRUG$ metoprolol nifedipine phenytoin @DRUG$ midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p250", "DRUGA": ["contraceptive", "group", "343-355"], "DRUGB": ["warfarin", "drug", "428-435"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide @DRUG$ metoprolol nifedipine phenytoin warfarin @DRUG$ clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p251", "DRUGA": ["contraceptive", "group", "343-355"], "DRUGB": ["midazolam", "drug", "438-446"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide @DRUG$ metoprolol nifedipine phenytoin warfarin midazolam @DRUG$ metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p252", "DRUGA": ["contraceptive", "group", "343-355"], "DRUGB": ["clarithromycin", "drug", "449-462"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide @DRUG$ metoprolol nifedipine phenytoin warfarin midazolam clarithromycin @DRUG$ amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p253", "DRUGA": ["contraceptive", "group", "343-355"], "DRUGB": ["metronidazole", "drug", "465-477"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide @DRUG$ metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p254", "DRUGA": ["contraceptive", "group", "343-355"], "DRUGB": ["amoxicillin", "drug", "483-493"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p255", "DRUGA": ["levonorgestrel", "drug", "358-371"], "DRUGB": ["ethinyl estradiol", "drug", "373-389"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive @DRUG$ nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p256", "DRUGA": ["levonorgestrel", "drug", "358-371"], "DRUGB": ["metoprolol", "drug", "393-402"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol @DRUG$ phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p257", "DRUGA": ["levonorgestrel", "drug", "358-371"], "DRUGB": ["nifedipine", "drug", "405-414"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine @DRUG$ warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p258", "DRUGA": ["levonorgestrel", "drug", "358-371"], "DRUGB": ["phenytoin", "drug", "417-425"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin @DRUG$ midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p259", "DRUGA": ["levonorgestrel", "drug", "358-371"], "DRUGB": ["warfarin", "drug", "428-435"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin @DRUG$ clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p260", "DRUGA": ["levonorgestrel", "drug", "358-371"], "DRUGB": ["midazolam", "drug", "438-446"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam @DRUG$ metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p261", "DRUGA": ["levonorgestrel", "drug", "358-371"], "DRUGB": ["clarithromycin", "drug", "449-462"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin @DRUG$ amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p262", "DRUGA": ["levonorgestrel", "drug", "358-371"], "DRUGB": ["metronidazole", "drug", "465-477"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p263", "DRUGA": ["levonorgestrel", "drug", "358-371"], "DRUGB": ["amoxicillin", "drug", "483-493"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive @DRUG$ nifedipine phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p264", "DRUGA": ["ethinyl estradiol", "drug", "373-389"], "DRUGB": ["metoprolol", "drug", "393-402"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol @DRUG$ phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p265", "DRUGA": ["ethinyl estradiol", "drug", "373-389"], "DRUGB": ["nifedipine", "drug", "405-414"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine @DRUG$ warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p266", "DRUGA": ["ethinyl estradiol", "drug", "373-389"], "DRUGB": ["phenytoin", "drug", "417-425"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin @DRUG$ midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p267", "DRUGA": ["ethinyl estradiol", "drug", "373-389"], "DRUGB": ["warfarin", "drug", "428-435"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin @DRUG$ clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p268", "DRUGA": ["ethinyl estradiol", "drug", "373-389"], "DRUGB": ["midazolam", "drug", "438-446"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam @DRUG$ metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p269", "DRUGA": ["ethinyl estradiol", "drug", "373-389"], "DRUGB": ["clarithromycin", "drug", "449-462"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin @DRUG$ amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p270", "DRUGA": ["ethinyl estradiol", "drug", "373-389"], "DRUGB": ["metronidazole", "drug", "465-477"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin metronidazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p271", "DRUGA": ["ethinyl estradiol", "drug", "373-389"], "DRUGB": ["amoxicillin", "drug", "483-493"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive @DRUG$ @DRUG$ phenytoin warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p272", "DRUGA": ["metoprolol", "drug", "393-402"], "DRUGB": ["nifedipine", "drug", "405-414"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive @DRUG$ nifedipine @DRUG$ warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p273", "DRUGA": ["metoprolol", "drug", "393-402"], "DRUGB": ["phenytoin", "drug", "417-425"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive @DRUG$ nifedipine phenytoin @DRUG$ midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p274", "DRUGA": ["metoprolol", "drug", "393-402"], "DRUGB": ["warfarin", "drug", "428-435"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive @DRUG$ nifedipine phenytoin warfarin @DRUG$ clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p275", "DRUGA": ["metoprolol", "drug", "393-402"], "DRUGB": ["midazolam", "drug", "438-446"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive @DRUG$ nifedipine phenytoin warfarin midazolam @DRUG$ metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p276", "DRUGA": ["metoprolol", "drug", "393-402"], "DRUGB": ["clarithromycin", "drug", "449-462"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive @DRUG$ nifedipine phenytoin warfarin midazolam clarithromycin @DRUG$ amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p277", "DRUGA": ["metoprolol", "drug", "393-402"], "DRUGB": ["metronidazole", "drug", "465-477"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive @DRUG$ nifedipine phenytoin warfarin midazolam clarithromycin metronidazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p278", "DRUGA": ["metoprolol", "drug", "393-402"], "DRUGB": ["amoxicillin", "drug", "483-493"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol @DRUG$ @DRUG$ warfarin midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p279", "DRUGA": ["nifedipine", "drug", "405-414"], "DRUGB": ["phenytoin", "drug", "417-425"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol @DRUG$ phenytoin @DRUG$ midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p280", "DRUGA": ["nifedipine", "drug", "405-414"], "DRUGB": ["warfarin", "drug", "428-435"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol @DRUG$ phenytoin warfarin @DRUG$ clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p281", "DRUGA": ["nifedipine", "drug", "405-414"], "DRUGB": ["midazolam", "drug", "438-446"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol @DRUG$ phenytoin warfarin midazolam @DRUG$ metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p282", "DRUGA": ["nifedipine", "drug", "405-414"], "DRUGB": ["clarithromycin", "drug", "449-462"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol @DRUG$ phenytoin warfarin midazolam clarithromycin @DRUG$ amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p283", "DRUGA": ["nifedipine", "drug", "405-414"], "DRUGB": ["metronidazole", "drug", "465-477"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol @DRUG$ phenytoin warfarin midazolam clarithromycin metronidazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p284", "DRUGA": ["nifedipine", "drug", "405-414"], "DRUGB": ["amoxicillin", "drug", "483-493"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine @DRUG$ @DRUG$ midazolam clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p285", "DRUGA": ["phenytoin", "drug", "417-425"], "DRUGB": ["warfarin", "drug", "428-435"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine @DRUG$ warfarin @DRUG$ clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p286", "DRUGA": ["phenytoin", "drug", "417-425"], "DRUGB": ["midazolam", "drug", "438-446"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine @DRUG$ warfarin midazolam @DRUG$ metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p287", "DRUGA": ["phenytoin", "drug", "417-425"], "DRUGB": ["clarithromycin", "drug", "449-462"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine @DRUG$ warfarin midazolam clarithromycin @DRUG$ amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p288", "DRUGA": ["phenytoin", "drug", "417-425"], "DRUGB": ["metronidazole", "drug", "465-477"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine @DRUG$ warfarin midazolam clarithromycin metronidazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p289", "DRUGA": ["phenytoin", "drug", "417-425"], "DRUGB": ["amoxicillin", "drug", "483-493"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin @DRUG$ @DRUG$ clarithromycin metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p290", "DRUGA": ["warfarin", "drug", "428-435"], "DRUGB": ["midazolam", "drug", "438-446"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin @DRUG$ midazolam @DRUG$ metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p291", "DRUGA": ["warfarin", "drug", "428-435"], "DRUGB": ["clarithromycin", "drug", "449-462"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin @DRUG$ midazolam clarithromycin @DRUG$ amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p292", "DRUGA": ["warfarin", "drug", "428-435"], "DRUGB": ["metronidazole", "drug", "465-477"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin @DRUG$ midazolam clarithromycin metronidazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p293", "DRUGA": ["warfarin", "drug", "428-435"], "DRUGB": ["amoxicillin", "drug", "483-493"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin @DRUG$ @DRUG$ metronidazole amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p294", "DRUGA": ["midazolam", "drug", "438-446"], "DRUGB": ["clarithromycin", "drug", "449-462"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin @DRUG$ clarithromycin @DRUG$ amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p295", "DRUGA": ["midazolam", "drug", "438-446"], "DRUGB": ["metronidazole", "drug", "465-477"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin @DRUG$ clarithromycin metronidazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p296", "DRUGA": ["midazolam", "drug", "438-446"], "DRUGB": ["amoxicillin", "drug", "483-493"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam @DRUG$ @DRUG$ amoxicillin", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p297", "DRUGA": ["clarithromycin", "drug", "449-462"], "DRUGB": ["metronidazole", "drug", "465-477"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam @DRUG$ metronidazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p298", "DRUGA": ["clarithromycin", "drug", "449-462"], "DRUGB": ["amoxicillin", "drug", "483-493"]}
{"TEXT1": "Based studies evaluating possible interactions pantoprazole drugs no dosage adjustment needed concomitant theophylline cisapride antipyrine caffeine carbamazepine diazepam active metabolite diclofenac naproxen piroxicam digoxin ethanol glyburide oral contraceptive metoprolol nifedipine phenytoin warfarin midazolam clarithromycin @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d680.s1.p299", "DRUGA": ["metronidazole", "drug", "465-477"], "DRUGB": ["amoxicillin", "drug", "483-493"]}
{"TEXT1": "@DRUG$ adjustment dosage @DRUG$ drugs not", "LBL": "0", "ID": "DDI-DrugBank.d680.s3.p0", "DRUGA": ["pantoprazole", "drug", "36-47"], "DRUGB": ["pantoprazole", "drug", "78-89"]}
{"TEXT1": "reports increased INR prothrombin time patients receiving @DRUG$ including @DRUG$ warfarin", "LBL": "0", "ID": "DDI-DrugBank.d680.s5.p0", "DRUGA": ["proton pump inhibitors", "group", "98-119"], "DRUGB": ["pantoprazole", "drug", "132-143"]}
{"TEXT1": "reports increased INR prothrombin time patients receiving @DRUG$ including pantoprazole @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d680.s5.p1", "DRUGA": ["proton pump inhibitors", "group", "98-119"], "DRUGB": ["warfarin", "drug", "150-157"]}
{"TEXT1": "reports increased INR prothrombin time patients receiving proton pump inhibitors including @DRUG$ @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d680.s5.p2", "DRUGA": ["pantoprazole", "drug", "132-143"], "DRUGB": ["warfarin", "drug", "150-157"]}
{"TEXT1": "Patients treated with @DRUG$ @DRUG$ monitored increases INR prothrombin time", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d680.s7.p0", "DRUGA": ["proton pump inhibitors", "group", "22-43"], "DRUGB": ["warfarin", "drug", "49-56"]}
{"TEXT1": "profound long inhibition gastric acid secretion @DRUG$ interfere absorption drugs important determinant bioavailability @DRUG$ ampicillin esters", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d680.s8.p0", "DRUGA": ["pantoprazole", "drug", "75-86"], "DRUGB": ["ketoconazole", "drug", "202-213"]}
{"TEXT1": "profound long inhibition gastric acid secretion @DRUG$ interfere absorption drugs important determinant bioavailability ketoconazole @DRUG$ esters", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d680.s8.p1", "DRUGA": ["pantoprazole", "drug", "75-86"], "DRUGB": ["ampicillin", "drug", "216-225"]}
{"TEXT1": "profound long inhibition gastric acid secretion @DRUG$ interfere absorption drugs important determinant bioavailability ketoconazole ampicillin esters @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d680.s8.p2", "DRUGA": ["pantoprazole", "drug", "75-86"], "DRUGB": ["iron", "drug", "239-242"]}
{"TEXT1": "profound long inhibition gastric acid secretion pantoprazole interfere absorption drugs important determinant bioavailability @DRUG$ @DRUG$ esters", "LBL": "0", "ID": "DDI-DrugBank.d680.s8.p3", "DRUGA": ["ketoconazole", "drug", "202-213"], "DRUGB": ["ampicillin", "drug", "216-225"]}
{"TEXT1": "profound long inhibition gastric acid secretion pantoprazole interfere absorption drugs important determinant bioavailability @DRUG$ ampicillin esters @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d680.s8.p4", "DRUGA": ["ketoconazole", "drug", "202-213"], "DRUGB": ["iron", "drug", "239-242"]}
{"TEXT1": "profound long inhibition gastric acid secretion pantoprazole interfere absorption drugs important determinant bioavailability ketoconazole @DRUG$ esters @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d680.s8.p5", "DRUGA": ["ampicillin", "drug", "216-225"], "DRUGB": ["iron", "drug", "239-242"]}
{"TEXT1": "Laboratory reports urine screening screening tests @DRUG$ patients receiving proton pump inhibitors including pantoprazole", "LBL": "0", "ID": "DDI-DrugBank.d680.s9.p0", "DRUGA": ["tetrahydrocannabinol", "drug", "85-104"], "DRUGB": ["THC", "drug", "107-109"]}
{"TEXT1": "Laboratory reports urine screening screening tests @DRUG$ patients receiving @DRUG$ including pantoprazole", "LBL": "0", "ID": "DDI-DrugBank.d680.s9.p1", "DRUGA": ["tetrahydrocannabinol", "drug", "85-104"], "DRUGB": ["proton pump inhibitors", "group", "139-160"]}
{"TEXT1": "Laboratory reports urine screening screening tests @DRUG$ patients receiving proton pump inhibitors including @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d680.s9.p2", "DRUGA": ["tetrahydrocannabinol", "drug", "85-104"], "DRUGB": ["pantoprazole", "drug", "173-184"]}
{"TEXT1": "Laboratory reports urine screening screening tests tetrahydrocannabinol patients receiving @DRUG$ including pantoprazole", "LBL": "0", "ID": "DDI-DrugBank.d680.s9.p3", "DRUGA": ["THC", "drug", "107-109"], "DRUGB": ["proton pump inhibitors", "group", "139-160"]}
{"TEXT1": "Laboratory reports urine screening screening tests tetrahydrocannabinol patients receiving proton pump inhibitors including @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d680.s9.p4", "DRUGA": ["THC", "drug", "107-109"], "DRUGB": ["pantoprazole", "drug", "173-184"]}
{"TEXT1": "Laboratory reports urine screening screening tests tetrahydrocannabinol patients receiving @DRUG$ including @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d680.s9.p5", "DRUGA": ["proton pump inhibitors", "group", "139-160"], "DRUGB": ["pantoprazole", "drug", "173-184"]}
{"TEXT1": "eye drops medications @DRUG$ carbachol decrease effects suprofen ophthalmic", "LBL": "0", "ID": "DDI-DrugBank.d723.s0.p0", "DRUGA": ["acetylcholine chloride", "drug", "39-60"], "DRUGB": ["Miochol", "brand", "63-69"]}
{"TEXT1": "eye drops medications @DRUG$ @DRUG$ decrease effects suprofen ophthalmic", "LBL": "0", "ID": "DDI-DrugBank.d723.s0.p1", "DRUGA": ["acetylcholine chloride", "drug", "39-60"], "DRUGB": ["carbachol", "drug", "76-84"]}
{"TEXT1": "eye drops medications @DRUG$ carbachol decrease effects suprofen ophthalmic", "LBL": "0", "ID": "DDI-DrugBank.d723.s0.p2", "DRUGA": ["acetylcholine chloride", "drug", "39-60"], "DRUGB": ["Carboptic", "brand", "87-95"]}
{"TEXT1": "eye drops medications @DRUG$ carbachol decrease effects suprofen ophthalmic", "LBL": "0", "ID": "DDI-DrugBank.d723.s0.p3", "DRUGA": ["acetylcholine chloride", "drug", "39-60"], "DRUGB": ["Isopto Carbachol", "brand", "98-113"]}
{"TEXT1": "eye drops medications @DRUG$ carbachol decrease effects @DRUG$ ophthalmic", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d723.s0.p4", "DRUGA": ["acetylcholine chloride", "drug", "39-60"], "DRUGB": ["suprofen", "drug", "144-151"]}
{"TEXT1": "eye drops medications acetylcholine chloride @DRUG$ decrease effects suprofen ophthalmic", "LBL": "0", "ID": "DDI-DrugBank.d723.s0.p5", "DRUGA": ["Miochol", "brand", "63-69"], "DRUGB": ["carbachol", "drug", "76-84"]}
{"TEXT1": "eye drops medications acetylcholine chloride carbachol decrease effects suprofen ophthalmic", "LBL": "0", "ID": "DDI-DrugBank.d723.s0.p6", "DRUGA": ["Miochol", "brand", "63-69"], "DRUGB": ["Carboptic", "brand", "87-95"]}
{"TEXT1": "eye drops medications acetylcholine chloride carbachol decrease effects suprofen ophthalmic", "LBL": "0", "ID": "DDI-DrugBank.d723.s0.p7", "DRUGA": ["Miochol", "brand", "63-69"], "DRUGB": ["Isopto Carbachol", "brand", "98-113"]}
{"TEXT1": "eye drops medications acetylcholine chloride carbachol decrease effects @DRUG$ ophthalmic", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d723.s0.p8", "DRUGA": ["Miochol", "brand", "63-69"], "DRUGB": ["suprofen", "drug", "144-151"]}
{"TEXT1": "eye drops medications acetylcholine chloride @DRUG$ decrease effects suprofen ophthalmic", "LBL": "0", "ID": "DDI-DrugBank.d723.s0.p9", "DRUGA": ["carbachol", "drug", "76-84"], "DRUGB": ["Carboptic", "brand", "87-95"]}
{"TEXT1": "eye drops medications acetylcholine chloride @DRUG$ decrease effects suprofen ophthalmic", "LBL": "0", "ID": "DDI-DrugBank.d723.s0.p10", "DRUGA": ["carbachol", "drug", "76-84"], "DRUGB": ["Isopto Carbachol", "brand", "98-113"]}
{"TEXT1": "eye drops medications acetylcholine chloride @DRUG$ decrease effects @DRUG$ ophthalmic", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d723.s0.p11", "DRUGA": ["carbachol", "drug", "76-84"], "DRUGB": ["suprofen", "drug", "144-151"]}
{"TEXT1": "eye drops medications acetylcholine chloride carbachol decrease effects suprofen ophthalmic", "LBL": "0", "ID": "DDI-DrugBank.d723.s0.p12", "DRUGA": ["Carboptic", "brand", "87-95"], "DRUGB": ["Isopto Carbachol", "brand", "98-113"]}
{"TEXT1": "eye drops medications acetylcholine chloride carbachol decrease effects @DRUG$ ophthalmic", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d723.s0.p13", "DRUGA": ["Carboptic", "brand", "87-95"], "DRUGB": ["suprofen", "drug", "144-151"]}
{"TEXT1": "eye drops medications acetylcholine chloride carbachol decrease effects @DRUG$ ophthalmic", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d723.s0.p14", "DRUGA": ["Isopto Carbachol", "brand", "98-113"], "DRUGB": ["suprofen", "drug", "144-151"]}
{"TEXT1": "take @DRUG$ taken @DRUG$ isocarboxazid tranylcypromine phenelzine last days", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d716.s0.p0", "DRUGA": ["mazindol", "drug", "16-23"], "DRUGB": ["monoamine oxidase inhibitor", "group", "45-71"]}
{"TEXT1": "take @DRUG$ taken a monoamine oxidase inhibitor isocarboxazid tranylcypromine phenelzine last days", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d716.s0.p1", "DRUGA": ["mazindol", "drug", "16-23"], "DRUGB": ["MAOI", "group", "74-77"]}
{"TEXT1": "take @DRUG$ taken a monoamine oxidase inhibitor @DRUG$ tranylcypromine phenelzine last days", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d716.s0.p2", "DRUGA": ["mazindol", "drug", "16-23"], "DRUGB": ["isocarboxazid", "drug", "88-100"]}
{"TEXT1": "take @DRUG$ taken a monoamine oxidase inhibitor isocarboxazid tranylcypromine phenelzine last days", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d716.s0.p3", "DRUGA": ["mazindol", "drug", "16-23"], "DRUGB": ["Marplan", "brand", "103-109"]}
{"TEXT1": "take @DRUG$ taken a monoamine oxidase inhibitor isocarboxazid @DRUG$ phenelzine last days", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d716.s0.p4", "DRUGA": ["mazindol", "drug", "16-23"], "DRUGB": ["tranylcypromine", "drug", "113-127"]}
{"TEXT1": "take @DRUG$ taken a monoamine oxidase inhibitor isocarboxazid tranylcypromine phenelzine last days", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d716.s0.p5", "DRUGA": ["mazindol", "drug", "16-23"], "DRUGB": ["Parnate", "brand", "130-136"]}
{"TEXT1": "take @DRUG$ taken a monoamine oxidase inhibitor isocarboxazid tranylcypromine @DRUG$ last days", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d716.s0.p6", "DRUGA": ["mazindol", "drug", "16-23"], "DRUGB": ["phenelzine", "drug", "143-152"]}
{"TEXT1": "take @DRUG$ taken a monoamine oxidase inhibitor isocarboxazid tranylcypromine phenelzine last days", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d716.s0.p7", "DRUGA": ["mazindol", "drug", "16-23"], "DRUGB": ["Nardil", "brand", "155-160"]}
{"TEXT1": "take mazindol taken @DRUG$ isocarboxazid tranylcypromine phenelzine last days", "LBL": "0", "ID": "DDI-DrugBank.d716.s0.p8", "DRUGA": ["monoamine oxidase inhibitor", "group", "45-71"], "DRUGB": ["MAOI", "group", "74-77"]}
{"TEXT1": "take mazindol taken @DRUG$ @DRUG$ tranylcypromine phenelzine last days", "LBL": "0", "ID": "DDI-DrugBank.d716.s0.p9", "DRUGA": ["monoamine oxidase inhibitor", "group", "45-71"], "DRUGB": ["isocarboxazid", "drug", "88-100"]}
{"TEXT1": "take mazindol taken @DRUG$ isocarboxazid tranylcypromine phenelzine last days", "LBL": "0", "ID": "DDI-DrugBank.d716.s0.p10", "DRUGA": ["monoamine oxidase inhibitor", "group", "45-71"], "DRUGB": ["Marplan", "brand", "103-109"]}
{"TEXT1": "take mazindol taken @DRUG$ isocarboxazid @DRUG$ phenelzine last days", "LBL": "0", "ID": "DDI-DrugBank.d716.s0.p11", "DRUGA": ["monoamine oxidase inhibitor", "group", "45-71"], "DRUGB": ["tranylcypromine", "drug", "113-127"]}
{"TEXT1": "take mazindol taken @DRUG$ isocarboxazid tranylcypromine phenelzine last days", "LBL": "0", "ID": "DDI-DrugBank.d716.s0.p12", "DRUGA": ["monoamine oxidase inhibitor", "group", "45-71"], "DRUGB": ["Parnate", "brand", "130-136"]}
{"TEXT1": "take mazindol taken @DRUG$ isocarboxazid tranylcypromine @DRUG$ last days", "LBL": "0", "ID": "DDI-DrugBank.d716.s0.p13", "DRUGA": ["monoamine oxidase inhibitor", "group", "45-71"], "DRUGB": ["phenelzine", "drug", "143-152"]}
{"TEXT1": "take mazindol taken @DRUG$ isocarboxazid tranylcypromine phenelzine last days", "LBL": "0", "ID": "DDI-DrugBank.d716.s0.p14", "DRUGA": ["monoamine oxidase inhibitor", "group", "45-71"], "DRUGB": ["Nardil", "brand", "155-160"]}
{"TEXT1": "take mazindol taken a monoamine oxidase inhibitor @DRUG$ tranylcypromine phenelzine last days", "LBL": "0", "ID": "DDI-DrugBank.d716.s0.p15", "DRUGA": ["MAOI", "group", "74-77"], "DRUGB": ["isocarboxazid", "drug", "88-100"]}
{"TEXT1": "take mazindol taken a monoamine oxidase inhibitor isocarboxazid tranylcypromine phenelzine last days", "LBL": "0", "ID": "DDI-DrugBank.d716.s0.p16", "DRUGA": ["MAOI", "group", "74-77"], "DRUGB": ["Marplan", "brand", "103-109"]}
{"TEXT1": "take mazindol taken a monoamine oxidase inhibitor isocarboxazid @DRUG$ phenelzine last days", "LBL": "0", "ID": "DDI-DrugBank.d716.s0.p17", "DRUGA": ["MAOI", "group", "74-77"], "DRUGB": ["tranylcypromine", "drug", "113-127"]}
{"TEXT1": "take mazindol taken a monoamine oxidase inhibitor isocarboxazid tranylcypromine phenelzine last days", "LBL": "0", "ID": "DDI-DrugBank.d716.s0.p18", "DRUGA": ["MAOI", "group", "74-77"], "DRUGB": ["Parnate", "brand", "130-136"]}
{"TEXT1": "take mazindol taken a monoamine oxidase inhibitor isocarboxazid tranylcypromine @DRUG$ last days", "LBL": "0", "ID": "DDI-DrugBank.d716.s0.p19", "DRUGA": ["MAOI", "group", "74-77"], "DRUGB": ["phenelzine", "drug", "143-152"]}
{"TEXT1": "take mazindol taken a monoamine oxidase inhibitor isocarboxazid tranylcypromine phenelzine last days", "LBL": "0", "ID": "DDI-DrugBank.d716.s0.p20", "DRUGA": ["MAOI", "group", "74-77"], "DRUGB": ["Nardil", "brand", "155-160"]}
{"TEXT1": "take mazindol taken a monoamine oxidase inhibitor @DRUG$ tranylcypromine phenelzine last days", "LBL": "0", "ID": "DDI-DrugBank.d716.s0.p21", "DRUGA": ["isocarboxazid", "drug", "88-100"], "DRUGB": ["Marplan", "brand", "103-109"]}
{"TEXT1": "take mazindol taken a monoamine oxidase inhibitor @DRUG$ @DRUG$ phenelzine last days", "LBL": "0", "ID": "DDI-DrugBank.d716.s0.p22", "DRUGA": ["isocarboxazid", "drug", "88-100"], "DRUGB": ["tranylcypromine", "drug", "113-127"]}
{"TEXT1": "take mazindol taken a monoamine oxidase inhibitor @DRUG$ tranylcypromine phenelzine last days", "LBL": "0", "ID": "DDI-DrugBank.d716.s0.p23", "DRUGA": ["isocarboxazid", "drug", "88-100"], "DRUGB": ["Parnate", "brand", "130-136"]}
{"TEXT1": "take mazindol taken a monoamine oxidase inhibitor @DRUG$ tranylcypromine @DRUG$ last days", "LBL": "0", "ID": "DDI-DrugBank.d716.s0.p24", "DRUGA": ["isocarboxazid", "drug", "88-100"], "DRUGB": ["phenelzine", "drug", "143-152"]}
{"TEXT1": "take mazindol taken a monoamine oxidase inhibitor @DRUG$ tranylcypromine phenelzine last days", "LBL": "0", "ID": "DDI-DrugBank.d716.s0.p25", "DRUGA": ["isocarboxazid", "drug", "88-100"], "DRUGB": ["Nardil", "brand", "155-160"]}
{"TEXT1": "take mazindol taken a monoamine oxidase inhibitor isocarboxazid @DRUG$ phenelzine last days", "LBL": "0", "ID": "DDI-DrugBank.d716.s0.p26", "DRUGA": ["Marplan", "brand", "103-109"], "DRUGB": ["tranylcypromine", "drug", "113-127"]}
{"TEXT1": "take mazindol taken a monoamine oxidase inhibitor isocarboxazid tranylcypromine phenelzine last days", "LBL": "0", "ID": "DDI-DrugBank.d716.s0.p27", "DRUGA": ["Marplan", "brand", "103-109"], "DRUGB": ["Parnate", "brand", "130-136"]}
{"TEXT1": "take mazindol taken a monoamine oxidase inhibitor isocarboxazid tranylcypromine @DRUG$ last days", "LBL": "0", "ID": "DDI-DrugBank.d716.s0.p28", "DRUGA": ["Marplan", "brand", "103-109"], "DRUGB": ["phenelzine", "drug", "143-152"]}
{"TEXT1": "take mazindol taken a monoamine oxidase inhibitor isocarboxazid tranylcypromine phenelzine last days", "LBL": "0", "ID": "DDI-DrugBank.d716.s0.p29", "DRUGA": ["Marplan", "brand", "103-109"], "DRUGB": ["Nardil", "brand", "155-160"]}
{"TEXT1": "take mazindol taken a monoamine oxidase inhibitor isocarboxazid @DRUG$ phenelzine last days", "LBL": "0", "ID": "DDI-DrugBank.d716.s0.p30", "DRUGA": ["tranylcypromine", "drug", "113-127"], "DRUGB": ["Parnate", "brand", "130-136"]}
{"TEXT1": "take mazindol taken a monoamine oxidase inhibitor isocarboxazid @DRUG$ @DRUG$ last days", "LBL": "0", "ID": "DDI-DrugBank.d716.s0.p31", "DRUGA": ["tranylcypromine", "drug", "113-127"], "DRUGB": ["phenelzine", "drug", "143-152"]}
{"TEXT1": "take mazindol taken a monoamine oxidase inhibitor isocarboxazid @DRUG$ phenelzine last days", "LBL": "0", "ID": "DDI-DrugBank.d716.s0.p32", "DRUGA": ["tranylcypromine", "drug", "113-127"], "DRUGB": ["Nardil", "brand", "155-160"]}
{"TEXT1": "take mazindol taken a monoamine oxidase inhibitor isocarboxazid tranylcypromine @DRUG$ last days", "LBL": "0", "ID": "DDI-DrugBank.d716.s0.p33", "DRUGA": ["Parnate", "brand", "130-136"], "DRUGB": ["phenelzine", "drug", "143-152"]}
{"TEXT1": "take mazindol taken a monoamine oxidase inhibitor isocarboxazid tranylcypromine phenelzine last days", "LBL": "0", "ID": "DDI-DrugBank.d716.s0.p34", "DRUGA": ["Parnate", "brand", "130-136"], "DRUGB": ["Nardil", "brand", "155-160"]}
{"TEXT1": "take mazindol taken a monoamine oxidase inhibitor isocarboxazid tranylcypromine @DRUG$ last days", "LBL": "0", "ID": "DDI-DrugBank.d716.s0.p35", "DRUGA": ["phenelzine", "drug", "143-152"], "DRUGB": ["Nardil", "brand", "155-160"]}
{"TEXT1": "Changes @DRUG$ diabetes therapies drug therapies treatment @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d716.s1.p0", "DRUGA": ["insulin", "drug", "11-17"], "DRUGB": ["mazindol", "drug", "92-99"]}
{"TEXT1": "@DRUG$ effects @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d716.s2.p0", "DRUGA": ["Mazindol", "drug", "0-7"], "DRUGB": ["guanethidine", "drug", "35-46"]}
{"TEXT1": "@DRUG$ effects guanethidine", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d716.s2.p1", "DRUGA": ["Mazindol", "drug", "0-7"], "DRUGB": ["Ismelin", "brand", "49-55"]}
{"TEXT1": "Mazindol effects @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d716.s2.p2", "DRUGA": ["guanethidine", "drug", "35-46"], "DRUGB": ["Ismelin", "brand", "49-55"]}
{"TEXT1": "taking medication doctor @DRUG$ @DRUG$ amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p0", "DRUGA": ["tricyclic antidepressant", "group", "68-91"], "DRUGB": ["amitriptyline", "drug", "101-113"]}
{"TEXT1": "taking medication doctor @DRUG$ amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p1", "DRUGA": ["tricyclic antidepressant", "group", "68-91"], "DRUGB": ["Elavil", "brand", "116-121"]}
{"TEXT1": "taking medication doctor @DRUG$ amitriptyline @DRUG$ doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p2", "DRUGA": ["tricyclic antidepressant", "group", "68-91"], "DRUGB": ["amoxapine", "drug", "125-133"]}
{"TEXT1": "taking medication doctor @DRUG$ amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p3", "DRUGA": ["tricyclic antidepressant", "group", "68-91"], "DRUGB": ["Asendin", "brand", "136-142"]}
{"TEXT1": "taking medication doctor @DRUG$ amitriptyline amoxapine @DRUG$ nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p4", "DRUGA": ["tricyclic antidepressant", "group", "68-91"], "DRUGB": ["doxepin", "drug", "146-152"]}
{"TEXT1": "taking medication doctor @DRUG$ amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p5", "DRUGA": ["tricyclic antidepressant", "group", "68-91"], "DRUGB": ["Sinequan", "brand", "155-162"]}
{"TEXT1": "taking medication doctor @DRUG$ amitriptyline amoxapine doxepin @DRUG$ imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p6", "DRUGA": ["tricyclic antidepressant", "group", "68-91"], "DRUGB": ["nortriptyline", "drug", "166-178"]}
{"TEXT1": "taking medication doctor @DRUG$ amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p7", "DRUGA": ["tricyclic antidepressant", "group", "68-91"], "DRUGB": ["Pamelor", "brand", "181-187"]}
{"TEXT1": "taking medication doctor @DRUG$ amitriptyline amoxapine doxepin nortriptyline @DRUG$ clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p8", "DRUGA": ["tricyclic antidepressant", "group", "68-91"], "DRUGB": ["imipramine", "drug", "191-200"]}
{"TEXT1": "taking medication doctor @DRUG$ amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p9", "DRUGA": ["tricyclic antidepressant", "group", "68-91"], "DRUGB": ["Tofranil", "brand", "203-210"]}
{"TEXT1": "taking medication doctor @DRUG$ amitriptyline amoxapine doxepin nortriptyline imipramine @DRUG$ protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p10", "DRUGA": ["tricyclic antidepressant", "group", "68-91"], "DRUGB": ["clomipramine", "drug", "214-225"]}
{"TEXT1": "taking medication doctor @DRUG$ amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p11", "DRUGA": ["tricyclic antidepressant", "group", "68-91"], "DRUGB": ["Anafranil", "brand", "228-236"]}
{"TEXT1": "taking medication doctor @DRUG$ amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine @DRUG$ desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p12", "DRUGA": ["tricyclic antidepressant", "group", "68-91"], "DRUGB": ["protriptyline", "drug", "240-252"]}
{"TEXT1": "taking medication doctor @DRUG$ amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p13", "DRUGA": ["tricyclic antidepressant", "group", "68-91"], "DRUGB": ["Vivactil", "brand", "255-262"]}
{"TEXT1": "taking medication doctor @DRUG$ amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p14", "DRUGA": ["tricyclic antidepressant", "group", "68-91"], "DRUGB": ["desipramine", "drug", "269-279"]}
{"TEXT1": "taking medication doctor @DRUG$ amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p15", "DRUGA": ["tricyclic antidepressant", "group", "68-91"], "DRUGB": ["Norpramin", "brand", "282-290"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant @DRUG$ amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p16", "DRUGA": ["amitriptyline", "drug", "101-113"], "DRUGB": ["Elavil", "brand", "116-121"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant @DRUG$ @DRUG$ doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p17", "DRUGA": ["amitriptyline", "drug", "101-113"], "DRUGB": ["amoxapine", "drug", "125-133"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant @DRUG$ amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p18", "DRUGA": ["amitriptyline", "drug", "101-113"], "DRUGB": ["Asendin", "brand", "136-142"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant @DRUG$ amoxapine @DRUG$ nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p19", "DRUGA": ["amitriptyline", "drug", "101-113"], "DRUGB": ["doxepin", "drug", "146-152"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant @DRUG$ amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p20", "DRUGA": ["amitriptyline", "drug", "101-113"], "DRUGB": ["Sinequan", "brand", "155-162"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant @DRUG$ amoxapine doxepin @DRUG$ imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p21", "DRUGA": ["amitriptyline", "drug", "101-113"], "DRUGB": ["nortriptyline", "drug", "166-178"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant @DRUG$ amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p22", "DRUGA": ["amitriptyline", "drug", "101-113"], "DRUGB": ["Pamelor", "brand", "181-187"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant @DRUG$ amoxapine doxepin nortriptyline @DRUG$ clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p23", "DRUGA": ["amitriptyline", "drug", "101-113"], "DRUGB": ["imipramine", "drug", "191-200"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant @DRUG$ amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p24", "DRUGA": ["amitriptyline", "drug", "101-113"], "DRUGB": ["Tofranil", "brand", "203-210"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant @DRUG$ amoxapine doxepin nortriptyline imipramine @DRUG$ protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p25", "DRUGA": ["amitriptyline", "drug", "101-113"], "DRUGB": ["clomipramine", "drug", "214-225"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant @DRUG$ amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p26", "DRUGA": ["amitriptyline", "drug", "101-113"], "DRUGB": ["Anafranil", "brand", "228-236"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant @DRUG$ amoxapine doxepin nortriptyline imipramine clomipramine @DRUG$ desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p27", "DRUGA": ["amitriptyline", "drug", "101-113"], "DRUGB": ["protriptyline", "drug", "240-252"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant @DRUG$ amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p28", "DRUGA": ["amitriptyline", "drug", "101-113"], "DRUGB": ["Vivactil", "brand", "255-262"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant @DRUG$ amoxapine doxepin nortriptyline imipramine clomipramine protriptyline @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p29", "DRUGA": ["amitriptyline", "drug", "101-113"], "DRUGB": ["desipramine", "drug", "269-279"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant @DRUG$ amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p30", "DRUGA": ["amitriptyline", "drug", "101-113"], "DRUGB": ["Norpramin", "brand", "282-290"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline @DRUG$ doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p31", "DRUGA": ["Elavil", "brand", "116-121"], "DRUGB": ["amoxapine", "drug", "125-133"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p32", "DRUGA": ["Elavil", "brand", "116-121"], "DRUGB": ["Asendin", "brand", "136-142"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine @DRUG$ nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p33", "DRUGA": ["Elavil", "brand", "116-121"], "DRUGB": ["doxepin", "drug", "146-152"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p34", "DRUGA": ["Elavil", "brand", "116-121"], "DRUGB": ["Sinequan", "brand", "155-162"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin @DRUG$ imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p35", "DRUGA": ["Elavil", "brand", "116-121"], "DRUGB": ["nortriptyline", "drug", "166-178"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p36", "DRUGA": ["Elavil", "brand", "116-121"], "DRUGB": ["Pamelor", "brand", "181-187"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline @DRUG$ clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p37", "DRUGA": ["Elavil", "brand", "116-121"], "DRUGB": ["imipramine", "drug", "191-200"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p38", "DRUGA": ["Elavil", "brand", "116-121"], "DRUGB": ["Tofranil", "brand", "203-210"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine @DRUG$ protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p39", "DRUGA": ["Elavil", "brand", "116-121"], "DRUGB": ["clomipramine", "drug", "214-225"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p40", "DRUGA": ["Elavil", "brand", "116-121"], "DRUGB": ["Anafranil", "brand", "228-236"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine @DRUG$ desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p41", "DRUGA": ["Elavil", "brand", "116-121"], "DRUGB": ["protriptyline", "drug", "240-252"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p42", "DRUGA": ["Elavil", "brand", "116-121"], "DRUGB": ["Vivactil", "brand", "255-262"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p43", "DRUGA": ["Elavil", "brand", "116-121"], "DRUGB": ["desipramine", "drug", "269-279"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p44", "DRUGA": ["Elavil", "brand", "116-121"], "DRUGB": ["Norpramin", "brand", "282-290"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline @DRUG$ doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p45", "DRUGA": ["amoxapine", "drug", "125-133"], "DRUGB": ["Asendin", "brand", "136-142"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline @DRUG$ @DRUG$ nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p46", "DRUGA": ["amoxapine", "drug", "125-133"], "DRUGB": ["doxepin", "drug", "146-152"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline @DRUG$ doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p47", "DRUGA": ["amoxapine", "drug", "125-133"], "DRUGB": ["Sinequan", "brand", "155-162"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline @DRUG$ doxepin @DRUG$ imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p48", "DRUGA": ["amoxapine", "drug", "125-133"], "DRUGB": ["nortriptyline", "drug", "166-178"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline @DRUG$ doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p49", "DRUGA": ["amoxapine", "drug", "125-133"], "DRUGB": ["Pamelor", "brand", "181-187"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline @DRUG$ doxepin nortriptyline @DRUG$ clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p50", "DRUGA": ["amoxapine", "drug", "125-133"], "DRUGB": ["imipramine", "drug", "191-200"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline @DRUG$ doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p51", "DRUGA": ["amoxapine", "drug", "125-133"], "DRUGB": ["Tofranil", "brand", "203-210"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline @DRUG$ doxepin nortriptyline imipramine @DRUG$ protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p52", "DRUGA": ["amoxapine", "drug", "125-133"], "DRUGB": ["clomipramine", "drug", "214-225"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline @DRUG$ doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p53", "DRUGA": ["amoxapine", "drug", "125-133"], "DRUGB": ["Anafranil", "brand", "228-236"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline @DRUG$ doxepin nortriptyline imipramine clomipramine @DRUG$ desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p54", "DRUGA": ["amoxapine", "drug", "125-133"], "DRUGB": ["protriptyline", "drug", "240-252"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline @DRUG$ doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p55", "DRUGA": ["amoxapine", "drug", "125-133"], "DRUGB": ["Vivactil", "brand", "255-262"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline @DRUG$ doxepin nortriptyline imipramine clomipramine protriptyline @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p56", "DRUGA": ["amoxapine", "drug", "125-133"], "DRUGB": ["desipramine", "drug", "269-279"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline @DRUG$ doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p57", "DRUGA": ["amoxapine", "drug", "125-133"], "DRUGB": ["Norpramin", "brand", "282-290"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine @DRUG$ nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p58", "DRUGA": ["Asendin", "brand", "136-142"], "DRUGB": ["doxepin", "drug", "146-152"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p59", "DRUGA": ["Asendin", "brand", "136-142"], "DRUGB": ["Sinequan", "brand", "155-162"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin @DRUG$ imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p60", "DRUGA": ["Asendin", "brand", "136-142"], "DRUGB": ["nortriptyline", "drug", "166-178"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p61", "DRUGA": ["Asendin", "brand", "136-142"], "DRUGB": ["Pamelor", "brand", "181-187"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline @DRUG$ clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p62", "DRUGA": ["Asendin", "brand", "136-142"], "DRUGB": ["imipramine", "drug", "191-200"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p63", "DRUGA": ["Asendin", "brand", "136-142"], "DRUGB": ["Tofranil", "brand", "203-210"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine @DRUG$ protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p64", "DRUGA": ["Asendin", "brand", "136-142"], "DRUGB": ["clomipramine", "drug", "214-225"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p65", "DRUGA": ["Asendin", "brand", "136-142"], "DRUGB": ["Anafranil", "brand", "228-236"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine @DRUG$ desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p66", "DRUGA": ["Asendin", "brand", "136-142"], "DRUGB": ["protriptyline", "drug", "240-252"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p67", "DRUGA": ["Asendin", "brand", "136-142"], "DRUGB": ["Vivactil", "brand", "255-262"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p68", "DRUGA": ["Asendin", "brand", "136-142"], "DRUGB": ["desipramine", "drug", "269-279"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p69", "DRUGA": ["Asendin", "brand", "136-142"], "DRUGB": ["Norpramin", "brand", "282-290"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine @DRUG$ nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p70", "DRUGA": ["doxepin", "drug", "146-152"], "DRUGB": ["Sinequan", "brand", "155-162"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine @DRUG$ @DRUG$ imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p71", "DRUGA": ["doxepin", "drug", "146-152"], "DRUGB": ["nortriptyline", "drug", "166-178"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine @DRUG$ nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p72", "DRUGA": ["doxepin", "drug", "146-152"], "DRUGB": ["Pamelor", "brand", "181-187"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine @DRUG$ nortriptyline @DRUG$ clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p73", "DRUGA": ["doxepin", "drug", "146-152"], "DRUGB": ["imipramine", "drug", "191-200"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine @DRUG$ nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p74", "DRUGA": ["doxepin", "drug", "146-152"], "DRUGB": ["Tofranil", "brand", "203-210"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine @DRUG$ nortriptyline imipramine @DRUG$ protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p75", "DRUGA": ["doxepin", "drug", "146-152"], "DRUGB": ["clomipramine", "drug", "214-225"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine @DRUG$ nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p76", "DRUGA": ["doxepin", "drug", "146-152"], "DRUGB": ["Anafranil", "brand", "228-236"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine @DRUG$ nortriptyline imipramine clomipramine @DRUG$ desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p77", "DRUGA": ["doxepin", "drug", "146-152"], "DRUGB": ["protriptyline", "drug", "240-252"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine @DRUG$ nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p78", "DRUGA": ["doxepin", "drug", "146-152"], "DRUGB": ["Vivactil", "brand", "255-262"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine @DRUG$ nortriptyline imipramine clomipramine protriptyline @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p79", "DRUGA": ["doxepin", "drug", "146-152"], "DRUGB": ["desipramine", "drug", "269-279"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine @DRUG$ nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p80", "DRUGA": ["doxepin", "drug", "146-152"], "DRUGB": ["Norpramin", "brand", "282-290"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin @DRUG$ imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p81", "DRUGA": ["Sinequan", "brand", "155-162"], "DRUGB": ["nortriptyline", "drug", "166-178"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p82", "DRUGA": ["Sinequan", "brand", "155-162"], "DRUGB": ["Pamelor", "brand", "181-187"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline @DRUG$ clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p83", "DRUGA": ["Sinequan", "brand", "155-162"], "DRUGB": ["imipramine", "drug", "191-200"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p84", "DRUGA": ["Sinequan", "brand", "155-162"], "DRUGB": ["Tofranil", "brand", "203-210"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine @DRUG$ protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p85", "DRUGA": ["Sinequan", "brand", "155-162"], "DRUGB": ["clomipramine", "drug", "214-225"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p86", "DRUGA": ["Sinequan", "brand", "155-162"], "DRUGB": ["Anafranil", "brand", "228-236"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine @DRUG$ desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p87", "DRUGA": ["Sinequan", "brand", "155-162"], "DRUGB": ["protriptyline", "drug", "240-252"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p88", "DRUGA": ["Sinequan", "brand", "155-162"], "DRUGB": ["Vivactil", "brand", "255-262"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p89", "DRUGA": ["Sinequan", "brand", "155-162"], "DRUGB": ["desipramine", "drug", "269-279"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p90", "DRUGA": ["Sinequan", "brand", "155-162"], "DRUGB": ["Norpramin", "brand", "282-290"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin @DRUG$ imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p91", "DRUGA": ["nortriptyline", "drug", "166-178"], "DRUGB": ["Pamelor", "brand", "181-187"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin @DRUG$ @DRUG$ clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p92", "DRUGA": ["nortriptyline", "drug", "166-178"], "DRUGB": ["imipramine", "drug", "191-200"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin @DRUG$ imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p93", "DRUGA": ["nortriptyline", "drug", "166-178"], "DRUGB": ["Tofranil", "brand", "203-210"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin @DRUG$ imipramine @DRUG$ protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p94", "DRUGA": ["nortriptyline", "drug", "166-178"], "DRUGB": ["clomipramine", "drug", "214-225"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin @DRUG$ imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p95", "DRUGA": ["nortriptyline", "drug", "166-178"], "DRUGB": ["Anafranil", "brand", "228-236"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin @DRUG$ imipramine clomipramine @DRUG$ desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p96", "DRUGA": ["nortriptyline", "drug", "166-178"], "DRUGB": ["protriptyline", "drug", "240-252"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin @DRUG$ imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p97", "DRUGA": ["nortriptyline", "drug", "166-178"], "DRUGB": ["Vivactil", "brand", "255-262"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin @DRUG$ imipramine clomipramine protriptyline @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p98", "DRUGA": ["nortriptyline", "drug", "166-178"], "DRUGB": ["desipramine", "drug", "269-279"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin @DRUG$ imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p99", "DRUGA": ["nortriptyline", "drug", "166-178"], "DRUGB": ["Norpramin", "brand", "282-290"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline @DRUG$ clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p100", "DRUGA": ["Pamelor", "brand", "181-187"], "DRUGB": ["imipramine", "drug", "191-200"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p101", "DRUGA": ["Pamelor", "brand", "181-187"], "DRUGB": ["Tofranil", "brand", "203-210"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine @DRUG$ protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p102", "DRUGA": ["Pamelor", "brand", "181-187"], "DRUGB": ["clomipramine", "drug", "214-225"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p103", "DRUGA": ["Pamelor", "brand", "181-187"], "DRUGB": ["Anafranil", "brand", "228-236"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine @DRUG$ desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p104", "DRUGA": ["Pamelor", "brand", "181-187"], "DRUGB": ["protriptyline", "drug", "240-252"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p105", "DRUGA": ["Pamelor", "brand", "181-187"], "DRUGB": ["Vivactil", "brand", "255-262"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p106", "DRUGA": ["Pamelor", "brand", "181-187"], "DRUGB": ["desipramine", "drug", "269-279"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p107", "DRUGA": ["Pamelor", "brand", "181-187"], "DRUGB": ["Norpramin", "brand", "282-290"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline @DRUG$ clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p108", "DRUGA": ["imipramine", "drug", "191-200"], "DRUGB": ["Tofranil", "brand", "203-210"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline @DRUG$ @DRUG$ protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p109", "DRUGA": ["imipramine", "drug", "191-200"], "DRUGB": ["clomipramine", "drug", "214-225"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline @DRUG$ clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p110", "DRUGA": ["imipramine", "drug", "191-200"], "DRUGB": ["Anafranil", "brand", "228-236"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline @DRUG$ clomipramine @DRUG$ desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p111", "DRUGA": ["imipramine", "drug", "191-200"], "DRUGB": ["protriptyline", "drug", "240-252"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline @DRUG$ clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p112", "DRUGA": ["imipramine", "drug", "191-200"], "DRUGB": ["Vivactil", "brand", "255-262"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline @DRUG$ clomipramine protriptyline @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p113", "DRUGA": ["imipramine", "drug", "191-200"], "DRUGB": ["desipramine", "drug", "269-279"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline @DRUG$ clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p114", "DRUGA": ["imipramine", "drug", "191-200"], "DRUGB": ["Norpramin", "brand", "282-290"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine @DRUG$ protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p115", "DRUGA": ["Tofranil", "brand", "203-210"], "DRUGB": ["clomipramine", "drug", "214-225"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p116", "DRUGA": ["Tofranil", "brand", "203-210"], "DRUGB": ["Anafranil", "brand", "228-236"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine @DRUG$ desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p117", "DRUGA": ["Tofranil", "brand", "203-210"], "DRUGB": ["protriptyline", "drug", "240-252"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p118", "DRUGA": ["Tofranil", "brand", "203-210"], "DRUGB": ["Vivactil", "brand", "255-262"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p119", "DRUGA": ["Tofranil", "brand", "203-210"], "DRUGB": ["desipramine", "drug", "269-279"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p120", "DRUGA": ["Tofranil", "brand", "203-210"], "DRUGB": ["Norpramin", "brand", "282-290"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine @DRUG$ protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p121", "DRUGA": ["clomipramine", "drug", "214-225"], "DRUGB": ["Anafranil", "brand", "228-236"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine @DRUG$ @DRUG$ desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p122", "DRUGA": ["clomipramine", "drug", "214-225"], "DRUGB": ["protriptyline", "drug", "240-252"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine @DRUG$ protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p123", "DRUGA": ["clomipramine", "drug", "214-225"], "DRUGB": ["Vivactil", "brand", "255-262"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine @DRUG$ protriptyline @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p124", "DRUGA": ["clomipramine", "drug", "214-225"], "DRUGB": ["desipramine", "drug", "269-279"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine @DRUG$ protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p125", "DRUGA": ["clomipramine", "drug", "214-225"], "DRUGB": ["Norpramin", "brand", "282-290"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine @DRUG$ desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p126", "DRUGA": ["Anafranil", "brand", "228-236"], "DRUGB": ["protriptyline", "drug", "240-252"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p127", "DRUGA": ["Anafranil", "brand", "228-236"], "DRUGB": ["Vivactil", "brand", "255-262"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p128", "DRUGA": ["Anafranil", "brand", "228-236"], "DRUGB": ["desipramine", "drug", "269-279"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p129", "DRUGA": ["Anafranil", "brand", "228-236"], "DRUGB": ["Norpramin", "brand", "282-290"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine @DRUG$ desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p130", "DRUGA": ["protriptyline", "drug", "240-252"], "DRUGB": ["Vivactil", "brand", "255-262"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p131", "DRUGA": ["protriptyline", "drug", "240-252"], "DRUGB": ["desipramine", "drug", "269-279"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine @DRUG$ desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p132", "DRUGA": ["protriptyline", "drug", "240-252"], "DRUGB": ["Norpramin", "brand", "282-290"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p133", "DRUGA": ["Vivactil", "brand", "255-262"], "DRUGB": ["desipramine", "drug", "269-279"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline desipramine", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p134", "DRUGA": ["Vivactil", "brand", "255-262"], "DRUGB": ["Norpramin", "brand", "282-290"]}
{"TEXT1": "taking medication doctor tricyclic antidepressant amitriptyline amoxapine doxepin nortriptyline imipramine clomipramine protriptyline @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d716.s5.p135", "DRUGA": ["desipramine", "drug", "269-279"], "DRUGB": ["Norpramin", "brand", "282-290"]}
{"TEXT1": "Pharmacokinetic properties @DRUG$ not altered addition @DRUG$ zidovudine combination lamivudine", "LBL": "0", "ID": "DDI-DrugBank.d610.s0.p0", "DRUGA": ["abacavir", "drug", "30-37"], "DRUGB": ["lamivudine", "drug", "82-91"]}
{"TEXT1": "Pharmacokinetic properties @DRUG$ not altered addition lamivudine @DRUG$ combination zidovudine", "LBL": "0", "ID": "DDI-DrugBank.d610.s0.p1", "DRUGA": ["abacavir", "drug", "30-37"], "DRUGB": ["zidovudine", "drug", "96-105"]}
{"TEXT1": "Pharmacokinetic properties @DRUG$ not altered addition lamivudine zidovudine combination @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d610.s0.p2", "DRUGA": ["abacavir", "drug", "30-37"], "DRUGB": ["lamivudine", "drug", "129-138"]}
{"TEXT1": "Pharmacokinetic properties @DRUG$ not altered addition lamivudine zidovudine combination @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d610.s0.p3", "DRUGA": ["abacavir", "drug", "30-37"], "DRUGB": ["zidovudine", "drug", "144-153"]}
{"TEXT1": "Pharmacokinetic properties abacavir not altered addition @DRUG$ @DRUG$ combination lamivudine zidovudine", "LBL": "0", "ID": "DDI-DrugBank.d610.s0.p4", "DRUGA": ["lamivudine", "drug", "82-91"], "DRUGB": ["zidovudine", "drug", "96-105"]}
{"TEXT1": "Pharmacokinetic properties abacavir not altered addition @DRUG$ zidovudine combination @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d610.s0.p5", "DRUGA": ["lamivudine", "drug", "82-91"], "DRUGB": ["lamivudine", "drug", "129-138"]}
{"TEXT1": "Pharmacokinetic properties abacavir not altered addition @DRUG$ zidovudine combination lamivudine @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d610.s0.p6", "DRUGA": ["lamivudine", "drug", "82-91"], "DRUGB": ["zidovudine", "drug", "144-153"]}
{"TEXT1": "Pharmacokinetic properties abacavir not altered addition lamivudine @DRUG$ combination @DRUG$ zidovudine", "LBL": "0", "ID": "DDI-DrugBank.d610.s0.p7", "DRUGA": ["zidovudine", "drug", "96-105"], "DRUGB": ["lamivudine", "drug", "129-138"]}
{"TEXT1": "Pharmacokinetic properties abacavir not altered addition lamivudine @DRUG$ combination @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d610.s0.p8", "DRUGA": ["zidovudine", "drug", "96-105"], "DRUGB": ["zidovudine", "drug", "144-153"]}
{"TEXT1": "Pharmacokinetic properties abacavir not altered addition lamivudine zidovudine combination @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d610.s0.p9", "DRUGA": ["lamivudine", "drug", "129-138"], "DRUGB": ["zidovudine", "drug", "144-153"]}
{"TEXT1": "significant changes @DRUG$ @DRUG$ pharmacokinetics observed following concomitant administration abacavir", "LBL": "0", "ID": "DDI-DrugBank.d610.s1.p0", "DRUGA": ["lamivudine", "drug", "37-46"], "DRUGB": ["zidovudine", "drug", "51-60"]}
{"TEXT1": "significant changes @DRUG$ zidovudine pharmacokinetics observed following concomitant administration @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d610.s1.p1", "DRUGA": ["lamivudine", "drug", "37-46"], "DRUGB": ["abacavir", "drug", "133-140"]}
{"TEXT1": "significant changes lamivudine @DRUG$ pharmacokinetics observed following concomitant administration @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d610.s1.p2", "DRUGA": ["zidovudine", "drug", "51-60"], "DRUGB": ["abacavir", "drug", "133-140"]}
{"TEXT1": "@DRUG$ no no effect pharmacokinetic properties @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d610.s2.p0", "DRUGA": ["Abacavir", "drug", "0-7"], "DRUGB": ["ethanol", "drug", "60-66"]}
{"TEXT1": "@DRUG$ decreases elimination @DRUG$ causing increase overall exposure addition methadone no significant effect pharmacokinetic properties abacavir", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d610.s3.p0", "DRUGA": ["Ethanol", "drug", "0-6"], "DRUGB": ["abacavir", "drug", "37-44"]}
{"TEXT1": "@DRUG$ decreases elimination abacavir causing increase overall exposure addition @DRUG$ no significant effect pharmacokinetic properties", "LBL": "0", "ID": "DDI-DrugBank.d610.s3.p1", "DRUGA": ["Ethanol", "drug", "0-6"], "DRUGB": ["methadone", "drug", "104-112"]}
{"TEXT1": "@DRUG$ decreases elimination abacavir causing increase overall exposure addition methadone no significant effect pharmacokinetic properties @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d610.s3.p2", "DRUGA": ["Ethanol", "drug", "0-6"], "DRUGB": ["abacavir", "drug", "188-195"]}
{"TEXT1": "Ethanol decreases elimination @DRUG$ causing increase overall exposure addition @DRUG$ no significant effect pharmacokinetic properties abacavir", "LBL": "0", "ID": "DDI-DrugBank.d610.s3.p3", "DRUGA": ["abacavir", "drug", "37-44"], "DRUGB": ["methadone", "drug", "104-112"]}
{"TEXT1": "Ethanol decreases elimination @DRUG$ causing increase overall exposure addition methadone no significant effect pharmacokinetic properties @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d610.s3.p4", "DRUGA": ["abacavir", "drug", "37-44"], "DRUGB": ["abacavir", "drug", "188-195"]}
{"TEXT1": "Ethanol decreases elimination abacavir causing increase overall exposure addition @DRUG$ no significant effect pharmacokinetic properties @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d610.s3.p5", "DRUGA": ["methadone", "drug", "104-112"], "DRUGB": ["abacavir", "drug", "188-195"]}
{"TEXT1": "study HIV infected patients receiving @DRUG$ maintenance therapy mg 90 600 @DRUG$ twice daily currently recommended oral methadone clearance increased CI", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d610.s4.p0", "DRUGA": ["methadone", "drug", "49-57"], "DRUGB": ["ZIAGEN", "brand", "118-123"]}
{"TEXT1": "study HIV infected patients receiving @DRUG$ maintenance therapy mg 90 600 ZIAGEN twice daily currently recommended oral @DRUG$ clearance increased CI", "LBL": "0", "ID": "DDI-DrugBank.d610.s4.p1", "DRUGA": ["methadone", "drug", "49-57"], "DRUGB": ["methadone", "drug", "182-190"]}
{"TEXT1": "study HIV infected patients receiving methadone maintenance therapy mg 90 600 @DRUG$ twice daily currently recommended oral @DRUG$ clearance increased CI", "LBL": "0", "ID": "DDI-DrugBank.d610.s4.p2", "DRUGA": ["ZIAGEN", "brand", "118-123"], "DRUGB": ["methadone", "drug", "182-190"]}
{"TEXT1": "@DRUG$ increase effects @DRUG$ tolbutamide", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d682.s0.p0", "DRUGA": ["Sulfoxone", "drug", "0-8"], "DRUGB": ["barbiturates", "group", "38-49"]}
{"TEXT1": "@DRUG$ increase effects barbiturates @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d682.s0.p1", "DRUGA": ["Sulfoxone", "drug", "0-8"], "DRUGB": ["tolbutamide", "drug", "52-62"]}
{"TEXT1": "@DRUG$ increase effects barbiturates tolbutamide @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d682.s0.p2", "DRUGA": ["Sulfoxone", "drug", "0-8"], "DRUGB": ["uricosurics", "group", "69-79"]}
{"TEXT1": "Sulfoxone increase effects @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d682.s0.p3", "DRUGA": ["barbiturates", "group", "38-49"], "DRUGB": ["tolbutamide", "drug", "52-62"]}
{"TEXT1": "Sulfoxone increase effects @DRUG$ tolbutamide @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d682.s0.p4", "DRUGA": ["barbiturates", "group", "38-49"], "DRUGB": ["uricosurics", "group", "69-79"]}
{"TEXT1": "Sulfoxone increase effects barbiturates @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d682.s0.p5", "DRUGA": ["tolbutamide", "drug", "52-62"], "DRUGB": ["uricosurics", "group", "69-79"]}
{"TEXT1": "@DRUG$ @DRUG$ sulfonylurea agents warfarin methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d682.s1.p0", "DRUGA": ["thiazides", "group", "26-34"], "DRUGB": ["cyclosporine", "drug", "66-77"]}
{"TEXT1": "@DRUG$ cyclosporine @DRUG$ warfarin methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d682.s1.p1", "DRUGA": ["thiazides", "group", "26-34"], "DRUGB": ["sulfonylurea agents", "group", "107-125"]}
{"TEXT1": "@DRUG$ cyclosporine sulfonylurea agents @DRUG$ methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d682.s1.p2", "DRUGA": ["thiazides", "group", "26-34"], "DRUGB": ["warfarin", "drug", "162-169"]}
{"TEXT1": "@DRUG$ cyclosporine sulfonylurea agents warfarin @DRUG$ renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d682.s1.p3", "DRUGA": ["thiazides", "group", "26-34"], "DRUGB": ["methotrexate", "drug", "205-216"]}
{"TEXT1": "@DRUG$ cyclosporine sulfonylurea agents warfarin methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d682.s1.p4", "DRUGA": ["thiazides", "group", "26-34"], "DRUGB": ["methotrexate", "drug", "248-259"]}
{"TEXT1": "@DRUG$ cyclosporine sulfonylurea agents warfarin methotrexate renal excretion @DRUG$ hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d682.s1.p5", "DRUGA": ["thiazides", "group", "26-34"], "DRUGB": ["phenytoin", "drug", "263-271"]}
{"TEXT1": "@DRUG$ cyclosporine sulfonylurea agents warfarin methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d682.s1.p6", "DRUGA": ["thiazides", "group", "26-34"], "DRUGB": ["phenytoin", "drug", "305-313"]}
{"TEXT1": "thiazides @DRUG$ @DRUG$ warfarin methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d682.s1.p7", "DRUGA": ["cyclosporine", "drug", "66-77"], "DRUGB": ["sulfonylurea agents", "group", "107-125"]}
{"TEXT1": "thiazides @DRUG$ sulfonylurea agents @DRUG$ methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d682.s1.p8", "DRUGA": ["cyclosporine", "drug", "66-77"], "DRUGB": ["warfarin", "drug", "162-169"]}
{"TEXT1": "thiazides @DRUG$ sulfonylurea agents warfarin @DRUG$ renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d682.s1.p9", "DRUGA": ["cyclosporine", "drug", "66-77"], "DRUGB": ["methotrexate", "drug", "205-216"]}
{"TEXT1": "thiazides @DRUG$ sulfonylurea agents warfarin methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d682.s1.p10", "DRUGA": ["cyclosporine", "drug", "66-77"], "DRUGB": ["methotrexate", "drug", "248-259"]}
{"TEXT1": "thiazides @DRUG$ sulfonylurea agents warfarin methotrexate renal excretion @DRUG$ hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d682.s1.p11", "DRUGA": ["cyclosporine", "drug", "66-77"], "DRUGB": ["phenytoin", "drug", "263-271"]}
{"TEXT1": "thiazides @DRUG$ sulfonylurea agents warfarin methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d682.s1.p12", "DRUGA": ["cyclosporine", "drug", "66-77"], "DRUGB": ["phenytoin", "drug", "305-313"]}
{"TEXT1": "thiazides cyclosporine @DRUG$ @DRUG$ methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d682.s1.p13", "DRUGA": ["sulfonylurea agents", "group", "107-125"], "DRUGB": ["warfarin", "drug", "162-169"]}
{"TEXT1": "thiazides cyclosporine @DRUG$ warfarin @DRUG$ renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d682.s1.p14", "DRUGA": ["sulfonylurea agents", "group", "107-125"], "DRUGB": ["methotrexate", "drug", "205-216"]}
{"TEXT1": "thiazides cyclosporine @DRUG$ warfarin methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d682.s1.p15", "DRUGA": ["sulfonylurea agents", "group", "107-125"], "DRUGB": ["methotrexate", "drug", "248-259"]}
{"TEXT1": "thiazides cyclosporine @DRUG$ warfarin methotrexate renal excretion @DRUG$ hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d682.s1.p16", "DRUGA": ["sulfonylurea agents", "group", "107-125"], "DRUGB": ["phenytoin", "drug", "263-271"]}
{"TEXT1": "thiazides cyclosporine @DRUG$ warfarin methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d682.s1.p17", "DRUGA": ["sulfonylurea agents", "group", "107-125"], "DRUGB": ["phenytoin", "drug", "305-313"]}
{"TEXT1": "thiazides cyclosporine sulfonylurea agents @DRUG$ @DRUG$ renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d682.s1.p18", "DRUGA": ["warfarin", "drug", "162-169"], "DRUGB": ["methotrexate", "drug", "205-216"]}
{"TEXT1": "thiazides cyclosporine sulfonylurea agents @DRUG$ methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d682.s1.p19", "DRUGA": ["warfarin", "drug", "162-169"], "DRUGB": ["methotrexate", "drug", "248-259"]}
{"TEXT1": "thiazides cyclosporine sulfonylurea agents @DRUG$ methotrexate renal excretion @DRUG$ hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d682.s1.p20", "DRUGA": ["warfarin", "drug", "162-169"], "DRUGB": ["phenytoin", "drug", "263-271"]}
{"TEXT1": "thiazides cyclosporine sulfonylurea agents @DRUG$ methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d682.s1.p21", "DRUGA": ["warfarin", "drug", "162-169"], "DRUGB": ["phenytoin", "drug", "305-313"]}
{"TEXT1": "thiazides cyclosporine sulfonylurea agents warfarin @DRUG$ renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d682.s1.p22", "DRUGA": ["methotrexate", "drug", "205-216"], "DRUGB": ["methotrexate", "drug", "248-259"]}
{"TEXT1": "thiazides cyclosporine sulfonylurea agents warfarin @DRUG$ renal excretion @DRUG$ hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d682.s1.p23", "DRUGA": ["methotrexate", "drug", "205-216"], "DRUGB": ["phenytoin", "drug", "263-271"]}
{"TEXT1": "thiazides cyclosporine sulfonylurea agents warfarin @DRUG$ renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d682.s1.p24", "DRUGA": ["methotrexate", "drug", "205-216"], "DRUGB": ["phenytoin", "drug", "305-313"]}
{"TEXT1": "thiazides cyclosporine sulfonylurea agents warfarin methotrexate renal excretion @DRUG$ hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d682.s1.p25", "DRUGA": ["methotrexate", "drug", "248-259"], "DRUGB": ["phenytoin", "drug", "263-271"]}
{"TEXT1": "thiazides cyclosporine sulfonylurea agents warfarin methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d682.s1.p26", "DRUGA": ["methotrexate", "drug", "248-259"], "DRUGB": ["phenytoin", "drug", "305-313"]}
{"TEXT1": "thiazides cyclosporine sulfonylurea agents warfarin methotrexate renal excretion @DRUG$ hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d682.s1.p27", "DRUGA": ["phenytoin", "drug", "263-271"], "DRUGB": ["phenytoin", "drug", "305-313"]}
{"TEXT1": "@DRUG$ capable @DRUG$ barbiturates anesthetics opiates alcohol etc", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d677.s0.p0", "DRUGA": ["Phenothiazines", "group", "0-13"], "DRUGB": ["CNS depressants", "group", "43-57"]}
{"TEXT1": "@DRUG$ capable CNS depressants @DRUG$ anesthetics opiates alcohol etc", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d677.s0.p1", "DRUGA": ["Phenothiazines", "group", "0-13"], "DRUGB": ["barbiturates", "group", "66-77"]}
{"TEXT1": "@DRUG$ capable CNS depressants barbiturates @DRUG$ opiates alcohol etc", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d677.s0.p2", "DRUGA": ["Phenothiazines", "group", "0-13"], "DRUGB": ["anesthetics", "group", "80-90"]}
{"TEXT1": "@DRUG$ capable CNS depressants barbiturates anesthetics @DRUG$ alcohol etc", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d677.s0.p3", "DRUGA": ["Phenothiazines", "group", "0-13"], "DRUGB": ["opiates", "group", "93-99"]}
{"TEXT1": "@DRUG$ capable CNS depressants barbiturates anesthetics opiates @DRUG$ etc", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d677.s0.p4", "DRUGA": ["Phenothiazines", "group", "0-13"], "DRUGB": ["alcohol", "drug", "102-108"]}
{"TEXT1": "Phenothiazines capable @DRUG$ @DRUG$ anesthetics opiates alcohol etc", "LBL": "0", "ID": "DDI-DrugBank.d677.s0.p5", "DRUGA": ["CNS depressants", "group", "43-57"], "DRUGB": ["barbiturates", "group", "66-77"]}
{"TEXT1": "Phenothiazines capable @DRUG$ barbiturates @DRUG$ opiates alcohol etc", "LBL": "0", "ID": "DDI-DrugBank.d677.s0.p6", "DRUGA": ["CNS depressants", "group", "43-57"], "DRUGB": ["anesthetics", "group", "80-90"]}
{"TEXT1": "Phenothiazines capable @DRUG$ barbiturates anesthetics @DRUG$ alcohol etc", "LBL": "0", "ID": "DDI-DrugBank.d677.s0.p7", "DRUGA": ["CNS depressants", "group", "43-57"], "DRUGB": ["opiates", "group", "93-99"]}
{"TEXT1": "Phenothiazines capable @DRUG$ barbiturates anesthetics opiates @DRUG$ etc", "LBL": "0", "ID": "DDI-DrugBank.d677.s0.p8", "DRUGA": ["CNS depressants", "group", "43-57"], "DRUGB": ["alcohol", "drug", "102-108"]}
{"TEXT1": "Phenothiazines capable CNS depressants @DRUG$ @DRUG$ opiates alcohol etc", "LBL": "0", "ID": "DDI-DrugBank.d677.s0.p9", "DRUGA": ["barbiturates", "group", "66-77"], "DRUGB": ["anesthetics", "group", "80-90"]}
{"TEXT1": "Phenothiazines capable CNS depressants @DRUG$ anesthetics @DRUG$ alcohol etc", "LBL": "0", "ID": "DDI-DrugBank.d677.s0.p10", "DRUGA": ["barbiturates", "group", "66-77"], "DRUGB": ["opiates", "group", "93-99"]}
{"TEXT1": "Phenothiazines capable CNS depressants @DRUG$ anesthetics opiates @DRUG$ etc", "LBL": "0", "ID": "DDI-DrugBank.d677.s0.p11", "DRUGA": ["barbiturates", "group", "66-77"], "DRUGB": ["alcohol", "drug", "102-108"]}
{"TEXT1": "Phenothiazines capable CNS depressants barbiturates @DRUG$ @DRUG$ alcohol etc", "LBL": "0", "ID": "DDI-DrugBank.d677.s0.p12", "DRUGA": ["anesthetics", "group", "80-90"], "DRUGB": ["opiates", "group", "93-99"]}
{"TEXT1": "Phenothiazines capable CNS depressants barbiturates @DRUG$ opiates @DRUG$ etc", "LBL": "0", "ID": "DDI-DrugBank.d677.s0.p13", "DRUGA": ["anesthetics", "group", "80-90"], "DRUGB": ["alcohol", "drug", "102-108"]}
{"TEXT1": "Phenothiazines capable CNS depressants barbiturates anesthetics @DRUG$ @DRUG$ etc", "LBL": "0", "ID": "DDI-DrugBank.d677.s0.p14", "DRUGA": ["opiates", "group", "93-99"], "DRUGB": ["alcohol", "drug", "102-108"]}
{"TEXT1": "@DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d677.s1.p0", "DRUGA": ["atropine", "drug", "11-18"], "DRUGB": ["phosphorous insecticides", "drug_n", "24-47"]}
{"TEXT1": "Pharmacokinetic studies show no significant alterations pharmacokinetic parameters @DRUG$ @DRUG$ to dosage adjustment megestrol acetate administered drugs", "LBL": "0", "ID": "DDI-DrugBank.d688.s0.p0", "DRUGA": ["zidovudine", "drug", "104-113"], "DRUGB": ["rifabutin", "drug", "118-126"]}
{"TEXT1": "Pharmacokinetic studies show no significant alterations pharmacokinetic parameters @DRUG$ rifabutin to dosage adjustment @DRUG$ administered drugs", "LBL": "0", "ID": "DDI-DrugBank.d688.s0.p1", "DRUGA": ["zidovudine", "drug", "104-113"], "DRUGB": ["megestrol acetate", "drug", "162-178"]}
{"TEXT1": "Pharmacokinetic studies show no significant alterations pharmacokinetic parameters zidovudine @DRUG$ to dosage adjustment @DRUG$ administered drugs", "LBL": "0", "ID": "DDI-DrugBank.d688.s0.p2", "DRUGA": ["rifabutin", "drug", "118-126"], "DRUGB": ["megestrol acetate", "drug", "162-178"]}
{"TEXT1": "pharmacokinetic study coadministration @DRUG$ @DRUG$ results significant decrease Cmax indinavir", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d688.s1.p0", "DRUGA": ["megestrol acetate", "drug", "62-78"], "DRUGB": ["indinavir", "drug", "84-92"]}
{"TEXT1": "pharmacokinetic study coadministration @DRUG$ indinavir results significant decrease Cmax @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d688.s1.p1", "DRUGA": ["megestrol acetate", "drug", "62-78"], "DRUGB": ["indinavir", "drug", "198-206"]}
{"TEXT1": "pharmacokinetic study coadministration megestrol acetate @DRUG$ results significant decrease Cmax @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d688.s1.p2", "DRUGA": ["indinavir", "drug", "84-92"], "DRUGB": ["indinavir", "drug", "198-206"]}
{"TEXT1": "Administration higher dose @DRUG$ considered @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d688.s2.p0", "DRUGA": ["indinavir", "drug", "35-43"], "DRUGB": ["megestrol acetate", "drug", "92-108"]}
{"TEXT1": "effects @DRUG$ @DRUG$ rifabutin pharmacokinetics megestrol acetate not studied", "LBL": "0", "ID": "DDI-DrugBank.d688.s3.p0", "DRUGA": ["indinavir", "drug", "15-23"], "DRUGB": ["zidovudine", "drug", "26-35"]}
{"TEXT1": "effects @DRUG$ zidovudine @DRUG$ pharmacokinetics megestrol acetate not studied", "LBL": "0", "ID": "DDI-DrugBank.d688.s3.p1", "DRUGA": ["indinavir", "drug", "15-23"], "DRUGB": ["rifabutin", "drug", "40-48"]}
{"TEXT1": "effects @DRUG$ zidovudine rifabutin pharmacokinetics @DRUG$ not studied", "LBL": "0", "ID": "DDI-DrugBank.d688.s3.p2", "DRUGA": ["indinavir", "drug", "15-23"], "DRUGB": ["megestrol acetate", "drug", "77-93"]}
{"TEXT1": "effects indinavir @DRUG$ @DRUG$ pharmacokinetics megestrol acetate not studied", "LBL": "0", "ID": "DDI-DrugBank.d688.s3.p3", "DRUGA": ["zidovudine", "drug", "26-35"], "DRUGB": ["rifabutin", "drug", "40-48"]}
{"TEXT1": "effects indinavir @DRUG$ rifabutin pharmacokinetics @DRUG$ not studied", "LBL": "0", "ID": "DDI-DrugBank.d688.s3.p4", "DRUGA": ["zidovudine", "drug", "26-35"], "DRUGB": ["megestrol acetate", "drug", "77-93"]}
{"TEXT1": "effects indinavir zidovudine @DRUG$ pharmacokinetics @DRUG$ not studied", "LBL": "0", "ID": "DDI-DrugBank.d688.s3.p5", "DRUGA": ["rifabutin", "drug", "40-48"], "DRUGB": ["megestrol acetate", "drug", "77-93"]}
{"TEXT1": "@DRUG$ reported to @DRUG$ lead severe", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d647.s1.p0", "DRUGA": ["Streptozocin", "drug", "0-11"], "DRUGB": ["doxorubicin", "drug", "71-81"]}
{"TEXT1": "reduction @DRUG$ dosage considered patients receiving @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d647.s2.p0", "DRUGA": ["doxorubicin", "drug", "19-29"], "DRUGB": ["ZANOSAR", "brand", "81-87"]}
{"TEXT1": "concurrent use of @DRUG$ @DRUG$ reported case one to result reduced streptozocin cytotoxicity", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d647.s3.p0", "DRUGA": ["streptozocin", "drug", "22-33"], "DRUGB": ["phenytoin", "drug", "39-47"]}
{"TEXT1": "concurrent use of @DRUG$ phenytoin reported case one to result reduced @DRUG$ cytotoxicity", "LBL": "0", "ID": "DDI-DrugBank.d647.s3.p1", "DRUGA": ["streptozocin", "drug", "22-33"], "DRUGB": ["streptozocin", "drug", "100-111"]}
{"TEXT1": "concurrent use of streptozocin @DRUG$ reported case one to result reduced @DRUG$ cytotoxicity", "LBL": "0", "ID": "DDI-DrugBank.d647.s3.p2", "DRUGA": ["phenytoin", "drug", "39-47"], "DRUGB": ["streptozocin", "drug", "100-111"]}
{"TEXT1": "@DRUG$ used with caution digitalized patients combination @DRUG$ sympathomimetic amines cause ectopic arrhythmias", "LBL": "0", "ID": "DDI-DrugBank.d746.s0.p0", "DRUGA": ["ARAMINE", "brand", "0-6"], "DRUGB": ["digitalis", "group", "86-94"]}
{"TEXT1": "@DRUG$ used with caution digitalized patients combination digitalis @DRUG$ cause ectopic arrhythmias", "LBL": "0", "ID": "DDI-DrugBank.d746.s0.p1", "DRUGA": ["ARAMINE", "brand", "0-6"], "DRUGB": ["sympathomimetic amines", "group", "100-121"]}
{"TEXT1": "ARAMINE used with caution digitalized patients combination @DRUG$ @DRUG$ cause ectopic arrhythmias", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d746.s0.p2", "DRUGA": ["digitalis", "group", "86-94"], "DRUGB": ["sympathomimetic amines", "group", "100-121"]}
{"TEXT1": "@DRUG$ @DRUG$ action sympathomimetic amines", "LBL": "0", "ID": "DDI-DrugBank.d746.s1.p0", "DRUGA": ["Monoamine oxidase inhibitors", "group", "0-27"], "DRUGB": ["tricyclic antidepressants", "group", "32-56"]}
{"TEXT1": "@DRUG$ tricyclic antidepressants action @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d746.s1.p1", "DRUGA": ["Monoamine oxidase inhibitors", "group", "0-27"], "DRUGB": ["sympathomimetic amines", "group", "87-108"]}
{"TEXT1": "Monoamine oxidase inhibitors @DRUG$ action @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d746.s1.p2", "DRUGA": ["tricyclic antidepressants", "group", "32-56"], "DRUGB": ["sympathomimetic amines", "group", "87-108"]}
{"TEXT1": "@DRUG$ @DRUG$ TCA MAOIs alcohol", "LBL": "DDI-int", "ID": "DDI-DrugBank.d699.s0.p0", "DRUGA": ["Mequitazine", "drug", "0-10"], "DRUGB": ["CNS depressant", "group", "30-43"]}
{"TEXT1": "@DRUG$ CNS depressant @DRUG$ TCA MAOIs alcohol", "LBL": "DDI-int", "ID": "DDI-DrugBank.d699.s0.p1", "DRUGA": ["Mequitazine", "drug", "0-10"], "DRUGB": ["antichlolinergic", "group", "46-61"]}
{"TEXT1": "@DRUG$ CNS depressant @DRUG$ MAOIs alcohol", "LBL": "DDI-int", "ID": "DDI-DrugBank.d699.s0.p2", "DRUGA": ["Mequitazine", "drug", "0-10"], "DRUGB": ["TCA", "group", "64-66"]}
{"TEXT1": "@DRUG$ CNS depressant TCA @DRUG$ alcohol", "LBL": "DDI-int", "ID": "DDI-DrugBank.d699.s0.p3", "DRUGA": ["Mequitazine", "drug", "0-10"], "DRUGB": ["MAOIs", "group", "69-73"]}
{"TEXT1": "@DRUG$ CNS depressant TCA MAOIs @DRUG$", "LBL": "DDI-int", "ID": "DDI-DrugBank.d699.s0.p4", "DRUGA": ["Mequitazine", "drug", "0-10"], "DRUGB": ["alcohol", "drug", "80-86"]}
{"TEXT1": "Mequitazine @DRUG$ @DRUG$ TCA MAOIs alcohol", "LBL": "0", "ID": "DDI-DrugBank.d699.s0.p5", "DRUGA": ["CNS depressant", "group", "30-43"], "DRUGB": ["antichlolinergic", "group", "46-61"]}
{"TEXT1": "Mequitazine @DRUG$ @DRUG$ MAOIs alcohol", "LBL": "0", "ID": "DDI-DrugBank.d699.s0.p6", "DRUGA": ["CNS depressant", "group", "30-43"], "DRUGB": ["TCA", "group", "64-66"]}
{"TEXT1": "Mequitazine @DRUG$ TCA @DRUG$ alcohol", "LBL": "0", "ID": "DDI-DrugBank.d699.s0.p7", "DRUGA": ["CNS depressant", "group", "30-43"], "DRUGB": ["MAOIs", "group", "69-73"]}
{"TEXT1": "Mequitazine @DRUG$ TCA MAOIs @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d699.s0.p8", "DRUGA": ["CNS depressant", "group", "30-43"], "DRUGB": ["alcohol", "drug", "80-86"]}
{"TEXT1": "Mequitazine CNS depressant @DRUG$ @DRUG$ MAOIs alcohol", "LBL": "0", "ID": "DDI-DrugBank.d699.s0.p9", "DRUGA": ["antichlolinergic", "group", "46-61"], "DRUGB": ["TCA", "group", "64-66"]}
{"TEXT1": "Mequitazine CNS depressant @DRUG$ TCA @DRUG$ alcohol", "LBL": "0", "ID": "DDI-DrugBank.d699.s0.p10", "DRUGA": ["antichlolinergic", "group", "46-61"], "DRUGB": ["MAOIs", "group", "69-73"]}
{"TEXT1": "Mequitazine CNS depressant @DRUG$ TCA MAOIs @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d699.s0.p11", "DRUGA": ["antichlolinergic", "group", "46-61"], "DRUGB": ["alcohol", "drug", "80-86"]}
{"TEXT1": "Mequitazine CNS depressant @DRUG$ @DRUG$ alcohol", "LBL": "0", "ID": "DDI-DrugBank.d699.s0.p12", "DRUGA": ["TCA", "group", "64-66"], "DRUGB": ["MAOIs", "group", "69-73"]}
{"TEXT1": "Mequitazine CNS depressant @DRUG$ MAOIs @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d699.s0.p13", "DRUGA": ["TCA", "group", "64-66"], "DRUGB": ["alcohol", "drug", "80-86"]}
{"TEXT1": "Mequitazine CNS depressant TCA @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d699.s0.p14", "DRUGA": ["MAOIs", "group", "69-73"], "DRUGB": ["alcohol", "drug", "80-86"]}
{"TEXT1": "@DRUG$ decrease effectiveness @DRUG$ certain antibiotics quinidine theophylline corticosteroids anticoagulants beta blockers", "LBL": "DDI-int", "ID": "DDI-DrugBank.d601.s0.p0", "DRUGA": ["Barbiturates", "group", "0-11"], "DRUGB": ["contraceptives", "group", "52-65"]}
{"TEXT1": "@DRUG$ decrease effectiveness oral contraceptives certain @DRUG$ quinidine theophylline corticosteroids anticoagulants beta blockers", "LBL": "DDI-int", "ID": "DDI-DrugBank.d601.s0.p1", "DRUGA": ["Barbiturates", "group", "0-11"], "DRUGB": ["antibiotics", "group", "76-86"]}
{"TEXT1": "@DRUG$ decrease effectiveness oral contraceptives certain antibiotics @DRUG$ theophylline corticosteroids anticoagulants beta blockers", "LBL": "DDI-int", "ID": "DDI-DrugBank.d601.s0.p2", "DRUGA": ["Barbiturates", "group", "0-11"], "DRUGB": ["quinidine", "group", "89-97"]}
{"TEXT1": "@DRUG$ decrease effectiveness oral contraceptives certain antibiotics quinidine @DRUG$ corticosteroids anticoagulants beta blockers", "LBL": "DDI-int", "ID": "DDI-DrugBank.d601.s0.p3", "DRUGA": ["Barbiturates", "group", "0-11"], "DRUGB": ["theophylline", "drug", "100-111"]}
{"TEXT1": "@DRUG$ decrease effectiveness oral contraceptives certain antibiotics quinidine theophylline @DRUG$ anticoagulants beta blockers", "LBL": "DDI-int", "ID": "DDI-DrugBank.d601.s0.p4", "DRUGA": ["Barbiturates", "group", "0-11"], "DRUGB": ["corticosteroids", "group", "114-128"]}
{"TEXT1": "@DRUG$ decrease effectiveness oral contraceptives certain antibiotics quinidine theophylline corticosteroids @DRUG$ beta blockers", "LBL": "DDI-int", "ID": "DDI-DrugBank.d601.s0.p5", "DRUGA": ["Barbiturates", "group", "0-11"], "DRUGB": ["anticoagulants", "group", "131-144"]}
{"TEXT1": "@DRUG$ decrease effectiveness oral contraceptives certain antibiotics quinidine theophylline corticosteroids anticoagulants @DRUG$", "LBL": "DDI-int", "ID": "DDI-DrugBank.d601.s0.p6", "DRUGA": ["Barbiturates", "group", "0-11"], "DRUGB": ["beta blockers", "group", "151-163"]}
{"TEXT1": "Barbiturates decrease effectiveness @DRUG$ certain @DRUG$ quinidine theophylline corticosteroids anticoagulants beta blockers", "LBL": "0", "ID": "DDI-DrugBank.d601.s0.p7", "DRUGA": ["contraceptives", "group", "52-65"], "DRUGB": ["antibiotics", "group", "76-86"]}
{"TEXT1": "Barbiturates decrease effectiveness @DRUG$ certain antibiotics @DRUG$ theophylline corticosteroids anticoagulants beta blockers", "LBL": "0", "ID": "DDI-DrugBank.d601.s0.p8", "DRUGA": ["contraceptives", "group", "52-65"], "DRUGB": ["quinidine", "group", "89-97"]}
{"TEXT1": "Barbiturates decrease effectiveness @DRUG$ certain antibiotics quinidine @DRUG$ corticosteroids anticoagulants beta blockers", "LBL": "0", "ID": "DDI-DrugBank.d601.s0.p9", "DRUGA": ["contraceptives", "group", "52-65"], "DRUGB": ["theophylline", "drug", "100-111"]}
{"TEXT1": "Barbiturates decrease effectiveness @DRUG$ certain antibiotics quinidine theophylline @DRUG$ anticoagulants beta blockers", "LBL": "0", "ID": "DDI-DrugBank.d601.s0.p10", "DRUGA": ["contraceptives", "group", "52-65"], "DRUGB": ["corticosteroids", "group", "114-128"]}
{"TEXT1": "Barbiturates decrease effectiveness @DRUG$ certain antibiotics quinidine theophylline corticosteroids @DRUG$ beta blockers", "LBL": "0", "ID": "DDI-DrugBank.d601.s0.p11", "DRUGA": ["contraceptives", "group", "52-65"], "DRUGB": ["anticoagulants", "group", "131-144"]}
{"TEXT1": "Barbiturates decrease effectiveness @DRUG$ certain antibiotics quinidine theophylline corticosteroids anticoagulants @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d601.s0.p12", "DRUGA": ["contraceptives", "group", "52-65"], "DRUGB": ["beta blockers", "group", "151-163"]}
{"TEXT1": "Barbiturates decrease effectiveness oral contraceptives certain @DRUG$ @DRUG$ theophylline corticosteroids anticoagulants beta blockers", "LBL": "0", "ID": "DDI-DrugBank.d601.s0.p13", "DRUGA": ["antibiotics", "group", "76-86"], "DRUGB": ["quinidine", "group", "89-97"]}
{"TEXT1": "Barbiturates decrease effectiveness oral contraceptives certain @DRUG$ quinidine @DRUG$ corticosteroids anticoagulants beta blockers", "LBL": "0", "ID": "DDI-DrugBank.d601.s0.p14", "DRUGA": ["antibiotics", "group", "76-86"], "DRUGB": ["theophylline", "drug", "100-111"]}
{"TEXT1": "Barbiturates decrease effectiveness oral contraceptives certain @DRUG$ quinidine theophylline @DRUG$ anticoagulants beta blockers", "LBL": "0", "ID": "DDI-DrugBank.d601.s0.p15", "DRUGA": ["antibiotics", "group", "76-86"], "DRUGB": ["corticosteroids", "group", "114-128"]}
{"TEXT1": "Barbiturates decrease effectiveness oral contraceptives certain @DRUG$ quinidine theophylline corticosteroids @DRUG$ beta blockers", "LBL": "0", "ID": "DDI-DrugBank.d601.s0.p16", "DRUGA": ["antibiotics", "group", "76-86"], "DRUGB": ["anticoagulants", "group", "131-144"]}
{"TEXT1": "Barbiturates decrease effectiveness oral contraceptives certain @DRUG$ quinidine theophylline corticosteroids anticoagulants @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d601.s0.p17", "DRUGA": ["antibiotics", "group", "76-86"], "DRUGB": ["beta blockers", "group", "151-163"]}
{"TEXT1": "Barbiturates decrease effectiveness oral contraceptives certain antibiotics @DRUG$ @DRUG$ corticosteroids anticoagulants beta blockers", "LBL": "0", "ID": "DDI-DrugBank.d601.s0.p18", "DRUGA": ["quinidine", "group", "89-97"], "DRUGB": ["theophylline", "drug", "100-111"]}
{"TEXT1": "Barbiturates decrease effectiveness oral contraceptives certain antibiotics @DRUG$ theophylline @DRUG$ anticoagulants beta blockers", "LBL": "0", "ID": "DDI-DrugBank.d601.s0.p19", "DRUGA": ["quinidine", "group", "89-97"], "DRUGB": ["corticosteroids", "group", "114-128"]}
{"TEXT1": "Barbiturates decrease effectiveness oral contraceptives certain antibiotics @DRUG$ theophylline corticosteroids @DRUG$ beta blockers", "LBL": "0", "ID": "DDI-DrugBank.d601.s0.p20", "DRUGA": ["quinidine", "group", "89-97"], "DRUGB": ["anticoagulants", "group", "131-144"]}
{"TEXT1": "Barbiturates decrease effectiveness oral contraceptives certain antibiotics @DRUG$ theophylline corticosteroids anticoagulants @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d601.s0.p21", "DRUGA": ["quinidine", "group", "89-97"], "DRUGB": ["beta blockers", "group", "151-163"]}
{"TEXT1": "Barbiturates decrease effectiveness oral contraceptives certain antibiotics quinidine @DRUG$ @DRUG$ anticoagulants beta blockers", "LBL": "0", "ID": "DDI-DrugBank.d601.s0.p22", "DRUGA": ["theophylline", "drug", "100-111"], "DRUGB": ["corticosteroids", "group", "114-128"]}
{"TEXT1": "Barbiturates decrease effectiveness oral contraceptives certain antibiotics quinidine @DRUG$ corticosteroids @DRUG$ beta blockers", "LBL": "0", "ID": "DDI-DrugBank.d601.s0.p23", "DRUGA": ["theophylline", "drug", "100-111"], "DRUGB": ["anticoagulants", "group", "131-144"]}
{"TEXT1": "Barbiturates decrease effectiveness oral contraceptives certain antibiotics quinidine @DRUG$ corticosteroids anticoagulants @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d601.s0.p24", "DRUGA": ["theophylline", "drug", "100-111"], "DRUGB": ["beta blockers", "group", "151-163"]}
{"TEXT1": "Barbiturates decrease effectiveness oral contraceptives certain antibiotics quinidine theophylline @DRUG$ @DRUG$ beta blockers", "LBL": "0", "ID": "DDI-DrugBank.d601.s0.p25", "DRUGA": ["corticosteroids", "group", "114-128"], "DRUGB": ["anticoagulants", "group", "131-144"]}
{"TEXT1": "Barbiturates decrease effectiveness oral contraceptives certain antibiotics quinidine theophylline @DRUG$ anticoagulants @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d601.s0.p26", "DRUGA": ["corticosteroids", "group", "114-128"], "DRUGB": ["beta blockers", "group", "151-163"]}
{"TEXT1": "Barbiturates decrease effectiveness oral contraceptives certain antibiotics quinidine theophylline corticosteroids @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d601.s0.p27", "DRUGA": ["anticoagulants", "group", "131-144"], "DRUGB": ["beta blockers", "group", "151-163"]}
{"TEXT1": "@DRUG$ increase effects @DRUG$ tolbutamide", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d649.s0.p0", "DRUGA": ["Sulfamethizole", "drug", "0-13"], "DRUGB": ["barbiturates", "group", "43-54"]}
{"TEXT1": "@DRUG$ increase effects barbiturates @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d649.s0.p1", "DRUGA": ["Sulfamethizole", "drug", "0-13"], "DRUGB": ["tolbutamide", "drug", "57-67"]}
{"TEXT1": "@DRUG$ increase effects barbiturates tolbutamide @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d649.s0.p2", "DRUGA": ["Sulfamethizole", "drug", "0-13"], "DRUGB": ["uricosurics", "group", "74-84"]}
{"TEXT1": "Sulfamethizole increase effects @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d649.s0.p3", "DRUGA": ["barbiturates", "group", "43-54"], "DRUGB": ["tolbutamide", "drug", "57-67"]}
{"TEXT1": "Sulfamethizole increase effects @DRUG$ tolbutamide @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d649.s0.p4", "DRUGA": ["barbiturates", "group", "43-54"], "DRUGB": ["uricosurics", "group", "74-84"]}
{"TEXT1": "Sulfamethizole increase effects barbiturates @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d649.s0.p5", "DRUGA": ["tolbutamide", "drug", "57-67"], "DRUGB": ["uricosurics", "group", "74-84"]}
{"TEXT1": "@DRUG$ @DRUG$ sulfonylurea agents warfarin methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d649.s1.p0", "DRUGA": ["thiazides", "group", "26-34"], "DRUGB": ["cyclosporine", "drug", "66-77"]}
{"TEXT1": "@DRUG$ cyclosporine @DRUG$ warfarin methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d649.s1.p1", "DRUGA": ["thiazides", "group", "26-34"], "DRUGB": ["sulfonylurea agents", "group", "107-125"]}
{"TEXT1": "@DRUG$ cyclosporine sulfonylurea agents @DRUG$ methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d649.s1.p2", "DRUGA": ["thiazides", "group", "26-34"], "DRUGB": ["warfarin", "drug", "162-169"]}
{"TEXT1": "@DRUG$ cyclosporine sulfonylurea agents warfarin @DRUG$ renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d649.s1.p3", "DRUGA": ["thiazides", "group", "26-34"], "DRUGB": ["methotrexate", "drug", "205-216"]}
{"TEXT1": "@DRUG$ cyclosporine sulfonylurea agents warfarin methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d649.s1.p4", "DRUGA": ["thiazides", "group", "26-34"], "DRUGB": ["methotrexate", "drug", "248-259"]}
{"TEXT1": "@DRUG$ cyclosporine sulfonylurea agents warfarin methotrexate renal excretion @DRUG$ hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d649.s1.p5", "DRUGA": ["thiazides", "group", "26-34"], "DRUGB": ["phenytoin", "drug", "263-271"]}
{"TEXT1": "@DRUG$ cyclosporine sulfonylurea agents warfarin methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d649.s1.p6", "DRUGA": ["thiazides", "group", "26-34"], "DRUGB": ["phenytoin", "drug", "305-313"]}
{"TEXT1": "thiazides @DRUG$ @DRUG$ warfarin methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d649.s1.p7", "DRUGA": ["cyclosporine", "drug", "66-77"], "DRUGB": ["sulfonylurea agents", "group", "107-125"]}
{"TEXT1": "thiazides @DRUG$ sulfonylurea agents @DRUG$ methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d649.s1.p8", "DRUGA": ["cyclosporine", "drug", "66-77"], "DRUGB": ["warfarin", "drug", "162-169"]}
{"TEXT1": "thiazides @DRUG$ sulfonylurea agents warfarin @DRUG$ renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d649.s1.p9", "DRUGA": ["cyclosporine", "drug", "66-77"], "DRUGB": ["methotrexate", "drug", "205-216"]}
{"TEXT1": "thiazides @DRUG$ sulfonylurea agents warfarin methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d649.s1.p10", "DRUGA": ["cyclosporine", "drug", "66-77"], "DRUGB": ["methotrexate", "drug", "248-259"]}
{"TEXT1": "thiazides @DRUG$ sulfonylurea agents warfarin methotrexate renal excretion @DRUG$ hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d649.s1.p11", "DRUGA": ["cyclosporine", "drug", "66-77"], "DRUGB": ["phenytoin", "drug", "263-271"]}
{"TEXT1": "thiazides @DRUG$ sulfonylurea agents warfarin methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d649.s1.p12", "DRUGA": ["cyclosporine", "drug", "66-77"], "DRUGB": ["phenytoin", "drug", "305-313"]}
{"TEXT1": "thiazides cyclosporine @DRUG$ @DRUG$ methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d649.s1.p13", "DRUGA": ["sulfonylurea agents", "group", "107-125"], "DRUGB": ["warfarin", "drug", "162-169"]}
{"TEXT1": "thiazides cyclosporine @DRUG$ warfarin @DRUG$ renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d649.s1.p14", "DRUGA": ["sulfonylurea agents", "group", "107-125"], "DRUGB": ["methotrexate", "drug", "205-216"]}
{"TEXT1": "thiazides cyclosporine @DRUG$ warfarin methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d649.s1.p15", "DRUGA": ["sulfonylurea agents", "group", "107-125"], "DRUGB": ["methotrexate", "drug", "248-259"]}
{"TEXT1": "thiazides cyclosporine @DRUG$ warfarin methotrexate renal excretion @DRUG$ hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d649.s1.p16", "DRUGA": ["sulfonylurea agents", "group", "107-125"], "DRUGB": ["phenytoin", "drug", "263-271"]}
{"TEXT1": "thiazides cyclosporine @DRUG$ warfarin methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d649.s1.p17", "DRUGA": ["sulfonylurea agents", "group", "107-125"], "DRUGB": ["phenytoin", "drug", "305-313"]}
{"TEXT1": "thiazides cyclosporine sulfonylurea agents @DRUG$ @DRUG$ renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d649.s1.p18", "DRUGA": ["warfarin", "drug", "162-169"], "DRUGB": ["methotrexate", "drug", "205-216"]}
{"TEXT1": "thiazides cyclosporine sulfonylurea agents @DRUG$ methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d649.s1.p19", "DRUGA": ["warfarin", "drug", "162-169"], "DRUGB": ["methotrexate", "drug", "248-259"]}
{"TEXT1": "thiazides cyclosporine sulfonylurea agents @DRUG$ methotrexate renal excretion @DRUG$ hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d649.s1.p20", "DRUGA": ["warfarin", "drug", "162-169"], "DRUGB": ["phenytoin", "drug", "263-271"]}
{"TEXT1": "thiazides cyclosporine sulfonylurea agents @DRUG$ methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d649.s1.p21", "DRUGA": ["warfarin", "drug", "162-169"], "DRUGB": ["phenytoin", "drug", "305-313"]}
{"TEXT1": "thiazides cyclosporine sulfonylurea agents warfarin @DRUG$ renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d649.s1.p22", "DRUGA": ["methotrexate", "drug", "205-216"], "DRUGB": ["methotrexate", "drug", "248-259"]}
{"TEXT1": "thiazides cyclosporine sulfonylurea agents warfarin @DRUG$ renal excretion @DRUG$ hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d649.s1.p23", "DRUGA": ["methotrexate", "drug", "205-216"], "DRUGB": ["phenytoin", "drug", "263-271"]}
{"TEXT1": "thiazides cyclosporine sulfonylurea agents warfarin @DRUG$ renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d649.s1.p24", "DRUGA": ["methotrexate", "drug", "205-216"], "DRUGB": ["phenytoin", "drug", "305-313"]}
{"TEXT1": "thiazides cyclosporine sulfonylurea agents warfarin methotrexate renal excretion @DRUG$ hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d649.s1.p25", "DRUGA": ["methotrexate", "drug", "248-259"], "DRUGB": ["phenytoin", "drug", "263-271"]}
{"TEXT1": "thiazides cyclosporine sulfonylurea agents warfarin methotrexate renal excretion phenytoin hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d649.s1.p26", "DRUGA": ["methotrexate", "drug", "248-259"], "DRUGB": ["phenytoin", "drug", "305-313"]}
{"TEXT1": "thiazides cyclosporine sulfonylurea agents warfarin methotrexate renal excretion @DRUG$ hepatic clearance", "LBL": "0", "ID": "DDI-DrugBank.d649.s1.p27", "DRUGA": ["phenytoin", "drug", "263-271"], "DRUGB": ["phenytoin", "drug", "305-313"]}
{"TEXT1": "Patients studied clinical trials @DRUG$ treated with @DRUG$ aspirin", "LBL": "0", "ID": "DDI-DrugBank.d773.s1.p0", "DRUGA": ["TNKase", "brand", "39-44"], "DRUGB": ["heparin", "drug", "74-80"]}
{"TEXT1": "Patients studied clinical trials @DRUG$ treated with heparin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d773.s1.p1", "DRUGA": ["TNKase", "brand", "39-44"], "DRUGB": ["aspirin", "brand", "86-92"]}
{"TEXT1": "Patients studied clinical trials TNKase treated with @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d773.s1.p2", "DRUGA": ["heparin", "drug", "74-80"], "DRUGB": ["aspirin", "brand", "86-92"]}
{"TEXT1": "@DRUG$ @DRUG$ drugs alter platelet function acetylsalicylic acid dipyridamole GP IIb/IIIa increase risk bleeding administered prior to TNKase therapy", "LBL": "0", "ID": "DDI-DrugBank.d773.s2.p0", "DRUGA": ["Anticoagulants", "group", "0-13"], "DRUGB": ["heparin", "drug", "24-30"]}
{"TEXT1": "@DRUG$ heparin drugs alter platelet function acetylsalicylic acid dipyridamole GP IIb/IIIa increase risk bleeding administered prior to TNKase therapy", "LBL": "0", "ID": "DDI-DrugBank.d773.s2.p1", "DRUGA": ["Anticoagulants", "group", "0-13"], "DRUGB": ["vitamin K antagonists", "group", "36-56"]}
{"TEXT1": "@DRUG$ heparin drugs alter platelet function @DRUG$ dipyridamole GP IIb/IIIa increase risk bleeding administered prior to TNKase therapy", "LBL": "0", "ID": "DDI-DrugBank.d773.s2.p2", "DRUGA": ["Anticoagulants", "group", "0-13"], "DRUGB": ["acetylsalicylic acid", "drug", "107-126"]}
{"TEXT1": "@DRUG$ heparin drugs alter platelet function acetylsalicylic acid @DRUG$ GP IIb/IIIa increase risk bleeding administered prior to TNKase therapy", "LBL": "0", "ID": "DDI-DrugBank.d773.s2.p3", "DRUGA": ["Anticoagulants", "group", "0-13"], "DRUGB": ["dipyridamole", "drug", "129-140"]}
{"TEXT1": "@DRUG$ heparin drugs alter platelet function acetylsalicylic acid dipyridamole GP IIb/IIIa increase risk bleeding administered prior to @DRUG$ therapy", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d773.s2.p4", "DRUGA": ["Anticoagulants", "group", "0-13"], "DRUGB": ["TNKase", "brand", "248-253"]}
{"TEXT1": "Anticoagulants @DRUG$ drugs alter platelet function acetylsalicylic acid dipyridamole GP IIb/IIIa increase risk bleeding administered prior to TNKase therapy", "LBL": "0", "ID": "DDI-DrugBank.d773.s2.p5", "DRUGA": ["heparin", "drug", "24-30"], "DRUGB": ["vitamin K antagonists", "group", "36-56"]}
{"TEXT1": "Anticoagulants @DRUG$ drugs alter platelet function @DRUG$ dipyridamole GP IIb/IIIa increase risk bleeding administered prior to TNKase therapy", "LBL": "0", "ID": "DDI-DrugBank.d773.s2.p6", "DRUGA": ["heparin", "drug", "24-30"], "DRUGB": ["acetylsalicylic acid", "drug", "107-126"]}
{"TEXT1": "Anticoagulants @DRUG$ drugs alter platelet function acetylsalicylic acid @DRUG$ GP IIb/IIIa increase risk bleeding administered prior to TNKase therapy", "LBL": "0", "ID": "DDI-DrugBank.d773.s2.p7", "DRUGA": ["heparin", "drug", "24-30"], "DRUGB": ["dipyridamole", "drug", "129-140"]}
{"TEXT1": "Anticoagulants @DRUG$ drugs alter platelet function acetylsalicylic acid dipyridamole GP IIb/IIIa increase risk bleeding administered prior to @DRUG$ therapy", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d773.s2.p8", "DRUGA": ["heparin", "drug", "24-30"], "DRUGB": ["TNKase", "brand", "248-253"]}
{"TEXT1": "Anticoagulants heparin drugs alter platelet function @DRUG$ dipyridamole GP IIb/IIIa increase risk bleeding administered prior to TNKase therapy", "LBL": "0", "ID": "DDI-DrugBank.d773.s2.p9", "DRUGA": ["vitamin K antagonists", "group", "36-56"], "DRUGB": ["acetylsalicylic acid", "drug", "107-126"]}
{"TEXT1": "Anticoagulants heparin drugs alter platelet function acetylsalicylic acid @DRUG$ GP IIb/IIIa increase risk bleeding administered prior to TNKase therapy", "LBL": "0", "ID": "DDI-DrugBank.d773.s2.p10", "DRUGA": ["vitamin K antagonists", "group", "36-56"], "DRUGB": ["dipyridamole", "drug", "129-140"]}
{"TEXT1": "Anticoagulants heparin drugs alter platelet function acetylsalicylic acid dipyridamole GP IIb/IIIa increase risk bleeding administered prior to @DRUG$ therapy", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d773.s2.p11", "DRUGA": ["vitamin K antagonists", "group", "36-56"], "DRUGB": ["TNKase", "brand", "248-253"]}
{"TEXT1": "Anticoagulants heparin drugs alter platelet function @DRUG$ @DRUG$ GP IIb/IIIa increase risk bleeding administered prior to TNKase therapy", "LBL": "0", "ID": "DDI-DrugBank.d773.s2.p12", "DRUGA": ["acetylsalicylic acid", "drug", "107-126"], "DRUGB": ["dipyridamole", "drug", "129-140"]}
{"TEXT1": "Anticoagulants heparin drugs alter platelet function @DRUG$ dipyridamole GP IIb/IIIa increase risk bleeding administered prior to @DRUG$ therapy", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d773.s2.p13", "DRUGA": ["acetylsalicylic acid", "drug", "107-126"], "DRUGB": ["TNKase", "brand", "248-253"]}
{"TEXT1": "Anticoagulants heparin drugs alter platelet function acetylsalicylic acid @DRUG$ GP IIb/IIIa increase risk bleeding administered prior to @DRUG$ therapy", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d773.s2.p14", "DRUGA": ["dipyridamole", "drug", "129-140"], "DRUGB": ["TNKase", "brand", "248-253"]}
{"TEXT1": "effects chronic @DRUG$ metabolism rimantadine not known", "LBL": "0", "ID": "DDI-DrugBank.d710.s0.p0", "DRUGA": ["Cimetidine", "drug", "0-9"], "DRUGB": ["cimetidine", "drug", "35-44"]}
{"TEXT1": "effects chronic cimetidine metabolism @DRUG$ not known", "LBL": "0", "ID": "DDI-DrugBank.d710.s0.p1", "DRUGA": ["Cimetidine", "drug", "0-9"], "DRUGB": ["rimantadine", "drug", "71-81"]}
{"TEXT1": "effects chronic @DRUG$ metabolism @DRUG$ not known", "LBL": "0", "ID": "DDI-DrugBank.d710.s0.p2", "DRUGA": ["cimetidine", "drug", "35-44"], "DRUGB": ["rimantadine", "drug", "71-81"]}
{"TEXT1": "single 100 mg dose @DRUG$ administered one hour initiation @DRUG$ four times apparent total rimantadine clearance normal healthy adults reduced same subjects absence", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d710.s1.p0", "DRUGA": ["rimantadine HCl", "drug", "29-43"], "DRUGB": ["Cimetidine", "drug", "95-104"]}
{"TEXT1": "single 100 mg dose @DRUG$ administered one hour initiation four times apparent total @DRUG$ clearance normal healthy adults reduced rimantadine same subjects absence", "LBL": "0", "ID": "DDI-DrugBank.d710.s1.p1", "DRUGA": ["rimantadine HCl", "drug", "29-43"], "DRUGB": ["rimantadine", "drug", "152-162"]}
{"TEXT1": "single 100 mg dose @DRUG$ administered one hour initiation four times apparent total rimantadine clearance normal healthy adults reduced @DRUG$ same subjects absence", "LBL": "0", "ID": "DDI-DrugBank.d710.s1.p2", "DRUGA": ["rimantadine HCl", "drug", "29-43"], "DRUGB": ["rimantadine", "drug", "270-280"]}
{"TEXT1": "single 100 mg dose @DRUG$ administered one hour initiation four times apparent total rimantadine clearance normal healthy adults reduced same subjects absence", "LBL": "0", "ID": "DDI-DrugBank.d710.s1.p3", "DRUGA": ["rimantadine HCl", "drug", "29-43"], "DRUGB": ["cimetidine", "drug", "331-340"]}
{"TEXT1": "single 100 mg dose rimantadine administered one hour initiation @DRUG$ four times apparent total @DRUG$ clearance normal healthy adults reduced same subjects absence", "LBL": "0", "ID": "DDI-DrugBank.d710.s1.p4", "DRUGA": ["Cimetidine", "drug", "95-104"], "DRUGB": ["rimantadine", "drug", "152-162"]}
{"TEXT1": "single 100 mg dose rimantadine administered one hour initiation @DRUG$ four times apparent total clearance normal healthy adults reduced @DRUG$ same subjects absence", "LBL": "0", "ID": "DDI-DrugBank.d710.s1.p5", "DRUGA": ["Cimetidine", "drug", "95-104"], "DRUGB": ["rimantadine", "drug", "270-280"]}
{"TEXT1": "single 100 mg dose rimantadine administered one hour initiation @DRUG$ four times apparent total clearance normal healthy adults reduced same subjects absence", "LBL": "0", "ID": "DDI-DrugBank.d710.s1.p6", "DRUGA": ["Cimetidine", "drug", "95-104"], "DRUGB": ["cimetidine", "drug", "331-340"]}
{"TEXT1": "single 100 mg dose rimantadine administered one hour initiation four times apparent total @DRUG$ clearance normal healthy adults reduced @DRUG$ same subjects absence", "LBL": "0", "ID": "DDI-DrugBank.d710.s1.p7", "DRUGA": ["rimantadine", "drug", "152-162"], "DRUGB": ["rimantadine", "drug", "270-280"]}
{"TEXT1": "single 100 mg dose rimantadine administered one hour initiation four times apparent total @DRUG$ clearance normal healthy adults reduced same subjects absence", "LBL": "0", "ID": "DDI-DrugBank.d710.s1.p8", "DRUGA": ["rimantadine", "drug", "152-162"], "DRUGB": ["cimetidine", "drug", "331-340"]}
{"TEXT1": "single 100 mg dose rimantadine administered one hour initiation four times apparent total clearance normal healthy adults reduced @DRUG$ same subjects absence", "LBL": "0", "ID": "DDI-DrugBank.d710.s1.p9", "DRUGA": ["rimantadine", "drug", "270-280"], "DRUGB": ["cimetidine", "drug", "331-340"]}
{"TEXT1": "@DRUG$ 100 mg given twice daily days healthy volunteers", "LBL": "0", "ID": "DDI-DrugBank.d710.s2.p0", "DRUGA": ["Acetaminophen", "drug", "0-12"], "DRUGB": ["Rimantadine HCl", "drug", "15-29"]}
{"TEXT1": "Coadministration @DRUG$ reduced peak concentration AUC values @DRUG$ approximately", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d710.s5.p0", "DRUGA": ["acetaminophen", "drug", "22-34"], "DRUGB": ["rimantadine", "drug", "86-96"]}
{"TEXT1": "@DRUG$ 100 mg given twice daily fro days healthy volunteers", "LBL": "0", "ID": "DDI-DrugBank.d710.s6.p0", "DRUGA": ["Aspirin", "brand", "0-6"], "DRUGB": ["Rimantadine HCl", "drug", "9-23"]}
{"TEXT1": "Peak concentrations plasma concentrations AUC @DRUG$ reduced approximately presence @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d710.s9.p0", "DRUGA": ["rimantadine", "drug", "38-48"], "DRUGB": ["aspirin", "brand", "100-106"]}
{"TEXT1": "@DRUG$ inhibit hepatic metabolism @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d598.s0.p0", "DRUGA": ["Trimethoprim", "drug", "0-11"], "DRUGB": ["phenytoin", "drug", "51-59"]}
{"TEXT1": "@DRUG$ given common clinical dosage increased @DRUG$ decreased phenytoin metabolic clearance rate", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d598.s1.p0", "DRUGA": ["Trimethoprim", "drug", "0-11"], "DRUGB": ["phenytoin", "drug", "63-71"]}
{"TEXT1": "@DRUG$ given common clinical dosage increased phenytoin decreased @DRUG$ metabolic clearance rate", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d598.s1.p1", "DRUGA": ["Trimethoprim", "drug", "0-11"], "DRUGB": ["phenytoin", "drug", "108-116"]}
{"TEXT1": "Trimethoprim given common clinical dosage increased @DRUG$ decreased @DRUG$ metabolic clearance rate", "LBL": "0", "ID": "DDI-DrugBank.d598.s1.p2", "DRUGA": ["phenytoin", "drug", "63-71"], "DRUGB": ["phenytoin", "drug", "108-116"]}
{"TEXT1": "@DRUG$ administered patients taking @DRUG$ possibility conduction disturbances", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d627.s0.p0", "DRUGA": ["Pilocarpine", "drug", "0-10"], "DRUGB": ["beta adrenergic antagonists", "group", "67-93"]}
{"TEXT1": "effects considered anticholinergic properties contributing therapeutic effect concomitant medication @DRUG$ inhaled", "LBL": "0", "ID": "DDI-DrugBank.d627.s3.p0", "DRUGA": ["atropine", "drug", "146-153"], "DRUGB": ["ipratropium", "drug", "164-174"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj @DRUG$ artificial tears @DRUG$ conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p0", "DRUGA": ["acetylsalicylic acid", "drug", "179-198"], "DRUGB": ["calcium", "drug", "219-225"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj @DRUG$ artificial tears calcium @DRUG$ hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p1", "DRUGA": ["acetylsalicylic acid", "drug", "179-198"], "DRUGB": ["conjugated estrogens", "drug", "228-247"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj @DRUG$ artificial tears calcium conjugated estrogens @DRUG$ ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p2", "DRUGA": ["acetylsalicylic acid", "drug", "179-198"], "DRUGB": ["hydroxychloroquine sulfate", "drug", "250-275"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj @DRUG$ artificial tears calcium conjugated estrogens hydroxychloroquine sulfate @DRUG$ levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p3", "DRUGA": ["acetylsalicylic acid", "drug", "179-198"], "DRUGB": ["ibuprofen", "drug", "278-286"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj @DRUG$ artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen @DRUG$ medroxyprogesterone acetate methotrexate multivitamins naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p4", "DRUGA": ["acetylsalicylic acid", "drug", "179-198"], "DRUGB": ["levothyroxine sodium", "drug", "289-308"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj @DRUG$ artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium @DRUG$ methotrexate multivitamins naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p5", "DRUGA": ["acetylsalicylic acid", "drug", "179-198"], "DRUGB": ["medroxyprogesterone acetate", "drug", "311-337"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj @DRUG$ artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate @DRUG$ multivitamins naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p6", "DRUGA": ["acetylsalicylic acid", "drug", "179-198"], "DRUGB": ["methotrexate", "drug", "340-351"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj @DRUG$ artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate @DRUG$ naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p7", "DRUGA": ["acetylsalicylic acid", "drug", "179-198"], "DRUGB": ["multivitamins", "group", "354-366"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj @DRUG$ artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins @DRUG$ omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p8", "DRUGA": ["acetylsalicylic acid", "drug", "179-198"], "DRUGB": ["naproxen", "drug", "369-376"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj @DRUG$ artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins naproxen @DRUG$ paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p9", "DRUGA": ["acetylsalicylic acid", "drug", "179-198"], "DRUGB": ["omeprazole", "drug", "379-388"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj @DRUG$ artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins naproxen omeprazole @DRUG$ prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p10", "DRUGA": ["acetylsalicylic acid", "drug", "179-198"], "DRUGB": ["paracetamol", "drug", "391-401"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj @DRUG$ artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins naproxen omeprazole paracetamol @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p11", "DRUGA": ["acetylsalicylic acid", "drug", "179-198"], "DRUGB": ["prednisone", "drug", "408-417"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears @DRUG$ @DRUG$ hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p12", "DRUGA": ["calcium", "drug", "219-225"], "DRUGB": ["conjugated estrogens", "drug", "228-247"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears @DRUG$ conjugated estrogens @DRUG$ ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p13", "DRUGA": ["calcium", "drug", "219-225"], "DRUGB": ["hydroxychloroquine sulfate", "drug", "250-275"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears @DRUG$ conjugated estrogens hydroxychloroquine sulfate @DRUG$ levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p14", "DRUGA": ["calcium", "drug", "219-225"], "DRUGB": ["ibuprofen", "drug", "278-286"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears @DRUG$ conjugated estrogens hydroxychloroquine sulfate ibuprofen @DRUG$ medroxyprogesterone acetate methotrexate multivitamins naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p15", "DRUGA": ["calcium", "drug", "219-225"], "DRUGB": ["levothyroxine sodium", "drug", "289-308"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears @DRUG$ conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium @DRUG$ methotrexate multivitamins naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p16", "DRUGA": ["calcium", "drug", "219-225"], "DRUGB": ["medroxyprogesterone acetate", "drug", "311-337"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears @DRUG$ conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate @DRUG$ multivitamins naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p17", "DRUGA": ["calcium", "drug", "219-225"], "DRUGB": ["methotrexate", "drug", "340-351"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears @DRUG$ conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate @DRUG$ naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p18", "DRUGA": ["calcium", "drug", "219-225"], "DRUGB": ["multivitamins", "group", "354-366"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears @DRUG$ conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins @DRUG$ omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p19", "DRUGA": ["calcium", "drug", "219-225"], "DRUGB": ["naproxen", "drug", "369-376"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears @DRUG$ conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins naproxen @DRUG$ paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p20", "DRUGA": ["calcium", "drug", "219-225"], "DRUGB": ["omeprazole", "drug", "379-388"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears @DRUG$ conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins naproxen omeprazole @DRUG$ prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p21", "DRUGA": ["calcium", "drug", "219-225"], "DRUGB": ["paracetamol", "drug", "391-401"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears @DRUG$ conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins naproxen omeprazole paracetamol @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p22", "DRUGA": ["calcium", "drug", "219-225"], "DRUGB": ["prednisone", "drug", "408-417"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium @DRUG$ @DRUG$ ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p23", "DRUGA": ["conjugated estrogens", "drug", "228-247"], "DRUGB": ["hydroxychloroquine sulfate", "drug", "250-275"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium @DRUG$ hydroxychloroquine sulfate @DRUG$ levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p24", "DRUGA": ["conjugated estrogens", "drug", "228-247"], "DRUGB": ["ibuprofen", "drug", "278-286"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium @DRUG$ hydroxychloroquine sulfate ibuprofen @DRUG$ medroxyprogesterone acetate methotrexate multivitamins naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p25", "DRUGA": ["conjugated estrogens", "drug", "228-247"], "DRUGB": ["levothyroxine sodium", "drug", "289-308"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium @DRUG$ hydroxychloroquine sulfate ibuprofen levothyroxine sodium @DRUG$ methotrexate multivitamins naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p26", "DRUGA": ["conjugated estrogens", "drug", "228-247"], "DRUGB": ["medroxyprogesterone acetate", "drug", "311-337"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium @DRUG$ hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate @DRUG$ multivitamins naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p27", "DRUGA": ["conjugated estrogens", "drug", "228-247"], "DRUGB": ["methotrexate", "drug", "340-351"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium @DRUG$ hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate @DRUG$ naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p28", "DRUGA": ["conjugated estrogens", "drug", "228-247"], "DRUGB": ["multivitamins", "group", "354-366"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium @DRUG$ hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins @DRUG$ omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p29", "DRUGA": ["conjugated estrogens", "drug", "228-247"], "DRUGB": ["naproxen", "drug", "369-376"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium @DRUG$ hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins naproxen @DRUG$ paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p30", "DRUGA": ["conjugated estrogens", "drug", "228-247"], "DRUGB": ["omeprazole", "drug", "379-388"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium @DRUG$ hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins naproxen omeprazole @DRUG$ prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p31", "DRUGA": ["conjugated estrogens", "drug", "228-247"], "DRUGB": ["paracetamol", "drug", "391-401"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium @DRUG$ hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins naproxen omeprazole paracetamol @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p32", "DRUGA": ["conjugated estrogens", "drug", "228-247"], "DRUGB": ["prednisone", "drug", "408-417"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens @DRUG$ @DRUG$ levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p33", "DRUGA": ["hydroxychloroquine sulfate", "drug", "250-275"], "DRUGB": ["ibuprofen", "drug", "278-286"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens @DRUG$ ibuprofen @DRUG$ medroxyprogesterone acetate methotrexate multivitamins naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p34", "DRUGA": ["hydroxychloroquine sulfate", "drug", "250-275"], "DRUGB": ["levothyroxine sodium", "drug", "289-308"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens @DRUG$ ibuprofen levothyroxine sodium @DRUG$ methotrexate multivitamins naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p35", "DRUGA": ["hydroxychloroquine sulfate", "drug", "250-275"], "DRUGB": ["medroxyprogesterone acetate", "drug", "311-337"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens @DRUG$ ibuprofen levothyroxine sodium medroxyprogesterone acetate @DRUG$ multivitamins naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p36", "DRUGA": ["hydroxychloroquine sulfate", "drug", "250-275"], "DRUGB": ["methotrexate", "drug", "340-351"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens @DRUG$ ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate @DRUG$ naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p37", "DRUGA": ["hydroxychloroquine sulfate", "drug", "250-275"], "DRUGB": ["multivitamins", "group", "354-366"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens @DRUG$ ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins @DRUG$ omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p38", "DRUGA": ["hydroxychloroquine sulfate", "drug", "250-275"], "DRUGB": ["naproxen", "drug", "369-376"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens @DRUG$ ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins naproxen @DRUG$ paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p39", "DRUGA": ["hydroxychloroquine sulfate", "drug", "250-275"], "DRUGB": ["omeprazole", "drug", "379-388"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens @DRUG$ ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins naproxen omeprazole @DRUG$ prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p40", "DRUGA": ["hydroxychloroquine sulfate", "drug", "250-275"], "DRUGB": ["paracetamol", "drug", "391-401"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens @DRUG$ ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins naproxen omeprazole paracetamol @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p41", "DRUGA": ["hydroxychloroquine sulfate", "drug", "250-275"], "DRUGB": ["prednisone", "drug", "408-417"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate @DRUG$ @DRUG$ medroxyprogesterone acetate methotrexate multivitamins naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p42", "DRUGA": ["ibuprofen", "drug", "278-286"], "DRUGB": ["levothyroxine sodium", "drug", "289-308"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate @DRUG$ levothyroxine sodium @DRUG$ methotrexate multivitamins naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p43", "DRUGA": ["ibuprofen", "drug", "278-286"], "DRUGB": ["medroxyprogesterone acetate", "drug", "311-337"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate @DRUG$ levothyroxine sodium medroxyprogesterone acetate @DRUG$ multivitamins naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p44", "DRUGA": ["ibuprofen", "drug", "278-286"], "DRUGB": ["methotrexate", "drug", "340-351"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate @DRUG$ levothyroxine sodium medroxyprogesterone acetate methotrexate @DRUG$ naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p45", "DRUGA": ["ibuprofen", "drug", "278-286"], "DRUGB": ["multivitamins", "group", "354-366"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate @DRUG$ levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins @DRUG$ omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p46", "DRUGA": ["ibuprofen", "drug", "278-286"], "DRUGB": ["naproxen", "drug", "369-376"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate @DRUG$ levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins naproxen @DRUG$ paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p47", "DRUGA": ["ibuprofen", "drug", "278-286"], "DRUGB": ["omeprazole", "drug", "379-388"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate @DRUG$ levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins naproxen omeprazole @DRUG$ prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p48", "DRUGA": ["ibuprofen", "drug", "278-286"], "DRUGB": ["paracetamol", "drug", "391-401"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate @DRUG$ levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins naproxen omeprazole paracetamol @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p49", "DRUGA": ["ibuprofen", "drug", "278-286"], "DRUGB": ["prednisone", "drug", "408-417"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen @DRUG$ @DRUG$ methotrexate multivitamins naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p50", "DRUGA": ["levothyroxine sodium", "drug", "289-308"], "DRUGB": ["medroxyprogesterone acetate", "drug", "311-337"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen @DRUG$ medroxyprogesterone acetate @DRUG$ multivitamins naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p51", "DRUGA": ["levothyroxine sodium", "drug", "289-308"], "DRUGB": ["methotrexate", "drug", "340-351"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen @DRUG$ medroxyprogesterone acetate methotrexate @DRUG$ naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p52", "DRUGA": ["levothyroxine sodium", "drug", "289-308"], "DRUGB": ["multivitamins", "group", "354-366"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen @DRUG$ medroxyprogesterone acetate methotrexate multivitamins @DRUG$ omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p53", "DRUGA": ["levothyroxine sodium", "drug", "289-308"], "DRUGB": ["naproxen", "drug", "369-376"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen @DRUG$ medroxyprogesterone acetate methotrexate multivitamins naproxen @DRUG$ paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p54", "DRUGA": ["levothyroxine sodium", "drug", "289-308"], "DRUGB": ["omeprazole", "drug", "379-388"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen @DRUG$ medroxyprogesterone acetate methotrexate multivitamins naproxen omeprazole @DRUG$ prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p55", "DRUGA": ["levothyroxine sodium", "drug", "289-308"], "DRUGB": ["paracetamol", "drug", "391-401"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen @DRUG$ medroxyprogesterone acetate methotrexate multivitamins naproxen omeprazole paracetamol @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p56", "DRUGA": ["levothyroxine sodium", "drug", "289-308"], "DRUGB": ["prednisone", "drug", "408-417"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium @DRUG$ @DRUG$ multivitamins naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p57", "DRUGA": ["medroxyprogesterone acetate", "drug", "311-337"], "DRUGB": ["methotrexate", "drug", "340-351"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium @DRUG$ methotrexate @DRUG$ naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p58", "DRUGA": ["medroxyprogesterone acetate", "drug", "311-337"], "DRUGB": ["multivitamins", "group", "354-366"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium @DRUG$ methotrexate multivitamins @DRUG$ omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p59", "DRUGA": ["medroxyprogesterone acetate", "drug", "311-337"], "DRUGB": ["naproxen", "drug", "369-376"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium @DRUG$ methotrexate multivitamins naproxen @DRUG$ paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p60", "DRUGA": ["medroxyprogesterone acetate", "drug", "311-337"], "DRUGB": ["omeprazole", "drug", "379-388"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium @DRUG$ methotrexate multivitamins naproxen omeprazole @DRUG$ prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p61", "DRUGA": ["medroxyprogesterone acetate", "drug", "311-337"], "DRUGB": ["paracetamol", "drug", "391-401"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium @DRUG$ methotrexate multivitamins naproxen omeprazole paracetamol @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p62", "DRUGA": ["medroxyprogesterone acetate", "drug", "311-337"], "DRUGB": ["prednisone", "drug", "408-417"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate @DRUG$ @DRUG$ naproxen omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p63", "DRUGA": ["methotrexate", "drug", "340-351"], "DRUGB": ["multivitamins", "group", "354-366"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate @DRUG$ multivitamins @DRUG$ omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p64", "DRUGA": ["methotrexate", "drug", "340-351"], "DRUGB": ["naproxen", "drug", "369-376"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate @DRUG$ multivitamins naproxen @DRUG$ paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p65", "DRUGA": ["methotrexate", "drug", "340-351"], "DRUGB": ["omeprazole", "drug", "379-388"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate @DRUG$ multivitamins naproxen omeprazole @DRUG$ prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p66", "DRUGA": ["methotrexate", "drug", "340-351"], "DRUGB": ["paracetamol", "drug", "391-401"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate @DRUG$ multivitamins naproxen omeprazole paracetamol @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p67", "DRUGA": ["methotrexate", "drug", "340-351"], "DRUGB": ["prednisone", "drug", "408-417"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate @DRUG$ @DRUG$ omeprazole paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p68", "DRUGA": ["multivitamins", "group", "354-366"], "DRUGB": ["naproxen", "drug", "369-376"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate @DRUG$ naproxen @DRUG$ paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p69", "DRUGA": ["multivitamins", "group", "354-366"], "DRUGB": ["omeprazole", "drug", "379-388"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate @DRUG$ naproxen omeprazole @DRUG$ prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p70", "DRUGA": ["multivitamins", "group", "354-366"], "DRUGB": ["paracetamol", "drug", "391-401"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate @DRUG$ naproxen omeprazole paracetamol @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p71", "DRUGA": ["multivitamins", "group", "354-366"], "DRUGB": ["prednisone", "drug", "408-417"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins @DRUG$ @DRUG$ paracetamol prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p72", "DRUGA": ["naproxen", "drug", "369-376"], "DRUGB": ["omeprazole", "drug", "379-388"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins @DRUG$ omeprazole @DRUG$ prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p73", "DRUGA": ["naproxen", "drug", "369-376"], "DRUGB": ["paracetamol", "drug", "391-401"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins @DRUG$ omeprazole paracetamol @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p74", "DRUGA": ["naproxen", "drug", "369-376"], "DRUGB": ["prednisone", "drug", "408-417"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins naproxen @DRUG$ @DRUG$ prednisone", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p75", "DRUGA": ["omeprazole", "drug", "379-388"], "DRUGB": ["paracetamol", "drug", "391-401"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins naproxen @DRUG$ paracetamol @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p76", "DRUGA": ["omeprazole", "drug", "379-388"], "DRUGB": ["prednisone", "drug", "408-417"]}
{"TEXT1": "no formal drug interaction studies performed following concomitant drugs patients Sj acetylsalicylic acid artificial tears calcium conjugated estrogens hydroxychloroquine sulfate ibuprofen levothyroxine sodium medroxyprogesterone acetate methotrexate multivitamins naproxen omeprazole @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d627.s4.p77", "DRUGA": ["paracetamol", "drug", "391-401"], "DRUGB": ["prednisone", "drug", "408-417"]}
{"TEXT1": "Mutual inhibition metabolism occurs concurrent @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d578.s1.p0", "DRUGA": ["cyclosporin", "drug", "62-72"], "DRUGB": ["methylprednisolone", "drug", "78-95"]}
{"TEXT1": "convulsions reported concurrent use of @DRUG$ @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d578.s3.p0", "DRUGA": ["methylprednisolone", "drug", "54-71"], "DRUGB": ["cyclosporin", "drug", "77-87"]}
{"TEXT1": "Drugs induce hepatic enzymes @DRUG$ @DRUG$ rifampin increase clearance methylprednisolone to desired response", "LBL": "0", "ID": "DDI-DrugBank.d578.s4.p0", "DRUGA": ["phenobarbital", "drug", "42-54"], "DRUGB": ["phenytoin", "drug", "57-65"]}
{"TEXT1": "Drugs induce hepatic enzymes @DRUG$ phenytoin @DRUG$ increase clearance methylprednisolone to desired response", "LBL": "0", "ID": "DDI-DrugBank.d578.s4.p1", "DRUGA": ["phenobarbital", "drug", "42-54"], "DRUGB": ["rifampin", "drug", "72-79"]}
{"TEXT1": "Drugs induce hepatic enzymes @DRUG$ phenytoin rifampin increase clearance @DRUG$ methylprednisolone to desired response", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d578.s4.p2", "DRUGA": ["phenobarbital", "drug", "42-54"], "DRUGB": ["methylprednisolone", "drug", "111-128"]}
{"TEXT1": "Drugs induce hepatic enzymes @DRUG$ phenytoin rifampin increase clearance methylprednisolone increased dose @DRUG$ to desired response", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d578.s4.p3", "DRUGA": ["phenobarbital", "drug", "42-54"], "DRUGB": ["methylprednisolone", "drug", "159-176"]}
{"TEXT1": "Drugs induce hepatic enzymes phenobarbital @DRUG$ @DRUG$ increase clearance methylprednisolone to desired response", "LBL": "0", "ID": "DDI-DrugBank.d578.s4.p4", "DRUGA": ["phenytoin", "drug", "57-65"], "DRUGB": ["rifampin", "drug", "72-79"]}
{"TEXT1": "Drugs induce hepatic enzymes phenobarbital @DRUG$ rifampin increase clearance @DRUG$ methylprednisolone to desired response", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d578.s4.p5", "DRUGA": ["phenytoin", "drug", "57-65"], "DRUGB": ["methylprednisolone", "drug", "111-128"]}
{"TEXT1": "Drugs induce hepatic enzymes phenobarbital @DRUG$ rifampin increase clearance methylprednisolone increased dose @DRUG$ to desired response", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d578.s4.p6", "DRUGA": ["phenytoin", "drug", "57-65"], "DRUGB": ["methylprednisolone", "drug", "159-176"]}
{"TEXT1": "Drugs induce hepatic enzymes phenobarbital phenytoin @DRUG$ increase clearance @DRUG$ methylprednisolone to desired response", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d578.s4.p7", "DRUGA": ["rifampin", "drug", "72-79"], "DRUGB": ["methylprednisolone", "drug", "111-128"]}
{"TEXT1": "Drugs induce hepatic enzymes phenobarbital phenytoin @DRUG$ increase clearance methylprednisolone increased dose @DRUG$ to desired response", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d578.s4.p8", "DRUGA": ["rifampin", "drug", "72-79"], "DRUGB": ["methylprednisolone", "drug", "159-176"]}
{"TEXT1": "Drugs induce hepatic enzymes phenobarbital phenytoin rifampin increase clearance @DRUG$ increased dose @DRUG$ to desired response", "LBL": "0", "ID": "DDI-DrugBank.d578.s4.p9", "DRUGA": ["methylprednisolone", "drug", "111-128"], "DRUGB": ["methylprednisolone", "drug", "159-176"]}
{"TEXT1": "Drugs @DRUG$ @DRUG$ inhibit metabolism methylprednisolone decrease clearance", "LBL": "0", "ID": "DDI-DrugBank.d578.s5.p0", "DRUGA": ["troleandomycin", "drug", "14-27"], "DRUGB": ["ketoconazole", "drug", "33-44"]}
{"TEXT1": "Drugs @DRUG$ ketoconazole inhibit metabolism @DRUG$ decrease clearance", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d578.s5.p1", "DRUGA": ["troleandomycin", "drug", "14-27"], "DRUGB": ["methylprednisolone", "drug", "76-93"]}
{"TEXT1": "Drugs troleandomycin @DRUG$ inhibit metabolism @DRUG$ decrease clearance", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d578.s5.p2", "DRUGA": ["ketoconazole", "drug", "33-44"], "DRUGB": ["methylprednisolone", "drug", "76-93"]}
{"TEXT1": "@DRUG$ increase clearance chronic high dose @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d578.s7.p0", "DRUGA": ["Methylprednisolone", "drug", "0-17"], "DRUGB": ["aspirin", "brand", "67-73"]}
{"TEXT1": "lead decreased @DRUG$ increase risk @DRUG$ methylprednisolone withdrawn", "LBL": "0", "ID": "DDI-DrugBank.d578.s8.p0", "DRUGA": ["salicylate", "group", "29-38"], "DRUGB": ["salicylate", "group", "77-86"]}
{"TEXT1": "lead decreased @DRUG$ increase risk salicylate toxicity @DRUG$ withdrawn", "LBL": "0", "ID": "DDI-DrugBank.d578.s8.p1", "DRUGA": ["salicylate", "group", "29-38"], "DRUGB": ["methylprednisolone", "drug", "102-119"]}
{"TEXT1": "lead decreased salicylate serum levels increase risk @DRUG$ @DRUG$ withdrawn", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d578.s8.p2", "DRUGA": ["salicylate", "group", "77-86"], "DRUGB": ["methylprednisolone", "drug", "102-119"]}
{"TEXT1": "@DRUG$ used conjunction @DRUG$ patients suffering hypoprothrombinemia", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d578.s9.p0", "DRUGA": ["Aspirin", "brand", "0-6"], "DRUGB": ["corticosteroids", "group", "54-68"]}
{"TEXT1": "effect @DRUG$ @DRUG$ variable", "LBL": "0", "ID": "DDI-DrugBank.d578.s10.p0", "DRUGA": ["methylprednisolone", "drug", "14-31"], "DRUGB": ["anticoagulants", "group", "41-54"]}
{"TEXT1": "reports enhanced diminished @DRUG$ given @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d578.s11.p0", "DRUGA": ["anticoagulant", "group", "63-75"], "DRUGB": ["corticosteroids", "group", "106-120"]}
{"TEXT1": "effects @DRUG$ gastrointestinal motility @DRUG$ narcotic analgesics", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d652.s0.p0", "DRUGA": ["metoclopramide", "drug", "15-28"], "DRUGB": ["anticholinergic drugs", "group", "78-98"]}
{"TEXT1": "effects @DRUG$ gastrointestinal motility anticholinergic drugs @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d652.s0.p1", "DRUGA": ["metoclopramide", "drug", "15-28"], "DRUGB": ["narcotic analgesics", "group", "104-122"]}
{"TEXT1": "effects metoclopramide gastrointestinal motility @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d652.s0.p2", "DRUGA": ["anticholinergic drugs", "group", "78-98"], "DRUGB": ["narcotic analgesics", "group", "104-122"]}
{"TEXT1": "Additive sedative effects occur @DRUG$ given @DRUG$ sedatives hypnotics narcotics tranquilizers", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d652.s1.p0", "DRUGA": ["metoclopramide", "drug", "41-54"], "DRUGB": ["alcohol", "drug", "70-76"]}
{"TEXT1": "Additive sedative effects occur @DRUG$ given alcohol @DRUG$ hypnotics narcotics tranquilizers", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d652.s1.p1", "DRUGA": ["metoclopramide", "drug", "41-54"], "DRUGB": ["sedatives", "group", "79-87"]}
{"TEXT1": "Additive sedative effects occur @DRUG$ given alcohol sedatives @DRUG$ narcotics tranquilizers", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d652.s1.p2", "DRUGA": ["metoclopramide", "drug", "41-54"], "DRUGB": ["hypnotics", "group", "90-98"]}
{"TEXT1": "Additive sedative effects occur @DRUG$ given alcohol sedatives hypnotics @DRUG$ tranquilizers", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d652.s1.p3", "DRUGA": ["metoclopramide", "drug", "41-54"], "DRUGB": ["narcotics", "group", "101-109"]}
{"TEXT1": "Additive sedative effects occur @DRUG$ given alcohol sedatives hypnotics narcotics @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d652.s1.p4", "DRUGA": ["metoclopramide", "drug", "41-54"], "DRUGB": ["tranquilizers", "group", "115-127"]}
{"TEXT1": "Additive sedative effects occur metoclopramide given @DRUG$ @DRUG$ hypnotics narcotics tranquilizers", "LBL": "0", "ID": "DDI-DrugBank.d652.s1.p5", "DRUGA": ["alcohol", "drug", "70-76"], "DRUGB": ["sedatives", "group", "79-87"]}
{"TEXT1": "Additive sedative effects occur metoclopramide given @DRUG$ sedatives @DRUG$ narcotics tranquilizers", "LBL": "0", "ID": "DDI-DrugBank.d652.s1.p6", "DRUGA": ["alcohol", "drug", "70-76"], "DRUGB": ["hypnotics", "group", "90-98"]}
{"TEXT1": "Additive sedative effects occur metoclopramide given @DRUG$ sedatives hypnotics @DRUG$ tranquilizers", "LBL": "0", "ID": "DDI-DrugBank.d652.s1.p7", "DRUGA": ["alcohol", "drug", "70-76"], "DRUGB": ["narcotics", "group", "101-109"]}
{"TEXT1": "Additive sedative effects occur metoclopramide given @DRUG$ sedatives hypnotics narcotics @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d652.s1.p8", "DRUGA": ["alcohol", "drug", "70-76"], "DRUGB": ["tranquilizers", "group", "115-127"]}
{"TEXT1": "Additive sedative effects occur metoclopramide given alcohol @DRUG$ @DRUG$ narcotics tranquilizers", "LBL": "0", "ID": "DDI-DrugBank.d652.s1.p9", "DRUGA": ["sedatives", "group", "79-87"], "DRUGB": ["hypnotics", "group", "90-98"]}
{"TEXT1": "Additive sedative effects occur metoclopramide given alcohol @DRUG$ hypnotics @DRUG$ tranquilizers", "LBL": "0", "ID": "DDI-DrugBank.d652.s1.p10", "DRUGA": ["sedatives", "group", "79-87"], "DRUGB": ["narcotics", "group", "101-109"]}
{"TEXT1": "Additive sedative effects occur metoclopramide given alcohol @DRUG$ hypnotics narcotics @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d652.s1.p11", "DRUGA": ["sedatives", "group", "79-87"], "DRUGB": ["tranquilizers", "group", "115-127"]}
{"TEXT1": "Additive sedative effects occur metoclopramide given alcohol sedatives @DRUG$ @DRUG$ tranquilizers", "LBL": "0", "ID": "DDI-DrugBank.d652.s1.p12", "DRUGA": ["hypnotics", "group", "90-98"], "DRUGB": ["narcotics", "group", "101-109"]}
{"TEXT1": "Additive sedative effects occur metoclopramide given alcohol sedatives @DRUG$ narcotics @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d652.s1.p13", "DRUGA": ["hypnotics", "group", "90-98"], "DRUGB": ["tranquilizers", "group", "115-127"]}
{"TEXT1": "Additive sedative effects occur metoclopramide given alcohol sedatives hypnotics @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d652.s1.p14", "DRUGA": ["narcotics", "group", "101-109"], "DRUGB": ["tranquilizers", "group", "115-127"]}
{"TEXT1": "finding @DRUG$ releases catecholamines patients essential hypertension suggests used receiving @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d652.s2.p0", "DRUGA": ["metoclopramide", "drug", "17-30"], "DRUGB": ["monoamine oxi-dase inhibitors", "group", "173-201"]}
{"TEXT1": "stomach diminished @DRUG$ rate extent small bowel increased acetaminophen tetracycline levodopa ethanol", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d652.s3.p0", "DRUGA": ["digoxin", "drug", "62-68"], "DRUGB": ["metoclopramide", "drug", "74-87"]}
{"TEXT1": "stomach diminished metoclopramide rate extent small bowel increased @DRUG$ tetracycline levodopa ethanol", "LBL": "0", "ID": "DDI-DrugBank.d652.s3.p1", "DRUGA": ["digoxin", "drug", "62-68"], "DRUGB": ["acetaminophen", "drug", "189-201"]}
{"TEXT1": "stomach diminished metoclopramide rate extent small bowel increased acetaminophen @DRUG$ levodopa ethanol", "LBL": "0", "ID": "DDI-DrugBank.d652.s3.p2", "DRUGA": ["digoxin", "drug", "62-68"], "DRUGB": ["tetracycline", "drug", "204-215"]}
{"TEXT1": "stomach diminished metoclopramide rate extent small bowel increased acetaminophen tetracycline @DRUG$ ethanol", "LBL": "0", "ID": "DDI-DrugBank.d652.s3.p3", "DRUGA": ["digoxin", "drug", "62-68"], "DRUGB": ["levodopa", "drug", "218-225"]}
{"TEXT1": "stomach diminished metoclopramide rate extent small bowel increased acetaminophen tetracycline levodopa @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d652.s3.p4", "DRUGA": ["digoxin", "drug", "62-68"], "DRUGB": ["ethanol", "drug", "228-234"]}
{"TEXT1": "stomach diminished metoclopramide rate extent small bowel increased acetaminophen tetracycline levodopa ethanol", "LBL": "0", "ID": "DDI-DrugBank.d652.s3.p5", "DRUGA": ["digoxin", "drug", "62-68"], "DRUGB": ["cyclosporine", "drug", "237-248"]}
{"TEXT1": "stomach diminished @DRUG$ rate extent small bowel increased @DRUG$ tetracycline levodopa ethanol", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d652.s3.p6", "DRUGA": ["metoclopramide", "drug", "74-87"], "DRUGB": ["acetaminophen", "drug", "189-201"]}
{"TEXT1": "stomach diminished @DRUG$ rate extent small bowel increased acetaminophen @DRUG$ levodopa ethanol", "LBL": "0", "ID": "DDI-DrugBank.d652.s3.p7", "DRUGA": ["metoclopramide", "drug", "74-87"], "DRUGB": ["tetracycline", "drug", "204-215"]}
{"TEXT1": "stomach diminished @DRUG$ rate extent small bowel increased acetaminophen tetracycline @DRUG$ ethanol", "LBL": "0", "ID": "DDI-DrugBank.d652.s3.p8", "DRUGA": ["metoclopramide", "drug", "74-87"], "DRUGB": ["levodopa", "drug", "218-225"]}
{"TEXT1": "stomach diminished @DRUG$ rate extent small bowel increased acetaminophen tetracycline levodopa @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d652.s3.p9", "DRUGA": ["metoclopramide", "drug", "74-87"], "DRUGB": ["ethanol", "drug", "228-234"]}
{"TEXT1": "stomach diminished @DRUG$ rate extent small bowel increased acetaminophen tetracycline levodopa ethanol", "LBL": "0", "ID": "DDI-DrugBank.d652.s3.p10", "DRUGA": ["metoclopramide", "drug", "74-87"], "DRUGB": ["cyclosporine", "drug", "237-248"]}
{"TEXT1": "stomach diminished metoclopramide rate extent small bowel increased @DRUG$ @DRUG$ levodopa ethanol", "LBL": "0", "ID": "DDI-DrugBank.d652.s3.p11", "DRUGA": ["acetaminophen", "drug", "189-201"], "DRUGB": ["tetracycline", "drug", "204-215"]}
{"TEXT1": "stomach diminished metoclopramide rate extent small bowel increased @DRUG$ tetracycline @DRUG$ ethanol", "LBL": "0", "ID": "DDI-DrugBank.d652.s3.p12", "DRUGA": ["acetaminophen", "drug", "189-201"], "DRUGB": ["levodopa", "drug", "218-225"]}
{"TEXT1": "stomach diminished metoclopramide rate extent small bowel increased @DRUG$ tetracycline levodopa @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d652.s3.p13", "DRUGA": ["acetaminophen", "drug", "189-201"], "DRUGB": ["ethanol", "drug", "228-234"]}
{"TEXT1": "stomach diminished metoclopramide rate extent small bowel increased @DRUG$ tetracycline levodopa ethanol", "LBL": "0", "ID": "DDI-DrugBank.d652.s3.p14", "DRUGA": ["acetaminophen", "drug", "189-201"], "DRUGB": ["cyclosporine", "drug", "237-248"]}
{"TEXT1": "stomach diminished metoclopramide rate extent small bowel increased acetaminophen @DRUG$ @DRUG$ ethanol", "LBL": "0", "ID": "DDI-DrugBank.d652.s3.p15", "DRUGA": ["tetracycline", "drug", "204-215"], "DRUGB": ["levodopa", "drug", "218-225"]}
{"TEXT1": "stomach diminished metoclopramide rate extent small bowel increased acetaminophen @DRUG$ levodopa @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d652.s3.p16", "DRUGA": ["tetracycline", "drug", "204-215"], "DRUGB": ["ethanol", "drug", "228-234"]}
{"TEXT1": "stomach diminished metoclopramide rate extent small bowel increased acetaminophen @DRUG$ levodopa ethanol", "LBL": "0", "ID": "DDI-DrugBank.d652.s3.p17", "DRUGA": ["tetracycline", "drug", "204-215"], "DRUGB": ["cyclosporine", "drug", "237-248"]}
{"TEXT1": "stomach diminished metoclopramide rate extent small bowel increased acetaminophen tetracycline @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d652.s3.p18", "DRUGA": ["levodopa", "drug", "218-225"], "DRUGB": ["ethanol", "drug", "228-234"]}
{"TEXT1": "stomach diminished metoclopramide rate extent small bowel increased acetaminophen tetracycline @DRUG$ ethanol", "LBL": "0", "ID": "DDI-DrugBank.d652.s3.p19", "DRUGA": ["levodopa", "drug", "218-225"], "DRUGB": ["cyclosporine", "drug", "237-248"]}
{"TEXT1": "stomach diminished metoclopramide rate extent small bowel increased acetaminophen tetracycline levodopa @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d652.s3.p20", "DRUGA": ["ethanol", "drug", "228-234"], "DRUGB": ["cyclosporine", "drug", "237-248"]}
{"TEXT1": "action @DRUG$ delivery food intestines rate absorption @DRUG$ dosage timing adjustment", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d652.s6.p0", "DRUGA": ["metoclopramide", "drug", "22-35"], "DRUGB": ["insulin", "drug", "124-130"]}
{"TEXT1": "@DRUG$ @DRUG$ cause serious cardiac arrhythmias halothane anesthesia used only great not at all", "LBL": "0", "ID": "DDI-DrugBank.d725.s0.p0", "DRUGA": ["Vasopressors", "group", "0-11"], "DRUGB": ["metaraminol", "drug", "27-37"]}
{"TEXT1": "@DRUG$ metaraminol cause serious cardiac arrhythmias @DRUG$ anesthesia used only great not at all", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d725.s0.p1", "DRUGA": ["Vasopressors", "group", "0-11"], "DRUGB": ["halothane", "drug", "85-93"]}
{"TEXT1": "Vasopressors @DRUG$ cause serious cardiac arrhythmias @DRUG$ anesthesia used only great not at all", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d725.s0.p2", "DRUGA": ["metaraminol", "drug", "27-37"], "DRUGB": ["halothane", "drug", "85-93"]}
{"TEXT1": "pressor effect @DRUG$ markedly patients receiving monoamine oxidase inhibitors", "LBL": "0", "ID": "DDI-DrugBank.d725.s1.p0", "DRUGA": ["MAO Inhibitors", "group", "0-13"], "DRUGB": ["sympathomimetic pressor amines", "group", "38-67"]}
{"TEXT1": "pressor effect sympathomimetic amines markedly patients receiving @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d725.s1.p1", "DRUGA": ["MAO Inhibitors", "group", "0-13"], "DRUGB": ["monoamine oxidase inhibitors", "group", "115-142"]}
{"TEXT1": "pressor effect sympathomimetic amines markedly patients receiving monoamine oxidase inhibitors", "LBL": "0", "ID": "DDI-DrugBank.d725.s1.p2", "DRUGA": ["MAO Inhibitors", "group", "0-13"], "DRUGB": ["MAOI", "group", "145-148"]}
{"TEXT1": "pressor effect @DRUG$ markedly patients receiving @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d725.s1.p3", "DRUGA": ["sympathomimetic pressor amines", "group", "38-67"], "DRUGB": ["monoamine oxidase inhibitors", "group", "115-142"]}
{"TEXT1": "pressor effect @DRUG$ markedly patients receiving monoamine oxidase inhibitors", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d725.s1.p4", "DRUGA": ["sympathomimetic pressor amines", "group", "38-67"], "DRUGB": ["MAOI", "group", "145-148"]}
{"TEXT1": "pressor effect sympathomimetic amines markedly patients receiving @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d725.s1.p5", "DRUGA": ["monoamine oxidase inhibitors", "group", "115-142"], "DRUGB": ["MAOI", "group", "145-148"]}
{"TEXT1": "pressor response @DRUG$ @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d725.s3.p0", "DRUGA": ["adrenergic agents", "group", "24-40"], "DRUGB": ["tricyclic antidepressants", "group", "69-93"]}
{"TEXT1": "@DRUG$ @DRUG$ MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p0", "DRUGA": ["Methscopolamine", "drug", "0-14"], "DRUGB": ["antidepressants", "group", "34-48"]}
{"TEXT1": "@DRUG$ antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d655.s0.p1", "DRUGA": ["Methscopolamine", "drug", "0-14"], "DRUGB": ["tricyclic", "group", "51-59"]}
{"TEXT1": "@DRUG$ antidepressants @DRUG$ phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d655.s0.p2", "DRUGA": ["Methscopolamine", "drug", "0-14"], "DRUGB": ["MAO inhibitors", "group", "68-81"]}
{"TEXT1": "@DRUG$ antidepressants MAO inhibitors @DRUG$ linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d655.s0.p3", "DRUGA": ["Methscopolamine", "drug", "0-14"], "DRUGB": ["phenelzine", "drug", "90-99"]}
{"TEXT1": "@DRUG$ antidepressants MAO inhibitors phenelzine @DRUG$ tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d655.s0.p4", "DRUGA": ["Methscopolamine", "drug", "0-14"], "DRUGB": ["linezolid", "drug", "102-110"]}
{"TEXT1": "@DRUG$ antidepressants MAO inhibitors phenelzine linezolid @DRUG$ isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d655.s0.p5", "DRUGA": ["Methscopolamine", "drug", "0-14"], "DRUGB": ["tranylcypromine", "drug", "113-127"]}
{"TEXT1": "@DRUG$ antidepressants MAO inhibitors phenelzine linezolid tranylcypromine @DRUG$ selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d655.s0.p6", "DRUGA": ["Methscopolamine", "drug", "0-14"], "DRUGB": ["isocarboxazid", "drug", "130-142"]}
{"TEXT1": "@DRUG$ antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid @DRUG$ quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d655.s0.p7", "DRUGA": ["Methscopolamine", "drug", "0-14"], "DRUGB": ["selegiline", "drug", "145-154"]}
{"TEXT1": "@DRUG$ antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d655.s0.p8", "DRUGA": ["Methscopolamine", "drug", "0-14"], "DRUGB": ["furazolidone", "drug", "157-168"]}
{"TEXT1": "@DRUG$ antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline @DRUG$ amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d655.s0.p9", "DRUGA": ["Methscopolamine", "drug", "0-14"], "DRUGB": ["quinidine", "drug", "172-180"]}
{"TEXT1": "@DRUG$ antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine @DRUG$ antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d655.s0.p10", "DRUGA": ["Methscopolamine", "drug", "0-14"], "DRUGB": ["amantadine", "drug", "183-192"]}
{"TEXT1": "@DRUG$ antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine @DRUG$ anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d655.s0.p11", "DRUGA": ["Methscopolamine", "drug", "0-14"], "DRUGB": ["antihistamines", "group", "195-208"]}
{"TEXT1": "@DRUG$ antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d655.s0.p12", "DRUGA": ["Methscopolamine", "drug", "0-14"], "DRUGB": ["diphenhydramine", "drug", "217-231"]}
{"TEXT1": "@DRUG$ antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines @DRUG$ potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d655.s0.p13", "DRUGA": ["Methscopolamine", "drug", "0-14"], "DRUGB": ["anticholinergics", "group", "241-256"]}
{"TEXT1": "@DRUG$ antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics @DRUG$ antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d655.s0.p14", "DRUGA": ["Methscopolamine", "drug", "0-14"], "DRUGB": ["potassium chloride", "drug", "259-276"]}
{"TEXT1": "@DRUG$ antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements @DRUG$ absorbent type medicines phenothiazines chlorpromazine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d655.s0.p15", "DRUGA": ["Methscopolamine", "drug", "0-14"], "DRUGB": ["antacids", "group", "291-298"]}
{"TEXT1": "@DRUG$ antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids @DRUG$ phenothiazines chlorpromazine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d655.s0.p16", "DRUGA": ["Methscopolamine", "drug", "0-14"], "DRUGB": ["absorbent-type anti-diarrhea medicines", "group", "301-338"]}
{"TEXT1": "@DRUG$ antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ phenothiazines chlorpromazine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d655.s0.p17", "DRUGA": ["Methscopolamine", "drug", "0-14"], "DRUGB": ["kaolin", "drug", "347-352"]}
{"TEXT1": "@DRUG$ antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d655.s0.p18", "DRUGA": ["Methscopolamine", "drug", "0-14"], "DRUGB": ["pectin", "drug", "354-359"]}
{"TEXT1": "@DRUG$ antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ chlorpromazine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d655.s0.p19", "DRUGA": ["Methscopolamine", "drug", "0-14"], "DRUGB": ["phenothiazines", "group", "363-376"]}
{"TEXT1": "@DRUG$ antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines @DRUG$", "LBL": "DDI-int", "ID": "DDI-DrugBank.d655.s0.p20", "DRUGA": ["Methscopolamine", "drug", "0-14"], "DRUGB": ["chlorpromazine", "drug", "385-398"]}
{"TEXT1": "@DRUG$ antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "DDI-int", "ID": "DDI-DrugBank.d655.s0.p21", "DRUGA": ["Methscopolamine", "drug", "0-14"], "DRUGB": ["promethazine", "drug", "401-412"]}
{"TEXT1": "Methscopolamine @DRUG$ MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p22", "DRUGA": ["antidepressants", "group", "34-48"], "DRUGB": ["tricyclic", "group", "51-59"]}
{"TEXT1": "Methscopolamine @DRUG$ @DRUG$ phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p23", "DRUGA": ["antidepressants", "group", "34-48"], "DRUGB": ["MAO inhibitors", "group", "68-81"]}
{"TEXT1": "Methscopolamine @DRUG$ MAO inhibitors @DRUG$ linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p24", "DRUGA": ["antidepressants", "group", "34-48"], "DRUGB": ["phenelzine", "drug", "90-99"]}
{"TEXT1": "Methscopolamine @DRUG$ MAO inhibitors phenelzine @DRUG$ tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p25", "DRUGA": ["antidepressants", "group", "34-48"], "DRUGB": ["linezolid", "drug", "102-110"]}
{"TEXT1": "Methscopolamine @DRUG$ MAO inhibitors phenelzine linezolid @DRUG$ isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p26", "DRUGA": ["antidepressants", "group", "34-48"], "DRUGB": ["tranylcypromine", "drug", "113-127"]}
{"TEXT1": "Methscopolamine @DRUG$ MAO inhibitors phenelzine linezolid tranylcypromine @DRUG$ selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p27", "DRUGA": ["antidepressants", "group", "34-48"], "DRUGB": ["isocarboxazid", "drug", "130-142"]}
{"TEXT1": "Methscopolamine @DRUG$ MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid @DRUG$ quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p28", "DRUGA": ["antidepressants", "group", "34-48"], "DRUGB": ["selegiline", "drug", "145-154"]}
{"TEXT1": "Methscopolamine @DRUG$ MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p29", "DRUGA": ["antidepressants", "group", "34-48"], "DRUGB": ["furazolidone", "drug", "157-168"]}
{"TEXT1": "Methscopolamine @DRUG$ MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline @DRUG$ amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p30", "DRUGA": ["antidepressants", "group", "34-48"], "DRUGB": ["quinidine", "drug", "172-180"]}
{"TEXT1": "Methscopolamine @DRUG$ MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine @DRUG$ antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p31", "DRUGA": ["antidepressants", "group", "34-48"], "DRUGB": ["amantadine", "drug", "183-192"]}
{"TEXT1": "Methscopolamine @DRUG$ MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine @DRUG$ anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p32", "DRUGA": ["antidepressants", "group", "34-48"], "DRUGB": ["antihistamines", "group", "195-208"]}
{"TEXT1": "Methscopolamine @DRUG$ MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p33", "DRUGA": ["antidepressants", "group", "34-48"], "DRUGB": ["diphenhydramine", "drug", "217-231"]}
{"TEXT1": "Methscopolamine @DRUG$ MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines @DRUG$ potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p34", "DRUGA": ["antidepressants", "group", "34-48"], "DRUGB": ["anticholinergics", "group", "241-256"]}
{"TEXT1": "Methscopolamine @DRUG$ MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics @DRUG$ antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p35", "DRUGA": ["antidepressants", "group", "34-48"], "DRUGB": ["potassium chloride", "drug", "259-276"]}
{"TEXT1": "Methscopolamine @DRUG$ MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements @DRUG$ absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p36", "DRUGA": ["antidepressants", "group", "34-48"], "DRUGB": ["antacids", "group", "291-298"]}
{"TEXT1": "Methscopolamine @DRUG$ MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p37", "DRUGA": ["antidepressants", "group", "34-48"], "DRUGB": ["absorbent-type anti-diarrhea medicines", "group", "301-338"]}
{"TEXT1": "Methscopolamine @DRUG$ MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p38", "DRUGA": ["antidepressants", "group", "34-48"], "DRUGB": ["kaolin", "drug", "347-352"]}
{"TEXT1": "Methscopolamine @DRUG$ MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p39", "DRUGA": ["antidepressants", "group", "34-48"], "DRUGB": ["pectin", "drug", "354-359"]}
{"TEXT1": "Methscopolamine @DRUG$ MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p40", "DRUGA": ["antidepressants", "group", "34-48"], "DRUGB": ["phenothiazines", "group", "363-376"]}
{"TEXT1": "Methscopolamine @DRUG$ MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p41", "DRUGA": ["antidepressants", "group", "34-48"], "DRUGB": ["chlorpromazine", "drug", "385-398"]}
{"TEXT1": "Methscopolamine @DRUG$ MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p42", "DRUGA": ["antidepressants", "group", "34-48"], "DRUGB": ["promethazine", "drug", "401-412"]}
{"TEXT1": "Methscopolamine antidepressants @DRUG$ phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p43", "DRUGA": ["tricyclic", "group", "51-59"], "DRUGB": ["MAO inhibitors", "group", "68-81"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors @DRUG$ linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p44", "DRUGA": ["tricyclic", "group", "51-59"], "DRUGB": ["phenelzine", "drug", "90-99"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine @DRUG$ tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p45", "DRUGA": ["tricyclic", "group", "51-59"], "DRUGB": ["linezolid", "drug", "102-110"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid @DRUG$ isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p46", "DRUGA": ["tricyclic", "group", "51-59"], "DRUGB": ["tranylcypromine", "drug", "113-127"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine @DRUG$ selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p47", "DRUGA": ["tricyclic", "group", "51-59"], "DRUGB": ["isocarboxazid", "drug", "130-142"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid @DRUG$ quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p48", "DRUGA": ["tricyclic", "group", "51-59"], "DRUGB": ["selegiline", "drug", "145-154"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p49", "DRUGA": ["tricyclic", "group", "51-59"], "DRUGB": ["furazolidone", "drug", "157-168"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline @DRUG$ amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p50", "DRUGA": ["tricyclic", "group", "51-59"], "DRUGB": ["quinidine", "drug", "172-180"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine @DRUG$ antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p51", "DRUGA": ["tricyclic", "group", "51-59"], "DRUGB": ["amantadine", "drug", "183-192"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine @DRUG$ anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p52", "DRUGA": ["tricyclic", "group", "51-59"], "DRUGB": ["antihistamines", "group", "195-208"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p53", "DRUGA": ["tricyclic", "group", "51-59"], "DRUGB": ["diphenhydramine", "drug", "217-231"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines @DRUG$ potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p54", "DRUGA": ["tricyclic", "group", "51-59"], "DRUGB": ["anticholinergics", "group", "241-256"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics @DRUG$ antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p55", "DRUGA": ["tricyclic", "group", "51-59"], "DRUGB": ["potassium chloride", "drug", "259-276"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements @DRUG$ absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p56", "DRUGA": ["tricyclic", "group", "51-59"], "DRUGB": ["antacids", "group", "291-298"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p57", "DRUGA": ["tricyclic", "group", "51-59"], "DRUGB": ["absorbent-type anti-diarrhea medicines", "group", "301-338"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p58", "DRUGA": ["tricyclic", "group", "51-59"], "DRUGB": ["kaolin", "drug", "347-352"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p59", "DRUGA": ["tricyclic", "group", "51-59"], "DRUGB": ["pectin", "drug", "354-359"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p60", "DRUGA": ["tricyclic", "group", "51-59"], "DRUGB": ["phenothiazines", "group", "363-376"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p61", "DRUGA": ["tricyclic", "group", "51-59"], "DRUGB": ["chlorpromazine", "drug", "385-398"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p62", "DRUGA": ["tricyclic", "group", "51-59"], "DRUGB": ["promethazine", "drug", "401-412"]}
{"TEXT1": "Methscopolamine antidepressants @DRUG$ @DRUG$ linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p63", "DRUGA": ["MAO inhibitors", "group", "68-81"], "DRUGB": ["phenelzine", "drug", "90-99"]}
{"TEXT1": "Methscopolamine antidepressants @DRUG$ phenelzine @DRUG$ tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p64", "DRUGA": ["MAO inhibitors", "group", "68-81"], "DRUGB": ["linezolid", "drug", "102-110"]}
{"TEXT1": "Methscopolamine antidepressants @DRUG$ phenelzine linezolid @DRUG$ isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p65", "DRUGA": ["MAO inhibitors", "group", "68-81"], "DRUGB": ["tranylcypromine", "drug", "113-127"]}
{"TEXT1": "Methscopolamine antidepressants @DRUG$ phenelzine linezolid tranylcypromine @DRUG$ selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p66", "DRUGA": ["MAO inhibitors", "group", "68-81"], "DRUGB": ["isocarboxazid", "drug", "130-142"]}
{"TEXT1": "Methscopolamine antidepressants @DRUG$ phenelzine linezolid tranylcypromine isocarboxazid @DRUG$ quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p67", "DRUGA": ["MAO inhibitors", "group", "68-81"], "DRUGB": ["selegiline", "drug", "145-154"]}
{"TEXT1": "Methscopolamine antidepressants @DRUG$ phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p68", "DRUGA": ["MAO inhibitors", "group", "68-81"], "DRUGB": ["furazolidone", "drug", "157-168"]}
{"TEXT1": "Methscopolamine antidepressants @DRUG$ phenelzine linezolid tranylcypromine isocarboxazid selegiline @DRUG$ amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p69", "DRUGA": ["MAO inhibitors", "group", "68-81"], "DRUGB": ["quinidine", "drug", "172-180"]}
{"TEXT1": "Methscopolamine antidepressants @DRUG$ phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine @DRUG$ antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p70", "DRUGA": ["MAO inhibitors", "group", "68-81"], "DRUGB": ["amantadine", "drug", "183-192"]}
{"TEXT1": "Methscopolamine antidepressants @DRUG$ phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine @DRUG$ anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p71", "DRUGA": ["MAO inhibitors", "group", "68-81"], "DRUGB": ["antihistamines", "group", "195-208"]}
{"TEXT1": "Methscopolamine antidepressants @DRUG$ phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p72", "DRUGA": ["MAO inhibitors", "group", "68-81"], "DRUGB": ["diphenhydramine", "drug", "217-231"]}
{"TEXT1": "Methscopolamine antidepressants @DRUG$ phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines @DRUG$ potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p73", "DRUGA": ["MAO inhibitors", "group", "68-81"], "DRUGB": ["anticholinergics", "group", "241-256"]}
{"TEXT1": "Methscopolamine antidepressants @DRUG$ phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics @DRUG$ antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p74", "DRUGA": ["MAO inhibitors", "group", "68-81"], "DRUGB": ["potassium chloride", "drug", "259-276"]}
{"TEXT1": "Methscopolamine antidepressants @DRUG$ phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements @DRUG$ absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p75", "DRUGA": ["MAO inhibitors", "group", "68-81"], "DRUGB": ["antacids", "group", "291-298"]}
{"TEXT1": "Methscopolamine antidepressants @DRUG$ phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p76", "DRUGA": ["MAO inhibitors", "group", "68-81"], "DRUGB": ["absorbent-type anti-diarrhea medicines", "group", "301-338"]}
{"TEXT1": "Methscopolamine antidepressants @DRUG$ phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p77", "DRUGA": ["MAO inhibitors", "group", "68-81"], "DRUGB": ["kaolin", "drug", "347-352"]}
{"TEXT1": "Methscopolamine antidepressants @DRUG$ phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p78", "DRUGA": ["MAO inhibitors", "group", "68-81"], "DRUGB": ["pectin", "drug", "354-359"]}
{"TEXT1": "Methscopolamine antidepressants @DRUG$ phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p79", "DRUGA": ["MAO inhibitors", "group", "68-81"], "DRUGB": ["phenothiazines", "group", "363-376"]}
{"TEXT1": "Methscopolamine antidepressants @DRUG$ phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p80", "DRUGA": ["MAO inhibitors", "group", "68-81"], "DRUGB": ["chlorpromazine", "drug", "385-398"]}
{"TEXT1": "Methscopolamine antidepressants @DRUG$ phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p81", "DRUGA": ["MAO inhibitors", "group", "68-81"], "DRUGB": ["promethazine", "drug", "401-412"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors @DRUG$ @DRUG$ tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p82", "DRUGA": ["phenelzine", "drug", "90-99"], "DRUGB": ["linezolid", "drug", "102-110"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors @DRUG$ linezolid @DRUG$ isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p83", "DRUGA": ["phenelzine", "drug", "90-99"], "DRUGB": ["tranylcypromine", "drug", "113-127"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors @DRUG$ linezolid tranylcypromine @DRUG$ selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p84", "DRUGA": ["phenelzine", "drug", "90-99"], "DRUGB": ["isocarboxazid", "drug", "130-142"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors @DRUG$ linezolid tranylcypromine isocarboxazid @DRUG$ quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p85", "DRUGA": ["phenelzine", "drug", "90-99"], "DRUGB": ["selegiline", "drug", "145-154"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors @DRUG$ linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p86", "DRUGA": ["phenelzine", "drug", "90-99"], "DRUGB": ["furazolidone", "drug", "157-168"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors @DRUG$ linezolid tranylcypromine isocarboxazid selegiline @DRUG$ amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p87", "DRUGA": ["phenelzine", "drug", "90-99"], "DRUGB": ["quinidine", "drug", "172-180"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors @DRUG$ linezolid tranylcypromine isocarboxazid selegiline quinidine @DRUG$ antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p88", "DRUGA": ["phenelzine", "drug", "90-99"], "DRUGB": ["amantadine", "drug", "183-192"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors @DRUG$ linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine @DRUG$ anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p89", "DRUGA": ["phenelzine", "drug", "90-99"], "DRUGB": ["antihistamines", "group", "195-208"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors @DRUG$ linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p90", "DRUGA": ["phenelzine", "drug", "90-99"], "DRUGB": ["diphenhydramine", "drug", "217-231"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors @DRUG$ linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines @DRUG$ potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p91", "DRUGA": ["phenelzine", "drug", "90-99"], "DRUGB": ["anticholinergics", "group", "241-256"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors @DRUG$ linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics @DRUG$ antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p92", "DRUGA": ["phenelzine", "drug", "90-99"], "DRUGB": ["potassium chloride", "drug", "259-276"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors @DRUG$ linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements @DRUG$ absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p93", "DRUGA": ["phenelzine", "drug", "90-99"], "DRUGB": ["antacids", "group", "291-298"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors @DRUG$ linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p94", "DRUGA": ["phenelzine", "drug", "90-99"], "DRUGB": ["absorbent-type anti-diarrhea medicines", "group", "301-338"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors @DRUG$ linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p95", "DRUGA": ["phenelzine", "drug", "90-99"], "DRUGB": ["kaolin", "drug", "347-352"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors @DRUG$ linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p96", "DRUGA": ["phenelzine", "drug", "90-99"], "DRUGB": ["pectin", "drug", "354-359"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors @DRUG$ linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p97", "DRUGA": ["phenelzine", "drug", "90-99"], "DRUGB": ["phenothiazines", "group", "363-376"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors @DRUG$ linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p98", "DRUGA": ["phenelzine", "drug", "90-99"], "DRUGB": ["chlorpromazine", "drug", "385-398"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors @DRUG$ linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p99", "DRUGA": ["phenelzine", "drug", "90-99"], "DRUGB": ["promethazine", "drug", "401-412"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine @DRUG$ @DRUG$ isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p100", "DRUGA": ["linezolid", "drug", "102-110"], "DRUGB": ["tranylcypromine", "drug", "113-127"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine @DRUG$ tranylcypromine @DRUG$ selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p101", "DRUGA": ["linezolid", "drug", "102-110"], "DRUGB": ["isocarboxazid", "drug", "130-142"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine @DRUG$ tranylcypromine isocarboxazid @DRUG$ quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p102", "DRUGA": ["linezolid", "drug", "102-110"], "DRUGB": ["selegiline", "drug", "145-154"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine @DRUG$ tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p103", "DRUGA": ["linezolid", "drug", "102-110"], "DRUGB": ["furazolidone", "drug", "157-168"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine @DRUG$ tranylcypromine isocarboxazid selegiline @DRUG$ amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p104", "DRUGA": ["linezolid", "drug", "102-110"], "DRUGB": ["quinidine", "drug", "172-180"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine @DRUG$ tranylcypromine isocarboxazid selegiline quinidine @DRUG$ antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p105", "DRUGA": ["linezolid", "drug", "102-110"], "DRUGB": ["amantadine", "drug", "183-192"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine @DRUG$ tranylcypromine isocarboxazid selegiline quinidine amantadine @DRUG$ anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p106", "DRUGA": ["linezolid", "drug", "102-110"], "DRUGB": ["antihistamines", "group", "195-208"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine @DRUG$ tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p107", "DRUGA": ["linezolid", "drug", "102-110"], "DRUGB": ["diphenhydramine", "drug", "217-231"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine @DRUG$ tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines @DRUG$ potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p108", "DRUGA": ["linezolid", "drug", "102-110"], "DRUGB": ["anticholinergics", "group", "241-256"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine @DRUG$ tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics @DRUG$ antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p109", "DRUGA": ["linezolid", "drug", "102-110"], "DRUGB": ["potassium chloride", "drug", "259-276"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine @DRUG$ tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements @DRUG$ absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p110", "DRUGA": ["linezolid", "drug", "102-110"], "DRUGB": ["antacids", "group", "291-298"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine @DRUG$ tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p111", "DRUGA": ["linezolid", "drug", "102-110"], "DRUGB": ["absorbent-type anti-diarrhea medicines", "group", "301-338"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine @DRUG$ tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p112", "DRUGA": ["linezolid", "drug", "102-110"], "DRUGB": ["kaolin", "drug", "347-352"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine @DRUG$ tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p113", "DRUGA": ["linezolid", "drug", "102-110"], "DRUGB": ["pectin", "drug", "354-359"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine @DRUG$ tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p114", "DRUGA": ["linezolid", "drug", "102-110"], "DRUGB": ["phenothiazines", "group", "363-376"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine @DRUG$ tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p115", "DRUGA": ["linezolid", "drug", "102-110"], "DRUGB": ["chlorpromazine", "drug", "385-398"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine @DRUG$ tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p116", "DRUGA": ["linezolid", "drug", "102-110"], "DRUGB": ["promethazine", "drug", "401-412"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid @DRUG$ @DRUG$ selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p117", "DRUGA": ["tranylcypromine", "drug", "113-127"], "DRUGB": ["isocarboxazid", "drug", "130-142"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid @DRUG$ isocarboxazid @DRUG$ quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p118", "DRUGA": ["tranylcypromine", "drug", "113-127"], "DRUGB": ["selegiline", "drug", "145-154"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid @DRUG$ isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p119", "DRUGA": ["tranylcypromine", "drug", "113-127"], "DRUGB": ["furazolidone", "drug", "157-168"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid @DRUG$ isocarboxazid selegiline @DRUG$ amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p120", "DRUGA": ["tranylcypromine", "drug", "113-127"], "DRUGB": ["quinidine", "drug", "172-180"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid @DRUG$ isocarboxazid selegiline quinidine @DRUG$ antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p121", "DRUGA": ["tranylcypromine", "drug", "113-127"], "DRUGB": ["amantadine", "drug", "183-192"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid @DRUG$ isocarboxazid selegiline quinidine amantadine @DRUG$ anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p122", "DRUGA": ["tranylcypromine", "drug", "113-127"], "DRUGB": ["antihistamines", "group", "195-208"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid @DRUG$ isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p123", "DRUGA": ["tranylcypromine", "drug", "113-127"], "DRUGB": ["diphenhydramine", "drug", "217-231"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid @DRUG$ isocarboxazid selegiline quinidine amantadine antihistamines @DRUG$ potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p124", "DRUGA": ["tranylcypromine", "drug", "113-127"], "DRUGB": ["anticholinergics", "group", "241-256"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid @DRUG$ isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics @DRUG$ antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p125", "DRUGA": ["tranylcypromine", "drug", "113-127"], "DRUGB": ["potassium chloride", "drug", "259-276"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid @DRUG$ isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements @DRUG$ absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p126", "DRUGA": ["tranylcypromine", "drug", "113-127"], "DRUGB": ["antacids", "group", "291-298"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid @DRUG$ isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p127", "DRUGA": ["tranylcypromine", "drug", "113-127"], "DRUGB": ["absorbent-type anti-diarrhea medicines", "group", "301-338"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid @DRUG$ isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p128", "DRUGA": ["tranylcypromine", "drug", "113-127"], "DRUGB": ["kaolin", "drug", "347-352"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid @DRUG$ isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p129", "DRUGA": ["tranylcypromine", "drug", "113-127"], "DRUGB": ["pectin", "drug", "354-359"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid @DRUG$ isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p130", "DRUGA": ["tranylcypromine", "drug", "113-127"], "DRUGB": ["phenothiazines", "group", "363-376"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid @DRUG$ isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p131", "DRUGA": ["tranylcypromine", "drug", "113-127"], "DRUGB": ["chlorpromazine", "drug", "385-398"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid @DRUG$ isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p132", "DRUGA": ["tranylcypromine", "drug", "113-127"], "DRUGB": ["promethazine", "drug", "401-412"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine @DRUG$ @DRUG$ quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p133", "DRUGA": ["isocarboxazid", "drug", "130-142"], "DRUGB": ["selegiline", "drug", "145-154"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine @DRUG$ selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p134", "DRUGA": ["isocarboxazid", "drug", "130-142"], "DRUGB": ["furazolidone", "drug", "157-168"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine @DRUG$ selegiline @DRUG$ amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p135", "DRUGA": ["isocarboxazid", "drug", "130-142"], "DRUGB": ["quinidine", "drug", "172-180"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine @DRUG$ selegiline quinidine @DRUG$ antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p136", "DRUGA": ["isocarboxazid", "drug", "130-142"], "DRUGB": ["amantadine", "drug", "183-192"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine @DRUG$ selegiline quinidine amantadine @DRUG$ anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p137", "DRUGA": ["isocarboxazid", "drug", "130-142"], "DRUGB": ["antihistamines", "group", "195-208"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine @DRUG$ selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p138", "DRUGA": ["isocarboxazid", "drug", "130-142"], "DRUGB": ["diphenhydramine", "drug", "217-231"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine @DRUG$ selegiline quinidine amantadine antihistamines @DRUG$ potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p139", "DRUGA": ["isocarboxazid", "drug", "130-142"], "DRUGB": ["anticholinergics", "group", "241-256"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine @DRUG$ selegiline quinidine amantadine antihistamines anticholinergics @DRUG$ antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p140", "DRUGA": ["isocarboxazid", "drug", "130-142"], "DRUGB": ["potassium chloride", "drug", "259-276"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine @DRUG$ selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements @DRUG$ absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p141", "DRUGA": ["isocarboxazid", "drug", "130-142"], "DRUGB": ["antacids", "group", "291-298"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine @DRUG$ selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p142", "DRUGA": ["isocarboxazid", "drug", "130-142"], "DRUGB": ["absorbent-type anti-diarrhea medicines", "group", "301-338"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine @DRUG$ selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p143", "DRUGA": ["isocarboxazid", "drug", "130-142"], "DRUGB": ["kaolin", "drug", "347-352"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine @DRUG$ selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p144", "DRUGA": ["isocarboxazid", "drug", "130-142"], "DRUGB": ["pectin", "drug", "354-359"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine @DRUG$ selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p145", "DRUGA": ["isocarboxazid", "drug", "130-142"], "DRUGB": ["phenothiazines", "group", "363-376"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine @DRUG$ selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p146", "DRUGA": ["isocarboxazid", "drug", "130-142"], "DRUGB": ["chlorpromazine", "drug", "385-398"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine @DRUG$ selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p147", "DRUGA": ["isocarboxazid", "drug", "130-142"], "DRUGB": ["promethazine", "drug", "401-412"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid @DRUG$ quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p148", "DRUGA": ["selegiline", "drug", "145-154"], "DRUGB": ["furazolidone", "drug", "157-168"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid @DRUG$ @DRUG$ amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p149", "DRUGA": ["selegiline", "drug", "145-154"], "DRUGB": ["quinidine", "drug", "172-180"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid @DRUG$ quinidine @DRUG$ antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p150", "DRUGA": ["selegiline", "drug", "145-154"], "DRUGB": ["amantadine", "drug", "183-192"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid @DRUG$ quinidine amantadine @DRUG$ anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p151", "DRUGA": ["selegiline", "drug", "145-154"], "DRUGB": ["antihistamines", "group", "195-208"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid @DRUG$ quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p152", "DRUGA": ["selegiline", "drug", "145-154"], "DRUGB": ["diphenhydramine", "drug", "217-231"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid @DRUG$ quinidine amantadine antihistamines @DRUG$ potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p153", "DRUGA": ["selegiline", "drug", "145-154"], "DRUGB": ["anticholinergics", "group", "241-256"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid @DRUG$ quinidine amantadine antihistamines anticholinergics @DRUG$ antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p154", "DRUGA": ["selegiline", "drug", "145-154"], "DRUGB": ["potassium chloride", "drug", "259-276"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid @DRUG$ quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements @DRUG$ absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p155", "DRUGA": ["selegiline", "drug", "145-154"], "DRUGB": ["antacids", "group", "291-298"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid @DRUG$ quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p156", "DRUGA": ["selegiline", "drug", "145-154"], "DRUGB": ["absorbent-type anti-diarrhea medicines", "group", "301-338"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid @DRUG$ quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p157", "DRUGA": ["selegiline", "drug", "145-154"], "DRUGB": ["kaolin", "drug", "347-352"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid @DRUG$ quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p158", "DRUGA": ["selegiline", "drug", "145-154"], "DRUGB": ["pectin", "drug", "354-359"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid @DRUG$ quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p159", "DRUGA": ["selegiline", "drug", "145-154"], "DRUGB": ["phenothiazines", "group", "363-376"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid @DRUG$ quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p160", "DRUGA": ["selegiline", "drug", "145-154"], "DRUGB": ["chlorpromazine", "drug", "385-398"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid @DRUG$ quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p161", "DRUGA": ["selegiline", "drug", "145-154"], "DRUGB": ["promethazine", "drug", "401-412"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline @DRUG$ amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p162", "DRUGA": ["furazolidone", "drug", "157-168"], "DRUGB": ["quinidine", "drug", "172-180"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine @DRUG$ antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p163", "DRUGA": ["furazolidone", "drug", "157-168"], "DRUGB": ["amantadine", "drug", "183-192"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine @DRUG$ anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p164", "DRUGA": ["furazolidone", "drug", "157-168"], "DRUGB": ["antihistamines", "group", "195-208"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p165", "DRUGA": ["furazolidone", "drug", "157-168"], "DRUGB": ["diphenhydramine", "drug", "217-231"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines @DRUG$ potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p166", "DRUGA": ["furazolidone", "drug", "157-168"], "DRUGB": ["anticholinergics", "group", "241-256"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics @DRUG$ antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p167", "DRUGA": ["furazolidone", "drug", "157-168"], "DRUGB": ["potassium chloride", "drug", "259-276"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements @DRUG$ absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p168", "DRUGA": ["furazolidone", "drug", "157-168"], "DRUGB": ["antacids", "group", "291-298"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p169", "DRUGA": ["furazolidone", "drug", "157-168"], "DRUGB": ["absorbent-type anti-diarrhea medicines", "group", "301-338"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p170", "DRUGA": ["furazolidone", "drug", "157-168"], "DRUGB": ["kaolin", "drug", "347-352"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p171", "DRUGA": ["furazolidone", "drug", "157-168"], "DRUGB": ["pectin", "drug", "354-359"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p172", "DRUGA": ["furazolidone", "drug", "157-168"], "DRUGB": ["phenothiazines", "group", "363-376"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p173", "DRUGA": ["furazolidone", "drug", "157-168"], "DRUGB": ["chlorpromazine", "drug", "385-398"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p174", "DRUGA": ["furazolidone", "drug", "157-168"], "DRUGB": ["promethazine", "drug", "401-412"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline @DRUG$ @DRUG$ antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p175", "DRUGA": ["quinidine", "drug", "172-180"], "DRUGB": ["amantadine", "drug", "183-192"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline @DRUG$ amantadine @DRUG$ anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p176", "DRUGA": ["quinidine", "drug", "172-180"], "DRUGB": ["antihistamines", "group", "195-208"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline @DRUG$ amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p177", "DRUGA": ["quinidine", "drug", "172-180"], "DRUGB": ["diphenhydramine", "drug", "217-231"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline @DRUG$ amantadine antihistamines @DRUG$ potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p178", "DRUGA": ["quinidine", "drug", "172-180"], "DRUGB": ["anticholinergics", "group", "241-256"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline @DRUG$ amantadine antihistamines anticholinergics @DRUG$ antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p179", "DRUGA": ["quinidine", "drug", "172-180"], "DRUGB": ["potassium chloride", "drug", "259-276"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline @DRUG$ amantadine antihistamines anticholinergics potassium supplements chloride supplements @DRUG$ absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p180", "DRUGA": ["quinidine", "drug", "172-180"], "DRUGB": ["antacids", "group", "291-298"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline @DRUG$ amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p181", "DRUGA": ["quinidine", "drug", "172-180"], "DRUGB": ["absorbent-type anti-diarrhea medicines", "group", "301-338"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline @DRUG$ amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p182", "DRUGA": ["quinidine", "drug", "172-180"], "DRUGB": ["kaolin", "drug", "347-352"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline @DRUG$ amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p183", "DRUGA": ["quinidine", "drug", "172-180"], "DRUGB": ["pectin", "drug", "354-359"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline @DRUG$ amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p184", "DRUGA": ["quinidine", "drug", "172-180"], "DRUGB": ["phenothiazines", "group", "363-376"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline @DRUG$ amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p185", "DRUGA": ["quinidine", "drug", "172-180"], "DRUGB": ["chlorpromazine", "drug", "385-398"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline @DRUG$ amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p186", "DRUGA": ["quinidine", "drug", "172-180"], "DRUGB": ["promethazine", "drug", "401-412"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine @DRUG$ @DRUG$ anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p187", "DRUGA": ["amantadine", "drug", "183-192"], "DRUGB": ["antihistamines", "group", "195-208"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine @DRUG$ antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p188", "DRUGA": ["amantadine", "drug", "183-192"], "DRUGB": ["diphenhydramine", "drug", "217-231"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine @DRUG$ antihistamines @DRUG$ potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p189", "DRUGA": ["amantadine", "drug", "183-192"], "DRUGB": ["anticholinergics", "group", "241-256"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine @DRUG$ antihistamines anticholinergics @DRUG$ antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p190", "DRUGA": ["amantadine", "drug", "183-192"], "DRUGB": ["potassium chloride", "drug", "259-276"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine @DRUG$ antihistamines anticholinergics potassium supplements chloride supplements @DRUG$ absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p191", "DRUGA": ["amantadine", "drug", "183-192"], "DRUGB": ["antacids", "group", "291-298"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine @DRUG$ antihistamines anticholinergics potassium supplements chloride supplements antacids @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p192", "DRUGA": ["amantadine", "drug", "183-192"], "DRUGB": ["absorbent-type anti-diarrhea medicines", "group", "301-338"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine @DRUG$ antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p193", "DRUGA": ["amantadine", "drug", "183-192"], "DRUGB": ["kaolin", "drug", "347-352"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine @DRUG$ antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p194", "DRUGA": ["amantadine", "drug", "183-192"], "DRUGB": ["pectin", "drug", "354-359"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine @DRUG$ antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p195", "DRUGA": ["amantadine", "drug", "183-192"], "DRUGB": ["phenothiazines", "group", "363-376"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine @DRUG$ antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p196", "DRUGA": ["amantadine", "drug", "183-192"], "DRUGB": ["chlorpromazine", "drug", "385-398"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine @DRUG$ antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p197", "DRUGA": ["amantadine", "drug", "183-192"], "DRUGB": ["promethazine", "drug", "401-412"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine @DRUG$ anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p198", "DRUGA": ["antihistamines", "group", "195-208"], "DRUGB": ["diphenhydramine", "drug", "217-231"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine @DRUG$ @DRUG$ potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p199", "DRUGA": ["antihistamines", "group", "195-208"], "DRUGB": ["anticholinergics", "group", "241-256"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine @DRUG$ anticholinergics @DRUG$ antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p200", "DRUGA": ["antihistamines", "group", "195-208"], "DRUGB": ["potassium chloride", "drug", "259-276"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine @DRUG$ anticholinergics potassium supplements chloride supplements @DRUG$ absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p201", "DRUGA": ["antihistamines", "group", "195-208"], "DRUGB": ["antacids", "group", "291-298"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine @DRUG$ anticholinergics potassium supplements chloride supplements antacids @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p202", "DRUGA": ["antihistamines", "group", "195-208"], "DRUGB": ["absorbent-type anti-diarrhea medicines", "group", "301-338"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine @DRUG$ anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p203", "DRUGA": ["antihistamines", "group", "195-208"], "DRUGB": ["kaolin", "drug", "347-352"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine @DRUG$ anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p204", "DRUGA": ["antihistamines", "group", "195-208"], "DRUGB": ["pectin", "drug", "354-359"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine @DRUG$ anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p205", "DRUGA": ["antihistamines", "group", "195-208"], "DRUGB": ["phenothiazines", "group", "363-376"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine @DRUG$ anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p206", "DRUGA": ["antihistamines", "group", "195-208"], "DRUGB": ["chlorpromazine", "drug", "385-398"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine @DRUG$ anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p207", "DRUGA": ["antihistamines", "group", "195-208"], "DRUGB": ["promethazine", "drug", "401-412"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines @DRUG$ potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p208", "DRUGA": ["diphenhydramine", "drug", "217-231"], "DRUGB": ["anticholinergics", "group", "241-256"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics @DRUG$ antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p209", "DRUGA": ["diphenhydramine", "drug", "217-231"], "DRUGB": ["potassium chloride", "drug", "259-276"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements @DRUG$ absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p210", "DRUGA": ["diphenhydramine", "drug", "217-231"], "DRUGB": ["antacids", "group", "291-298"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p211", "DRUGA": ["diphenhydramine", "drug", "217-231"], "DRUGB": ["absorbent-type anti-diarrhea medicines", "group", "301-338"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p212", "DRUGA": ["diphenhydramine", "drug", "217-231"], "DRUGB": ["kaolin", "drug", "347-352"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p213", "DRUGA": ["diphenhydramine", "drug", "217-231"], "DRUGB": ["pectin", "drug", "354-359"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p214", "DRUGA": ["diphenhydramine", "drug", "217-231"], "DRUGB": ["phenothiazines", "group", "363-376"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p215", "DRUGA": ["diphenhydramine", "drug", "217-231"], "DRUGB": ["chlorpromazine", "drug", "385-398"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p216", "DRUGA": ["diphenhydramine", "drug", "217-231"], "DRUGB": ["promethazine", "drug", "401-412"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines @DRUG$ @DRUG$ antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p217", "DRUGA": ["anticholinergics", "group", "241-256"], "DRUGB": ["potassium chloride", "drug", "259-276"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines @DRUG$ potassium supplements chloride supplements @DRUG$ absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p218", "DRUGA": ["anticholinergics", "group", "241-256"], "DRUGB": ["antacids", "group", "291-298"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines @DRUG$ potassium supplements chloride supplements antacids @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p219", "DRUGA": ["anticholinergics", "group", "241-256"], "DRUGB": ["absorbent-type anti-diarrhea medicines", "group", "301-338"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines @DRUG$ potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p220", "DRUGA": ["anticholinergics", "group", "241-256"], "DRUGB": ["kaolin", "drug", "347-352"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines @DRUG$ potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p221", "DRUGA": ["anticholinergics", "group", "241-256"], "DRUGB": ["pectin", "drug", "354-359"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines @DRUG$ potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p222", "DRUGA": ["anticholinergics", "group", "241-256"], "DRUGB": ["phenothiazines", "group", "363-376"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines @DRUG$ potassium supplements chloride supplements antacids absorbent type medicines phenothiazines @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p223", "DRUGA": ["anticholinergics", "group", "241-256"], "DRUGB": ["chlorpromazine", "drug", "385-398"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines @DRUG$ potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p224", "DRUGA": ["anticholinergics", "group", "241-256"], "DRUGB": ["promethazine", "drug", "401-412"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics @DRUG$ @DRUG$ absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p225", "DRUGA": ["potassium chloride", "drug", "259-276"], "DRUGB": ["antacids", "group", "291-298"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics @DRUG$ antacids @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p226", "DRUGA": ["potassium chloride", "drug", "259-276"], "DRUGB": ["absorbent-type anti-diarrhea medicines", "group", "301-338"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics @DRUG$ antacids absorbent type medicines @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p227", "DRUGA": ["potassium chloride", "drug", "259-276"], "DRUGB": ["kaolin", "drug", "347-352"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics @DRUG$ antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p228", "DRUGA": ["potassium chloride", "drug", "259-276"], "DRUGB": ["pectin", "drug", "354-359"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics @DRUG$ antacids absorbent type medicines @DRUG$ chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p229", "DRUGA": ["potassium chloride", "drug", "259-276"], "DRUGB": ["phenothiazines", "group", "363-376"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics @DRUG$ antacids absorbent type medicines phenothiazines @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p230", "DRUGA": ["potassium chloride", "drug", "259-276"], "DRUGB": ["chlorpromazine", "drug", "385-398"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics @DRUG$ antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p231", "DRUGA": ["potassium chloride", "drug", "259-276"], "DRUGB": ["promethazine", "drug", "401-412"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements @DRUG$ @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p232", "DRUGA": ["antacids", "group", "291-298"], "DRUGB": ["absorbent-type anti-diarrhea medicines", "group", "301-338"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements @DRUG$ absorbent type medicines @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p233", "DRUGA": ["antacids", "group", "291-298"], "DRUGB": ["kaolin", "drug", "347-352"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements @DRUG$ absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p234", "DRUGA": ["antacids", "group", "291-298"], "DRUGB": ["pectin", "drug", "354-359"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements @DRUG$ absorbent type medicines @DRUG$ chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p235", "DRUGA": ["antacids", "group", "291-298"], "DRUGB": ["phenothiazines", "group", "363-376"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements @DRUG$ absorbent type medicines phenothiazines @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p236", "DRUGA": ["antacids", "group", "291-298"], "DRUGB": ["chlorpromazine", "drug", "385-398"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements @DRUG$ absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p237", "DRUGA": ["antacids", "group", "291-298"], "DRUGB": ["promethazine", "drug", "401-412"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids @DRUG$ @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p238", "DRUGA": ["absorbent-type anti-diarrhea medicines", "group", "301-338"], "DRUGB": ["kaolin", "drug", "347-352"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p239", "DRUGA": ["absorbent-type anti-diarrhea medicines", "group", "301-338"], "DRUGB": ["pectin", "drug", "354-359"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids @DRUG$ @DRUG$ chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p240", "DRUGA": ["absorbent-type anti-diarrhea medicines", "group", "301-338"], "DRUGB": ["phenothiazines", "group", "363-376"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids @DRUG$ phenothiazines @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p241", "DRUGA": ["absorbent-type anti-diarrhea medicines", "group", "301-338"], "DRUGB": ["chlorpromazine", "drug", "385-398"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p242", "DRUGA": ["absorbent-type anti-diarrhea medicines", "group", "301-338"], "DRUGB": ["promethazine", "drug", "401-412"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p243", "DRUGA": ["kaolin", "drug", "347-352"], "DRUGB": ["pectin", "drug", "354-359"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ @DRUG$ chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p244", "DRUGA": ["kaolin", "drug", "347-352"], "DRUGB": ["phenothiazines", "group", "363-376"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ phenothiazines @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p245", "DRUGA": ["kaolin", "drug", "347-352"], "DRUGB": ["chlorpromazine", "drug", "385-398"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p246", "DRUGA": ["kaolin", "drug", "347-352"], "DRUGB": ["promethazine", "drug", "401-412"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p247", "DRUGA": ["pectin", "drug", "354-359"], "DRUGB": ["phenothiazines", "group", "363-376"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p248", "DRUGA": ["pectin", "drug", "354-359"], "DRUGB": ["chlorpromazine", "drug", "385-398"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p249", "DRUGA": ["pectin", "drug", "354-359"], "DRUGB": ["promethazine", "drug", "401-412"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p250", "DRUGA": ["phenothiazines", "group", "363-376"], "DRUGB": ["chlorpromazine", "drug", "385-398"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines @DRUG$ chlorpromazine", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p251", "DRUGA": ["phenothiazines", "group", "363-376"], "DRUGB": ["promethazine", "drug", "401-412"]}
{"TEXT1": "Methscopolamine antidepressants MAO inhibitors phenelzine linezolid tranylcypromine isocarboxazid selegiline quinidine amantadine antihistamines anticholinergics potassium supplements chloride supplements antacids absorbent type medicines phenothiazines @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d655.s0.p252", "DRUGA": ["chlorpromazine", "drug", "385-398"], "DRUGB": ["promethazine", "drug", "401-412"]}
{"TEXT1": "Due to effects gastric emptying @DRUG$ therapy not considered patients taking drugs alter gastrointestinal motility @DRUG$ agents slow intestinal absorption of nutrients", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d632.s0.p0", "DRUGA": ["SYMLIN", "brand", "40-45"], "DRUGB": ["anticholinergic agents", "group", "150-171"]}
{"TEXT1": "Due to effects gastric emptying @DRUG$ therapy not considered patients taking drugs alter gastrointestinal motility anticholinergic agents slow intestinal absorption of nutrients", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d632.s0.p1", "DRUGA": ["SYMLIN", "brand", "40-45"], "DRUGB": ["atropine", "drug", "181-188"]}
{"TEXT1": "Due to effects gastric emptying @DRUG$ therapy not considered patients taking drugs alter gastrointestinal motility anticholinergic agents slow intestinal absorption of nutrients", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d632.s0.p2", "DRUGA": ["SYMLIN", "brand", "40-45"], "DRUGB": ["alpha glucosidase inhibitors", "group", "258-285"]}
{"TEXT1": "Due to effects gastric emptying SYMLIN therapy not considered patients taking drugs alter gastrointestinal motility @DRUG$ agents slow intestinal absorption of nutrients", "LBL": "0", "ID": "DDI-DrugBank.d632.s0.p3", "DRUGA": ["anticholinergic agents", "group", "150-171"], "DRUGB": ["atropine", "drug", "181-188"]}
{"TEXT1": "Due to effects gastric emptying SYMLIN therapy not considered patients taking drugs alter gastrointestinal motility @DRUG$ agents slow intestinal absorption of nutrients", "LBL": "0", "ID": "DDI-DrugBank.d632.s0.p4", "DRUGA": ["anticholinergic agents", "group", "150-171"], "DRUGB": ["alpha glucosidase inhibitors", "group", "258-285"]}
{"TEXT1": "Due to effects gastric emptying SYMLIN therapy not considered patients taking drugs alter gastrointestinal motility anticholinergic agents slow intestinal absorption of nutrients", "LBL": "0", "ID": "DDI-DrugBank.d632.s0.p5", "DRUGA": ["atropine", "drug", "181-188"], "DRUGB": ["alpha glucosidase inhibitors", "group", "258-285"]}
{"TEXT1": "rapid onset orally administered agent critical determinant effectiveness hour prior to 2 hours @DRUG$ injection", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d632.s3.p0", "DRUGA": ["analgesics", "group", "116-125"], "DRUGB": ["SYMLIN", "brand", "204-209"]}
{"TEXT1": "clinical trials concomitant use of @DRUG$ @DRUG$ not alter adverse event profile SYMLIN", "LBL": "0", "ID": "DDI-DrugBank.d632.s4.p0", "DRUGA": ["sulfonylureas", "group", "43-55"], "DRUGB": ["biguanides", "group", "60-69"]}
{"TEXT1": "clinical trials concomitant use of @DRUG$ biguanides not alter adverse event profile @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d632.s4.p1", "DRUGA": ["sulfonylureas", "group", "43-55"], "DRUGB": ["SYMLIN", "brand", "114-119"]}
{"TEXT1": "clinical trials concomitant use of sulfonylureas @DRUG$ not alter adverse event profile @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d632.s4.p2", "DRUGA": ["biguanides", "group", "60-69"], "DRUGB": ["SYMLIN", "brand", "114-119"]}
{"TEXT1": "formal interaction studies performed to assess effect @DRUG$ kinetics oral @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d632.s5.p0", "DRUGA": ["SYMLIN", "brand", "74-79"], "DRUGB": ["antidiabetic agents", "group", "105-123"]}
{"TEXT1": "Mixing @DRUG$ @DRUG$ pharmacokinetic parameters SYMLIN altered mixed regular NPH formulations recombinant human immediately injection", "LBL": "0", "ID": "DDI-DrugBank.d632.s6.p0", "DRUGA": ["SYMLIN", "brand", "7-12"], "DRUGB": ["Insulin", "drug", "18-24"]}
{"TEXT1": "Mixing @DRUG$ Insulin pharmacokinetic parameters @DRUG$ altered mixed regular NPH formulations recombinant human immediately injection", "LBL": "0", "ID": "DDI-DrugBank.d632.s6.p1", "DRUGA": ["SYMLIN", "brand", "7-12"], "DRUGB": ["SYMLIN", "brand", "60-65"]}
{"TEXT1": "Mixing @DRUG$ Insulin pharmacokinetic parameters SYMLIN altered mixed regular NPH formulations recombinant @DRUG$ immediately injection", "LBL": "0", "ID": "DDI-DrugBank.d632.s6.p2", "DRUGA": ["SYMLIN", "brand", "7-12"], "DRUGB": ["human insulin", "drug", "157-169"]}
{"TEXT1": "Mixing SYMLIN @DRUG$ pharmacokinetic parameters @DRUG$ altered mixed regular NPH formulations recombinant human immediately injection", "LBL": "0", "ID": "DDI-DrugBank.d632.s6.p3", "DRUGA": ["Insulin", "drug", "18-24"], "DRUGB": ["SYMLIN", "brand", "60-65"]}
{"TEXT1": "Mixing SYMLIN @DRUG$ pharmacokinetic parameters altered mixed regular NPH formulations recombinant @DRUG$ immediately injection", "LBL": "0", "ID": "DDI-DrugBank.d632.s6.p4", "DRUGA": ["Insulin", "drug", "18-24"], "DRUGB": ["human insulin", "drug", "157-169"]}
{"TEXT1": "Mixing SYMLIN Insulin pharmacokinetic parameters @DRUG$ altered mixed regular NPH formulations recombinant @DRUG$ immediately injection", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d632.s6.p5", "DRUGA": ["SYMLIN", "brand", "60-65"], "DRUGB": ["human insulin", "drug", "157-169"]}
{"TEXT1": "@DRUG$ @DRUG$ not mixed administered", "LBL": "0", "ID": "DDI-DrugBank.d632.s7.p0", "DRUGA": ["SYMLIN", "brand", "6-11"], "DRUGB": ["insulin", "drug", "17-23"]}
{"TEXT1": "Patients receiving @DRUG$ @DRUG$ not treated with ganglion blockers", "LBL": "0", "ID": "DDI-DrugBank.d579.s0.p0", "DRUGA": ["antibiotics", "group", "19-29"], "DRUGB": ["sulfonamides", "group", "35-46"]}
{"TEXT1": "Patients receiving @DRUG$ sulfonamides not treated with @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d579.s0.p1", "DRUGA": ["antibiotics", "group", "19-29"], "DRUGB": ["ganglion blockers", "group", "85-101"]}
{"TEXT1": "Patients receiving antibiotics @DRUG$ not treated with @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d579.s0.p2", "DRUGA": ["sulfonamides", "group", "35-46"], "DRUGB": ["ganglion blockers", "group", "85-101"]}
{"TEXT1": "action @DRUG$ anesthesia @DRUG$ alcohol", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d579.s1.p0", "DRUGA": ["Mecamylamine", "drug", "14-25"], "DRUGB": ["antihypertensive drugs", "group", "67-88"]}
{"TEXT1": "action @DRUG$ anesthesia antihypertensive drugs @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d579.s1.p1", "DRUGA": ["Mecamylamine", "drug", "14-25"], "DRUGB": ["alcohol", "drug", "94-100"]}
{"TEXT1": "action Mecamylamine anesthesia @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d579.s1.p2", "DRUGA": ["antihypertensive drugs", "group", "67-88"], "DRUGB": ["alcohol", "drug", "94-100"]}
{"TEXT1": "@DRUG$ reported to anticoagulant effect @DRUG$ warfarin resulting in prolongation prothrombin time", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d629.s0.p0", "DRUGA": ["metronidazole", "drug", "5-17"], "DRUGB": ["coumarin", "group", "79-86"]}
{"TEXT1": "@DRUG$ reported to anticoagulant effect coumarin @DRUG$ resulting in prolongation prothrombin time", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d629.s0.p1", "DRUGA": ["metronidazole", "drug", "5-17"], "DRUGB": ["warfarin", "drug", "92-99"]}
{"TEXT1": "Oral metronidazole reported to anticoagulant effect @DRUG$ @DRUG$ resulting in prolongation prothrombin time", "LBL": "0", "ID": "DDI-DrugBank.d629.s0.p2", "DRUGA": ["coumarin", "group", "79-86"], "DRUGB": ["warfarin", "drug", "92-99"]}
{"TEXT1": "Drug interactions kept mind @DRUG$ prescribed patients receiving anticoagulant treatment less likely to occur topical administration metronidazole administration low absorption", "LBL": "0", "ID": "DDI-DrugBank.d629.s1.p0", "DRUGA": ["METROGEL", "brand", "46-53"], "DRUGB": ["metronidazole", "drug", "56-68"]}
{"TEXT1": "Drug interactions kept mind @DRUG$ prescribed patients receiving anticoagulant treatment less likely to occur topical administration @DRUG$ low absorption", "LBL": "0", "ID": "DDI-DrugBank.d629.s1.p1", "DRUGA": ["METROGEL", "brand", "46-53"], "DRUGB": ["metronidazole", "drug", "201-213"]}
{"TEXT1": "Drug interactions kept mind METROGEL prescribed patients receiving anticoagulant treatment less likely to occur topical administration @DRUG$ low absorption", "LBL": "0", "ID": "DDI-DrugBank.d629.s1.p2", "DRUGA": ["metronidazole", "drug", "56-68"], "DRUGB": ["metronidazole", "drug", "201-213"]}
{"TEXT1": "Concomitant use of @DRUG$ @DRUG$ result adverse drug interaction", "LBL": "DDI-int", "ID": "DDI-DrugBank.d750.s0.p0", "DRUGA": ["alcohol", "drug", "19-25"], "DRUGB": ["phentermine hydrochloride", "drug", "32-56"]}
{"TEXT1": "@DRUG$ not used @DRUG$ additive effects", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d635.s0.p0", "DRUGA": ["short-acting beta adrenergic aerosol bronchodilators", "group", "6-57"], "DRUGB": ["MAXAIR AUTOHALER", "brand", "97-112"]}
{"TEXT1": "study published found @DRUG$ causes statistically significant increase plasma clearance @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d613.s0.p0", "DRUGA": ["vigabatrin", "drug", "37-46"], "DRUGB": ["carbamazepine", "drug", "115-127"]}
{"TEXT1": "Drs University Wales reported @DRUG$ @DRUG$ lowered serum concentration phenytoin patients treatment resistant epilepsy", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d613.s1.p0", "DRUGA": ["vigabatrin", "drug", "87-96"], "DRUGB": ["phenytoin", "drug", "103-111"]}
{"TEXT1": "Drs University Wales reported @DRUG$ phenytoin lowered serum concentration @DRUG$ patients treatment resistant epilepsy", "LBL": "0", "ID": "DDI-DrugBank.d613.s1.p1", "DRUGA": ["vigabatrin", "drug", "87-96"], "DRUGB": ["phenytoin", "drug", "131-139"]}
{"TEXT1": "Drs University Wales reported vigabatrin @DRUG$ lowered serum concentration @DRUG$ patients treatment resistant epilepsy", "LBL": "0", "ID": "DDI-DrugBank.d613.s1.p2", "DRUGA": ["phenytoin", "drug", "103-111"], "DRUGB": ["phenytoin", "drug", "131-139"]}
{"TEXT1": "Concurrent use of @DRUG$ result increased systemic toxicity anticholinesterases inhibit breakdown procaine hydrochloride", "LBL": "0", "ID": "DDI-DrugBank.d780.s0.p0", "DRUGA": ["Anticholinesterases", "group", "0-18"], "DRUGB": ["procaine hydrochloride", "drug", "39-60"]}
{"TEXT1": "Concurrent use of procaine hydrochloride @DRUG$ result increased systemic toxicity anticholinesterases inhibit breakdown", "LBL": "0", "ID": "DDI-DrugBank.d780.s0.p1", "DRUGA": ["Anticholinesterases", "group", "0-18"], "DRUGB": ["anticholinesterase agents", "group", "66-90"]}
{"TEXT1": "Concurrent use of procaine hydrochloride result increased systemic toxicity @DRUG$ inhibit breakdown", "LBL": "0", "ID": "DDI-DrugBank.d780.s0.p2", "DRUGA": ["Anticholinesterases", "group", "0-18"], "DRUGB": ["anticholinesterases", "group", "140-158"]}
{"TEXT1": "Concurrent use of procaine hydrochloride result increased systemic toxicity anticholinesterases inhibit breakdown @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d780.s0.p3", "DRUGA": ["Anticholinesterases", "group", "0-18"], "DRUGB": ["procaine hydrochloride", "drug", "185-206"]}
{"TEXT1": "Concurrent use of @DRUG$ @DRUG$ result increased systemic toxicity anticholinesterases inhibit breakdown procaine hydrochloride", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d780.s0.p4", "DRUGA": ["procaine hydrochloride", "drug", "39-60"], "DRUGB": ["anticholinesterase agents", "group", "66-90"]}
{"TEXT1": "Concurrent use of @DRUG$ result increased systemic toxicity @DRUG$ inhibit breakdown procaine hydrochloride", "LBL": "0", "ID": "DDI-DrugBank.d780.s0.p5", "DRUGA": ["procaine hydrochloride", "drug", "39-60"], "DRUGB": ["anticholinesterases", "group", "140-158"]}
{"TEXT1": "Concurrent use of @DRUG$ result increased systemic toxicity anticholinesterases inhibit breakdown @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d780.s0.p6", "DRUGA": ["procaine hydrochloride", "drug", "39-60"], "DRUGB": ["procaine hydrochloride", "drug", "185-206"]}
{"TEXT1": "Concurrent use of procaine hydrochloride @DRUG$ result increased systemic toxicity @DRUG$ inhibit breakdown", "LBL": "0", "ID": "DDI-DrugBank.d780.s0.p7", "DRUGA": ["anticholinesterase agents", "group", "66-90"], "DRUGB": ["anticholinesterases", "group", "140-158"]}
{"TEXT1": "Concurrent use of procaine hydrochloride @DRUG$ result increased systemic toxicity anticholinesterases inhibit breakdown @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d780.s0.p8", "DRUGA": ["anticholinesterase agents", "group", "66-90"], "DRUGB": ["procaine hydrochloride", "drug", "185-206"]}
{"TEXT1": "Concurrent use of procaine hydrochloride result increased systemic toxicity @DRUG$ inhibit breakdown @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d780.s0.p9", "DRUGA": ["anticholinesterases", "group", "140-158"], "DRUGB": ["procaine hydrochloride", "drug", "185-206"]}
{"TEXT1": "@DRUG$ Concurrent use of @DRUG$ CNS medications result additive effects", "LBL": "0", "ID": "DDI-DrugBank.d780.s4.p0", "DRUGA": ["CNS depressant", "group", "0-13"], "DRUGB": ["procaine hydrochloride", "drug", "46-67"]}
{"TEXT1": "@DRUG$ Concurrent use of procaine hydrochloride @DRUG$ result additive effects", "LBL": "0", "ID": "DDI-DrugBank.d780.s4.p1", "DRUGA": ["CNS depressant", "group", "0-13"], "DRUGB": ["CNS depressant medications", "group", "73-98"]}
{"TEXT1": "Concurrent use of @DRUG$ @DRUG$ result additive effects", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d780.s4.p2", "DRUGA": ["procaine hydrochloride", "drug", "46-67"], "DRUGB": ["CNS depressant medications", "group", "73-98"]}
{"TEXT1": "@DRUG$ increase diffusion rate procaine hydrochloride resulting in decreased time of onset systemic toxicity", "LBL": "0", "ID": "DDI-DrugBank.d780.s5.p0", "DRUGA": ["Hyaluronidase", "drug", "0-12"], "DRUGB": ["Hyaluronidase", "drug", "15-27"]}
{"TEXT1": "Hyaluronidase increase diffusion rate @DRUG$ resulting in decreased time of onset systemic toxicity", "LBL": "0", "ID": "DDI-DrugBank.d780.s5.p1", "DRUGA": ["Hyaluronidase", "drug", "0-12"], "DRUGB": ["procaine hydrochloride", "drug", "64-85"]}
{"TEXT1": "@DRUG$ increase diffusion rate @DRUG$ resulting in decreased time of onset systemic toxicity", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d780.s5.p2", "DRUGA": ["Hyaluronidase", "drug", "15-27"], "DRUGB": ["procaine hydrochloride", "drug", "64-85"]}
{"TEXT1": "@DRUG$ Concurrent use of procaine hydrochloride neuromuscular blocking agents result prolongation enhancement", "LBL": "0", "ID": "DDI-DrugBank.d780.s6.p0", "DRUGA": ["Neuromuscular blocking agents", "group", "0-28"], "DRUGB": ["suxamethonium chloride", "drug", "39-60"]}
{"TEXT1": "@DRUG$ Concurrent use of @DRUG$ neuromuscular blocking agents result prolongation enhancement", "LBL": "0", "ID": "DDI-DrugBank.d780.s6.p1", "DRUGA": ["Neuromuscular blocking agents", "group", "0-28"], "DRUGB": ["procaine hydrochloride", "drug", "82-103"]}
{"TEXT1": "@DRUG$ Concurrent use of procaine hydrochloride @DRUG$ result prolongation enhancement neuromuscular blockade", "LBL": "0", "ID": "DDI-DrugBank.d780.s6.p2", "DRUGA": ["Neuromuscular blocking agents", "group", "0-28"], "DRUGB": ["neuromuscular blocking agents", "group", "109-137"]}
{"TEXT1": "Concurrent use of @DRUG$ result prolongation enhancement", "LBL": "0", "ID": "DDI-DrugBank.d780.s6.p3", "DRUGA": ["suxamethonium chloride", "drug", "39-60"], "DRUGB": ["procaine hydrochloride", "drug", "82-103"]}
{"TEXT1": "Concurrent use of procaine hydrochloride @DRUG$ result prolongation enhancement neuromuscular blockade", "LBL": "0", "ID": "DDI-DrugBank.d780.s6.p4", "DRUGA": ["suxamethonium chloride", "drug", "39-60"], "DRUGB": ["neuromuscular blocking agents", "group", "109-137"]}
{"TEXT1": "Concurrent use of @DRUG$ @DRUG$ result prolongation enhancement neuromuscular blockade", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d780.s6.p5", "DRUGA": ["procaine hydrochloride", "drug", "82-103"], "DRUGB": ["neuromuscular blocking agents", "group", "109-137"]}
{"TEXT1": "Concurrent use of @DRUG$ sulfonamides reduction antibacterial sulfonamide", "LBL": "0", "ID": "DDI-DrugBank.d780.s7.p0", "DRUGA": ["Sulfonamides", "group", "0-11"], "DRUGB": ["procaine hydrochloride", "drug", "32-53"]}
{"TEXT1": "Concurrent use of procaine hydrochloride @DRUG$ reduction antibacterial sulfonamide", "LBL": "0", "ID": "DDI-DrugBank.d780.s7.p1", "DRUGA": ["Sulfonamides", "group", "0-11"], "DRUGB": ["sulfonamides", "group", "59-70"]}
{"TEXT1": "Concurrent use of procaine hydrochloride sulfonamides reduction antibacterial @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d780.s7.p2", "DRUGA": ["Sulfonamides", "group", "0-11"], "DRUGB": ["sulfonamide", "group", "133-143"]}
{"TEXT1": "Concurrent use of @DRUG$ @DRUG$ reduction antibacterial sulfonamide", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d780.s7.p3", "DRUGA": ["procaine hydrochloride", "drug", "32-53"], "DRUGB": ["sulfonamides", "group", "59-70"]}
{"TEXT1": "Concurrent use of @DRUG$ sulfonamides reduction antibacterial @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d780.s7.p4", "DRUGA": ["procaine hydrochloride", "drug", "32-53"], "DRUGB": ["sulfonamide", "group", "133-143"]}
{"TEXT1": "Concurrent use of procaine hydrochloride @DRUG$ reduction antibacterial @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d780.s7.p5", "DRUGA": ["sulfonamides", "group", "59-70"], "DRUGB": ["sulfonamide", "group", "133-143"]}
{"TEXT1": "Concurrent use of @DRUG$ procaine hydrochloride extend plasma", "LBL": "0", "ID": "DDI-DrugBank.d780.s8.p0", "DRUGA": ["Acetazolamide", "drug", "0-12"], "DRUGB": ["acetazolamide", "drug", "33-45"]}
{"TEXT1": "Concurrent use of acetazolamide @DRUG$ extend plasma procaine", "LBL": "0", "ID": "DDI-DrugBank.d780.s8.p1", "DRUGA": ["Acetazolamide", "drug", "0-12"], "DRUGB": ["procaine hydrochloride", "drug", "51-72"]}
{"TEXT1": "Concurrent use of acetazolamide procaine hydrochloride extend plasma @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d780.s8.p2", "DRUGA": ["Acetazolamide", "drug", "0-12"], "DRUGB": ["procaine", "drug", "109-116"]}
{"TEXT1": "Concurrent use of @DRUG$ @DRUG$ extend plasma procaine", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d780.s8.p3", "DRUGA": ["acetazolamide", "drug", "33-45"], "DRUGB": ["procaine hydrochloride", "drug", "51-72"]}
{"TEXT1": "Concurrent use of @DRUG$ procaine hydrochloride extend plasma @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d780.s8.p4", "DRUGA": ["acetazolamide", "drug", "33-45"], "DRUGB": ["procaine", "drug", "109-116"]}
{"TEXT1": "Concurrent use of acetazolamide @DRUG$ extend plasma @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d780.s8.p5", "DRUGA": ["procaine hydrochloride", "drug", "51-72"], "DRUGB": ["procaine", "drug", "109-116"]}
{"TEXT1": "@DRUG$ strong inhibitors CYP3A4 family @DRUG$ itraconazole clarithromycin atazanavir indinavir nefazodone nelfinavir ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d639.s0.p0", "DRUGA": ["SUTENT", "brand", "21-26"], "DRUGB": ["ketoconazole", "drug", "79-90"]}
{"TEXT1": "@DRUG$ strong inhibitors CYP3A4 family ketoconazole @DRUG$ clarithromycin atazanavir indinavir nefazodone nelfinavir ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d639.s0.p1", "DRUGA": ["SUTENT", "brand", "21-26"], "DRUGB": ["itraconazole", "drug", "93-104"]}
{"TEXT1": "@DRUG$ strong inhibitors CYP3A4 family ketoconazole itraconazole @DRUG$ atazanavir indinavir nefazodone nelfinavir ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d639.s0.p2", "DRUGA": ["SUTENT", "brand", "21-26"], "DRUGB": ["clarithromycin", "drug", "107-120"]}
{"TEXT1": "@DRUG$ strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin @DRUG$ indinavir nefazodone nelfinavir ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d639.s0.p3", "DRUGA": ["SUTENT", "brand", "21-26"], "DRUGB": ["atazanavir", "drug", "123-132"]}
{"TEXT1": "@DRUG$ strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir @DRUG$ nefazodone nelfinavir ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d639.s0.p4", "DRUGA": ["SUTENT", "brand", "21-26"], "DRUGB": ["indinavir", "drug", "135-143"]}
{"TEXT1": "@DRUG$ strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir indinavir @DRUG$ nelfinavir ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d639.s0.p5", "DRUGA": ["SUTENT", "brand", "21-26"], "DRUGB": ["nefazodone", "drug", "146-155"]}
{"TEXT1": "@DRUG$ strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir indinavir nefazodone @DRUG$ ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d639.s0.p6", "DRUGA": ["SUTENT", "brand", "21-26"], "DRUGB": ["nelfinavir", "drug", "158-167"]}
{"TEXT1": "@DRUG$ strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir indinavir nefazodone nelfinavir @DRUG$ saquinavir telithromycin increases sunitinib concentrations", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d639.s0.p7", "DRUGA": ["SUTENT", "brand", "21-26"], "DRUGB": ["ritonavir", "drug", "170-178"]}
{"TEXT1": "@DRUG$ strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir indinavir nefazodone nelfinavir ritonavir @DRUG$ telithromycin increases sunitinib concentrations", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d639.s0.p8", "DRUGA": ["SUTENT", "brand", "21-26"], "DRUGB": ["saquinavir", "drug", "181-190"]}
{"TEXT1": "@DRUG$ strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir indinavir nefazodone nelfinavir ritonavir saquinavir @DRUG$ increases sunitinib concentrations", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d639.s0.p9", "DRUGA": ["SUTENT", "brand", "21-26"], "DRUGB": ["telithromycin", "drug", "193-205"]}
{"TEXT1": "@DRUG$ strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir indinavir nefazodone nelfinavir ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d639.s0.p10", "DRUGA": ["SUTENT", "brand", "21-26"], "DRUGB": ["voriconizole", "drug", "208-219"]}
{"TEXT1": "@DRUG$ strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir indinavir nefazodone nelfinavir ritonavir saquinavir telithromycin increases @DRUG$ concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p11", "DRUGA": ["SUTENT", "brand", "21-26"], "DRUGB": ["sunitinib", "drug", "236-244"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family @DRUG$ @DRUG$ clarithromycin atazanavir indinavir nefazodone nelfinavir ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p12", "DRUGA": ["ketoconazole", "drug", "79-90"], "DRUGB": ["itraconazole", "drug", "93-104"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family @DRUG$ itraconazole @DRUG$ atazanavir indinavir nefazodone nelfinavir ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p13", "DRUGA": ["ketoconazole", "drug", "79-90"], "DRUGB": ["clarithromycin", "drug", "107-120"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family @DRUG$ itraconazole clarithromycin @DRUG$ indinavir nefazodone nelfinavir ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p14", "DRUGA": ["ketoconazole", "drug", "79-90"], "DRUGB": ["atazanavir", "drug", "123-132"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family @DRUG$ itraconazole clarithromycin atazanavir @DRUG$ nefazodone nelfinavir ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p15", "DRUGA": ["ketoconazole", "drug", "79-90"], "DRUGB": ["indinavir", "drug", "135-143"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family @DRUG$ itraconazole clarithromycin atazanavir indinavir @DRUG$ nelfinavir ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p16", "DRUGA": ["ketoconazole", "drug", "79-90"], "DRUGB": ["nefazodone", "drug", "146-155"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family @DRUG$ itraconazole clarithromycin atazanavir indinavir nefazodone @DRUG$ ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p17", "DRUGA": ["ketoconazole", "drug", "79-90"], "DRUGB": ["nelfinavir", "drug", "158-167"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family @DRUG$ itraconazole clarithromycin atazanavir indinavir nefazodone nelfinavir @DRUG$ saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p18", "DRUGA": ["ketoconazole", "drug", "79-90"], "DRUGB": ["ritonavir", "drug", "170-178"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family @DRUG$ itraconazole clarithromycin atazanavir indinavir nefazodone nelfinavir ritonavir @DRUG$ telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p19", "DRUGA": ["ketoconazole", "drug", "79-90"], "DRUGB": ["saquinavir", "drug", "181-190"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family @DRUG$ itraconazole clarithromycin atazanavir indinavir nefazodone nelfinavir ritonavir saquinavir @DRUG$ increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p20", "DRUGA": ["ketoconazole", "drug", "79-90"], "DRUGB": ["telithromycin", "drug", "193-205"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family @DRUG$ itraconazole clarithromycin atazanavir indinavir nefazodone nelfinavir ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p21", "DRUGA": ["ketoconazole", "drug", "79-90"], "DRUGB": ["voriconizole", "drug", "208-219"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family @DRUG$ itraconazole clarithromycin atazanavir indinavir nefazodone nelfinavir ritonavir saquinavir telithromycin increases @DRUG$ concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p22", "DRUGA": ["ketoconazole", "drug", "79-90"], "DRUGB": ["sunitinib", "drug", "236-244"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole @DRUG$ @DRUG$ atazanavir indinavir nefazodone nelfinavir ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p23", "DRUGA": ["itraconazole", "drug", "93-104"], "DRUGB": ["clarithromycin", "drug", "107-120"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole @DRUG$ clarithromycin @DRUG$ indinavir nefazodone nelfinavir ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p24", "DRUGA": ["itraconazole", "drug", "93-104"], "DRUGB": ["atazanavir", "drug", "123-132"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole @DRUG$ clarithromycin atazanavir @DRUG$ nefazodone nelfinavir ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p25", "DRUGA": ["itraconazole", "drug", "93-104"], "DRUGB": ["indinavir", "drug", "135-143"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole @DRUG$ clarithromycin atazanavir indinavir @DRUG$ nelfinavir ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p26", "DRUGA": ["itraconazole", "drug", "93-104"], "DRUGB": ["nefazodone", "drug", "146-155"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole @DRUG$ clarithromycin atazanavir indinavir nefazodone @DRUG$ ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p27", "DRUGA": ["itraconazole", "drug", "93-104"], "DRUGB": ["nelfinavir", "drug", "158-167"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole @DRUG$ clarithromycin atazanavir indinavir nefazodone nelfinavir @DRUG$ saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p28", "DRUGA": ["itraconazole", "drug", "93-104"], "DRUGB": ["ritonavir", "drug", "170-178"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole @DRUG$ clarithromycin atazanavir indinavir nefazodone nelfinavir ritonavir @DRUG$ telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p29", "DRUGA": ["itraconazole", "drug", "93-104"], "DRUGB": ["saquinavir", "drug", "181-190"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole @DRUG$ clarithromycin atazanavir indinavir nefazodone nelfinavir ritonavir saquinavir @DRUG$ increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p30", "DRUGA": ["itraconazole", "drug", "93-104"], "DRUGB": ["telithromycin", "drug", "193-205"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole @DRUG$ clarithromycin atazanavir indinavir nefazodone nelfinavir ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p31", "DRUGA": ["itraconazole", "drug", "93-104"], "DRUGB": ["voriconizole", "drug", "208-219"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole @DRUG$ clarithromycin atazanavir indinavir nefazodone nelfinavir ritonavir saquinavir telithromycin increases @DRUG$ concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p32", "DRUGA": ["itraconazole", "drug", "93-104"], "DRUGB": ["sunitinib", "drug", "236-244"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole @DRUG$ @DRUG$ indinavir nefazodone nelfinavir ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p33", "DRUGA": ["clarithromycin", "drug", "107-120"], "DRUGB": ["atazanavir", "drug", "123-132"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole @DRUG$ atazanavir @DRUG$ nefazodone nelfinavir ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p34", "DRUGA": ["clarithromycin", "drug", "107-120"], "DRUGB": ["indinavir", "drug", "135-143"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole @DRUG$ atazanavir indinavir @DRUG$ nelfinavir ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p35", "DRUGA": ["clarithromycin", "drug", "107-120"], "DRUGB": ["nefazodone", "drug", "146-155"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole @DRUG$ atazanavir indinavir nefazodone @DRUG$ ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p36", "DRUGA": ["clarithromycin", "drug", "107-120"], "DRUGB": ["nelfinavir", "drug", "158-167"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole @DRUG$ atazanavir indinavir nefazodone nelfinavir @DRUG$ saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p37", "DRUGA": ["clarithromycin", "drug", "107-120"], "DRUGB": ["ritonavir", "drug", "170-178"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole @DRUG$ atazanavir indinavir nefazodone nelfinavir ritonavir @DRUG$ telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p38", "DRUGA": ["clarithromycin", "drug", "107-120"], "DRUGB": ["saquinavir", "drug", "181-190"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole @DRUG$ atazanavir indinavir nefazodone nelfinavir ritonavir saquinavir @DRUG$ increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p39", "DRUGA": ["clarithromycin", "drug", "107-120"], "DRUGB": ["telithromycin", "drug", "193-205"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole @DRUG$ atazanavir indinavir nefazodone nelfinavir ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p40", "DRUGA": ["clarithromycin", "drug", "107-120"], "DRUGB": ["voriconizole", "drug", "208-219"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole @DRUG$ atazanavir indinavir nefazodone nelfinavir ritonavir saquinavir telithromycin increases @DRUG$ concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p41", "DRUGA": ["clarithromycin", "drug", "107-120"], "DRUGB": ["sunitinib", "drug", "236-244"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin @DRUG$ @DRUG$ nefazodone nelfinavir ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p42", "DRUGA": ["atazanavir", "drug", "123-132"], "DRUGB": ["indinavir", "drug", "135-143"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin @DRUG$ indinavir @DRUG$ nelfinavir ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p43", "DRUGA": ["atazanavir", "drug", "123-132"], "DRUGB": ["nefazodone", "drug", "146-155"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin @DRUG$ indinavir nefazodone @DRUG$ ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p44", "DRUGA": ["atazanavir", "drug", "123-132"], "DRUGB": ["nelfinavir", "drug", "158-167"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin @DRUG$ indinavir nefazodone nelfinavir @DRUG$ saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p45", "DRUGA": ["atazanavir", "drug", "123-132"], "DRUGB": ["ritonavir", "drug", "170-178"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin @DRUG$ indinavir nefazodone nelfinavir ritonavir @DRUG$ telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p46", "DRUGA": ["atazanavir", "drug", "123-132"], "DRUGB": ["saquinavir", "drug", "181-190"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin @DRUG$ indinavir nefazodone nelfinavir ritonavir saquinavir @DRUG$ increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p47", "DRUGA": ["atazanavir", "drug", "123-132"], "DRUGB": ["telithromycin", "drug", "193-205"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin @DRUG$ indinavir nefazodone nelfinavir ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p48", "DRUGA": ["atazanavir", "drug", "123-132"], "DRUGB": ["voriconizole", "drug", "208-219"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin @DRUG$ indinavir nefazodone nelfinavir ritonavir saquinavir telithromycin increases @DRUG$ concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p49", "DRUGA": ["atazanavir", "drug", "123-132"], "DRUGB": ["sunitinib", "drug", "236-244"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir @DRUG$ @DRUG$ nelfinavir ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p50", "DRUGA": ["indinavir", "drug", "135-143"], "DRUGB": ["nefazodone", "drug", "146-155"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir @DRUG$ nefazodone @DRUG$ ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p51", "DRUGA": ["indinavir", "drug", "135-143"], "DRUGB": ["nelfinavir", "drug", "158-167"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir @DRUG$ nefazodone nelfinavir @DRUG$ saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p52", "DRUGA": ["indinavir", "drug", "135-143"], "DRUGB": ["ritonavir", "drug", "170-178"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir @DRUG$ nefazodone nelfinavir ritonavir @DRUG$ telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p53", "DRUGA": ["indinavir", "drug", "135-143"], "DRUGB": ["saquinavir", "drug", "181-190"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir @DRUG$ nefazodone nelfinavir ritonavir saquinavir @DRUG$ increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p54", "DRUGA": ["indinavir", "drug", "135-143"], "DRUGB": ["telithromycin", "drug", "193-205"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir @DRUG$ nefazodone nelfinavir ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p55", "DRUGA": ["indinavir", "drug", "135-143"], "DRUGB": ["voriconizole", "drug", "208-219"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir @DRUG$ nefazodone nelfinavir ritonavir saquinavir telithromycin increases @DRUG$ concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p56", "DRUGA": ["indinavir", "drug", "135-143"], "DRUGB": ["sunitinib", "drug", "236-244"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir indinavir @DRUG$ @DRUG$ ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p57", "DRUGA": ["nefazodone", "drug", "146-155"], "DRUGB": ["nelfinavir", "drug", "158-167"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir indinavir @DRUG$ nelfinavir @DRUG$ saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p58", "DRUGA": ["nefazodone", "drug", "146-155"], "DRUGB": ["ritonavir", "drug", "170-178"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir indinavir @DRUG$ nelfinavir ritonavir @DRUG$ telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p59", "DRUGA": ["nefazodone", "drug", "146-155"], "DRUGB": ["saquinavir", "drug", "181-190"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir indinavir @DRUG$ nelfinavir ritonavir saquinavir @DRUG$ increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p60", "DRUGA": ["nefazodone", "drug", "146-155"], "DRUGB": ["telithromycin", "drug", "193-205"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir indinavir @DRUG$ nelfinavir ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p61", "DRUGA": ["nefazodone", "drug", "146-155"], "DRUGB": ["voriconizole", "drug", "208-219"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir indinavir @DRUG$ nelfinavir ritonavir saquinavir telithromycin increases @DRUG$ concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p62", "DRUGA": ["nefazodone", "drug", "146-155"], "DRUGB": ["sunitinib", "drug", "236-244"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir indinavir nefazodone @DRUG$ @DRUG$ saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p63", "DRUGA": ["nelfinavir", "drug", "158-167"], "DRUGB": ["ritonavir", "drug", "170-178"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir indinavir nefazodone @DRUG$ ritonavir @DRUG$ telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p64", "DRUGA": ["nelfinavir", "drug", "158-167"], "DRUGB": ["saquinavir", "drug", "181-190"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir indinavir nefazodone @DRUG$ ritonavir saquinavir @DRUG$ increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p65", "DRUGA": ["nelfinavir", "drug", "158-167"], "DRUGB": ["telithromycin", "drug", "193-205"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir indinavir nefazodone @DRUG$ ritonavir saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p66", "DRUGA": ["nelfinavir", "drug", "158-167"], "DRUGB": ["voriconizole", "drug", "208-219"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir indinavir nefazodone @DRUG$ ritonavir saquinavir telithromycin increases @DRUG$ concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p67", "DRUGA": ["nelfinavir", "drug", "158-167"], "DRUGB": ["sunitinib", "drug", "236-244"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir indinavir nefazodone nelfinavir @DRUG$ @DRUG$ telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p68", "DRUGA": ["ritonavir", "drug", "170-178"], "DRUGB": ["saquinavir", "drug", "181-190"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir indinavir nefazodone nelfinavir @DRUG$ saquinavir @DRUG$ increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p69", "DRUGA": ["ritonavir", "drug", "170-178"], "DRUGB": ["telithromycin", "drug", "193-205"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir indinavir nefazodone nelfinavir @DRUG$ saquinavir telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p70", "DRUGA": ["ritonavir", "drug", "170-178"], "DRUGB": ["voriconizole", "drug", "208-219"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir indinavir nefazodone nelfinavir @DRUG$ saquinavir telithromycin increases @DRUG$ concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p71", "DRUGA": ["ritonavir", "drug", "170-178"], "DRUGB": ["sunitinib", "drug", "236-244"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir indinavir nefazodone nelfinavir ritonavir @DRUG$ @DRUG$ increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p72", "DRUGA": ["saquinavir", "drug", "181-190"], "DRUGB": ["telithromycin", "drug", "193-205"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir indinavir nefazodone nelfinavir ritonavir @DRUG$ telithromycin increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p73", "DRUGA": ["saquinavir", "drug", "181-190"], "DRUGB": ["voriconizole", "drug", "208-219"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir indinavir nefazodone nelfinavir ritonavir @DRUG$ telithromycin increases @DRUG$ concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p74", "DRUGA": ["saquinavir", "drug", "181-190"], "DRUGB": ["sunitinib", "drug", "236-244"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir indinavir nefazodone nelfinavir ritonavir saquinavir @DRUG$ increases sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p75", "DRUGA": ["telithromycin", "drug", "193-205"], "DRUGB": ["voriconizole", "drug", "208-219"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir indinavir nefazodone nelfinavir ritonavir saquinavir @DRUG$ increases @DRUG$ concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p76", "DRUGA": ["telithromycin", "drug", "193-205"], "DRUGB": ["sunitinib", "drug", "236-244"]}
{"TEXT1": "SUTENT strong inhibitors CYP3A4 family ketoconazole itraconazole clarithromycin atazanavir indinavir nefazodone nelfinavir ritonavir saquinavir telithromycin increases @DRUG$ concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s0.p77", "DRUGA": ["voriconizole", "drug", "208-219"], "DRUGB": ["sunitinib", "drug", "236-244"]}
{"TEXT1": "@DRUG$ inducers CYP3A4 family @DRUG$ phenytoin carbamazepine rifampin rifabutin phenobarbital decrease sunitinib concentrations", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d639.s2.p0", "DRUGA": ["SUTENT", "brand", "21-26"], "DRUGB": ["dexamethasone", "drug", "70-82"]}
{"TEXT1": "@DRUG$ inducers CYP3A4 family dexamethasone @DRUG$ carbamazepine rifampin rifabutin phenobarbital decrease sunitinib concentrations", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d639.s2.p1", "DRUGA": ["SUTENT", "brand", "21-26"], "DRUGB": ["phenytoin", "drug", "85-93"]}
{"TEXT1": "@DRUG$ inducers CYP3A4 family dexamethasone phenytoin @DRUG$ rifampin rifabutin phenobarbital decrease sunitinib concentrations", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d639.s2.p2", "DRUGA": ["SUTENT", "brand", "21-26"], "DRUGB": ["carbamazepine", "drug", "96-108"]}
{"TEXT1": "@DRUG$ inducers CYP3A4 family dexamethasone phenytoin carbamazepine @DRUG$ rifabutin phenobarbital decrease sunitinib concentrations", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d639.s2.p3", "DRUGA": ["SUTENT", "brand", "21-26"], "DRUGB": ["rifampin", "drug", "111-118"]}
{"TEXT1": "@DRUG$ inducers CYP3A4 family dexamethasone phenytoin carbamazepine rifampin @DRUG$ phenobarbital decrease sunitinib concentrations", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d639.s2.p4", "DRUGA": ["SUTENT", "brand", "21-26"], "DRUGB": ["rifabutin", "drug", "121-129"]}
{"TEXT1": "@DRUG$ inducers CYP3A4 family dexamethasone phenytoin carbamazepine rifampin rifabutin @DRUG$ phenobarbital decrease sunitinib concentrations", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d639.s2.p5", "DRUGA": ["SUTENT", "brand", "21-26"], "DRUGB": ["rifapentin", "drug", "132-141"]}
{"TEXT1": "@DRUG$ inducers CYP3A4 family dexamethasone phenytoin carbamazepine rifampin rifabutin @DRUG$ decrease sunitinib concentrations", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d639.s2.p6", "DRUGA": ["SUTENT", "brand", "21-26"], "DRUGB": ["phenobarbital", "drug", "144-156"]}
{"TEXT1": "@DRUG$ inducers CYP3A4 family dexamethasone phenytoin carbamazepine rifampin rifabutin phenobarbital decrease @DRUG$ concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s2.p7", "DRUGA": ["SUTENT", "brand", "21-26"], "DRUGB": ["sunitinib", "drug", "188-196"]}
{"TEXT1": "SUTENT inducers CYP3A4 family @DRUG$ @DRUG$ carbamazepine rifampin rifabutin phenobarbital decrease sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s2.p8", "DRUGA": ["dexamethasone", "drug", "70-82"], "DRUGB": ["phenytoin", "drug", "85-93"]}
{"TEXT1": "SUTENT inducers CYP3A4 family @DRUG$ phenytoin @DRUG$ rifampin rifabutin phenobarbital decrease sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s2.p9", "DRUGA": ["dexamethasone", "drug", "70-82"], "DRUGB": ["carbamazepine", "drug", "96-108"]}
{"TEXT1": "SUTENT inducers CYP3A4 family @DRUG$ phenytoin carbamazepine @DRUG$ rifabutin phenobarbital decrease sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s2.p10", "DRUGA": ["dexamethasone", "drug", "70-82"], "DRUGB": ["rifampin", "drug", "111-118"]}
{"TEXT1": "SUTENT inducers CYP3A4 family @DRUG$ phenytoin carbamazepine rifampin @DRUG$ phenobarbital decrease sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s2.p11", "DRUGA": ["dexamethasone", "drug", "70-82"], "DRUGB": ["rifabutin", "drug", "121-129"]}
{"TEXT1": "SUTENT inducers CYP3A4 family @DRUG$ phenytoin carbamazepine rifampin rifabutin @DRUG$ phenobarbital decrease sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s2.p12", "DRUGA": ["dexamethasone", "drug", "70-82"], "DRUGB": ["rifapentin", "drug", "132-141"]}
{"TEXT1": "SUTENT inducers CYP3A4 family @DRUG$ phenytoin carbamazepine rifampin rifabutin @DRUG$ decrease sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s2.p13", "DRUGA": ["dexamethasone", "drug", "70-82"], "DRUGB": ["phenobarbital", "drug", "144-156"]}
{"TEXT1": "SUTENT inducers CYP3A4 family @DRUG$ phenytoin carbamazepine rifampin rifabutin phenobarbital decrease @DRUG$ concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s2.p14", "DRUGA": ["dexamethasone", "drug", "70-82"], "DRUGB": ["sunitinib", "drug", "188-196"]}
{"TEXT1": "SUTENT inducers CYP3A4 family dexamethasone @DRUG$ @DRUG$ rifampin rifabutin phenobarbital decrease sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s2.p15", "DRUGA": ["phenytoin", "drug", "85-93"], "DRUGB": ["carbamazepine", "drug", "96-108"]}
{"TEXT1": "SUTENT inducers CYP3A4 family dexamethasone @DRUG$ carbamazepine @DRUG$ rifabutin phenobarbital decrease sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s2.p16", "DRUGA": ["phenytoin", "drug", "85-93"], "DRUGB": ["rifampin", "drug", "111-118"]}
{"TEXT1": "SUTENT inducers CYP3A4 family dexamethasone @DRUG$ carbamazepine rifampin @DRUG$ phenobarbital decrease sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s2.p17", "DRUGA": ["phenytoin", "drug", "85-93"], "DRUGB": ["rifabutin", "drug", "121-129"]}
{"TEXT1": "SUTENT inducers CYP3A4 family dexamethasone @DRUG$ carbamazepine rifampin rifabutin @DRUG$ phenobarbital decrease sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s2.p18", "DRUGA": ["phenytoin", "drug", "85-93"], "DRUGB": ["rifapentin", "drug", "132-141"]}
{"TEXT1": "SUTENT inducers CYP3A4 family dexamethasone @DRUG$ carbamazepine rifampin rifabutin @DRUG$ decrease sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s2.p19", "DRUGA": ["phenytoin", "drug", "85-93"], "DRUGB": ["phenobarbital", "drug", "144-156"]}
{"TEXT1": "SUTENT inducers CYP3A4 family dexamethasone @DRUG$ carbamazepine rifampin rifabutin phenobarbital decrease @DRUG$ concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s2.p20", "DRUGA": ["phenytoin", "drug", "85-93"], "DRUGB": ["sunitinib", "drug", "188-196"]}
{"TEXT1": "SUTENT inducers CYP3A4 family dexamethasone phenytoin @DRUG$ @DRUG$ rifabutin phenobarbital decrease sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s2.p21", "DRUGA": ["carbamazepine", "drug", "96-108"], "DRUGB": ["rifampin", "drug", "111-118"]}
{"TEXT1": "SUTENT inducers CYP3A4 family dexamethasone phenytoin @DRUG$ rifampin @DRUG$ phenobarbital decrease sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s2.p22", "DRUGA": ["carbamazepine", "drug", "96-108"], "DRUGB": ["rifabutin", "drug", "121-129"]}
{"TEXT1": "SUTENT inducers CYP3A4 family dexamethasone phenytoin @DRUG$ rifampin rifabutin @DRUG$ phenobarbital decrease sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s2.p23", "DRUGA": ["carbamazepine", "drug", "96-108"], "DRUGB": ["rifapentin", "drug", "132-141"]}
{"TEXT1": "SUTENT inducers CYP3A4 family dexamethasone phenytoin @DRUG$ rifampin rifabutin @DRUG$ decrease sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s2.p24", "DRUGA": ["carbamazepine", "drug", "96-108"], "DRUGB": ["phenobarbital", "drug", "144-156"]}
{"TEXT1": "SUTENT inducers CYP3A4 family dexamethasone phenytoin @DRUG$ rifampin rifabutin phenobarbital decrease @DRUG$ concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s2.p25", "DRUGA": ["carbamazepine", "drug", "96-108"], "DRUGB": ["sunitinib", "drug", "188-196"]}
{"TEXT1": "SUTENT inducers CYP3A4 family dexamethasone phenytoin carbamazepine @DRUG$ @DRUG$ phenobarbital decrease sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s2.p26", "DRUGA": ["rifampin", "drug", "111-118"], "DRUGB": ["rifabutin", "drug", "121-129"]}
{"TEXT1": "SUTENT inducers CYP3A4 family dexamethasone phenytoin carbamazepine @DRUG$ rifabutin @DRUG$ phenobarbital decrease sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s2.p27", "DRUGA": ["rifampin", "drug", "111-118"], "DRUGB": ["rifapentin", "drug", "132-141"]}
{"TEXT1": "SUTENT inducers CYP3A4 family dexamethasone phenytoin carbamazepine @DRUG$ rifabutin @DRUG$ decrease sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s2.p28", "DRUGA": ["rifampin", "drug", "111-118"], "DRUGB": ["phenobarbital", "drug", "144-156"]}
{"TEXT1": "SUTENT inducers CYP3A4 family dexamethasone phenytoin carbamazepine @DRUG$ rifabutin phenobarbital decrease @DRUG$ concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s2.p29", "DRUGA": ["rifampin", "drug", "111-118"], "DRUGB": ["sunitinib", "drug", "188-196"]}
{"TEXT1": "SUTENT inducers CYP3A4 family dexamethasone phenytoin carbamazepine rifampin @DRUG$ @DRUG$ phenobarbital decrease sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s2.p30", "DRUGA": ["rifabutin", "drug", "121-129"], "DRUGB": ["rifapentin", "drug", "132-141"]}
{"TEXT1": "SUTENT inducers CYP3A4 family dexamethasone phenytoin carbamazepine rifampin @DRUG$ @DRUG$ decrease sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s2.p31", "DRUGA": ["rifabutin", "drug", "121-129"], "DRUGB": ["phenobarbital", "drug", "144-156"]}
{"TEXT1": "SUTENT inducers CYP3A4 family dexamethasone phenytoin carbamazepine rifampin @DRUG$ phenobarbital decrease @DRUG$ concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s2.p32", "DRUGA": ["rifabutin", "drug", "121-129"], "DRUGB": ["sunitinib", "drug", "188-196"]}
{"TEXT1": "SUTENT inducers CYP3A4 family dexamethasone phenytoin carbamazepine rifampin rifabutin @DRUG$ @DRUG$ decrease sunitinib concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s2.p33", "DRUGA": ["rifapentin", "drug", "132-141"], "DRUGB": ["phenobarbital", "drug", "144-156"]}
{"TEXT1": "SUTENT inducers CYP3A4 family dexamethasone phenytoin carbamazepine rifampin rifabutin @DRUG$ phenobarbital decrease @DRUG$ concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s2.p34", "DRUGA": ["rifapentin", "drug", "132-141"], "DRUGB": ["sunitinib", "drug", "188-196"]}
{"TEXT1": "SUTENT inducers CYP3A4 family dexamethasone phenytoin carbamazepine rifampin rifabutin @DRUG$ decrease @DRUG$ concentrations", "LBL": "0", "ID": "DDI-DrugBank.d639.s2.p35", "DRUGA": ["phenobarbital", "drug", "144-156"], "DRUGB": ["sunitinib", "drug", "188-196"]}
{"TEXT1": "Drugs induce hepatic enzymes @DRUG$ @DRUG$ rifampin increase clearance corticosteroids corticosteroid to desired response", "LBL": "0", "ID": "DDI-DrugBank.d653.s1.p0", "DRUGA": ["phenobarbital", "drug", "42-54"], "DRUGB": ["phenytoin", "drug", "57-65"]}
{"TEXT1": "Drugs induce hepatic enzymes @DRUG$ phenytoin @DRUG$ increase clearance corticosteroids corticosteroid to desired response", "LBL": "0", "ID": "DDI-DrugBank.d653.s1.p1", "DRUGA": ["phenobarbital", "drug", "42-54"], "DRUGB": ["rifampin", "drug", "71-78"]}
{"TEXT1": "Drugs induce hepatic enzymes @DRUG$ phenytoin rifampin increase clearance @DRUG$ corticosteroid to desired response", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d653.s1.p2", "DRUGA": ["phenobarbital", "drug", "42-54"], "DRUGB": ["corticosteroids", "group", "110-124"]}
{"TEXT1": "Drugs induce hepatic enzymes @DRUG$ phenytoin rifampin increase clearance corticosteroids increases dose @DRUG$ to desired response", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d653.s1.p3", "DRUGA": ["phenobarbital", "drug", "42-54"], "DRUGB": ["corticosteroid", "group", "155-168"]}
{"TEXT1": "Drugs induce hepatic enzymes phenobarbital @DRUG$ @DRUG$ increase clearance corticosteroids corticosteroid to desired response", "LBL": "0", "ID": "DDI-DrugBank.d653.s1.p4", "DRUGA": ["phenytoin", "drug", "57-65"], "DRUGB": ["rifampin", "drug", "71-78"]}
{"TEXT1": "Drugs induce hepatic enzymes phenobarbital @DRUG$ rifampin increase clearance @DRUG$ corticosteroid to desired response", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d653.s1.p5", "DRUGA": ["phenytoin", "drug", "57-65"], "DRUGB": ["corticosteroids", "group", "110-124"]}
{"TEXT1": "Drugs induce hepatic enzymes phenobarbital @DRUG$ rifampin increase clearance corticosteroids increases dose @DRUG$ to desired response", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d653.s1.p6", "DRUGA": ["phenytoin", "drug", "57-65"], "DRUGB": ["corticosteroid", "group", "155-168"]}
{"TEXT1": "Drugs induce hepatic enzymes phenobarbital phenytoin @DRUG$ increase clearance @DRUG$ corticosteroid to desired response", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d653.s1.p7", "DRUGA": ["rifampin", "drug", "71-78"], "DRUGB": ["corticosteroids", "group", "110-124"]}
{"TEXT1": "Drugs induce hepatic enzymes phenobarbital phenytoin @DRUG$ increase clearance corticosteroids increases dose @DRUG$ to desired response", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d653.s1.p8", "DRUGA": ["rifampin", "drug", "71-78"], "DRUGB": ["corticosteroid", "group", "155-168"]}
{"TEXT1": "Drugs induce hepatic enzymes phenobarbital phenytoin rifampin increase clearance @DRUG$ increases dose @DRUG$ to desired response", "LBL": "0", "ID": "DDI-DrugBank.d653.s1.p9", "DRUGA": ["corticosteroids", "group", "110-124"], "DRUGB": ["corticosteroid", "group", "155-168"]}
{"TEXT1": "Drugs @DRUG$ @DRUG$ inhibit metabolism corticosteroids decrease clearance", "LBL": "0", "ID": "DDI-DrugBank.d653.s2.p0", "DRUGA": ["troleandomycin", "drug", "14-27"], "DRUGB": ["ketoconazole", "drug", "33-44"]}
{"TEXT1": "Drugs @DRUG$ ketoconazole inhibit metabolism @DRUG$ decrease clearance", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d653.s2.p1", "DRUGA": ["troleandomycin", "drug", "14-27"], "DRUGB": ["corticosteroids", "group", "76-90"]}
{"TEXT1": "Drugs troleandomycin @DRUG$ inhibit metabolism @DRUG$ decrease clearance", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d653.s2.p2", "DRUGA": ["ketoconazole", "drug", "33-44"], "DRUGB": ["corticosteroids", "group", "76-90"]}
{"TEXT1": "@DRUG$ increase clearance chronic high dose @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d653.s4.p0", "DRUGA": ["Corticosteroids", "group", "0-14"], "DRUGB": ["aspirin", "brand", "64-70"]}
{"TEXT1": "lead decreased @DRUG$ increase risk @DRUG$ corticosteroid withdrawn", "LBL": "0", "ID": "DDI-DrugBank.d653.s5.p0", "DRUGA": ["salicylate", "group", "29-38"], "DRUGB": ["salicylate", "group", "77-86"]}
{"TEXT1": "lead decreased @DRUG$ increase risk salicylate toxicity @DRUG$ withdrawn", "LBL": "0", "ID": "DDI-DrugBank.d653.s5.p1", "DRUGA": ["salicylate", "group", "29-38"], "DRUGB": ["corticosteroid", "group", "102-115"]}
{"TEXT1": "lead decreased salicylate serum levels increase risk @DRUG$ @DRUG$ withdrawn", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d653.s5.p2", "DRUGA": ["salicylate", "group", "77-86"], "DRUGB": ["corticosteroid", "group", "102-115"]}
{"TEXT1": "@DRUG$ used conjunction @DRUG$ patients suffering hypoprothrombinemia", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d653.s6.p0", "DRUGA": ["Aspirin", "brand", "0-6"], "DRUGB": ["corticosteroids", "group", "54-68"]}
{"TEXT1": "effect @DRUG$ @DRUG$ variable", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d653.s7.p0", "DRUGA": ["corticosteroids", "group", "14-28"], "DRUGB": ["anticoagulants", "group", "38-51"]}
{"TEXT1": "reports enhanced diminished @DRUG$ given @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d653.s8.p0", "DRUGA": ["anticoagulants", "group", "63-76"], "DRUGB": ["corticosteroids", "group", "107-121"]}
{"TEXT1": "Interactions @DRUG$ Loop Diuretics Oral Contraceptives Stavudine Tricyclic Antidepressants", "LBL": "0", "ID": "DDI-DrugBank.d697.s0.p0", "DRUGA": ["Vitamin B1", "drug", "17-26"], "DRUGB": ["Thiamine", "drug", "29-36"]}
{"TEXT1": "Interactions @DRUG$ @DRUG$ Oral Contraceptives Stavudine Tricyclic Antidepressants", "LBL": "DDI-int", "ID": "DDI-DrugBank.d697.s0.p1", "DRUGA": ["Vitamin B1", "drug", "17-26"], "DRUGB": ["Loop Diuretics", "group", "41-54"]}
{"TEXT1": "Interactions @DRUG$ Loop Diuretics @DRUG$ Stavudine Tricyclic Antidepressants", "LBL": "DDI-int", "ID": "DDI-DrugBank.d697.s0.p2", "DRUGA": ["Vitamin B1", "drug", "17-26"], "DRUGB": ["Contraceptives", "group", "62-75"]}
{"TEXT1": "Interactions @DRUG$ Loop Diuretics Oral Contraceptives @DRUG$ Tricyclic Antidepressants", "LBL": "DDI-int", "ID": "DDI-DrugBank.d697.s0.p3", "DRUGA": ["Vitamin B1", "drug", "17-26"], "DRUGB": ["Stavudine", "drug", "78-86"]}
{"TEXT1": "Interactions @DRUG$ Loop Diuretics Oral Contraceptives Stavudine @DRUG$", "LBL": "DDI-int", "ID": "DDI-DrugBank.d697.s0.p4", "DRUGA": ["Vitamin B1", "drug", "17-26"], "DRUGB": ["Tricyclic Antidepressants", "group", "89-113"]}
{"TEXT1": "Interactions Vitamin B1 @DRUG$ Oral Contraceptives Stavudine Tricyclic Antidepressants", "LBL": "DDI-int", "ID": "DDI-DrugBank.d697.s0.p5", "DRUGA": ["Thiamine", "drug", "29-36"], "DRUGB": ["Loop Diuretics", "group", "41-54"]}
{"TEXT1": "Interactions Vitamin B1 Loop Diuretics @DRUG$ Stavudine Tricyclic Antidepressants", "LBL": "DDI-int", "ID": "DDI-DrugBank.d697.s0.p6", "DRUGA": ["Thiamine", "drug", "29-36"], "DRUGB": ["Contraceptives", "group", "62-75"]}
{"TEXT1": "Interactions Vitamin B1 Loop Diuretics Oral Contraceptives @DRUG$ Tricyclic Antidepressants", "LBL": "DDI-int", "ID": "DDI-DrugBank.d697.s0.p7", "DRUGA": ["Thiamine", "drug", "29-36"], "DRUGB": ["Stavudine", "drug", "78-86"]}
{"TEXT1": "Interactions Vitamin B1 Loop Diuretics Oral Contraceptives Stavudine @DRUG$", "LBL": "DDI-int", "ID": "DDI-DrugBank.d697.s0.p8", "DRUGA": ["Thiamine", "drug", "29-36"], "DRUGB": ["Tricyclic Antidepressants", "group", "89-113"]}
{"TEXT1": "Interactions Vitamin B1 @DRUG$ @DRUG$ Stavudine Tricyclic Antidepressants", "LBL": "0", "ID": "DDI-DrugBank.d697.s0.p9", "DRUGA": ["Loop Diuretics", "group", "41-54"], "DRUGB": ["Contraceptives", "group", "62-75"]}
{"TEXT1": "Interactions Vitamin B1 @DRUG$ Oral Contraceptives @DRUG$ Tricyclic Antidepressants", "LBL": "0", "ID": "DDI-DrugBank.d697.s0.p10", "DRUGA": ["Loop Diuretics", "group", "41-54"], "DRUGB": ["Stavudine", "drug", "78-86"]}
{"TEXT1": "Interactions Vitamin B1 @DRUG$ Oral Contraceptives Stavudine @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d697.s0.p11", "DRUGA": ["Loop Diuretics", "group", "41-54"], "DRUGB": ["Tricyclic Antidepressants", "group", "89-113"]}
{"TEXT1": "Interactions Vitamin B1 Loop Diuretics @DRUG$ @DRUG$ Tricyclic Antidepressants", "LBL": "0", "ID": "DDI-DrugBank.d697.s0.p12", "DRUGA": ["Contraceptives", "group", "62-75"], "DRUGB": ["Stavudine", "drug", "78-86"]}
{"TEXT1": "Interactions Vitamin B1 Loop Diuretics @DRUG$ Stavudine @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d697.s0.p13", "DRUGA": ["Contraceptives", "group", "62-75"], "DRUGB": ["Tricyclic Antidepressants", "group", "89-113"]}
{"TEXT1": "Interactions Vitamin B1 Loop Diuretics Oral Contraceptives @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d697.s0.p14", "DRUGA": ["Stavudine", "drug", "78-86"], "DRUGB": ["Tricyclic Antidepressants", "group", "89-113"]}
{"TEXT1": "Effect @DRUG$ Rivastigmine metabolized hydrolysis esterases", "LBL": "0", "ID": "DDI-DrugBank.d596.s0.p0", "DRUGA": ["Exelon", "brand", "33-38"], "DRUGB": ["rivastigmine tartrate", "drug", "44-64"]}
{"TEXT1": "Effect @DRUG$ @DRUG$ metabolized hydrolysis esterases", "LBL": "0", "ID": "DDI-DrugBank.d596.s0.p1", "DRUGA": ["Exelon", "brand", "33-38"], "DRUGB": ["Rivastigmine", "drug", "101-112"]}
{"TEXT1": "Effect Exelon @DRUG$ metabolized hydrolysis esterases", "LBL": "0", "ID": "DDI-DrugBank.d596.s0.p2", "DRUGA": ["rivastigmine tartrate", "drug", "44-64"], "DRUGB": ["Rivastigmine", "drug", "101-112"]}
{"TEXT1": "pharmacokinetic interaction observed @DRUG$ @DRUG$ warfarin diazepam fluoxetine studies healthy volunteers", "LBL": "0", "ID": "DDI-DrugBank.d596.s3.p0", "DRUGA": ["rivastigmine", "drug", "52-63"], "DRUGB": ["digoxin", "drug", "69-75"]}
{"TEXT1": "pharmacokinetic interaction observed @DRUG$ digoxin @DRUG$ diazepam fluoxetine studies healthy volunteers", "LBL": "0", "ID": "DDI-DrugBank.d596.s3.p1", "DRUGA": ["rivastigmine", "drug", "52-63"], "DRUGB": ["warfarin", "drug", "78-85"]}
{"TEXT1": "pharmacokinetic interaction observed @DRUG$ digoxin warfarin @DRUG$ fluoxetine studies healthy volunteers", "LBL": "0", "ID": "DDI-DrugBank.d596.s3.p2", "DRUGA": ["rivastigmine", "drug", "52-63"], "DRUGB": ["diazepam", "drug", "88-95"]}
{"TEXT1": "pharmacokinetic interaction observed @DRUG$ digoxin warfarin diazepam @DRUG$ studies healthy volunteers", "LBL": "0", "ID": "DDI-DrugBank.d596.s3.p3", "DRUGA": ["rivastigmine", "drug", "52-63"], "DRUGB": ["fluoxetine", "drug", "101-110"]}
{"TEXT1": "pharmacokinetic interaction observed rivastigmine @DRUG$ @DRUG$ diazepam fluoxetine studies healthy volunteers", "LBL": "0", "ID": "DDI-DrugBank.d596.s3.p4", "DRUGA": ["digoxin", "drug", "69-75"], "DRUGB": ["warfarin", "drug", "78-85"]}
{"TEXT1": "pharmacokinetic interaction observed rivastigmine @DRUG$ warfarin @DRUG$ fluoxetine studies healthy volunteers", "LBL": "0", "ID": "DDI-DrugBank.d596.s3.p5", "DRUGA": ["digoxin", "drug", "69-75"], "DRUGB": ["diazepam", "drug", "88-95"]}
{"TEXT1": "pharmacokinetic interaction observed rivastigmine @DRUG$ warfarin diazepam @DRUG$ studies healthy volunteers", "LBL": "0", "ID": "DDI-DrugBank.d596.s3.p6", "DRUGA": ["digoxin", "drug", "69-75"], "DRUGB": ["fluoxetine", "drug", "101-110"]}
{"TEXT1": "pharmacokinetic interaction observed rivastigmine digoxin @DRUG$ @DRUG$ fluoxetine studies healthy volunteers", "LBL": "0", "ID": "DDI-DrugBank.d596.s3.p7", "DRUGA": ["warfarin", "drug", "78-85"], "DRUGB": ["diazepam", "drug", "88-95"]}
{"TEXT1": "pharmacokinetic interaction observed rivastigmine digoxin @DRUG$ diazepam @DRUG$ studies healthy volunteers", "LBL": "0", "ID": "DDI-DrugBank.d596.s3.p8", "DRUGA": ["warfarin", "drug", "78-85"], "DRUGB": ["fluoxetine", "drug", "101-110"]}
{"TEXT1": "pharmacokinetic interaction observed rivastigmine digoxin warfarin @DRUG$ @DRUG$ studies healthy volunteers", "LBL": "0", "ID": "DDI-DrugBank.d596.s3.p9", "DRUGA": ["diazepam", "drug", "88-95"], "DRUGB": ["fluoxetine", "drug", "101-110"]}
{"TEXT1": "elevation prothrombin time induced @DRUG$ not affected administration @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d596.s4.p0", "DRUGA": ["warfarin", "drug", "45-52"], "DRUGB": ["Exelon", "brand", "91-96"]}
{"TEXT1": "Effect of Drugs induce inhibit CYP450 metabolism not expected to alter @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d596.s5.p0", "DRUGA": ["Exelon", "brand", "43-48"], "DRUGB": ["rivastigmine", "drug", "142-153"]}
{"TEXT1": "Single dose pharmacokinetic studies metabolism @DRUG$ not affected concurrent @DRUG$ warfarin diazepam fluoxetine", "LBL": "0", "ID": "DDI-DrugBank.d596.s6.p0", "DRUGA": ["rivastigmine", "drug", "72-83"], "DRUGB": ["digoxin", "drug", "147-153"]}
{"TEXT1": "Single dose pharmacokinetic studies metabolism @DRUG$ not affected concurrent administration digoxin @DRUG$ diazepam fluoxetine", "LBL": "0", "ID": "DDI-DrugBank.d596.s6.p1", "DRUGA": ["rivastigmine", "drug", "72-83"], "DRUGB": ["warfarin", "drug", "156-163"]}
{"TEXT1": "Single dose pharmacokinetic studies metabolism @DRUG$ not affected concurrent administration digoxin warfarin @DRUG$ fluoxetine", "LBL": "0", "ID": "DDI-DrugBank.d596.s6.p2", "DRUGA": ["rivastigmine", "drug", "72-83"], "DRUGB": ["diazepam", "drug", "166-173"]}
{"TEXT1": "Single dose pharmacokinetic studies metabolism @DRUG$ not affected concurrent administration digoxin warfarin diazepam @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d596.s6.p3", "DRUGA": ["rivastigmine", "drug", "72-83"], "DRUGB": ["fluoxetine", "drug", "179-188"]}
{"TEXT1": "Single dose pharmacokinetic studies metabolism rivastigmine not affected concurrent @DRUG$ @DRUG$ diazepam fluoxetine", "LBL": "0", "ID": "DDI-DrugBank.d596.s6.p4", "DRUGA": ["digoxin", "drug", "147-153"], "DRUGB": ["warfarin", "drug", "156-163"]}
{"TEXT1": "Single dose pharmacokinetic studies metabolism rivastigmine not affected concurrent @DRUG$ warfarin @DRUG$ fluoxetine", "LBL": "0", "ID": "DDI-DrugBank.d596.s6.p5", "DRUGA": ["digoxin", "drug", "147-153"], "DRUGB": ["diazepam", "drug", "166-173"]}
{"TEXT1": "Single dose pharmacokinetic studies metabolism rivastigmine not affected concurrent @DRUG$ warfarin diazepam @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d596.s6.p6", "DRUGA": ["digoxin", "drug", "147-153"], "DRUGB": ["fluoxetine", "drug", "179-188"]}
{"TEXT1": "Single dose pharmacokinetic studies metabolism rivastigmine not affected concurrent administration digoxin @DRUG$ @DRUG$ fluoxetine", "LBL": "0", "ID": "DDI-DrugBank.d596.s6.p7", "DRUGA": ["warfarin", "drug", "156-163"], "DRUGB": ["diazepam", "drug", "166-173"]}
{"TEXT1": "Single dose pharmacokinetic studies metabolism rivastigmine not affected concurrent administration digoxin @DRUG$ diazepam @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d596.s6.p8", "DRUGA": ["warfarin", "drug", "156-163"], "DRUGB": ["fluoxetine", "drug", "179-188"]}
{"TEXT1": "Single dose pharmacokinetic studies metabolism rivastigmine not affected concurrent administration digoxin warfarin @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d596.s6.p9", "DRUGA": ["diazepam", "drug", "166-173"], "DRUGB": ["fluoxetine", "drug", "179-188"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics @DRUG$ not influenced prescribed medications @DRUG$ antihypertensives calcium channel blockers antidiabetics estrogens salicylate analgesics antianginals antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p0", "DRUGA": ["rivastigmine", "drug", "91-102"], "DRUGB": ["antacids", "group", "167-174"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics @DRUG$ not influenced prescribed medications antacids @DRUG$ calcium channel blockers antidiabetics estrogens salicylate analgesics antianginals antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p1", "DRUGA": ["rivastigmine", "drug", "91-102"], "DRUGB": ["antihypertensives", "group", "184-200"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics @DRUG$ not influenced prescribed medications antacids antihypertensives @DRUG$ antidiabetics estrogens salicylate analgesics antianginals antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p2", "DRUGA": ["rivastigmine", "drug", "91-102"], "DRUGB": ["calcium channel blockers", "group", "210-233"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics @DRUG$ not influenced prescribed medications antacids antihypertensives calcium channel blockers @DRUG$ estrogens salicylate analgesics antianginals antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p3", "DRUGA": ["rivastigmine", "drug", "91-102"], "DRUGB": ["antidiabetics", "group", "243-255"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics @DRUG$ not influenced prescribed medications antacids antihypertensives calcium channel blockers antidiabetics @DRUG$ estrogens salicylate analgesics antianginals antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p4", "DRUGA": ["rivastigmine", "drug", "91-102"], "DRUGB": ["nonsteroidal anti-inflammatory drugs", "group", "265-300"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics @DRUG$ not influenced prescribed medications antacids antihypertensives calcium channel blockers antidiabetics @DRUG$ salicylate analgesics antianginals antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p5", "DRUGA": ["rivastigmine", "drug", "91-102"], "DRUGB": ["estrogens", "group", "310-318"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics @DRUG$ not influenced prescribed medications antacids antihypertensives calcium channel blockers antidiabetics estrogens @DRUG$ antianginals antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p6", "DRUGA": ["rivastigmine", "drug", "91-102"], "DRUGB": ["salicylate analgesics", "group", "328-348"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics @DRUG$ not influenced prescribed medications antacids antihypertensives calcium channel blockers antidiabetics estrogens salicylate analgesics @DRUG$ antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p7", "DRUGA": ["rivastigmine", "drug", "91-102"], "DRUGB": ["antianginals", "group", "359-370"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics @DRUG$ not influenced prescribed medications antacids antihypertensives calcium channel blockers antidiabetics estrogens salicylate analgesics antianginals @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p8", "DRUGA": ["rivastigmine", "drug", "91-102"], "DRUGB": ["antihistamines", "group", "384-397"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications @DRUG$ @DRUG$ calcium channel blockers antidiabetics estrogens salicylate analgesics antianginals antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p9", "DRUGA": ["antacids", "group", "167-174"], "DRUGB": ["antihypertensives", "group", "184-200"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications @DRUG$ antihypertensives @DRUG$ antidiabetics estrogens salicylate analgesics antianginals antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p10", "DRUGA": ["antacids", "group", "167-174"], "DRUGB": ["calcium channel blockers", "group", "210-233"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications @DRUG$ antihypertensives calcium channel blockers @DRUG$ estrogens salicylate analgesics antianginals antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p11", "DRUGA": ["antacids", "group", "167-174"], "DRUGB": ["antidiabetics", "group", "243-255"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications @DRUG$ antihypertensives calcium channel blockers antidiabetics @DRUG$ estrogens salicylate analgesics antianginals antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p12", "DRUGA": ["antacids", "group", "167-174"], "DRUGB": ["nonsteroidal anti-inflammatory drugs", "group", "265-300"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications @DRUG$ antihypertensives calcium channel blockers antidiabetics @DRUG$ salicylate analgesics antianginals antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p13", "DRUGA": ["antacids", "group", "167-174"], "DRUGB": ["estrogens", "group", "310-318"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications @DRUG$ antihypertensives calcium channel blockers antidiabetics estrogens @DRUG$ antianginals antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p14", "DRUGA": ["antacids", "group", "167-174"], "DRUGB": ["salicylate analgesics", "group", "328-348"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications @DRUG$ antihypertensives calcium channel blockers antidiabetics estrogens salicylate analgesics @DRUG$ antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p15", "DRUGA": ["antacids", "group", "167-174"], "DRUGB": ["antianginals", "group", "359-370"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications @DRUG$ antihypertensives calcium channel blockers antidiabetics estrogens salicylate analgesics antianginals @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p16", "DRUGA": ["antacids", "group", "167-174"], "DRUGB": ["antihistamines", "group", "384-397"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications antacids @DRUG$ @DRUG$ antidiabetics estrogens salicylate analgesics antianginals antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p17", "DRUGA": ["antihypertensives", "group", "184-200"], "DRUGB": ["calcium channel blockers", "group", "210-233"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications antacids @DRUG$ calcium channel blockers @DRUG$ estrogens salicylate analgesics antianginals antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p18", "DRUGA": ["antihypertensives", "group", "184-200"], "DRUGB": ["antidiabetics", "group", "243-255"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications antacids @DRUG$ calcium channel blockers antidiabetics @DRUG$ estrogens salicylate analgesics antianginals antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p19", "DRUGA": ["antihypertensives", "group", "184-200"], "DRUGB": ["nonsteroidal anti-inflammatory drugs", "group", "265-300"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications antacids @DRUG$ calcium channel blockers antidiabetics @DRUG$ salicylate analgesics antianginals antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p20", "DRUGA": ["antihypertensives", "group", "184-200"], "DRUGB": ["estrogens", "group", "310-318"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications antacids @DRUG$ calcium channel blockers antidiabetics estrogens @DRUG$ antianginals antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p21", "DRUGA": ["antihypertensives", "group", "184-200"], "DRUGB": ["salicylate analgesics", "group", "328-348"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications antacids @DRUG$ calcium channel blockers antidiabetics estrogens salicylate analgesics @DRUG$ antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p22", "DRUGA": ["antihypertensives", "group", "184-200"], "DRUGB": ["antianginals", "group", "359-370"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications antacids @DRUG$ calcium channel blockers antidiabetics estrogens salicylate analgesics antianginals @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p23", "DRUGA": ["antihypertensives", "group", "184-200"], "DRUGB": ["antihistamines", "group", "384-397"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications antacids antihypertensives @DRUG$ @DRUG$ estrogens salicylate analgesics antianginals antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p24", "DRUGA": ["calcium channel blockers", "group", "210-233"], "DRUGB": ["antidiabetics", "group", "243-255"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications antacids antihypertensives @DRUG$ antidiabetics @DRUG$ estrogens salicylate analgesics antianginals antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p25", "DRUGA": ["calcium channel blockers", "group", "210-233"], "DRUGB": ["nonsteroidal anti-inflammatory drugs", "group", "265-300"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications antacids antihypertensives @DRUG$ antidiabetics @DRUG$ salicylate analgesics antianginals antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p26", "DRUGA": ["calcium channel blockers", "group", "210-233"], "DRUGB": ["estrogens", "group", "310-318"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications antacids antihypertensives @DRUG$ antidiabetics estrogens @DRUG$ antianginals antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p27", "DRUGA": ["calcium channel blockers", "group", "210-233"], "DRUGB": ["salicylate analgesics", "group", "328-348"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications antacids antihypertensives @DRUG$ antidiabetics estrogens salicylate analgesics @DRUG$ antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p28", "DRUGA": ["calcium channel blockers", "group", "210-233"], "DRUGB": ["antianginals", "group", "359-370"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications antacids antihypertensives @DRUG$ antidiabetics estrogens salicylate analgesics antianginals @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p29", "DRUGA": ["calcium channel blockers", "group", "210-233"], "DRUGB": ["antihistamines", "group", "384-397"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications antacids antihypertensives calcium channel blockers @DRUG$ @DRUG$ estrogens salicylate analgesics antianginals antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p30", "DRUGA": ["antidiabetics", "group", "243-255"], "DRUGB": ["nonsteroidal anti-inflammatory drugs", "group", "265-300"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications antacids antihypertensives calcium channel blockers @DRUG$ @DRUG$ salicylate analgesics antianginals antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p31", "DRUGA": ["antidiabetics", "group", "243-255"], "DRUGB": ["estrogens", "group", "310-318"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications antacids antihypertensives calcium channel blockers @DRUG$ estrogens @DRUG$ antianginals antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p32", "DRUGA": ["antidiabetics", "group", "243-255"], "DRUGB": ["salicylate analgesics", "group", "328-348"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications antacids antihypertensives calcium channel blockers @DRUG$ estrogens salicylate analgesics @DRUG$ antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p33", "DRUGA": ["antidiabetics", "group", "243-255"], "DRUGB": ["antianginals", "group", "359-370"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications antacids antihypertensives calcium channel blockers @DRUG$ estrogens salicylate analgesics antianginals @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p34", "DRUGA": ["antidiabetics", "group", "243-255"], "DRUGB": ["antihistamines", "group", "384-397"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications antacids antihypertensives calcium channel blockers antidiabetics @DRUG$ @DRUG$ salicylate analgesics antianginals antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p35", "DRUGA": ["nonsteroidal anti-inflammatory drugs", "group", "265-300"], "DRUGB": ["estrogens", "group", "310-318"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications antacids antihypertensives calcium channel blockers antidiabetics @DRUG$ estrogens @DRUG$ antianginals antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p36", "DRUGA": ["nonsteroidal anti-inflammatory drugs", "group", "265-300"], "DRUGB": ["salicylate analgesics", "group", "328-348"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications antacids antihypertensives calcium channel blockers antidiabetics @DRUG$ estrogens salicylate analgesics @DRUG$ antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p37", "DRUGA": ["nonsteroidal anti-inflammatory drugs", "group", "265-300"], "DRUGB": ["antianginals", "group", "359-370"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications antacids antihypertensives calcium channel blockers antidiabetics @DRUG$ estrogens salicylate analgesics antianginals @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p38", "DRUGA": ["nonsteroidal anti-inflammatory drugs", "group", "265-300"], "DRUGB": ["antihistamines", "group", "384-397"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications antacids antihypertensives calcium channel blockers antidiabetics @DRUG$ @DRUG$ antianginals antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p39", "DRUGA": ["estrogens", "group", "310-318"], "DRUGB": ["salicylate analgesics", "group", "328-348"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications antacids antihypertensives calcium channel blockers antidiabetics @DRUG$ salicylate analgesics @DRUG$ antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p40", "DRUGA": ["estrogens", "group", "310-318"], "DRUGB": ["antianginals", "group", "359-370"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications antacids antihypertensives calcium channel blockers antidiabetics @DRUG$ salicylate analgesics antianginals @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p41", "DRUGA": ["estrogens", "group", "310-318"], "DRUGB": ["antihistamines", "group", "384-397"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications antacids antihypertensives calcium channel blockers antidiabetics estrogens @DRUG$ @DRUG$ antihistamines", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p42", "DRUGA": ["salicylate analgesics", "group", "328-348"], "DRUGB": ["antianginals", "group", "359-370"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications antacids antihypertensives calcium channel blockers antidiabetics estrogens @DRUG$ antianginals @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p43", "DRUGA": ["salicylate analgesics", "group", "328-348"], "DRUGB": ["antihistamines", "group", "384-397"]}
{"TEXT1": "Population analysis PK database 625 patients showed pharmacokinetics rivastigmine not influenced prescribed medications antacids antihypertensives calcium channel blockers antidiabetics estrogens salicylate analgesics @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d596.s7.p44", "DRUGA": ["antianginals", "group", "359-370"], "DRUGB": ["antihistamines", "group", "384-397"]}
{"TEXT1": "Use of mechanism action @DRUG$ potential to interfere activity", "LBL": "0", "ID": "DDI-DrugBank.d596.s8.p0", "DRUGA": ["Anticholinergics", "group", "9-24"], "DRUGB": ["cholinesterase inhibitors", "group", "65-89"]}
{"TEXT1": "Use of mechanism action cholinesterase inhibitors potential to interfere activity @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d596.s8.p1", "DRUGA": ["Anticholinergics", "group", "9-24"], "DRUGB": ["anticholinergic medications", "group", "144-170"]}
{"TEXT1": "Use of mechanism action @DRUG$ potential to interfere activity @DRUG$", "LBL": "DDI-int", "ID": "DDI-DrugBank.d596.s8.p2", "DRUGA": ["cholinesterase inhibitors", "group", "65-89"], "DRUGB": ["anticholinergic medications", "group", "144-170"]}
{"TEXT1": "Use @DRUG$ synergistic effect expected cholinesterase inhibitors given succinylcholine similar neuromuscular blocking agents cholinergic agonists bethanechol", "LBL": "0", "ID": "DDI-DrugBank.d596.s9.p0", "DRUGA": ["Cholinomimetics", "group", "9-23"], "DRUGB": ["Cholinesterase Inhibitors", "group", "35-59"]}
{"TEXT1": "Use @DRUG$ synergistic effect expected @DRUG$ given succinylcholine similar neuromuscular blocking agents cholinergic agonists bethanechol", "LBL": "0", "ID": "DDI-DrugBank.d596.s9.p1", "DRUGA": ["Cholinomimetics", "group", "9-23"], "DRUGB": ["cholinesterase inhibitors", "group", "104-128"]}
{"TEXT1": "Use @DRUG$ synergistic effect expected cholinesterase inhibitors given @DRUG$ similar neuromuscular blocking agents cholinergic agonists bethanechol", "LBL": "0", "ID": "DDI-DrugBank.d596.s9.p2", "DRUGA": ["Cholinomimetics", "group", "9-23"], "DRUGB": ["succinylcholine", "drug", "158-172"]}
{"TEXT1": "Use @DRUG$ synergistic effect expected cholinesterase inhibitors given succinylcholine similar @DRUG$ cholinergic agonists bethanechol", "LBL": "0", "ID": "DDI-DrugBank.d596.s9.p3", "DRUGA": ["Cholinomimetics", "group", "9-23"], "DRUGB": ["neuromuscular blocking agents", "group", "183-211"]}
{"TEXT1": "Use @DRUG$ synergistic effect expected cholinesterase inhibitors given succinylcholine similar neuromuscular blocking agents @DRUG$ bethanechol", "LBL": "0", "ID": "DDI-DrugBank.d596.s9.p4", "DRUGA": ["Cholinomimetics", "group", "9-23"], "DRUGB": ["cholinergic agonists", "group", "216-235"]}
{"TEXT1": "Use @DRUG$ synergistic effect expected cholinesterase inhibitors given succinylcholine similar neuromuscular blocking agents cholinergic agonists @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d596.s9.p5", "DRUGA": ["Cholinomimetics", "group", "9-23"], "DRUGB": ["bethanechol", "drug", "245-255"]}
{"TEXT1": "Use Cholinomimetics synergistic effect expected @DRUG$ given succinylcholine similar neuromuscular blocking agents cholinergic agonists bethanechol", "LBL": "0", "ID": "DDI-DrugBank.d596.s9.p6", "DRUGA": ["Cholinesterase Inhibitors", "group", "35-59"], "DRUGB": ["cholinesterase inhibitors", "group", "104-128"]}
{"TEXT1": "Use Cholinomimetics synergistic effect expected cholinesterase inhibitors given @DRUG$ similar neuromuscular blocking agents cholinergic agonists bethanechol", "LBL": "0", "ID": "DDI-DrugBank.d596.s9.p7", "DRUGA": ["Cholinesterase Inhibitors", "group", "35-59"], "DRUGB": ["succinylcholine", "drug", "158-172"]}
{"TEXT1": "Use Cholinomimetics synergistic effect expected cholinesterase inhibitors given succinylcholine similar @DRUG$ cholinergic agonists bethanechol", "LBL": "0", "ID": "DDI-DrugBank.d596.s9.p8", "DRUGA": ["Cholinesterase Inhibitors", "group", "35-59"], "DRUGB": ["neuromuscular blocking agents", "group", "183-211"]}
{"TEXT1": "Use Cholinomimetics synergistic effect expected cholinesterase inhibitors given succinylcholine similar neuromuscular blocking agents @DRUG$ bethanechol", "LBL": "0", "ID": "DDI-DrugBank.d596.s9.p9", "DRUGA": ["Cholinesterase Inhibitors", "group", "35-59"], "DRUGB": ["cholinergic agonists", "group", "216-235"]}
{"TEXT1": "Use Cholinomimetics synergistic effect expected cholinesterase inhibitors given succinylcholine similar neuromuscular blocking agents cholinergic agonists @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d596.s9.p10", "DRUGA": ["Cholinesterase Inhibitors", "group", "35-59"], "DRUGB": ["bethanechol", "drug", "245-255"]}
{"TEXT1": "Use Cholinomimetics synergistic effect expected @DRUG$ given @DRUG$ similar neuromuscular blocking agents cholinergic agonists bethanechol", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d596.s9.p11", "DRUGA": ["cholinesterase inhibitors", "group", "104-128"], "DRUGB": ["succinylcholine", "drug", "158-172"]}
{"TEXT1": "Use Cholinomimetics synergistic effect expected @DRUG$ given succinylcholine similar @DRUG$ cholinergic agonists bethanechol", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d596.s9.p12", "DRUGA": ["cholinesterase inhibitors", "group", "104-128"], "DRUGB": ["neuromuscular blocking agents", "group", "183-211"]}
{"TEXT1": "Use Cholinomimetics synergistic effect expected @DRUG$ given succinylcholine similar neuromuscular blocking agents @DRUG$ bethanechol", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d596.s9.p13", "DRUGA": ["cholinesterase inhibitors", "group", "104-128"], "DRUGB": ["cholinergic agonists", "group", "216-235"]}
{"TEXT1": "Use Cholinomimetics synergistic effect expected @DRUG$ given succinylcholine similar neuromuscular blocking agents cholinergic agonists @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d596.s9.p14", "DRUGA": ["cholinesterase inhibitors", "group", "104-128"], "DRUGB": ["bethanechol", "drug", "245-255"]}
{"TEXT1": "Use Cholinomimetics synergistic effect expected cholinesterase inhibitors given @DRUG$ similar @DRUG$ cholinergic agonists bethanechol", "LBL": "0", "ID": "DDI-DrugBank.d596.s9.p15", "DRUGA": ["succinylcholine", "drug", "158-172"], "DRUGB": ["neuromuscular blocking agents", "group", "183-211"]}
{"TEXT1": "Use Cholinomimetics synergistic effect expected cholinesterase inhibitors given @DRUG$ similar neuromuscular blocking agents @DRUG$ bethanechol", "LBL": "0", "ID": "DDI-DrugBank.d596.s9.p16", "DRUGA": ["succinylcholine", "drug", "158-172"], "DRUGB": ["cholinergic agonists", "group", "216-235"]}
{"TEXT1": "Use Cholinomimetics synergistic effect expected cholinesterase inhibitors given @DRUG$ similar neuromuscular blocking agents cholinergic agonists @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d596.s9.p17", "DRUGA": ["succinylcholine", "drug", "158-172"], "DRUGB": ["bethanechol", "drug", "245-255"]}
{"TEXT1": "Use Cholinomimetics synergistic effect expected cholinesterase inhibitors given succinylcholine similar @DRUG$ @DRUG$ bethanechol", "LBL": "0", "ID": "DDI-DrugBank.d596.s9.p18", "DRUGA": ["neuromuscular blocking agents", "group", "183-211"], "DRUGB": ["cholinergic agonists", "group", "216-235"]}
{"TEXT1": "Use Cholinomimetics synergistic effect expected cholinesterase inhibitors given succinylcholine similar @DRUG$ cholinergic agonists @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d596.s9.p19", "DRUGA": ["neuromuscular blocking agents", "group", "183-211"], "DRUGB": ["bethanechol", "drug", "245-255"]}
{"TEXT1": "Use Cholinomimetics synergistic effect expected cholinesterase inhibitors given succinylcholine similar neuromuscular blocking agents @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d596.s9.p20", "DRUGA": ["cholinergic agonists", "group", "216-235"], "DRUGB": ["bethanechol", "drug", "245-255"]}
{"TEXT1": "Spontaneous adverse reaction reports patients taking concomitant @DRUG$ recommended doses terfenadine QT prolongation interval rare serious cardiac events", "LBL": "0", "ID": "DDI-DrugBank.d743.s0.p0", "DRUGA": ["Ketoconazole", "drug", "0-11"], "DRUGB": ["ketoconazole", "drug", "82-93"]}
{"TEXT1": "Spontaneous adverse reaction reports patients taking concomitant ketoconazole recommended doses @DRUG$ QT prolongation interval rare serious cardiac events", "LBL": "0", "ID": "DDI-DrugBank.d743.s0.p1", "DRUGA": ["Ketoconazole", "drug", "0-11"], "DRUGB": ["terfenadine", "drug", "121-131"]}
{"TEXT1": "Spontaneous adverse reaction reports patients taking concomitant @DRUG$ recommended doses @DRUG$ QT prolongation interval rare serious cardiac events", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d743.s0.p2", "DRUGA": ["ketoconazole", "drug", "82-93"], "DRUGB": ["terfenadine", "drug", "121-131"]}
{"TEXT1": "Pharmacokinetic data @DRUG$ markedly inhibits metabolism @DRUG$ resulting in elevated plasma terfenadine levels", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d743.s2.p0", "DRUGA": ["ketoconazole", "drug", "35-46"], "DRUGB": ["terfenadine", "drug", "84-94"]}
{"TEXT1": "Pharmacokinetic data @DRUG$ markedly inhibits metabolism terfenadine resulting in elevated plasma @DRUG$ levels", "LBL": "0", "ID": "DDI-DrugBank.d743.s2.p1", "DRUGA": ["ketoconazole", "drug", "35-46"], "DRUGB": ["terfenadine", "drug", "126-136"]}
{"TEXT1": "Pharmacokinetic data ketoconazole markedly inhibits metabolism @DRUG$ resulting in elevated plasma @DRUG$ levels", "LBL": "0", "ID": "DDI-DrugBank.d743.s2.p2", "DRUGA": ["terfenadine", "drug", "84-94"], "DRUGB": ["terfenadine", "drug", "126-136"]}
{"TEXT1": "Concomitant administration @DRUG$ @DRUG$ contraindicated", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d743.s4.p0", "DRUGA": ["ketoconazole", "drug", "30-41"], "DRUGB": ["terfenadine", "drug", "47-57"]}
{"TEXT1": "Torsades de pointes elevated parent @DRUG$ levels reported concomitant use of terfenadine itraconazole clinical trials foreign post marketing sources", "LBL": "0", "ID": "DDI-DrugBank.d743.s5.p0", "DRUGA": ["Itraconazole", "drug", "0-11"], "DRUGB": ["terfenadine", "drug", "54-64"]}
{"TEXT1": "Torsades de pointes elevated parent terfenadine levels reported concomitant use of @DRUG$ itraconazole clinical trials foreign post marketing sources", "LBL": "0", "ID": "DDI-DrugBank.d743.s5.p1", "DRUGA": ["Itraconazole", "drug", "0-11"], "DRUGB": ["terfenadine", "drug", "118-128"]}
{"TEXT1": "Torsades de pointes elevated parent terfenadine levels reported concomitant use of @DRUG$ clinical trials itraconazole foreign post marketing sources", "LBL": "0", "ID": "DDI-DrugBank.d743.s5.p2", "DRUGA": ["Itraconazole", "drug", "0-11"], "DRUGB": ["itraconazole", "drug", "134-145"]}
{"TEXT1": "Torsades de pointes elevated parent terfenadine levels reported concomitant use of itraconazole clinical trials @DRUG$ foreign post marketing sources", "LBL": "0", "ID": "DDI-DrugBank.d743.s5.p3", "DRUGA": ["Itraconazole", "drug", "0-11"], "DRUGB": ["itraconazole", "drug", "169-180"]}
{"TEXT1": "Torsades de pointes elevated parent @DRUG$ levels reported concomitant use of @DRUG$ itraconazole clinical trials foreign post marketing sources", "LBL": "0", "ID": "DDI-DrugBank.d743.s5.p4", "DRUGA": ["terfenadine", "drug", "54-64"], "DRUGB": ["terfenadine", "drug", "118-128"]}
{"TEXT1": "Torsades de pointes elevated parent @DRUG$ levels reported concomitant use of terfenadine @DRUG$ clinical trials itraconazole foreign post marketing sources", "LBL": "0", "ID": "DDI-DrugBank.d743.s5.p5", "DRUGA": ["terfenadine", "drug", "54-64"], "DRUGB": ["itraconazole", "drug", "134-145"]}
{"TEXT1": "Torsades de pointes elevated parent @DRUG$ levels reported concomitant use of terfenadine itraconazole clinical trials @DRUG$ foreign post marketing sources", "LBL": "0", "ID": "DDI-DrugBank.d743.s5.p6", "DRUGA": ["terfenadine", "drug", "54-64"], "DRUGB": ["itraconazole", "drug", "169-180"]}
{"TEXT1": "Torsades de pointes elevated parent terfenadine levels reported concomitant use of @DRUG$ @DRUG$ clinical trials itraconazole foreign post marketing sources", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d743.s5.p7", "DRUGA": ["terfenadine", "drug", "118-128"], "DRUGB": ["itraconazole", "drug", "134-145"]}
{"TEXT1": "Torsades de pointes elevated parent terfenadine levels reported concomitant use of @DRUG$ itraconazole clinical trials @DRUG$ foreign post marketing sources", "LBL": "0", "ID": "DDI-DrugBank.d743.s5.p8", "DRUGA": ["terfenadine", "drug", "118-128"], "DRUGB": ["itraconazole", "drug", "169-180"]}
{"TEXT1": "Torsades de pointes elevated parent terfenadine levels reported concomitant use of @DRUG$ clinical trials @DRUG$ foreign post marketing sources", "LBL": "0", "ID": "DDI-DrugBank.d743.s5.p9", "DRUGA": ["itraconazole", "drug", "134-145"], "DRUGB": ["itraconazole", "drug", "169-180"]}
{"TEXT1": "Concomitant administration @DRUG$ @DRUG$ contraindicated", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d743.s7.p0", "DRUGA": ["itraconazole", "drug", "30-41"], "DRUGB": ["terfenadine", "drug", "47-57"]}
{"TEXT1": "Due to chemical similarity @DRUG$ @DRUG$ metronidazole ketoconazole itraconazole concomitant products terfenadine not recommended full examination potential interactions", "LBL": "0", "ID": "DDI-DrugBank.d743.s8.p0", "DRUGA": ["azole-type antifungal agents", "group", "40-67"], "DRUGB": ["fluconazole", "drug", "80-90"]}
{"TEXT1": "Due to chemical similarity @DRUG$ fluconazole @DRUG$ ketoconazole itraconazole concomitant products terfenadine not recommended full examination potential interactions", "LBL": "0", "ID": "DDI-DrugBank.d743.s8.p1", "DRUGA": ["azole-type antifungal agents", "group", "40-67"], "DRUGB": ["metronidazole", "drug", "93-105"]}
{"TEXT1": "Due to chemical similarity @DRUG$ fluconazole metronidazole ketoconazole itraconazole concomitant products terfenadine not recommended full examination potential interactions", "LBL": "0", "ID": "DDI-DrugBank.d743.s8.p2", "DRUGA": ["azole-type antifungal agents", "group", "40-67"], "DRUGB": ["miconazole", "drug", "112-121"]}
{"TEXT1": "Due to chemical similarity @DRUG$ fluconazole metronidazole @DRUG$ itraconazole concomitant products terfenadine not recommended full examination potential interactions", "LBL": "0", "ID": "DDI-DrugBank.d743.s8.p3", "DRUGA": ["azole-type antifungal agents", "group", "40-67"], "DRUGB": ["ketoconazole", "drug", "127-138"]}
{"TEXT1": "Due to chemical similarity @DRUG$ fluconazole metronidazole ketoconazole @DRUG$ concomitant products terfenadine not recommended full examination potential interactions", "LBL": "0", "ID": "DDI-DrugBank.d743.s8.p4", "DRUGA": ["azole-type antifungal agents", "group", "40-67"], "DRUGB": ["itraconazole", "drug", "145-156"]}
{"TEXT1": "Due to chemical similarity @DRUG$ fluconazole metronidazole ketoconazole itraconazole concomitant products @DRUG$ not recommended full examination potential interactions", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d743.s8.p5", "DRUGA": ["azole-type antifungal agents", "group", "40-67"], "DRUGB": ["terfenadine", "drug", "198-208"]}
{"TEXT1": "Due to chemical similarity azole antifungal agents type @DRUG$ @DRUG$ ketoconazole itraconazole concomitant products terfenadine not recommended full examination potential interactions", "LBL": "0", "ID": "DDI-DrugBank.d743.s8.p6", "DRUGA": ["fluconazole", "drug", "80-90"], "DRUGB": ["metronidazole", "drug", "93-105"]}
{"TEXT1": "Due to chemical similarity azole antifungal agents type @DRUG$ metronidazole ketoconazole itraconazole concomitant products terfenadine not recommended full examination potential interactions", "LBL": "0", "ID": "DDI-DrugBank.d743.s8.p7", "DRUGA": ["fluconazole", "drug", "80-90"], "DRUGB": ["miconazole", "drug", "112-121"]}
{"TEXT1": "Due to chemical similarity azole antifungal agents type @DRUG$ metronidazole @DRUG$ itraconazole concomitant products terfenadine not recommended full examination potential interactions", "LBL": "0", "ID": "DDI-DrugBank.d743.s8.p8", "DRUGA": ["fluconazole", "drug", "80-90"], "DRUGB": ["ketoconazole", "drug", "127-138"]}
{"TEXT1": "Due to chemical similarity azole antifungal agents type @DRUG$ metronidazole ketoconazole @DRUG$ concomitant products terfenadine not recommended full examination potential interactions", "LBL": "0", "ID": "DDI-DrugBank.d743.s8.p9", "DRUGA": ["fluconazole", "drug", "80-90"], "DRUGB": ["itraconazole", "drug", "145-156"]}
{"TEXT1": "Due to chemical similarity azole antifungal agents type @DRUG$ metronidazole ketoconazole itraconazole concomitant products @DRUG$ not recommended full examination potential interactions", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d743.s8.p10", "DRUGA": ["fluconazole", "drug", "80-90"], "DRUGB": ["terfenadine", "drug", "198-208"]}
{"TEXT1": "Due to chemical similarity azole antifungal agents type fluconazole @DRUG$ ketoconazole itraconazole concomitant products terfenadine not recommended full examination potential interactions", "LBL": "0", "ID": "DDI-DrugBank.d743.s8.p11", "DRUGA": ["metronidazole", "drug", "93-105"], "DRUGB": ["miconazole", "drug", "112-121"]}
{"TEXT1": "Due to chemical similarity azole antifungal agents type fluconazole @DRUG$ @DRUG$ itraconazole concomitant products terfenadine not recommended full examination potential interactions", "LBL": "0", "ID": "DDI-DrugBank.d743.s8.p12", "DRUGA": ["metronidazole", "drug", "93-105"], "DRUGB": ["ketoconazole", "drug", "127-138"]}
{"TEXT1": "Due to chemical similarity azole antifungal agents type fluconazole @DRUG$ ketoconazole @DRUG$ concomitant products terfenadine not recommended full examination potential interactions", "LBL": "0", "ID": "DDI-DrugBank.d743.s8.p13", "DRUGA": ["metronidazole", "drug", "93-105"], "DRUGB": ["itraconazole", "drug", "145-156"]}
{"TEXT1": "Due to chemical similarity azole antifungal agents type fluconazole @DRUG$ ketoconazole itraconazole concomitant products @DRUG$ not recommended full examination potential interactions", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d743.s8.p14", "DRUGA": ["metronidazole", "drug", "93-105"], "DRUGB": ["terfenadine", "drug", "198-208"]}
{"TEXT1": "Due to chemical similarity azole antifungal agents type fluconazole metronidazole @DRUG$ itraconazole concomitant products terfenadine not recommended full examination potential interactions", "LBL": "0", "ID": "DDI-DrugBank.d743.s8.p15", "DRUGA": ["miconazole", "drug", "112-121"], "DRUGB": ["ketoconazole", "drug", "127-138"]}
{"TEXT1": "Due to chemical similarity azole antifungal agents type fluconazole metronidazole ketoconazole @DRUG$ concomitant products terfenadine not recommended full examination potential interactions", "LBL": "0", "ID": "DDI-DrugBank.d743.s8.p16", "DRUGA": ["miconazole", "drug", "112-121"], "DRUGB": ["itraconazole", "drug", "145-156"]}
{"TEXT1": "Due to chemical similarity azole antifungal agents type fluconazole metronidazole ketoconazole itraconazole concomitant products @DRUG$ not recommended full examination potential interactions", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d743.s8.p17", "DRUGA": ["miconazole", "drug", "112-121"], "DRUGB": ["terfenadine", "drug", "198-208"]}
{"TEXT1": "Due to chemical similarity azole antifungal agents type fluconazole metronidazole @DRUG$ @DRUG$ concomitant products terfenadine not recommended full examination potential interactions", "LBL": "0", "ID": "DDI-DrugBank.d743.s8.p18", "DRUGA": ["ketoconazole", "drug", "127-138"], "DRUGB": ["itraconazole", "drug", "145-156"]}
{"TEXT1": "Due to chemical similarity azole antifungal agents type fluconazole metronidazole @DRUG$ itraconazole concomitant products @DRUG$ not recommended full examination potential interactions", "LBL": "0", "ID": "DDI-DrugBank.d743.s8.p19", "DRUGA": ["ketoconazole", "drug", "127-138"], "DRUGB": ["terfenadine", "drug", "198-208"]}
{"TEXT1": "Due to chemical similarity azole antifungal agents type fluconazole metronidazole ketoconazole @DRUG$ concomitant products @DRUG$ not recommended full examination potential interactions", "LBL": "0", "ID": "DDI-DrugBank.d743.s8.p20", "DRUGA": ["itraconazole", "drug", "145-156"], "DRUGB": ["terfenadine", "drug", "198-208"]}
{"TEXT1": "drug interaction @DRUG$ clarithromycin exert effect terfenadine metabolism mechanism similar ketoconazole lesser extent", "LBL": "0", "ID": "DDI-DrugBank.d743.s9.p0", "DRUGA": ["Macrolides", "group", "0-9"], "DRUGB": ["erythromycin", "drug", "60-71"]}
{"TEXT1": "drug interaction erythromycin @DRUG$ exert effect terfenadine metabolism mechanism similar ketoconazole lesser extent", "LBL": "0", "ID": "DDI-DrugBank.d743.s9.p1", "DRUGA": ["Macrolides", "group", "0-9"], "DRUGB": ["clarithromycin", "drug", "77-90"]}
{"TEXT1": "drug interaction erythromycin clarithromycin exert effect @DRUG$ metabolism mechanism similar ketoconazole lesser extent", "LBL": "0", "ID": "DDI-DrugBank.d743.s9.p2", "DRUGA": ["Macrolides", "group", "0-9"], "DRUGB": ["terfenadine", "drug", "115-125"]}
{"TEXT1": "drug interaction erythromycin clarithromycin exert effect terfenadine metabolism mechanism similar @DRUG$ lesser extent", "LBL": "0", "ID": "DDI-DrugBank.d743.s9.p3", "DRUGA": ["Macrolides", "group", "0-9"], "DRUGB": ["ketoconazole", "drug", "185-196"]}
{"TEXT1": "drug interaction @DRUG$ @DRUG$ exert effect terfenadine metabolism mechanism similar ketoconazole lesser extent", "LBL": "0", "ID": "DDI-DrugBank.d743.s9.p4", "DRUGA": ["erythromycin", "drug", "60-71"], "DRUGB": ["clarithromycin", "drug", "77-90"]}
{"TEXT1": "drug interaction @DRUG$ clarithromycin exert effect @DRUG$ metabolism mechanism similar ketoconazole lesser extent", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d743.s9.p5", "DRUGA": ["erythromycin", "drug", "60-71"], "DRUGB": ["terfenadine", "drug", "115-125"]}
{"TEXT1": "drug interaction @DRUG$ clarithromycin exert effect terfenadine metabolism mechanism similar @DRUG$ lesser extent", "LBL": "0", "ID": "DDI-DrugBank.d743.s9.p6", "DRUGA": ["erythromycin", "drug", "60-71"], "DRUGB": ["ketoconazole", "drug", "185-196"]}
{"TEXT1": "drug interaction erythromycin @DRUG$ exert effect @DRUG$ metabolism mechanism similar ketoconazole lesser extent", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d743.s9.p7", "DRUGA": ["clarithromycin", "drug", "77-90"], "DRUGB": ["terfenadine", "drug", "115-125"]}
{"TEXT1": "drug interaction erythromycin @DRUG$ exert effect terfenadine metabolism mechanism similar @DRUG$ lesser extent", "LBL": "0", "ID": "DDI-DrugBank.d743.s9.p8", "DRUGA": ["clarithromycin", "drug", "77-90"], "DRUGB": ["ketoconazole", "drug", "185-196"]}
{"TEXT1": "drug interaction erythromycin clarithromycin exert effect @DRUG$ metabolism mechanism similar @DRUG$ lesser extent", "LBL": "0", "ID": "DDI-DrugBank.d743.s9.p9", "DRUGA": ["terfenadine", "drug", "115-125"], "DRUGB": ["ketoconazole", "drug", "185-196"]}
{"TEXT1": "spontaneous accounts QT interval prolongation ventricular arrhythmia including torsades de pointes reported patients receiving @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d743.s11.p0", "DRUGA": ["erythromycin", "drug", "155-166"], "DRUGB": ["troleandomycin", "drug", "171-184"]}
{"TEXT1": "administration @DRUG$ @DRUG$ erythromycin troleandomycin full characterization potential interactions concomitant terfenadine macrolide antibiotics including azithromycin not recommended", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d743.s12.p0", "DRUGA": ["terfenadine", "drug", "30-40"], "DRUGB": ["clarithromycin", "drug", "47-60"]}
{"TEXT1": "administration @DRUG$ clarithromycin @DRUG$ troleandomycin full characterization potential interactions concomitant terfenadine macrolide antibiotics including azithromycin not recommended", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d743.s12.p1", "DRUGA": ["terfenadine", "drug", "30-40"], "DRUGB": ["erythromycin", "drug", "63-74"]}
{"TEXT1": "administration @DRUG$ clarithromycin erythromycin @DRUG$ full characterization potential interactions concomitant terfenadine macrolide antibiotics including azithromycin not recommended", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d743.s12.p2", "DRUGA": ["terfenadine", "drug", "30-40"], "DRUGB": ["troleandomycin", "drug", "80-93"]}
{"TEXT1": "administration @DRUG$ clarithromycin erythromycin troleandomycin full characterization potential interactions concomitant @DRUG$ macrolide antibiotics including azithromycin not recommended", "LBL": "0", "ID": "DDI-DrugBank.d743.s12.p3", "DRUGA": ["terfenadine", "drug", "30-40"], "DRUGB": ["terfenadine", "drug", "202-212"]}
{"TEXT1": "administration @DRUG$ clarithromycin erythromycin troleandomycin full characterization potential interactions concomitant terfenadine @DRUG$ including azithromycin not recommended", "LBL": "0", "ID": "DDI-DrugBank.d743.s12.p4", "DRUGA": ["terfenadine", "drug", "30-40"], "DRUGB": ["macrolide antibiotics", "group", "225-245"]}
{"TEXT1": "administration @DRUG$ clarithromycin erythromycin troleandomycin full characterization potential interactions concomitant terfenadine macrolide antibiotics including @DRUG$ not recommended", "LBL": "0", "ID": "DDI-DrugBank.d743.s12.p5", "DRUGA": ["terfenadine", "drug", "30-40"], "DRUGB": ["azithromycin", "drug", "258-269"]}
{"TEXT1": "administration terfenadine @DRUG$ @DRUG$ troleandomycin full characterization potential interactions concomitant macrolide antibiotics including azithromycin not recommended", "LBL": "0", "ID": "DDI-DrugBank.d743.s12.p6", "DRUGA": ["clarithromycin", "drug", "47-60"], "DRUGB": ["erythromycin", "drug", "63-74"]}
{"TEXT1": "administration terfenadine @DRUG$ erythromycin @DRUG$ full characterization potential interactions concomitant macrolide antibiotics including azithromycin not recommended", "LBL": "0", "ID": "DDI-DrugBank.d743.s12.p7", "DRUGA": ["clarithromycin", "drug", "47-60"], "DRUGB": ["troleandomycin", "drug", "80-93"]}
{"TEXT1": "administration terfenadine @DRUG$ erythromycin troleandomycin full characterization potential interactions concomitant @DRUG$ macrolide antibiotics including azithromycin not recommended", "LBL": "0", "ID": "DDI-DrugBank.d743.s12.p8", "DRUGA": ["clarithromycin", "drug", "47-60"], "DRUGB": ["terfenadine", "drug", "202-212"]}
{"TEXT1": "administration terfenadine @DRUG$ erythromycin troleandomycin full characterization potential interactions concomitant @DRUG$ including azithromycin not recommended", "LBL": "0", "ID": "DDI-DrugBank.d743.s12.p9", "DRUGA": ["clarithromycin", "drug", "47-60"], "DRUGB": ["macrolide antibiotics", "group", "225-245"]}
{"TEXT1": "administration terfenadine @DRUG$ erythromycin troleandomycin full characterization potential interactions concomitant macrolide antibiotics including @DRUG$ not recommended", "LBL": "0", "ID": "DDI-DrugBank.d743.s12.p10", "DRUGA": ["clarithromycin", "drug", "47-60"], "DRUGB": ["azithromycin", "drug", "258-269"]}
{"TEXT1": "administration terfenadine clarithromycin @DRUG$ @DRUG$ full characterization potential interactions concomitant macrolide antibiotics including azithromycin not recommended", "LBL": "0", "ID": "DDI-DrugBank.d743.s12.p11", "DRUGA": ["erythromycin", "drug", "63-74"], "DRUGB": ["troleandomycin", "drug", "80-93"]}
{"TEXT1": "administration terfenadine clarithromycin @DRUG$ troleandomycin full characterization potential interactions concomitant @DRUG$ macrolide antibiotics including azithromycin not recommended", "LBL": "0", "ID": "DDI-DrugBank.d743.s12.p12", "DRUGA": ["erythromycin", "drug", "63-74"], "DRUGB": ["terfenadine", "drug", "202-212"]}
{"TEXT1": "administration terfenadine clarithromycin @DRUG$ troleandomycin full characterization potential interactions concomitant @DRUG$ including azithromycin not recommended", "LBL": "0", "ID": "DDI-DrugBank.d743.s12.p13", "DRUGA": ["erythromycin", "drug", "63-74"], "DRUGB": ["macrolide antibiotics", "group", "225-245"]}
{"TEXT1": "administration terfenadine clarithromycin @DRUG$ troleandomycin full characterization potential interactions concomitant macrolide antibiotics including @DRUG$ not recommended", "LBL": "0", "ID": "DDI-DrugBank.d743.s12.p14", "DRUGA": ["erythromycin", "drug", "63-74"], "DRUGB": ["azithromycin", "drug", "258-269"]}
{"TEXT1": "administration terfenadine clarithromycin erythromycin @DRUG$ full characterization potential interactions concomitant @DRUG$ macrolide antibiotics including azithromycin not recommended", "LBL": "0", "ID": "DDI-DrugBank.d743.s12.p15", "DRUGA": ["troleandomycin", "drug", "80-93"], "DRUGB": ["terfenadine", "drug", "202-212"]}
{"TEXT1": "administration terfenadine clarithromycin erythromycin @DRUG$ full characterization potential interactions concomitant @DRUG$ including azithromycin not recommended", "LBL": "0", "ID": "DDI-DrugBank.d743.s12.p16", "DRUGA": ["troleandomycin", "drug", "80-93"], "DRUGB": ["macrolide antibiotics", "group", "225-245"]}
{"TEXT1": "administration terfenadine clarithromycin erythromycin @DRUG$ full characterization potential interactions concomitant macrolide antibiotics including @DRUG$ not recommended", "LBL": "0", "ID": "DDI-DrugBank.d743.s12.p17", "DRUGA": ["troleandomycin", "drug", "80-93"], "DRUGB": ["azithromycin", "drug", "258-269"]}
{"TEXT1": "administration terfenadine clarithromycin erythromycin troleandomycin full characterization potential interactions concomitant @DRUG$ @DRUG$ including azithromycin not recommended", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d743.s12.p18", "DRUGA": ["terfenadine", "drug", "202-212"], "DRUGB": ["macrolide antibiotics", "group", "225-245"]}
{"TEXT1": "administration terfenadine clarithromycin erythromycin troleandomycin full characterization potential interactions concomitant @DRUG$ macrolide antibiotics including @DRUG$ not recommended", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d743.s12.p19", "DRUGA": ["terfenadine", "drug", "202-212"], "DRUGB": ["azithromycin", "drug", "258-269"]}
{"TEXT1": "administration terfenadine clarithromycin erythromycin troleandomycin full characterization potential interactions concomitant @DRUG$ including @DRUG$ not recommended", "LBL": "0", "ID": "DDI-DrugBank.d743.s12.p20", "DRUGA": ["macrolide antibiotics", "group", "225-245"], "DRUGB": ["azithromycin", "drug", "258-269"]}
{"TEXT1": "Studies to evaluate potential interactions @DRUG$ @DRUG$ in progress", "LBL": "0", "ID": "DDI-DrugBank.d743.s13.p0", "DRUGA": ["terfenadine", "drug", "46-56"], "DRUGB": ["azithromycin", "drug", "63-74"]}
{"TEXT1": "recommended administering @DRUG$ compounds UGT1A1 pathway", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d602.s0.p0", "DRUGA": ["NEXAVAR", "brand", "42-48"], "DRUGB": ["irinotecan", "drug", "139-148"]}
{"TEXT1": "Concomitant treatment @DRUG$ resulted increase AUC @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d602.s1.p0", "DRUGA": ["NEXAVAR", "brand", "27-33"], "DRUGB": ["doxorubicin", "drug", "76-86"]}
{"TEXT1": "recommended administering @DRUG$ @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d602.s2.p0", "DRUGA": ["doxorubicin", "drug", "42-52"], "DRUGB": ["NEXAVAR", "brand", "59-65"]}
{"TEXT1": "pharmacokinetic study chronic patients receiving @DRUG$ treatment @DRUG$ once weekly weeks mean increase methadone", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d741.s0.p0", "DRUGA": ["methadone", "drug", "86-94"], "DRUGB": ["PEG-Intron", "brand", "112-121"]}
{"TEXT1": "pharmacokinetic study chronic patients receiving @DRUG$ treatment once weekly weeks mean increase @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d741.s0.p1", "DRUGA": ["methadone", "drug", "86-94"], "DRUGB": ["methadone", "drug", "193-201"]}
{"TEXT1": "pharmacokinetic study chronic patients receiving methadone treatment @DRUG$ once weekly weeks mean increase @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d741.s0.p2", "DRUGA": ["PEG-Intron", "brand", "112-121"], "DRUGB": ["methadone", "drug", "193-201"]}
{"TEXT1": "@DRUG$ substrate metabolic pathways involving CYP2D6 CYP1A2 enzymes inhibition expected to alter @DRUG$ plasma concentrations", "LBL": "0", "ID": "DDI-DrugBank.d633.s0.p0", "DRUGA": ["MEXITIL", "brand", "6-12"], "DRUGB": ["mexiletine", "drug", "171-180"]}
{"TEXT1": "formal dose single interaction study clearance @DRUG$ decreased following coadministration @DRUG$ inhibitor CYP1A2", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d633.s1.p0", "DRUGA": ["mexiletine", "drug", "74-83"], "DRUGB": ["fluvoxamine", "drug", "140-150"]}
{"TEXT1": "formal study extensive n coadministration @DRUG$ not alter kinetics @DRUG$ CYP2D6 group", "LBL": "0", "ID": "DDI-DrugBank.d633.s2.p0", "DRUGA": ["propafenone", "drug", "101-111"], "DRUGB": ["mexiletine", "drug", "143-152"]}
{"TEXT1": "steady state pharmacokinetics @DRUG$ unaffected phenotype coadministration @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d633.s4.p0", "DRUGA": ["propafenone", "drug", "62-72"], "DRUGB": ["mexiletine", "drug", "137-146"]}
{"TEXT1": "Addition @DRUG$ @DRUG$ not lead electrocardiographic further parameters changes RR PR intervals propafenone alone", "LBL": "0", "ID": "DDI-DrugBank.d633.s5.p0", "DRUGA": ["mexiletine", "drug", "12-21"], "DRUGB": ["propafenone", "drug", "26-36"]}
{"TEXT1": "Addition @DRUG$ propafenone not lead electrocardiographic further parameters changes RR PR intervals @DRUG$ alone", "LBL": "0", "ID": "DDI-DrugBank.d633.s5.p1", "DRUGA": ["mexiletine", "drug", "12-21"], "DRUGB": ["propafenone", "drug", "141-151"]}
{"TEXT1": "Addition mexiletine @DRUG$ not lead electrocardiographic further parameters changes RR PR intervals @DRUG$ alone", "LBL": "0", "ID": "DDI-DrugBank.d633.s5.p2", "DRUGA": ["propafenone", "drug", "26-36"], "DRUGB": ["propafenone", "drug", "141-151"]}
{"TEXT1": "concomitant two @DRUG$ initiated @DRUG$ slowly titrated desired effect", "LBL": "0", "ID": "DDI-DrugBank.d633.s6.p0", "DRUGA": ["mexiletine", "drug", "66-75"], "DRUGB": ["mexiletine", "drug", "103-112"]}
{"TEXT1": "large compassionate use program @DRUG$ used employed antianginal @DRUG$ anticoagulant drugs observed interactions", "LBL": "0", "ID": "DDI-DrugBank.d633.s7.p0", "DRUGA": ["Mexitil", "brand", "37-43"], "DRUGB": ["antihypertensive", "group", "111-126"]}
{"TEXT1": "large compassionate use program @DRUG$ used employed antianginal antihypertensive @DRUG$ observed interactions", "LBL": "0", "ID": "DDI-DrugBank.d633.s7.p1", "DRUGA": ["Mexitil", "brand", "37-43"], "DRUGB": ["anticoagulant drugs", "group", "133-151"]}
{"TEXT1": "large compassionate use program Mexitil used employed antianginal @DRUG$ @DRUG$ observed interactions", "LBL": "0", "ID": "DDI-DrugBank.d633.s7.p2", "DRUGA": ["antihypertensive", "group", "111-126"], "DRUGB": ["anticoagulant drugs", "group", "133-151"]}
{"TEXT1": "variety @DRUG$ @DRUG$ propranolol added sometimes improved control ventricular ectopy", "LBL": "0", "ID": "DDI-DrugBank.d633.s8.p0", "DRUGA": ["antiarrhythmics", "group", "13-27"], "DRUGB": ["quinidine", "drug", "37-45"]}
{"TEXT1": "variety @DRUG$ quinidine @DRUG$ added sometimes improved control ventricular ectopy", "LBL": "0", "ID": "DDI-DrugBank.d633.s8.p1", "DRUGA": ["antiarrhythmics", "group", "13-27"], "DRUGB": ["propranolol", "drug", "50-60"]}
{"TEXT1": "variety antiarrhythmics @DRUG$ @DRUG$ added sometimes improved control ventricular ectopy", "LBL": "0", "ID": "DDI-DrugBank.d633.s8.p2", "DRUGA": ["quinidine", "drug", "37-45"], "DRUGB": ["propranolol", "drug", "50-60"]}
{"TEXT1": "@DRUG$ hepatic enzyme inducers @DRUG$ phenobarbital taken Mexitil lowered plasma levels reported", "LBL": "0", "ID": "DDI-DrugBank.d633.s9.p0", "DRUGA": ["phenytoin", "drug", "5-13"], "DRUGB": ["rifampin", "drug", "56-63"]}
{"TEXT1": "@DRUG$ hepatic enzyme inducers rifampin @DRUG$ taken Mexitil lowered plasma levels reported", "LBL": "0", "ID": "DDI-DrugBank.d633.s9.p1", "DRUGA": ["phenytoin", "drug", "5-13"], "DRUGB": ["phenobarbital", "drug", "69-81"]}
{"TEXT1": "@DRUG$ hepatic enzyme inducers rifampin phenobarbital taken @DRUG$ lowered Mexitil plasma levels reported", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d633.s9.p2", "DRUGA": ["phenytoin", "drug", "5-13"], "DRUGB": ["Mexitil", "brand", "117-123"]}
{"TEXT1": "@DRUG$ hepatic enzyme inducers rifampin phenobarbital taken Mexitil lowered @DRUG$ plasma levels reported", "LBL": "0", "ID": "DDI-DrugBank.d633.s9.p3", "DRUGA": ["phenytoin", "drug", "5-13"], "DRUGB": ["Mexitil", "brand", "137-143"]}
{"TEXT1": "phenytoin hepatic enzyme inducers @DRUG$ @DRUG$ taken Mexitil lowered plasma levels reported", "LBL": "0", "ID": "DDI-DrugBank.d633.s9.p4", "DRUGA": ["rifampin", "drug", "56-63"], "DRUGB": ["phenobarbital", "drug", "69-81"]}
{"TEXT1": "phenytoin hepatic enzyme inducers @DRUG$ phenobarbital taken @DRUG$ lowered Mexitil plasma levels reported", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d633.s9.p5", "DRUGA": ["rifampin", "drug", "56-63"], "DRUGB": ["Mexitil", "brand", "117-123"]}
{"TEXT1": "phenytoin hepatic enzyme inducers @DRUG$ phenobarbital taken Mexitil lowered @DRUG$ plasma levels reported", "LBL": "0", "ID": "DDI-DrugBank.d633.s9.p6", "DRUGA": ["rifampin", "drug", "56-63"], "DRUGB": ["Mexitil", "brand", "137-143"]}
{"TEXT1": "phenytoin hepatic enzyme inducers rifampin @DRUG$ taken @DRUG$ lowered Mexitil plasma levels reported", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d633.s9.p7", "DRUGA": ["phenobarbital", "drug", "69-81"], "DRUGB": ["Mexitil", "brand", "117-123"]}
{"TEXT1": "phenytoin hepatic enzyme inducers rifampin @DRUG$ taken Mexitil lowered @DRUG$ plasma levels reported", "LBL": "0", "ID": "DDI-DrugBank.d633.s9.p8", "DRUGA": ["phenobarbital", "drug", "69-81"], "DRUGB": ["Mexitil", "brand", "137-143"]}
{"TEXT1": "phenytoin hepatic enzyme inducers rifampin phenobarbital taken @DRUG$ lowered @DRUG$ plasma levels reported", "LBL": "0", "ID": "DDI-DrugBank.d633.s9.p9", "DRUGA": ["Mexitil", "brand", "117-123"], "DRUGB": ["Mexitil", "brand", "137-143"]}
{"TEXT1": "formal study @DRUG$ shown not to affect @DRUG$ plasma concentrations", "LBL": "0", "ID": "DDI-DrugBank.d633.s11.p0", "DRUGA": ["benzodiazepines", "group", "19-33"], "DRUGB": ["Mexitil", "brand", "60-66"]}
{"TEXT1": "ECG intervals not affected concurrent @DRUG$ @DRUG$ diuretics propranolol", "LBL": "0", "ID": "DDI-DrugBank.d633.s12.p0", "DRUGA": ["Mexitil", "brand", "64-70"], "DRUGB": ["digoxin", "drug", "79-85"]}
{"TEXT1": "ECG intervals not affected concurrent @DRUG$ digoxin @DRUG$ propranolol", "LBL": "0", "ID": "DDI-DrugBank.d633.s12.p1", "DRUGA": ["Mexitil", "brand", "64-70"], "DRUGB": ["diuretics", "group", "88-96"]}
{"TEXT1": "ECG intervals not affected concurrent @DRUG$ digoxin diuretics @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d633.s12.p2", "DRUGA": ["Mexitil", "brand", "64-70"], "DRUGB": ["propranolol", "drug", "102-112"]}
{"TEXT1": "ECG intervals not affected concurrent Mexitil @DRUG$ @DRUG$ propranolol", "LBL": "0", "ID": "DDI-DrugBank.d633.s12.p3", "DRUGA": ["digoxin", "drug", "79-85"], "DRUGB": ["diuretics", "group", "88-96"]}
{"TEXT1": "ECG intervals not affected concurrent Mexitil @DRUG$ diuretics @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d633.s12.p4", "DRUGA": ["digoxin", "drug", "79-85"], "DRUGB": ["propranolol", "drug", "102-112"]}
{"TEXT1": "ECG intervals not affected concurrent Mexitil digoxin @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d633.s12.p5", "DRUGA": ["diuretics", "group", "88-96"], "DRUGB": ["propranolol", "drug", "102-112"]}
{"TEXT1": "Concurrent administration @DRUG$ @DRUG$ reported to increase decrease leave unchanged Mexitil plasma", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d633.s13.p0", "DRUGA": ["cimetidine", "drug", "29-38"], "DRUGB": ["Mexitil", "brand", "44-50"]}
{"TEXT1": "Concurrent administration @DRUG$ Mexitil reported to increase decrease leave unchanged @DRUG$ plasma", "LBL": "0", "ID": "DDI-DrugBank.d633.s13.p1", "DRUGA": ["cimetidine", "drug", "29-38"], "DRUGB": ["Mexitil", "brand", "115-121"]}
{"TEXT1": "Concurrent administration cimetidine @DRUG$ reported to increase decrease leave unchanged @DRUG$ plasma", "LBL": "0", "ID": "DDI-DrugBank.d633.s13.p2", "DRUGA": ["Mexitil", "brand", "44-50"], "DRUGB": ["Mexitil", "brand", "115-121"]}
{"TEXT1": "@DRUG$ not alter serum digoxin levels @DRUG$ used to treat gastrointestinal symptoms Mexitil reported lower", "LBL": "0", "ID": "DDI-DrugBank.d633.s15.p0", "DRUGA": ["Mexitil", "brand", "0-6"], "DRUGB": ["digoxin", "drug", "32-38"]}
{"TEXT1": "@DRUG$ not alter serum digoxin levels @DRUG$ used to treat gastrointestinal symptoms Mexitil reported lower", "LBL": "0", "ID": "DDI-DrugBank.d633.s15.p1", "DRUGA": ["Mexitil", "brand", "0-6"], "DRUGB": ["magnesium-aluminum hydroxide", "drug", "51-78"]}
{"TEXT1": "@DRUG$ not alter serum digoxin levels used to treat gastrointestinal symptoms @DRUG$ reported lower", "LBL": "0", "ID": "DDI-DrugBank.d633.s15.p2", "DRUGA": ["Mexitil", "brand", "0-6"], "DRUGB": ["Mexitil", "brand", "133-139"]}
{"TEXT1": "@DRUG$ not alter serum digoxin levels used to treat gastrointestinal symptoms Mexitil reported lower @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d633.s15.p3", "DRUGA": ["Mexitil", "brand", "0-6"], "DRUGB": ["digoxin", "drug", "178-184"]}
{"TEXT1": "Mexitil not alter serum digoxin levels @DRUG$ @DRUG$ used to treat gastrointestinal symptoms reported lower", "LBL": "0", "ID": "DDI-DrugBank.d633.s15.p4", "DRUGA": ["digoxin", "drug", "32-38"], "DRUGB": ["magnesium-aluminum hydroxide", "drug", "51-78"]}
{"TEXT1": "Mexitil not alter serum digoxin levels @DRUG$ used to treat gastrointestinal symptoms @DRUG$ reported lower", "LBL": "0", "ID": "DDI-DrugBank.d633.s15.p5", "DRUGA": ["digoxin", "drug", "32-38"], "DRUGB": ["Mexitil", "brand", "133-139"]}
{"TEXT1": "Mexitil not alter serum digoxin levels @DRUG$ used to treat gastrointestinal symptoms reported lower @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d633.s15.p6", "DRUGA": ["digoxin", "drug", "32-38"], "DRUGB": ["digoxin", "drug", "178-184"]}
{"TEXT1": "Mexitil not alter serum digoxin levels @DRUG$ used to treat gastrointestinal symptoms @DRUG$ reported lower", "LBL": "0", "ID": "DDI-DrugBank.d633.s15.p7", "DRUGA": ["magnesium-aluminum hydroxide", "drug", "51-78"], "DRUGB": ["Mexitil", "brand", "133-139"]}
{"TEXT1": "Mexitil not alter serum digoxin levels @DRUG$ used to treat gastrointestinal symptoms reported lower @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d633.s15.p8", "DRUGA": ["magnesium-aluminum hydroxide", "drug", "51-78"], "DRUGB": ["digoxin", "drug", "178-184"]}
{"TEXT1": "Mexitil not alter serum digoxin levels used to treat gastrointestinal symptoms @DRUG$ reported lower @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d633.s15.p9", "DRUGA": ["Mexitil", "brand", "133-139"], "DRUGB": ["digoxin", "drug", "178-184"]}
{"TEXT1": "Concurrent use of @DRUG$ @DRUG$ lead increased plasma theophylline levels theophylline", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d633.s16.p0", "DRUGA": ["Mexitil", "brand", "18-24"], "DRUGB": ["theophylline", "drug", "33-44"]}
{"TEXT1": "Concurrent use of @DRUG$ theophylline lead increased @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d633.s16.p1", "DRUGA": ["Mexitil", "brand", "18-24"], "DRUGB": ["theophylline", "drug", "75-86"]}
{"TEXT1": "Concurrent use of Mexitil @DRUG$ lead increased @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d633.s16.p2", "DRUGA": ["theophylline", "drug", "33-44"], "DRUGB": ["theophylline", "drug", "75-86"]}
{"TEXT1": "increase observed first test point second day starting @DRUG$ @DRUG$ returned to pre Mexitil values 48 hours discontinuing theophylline used blood monitored dose changed", "LBL": "0", "ID": "DDI-DrugBank.d633.s18.p0", "DRUGA": ["Mexitil", "brand", "91-97"], "DRUGB": ["Theophylline", "drug", "103-114"]}
{"TEXT1": "increase observed first test point second day starting @DRUG$ Theophylline plasma levels returned to pre @DRUG$ values 48 hours discontinuing Mexitil theophylline used blood monitored dose changed", "LBL": "0", "ID": "DDI-DrugBank.d633.s18.p1", "DRUGA": ["Mexitil", "brand", "91-97"], "DRUGB": ["Mexitil", "brand", "146-152"]}
{"TEXT1": "increase observed first test point second day starting @DRUG$ Theophylline plasma levels returned to pre Mexitil values 48 hours discontinuing @DRUG$ theophylline used blood monitored dose changed", "LBL": "0", "ID": "DDI-DrugBank.d633.s18.p2", "DRUGA": ["Mexitil", "brand", "91-97"], "DRUGB": ["Mexitil", "brand", "200-206"]}
{"TEXT1": "increase observed first test point second day starting @DRUG$ Theophylline plasma levels returned to pre Mexitil values 48 hours discontinuing @DRUG$ theophylline used blood monitored dose changed", "LBL": "0", "ID": "DDI-DrugBank.d633.s18.p3", "DRUGA": ["Mexitil", "brand", "91-97"], "DRUGB": ["Mexitil", "brand", "215-221"]}
{"TEXT1": "increase observed first test point second day starting @DRUG$ Theophylline plasma levels returned to pre Mexitil values 48 hours discontinuing @DRUG$ used theophylline blood monitored dose changed", "LBL": "0", "ID": "DDI-DrugBank.d633.s18.p4", "DRUGA": ["Mexitil", "brand", "91-97"], "DRUGB": ["theophylline", "drug", "227-238"]}
{"TEXT1": "increase observed first test point second day starting @DRUG$ Theophylline plasma levels returned to pre Mexitil values 48 hours discontinuing theophylline used @DRUG$ blood monitored dose changed", "LBL": "0", "ID": "DDI-DrugBank.d633.s18.p5", "DRUGA": ["Mexitil", "brand", "91-97"], "DRUGB": ["theophylline", "drug", "269-280"]}
{"TEXT1": "increase observed first test point second day starting @DRUG$ Theophylline plasma levels returned to pre Mexitil values 48 hours discontinuing theophylline used blood monitored @DRUG$ dose changed", "LBL": "0", "ID": "DDI-DrugBank.d633.s18.p6", "DRUGA": ["Mexitil", "brand", "91-97"], "DRUGB": ["Mexitil", "brand", "338-344"]}
{"TEXT1": "increase observed first test point second day starting Mexitil @DRUG$ returned to pre @DRUG$ values 48 hours discontinuing theophylline used blood monitored dose changed", "LBL": "0", "ID": "DDI-DrugBank.d633.s18.p7", "DRUGA": ["Theophylline", "drug", "103-114"], "DRUGB": ["Mexitil", "brand", "146-152"]}
{"TEXT1": "increase observed first test point second day starting Mexitil @DRUG$ returned to pre values 48 hours discontinuing @DRUG$ theophylline used blood monitored dose changed", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d633.s18.p8", "DRUGA": ["Theophylline", "drug", "103-114"], "DRUGB": ["Mexitil", "brand", "200-206"]}
{"TEXT1": "increase observed first test point second day starting Mexitil @DRUG$ returned to pre values 48 hours discontinuing @DRUG$ theophylline used blood monitored dose changed", "LBL": "0", "ID": "DDI-DrugBank.d633.s18.p9", "DRUGA": ["Theophylline", "drug", "103-114"], "DRUGB": ["Mexitil", "brand", "215-221"]}
{"TEXT1": "increase observed first test point second day starting Mexitil @DRUG$ returned to pre values 48 hours discontinuing @DRUG$ used theophylline blood monitored dose changed", "LBL": "0", "ID": "DDI-DrugBank.d633.s18.p10", "DRUGA": ["Theophylline", "drug", "103-114"], "DRUGB": ["theophylline", "drug", "227-238"]}
{"TEXT1": "increase observed first test point second day starting Mexitil @DRUG$ returned to pre values 48 hours discontinuing theophylline used @DRUG$ blood monitored dose changed", "LBL": "0", "ID": "DDI-DrugBank.d633.s18.p11", "DRUGA": ["Theophylline", "drug", "103-114"], "DRUGB": ["theophylline", "drug", "269-280"]}
{"TEXT1": "increase observed first test point second day starting Mexitil @DRUG$ returned to pre values 48 hours discontinuing theophylline used blood monitored @DRUG$ dose changed", "LBL": "0", "ID": "DDI-DrugBank.d633.s18.p12", "DRUGA": ["Theophylline", "drug", "103-114"], "DRUGB": ["Mexitil", "brand", "338-344"]}
{"TEXT1": "increase observed first test point second day starting Mexitil Theophylline plasma levels returned to pre @DRUG$ values 48 hours discontinuing @DRUG$ theophylline used blood monitored dose changed", "LBL": "0", "ID": "DDI-DrugBank.d633.s18.p13", "DRUGA": ["Mexitil", "brand", "146-152"], "DRUGB": ["Mexitil", "brand", "200-206"]}
{"TEXT1": "increase observed first test point second day starting Mexitil Theophylline plasma levels returned to pre @DRUG$ values 48 hours discontinuing @DRUG$ theophylline used blood monitored dose changed", "LBL": "0", "ID": "DDI-DrugBank.d633.s18.p14", "DRUGA": ["Mexitil", "brand", "146-152"], "DRUGB": ["Mexitil", "brand", "215-221"]}
{"TEXT1": "increase observed first test point second day starting Mexitil Theophylline plasma levels returned to pre @DRUG$ values 48 hours discontinuing @DRUG$ used theophylline blood monitored dose changed", "LBL": "0", "ID": "DDI-DrugBank.d633.s18.p15", "DRUGA": ["Mexitil", "brand", "146-152"], "DRUGB": ["theophylline", "drug", "227-238"]}
{"TEXT1": "increase observed first test point second day starting Mexitil Theophylline plasma levels returned to pre @DRUG$ values 48 hours discontinuing theophylline used @DRUG$ blood monitored dose changed", "LBL": "0", "ID": "DDI-DrugBank.d633.s18.p16", "DRUGA": ["Mexitil", "brand", "146-152"], "DRUGB": ["theophylline", "drug", "269-280"]}
{"TEXT1": "increase observed first test point second day starting Mexitil Theophylline plasma levels returned to pre @DRUG$ values 48 hours discontinuing theophylline used blood monitored @DRUG$ dose changed", "LBL": "0", "ID": "DDI-DrugBank.d633.s18.p17", "DRUGA": ["Mexitil", "brand", "146-152"], "DRUGB": ["Mexitil", "brand", "338-344"]}
{"TEXT1": "increase observed first test point second day starting Mexitil Theophylline plasma levels returned to pre values 48 hours discontinuing @DRUG$ @DRUG$ theophylline used blood monitored dose changed", "LBL": "0", "ID": "DDI-DrugBank.d633.s18.p18", "DRUGA": ["Mexitil", "brand", "200-206"], "DRUGB": ["Mexitil", "brand", "215-221"]}
{"TEXT1": "increase observed first test point second day starting Mexitil Theophylline plasma levels returned to pre values 48 hours discontinuing @DRUG$ @DRUG$ used theophylline blood monitored dose changed", "LBL": "0", "ID": "DDI-DrugBank.d633.s18.p19", "DRUGA": ["Mexitil", "brand", "200-206"], "DRUGB": ["theophylline", "drug", "227-238"]}
{"TEXT1": "increase observed first test point second day starting Mexitil Theophylline plasma levels returned to pre values 48 hours discontinuing @DRUG$ theophylline used @DRUG$ blood monitored dose changed", "LBL": "0", "ID": "DDI-DrugBank.d633.s18.p20", "DRUGA": ["Mexitil", "brand", "200-206"], "DRUGB": ["theophylline", "drug", "269-280"]}
{"TEXT1": "increase observed first test point second day starting Mexitil Theophylline plasma levels returned to pre values 48 hours discontinuing @DRUG$ theophylline used blood monitored @DRUG$ dose changed", "LBL": "0", "ID": "DDI-DrugBank.d633.s18.p21", "DRUGA": ["Mexitil", "brand", "200-206"], "DRUGB": ["Mexitil", "brand", "338-344"]}
{"TEXT1": "increase observed first test point second day starting Mexitil Theophylline plasma levels returned to pre values 48 hours discontinuing @DRUG$ @DRUG$ used theophylline blood monitored dose changed", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d633.s18.p22", "DRUGA": ["Mexitil", "brand", "215-221"], "DRUGB": ["theophylline", "drug", "227-238"]}
{"TEXT1": "increase observed first test point second day starting Mexitil Theophylline plasma levels returned to pre values 48 hours discontinuing @DRUG$ theophylline used @DRUG$ blood monitored dose changed", "LBL": "0", "ID": "DDI-DrugBank.d633.s18.p23", "DRUGA": ["Mexitil", "brand", "215-221"], "DRUGB": ["theophylline", "drug", "269-280"]}
{"TEXT1": "increase observed first test point second day starting Mexitil Theophylline plasma levels returned to pre values 48 hours discontinuing @DRUG$ theophylline used blood monitored @DRUG$ dose changed", "LBL": "0", "ID": "DDI-DrugBank.d633.s18.p24", "DRUGA": ["Mexitil", "brand", "215-221"], "DRUGB": ["Mexitil", "brand", "338-344"]}
{"TEXT1": "increase observed first test point second day starting Mexitil Theophylline plasma levels returned to pre values 48 hours discontinuing @DRUG$ used @DRUG$ blood monitored dose changed", "LBL": "0", "ID": "DDI-DrugBank.d633.s18.p25", "DRUGA": ["theophylline", "drug", "227-238"], "DRUGB": ["theophylline", "drug", "269-280"]}
{"TEXT1": "increase observed first test point second day starting Mexitil Theophylline plasma levels returned to pre values 48 hours discontinuing @DRUG$ used theophylline blood monitored @DRUG$ dose changed", "LBL": "0", "ID": "DDI-DrugBank.d633.s18.p26", "DRUGA": ["theophylline", "drug", "227-238"], "DRUGB": ["Mexitil", "brand", "338-344"]}
{"TEXT1": "increase observed first test point second day starting Mexitil Theophylline plasma levels returned to pre values 48 hours discontinuing theophylline used @DRUG$ blood monitored @DRUG$ dose changed", "LBL": "0", "ID": "DDI-DrugBank.d633.s18.p27", "DRUGA": ["theophylline", "drug", "269-280"], "DRUGB": ["Mexitil", "brand", "338-344"]}
{"TEXT1": "one controlled five normal seven patients clearance @DRUG$ decreased following administration @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d633.s20.p0", "DRUGA": ["caffeine", "drug", "99-106"], "DRUGB": ["Mexitil", "brand", "158-164"]}
{"TEXT1": "Usage Due to potential CNS depressants @DRUG$ used with caution patients currently receiving pentazocine", "LBL": "0", "ID": "DDI-DrugBank.d757.s0.p0", "DRUGA": ["Alcohol", "drug", "11-17"], "DRUGB": ["alcohol", "drug", "80-86"]}
{"TEXT1": "Usage Due to potential CNS depressants alcohol used with caution patients currently receiving @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d757.s0.p1", "DRUGA": ["Alcohol", "drug", "11-17"], "DRUGB": ["pentazocine", "drug", "156-166"]}
{"TEXT1": "Usage Due to potential CNS depressants @DRUG$ used with caution patients currently receiving @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d757.s0.p2", "DRUGA": ["alcohol", "drug", "80-86"], "DRUGB": ["pentazocine", "drug", "156-166"]}
{"TEXT1": "@DRUG$ drugs @DRUG$ sites of metabolism liver elevating serum levels compounds toxic", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d686.s0.p0", "DRUGA": ["Thiabendazole", "drug", "0-12"], "DRUGB": ["theophylline", "drug", "52-63"]}
{"TEXT1": "concomitant use of @DRUG$ @DRUG$ anticipated to monitor blood levels dosage compounds", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d686.s1.p0", "DRUGA": ["thiabendazole", "drug", "35-47"], "DRUGB": ["xanthine derivatives", "group", "53-72"]}
{"TEXT1": "@DRUG$ used @DRUG$ quinine antimalarials antibiotics", "LBL": "0", "ID": "DDI-DrugBank.d631.s0.p0", "DRUGA": ["Pyrimethamine", "drug", "0-12"], "DRUGB": ["sulfonamides", "group", "31-42"]}
{"TEXT1": "@DRUG$ used sulfonamides @DRUG$ antimalarials antibiotics", "LBL": "0", "ID": "DDI-DrugBank.d631.s0.p1", "DRUGA": ["Pyrimethamine", "drug", "0-12"], "DRUGB": ["quinine", "drug", "45-51"]}
{"TEXT1": "@DRUG$ used sulfonamides quinine @DRUG$ antibiotics", "LBL": "0", "ID": "DDI-DrugBank.d631.s0.p2", "DRUGA": ["Pyrimethamine", "drug", "0-12"], "DRUGB": ["antimalarials", "group", "63-75"]}
{"TEXT1": "@DRUG$ used sulfonamides quinine antimalarials @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d631.s0.p3", "DRUGA": ["Pyrimethamine", "drug", "0-12"], "DRUGB": ["antibiotics", "group", "93-103"]}
{"TEXT1": "Pyrimethamine used @DRUG$ @DRUG$ antimalarials antibiotics", "LBL": "0", "ID": "DDI-DrugBank.d631.s0.p4", "DRUGA": ["sulfonamides", "group", "31-42"], "DRUGB": ["quinine", "drug", "45-51"]}
{"TEXT1": "Pyrimethamine used @DRUG$ quinine @DRUG$ antibiotics", "LBL": "0", "ID": "DDI-DrugBank.d631.s0.p5", "DRUGA": ["sulfonamides", "group", "31-42"], "DRUGB": ["antimalarials", "group", "63-75"]}
{"TEXT1": "Pyrimethamine used @DRUG$ quinine antimalarials @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d631.s0.p6", "DRUGA": ["sulfonamides", "group", "31-42"], "DRUGB": ["antibiotics", "group", "93-103"]}
{"TEXT1": "Pyrimethamine used sulfonamides @DRUG$ @DRUG$ antibiotics", "LBL": "0", "ID": "DDI-DrugBank.d631.s0.p7", "DRUGA": ["quinine", "drug", "45-51"], "DRUGB": ["antimalarials", "group", "63-75"]}
{"TEXT1": "Pyrimethamine used sulfonamides @DRUG$ antimalarials @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d631.s0.p8", "DRUGA": ["quinine", "drug", "45-51"], "DRUGB": ["antibiotics", "group", "93-103"]}
{"TEXT1": "Pyrimethamine used sulfonamides quinine @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d631.s0.p9", "DRUGA": ["antimalarials", "group", "63-75"], "DRUGB": ["antibiotics", "group", "93-103"]}
{"TEXT1": "@DRUG$ administered normal hematopoiesis", "LBL": "0", "ID": "DDI-DrugBank.d631.s2.p0", "DRUGA": ["Folinic acid", "drug", "0-11"], "DRUGB": ["leucovorin", "drug", "14-23"]}
{"TEXT1": "Mild hepatotoxicity reported patients @DRUG$ @DRUG$ administered", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d631.s3.p0", "DRUGA": ["lorazepam", "drug", "60-68"], "DRUGB": ["pyrimethamine", "drug", "74-86"]}
{"TEXT1": "@DRUG$ inhibits liver's ability to drugs @DRUG$ astemizole cisapride cyclosporine tricyclic antidepressants", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d783.s0.p0", "DRUGA": ["Posicor", "brand", "0-6"], "DRUGB": ["terfenadine", "drug", "78-88"]}
{"TEXT1": "@DRUG$ inhibits liver's ability to drugs terfenadine @DRUG$ cisapride cyclosporine tricyclic antidepressants", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d783.s0.p1", "DRUGA": ["Posicor", "brand", "0-6"], "DRUGB": ["astemizole", "drug", "91-100"]}
{"TEXT1": "@DRUG$ inhibits liver's ability to drugs terfenadine astemizole @DRUG$ cyclosporine tricyclic antidepressants", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d783.s0.p2", "DRUGA": ["Posicor", "brand", "0-6"], "DRUGB": ["cisapride", "drug", "103-111"]}
{"TEXT1": "@DRUG$ inhibits liver's ability to drugs terfenadine astemizole cisapride @DRUG$ tricyclic antidepressants", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d783.s0.p3", "DRUGA": ["Posicor", "brand", "0-6"], "DRUGB": ["cyclosporine", "drug", "114-125"]}
{"TEXT1": "@DRUG$ inhibits liver's ability to drugs terfenadine astemizole cisapride cyclosporine @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d783.s0.p4", "DRUGA": ["Posicor", "brand", "0-6"], "DRUGB": ["tricyclic antidepressants", "group", "132-156"]}
{"TEXT1": "Posicor inhibits liver's ability to drugs @DRUG$ @DRUG$ cisapride cyclosporine tricyclic antidepressants", "LBL": "0", "ID": "DDI-DrugBank.d783.s0.p5", "DRUGA": ["terfenadine", "drug", "78-88"], "DRUGB": ["astemizole", "drug", "91-100"]}
{"TEXT1": "Posicor inhibits liver's ability to drugs @DRUG$ astemizole @DRUG$ cyclosporine tricyclic antidepressants", "LBL": "0", "ID": "DDI-DrugBank.d783.s0.p6", "DRUGA": ["terfenadine", "drug", "78-88"], "DRUGB": ["cisapride", "drug", "103-111"]}
{"TEXT1": "Posicor inhibits liver's ability to drugs @DRUG$ astemizole cisapride @DRUG$ tricyclic antidepressants", "LBL": "0", "ID": "DDI-DrugBank.d783.s0.p7", "DRUGA": ["terfenadine", "drug", "78-88"], "DRUGB": ["cyclosporine", "drug", "114-125"]}
{"TEXT1": "Posicor inhibits liver's ability to drugs @DRUG$ astemizole cisapride cyclosporine @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d783.s0.p8", "DRUGA": ["terfenadine", "drug", "78-88"], "DRUGB": ["tricyclic antidepressants", "group", "132-156"]}
{"TEXT1": "Posicor inhibits liver's ability to drugs terfenadine @DRUG$ @DRUG$ cyclosporine tricyclic antidepressants", "LBL": "0", "ID": "DDI-DrugBank.d783.s0.p9", "DRUGA": ["astemizole", "drug", "91-100"], "DRUGB": ["cisapride", "drug", "103-111"]}
{"TEXT1": "Posicor inhibits liver's ability to drugs terfenadine @DRUG$ cisapride @DRUG$ tricyclic antidepressants", "LBL": "0", "ID": "DDI-DrugBank.d783.s0.p10", "DRUGA": ["astemizole", "drug", "91-100"], "DRUGB": ["cyclosporine", "drug", "114-125"]}
{"TEXT1": "Posicor inhibits liver's ability to drugs terfenadine @DRUG$ cisapride cyclosporine @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d783.s0.p11", "DRUGA": ["astemizole", "drug", "91-100"], "DRUGB": ["tricyclic antidepressants", "group", "132-156"]}
{"TEXT1": "Posicor inhibits liver's ability to drugs terfenadine astemizole @DRUG$ @DRUG$ tricyclic antidepressants", "LBL": "0", "ID": "DDI-DrugBank.d783.s0.p12", "DRUGA": ["cisapride", "drug", "103-111"], "DRUGB": ["cyclosporine", "drug", "114-125"]}
{"TEXT1": "Posicor inhibits liver's ability to drugs terfenadine astemizole @DRUG$ cyclosporine @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d783.s0.p13", "DRUGA": ["cisapride", "drug", "103-111"], "DRUGB": ["tricyclic antidepressants", "group", "132-156"]}
{"TEXT1": "Posicor inhibits liver's ability to drugs terfenadine astemizole cisapride @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d783.s0.p14", "DRUGA": ["cyclosporine", "drug", "114-125"], "DRUGB": ["tricyclic antidepressants", "group", "132-156"]}
{"TEXT1": "@DRUG$ @DRUG$ mitotane great decrease", "LBL": "DDI-int", "ID": "DDI-DrugBank.d774.s0.p0", "DRUGA": ["Trilostane", "drug", "0-9"], "DRUGB": ["aminoglutethimide", "drug", "29-45"]}
{"TEXT1": "@DRUG$ aminoglutethimide @DRUG$ great decrease", "LBL": "DDI-int", "ID": "DDI-DrugBank.d774.s0.p1", "DRUGA": ["Trilostane", "drug", "0-9"], "DRUGB": ["mitotane", "drug", "50-57"]}
{"TEXT1": "Trilostane @DRUG$ @DRUG$ great decrease", "LBL": "0", "ID": "DDI-DrugBank.d774.s0.p2", "DRUGA": ["aminoglutethimide", "drug", "29-45"], "DRUGB": ["mitotane", "drug", "50-57"]}
{"TEXT1": "Concomitant administration of substances secreted result delayed clearance @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d641.s2.p0", "DRUGA": ["probenecid", "drug", "81-90"], "DRUGB": ["ALIMTA", "brand", "142-147"]}
{"TEXT1": "@DRUG$ mg administered @DRUG$ patients normal renal function 80 used administering ibuprofen ALIMTA", "LBL": "0", "ID": "DDI-DrugBank.d641.s3.p0", "DRUGA": ["ibuprofen", "drug", "9-17"], "DRUGB": ["ALIMTA", "brand", "57-62"]}
{"TEXT1": "@DRUG$ mg administered ALIMTA patients normal renal function 80 used administering @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d641.s3.p1", "DRUGA": ["ibuprofen", "drug", "9-17"], "DRUGB": ["ibuprofen", "drug", "182-190"]}
{"TEXT1": "@DRUG$ mg administered ALIMTA patients normal renal function 80 used administering ibuprofen @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d641.s3.p2", "DRUGA": ["ibuprofen", "drug", "9-17"], "DRUGB": ["ALIMTA", "brand", "210-215"]}
{"TEXT1": "ibuprofen mg administered @DRUG$ patients normal renal function 80 used administering @DRUG$ ALIMTA", "LBL": "0", "ID": "DDI-DrugBank.d641.s3.p3", "DRUGA": ["ALIMTA", "brand", "57-62"], "DRUGB": ["ibuprofen", "drug", "182-190"]}
{"TEXT1": "ibuprofen mg administered @DRUG$ patients normal renal function 80 used administering @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d641.s3.p4", "DRUGA": ["ALIMTA", "brand", "57-62"], "DRUGB": ["ALIMTA", "brand", "210-215"]}
{"TEXT1": "ibuprofen mg administered ALIMTA patients normal renal function 80 used administering @DRUG$ @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d641.s3.p5", "DRUGA": ["ibuprofen", "drug", "182-190"], "DRUGB": ["ALIMTA", "brand", "210-215"]}
{"TEXT1": "Patients mild to moderate renal insufficiency taking @DRUG$ short period 2 days day following administration @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d641.s4.p0", "DRUGA": ["NSAIDs", "group", "71-76"], "DRUGB": ["ALIMTA", "brand", "194-199"]}
{"TEXT1": "absence data potential interaction @DRUG$ @DRUG$ longer patients taking NSAIDs interrupt dosing 5 days day following ALIMTA administration", "LBL": "0", "ID": "DDI-DrugBank.d641.s5.p0", "DRUGA": ["ALIMTA", "brand", "63-68"], "DRUGB": ["NSAIDs", "group", "74-79"]}
{"TEXT1": "absence data potential interaction @DRUG$ NSAIDs longer patients taking @DRUG$ interrupt dosing 5 days day following ALIMTA administration", "LBL": "0", "ID": "DDI-DrugBank.d641.s5.p1", "DRUGA": ["ALIMTA", "brand", "63-68"], "DRUGB": ["NSAIDs", "group", "131-136"]}
{"TEXT1": "absence data potential interaction @DRUG$ NSAIDs longer patients taking interrupt dosing 5 days day following @DRUG$ administration", "LBL": "0", "ID": "DDI-DrugBank.d641.s5.p2", "DRUGA": ["ALIMTA", "brand", "63-68"], "DRUGB": ["ALIMTA", "brand", "223-228"]}
{"TEXT1": "absence data potential interaction ALIMTA @DRUG$ longer patients taking @DRUG$ interrupt dosing 5 days day following administration", "LBL": "0", "ID": "DDI-DrugBank.d641.s5.p3", "DRUGA": ["NSAIDs", "group", "74-79"], "DRUGB": ["NSAIDs", "group", "131-136"]}
{"TEXT1": "absence data potential interaction ALIMTA @DRUG$ longer patients taking NSAIDs interrupt dosing 5 days day following @DRUG$ administration", "LBL": "0", "ID": "DDI-DrugBank.d641.s5.p4", "DRUGA": ["NSAIDs", "group", "74-79"], "DRUGB": ["ALIMTA", "brand", "223-228"]}
{"TEXT1": "absence data potential interaction ALIMTA NSAIDs longer patients taking @DRUG$ interrupt dosing 5 days day following @DRUG$ administration", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d641.s5.p5", "DRUGA": ["NSAIDs", "group", "131-136"], "DRUGB": ["ALIMTA", "brand", "223-228"]}
{"TEXT1": "@DRUG$ decrease hypotensive effect @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d638.s0.p0", "DRUGA": ["Ritalin", "brand", "0-6"], "DRUGB": ["guanethidine", "drug", "47-58"]}
{"TEXT1": "Human pharmacologic studies shown @DRUG$ inhibit @DRUG$ anticonvulsants diphenylhydantoin phenylbutazone drugs clomipramine", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d638.s2.p0", "DRUGA": ["Ritalin", "brand", "44-50"], "DRUGB": ["coumarin anticoagulants", "group", "82-104"]}
{"TEXT1": "Human pharmacologic studies shown @DRUG$ inhibit metabolism coumarin anticoagulants @DRUG$ diphenylhydantoin phenylbutazone drugs clomipramine", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d638.s2.p1", "DRUGA": ["Ritalin", "brand", "44-50"], "DRUGB": ["anticonvulsants", "group", "107-121"]}
{"TEXT1": "Human pharmacologic studies shown @DRUG$ inhibit metabolism coumarin anticoagulants anticonvulsants diphenylhydantoin phenylbutazone drugs clomipramine", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d638.s2.p2", "DRUGA": ["Ritalin", "brand", "44-50"], "DRUGB": ["phenobarbital", "drug", "124-136"]}
{"TEXT1": "Human pharmacologic studies shown @DRUG$ inhibit metabolism coumarin anticoagulants anticonvulsants @DRUG$ phenylbutazone drugs clomipramine", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d638.s2.p3", "DRUGA": ["Ritalin", "brand", "44-50"], "DRUGB": ["diphenylhydantoin", "drug", "139-155"]}
{"TEXT1": "Human pharmacologic studies shown @DRUG$ inhibit metabolism coumarin anticoagulants anticonvulsants diphenylhydantoin phenylbutazone drugs clomipramine", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d638.s2.p4", "DRUGA": ["Ritalin", "brand", "44-50"], "DRUGB": ["primidone", "drug", "158-166"]}
{"TEXT1": "Human pharmacologic studies shown @DRUG$ inhibit metabolism coumarin anticoagulants anticonvulsants diphenylhydantoin @DRUG$ drugs clomipramine", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d638.s2.p5", "DRUGA": ["Ritalin", "brand", "44-50"], "DRUGB": ["phenylbutazone", "drug", "170-183"]}
{"TEXT1": "Human pharmacologic studies shown @DRUG$ inhibit metabolism coumarin anticoagulants anticonvulsants diphenylhydantoin phenylbutazone @DRUG$ clomipramine", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d638.s2.p6", "DRUGA": ["Ritalin", "brand", "44-50"], "DRUGB": ["tricyclic drugs", "group", "190-204"]}
{"TEXT1": "Human pharmacologic studies shown @DRUG$ inhibit metabolism coumarin anticoagulants anticonvulsants diphenylhydantoin phenylbutazone drugs clomipramine", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d638.s2.p7", "DRUGA": ["Ritalin", "brand", "44-50"], "DRUGB": ["imipramine", "drug", "207-216"]}
{"TEXT1": "Human pharmacologic studies shown @DRUG$ inhibit metabolism coumarin anticoagulants anticonvulsants diphenylhydantoin phenylbutazone drugs @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d638.s2.p8", "DRUGA": ["Ritalin", "brand", "44-50"], "DRUGB": ["clomipramine", "drug", "219-230"]}
{"TEXT1": "Human pharmacologic studies shown @DRUG$ inhibit metabolism coumarin anticoagulants anticonvulsants diphenylhydantoin phenylbutazone drugs clomipramine", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d638.s2.p9", "DRUGA": ["Ritalin", "brand", "44-50"], "DRUGB": ["desipramine", "drug", "233-243"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit @DRUG$ @DRUG$ diphenylhydantoin phenylbutazone drugs clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p10", "DRUGA": ["coumarin anticoagulants", "group", "82-104"], "DRUGB": ["anticonvulsants", "group", "107-121"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit @DRUG$ anticonvulsants diphenylhydantoin phenylbutazone drugs clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p11", "DRUGA": ["coumarin anticoagulants", "group", "82-104"], "DRUGB": ["phenobarbital", "drug", "124-136"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit @DRUG$ anticonvulsants @DRUG$ phenylbutazone drugs clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p12", "DRUGA": ["coumarin anticoagulants", "group", "82-104"], "DRUGB": ["diphenylhydantoin", "drug", "139-155"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit @DRUG$ anticonvulsants diphenylhydantoin phenylbutazone drugs clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p13", "DRUGA": ["coumarin anticoagulants", "group", "82-104"], "DRUGB": ["primidone", "drug", "158-166"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit @DRUG$ anticonvulsants diphenylhydantoin @DRUG$ drugs clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p14", "DRUGA": ["coumarin anticoagulants", "group", "82-104"], "DRUGB": ["phenylbutazone", "drug", "170-183"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit @DRUG$ anticonvulsants diphenylhydantoin phenylbutazone @DRUG$ clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p15", "DRUGA": ["coumarin anticoagulants", "group", "82-104"], "DRUGB": ["tricyclic drugs", "group", "190-204"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit @DRUG$ anticonvulsants diphenylhydantoin phenylbutazone drugs clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p16", "DRUGA": ["coumarin anticoagulants", "group", "82-104"], "DRUGB": ["imipramine", "drug", "207-216"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit @DRUG$ anticonvulsants diphenylhydantoin phenylbutazone drugs @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p17", "DRUGA": ["coumarin anticoagulants", "group", "82-104"], "DRUGB": ["clomipramine", "drug", "219-230"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit @DRUG$ anticonvulsants diphenylhydantoin phenylbutazone drugs clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p18", "DRUGA": ["coumarin anticoagulants", "group", "82-104"], "DRUGB": ["desipramine", "drug", "233-243"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants @DRUG$ diphenylhydantoin phenylbutazone drugs clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p19", "DRUGA": ["anticonvulsants", "group", "107-121"], "DRUGB": ["phenobarbital", "drug", "124-136"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants @DRUG$ @DRUG$ phenylbutazone drugs clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p20", "DRUGA": ["anticonvulsants", "group", "107-121"], "DRUGB": ["diphenylhydantoin", "drug", "139-155"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants @DRUG$ diphenylhydantoin phenylbutazone drugs clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p21", "DRUGA": ["anticonvulsants", "group", "107-121"], "DRUGB": ["primidone", "drug", "158-166"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants @DRUG$ diphenylhydantoin @DRUG$ drugs clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p22", "DRUGA": ["anticonvulsants", "group", "107-121"], "DRUGB": ["phenylbutazone", "drug", "170-183"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants @DRUG$ diphenylhydantoin phenylbutazone @DRUG$ clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p23", "DRUGA": ["anticonvulsants", "group", "107-121"], "DRUGB": ["tricyclic drugs", "group", "190-204"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants @DRUG$ diphenylhydantoin phenylbutazone drugs clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p24", "DRUGA": ["anticonvulsants", "group", "107-121"], "DRUGB": ["imipramine", "drug", "207-216"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants @DRUG$ diphenylhydantoin phenylbutazone drugs @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p25", "DRUGA": ["anticonvulsants", "group", "107-121"], "DRUGB": ["clomipramine", "drug", "219-230"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants @DRUG$ diphenylhydantoin phenylbutazone drugs clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p26", "DRUGA": ["anticonvulsants", "group", "107-121"], "DRUGB": ["desipramine", "drug", "233-243"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants anticonvulsants @DRUG$ phenylbutazone drugs clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p27", "DRUGA": ["phenobarbital", "drug", "124-136"], "DRUGB": ["diphenylhydantoin", "drug", "139-155"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants anticonvulsants diphenylhydantoin phenylbutazone drugs clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p28", "DRUGA": ["phenobarbital", "drug", "124-136"], "DRUGB": ["primidone", "drug", "158-166"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants anticonvulsants diphenylhydantoin @DRUG$ drugs clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p29", "DRUGA": ["phenobarbital", "drug", "124-136"], "DRUGB": ["phenylbutazone", "drug", "170-183"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants anticonvulsants diphenylhydantoin phenylbutazone @DRUG$ clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p30", "DRUGA": ["phenobarbital", "drug", "124-136"], "DRUGB": ["tricyclic drugs", "group", "190-204"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants anticonvulsants diphenylhydantoin phenylbutazone drugs clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p31", "DRUGA": ["phenobarbital", "drug", "124-136"], "DRUGB": ["imipramine", "drug", "207-216"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants anticonvulsants diphenylhydantoin phenylbutazone drugs @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p32", "DRUGA": ["phenobarbital", "drug", "124-136"], "DRUGB": ["clomipramine", "drug", "219-230"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants anticonvulsants diphenylhydantoin phenylbutazone drugs clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p33", "DRUGA": ["phenobarbital", "drug", "124-136"], "DRUGB": ["desipramine", "drug", "233-243"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants anticonvulsants @DRUG$ phenylbutazone drugs clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p34", "DRUGA": ["diphenylhydantoin", "drug", "139-155"], "DRUGB": ["primidone", "drug", "158-166"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants anticonvulsants @DRUG$ @DRUG$ drugs clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p35", "DRUGA": ["diphenylhydantoin", "drug", "139-155"], "DRUGB": ["phenylbutazone", "drug", "170-183"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants anticonvulsants @DRUG$ phenylbutazone @DRUG$ clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p36", "DRUGA": ["diphenylhydantoin", "drug", "139-155"], "DRUGB": ["tricyclic drugs", "group", "190-204"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants anticonvulsants @DRUG$ phenylbutazone drugs clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p37", "DRUGA": ["diphenylhydantoin", "drug", "139-155"], "DRUGB": ["imipramine", "drug", "207-216"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants anticonvulsants @DRUG$ phenylbutazone drugs @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p38", "DRUGA": ["diphenylhydantoin", "drug", "139-155"], "DRUGB": ["clomipramine", "drug", "219-230"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants anticonvulsants @DRUG$ phenylbutazone drugs clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p39", "DRUGA": ["diphenylhydantoin", "drug", "139-155"], "DRUGB": ["desipramine", "drug", "233-243"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants anticonvulsants diphenylhydantoin @DRUG$ drugs clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p40", "DRUGA": ["primidone", "drug", "158-166"], "DRUGB": ["phenylbutazone", "drug", "170-183"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants anticonvulsants diphenylhydantoin phenylbutazone @DRUG$ clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p41", "DRUGA": ["primidone", "drug", "158-166"], "DRUGB": ["tricyclic drugs", "group", "190-204"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants anticonvulsants diphenylhydantoin phenylbutazone drugs clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p42", "DRUGA": ["primidone", "drug", "158-166"], "DRUGB": ["imipramine", "drug", "207-216"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants anticonvulsants diphenylhydantoin phenylbutazone drugs @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p43", "DRUGA": ["primidone", "drug", "158-166"], "DRUGB": ["clomipramine", "drug", "219-230"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants anticonvulsants diphenylhydantoin phenylbutazone drugs clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p44", "DRUGA": ["primidone", "drug", "158-166"], "DRUGB": ["desipramine", "drug", "233-243"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants anticonvulsants diphenylhydantoin @DRUG$ @DRUG$ clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p45", "DRUGA": ["phenylbutazone", "drug", "170-183"], "DRUGB": ["tricyclic drugs", "group", "190-204"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants anticonvulsants diphenylhydantoin @DRUG$ drugs clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p46", "DRUGA": ["phenylbutazone", "drug", "170-183"], "DRUGB": ["imipramine", "drug", "207-216"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants anticonvulsants diphenylhydantoin @DRUG$ drugs @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p47", "DRUGA": ["phenylbutazone", "drug", "170-183"], "DRUGB": ["clomipramine", "drug", "219-230"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants anticonvulsants diphenylhydantoin @DRUG$ drugs clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p48", "DRUGA": ["phenylbutazone", "drug", "170-183"], "DRUGB": ["desipramine", "drug", "233-243"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants anticonvulsants diphenylhydantoin phenylbutazone @DRUG$ clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p49", "DRUGA": ["tricyclic drugs", "group", "190-204"], "DRUGB": ["imipramine", "drug", "207-216"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants anticonvulsants diphenylhydantoin phenylbutazone @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p50", "DRUGA": ["tricyclic drugs", "group", "190-204"], "DRUGB": ["clomipramine", "drug", "219-230"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants anticonvulsants diphenylhydantoin phenylbutazone @DRUG$ clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p51", "DRUGA": ["tricyclic drugs", "group", "190-204"], "DRUGB": ["desipramine", "drug", "233-243"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants anticonvulsants diphenylhydantoin phenylbutazone drugs @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p52", "DRUGA": ["imipramine", "drug", "207-216"], "DRUGB": ["clomipramine", "drug", "219-230"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants anticonvulsants diphenylhydantoin phenylbutazone drugs clomipramine", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p53", "DRUGA": ["imipramine", "drug", "207-216"], "DRUGB": ["desipramine", "drug", "233-243"]}
{"TEXT1": "Human pharmacologic studies shown Ritalin inhibit metabolism coumarin anticoagulants anticonvulsants diphenylhydantoin phenylbutazone drugs @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d638.s2.p54", "DRUGA": ["clomipramine", "drug", "219-230"], "DRUGB": ["desipramine", "drug", "233-243"]}
{"TEXT1": "safety using @DRUG$ combination @DRUG$ acting not evaluated", "LBL": "0", "ID": "DDI-DrugBank.d638.s5.p0", "DRUGA": ["methylphenidate", "drug", "20-34"], "DRUGB": ["clonidine", "drug", "56-64"]}
{"TEXT1": "safety using @DRUG$ combination clonidine acting @DRUG$ not evaluated", "LBL": "0", "ID": "DDI-DrugBank.d638.s5.p1", "DRUGA": ["methylphenidate", "drug", "20-34"], "DRUGB": ["alpha-2 agonists", "group", "92-107"]}
{"TEXT1": "safety using methylphenidate combination @DRUG$ acting @DRUG$ not evaluated", "LBL": "0", "ID": "DDI-DrugBank.d638.s5.p2", "DRUGA": ["clonidine", "drug", "56-64"], "DRUGB": ["alpha-2 agonists", "group", "92-107"]}
{"TEXT1": "Prolongation prothrombin time International Normalized Ratio observed patients receiving @DRUG$ coumarin anticoagulants derivative", "LBL": "0", "ID": "DDI-DrugBank.d769.s0.p0", "DRUGA": ["Coumarin-Derivative Anticoagulants", "group", "0-33"], "DRUGB": ["ZOLINZA", "brand", "151-157"]}
{"TEXT1": "Prolongation prothrombin time International Normalized Ratio observed patients receiving ZOLINZA @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d769.s0.p1", "DRUGA": ["Coumarin-Derivative Anticoagulants", "group", "0-33"], "DRUGB": ["coumarin-derivative anticoagulants", "group", "178-211"]}
{"TEXT1": "Prolongation prothrombin time International Normalized Ratio observed patients receiving @DRUG$ @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d769.s0.p2", "DRUGA": ["ZOLINZA", "brand", "151-157"], "DRUGB": ["coumarin-derivative anticoagulants", "group", "178-211"]}
{"TEXT1": "Physicians monitor PT INR patients administered @DRUG$ @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d769.s1.p0", "DRUGA": ["ZOLINZA", "brand", "85-91"], "DRUGB": ["coumarin derivatives", "group", "97-116"]}
{"TEXT1": "@DRUG$ Severe thrombocytopenia gastrointestinal bleeding reported concomitant use of @DRUG$ HDAC inhibitors", "LBL": "0", "ID": "DDI-DrugBank.d769.s2.p0", "DRUGA": ["HDAC Inhibitors", "group", "6-20"], "DRUGB": ["ZOLINZA", "brand", "119-125"]}
{"TEXT1": "@DRUG$ Severe thrombocytopenia gastrointestinal bleeding reported concomitant use of ZOLINZA @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d769.s2.p1", "DRUGA": ["HDAC Inhibitors", "group", "6-20"], "DRUGB": ["HDAC inhibitors", "group", "137-151"]}
{"TEXT1": "@DRUG$ Severe thrombocytopenia gastrointestinal bleeding reported concomitant use of ZOLINZA HDAC inhibitors", "LBL": "0", "ID": "DDI-DrugBank.d769.s2.p2", "DRUGA": ["HDAC Inhibitors", "group", "6-20"], "DRUGB": ["valproic acid", "drug", "160-172"]}
{"TEXT1": "Severe thrombocytopenia gastrointestinal bleeding reported concomitant use of @DRUG$ @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d769.s2.p3", "DRUGA": ["ZOLINZA", "brand", "119-125"], "DRUGB": ["HDAC inhibitors", "group", "137-151"]}
{"TEXT1": "Severe thrombocytopenia gastrointestinal bleeding reported concomitant use of @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d769.s2.p4", "DRUGA": ["ZOLINZA", "brand", "119-125"], "DRUGB": ["valproic acid", "drug", "160-172"]}
{"TEXT1": "Severe thrombocytopenia gastrointestinal bleeding reported concomitant use of ZOLINZA @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d769.s2.p5", "DRUGA": ["HDAC inhibitors", "group", "137-151"], "DRUGB": ["valproic acid", "drug", "160-172"]}
{"TEXT1": "pharmacokinetic interaction 85 mg/m2 @DRUG$ infusional @DRUG$ observed patients treated 2 weeks", "LBL": "0", "ID": "DDI-DrugBank.d728.s1.p0", "DRUGA": ["ELOXATIN", "brand", "48-55"], "DRUGB": ["5-FU", "drug", "72-75"]}
{"TEXT1": "Increases @DRUG$ plasma concentrations approximately observed doses mg/m2 @DRUG$ dosed 3 weeks", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d728.s2.p0", "DRUGA": ["5-FU", "drug", "13-16"], "DRUGB": ["ELOXATIN", "brand", "104-111"]}
{"TEXT1": "multiple dose 30 normal weight coadministration @DRUG$ 40 grams alcohol approximately glasses not result alteration pharmacokinetics orlistat pharmacodynamics fat systemic exposure to", "LBL": "0", "ID": "DDI-DrugBank.d761.s0.p0", "DRUGA": ["Alcohol", "drug", "0-6"], "DRUGB": ["XENICAL", "brand", "84-90"]}
{"TEXT1": "multiple dose 30 normal weight coadministration XENICAL 40 grams @DRUG$ approximately glasses not result alteration alcohol pharmacokinetics orlistat pharmacodynamics fat systemic exposure to", "LBL": "0", "ID": "DDI-DrugBank.d761.s0.p1", "DRUGA": ["Alcohol", "drug", "0-6"], "DRUGB": ["alcohol", "drug", "108-114"]}
{"TEXT1": "multiple dose 30 normal weight coadministration XENICAL 40 grams alcohol approximately glasses not result alteration @DRUG$ pharmacokinetics orlistat pharmacodynamics fat systemic exposure to", "LBL": "0", "ID": "DDI-DrugBank.d761.s0.p2", "DRUGA": ["Alcohol", "drug", "0-6"], "DRUGB": ["alcohol", "drug", "188-194"]}
{"TEXT1": "multiple dose 30 normal weight coadministration XENICAL 40 grams alcohol approximately glasses not result alteration pharmacokinetics @DRUG$ pharmacodynamics fat systemic exposure to orlistat", "LBL": "0", "ID": "DDI-DrugBank.d761.s0.p3", "DRUGA": ["Alcohol", "drug", "0-6"], "DRUGB": ["orlistat", "drug", "214-221"]}
{"TEXT1": "multiple dose 30 normal weight coadministration XENICAL 40 grams alcohol approximately glasses not result alteration pharmacokinetics orlistat pharmacodynamics fat systemic exposure to @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s0.p4", "DRUGA": ["Alcohol", "drug", "0-6"], "DRUGB": ["orlistat", "drug", "287-294"]}
{"TEXT1": "multiple dose 30 normal weight coadministration @DRUG$ 40 grams @DRUG$ approximately glasses not result alteration alcohol pharmacokinetics orlistat pharmacodynamics fat systemic exposure to", "LBL": "0", "ID": "DDI-DrugBank.d761.s0.p5", "DRUGA": ["XENICAL", "brand", "84-90"], "DRUGB": ["alcohol", "drug", "108-114"]}
{"TEXT1": "multiple dose 30 normal weight coadministration @DRUG$ 40 grams alcohol approximately glasses not result alteration @DRUG$ pharmacokinetics orlistat pharmacodynamics fat systemic exposure to", "LBL": "0", "ID": "DDI-DrugBank.d761.s0.p6", "DRUGA": ["XENICAL", "brand", "84-90"], "DRUGB": ["alcohol", "drug", "188-194"]}
{"TEXT1": "multiple dose 30 normal weight coadministration @DRUG$ 40 grams alcohol approximately glasses not result alteration pharmacokinetics @DRUG$ pharmacodynamics fat systemic exposure to orlistat", "LBL": "0", "ID": "DDI-DrugBank.d761.s0.p7", "DRUGA": ["XENICAL", "brand", "84-90"], "DRUGB": ["orlistat", "drug", "214-221"]}
{"TEXT1": "multiple dose 30 normal weight coadministration @DRUG$ 40 grams alcohol approximately glasses not result alteration pharmacokinetics orlistat pharmacodynamics fat systemic exposure to @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s0.p8", "DRUGA": ["XENICAL", "brand", "84-90"], "DRUGB": ["orlistat", "drug", "287-294"]}
{"TEXT1": "multiple dose 30 normal weight coadministration XENICAL 40 grams @DRUG$ approximately glasses not result alteration @DRUG$ pharmacokinetics orlistat pharmacodynamics fat systemic exposure to", "LBL": "0", "ID": "DDI-DrugBank.d761.s0.p9", "DRUGA": ["alcohol", "drug", "108-114"], "DRUGB": ["alcohol", "drug", "188-194"]}
{"TEXT1": "multiple dose 30 normal weight coadministration XENICAL 40 grams @DRUG$ approximately glasses not result alteration alcohol pharmacokinetics @DRUG$ pharmacodynamics fat systemic exposure to orlistat", "LBL": "0", "ID": "DDI-DrugBank.d761.s0.p10", "DRUGA": ["alcohol", "drug", "108-114"], "DRUGB": ["orlistat", "drug", "214-221"]}
{"TEXT1": "multiple dose 30 normal weight coadministration XENICAL 40 grams @DRUG$ approximately glasses not result alteration alcohol pharmacokinetics orlistat pharmacodynamics fat systemic exposure to @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s0.p11", "DRUGA": ["alcohol", "drug", "108-114"], "DRUGB": ["orlistat", "drug", "287-294"]}
{"TEXT1": "multiple dose 30 normal weight coadministration XENICAL 40 grams alcohol approximately glasses not result alteration @DRUG$ pharmacokinetics @DRUG$ pharmacodynamics fat systemic exposure to orlistat", "LBL": "0", "ID": "DDI-DrugBank.d761.s0.p12", "DRUGA": ["alcohol", "drug", "188-194"], "DRUGB": ["orlistat", "drug", "214-221"]}
{"TEXT1": "multiple dose 30 normal weight coadministration XENICAL 40 grams alcohol approximately glasses not result alteration @DRUG$ pharmacokinetics orlistat pharmacodynamics fat systemic exposure to @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s0.p13", "DRUGA": ["alcohol", "drug", "188-194"], "DRUGB": ["orlistat", "drug", "287-294"]}
{"TEXT1": "multiple dose 30 normal weight coadministration XENICAL 40 grams alcohol approximately glasses not result alteration pharmacokinetics @DRUG$ pharmacodynamics fat systemic exposure to @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s0.p14", "DRUGA": ["orlistat", "drug", "214-221"], "DRUGB": ["orlistat", "drug", "287-294"]}
{"TEXT1": "Preliminary data @DRUG$ cyclosporine drug interaction study reduction XENICAL", "LBL": "0", "ID": "DDI-DrugBank.d761.s1.p0", "DRUGA": ["Cyclosporine", "drug", "0-11"], "DRUGB": ["XENICAL", "brand", "38-44"]}
{"TEXT1": "Preliminary data XENICAL @DRUG$ drug interaction study reduction cyclosporine plasma levels", "LBL": "0", "ID": "DDI-DrugBank.d761.s1.p1", "DRUGA": ["Cyclosporine", "drug", "0-11"], "DRUGB": ["cyclosporine", "drug", "50-61"]}
{"TEXT1": "Preliminary data XENICAL cyclosporine drug interaction study reduction @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s1.p2", "DRUGA": ["Cyclosporine", "drug", "0-11"], "DRUGB": ["cyclosporine", "drug", "110-121"]}
{"TEXT1": "Preliminary data XENICAL cyclosporine drug interaction study reduction @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s1.p3", "DRUGA": ["Cyclosporine", "drug", "0-11"], "DRUGB": ["XENICAL", "brand", "142-148"]}
{"TEXT1": "Preliminary data XENICAL cyclosporine drug interaction study reduction @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s1.p4", "DRUGA": ["Cyclosporine", "drug", "0-11"], "DRUGB": ["cyclosporine", "drug", "174-185"]}
{"TEXT1": "Preliminary data @DRUG$ @DRUG$ drug interaction study reduction cyclosporine plasma levels XENICAL", "LBL": "0", "ID": "DDI-DrugBank.d761.s1.p5", "DRUGA": ["XENICAL", "brand", "38-44"], "DRUGB": ["cyclosporine", "drug", "50-61"]}
{"TEXT1": "Preliminary data @DRUG$ cyclosporine drug interaction study reduction @DRUG$ XENICAL", "LBL": "0", "ID": "DDI-DrugBank.d761.s1.p6", "DRUGA": ["XENICAL", "brand", "38-44"], "DRUGB": ["cyclosporine", "drug", "110-121"]}
{"TEXT1": "Preliminary data @DRUG$ cyclosporine drug interaction study reduction @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s1.p7", "DRUGA": ["XENICAL", "brand", "38-44"], "DRUGB": ["XENICAL", "brand", "142-148"]}
{"TEXT1": "Preliminary data @DRUG$ cyclosporine drug interaction study reduction XENICAL @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s1.p8", "DRUGA": ["XENICAL", "brand", "38-44"], "DRUGB": ["cyclosporine", "drug", "174-185"]}
{"TEXT1": "Preliminary data XENICAL @DRUG$ drug interaction study reduction @DRUG$ cyclosporine", "LBL": "0", "ID": "DDI-DrugBank.d761.s1.p9", "DRUGA": ["cyclosporine", "drug", "50-61"], "DRUGB": ["cyclosporine", "drug", "110-121"]}
{"TEXT1": "Preliminary data XENICAL @DRUG$ drug interaction study reduction cyclosporine plasma levels @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s1.p10", "DRUGA": ["cyclosporine", "drug", "50-61"], "DRUGB": ["XENICAL", "brand", "142-148"]}
{"TEXT1": "Preliminary data XENICAL @DRUG$ drug interaction study reduction cyclosporine plasma levels @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s1.p11", "DRUGA": ["cyclosporine", "drug", "50-61"], "DRUGB": ["cyclosporine", "drug", "174-185"]}
{"TEXT1": "Preliminary data XENICAL cyclosporine drug interaction study reduction @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s1.p12", "DRUGA": ["cyclosporine", "drug", "110-121"], "DRUGB": ["XENICAL", "brand", "142-148"]}
{"TEXT1": "Preliminary data XENICAL cyclosporine drug interaction study reduction @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s1.p13", "DRUGA": ["cyclosporine", "drug", "110-121"], "DRUGB": ["cyclosporine", "drug", "174-185"]}
{"TEXT1": "Preliminary data XENICAL cyclosporine drug interaction study reduction @DRUG$ @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d761.s1.p14", "DRUGA": ["XENICAL", "brand", "142-148"], "DRUGB": ["cyclosporine", "drug", "174-185"]}
{"TEXT1": "subjects receiving @DRUG$ mg three times day 6 days XENICAL not alter pharmacokinetics single dose digoxin", "LBL": "0", "ID": "DDI-DrugBank.d761.s2.p0", "DRUGA": ["Digoxin", "drug", "0-6"], "DRUGB": ["XENICAL", "brand", "48-54"]}
{"TEXT1": "subjects receiving XENICAL mg three times day 6 days @DRUG$ not alter pharmacokinetics single dose digoxin", "LBL": "0", "ID": "DDI-DrugBank.d761.s2.p1", "DRUGA": ["Digoxin", "drug", "0-6"], "DRUGB": ["XENICAL", "brand", "93-99"]}
{"TEXT1": "subjects receiving XENICAL mg three times day 6 days not alter pharmacokinetics single @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s2.p2", "DRUGA": ["Digoxin", "drug", "0-6"], "DRUGB": ["digoxin", "drug", "156-162"]}
{"TEXT1": "subjects receiving @DRUG$ mg three times day 6 days @DRUG$ not alter pharmacokinetics single dose digoxin", "LBL": "0", "ID": "DDI-DrugBank.d761.s2.p3", "DRUGA": ["XENICAL", "brand", "48-54"], "DRUGB": ["XENICAL", "brand", "93-99"]}
{"TEXT1": "subjects receiving @DRUG$ mg three times day 6 days XENICAL not alter pharmacokinetics single @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s2.p4", "DRUGA": ["XENICAL", "brand", "48-54"], "DRUGB": ["digoxin", "drug", "156-162"]}
{"TEXT1": "subjects receiving XENICAL mg three times day 6 days @DRUG$ not alter pharmacokinetics single @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s2.p5", "DRUGA": ["XENICAL", "brand", "93-99"], "DRUGB": ["digoxin", "drug", "156-162"]}
{"TEXT1": "@DRUG$ pharmacokinetic study interaction showed reduction @DRUG$ supplement absorption administered XENICAL", "LBL": "0", "ID": "DDI-DrugBank.d761.s3.p0", "DRUGA": ["Fat-soluble Vitamin Supplements", "group", "0-30"], "DRUGB": ["beta-carotene", "drug", "109-121"]}
{"TEXT1": "@DRUG$ pharmacokinetic study interaction showed reduction supplement absorption administered @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s3.p1", "DRUGA": ["Fat-soluble Vitamin Supplements", "group", "0-30"], "DRUGB": ["XENICAL", "brand", "182-188"]}
{"TEXT1": "pharmacokinetic study interaction showed reduction @DRUG$ supplement absorption administered @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d761.s3.p2", "DRUGA": ["beta-carotene", "drug", "109-121"], "DRUGB": ["XENICAL", "brand", "182-188"]}
{"TEXT1": "@DRUG$ inhibited absorption @DRUG$ supplement approximately", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d761.s4.p0", "DRUGA": ["XENICAL", "brand", "0-6"], "DRUGB": ["vitamin E acetate", "drug", "34-50"]}
{"TEXT1": "effect @DRUG$ absorption @DRUG$ vitamin A derived not known time", "LBL": "0", "ID": "DDI-DrugBank.d761.s5.p0", "DRUGA": ["orlistat", "drug", "14-21"], "DRUGB": ["vitamin D", "group", "57-65"]}
{"TEXT1": "effect @DRUG$ absorption supplemental vitamin D @DRUG$ derived not known time", "LBL": "0", "ID": "DDI-DrugBank.d761.s5.p1", "DRUGA": ["orlistat", "drug", "14-21"], "DRUGB": ["vitamin A", "group", "68-76"]}
{"TEXT1": "effect @DRUG$ absorption supplemental vitamin D derived @DRUG$ not known time", "LBL": "0", "ID": "DDI-DrugBank.d761.s5.p2", "DRUGA": ["orlistat", "drug", "14-21"], "DRUGB": ["vitamin K", "group", "105-113"]}
{"TEXT1": "effect orlistat absorption @DRUG$ @DRUG$ derived vitamin K not known time", "LBL": "0", "ID": "DDI-DrugBank.d761.s5.p3", "DRUGA": ["vitamin D", "group", "57-65"], "DRUGB": ["vitamin A", "group", "68-76"]}
{"TEXT1": "effect orlistat absorption @DRUG$ vitamin A derived @DRUG$ not known time", "LBL": "0", "ID": "DDI-DrugBank.d761.s5.p4", "DRUGA": ["vitamin D", "group", "57-65"], "DRUGB": ["vitamin K", "group", "105-113"]}
{"TEXT1": "effect orlistat absorption supplemental vitamin D @DRUG$ derived @DRUG$ not known time", "LBL": "0", "ID": "DDI-DrugBank.d761.s5.p5", "DRUGA": ["vitamin A", "group", "68-76"], "DRUGB": ["vitamin K", "group", "105-113"]}
{"TEXT1": "subjects receiving @DRUG$ 80 mg three times day 5 days orlistat not alter pharmacokinetics pharmacodynamics glyburide", "LBL": "0", "ID": "DDI-DrugBank.d761.s6.p0", "DRUGA": ["Glyburide", "drug", "0-8"], "DRUGB": ["orlistat", "drug", "50-57"]}
{"TEXT1": "subjects receiving orlistat 80 mg three times day 5 days @DRUG$ not alter pharmacokinetics pharmacodynamics glyburide", "LBL": "0", "ID": "DDI-DrugBank.d761.s6.p1", "DRUGA": ["Glyburide", "drug", "0-8"], "DRUGB": ["orlistat", "drug", "95-102"]}
{"TEXT1": "subjects receiving orlistat 80 mg three times day 5 days not alter pharmacokinetics pharmacodynamics @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s6.p2", "DRUGA": ["Glyburide", "drug", "0-8"], "DRUGB": ["glyburide", "drug", "187-195"]}
{"TEXT1": "subjects receiving @DRUG$ 80 mg three times day 5 days @DRUG$ not alter pharmacokinetics pharmacodynamics glyburide", "LBL": "0", "ID": "DDI-DrugBank.d761.s6.p3", "DRUGA": ["orlistat", "drug", "50-57"], "DRUGB": ["orlistat", "drug", "95-102"]}
{"TEXT1": "subjects receiving @DRUG$ 80 mg three times day 5 days orlistat not alter pharmacokinetics pharmacodynamics @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s6.p4", "DRUGA": ["orlistat", "drug", "50-57"], "DRUGB": ["glyburide", "drug", "187-195"]}
{"TEXT1": "subjects receiving orlistat 80 mg three times day 5 days @DRUG$ not alter pharmacokinetics pharmacodynamics @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s6.p5", "DRUGA": ["orlistat", "drug", "95-102"], "DRUGB": ["glyburide", "drug", "187-195"]}
{"TEXT1": "@DRUG$ subjects receiving @DRUG$ mg three times day 6 days XENICAL not alter bioavailability nifedipine", "LBL": "0", "ID": "DDI-DrugBank.d761.s7.p0", "DRUGA": ["Nifedipine", "drug", "0-9"], "DRUGB": ["XENICAL", "brand", "78-84"]}
{"TEXT1": "@DRUG$ subjects receiving XENICAL mg three times day 6 days @DRUG$ not alter bioavailability nifedipine", "LBL": "0", "ID": "DDI-DrugBank.d761.s7.p1", "DRUGA": ["Nifedipine", "drug", "0-9"], "DRUGB": ["XENICAL", "brand", "123-129"]}
{"TEXT1": "@DRUG$ subjects receiving XENICAL mg three times day 6 days not alter bioavailability @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s7.p2", "DRUGA": ["Nifedipine", "drug", "0-9"], "DRUGB": ["nifedipine", "drug", "168-177"]}
{"TEXT1": "subjects receiving @DRUG$ mg three times day 6 days @DRUG$ not alter bioavailability nifedipine", "LBL": "0", "ID": "DDI-DrugBank.d761.s7.p3", "DRUGA": ["XENICAL", "brand", "78-84"], "DRUGB": ["XENICAL", "brand", "123-129"]}
{"TEXT1": "subjects receiving @DRUG$ mg three times day 6 days XENICAL not alter bioavailability @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s7.p4", "DRUGA": ["XENICAL", "brand", "78-84"], "DRUGB": ["nifedipine", "drug", "168-177"]}
{"TEXT1": "subjects receiving XENICAL mg three times day 6 days @DRUG$ not alter bioavailability @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s7.p5", "DRUGA": ["XENICAL", "brand", "123-129"], "DRUGB": ["nifedipine", "drug", "168-177"]}
{"TEXT1": "20 female subjects treatment @DRUG$ mg three times day 23 resulted no changes ovulation suppressing action oral contraceptives", "LBL": "0", "ID": "DDI-DrugBank.d761.s8.p0", "DRUGA": ["Contraceptives", "group", "5-18"], "DRUGB": ["XENICAL", "brand", "75-81"]}
{"TEXT1": "20 female subjects treatment XENICAL mg three times day 23 resulted no changes ovulation suppressing action @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s8.p1", "DRUGA": ["Contraceptives", "group", "5-18"], "DRUGB": ["contraceptives", "group", "187-200"]}
{"TEXT1": "20 female subjects treatment @DRUG$ mg three times day 23 resulted no changes ovulation suppressing action @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s8.p2", "DRUGA": ["XENICAL", "brand", "75-81"], "DRUGB": ["contraceptives", "group", "187-200"]}
{"TEXT1": "subjects receiving @DRUG$ mg three times day 7 days XENICAL not alter pharmacokinetics single 300 dose phenytoin", "LBL": "0", "ID": "DDI-DrugBank.d761.s9.p0", "DRUGA": ["Phenytoin", "drug", "0-8"], "DRUGB": ["XENICAL", "brand", "50-56"]}
{"TEXT1": "subjects receiving XENICAL mg three times day 7 days @DRUG$ not alter pharmacokinetics single 300 dose phenytoin", "LBL": "0", "ID": "DDI-DrugBank.d761.s9.p1", "DRUGA": ["Phenytoin", "drug", "0-8"], "DRUGB": ["XENICAL", "brand", "95-101"]}
{"TEXT1": "subjects receiving XENICAL mg three times day 7 days not alter pharmacokinetics single 300 @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s9.p2", "DRUGA": ["Phenytoin", "drug", "0-8"], "DRUGB": ["phenytoin", "drug", "165-173"]}
{"TEXT1": "subjects receiving @DRUG$ mg three times day 7 days @DRUG$ not alter pharmacokinetics single 300 dose phenytoin", "LBL": "0", "ID": "DDI-DrugBank.d761.s9.p3", "DRUGA": ["XENICAL", "brand", "50-56"], "DRUGB": ["XENICAL", "brand", "95-101"]}
{"TEXT1": "subjects receiving @DRUG$ mg three times day 7 days XENICAL not alter pharmacokinetics single 300 @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s9.p4", "DRUGA": ["XENICAL", "brand", "50-56"], "DRUGB": ["phenytoin", "drug", "165-173"]}
{"TEXT1": "subjects receiving XENICAL mg three times day 7 days @DRUG$ not alter pharmacokinetics single 300 @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s9.p5", "DRUGA": ["XENICAL", "brand", "95-101"], "DRUGB": ["phenytoin", "drug", "165-173"]}
{"TEXT1": "2 crossover study mildly patients receiving @DRUG$ mg three times day 6 days XENICAL not affect pharmacokinetics pravastatin", "LBL": "0", "ID": "DDI-DrugBank.d761.s10.p0", "DRUGA": ["Pravastatin", "drug", "0-10"], "DRUGB": ["XENICAL", "brand", "108-114"]}
{"TEXT1": "2 crossover study mildly patients receiving XENICAL mg three times day 6 days @DRUG$ not affect pharmacokinetics pravastatin", "LBL": "0", "ID": "DDI-DrugBank.d761.s10.p1", "DRUGA": ["Pravastatin", "drug", "0-10"], "DRUGB": ["XENICAL", "brand", "153-159"]}
{"TEXT1": "2 crossover study mildly patients receiving XENICAL mg three times day 6 days not affect pharmacokinetics @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s10.p2", "DRUGA": ["Pravastatin", "drug", "0-10"], "DRUGB": ["pravastatin", "drug", "200-210"]}
{"TEXT1": "2 crossover study mildly patients receiving @DRUG$ mg three times day 6 days @DRUG$ not affect pharmacokinetics pravastatin", "LBL": "0", "ID": "DDI-DrugBank.d761.s10.p3", "DRUGA": ["XENICAL", "brand", "108-114"], "DRUGB": ["XENICAL", "brand", "153-159"]}
{"TEXT1": "2 crossover study mildly patients receiving @DRUG$ mg three times day 6 days XENICAL not affect pharmacokinetics @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s10.p4", "DRUGA": ["XENICAL", "brand", "108-114"], "DRUGB": ["pravastatin", "drug", "200-210"]}
{"TEXT1": "2 crossover study mildly patients receiving XENICAL mg three times day 6 days @DRUG$ not affect pharmacokinetics @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s10.p5", "DRUGA": ["XENICAL", "brand", "153-159"], "DRUGB": ["pravastatin", "drug", "200-210"]}
{"TEXT1": "subjects @DRUG$ mg three day not result change either warfarin pharmacokinetics R pharmacodynamics serum", "LBL": "0", "ID": "DDI-DrugBank.d761.s11.p0", "DRUGA": ["Warfarin", "drug", "0-7"], "DRUGB": ["XENICAL", "brand", "58-64"]}
{"TEXT1": "subjects XENICAL mg three day not result change either @DRUG$ pharmacokinetics R pharmacodynamics serum", "LBL": "0", "ID": "DDI-DrugBank.d761.s11.p1", "DRUGA": ["Warfarin", "drug", "0-7"], "DRUGB": ["warfarin", "drug", "142-149"]}
{"TEXT1": "subjects @DRUG$ mg three day not result change either @DRUG$ pharmacokinetics R pharmacodynamics serum", "LBL": "0", "ID": "DDI-DrugBank.d761.s11.p2", "DRUGA": ["XENICAL", "brand", "58-64"], "DRUGB": ["warfarin", "drug", "142-149"]}
{"TEXT1": "osteocalcin marker vitamin K nutritional status unaltered @DRUG$ administration levels to subjects taking @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d761.s12.p0", "DRUGA": ["XENICAL", "brand", "101-107"], "DRUGB": ["XENICAL", "brand", "179-185"]}
{"TEXT1": "@DRUG$ absorption decreased @DRUG$ patients chronic stable doses warfarin prescribed XENICAL monitored changes coagulation parameters", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d761.s13.p0", "DRUGA": ["vitamin K", "group", "14-22"], "DRUGB": ["XENICAL", "brand", "57-63"]}
{"TEXT1": "@DRUG$ absorption decreased XENICAL patients chronic stable @DRUG$ prescribed monitored changes coagulation parameters", "LBL": "0", "ID": "DDI-DrugBank.d761.s13.p1", "DRUGA": ["vitamin K", "group", "14-22"], "DRUGB": ["warfarin", "drug", "102-109"]}
{"TEXT1": "@DRUG$ absorption decreased XENICAL patients chronic stable doses warfarin prescribed @DRUG$ monitored changes coagulation parameters", "LBL": "0", "ID": "DDI-DrugBank.d761.s13.p2", "DRUGA": ["vitamin K", "group", "14-22"], "DRUGB": ["XENICAL", "brand", "130-136"]}
{"TEXT1": "vitamin K absorption decreased @DRUG$ patients chronic stable @DRUG$ prescribed XENICAL monitored changes coagulation parameters", "LBL": "0", "ID": "DDI-DrugBank.d761.s13.p3", "DRUGA": ["XENICAL", "brand", "57-63"], "DRUGB": ["warfarin", "drug", "102-109"]}
{"TEXT1": "vitamin K absorption decreased @DRUG$ patients chronic stable doses warfarin prescribed @DRUG$ monitored changes coagulation parameters", "LBL": "0", "ID": "DDI-DrugBank.d761.s13.p4", "DRUGA": ["XENICAL", "brand", "57-63"], "DRUGB": ["XENICAL", "brand", "130-136"]}
{"TEXT1": "vitamin K absorption decreased XENICAL patients chronic stable @DRUG$ prescribed @DRUG$ monitored changes coagulation parameters", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d761.s13.p5", "DRUGA": ["warfarin", "drug", "102-109"], "DRUGB": ["XENICAL", "brand", "130-136"]}
{"TEXT1": "In vitro studies human liver microsomes showed @DRUG$ not inhibit metabolism @DRUG$ ethinylestradiol cyclosporine", "LBL": "0", "ID": "DDI-DrugBank.d645.s0.p0", "DRUGA": ["terbinafine", "drug", "57-67"], "DRUGB": ["tolbutamide", "drug", "104-114"]}
{"TEXT1": "In vitro studies human liver microsomes showed @DRUG$ not inhibit metabolism tolbutamide @DRUG$ cyclosporine", "LBL": "0", "ID": "DDI-DrugBank.d645.s0.p1", "DRUGA": ["terbinafine", "drug", "57-67"], "DRUGB": ["ethinylestradiol", "drug", "117-132"]}
{"TEXT1": "In vitro studies human liver microsomes showed @DRUG$ not inhibit metabolism tolbutamide ethinylestradiol @DRUG$ cyclosporine", "LBL": "0", "ID": "DDI-DrugBank.d645.s0.p2", "DRUGA": ["terbinafine", "drug", "57-67"], "DRUGB": ["ethoxycoumarin", "drug_n", "135-148"]}
{"TEXT1": "In vitro studies human liver microsomes showed @DRUG$ not inhibit metabolism tolbutamide ethinylestradiol @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d645.s0.p3", "DRUGA": ["terbinafine", "drug", "57-67"], "DRUGB": ["cyclosporine", "drug", "155-166"]}
{"TEXT1": "In vitro studies human liver microsomes showed terbinafine not inhibit metabolism @DRUG$ @DRUG$ cyclosporine", "LBL": "0", "ID": "DDI-DrugBank.d645.s0.p4", "DRUGA": ["tolbutamide", "drug", "104-114"], "DRUGB": ["ethinylestradiol", "drug", "117-132"]}
{"TEXT1": "In vitro studies human liver microsomes showed terbinafine not inhibit metabolism @DRUG$ ethinylestradiol @DRUG$ cyclosporine", "LBL": "0", "ID": "DDI-DrugBank.d645.s0.p5", "DRUGA": ["tolbutamide", "drug", "104-114"], "DRUGB": ["ethoxycoumarin", "drug_n", "135-148"]}
{"TEXT1": "In vitro studies human liver microsomes showed terbinafine not inhibit metabolism @DRUG$ ethinylestradiol @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d645.s0.p6", "DRUGA": ["tolbutamide", "drug", "104-114"], "DRUGB": ["cyclosporine", "drug", "155-166"]}
{"TEXT1": "In vitro studies human liver microsomes showed terbinafine not inhibit metabolism tolbutamide @DRUG$ @DRUG$ cyclosporine", "LBL": "0", "ID": "DDI-DrugBank.d645.s0.p7", "DRUGA": ["ethinylestradiol", "drug", "117-132"], "DRUGB": ["ethoxycoumarin", "drug_n", "135-148"]}
{"TEXT1": "In vitro studies human liver microsomes showed terbinafine not inhibit metabolism tolbutamide @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d645.s0.p8", "DRUGA": ["ethinylestradiol", "drug", "117-132"], "DRUGB": ["cyclosporine", "drug", "155-166"]}
{"TEXT1": "In vitro studies human liver microsomes showed terbinafine not inhibit metabolism tolbutamide ethinylestradiol @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d645.s0.p9", "DRUGA": ["ethoxycoumarin", "drug_n", "135-148"], "DRUGB": ["cyclosporine", "drug", "155-166"]}
{"TEXT1": "clinical relevance compounds metabolized enzyme @DRUG$ @DRUG$ monoamine oxidase Type B inhibitors narrow therapeutic window", "LBL": "0", "ID": "DDI-DrugBank.d645.s2.p0", "DRUGA": ["tricyclic antidepressants", "group", "98-122"], "DRUGB": ["selective serotonin reuptake inhibitors", "group", "139-177"]}
{"TEXT1": "clinical relevance compounds metabolized enzyme @DRUG$ selective serotonin reuptake inhibitors monoamine oxidase Type B narrow therapeutic window", "LBL": "0", "ID": "DDI-DrugBank.d645.s2.p1", "DRUGA": ["tricyclic antidepressants", "group", "98-122"], "DRUGB": ["SSRIs", "group", "180-184"]}
{"TEXT1": "clinical relevance compounds metabolized enzyme @DRUG$ selective serotonin reuptake inhibitors @DRUG$ narrow therapeutic window", "LBL": "0", "ID": "DDI-DrugBank.d645.s2.p2", "DRUGA": ["tricyclic antidepressants", "group", "98-122"], "DRUGB": ["monoamine oxidase inhibitors (MAO-Is) Type B", "group", "192-235"]}
{"TEXT1": "clinical relevance compounds metabolized enzyme tricyclic antidepressants @DRUG$ monoamine oxidase Type B inhibitors narrow therapeutic window", "LBL": "0", "ID": "DDI-DrugBank.d645.s2.p3", "DRUGA": ["selective serotonin reuptake inhibitors", "group", "139-177"], "DRUGB": ["SSRIs", "group", "180-184"]}
{"TEXT1": "clinical relevance compounds metabolized enzyme tricyclic antidepressants @DRUG$ @DRUG$ narrow therapeutic window", "LBL": "0", "ID": "DDI-DrugBank.d645.s2.p4", "DRUGA": ["selective serotonin reuptake inhibitors", "group", "139-177"], "DRUGB": ["monoamine oxidase inhibitors (MAO-Is) Type B", "group", "192-235"]}
{"TEXT1": "clinical relevance compounds metabolized enzyme tricyclic antidepressants selective serotonin reuptake inhibitors @DRUG$ narrow therapeutic window", "LBL": "0", "ID": "DDI-DrugBank.d645.s2.p5", "DRUGA": ["SSRIs", "group", "180-184"], "DRUGB": ["monoamine oxidase inhibitors (MAO-Is) Type B", "group", "192-235"]}
{"TEXT1": "conducted normal volunteer subjects showed @DRUG$ not affect clearance @DRUG$ digoxin", "LBL": "0", "ID": "DDI-DrugBank.d645.s3.p0", "DRUGA": ["terbinafine", "drug", "89-99"], "DRUGB": ["antipyrine", "drug", "134-143"]}
{"TEXT1": "conducted normal volunteer subjects showed @DRUG$ not affect clearance antipyrine @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d645.s3.p1", "DRUGA": ["terbinafine", "drug", "89-99"], "DRUGB": ["digoxin", "drug", "148-154"]}
{"TEXT1": "conducted normal volunteer subjects showed terbinafine not affect clearance @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d645.s3.p2", "DRUGA": ["antipyrine", "drug", "134-143"], "DRUGB": ["digoxin", "drug", "148-154"]}
{"TEXT1": "@DRUG$ decreases clearance @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d645.s4.p0", "DRUGA": ["Terbinafine", "drug", "0-10"], "DRUGB": ["caffeine", "drug", "39-46"]}
{"TEXT1": "@DRUG$ increases clearance @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d645.s5.p0", "DRUGA": ["Terbinafine", "drug", "0-10"], "DRUGB": ["cyclosporine", "drug", "39-50"]}
{"TEXT1": "spontaneous reports increase decrease prothrombin times patients taking oral @DRUG$ @DRUG$ causal relationship LAMISIL Tablets changes not established", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d645.s6.p0", "DRUGA": ["terbinafine", "drug", "119-129"], "DRUGB": ["warfarin", "drug", "135-142"]}
{"TEXT1": "spontaneous reports increase decrease prothrombin times patients taking oral @DRUG$ warfarin causal relationship @DRUG$ Tablets changes not established", "LBL": "0", "ID": "DDI-DrugBank.d645.s6.p1", "DRUGA": ["terbinafine", "drug", "119-129"], "DRUGB": ["LAMISIL", "brand", "184-190"]}
{"TEXT1": "spontaneous reports increase decrease prothrombin times patients taking oral terbinafine @DRUG$ causal relationship @DRUG$ Tablets changes not established", "LBL": "0", "ID": "DDI-DrugBank.d645.s6.p2", "DRUGA": ["warfarin", "drug", "135-142"], "DRUGB": ["LAMISIL", "brand", "184-190"]}
{"TEXT1": "@DRUG$ clearance increased @DRUG$ CyP450 enzyme inducer decreased cimetidine", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d645.s7.p0", "DRUGA": ["Terbinafine", "drug", "0-10"], "DRUGB": ["rifampin", "drug", "43-50"]}
{"TEXT1": "@DRUG$ clearance increased rifampin CyP450 enzyme inducer decreased @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d645.s7.p1", "DRUGA": ["Terbinafine", "drug", "0-10"], "DRUGB": ["cimetidine", "drug", "99-108"]}
{"TEXT1": "Terbinafine clearance increased @DRUG$ CyP450 enzyme inducer decreased @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d645.s7.p2", "DRUGA": ["rifampin", "drug", "43-50"], "DRUGB": ["cimetidine", "drug", "99-108"]}
{"TEXT1": "@DRUG$ clearance unaffected @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d645.s8.p0", "DRUGA": ["Terbinafine", "drug", "0-10"], "DRUGB": ["cyclosporine", "drug", "39-50"]}
{"TEXT1": "no information available adequate studies following classes @DRUG$ hormone replacement therapies @DRUG$ theophyllines thiazide diuretics beta blockers", "LBL": "0", "ID": "DDI-DrugBank.d645.s9.p0", "DRUGA": ["contraceptives", "group", "120-133"], "DRUGB": ["hypoglycemics", "group", "167-179"]}
{"TEXT1": "no information available adequate studies following classes @DRUG$ hormone replacement therapies hypoglycemics @DRUG$ thiazide diuretics beta blockers", "LBL": "0", "ID": "DDI-DrugBank.d645.s9.p1", "DRUGA": ["contraceptives", "group", "120-133"], "DRUGB": ["theophyllines", "drug", "182-194"]}
{"TEXT1": "no information available adequate studies following classes @DRUG$ hormone replacement therapies hypoglycemics theophyllines @DRUG$ thiazide diuretics beta blockers", "LBL": "0", "ID": "DDI-DrugBank.d645.s9.p2", "DRUGA": ["contraceptives", "group", "120-133"], "DRUGB": ["phenytoins", "drug", "197-206"]}
{"TEXT1": "no information available adequate studies following classes @DRUG$ hormone replacement therapies hypoglycemics theophyllines @DRUG$ beta blockers", "LBL": "0", "ID": "DDI-DrugBank.d645.s9.p3", "DRUGA": ["contraceptives", "group", "120-133"], "DRUGB": ["thiazide diuretics", "group", "209-226"]}
{"TEXT1": "no information available adequate studies following classes @DRUG$ hormone replacement therapies hypoglycemics theophyllines thiazide diuretics @DRUG$ calcium channel blockers", "LBL": "0", "ID": "DDI-DrugBank.d645.s9.p4", "DRUGA": ["contraceptives", "group", "120-133"], "DRUGB": ["beta blockers", "group", "229-241"]}
{"TEXT1": "no information available adequate studies following classes @DRUG$ hormone replacement therapies hypoglycemics theophyllines thiazide diuretics beta blockers @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d645.s9.p5", "DRUGA": ["contraceptives", "group", "120-133"], "DRUGB": ["calcium channel blockers", "group", "248-271"]}
{"TEXT1": "no information available adequate studies following classes oral contraceptives hormone replacement therapies @DRUG$ @DRUG$ thiazide diuretics beta blockers", "LBL": "0", "ID": "DDI-DrugBank.d645.s9.p6", "DRUGA": ["hypoglycemics", "group", "167-179"], "DRUGB": ["theophyllines", "drug", "182-194"]}
{"TEXT1": "no information available adequate studies following classes oral contraceptives hormone replacement therapies @DRUG$ theophyllines @DRUG$ thiazide diuretics beta blockers", "LBL": "0", "ID": "DDI-DrugBank.d645.s9.p7", "DRUGA": ["hypoglycemics", "group", "167-179"], "DRUGB": ["phenytoins", "drug", "197-206"]}
{"TEXT1": "no information available adequate studies following classes oral contraceptives hormone replacement therapies @DRUG$ theophyllines @DRUG$ beta blockers", "LBL": "0", "ID": "DDI-DrugBank.d645.s9.p8", "DRUGA": ["hypoglycemics", "group", "167-179"], "DRUGB": ["thiazide diuretics", "group", "209-226"]}
{"TEXT1": "no information available adequate studies following classes oral contraceptives hormone replacement therapies @DRUG$ theophyllines thiazide diuretics @DRUG$ calcium channel blockers", "LBL": "0", "ID": "DDI-DrugBank.d645.s9.p9", "DRUGA": ["hypoglycemics", "group", "167-179"], "DRUGB": ["beta blockers", "group", "229-241"]}
{"TEXT1": "no information available adequate studies following classes oral contraceptives hormone replacement therapies @DRUG$ theophyllines thiazide diuretics beta blockers @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d645.s9.p10", "DRUGA": ["hypoglycemics", "group", "167-179"], "DRUGB": ["calcium channel blockers", "group", "248-271"]}
{"TEXT1": "no information available adequate studies following classes oral contraceptives hormone replacement therapies hypoglycemics @DRUG$ @DRUG$ thiazide diuretics beta blockers", "LBL": "0", "ID": "DDI-DrugBank.d645.s9.p11", "DRUGA": ["theophyllines", "drug", "182-194"], "DRUGB": ["phenytoins", "drug", "197-206"]}
{"TEXT1": "no information available adequate studies following classes oral contraceptives hormone replacement therapies hypoglycemics @DRUG$ @DRUG$ beta blockers", "LBL": "0", "ID": "DDI-DrugBank.d645.s9.p12", "DRUGA": ["theophyllines", "drug", "182-194"], "DRUGB": ["thiazide diuretics", "group", "209-226"]}
{"TEXT1": "no information available adequate studies following classes oral contraceptives hormone replacement therapies hypoglycemics @DRUG$ thiazide diuretics @DRUG$ calcium channel blockers", "LBL": "0", "ID": "DDI-DrugBank.d645.s9.p13", "DRUGA": ["theophyllines", "drug", "182-194"], "DRUGB": ["beta blockers", "group", "229-241"]}
{"TEXT1": "no information available adequate studies following classes oral contraceptives hormone replacement therapies hypoglycemics @DRUG$ thiazide diuretics beta blockers @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d645.s9.p14", "DRUGA": ["theophyllines", "drug", "182-194"], "DRUGB": ["calcium channel blockers", "group", "248-271"]}
{"TEXT1": "no information available adequate studies following classes oral contraceptives hormone replacement therapies hypoglycemics theophyllines @DRUG$ @DRUG$ beta blockers", "LBL": "0", "ID": "DDI-DrugBank.d645.s9.p15", "DRUGA": ["phenytoins", "drug", "197-206"], "DRUGB": ["thiazide diuretics", "group", "209-226"]}
{"TEXT1": "no information available adequate studies following classes oral contraceptives hormone replacement therapies hypoglycemics theophyllines @DRUG$ thiazide diuretics @DRUG$ calcium channel blockers", "LBL": "0", "ID": "DDI-DrugBank.d645.s9.p16", "DRUGA": ["phenytoins", "drug", "197-206"], "DRUGB": ["beta blockers", "group", "229-241"]}
{"TEXT1": "no information available adequate studies following classes oral contraceptives hormone replacement therapies hypoglycemics theophyllines @DRUG$ thiazide diuretics beta blockers @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d645.s9.p17", "DRUGA": ["phenytoins", "drug", "197-206"], "DRUGB": ["calcium channel blockers", "group", "248-271"]}
{"TEXT1": "no information available adequate studies following classes oral contraceptives hormone replacement therapies hypoglycemics theophyllines @DRUG$ @DRUG$ calcium channel blockers", "LBL": "0", "ID": "DDI-DrugBank.d645.s9.p18", "DRUGA": ["thiazide diuretics", "group", "209-226"], "DRUGB": ["beta blockers", "group", "229-241"]}
{"TEXT1": "no information available adequate studies following classes oral contraceptives hormone replacement therapies hypoglycemics theophyllines @DRUG$ beta blockers @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d645.s9.p19", "DRUGA": ["thiazide diuretics", "group", "209-226"], "DRUGB": ["calcium channel blockers", "group", "248-271"]}
{"TEXT1": "no information available adequate studies following classes oral contraceptives hormone replacement therapies hypoglycemics theophyllines thiazide diuretics @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d645.s9.p20", "DRUGA": ["beta blockers", "group", "229-241"], "DRUGB": ["calcium channel blockers", "group", "248-271"]}
{"TEXT1": "@DRUG$ @DRUG$ ADDITIVE DISALCID INCREASE PLASMA CONCENTRATIONS SALICYLIC ACID TOXIC LEVELS", "LBL": "0", "ID": "DDI-DrugBank.d576.s1.p0", "DRUGA": ["ASPIRIN", "brand", "0-6"], "DRUGB": ["SALICYLATE DRUGS", "group", "18-33"]}
{"TEXT1": "@DRUG$ SALICYLATE DRUGS ADDITIVE @DRUG$ INCREASE PLASMA CONCENTRATIONS SALICYLIC ACID TOXIC LEVELS", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d576.s1.p1", "DRUGA": ["ASPIRIN", "brand", "0-6"], "DRUGB": ["DISALCID", "brand", "55-62"]}
{"TEXT1": "@DRUG$ SALICYLATE DRUGS ADDITIVE DISALCID INCREASE PLASMA CONCENTRATIONS @DRUG$ TOXIC LEVELS", "LBL": "0", "ID": "DDI-DrugBank.d576.s1.p2", "DRUGA": ["ASPIRIN", "brand", "0-6"], "DRUGB": ["SALICYLIC ACID", "drug", "106-119"]}
{"TEXT1": "ASPIRIN @DRUG$ ADDITIVE @DRUG$ INCREASE PLASMA CONCENTRATIONS SALICYLIC ACID TOXIC LEVELS", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d576.s1.p3", "DRUGA": ["SALICYLATE DRUGS", "group", "18-33"], "DRUGB": ["DISALCID", "brand", "55-62"]}
{"TEXT1": "ASPIRIN @DRUG$ ADDITIVE DISALCID INCREASE PLASMA CONCENTRATIONS @DRUG$ TOXIC LEVELS", "LBL": "0", "ID": "DDI-DrugBank.d576.s1.p4", "DRUGA": ["SALICYLATE DRUGS", "group", "18-33"], "DRUGB": ["SALICYLIC ACID", "drug", "106-119"]}
{"TEXT1": "ASPIRIN SALICYLATE DRUGS ADDITIVE @DRUG$ INCREASE PLASMA CONCENTRATIONS @DRUG$ TOXIC LEVELS", "LBL": "0", "ID": "DDI-DrugBank.d576.s1.p5", "DRUGA": ["DISALCID", "brand", "55-62"], "DRUGB": ["SALICYLIC ACID", "drug", "106-119"]}
{"TEXT1": "@DRUG$ given @DRUG$ systemic bleeding", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d576.s4.p0", "DRUGA": ["Salicylates", "group", "0-10"], "DRUGB": ["anticoagulant drugs", "group", "37-55"]}
{"TEXT1": "@DRUG$ enhance hypoglycemic oral @DRUG$ sulfonylurea class", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d576.s5.p0", "DRUGA": ["Salicylates", "group", "0-10"], "DRUGB": ["antidiabetic drugs", "group", "56-73"]}
{"TEXT1": "@DRUG$ number drugs protein binding sites @DRUG$ thiopental thyroxine triiodothyronine phenytoin sulfinpyrazone naproxen warfarin methotrexate possibly corticosteroids", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d576.s6.p0", "DRUGA": ["Salicylate", "group", "0-9"], "DRUGB": ["penicillin", "drug", "78-87"]}
{"TEXT1": "@DRUG$ number drugs protein binding sites penicillin @DRUG$ thyroxine triiodothyronine phenytoin sulfinpyrazone naproxen warfarin methotrexate possibly corticosteroids", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d576.s6.p1", "DRUGA": ["Salicylate", "group", "0-9"], "DRUGB": ["thiopental", "drug", "90-99"]}
{"TEXT1": "@DRUG$ number drugs protein binding sites penicillin thiopental @DRUG$ triiodothyronine phenytoin sulfinpyrazone naproxen warfarin methotrexate possibly corticosteroids", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d576.s6.p2", "DRUGA": ["Salicylate", "group", "0-9"], "DRUGB": ["thyroxine", "drug", "102-110"]}
{"TEXT1": "@DRUG$ number drugs protein binding sites penicillin thiopental thyroxine @DRUG$ phenytoin sulfinpyrazone naproxen warfarin methotrexate possibly corticosteroids", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d576.s6.p3", "DRUGA": ["Salicylate", "group", "0-9"], "DRUGB": ["triiodothyronine", "drug", "113-128"]}
{"TEXT1": "@DRUG$ number drugs protein binding sites penicillin thiopental thyroxine triiodothyronine @DRUG$ sulfinpyrazone naproxen warfarin methotrexate possibly corticosteroids", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d576.s6.p4", "DRUGA": ["Salicylate", "group", "0-9"], "DRUGB": ["phenytoin", "drug", "131-139"]}
{"TEXT1": "@DRUG$ number drugs protein binding sites penicillin thiopental thyroxine triiodothyronine phenytoin @DRUG$ naproxen warfarin methotrexate possibly corticosteroids", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d576.s6.p5", "DRUGA": ["Salicylate", "group", "0-9"], "DRUGB": ["sulfinpyrazone", "drug", "142-155"]}
{"TEXT1": "@DRUG$ number drugs protein binding sites penicillin thiopental thyroxine triiodothyronine phenytoin sulfinpyrazone @DRUG$ warfarin methotrexate possibly corticosteroids", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d576.s6.p6", "DRUGA": ["Salicylate", "group", "0-9"], "DRUGB": ["naproxen", "drug", "158-165"]}
{"TEXT1": "@DRUG$ number drugs protein binding sites penicillin thiopental thyroxine triiodothyronine phenytoin sulfinpyrazone naproxen @DRUG$ methotrexate possibly corticosteroids", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d576.s6.p7", "DRUGA": ["Salicylate", "group", "0-9"], "DRUGB": ["warfarin", "drug", "168-175"]}
{"TEXT1": "@DRUG$ number drugs protein binding sites penicillin thiopental thyroxine triiodothyronine phenytoin sulfinpyrazone naproxen warfarin @DRUG$ possibly corticosteroids", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d576.s6.p8", "DRUGA": ["Salicylate", "group", "0-9"], "DRUGB": ["methotrexate", "drug", "178-189"]}
{"TEXT1": "@DRUG$ number drugs protein binding sites penicillin thiopental thyroxine triiodothyronine phenytoin sulfinpyrazone naproxen warfarin methotrexate possibly @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d576.s6.p9", "DRUGA": ["Salicylate", "group", "0-9"], "DRUGB": ["corticosteroids", "group", "205-219"]}
{"TEXT1": "Salicylate number drugs protein binding sites @DRUG$ @DRUG$ thyroxine triiodothyronine phenytoin sulfinpyrazone naproxen warfarin methotrexate possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p10", "DRUGA": ["penicillin", "drug", "78-87"], "DRUGB": ["thiopental", "drug", "90-99"]}
{"TEXT1": "Salicylate number drugs protein binding sites @DRUG$ thiopental @DRUG$ triiodothyronine phenytoin sulfinpyrazone naproxen warfarin methotrexate possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p11", "DRUGA": ["penicillin", "drug", "78-87"], "DRUGB": ["thyroxine", "drug", "102-110"]}
{"TEXT1": "Salicylate number drugs protein binding sites @DRUG$ thiopental thyroxine @DRUG$ phenytoin sulfinpyrazone naproxen warfarin methotrexate possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p12", "DRUGA": ["penicillin", "drug", "78-87"], "DRUGB": ["triiodothyronine", "drug", "113-128"]}
{"TEXT1": "Salicylate number drugs protein binding sites @DRUG$ thiopental thyroxine triiodothyronine @DRUG$ sulfinpyrazone naproxen warfarin methotrexate possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p13", "DRUGA": ["penicillin", "drug", "78-87"], "DRUGB": ["phenytoin", "drug", "131-139"]}
{"TEXT1": "Salicylate number drugs protein binding sites @DRUG$ thiopental thyroxine triiodothyronine phenytoin @DRUG$ naproxen warfarin methotrexate possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p14", "DRUGA": ["penicillin", "drug", "78-87"], "DRUGB": ["sulfinpyrazone", "drug", "142-155"]}
{"TEXT1": "Salicylate number drugs protein binding sites @DRUG$ thiopental thyroxine triiodothyronine phenytoin sulfinpyrazone @DRUG$ warfarin methotrexate possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p15", "DRUGA": ["penicillin", "drug", "78-87"], "DRUGB": ["naproxen", "drug", "158-165"]}
{"TEXT1": "Salicylate number drugs protein binding sites @DRUG$ thiopental thyroxine triiodothyronine phenytoin sulfinpyrazone naproxen @DRUG$ methotrexate possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p16", "DRUGA": ["penicillin", "drug", "78-87"], "DRUGB": ["warfarin", "drug", "168-175"]}
{"TEXT1": "Salicylate number drugs protein binding sites @DRUG$ thiopental thyroxine triiodothyronine phenytoin sulfinpyrazone naproxen warfarin @DRUG$ possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p17", "DRUGA": ["penicillin", "drug", "78-87"], "DRUGB": ["methotrexate", "drug", "178-189"]}
{"TEXT1": "Salicylate number drugs protein binding sites @DRUG$ thiopental thyroxine triiodothyronine phenytoin sulfinpyrazone naproxen warfarin methotrexate possibly @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p18", "DRUGA": ["penicillin", "drug", "78-87"], "DRUGB": ["corticosteroids", "group", "205-219"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin @DRUG$ @DRUG$ triiodothyronine phenytoin sulfinpyrazone naproxen warfarin methotrexate possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p19", "DRUGA": ["thiopental", "drug", "90-99"], "DRUGB": ["thyroxine", "drug", "102-110"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin @DRUG$ thyroxine @DRUG$ phenytoin sulfinpyrazone naproxen warfarin methotrexate possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p20", "DRUGA": ["thiopental", "drug", "90-99"], "DRUGB": ["triiodothyronine", "drug", "113-128"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin @DRUG$ thyroxine triiodothyronine @DRUG$ sulfinpyrazone naproxen warfarin methotrexate possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p21", "DRUGA": ["thiopental", "drug", "90-99"], "DRUGB": ["phenytoin", "drug", "131-139"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin @DRUG$ thyroxine triiodothyronine phenytoin @DRUG$ naproxen warfarin methotrexate possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p22", "DRUGA": ["thiopental", "drug", "90-99"], "DRUGB": ["sulfinpyrazone", "drug", "142-155"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin @DRUG$ thyroxine triiodothyronine phenytoin sulfinpyrazone @DRUG$ warfarin methotrexate possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p23", "DRUGA": ["thiopental", "drug", "90-99"], "DRUGB": ["naproxen", "drug", "158-165"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin @DRUG$ thyroxine triiodothyronine phenytoin sulfinpyrazone naproxen @DRUG$ methotrexate possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p24", "DRUGA": ["thiopental", "drug", "90-99"], "DRUGB": ["warfarin", "drug", "168-175"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin @DRUG$ thyroxine triiodothyronine phenytoin sulfinpyrazone naproxen warfarin @DRUG$ possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p25", "DRUGA": ["thiopental", "drug", "90-99"], "DRUGB": ["methotrexate", "drug", "178-189"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin @DRUG$ thyroxine triiodothyronine phenytoin sulfinpyrazone naproxen warfarin methotrexate possibly @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p26", "DRUGA": ["thiopental", "drug", "90-99"], "DRUGB": ["corticosteroids", "group", "205-219"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin thiopental @DRUG$ @DRUG$ phenytoin sulfinpyrazone naproxen warfarin methotrexate possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p27", "DRUGA": ["thyroxine", "drug", "102-110"], "DRUGB": ["triiodothyronine", "drug", "113-128"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin thiopental @DRUG$ triiodothyronine @DRUG$ sulfinpyrazone naproxen warfarin methotrexate possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p28", "DRUGA": ["thyroxine", "drug", "102-110"], "DRUGB": ["phenytoin", "drug", "131-139"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin thiopental @DRUG$ triiodothyronine phenytoin @DRUG$ naproxen warfarin methotrexate possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p29", "DRUGA": ["thyroxine", "drug", "102-110"], "DRUGB": ["sulfinpyrazone", "drug", "142-155"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin thiopental @DRUG$ triiodothyronine phenytoin sulfinpyrazone @DRUG$ warfarin methotrexate possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p30", "DRUGA": ["thyroxine", "drug", "102-110"], "DRUGB": ["naproxen", "drug", "158-165"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin thiopental @DRUG$ triiodothyronine phenytoin sulfinpyrazone naproxen @DRUG$ methotrexate possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p31", "DRUGA": ["thyroxine", "drug", "102-110"], "DRUGB": ["warfarin", "drug", "168-175"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin thiopental @DRUG$ triiodothyronine phenytoin sulfinpyrazone naproxen warfarin @DRUG$ possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p32", "DRUGA": ["thyroxine", "drug", "102-110"], "DRUGB": ["methotrexate", "drug", "178-189"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin thiopental @DRUG$ triiodothyronine phenytoin sulfinpyrazone naproxen warfarin methotrexate possibly @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p33", "DRUGA": ["thyroxine", "drug", "102-110"], "DRUGB": ["corticosteroids", "group", "205-219"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin thiopental thyroxine @DRUG$ @DRUG$ sulfinpyrazone naproxen warfarin methotrexate possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p34", "DRUGA": ["triiodothyronine", "drug", "113-128"], "DRUGB": ["phenytoin", "drug", "131-139"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin thiopental thyroxine @DRUG$ phenytoin @DRUG$ naproxen warfarin methotrexate possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p35", "DRUGA": ["triiodothyronine", "drug", "113-128"], "DRUGB": ["sulfinpyrazone", "drug", "142-155"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin thiopental thyroxine @DRUG$ phenytoin sulfinpyrazone @DRUG$ warfarin methotrexate possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p36", "DRUGA": ["triiodothyronine", "drug", "113-128"], "DRUGB": ["naproxen", "drug", "158-165"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin thiopental thyroxine @DRUG$ phenytoin sulfinpyrazone naproxen @DRUG$ methotrexate possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p37", "DRUGA": ["triiodothyronine", "drug", "113-128"], "DRUGB": ["warfarin", "drug", "168-175"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin thiopental thyroxine @DRUG$ phenytoin sulfinpyrazone naproxen warfarin @DRUG$ possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p38", "DRUGA": ["triiodothyronine", "drug", "113-128"], "DRUGB": ["methotrexate", "drug", "178-189"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin thiopental thyroxine @DRUG$ phenytoin sulfinpyrazone naproxen warfarin methotrexate possibly @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p39", "DRUGA": ["triiodothyronine", "drug", "113-128"], "DRUGB": ["corticosteroids", "group", "205-219"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin thiopental thyroxine triiodothyronine @DRUG$ @DRUG$ naproxen warfarin methotrexate possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p40", "DRUGA": ["phenytoin", "drug", "131-139"], "DRUGB": ["sulfinpyrazone", "drug", "142-155"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin thiopental thyroxine triiodothyronine @DRUG$ sulfinpyrazone @DRUG$ warfarin methotrexate possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p41", "DRUGA": ["phenytoin", "drug", "131-139"], "DRUGB": ["naproxen", "drug", "158-165"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin thiopental thyroxine triiodothyronine @DRUG$ sulfinpyrazone naproxen @DRUG$ methotrexate possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p42", "DRUGA": ["phenytoin", "drug", "131-139"], "DRUGB": ["warfarin", "drug", "168-175"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin thiopental thyroxine triiodothyronine @DRUG$ sulfinpyrazone naproxen warfarin @DRUG$ possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p43", "DRUGA": ["phenytoin", "drug", "131-139"], "DRUGB": ["methotrexate", "drug", "178-189"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin thiopental thyroxine triiodothyronine @DRUG$ sulfinpyrazone naproxen warfarin methotrexate possibly @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p44", "DRUGA": ["phenytoin", "drug", "131-139"], "DRUGB": ["corticosteroids", "group", "205-219"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin thiopental thyroxine triiodothyronine phenytoin @DRUG$ @DRUG$ warfarin methotrexate possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p45", "DRUGA": ["sulfinpyrazone", "drug", "142-155"], "DRUGB": ["naproxen", "drug", "158-165"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin thiopental thyroxine triiodothyronine phenytoin @DRUG$ naproxen @DRUG$ methotrexate possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p46", "DRUGA": ["sulfinpyrazone", "drug", "142-155"], "DRUGB": ["warfarin", "drug", "168-175"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin thiopental thyroxine triiodothyronine phenytoin @DRUG$ naproxen warfarin @DRUG$ possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p47", "DRUGA": ["sulfinpyrazone", "drug", "142-155"], "DRUGB": ["methotrexate", "drug", "178-189"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin thiopental thyroxine triiodothyronine phenytoin @DRUG$ naproxen warfarin methotrexate possibly @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p48", "DRUGA": ["sulfinpyrazone", "drug", "142-155"], "DRUGB": ["corticosteroids", "group", "205-219"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin thiopental thyroxine triiodothyronine phenytoin sulfinpyrazone @DRUG$ @DRUG$ methotrexate possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p49", "DRUGA": ["naproxen", "drug", "158-165"], "DRUGB": ["warfarin", "drug", "168-175"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin thiopental thyroxine triiodothyronine phenytoin sulfinpyrazone @DRUG$ warfarin @DRUG$ possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p50", "DRUGA": ["naproxen", "drug", "158-165"], "DRUGB": ["methotrexate", "drug", "178-189"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin thiopental thyroxine triiodothyronine phenytoin sulfinpyrazone @DRUG$ warfarin methotrexate possibly @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p51", "DRUGA": ["naproxen", "drug", "158-165"], "DRUGB": ["corticosteroids", "group", "205-219"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin thiopental thyroxine triiodothyronine phenytoin sulfinpyrazone naproxen @DRUG$ @DRUG$ possibly corticosteroids", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p52", "DRUGA": ["warfarin", "drug", "168-175"], "DRUGB": ["methotrexate", "drug", "178-189"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin thiopental thyroxine triiodothyronine phenytoin sulfinpyrazone naproxen @DRUG$ methotrexate possibly @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p53", "DRUGA": ["warfarin", "drug", "168-175"], "DRUGB": ["corticosteroids", "group", "205-219"]}
{"TEXT1": "Salicylate number drugs protein binding sites penicillin thiopental thyroxine triiodothyronine phenytoin sulfinpyrazone naproxen warfarin @DRUG$ possibly @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d576.s6.p54", "DRUGA": ["methotrexate", "drug", "178-189"], "DRUGB": ["corticosteroids", "group", "205-219"]}
{"TEXT1": "Catecholamine depleting drugs additive effect given @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d666.s0.p0", "DRUGA": ["reserpine", "drug", "37-45"], "DRUGB": ["beta-blocking agents", "group", "92-111"]}
{"TEXT1": "@DRUG$ variety @DRUG$ including hydrochlorothiazide hydralazine guanethidine unexpected adverse interactions", "LBL": "0", "ID": "DDI-DrugBank.d666.s2.p0", "DRUGA": ["Pindolol", "drug", "0-7"], "DRUGB": ["antihypertensive agents", "group", "41-63"]}
{"TEXT1": "@DRUG$ variety antihypertensive agents including @DRUG$ hydralazine guanethidine unexpected adverse interactions", "LBL": "0", "ID": "DDI-DrugBank.d666.s2.p1", "DRUGA": ["Pindolol", "drug", "0-7"], "DRUGB": ["hydrochlorothiazide", "drug", "76-94"]}
{"TEXT1": "@DRUG$ variety antihypertensive agents including hydrochlorothiazide @DRUG$ guanethidine unexpected adverse interactions", "LBL": "0", "ID": "DDI-DrugBank.d666.s2.p2", "DRUGA": ["Pindolol", "drug", "0-7"], "DRUGB": ["hydralazine", "drug", "97-107"]}
{"TEXT1": "@DRUG$ variety antihypertensive agents including hydrochlorothiazide hydralazine @DRUG$ unexpected adverse interactions", "LBL": "0", "ID": "DDI-DrugBank.d666.s2.p3", "DRUGA": ["Pindolol", "drug", "0-7"], "DRUGB": ["guanethidine", "drug", "114-125"]}
{"TEXT1": "Pindolol variety @DRUG$ including @DRUG$ hydralazine guanethidine unexpected adverse interactions", "LBL": "0", "ID": "DDI-DrugBank.d666.s2.p4", "DRUGA": ["antihypertensive agents", "group", "41-63"], "DRUGB": ["hydrochlorothiazide", "drug", "76-94"]}
{"TEXT1": "Pindolol variety @DRUG$ including hydrochlorothiazide @DRUG$ guanethidine unexpected adverse interactions", "LBL": "0", "ID": "DDI-DrugBank.d666.s2.p5", "DRUGA": ["antihypertensive agents", "group", "41-63"], "DRUGB": ["hydralazine", "drug", "97-107"]}
{"TEXT1": "Pindolol variety @DRUG$ including hydrochlorothiazide hydralazine @DRUG$ unexpected adverse interactions", "LBL": "0", "ID": "DDI-DrugBank.d666.s2.p6", "DRUGA": ["antihypertensive agents", "group", "41-63"], "DRUGB": ["guanethidine", "drug", "114-125"]}
{"TEXT1": "Pindolol variety antihypertensive agents including @DRUG$ @DRUG$ guanethidine unexpected adverse interactions", "LBL": "0", "ID": "DDI-DrugBank.d666.s2.p7", "DRUGA": ["hydrochlorothiazide", "drug", "76-94"], "DRUGB": ["hydralazine", "drug", "97-107"]}
{"TEXT1": "Pindolol variety antihypertensive agents including @DRUG$ hydralazine @DRUG$ unexpected adverse interactions", "LBL": "0", "ID": "DDI-DrugBank.d666.s2.p8", "DRUGA": ["hydrochlorothiazide", "drug", "76-94"], "DRUGB": ["guanethidine", "drug", "114-125"]}
{"TEXT1": "Pindolol variety antihypertensive agents including hydrochlorothiazide @DRUG$ @DRUG$ unexpected adverse interactions", "LBL": "0", "ID": "DDI-DrugBank.d666.s2.p9", "DRUGA": ["hydralazine", "drug", "97-107"], "DRUGB": ["guanethidine", "drug", "114-125"]}
{"TEXT1": "@DRUG$ shown to increase serum @DRUG$ levels drugs co administered", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d666.s3.p0", "DRUGA": ["Pindolol", "drug", "0-7"], "DRUGB": ["thioridazine", "drug", "42-53"]}
{"TEXT1": "specific drug food interactions @DRUG$ not studied on basis metabolism CYP possible @DRUG$ itraconazole erythromycin grapefruit juice inhibit serum levels", "LBL": "0", "ID": "DDI-DrugBank.d668.s0.p0", "DRUGA": ["mifepristone", "drug", "49-60"], "DRUGB": ["ketoconazole", "drug", "158-169"]}
{"TEXT1": "specific drug food interactions @DRUG$ not studied on basis metabolism CYP possible ketoconazole @DRUG$ erythromycin grapefruit juice inhibit serum levels", "LBL": "0", "ID": "DDI-DrugBank.d668.s0.p1", "DRUGA": ["mifepristone", "drug", "49-60"], "DRUGB": ["itraconazole", "drug", "172-183"]}
{"TEXT1": "specific drug food interactions @DRUG$ not studied on basis metabolism CYP possible ketoconazole itraconazole @DRUG$ grapefruit juice inhibit serum levels", "LBL": "0", "ID": "DDI-DrugBank.d668.s0.p2", "DRUGA": ["mifepristone", "drug", "49-60"], "DRUGB": ["erythromycin", "drug", "186-197"]}
{"TEXT1": "specific drug food interactions @DRUG$ not studied on basis metabolism CYP possible ketoconazole itraconazole erythromycin grapefruit juice inhibit serum levels", "LBL": "0", "ID": "DDI-DrugBank.d668.s0.p3", "DRUGA": ["mifepristone", "drug", "49-60"], "DRUGB": ["mifepristone", "drug", "276-287"]}
{"TEXT1": "specific drug food interactions mifepristone not studied on basis metabolism CYP possible @DRUG$ @DRUG$ erythromycin grapefruit juice inhibit serum levels", "LBL": "0", "ID": "DDI-DrugBank.d668.s0.p4", "DRUGA": ["ketoconazole", "drug", "158-169"], "DRUGB": ["itraconazole", "drug", "172-183"]}
{"TEXT1": "specific drug food interactions mifepristone not studied on basis metabolism CYP possible @DRUG$ itraconazole @DRUG$ grapefruit juice inhibit serum levels", "LBL": "0", "ID": "DDI-DrugBank.d668.s0.p5", "DRUGA": ["ketoconazole", "drug", "158-169"], "DRUGB": ["erythromycin", "drug", "186-197"]}
{"TEXT1": "specific drug food interactions mifepristone not studied on basis metabolism CYP possible @DRUG$ itraconazole erythromycin grapefruit juice inhibit serum levels", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d668.s0.p6", "DRUGA": ["ketoconazole", "drug", "158-169"], "DRUGB": ["mifepristone", "drug", "276-287"]}
{"TEXT1": "specific drug food interactions mifepristone not studied on basis metabolism CYP possible ketoconazole @DRUG$ @DRUG$ grapefruit juice inhibit serum levels", "LBL": "0", "ID": "DDI-DrugBank.d668.s0.p7", "DRUGA": ["itraconazole", "drug", "172-183"], "DRUGB": ["erythromycin", "drug", "186-197"]}
{"TEXT1": "specific drug food interactions mifepristone not studied on basis metabolism CYP possible ketoconazole @DRUG$ erythromycin grapefruit juice inhibit serum levels", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d668.s0.p8", "DRUGA": ["itraconazole", "drug", "172-183"], "DRUGB": ["mifepristone", "drug", "276-287"]}
{"TEXT1": "specific drug food interactions mifepristone not studied on basis metabolism CYP possible ketoconazole itraconazole @DRUG$ grapefruit juice inhibit serum levels", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d668.s0.p9", "DRUGA": ["erythromycin", "drug", "186-197"], "DRUGB": ["mifepristone", "drug", "276-287"]}
{"TEXT1": "@DRUG$ @DRUG$ St", "LBL": "0", "ID": "DDI-DrugBank.d668.s1.p0", "DRUGA": ["rifampin", "drug", "13-20"], "DRUGB": ["dexamethasone", "drug", "23-35"]}
{"TEXT1": "certain @DRUG$ phenobarbital induce mifepristone metabolism serum levels", "LBL": "0", "ID": "DDI-DrugBank.d668.s2.p0", "DRUGA": ["anticonvulsants", "group", "27-41"], "DRUGB": ["phenytoin", "drug", "44-52"]}
{"TEXT1": "certain @DRUG$ @DRUG$ induce mifepristone metabolism serum levels", "LBL": "0", "ID": "DDI-DrugBank.d668.s2.p1", "DRUGA": ["anticonvulsants", "group", "27-41"], "DRUGB": ["phenobarbital", "drug", "55-67"]}
{"TEXT1": "certain @DRUG$ phenobarbital induce mifepristone metabolism serum levels", "LBL": "0", "ID": "DDI-DrugBank.d668.s2.p2", "DRUGA": ["anticonvulsants", "group", "27-41"], "DRUGB": ["carbamazepine", "drug", "70-82"]}
{"TEXT1": "certain @DRUG$ phenobarbital induce @DRUG$ metabolism serum levels", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d668.s2.p3", "DRUGA": ["anticonvulsants", "group", "27-41"], "DRUGB": ["mifepristone", "drug", "96-107"]}
{"TEXT1": "certain @DRUG$ phenobarbital induce mifepristone metabolism serum levels", "LBL": "0", "ID": "DDI-DrugBank.d668.s2.p4", "DRUGA": ["anticonvulsants", "group", "27-41"], "DRUGB": ["mifepristone", "drug", "146-157"]}
{"TEXT1": "certain anticonvulsants @DRUG$ induce mifepristone metabolism serum levels", "LBL": "0", "ID": "DDI-DrugBank.d668.s2.p5", "DRUGA": ["phenytoin", "drug", "44-52"], "DRUGB": ["phenobarbital", "drug", "55-67"]}
{"TEXT1": "certain anticonvulsants phenobarbital induce mifepristone metabolism serum levels", "LBL": "0", "ID": "DDI-DrugBank.d668.s2.p6", "DRUGA": ["phenytoin", "drug", "44-52"], "DRUGB": ["carbamazepine", "drug", "70-82"]}
{"TEXT1": "certain anticonvulsants phenobarbital induce @DRUG$ metabolism serum levels", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d668.s2.p7", "DRUGA": ["phenytoin", "drug", "44-52"], "DRUGB": ["mifepristone", "drug", "96-107"]}
{"TEXT1": "certain anticonvulsants phenobarbital induce mifepristone metabolism serum levels", "LBL": "0", "ID": "DDI-DrugBank.d668.s2.p8", "DRUGA": ["phenytoin", "drug", "44-52"], "DRUGB": ["mifepristone", "drug", "146-157"]}
{"TEXT1": "certain anticonvulsants @DRUG$ induce mifepristone metabolism serum levels", "LBL": "0", "ID": "DDI-DrugBank.d668.s2.p9", "DRUGA": ["phenobarbital", "drug", "55-67"], "DRUGB": ["carbamazepine", "drug", "70-82"]}
{"TEXT1": "certain anticonvulsants @DRUG$ induce @DRUG$ metabolism serum levels", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d668.s2.p10", "DRUGA": ["phenobarbital", "drug", "55-67"], "DRUGB": ["mifepristone", "drug", "96-107"]}
{"TEXT1": "certain anticonvulsants @DRUG$ induce mifepristone metabolism serum levels", "LBL": "0", "ID": "DDI-DrugBank.d668.s2.p11", "DRUGA": ["phenobarbital", "drug", "55-67"], "DRUGB": ["mifepristone", "drug", "146-157"]}
{"TEXT1": "certain anticonvulsants phenobarbital induce @DRUG$ metabolism serum levels", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d668.s2.p12", "DRUGA": ["carbamazepine", "drug", "70-82"], "DRUGB": ["mifepristone", "drug", "96-107"]}
{"TEXT1": "certain anticonvulsants phenobarbital induce mifepristone metabolism serum levels", "LBL": "0", "ID": "DDI-DrugBank.d668.s2.p13", "DRUGA": ["carbamazepine", "drug", "70-82"], "DRUGB": ["mifepristone", "drug", "146-157"]}
{"TEXT1": "certain anticonvulsants phenobarbital induce @DRUG$ metabolism serum levels", "LBL": "0", "ID": "DDI-DrugBank.d668.s2.p14", "DRUGA": ["mifepristone", "drug", "96-107"], "DRUGB": ["mifepristone", "drug", "146-157"]}
{"TEXT1": "In addition to bleeding associated with @DRUG$ @DRUG$ drugs alter platelet function aspirin dipyridamole increase administered Retavase therapy", "LBL": "0", "ID": "DDI-DrugBank.d618.s1.p0", "DRUGA": ["heparin", "drug", "40-46"], "DRUGB": ["vitamin K antagonists", "group", "52-72"]}
{"TEXT1": "In addition to bleeding associated with @DRUG$ vitamin K antagonists drugs alter platelet function @DRUG$ dipyridamole increase administered Retavase therapy", "LBL": "0", "ID": "DDI-DrugBank.d618.s1.p1", "DRUGA": ["heparin", "drug", "40-46"], "DRUGB": ["aspirin", "brand", "119-125"]}
{"TEXT1": "In addition to bleeding associated with @DRUG$ vitamin K antagonists drugs alter platelet function aspirin @DRUG$ increase administered Retavase therapy", "LBL": "0", "ID": "DDI-DrugBank.d618.s1.p2", "DRUGA": ["heparin", "drug", "40-46"], "DRUGB": ["dipyridamole", "drug", "128-139"]}
{"TEXT1": "In addition to bleeding associated with @DRUG$ vitamin K antagonists drugs alter platelet function aspirin dipyridamole increase administered Retavase therapy", "LBL": "0", "ID": "DDI-DrugBank.d618.s1.p3", "DRUGA": ["heparin", "drug", "40-46"], "DRUGB": ["abciximab", "drug", "146-154"]}
{"TEXT1": "In addition to bleeding associated with @DRUG$ vitamin K antagonists drugs alter platelet function aspirin dipyridamole increase administered @DRUG$ therapy", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d618.s1.p4", "DRUGA": ["heparin", "drug", "40-46"], "DRUGB": ["Retavase", "brand", "225-232"]}
{"TEXT1": "In addition to bleeding associated with heparin @DRUG$ drugs alter platelet function @DRUG$ dipyridamole increase administered Retavase therapy", "LBL": "0", "ID": "DDI-DrugBank.d618.s1.p5", "DRUGA": ["vitamin K antagonists", "group", "52-72"], "DRUGB": ["aspirin", "brand", "119-125"]}
{"TEXT1": "In addition to bleeding associated with heparin @DRUG$ drugs alter platelet function aspirin @DRUG$ increase administered Retavase therapy", "LBL": "0", "ID": "DDI-DrugBank.d618.s1.p6", "DRUGA": ["vitamin K antagonists", "group", "52-72"], "DRUGB": ["dipyridamole", "drug", "128-139"]}
{"TEXT1": "In addition to bleeding associated with heparin @DRUG$ drugs alter platelet function aspirin dipyridamole increase administered Retavase therapy", "LBL": "0", "ID": "DDI-DrugBank.d618.s1.p7", "DRUGA": ["vitamin K antagonists", "group", "52-72"], "DRUGB": ["abciximab", "drug", "146-154"]}
{"TEXT1": "In addition to bleeding associated with heparin @DRUG$ drugs alter platelet function aspirin dipyridamole increase administered @DRUG$ therapy", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d618.s1.p8", "DRUGA": ["vitamin K antagonists", "group", "52-72"], "DRUGB": ["Retavase", "brand", "225-232"]}
{"TEXT1": "In addition to bleeding associated with heparin vitamin K antagonists drugs alter platelet function @DRUG$ @DRUG$ increase administered Retavase therapy", "LBL": "0", "ID": "DDI-DrugBank.d618.s1.p9", "DRUGA": ["aspirin", "brand", "119-125"], "DRUGB": ["dipyridamole", "drug", "128-139"]}
{"TEXT1": "In addition to bleeding associated with heparin vitamin K antagonists drugs alter platelet function @DRUG$ dipyridamole increase administered Retavase therapy", "LBL": "0", "ID": "DDI-DrugBank.d618.s1.p10", "DRUGA": ["aspirin", "brand", "119-125"], "DRUGB": ["abciximab", "drug", "146-154"]}
{"TEXT1": "In addition to bleeding associated with heparin vitamin K antagonists drugs alter platelet function @DRUG$ dipyridamole increase administered @DRUG$ therapy", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d618.s1.p11", "DRUGA": ["aspirin", "brand", "119-125"], "DRUGB": ["Retavase", "brand", "225-232"]}
{"TEXT1": "In addition to bleeding associated with heparin vitamin K antagonists drugs alter platelet function aspirin @DRUG$ increase administered Retavase therapy", "LBL": "0", "ID": "DDI-DrugBank.d618.s1.p12", "DRUGA": ["dipyridamole", "drug", "128-139"], "DRUGB": ["abciximab", "drug", "146-154"]}
{"TEXT1": "In addition to bleeding associated with heparin vitamin K antagonists drugs alter platelet function aspirin @DRUG$ increase administered @DRUG$ therapy", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d618.s1.p13", "DRUGA": ["dipyridamole", "drug", "128-139"], "DRUGB": ["Retavase", "brand", "225-232"]}
{"TEXT1": "In addition to bleeding associated with heparin vitamin K antagonists drugs alter platelet function aspirin dipyridamole increase administered @DRUG$ therapy", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d618.s1.p14", "DRUGA": ["abciximab", "drug", "146-154"], "DRUGB": ["Retavase", "brand", "225-232"]}
{"TEXT1": "occurrence stupor muscular rigidity severe agitation elevated temperature reported patients receiving combination @DRUG$ @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d619.s0.p0", "DRUGA": ["selegiline", "drug", "152-161"], "DRUGB": ["meperidine", "drug", "167-176"]}
{"TEXT1": "typical interaction @DRUG$ @DRUG$", "LBL": "DDI-int", "ID": "DDI-DrugBank.d619.s2.p0", "DRUGA": ["meperidine", "drug", "38-47"], "DRUGB": ["MAOIs", "group", "53-57"]}
{"TEXT1": "Severe toxicity reported patients receiving combination @DRUG$ @DRUG$ selective serotonin reuptake inhibitors ELDEPRYL", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d619.s4.p0", "DRUGA": ["tricyclic antidepressants", "group", "80-104"], "DRUGB": ["ELDEPRYL", "brand", "110-117"]}
{"TEXT1": "Severe toxicity reported patients receiving combination @DRUG$ ELDEPRYL @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d619.s4.p1", "DRUGA": ["tricyclic antidepressants", "group", "80-104"], "DRUGB": ["selective serotonin reuptake inhibitors", "group", "123-161"]}
{"TEXT1": "Severe toxicity reported patients receiving combination @DRUG$ ELDEPRYL selective serotonin reuptake inhibitors @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d619.s4.p2", "DRUGA": ["tricyclic antidepressants", "group", "80-104"], "DRUGB": ["ELDEPRYL", "brand", "167-174"]}
{"TEXT1": "Severe toxicity reported patients receiving combination tricyclic antidepressants @DRUG$ @DRUG$ ELDEPRYL", "LBL": "0", "ID": "DDI-DrugBank.d619.s4.p3", "DRUGA": ["ELDEPRYL", "brand", "110-117"], "DRUGB": ["selective serotonin reuptake inhibitors", "group", "123-161"]}
{"TEXT1": "Severe toxicity reported patients receiving combination tricyclic antidepressants @DRUG$ selective serotonin reuptake inhibitors @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d619.s4.p4", "DRUGA": ["ELDEPRYL", "brand", "110-117"], "DRUGB": ["ELDEPRYL", "brand", "167-174"]}
{"TEXT1": "Severe toxicity reported patients receiving combination tricyclic antidepressants ELDEPRYL @DRUG$ @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d619.s4.p5", "DRUGA": ["selective serotonin reuptake inhibitors", "group", "123-161"], "DRUGB": ["ELDEPRYL", "brand", "167-174"]}
{"TEXT1": "One case hypertensive crisis reported patient taking recommended doses @DRUG$ @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d619.s5.p0", "DRUGA": ["selegiline", "drug", "95-104"], "DRUGB": ["sympathomimetic medication", "group", "112-137"]}
{"TEXT1": "One case hypertensive crisis reported patient taking recommended doses @DRUG$ sympathomimetic medication", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d619.s5.p1", "DRUGA": ["selegiline", "drug", "95-104"], "DRUGB": ["ephedrine", "drug", "140-148"]}
{"TEXT1": "One case hypertensive crisis reported patient taking recommended doses selegiline @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d619.s5.p2", "DRUGA": ["sympathomimetic medication", "group", "112-137"], "DRUGB": ["ephedrine", "drug", "140-148"]}
{"TEXT1": "exercised administering @DRUG$ therapy combination @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d616.s1.p0", "DRUGA": ["ZADAXIN", "brand", "47-53"], "DRUGB": ["immunomodulating drugs", "group", "89-110"]}
{"TEXT1": "observed administering @DRUG$ to patients receiving @DRUG$ haloperidol effects of drugs expected inhibition catecholamine synthesis", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d715.s0.p0", "DRUGA": ["DEMSER", "brand", "44-49"], "DRUGB": ["phenothiazines", "group", "73-86"]}
{"TEXT1": "observed administering @DRUG$ to patients receiving phenothiazines @DRUG$ effects of drugs expected inhibition catecholamine synthesis", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d715.s0.p1", "DRUGA": ["DEMSER", "brand", "44-49"], "DRUGB": ["haloperidol", "drug", "91-101"]}
{"TEXT1": "observed administering DEMSER to patients receiving @DRUG$ @DRUG$ effects of drugs expected inhibition catecholamine synthesis", "LBL": "0", "ID": "DDI-DrugBank.d715.s0.p2", "DRUGA": ["phenothiazines", "group", "73-86"], "DRUGB": ["haloperidol", "drug", "91-101"]}
{"TEXT1": "Concurrent use of @DRUG$ @DRUG$ CNS depressants increase sedative effects", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d715.s1.p0", "DRUGA": ["DEMSER", "brand", "18-23"], "DRUGB": ["alcohol", "drug", "30-36"]}
{"TEXT1": "Concurrent use of @DRUG$ alcohol @DRUG$ increase sedative effects", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d715.s1.p1", "DRUGA": ["DEMSER", "brand", "18-23"], "DRUGB": ["CNS depressants", "drug", "47-61"]}
{"TEXT1": "Concurrent use of DEMSER @DRUG$ @DRUG$ increase sedative effects", "LBL": "0", "ID": "DDI-DrugBank.d715.s1.p2", "DRUGA": ["alcohol", "drug", "30-36"], "DRUGB": ["CNS depressants", "drug", "47-61"]}
{"TEXT1": "metabolism @DRUG$ accelerated", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d678.s1.p0", "DRUGA": ["Metopirone", "brand", "18-27"], "DRUGB": ["phenytoin", "drug", "47-55"]}
{"TEXT1": "@DRUG$ inhibits glucuronidation @DRUG$ possibly acetaminophen toxicity", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d678.s4.p0", "DRUGA": ["Metopirone", "brand", "0-9"], "DRUGB": ["acetaminophen", "drug", "43-55"]}
{"TEXT1": "@DRUG$ inhibits glucuronidation acetaminophen possibly @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d678.s4.p1", "DRUGA": ["Metopirone", "brand", "0-9"], "DRUGB": ["acetaminophen", "drug", "87-99"]}
{"TEXT1": "Metopirone inhibits glucuronidation @DRUG$ possibly @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d678.s4.p2", "DRUGA": ["acetaminophen", "drug", "43-55"], "DRUGB": ["acetaminophen", "drug", "87-99"]}
{"TEXT1": "@DRUG$ @DRUG$ butyrophenones metoclopramide not administered Permax", "LBL": "0", "ID": "DDI-DrugBank.d650.s0.p0", "DRUGA": ["Dopamine antagonists", "group", "0-19"], "DRUGB": ["neuroleptics", "group", "34-45"]}
{"TEXT1": "@DRUG$ neuroleptics butyrophenones metoclopramide not administered Permax", "LBL": "0", "ID": "DDI-DrugBank.d650.s0.p1", "DRUGA": ["Dopamine antagonists", "group", "0-19"], "DRUGB": ["phenothiazines", "group", "48-61"]}
{"TEXT1": "@DRUG$ neuroleptics @DRUG$ metoclopramide not administered Permax", "LBL": "0", "ID": "DDI-DrugBank.d650.s0.p2", "DRUGA": ["Dopamine antagonists", "group", "0-19"], "DRUGB": ["butyrophenones", "group", "64-77"]}
{"TEXT1": "@DRUG$ neuroleptics butyrophenones @DRUG$ metoclopramide not administered Permax", "LBL": "0", "ID": "DDI-DrugBank.d650.s0.p3", "DRUGA": ["Dopamine antagonists", "group", "0-19"], "DRUGB": ["thioxanthines", "group", "80-92"]}
{"TEXT1": "@DRUG$ neuroleptics butyrophenones @DRUG$ not administered Permax", "LBL": "0", "ID": "DDI-DrugBank.d650.s0.p4", "DRUGA": ["Dopamine antagonists", "group", "0-19"], "DRUGB": ["metoclopramide", "drug", "99-112"]}
{"TEXT1": "@DRUG$ neuroleptics butyrophenones metoclopramide not administered @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d650.s0.p5", "DRUGA": ["Dopamine antagonists", "group", "0-19"], "DRUGB": ["Permax", "brand", "171-176"]}
{"TEXT1": "@DRUG$ neuroleptics butyrophenones metoclopramide not administered Permax", "LBL": "0", "ID": "DDI-DrugBank.d650.s0.p6", "DRUGA": ["Dopamine antagonists", "group", "0-19"], "DRUGB": ["dopamine agonist", "group", "181-196"]}
{"TEXT1": "Dopamine antagonists @DRUG$ butyrophenones metoclopramide not administered Permax", "LBL": "0", "ID": "DDI-DrugBank.d650.s0.p7", "DRUGA": ["neuroleptics", "group", "34-45"], "DRUGB": ["phenothiazines", "group", "48-61"]}
{"TEXT1": "Dopamine antagonists @DRUG$ @DRUG$ metoclopramide not administered Permax", "LBL": "0", "ID": "DDI-DrugBank.d650.s0.p8", "DRUGA": ["neuroleptics", "group", "34-45"], "DRUGB": ["butyrophenones", "group", "64-77"]}
{"TEXT1": "Dopamine antagonists @DRUG$ butyrophenones @DRUG$ metoclopramide not administered Permax", "LBL": "0", "ID": "DDI-DrugBank.d650.s0.p9", "DRUGA": ["neuroleptics", "group", "34-45"], "DRUGB": ["thioxanthines", "group", "80-92"]}
{"TEXT1": "Dopamine antagonists @DRUG$ butyrophenones @DRUG$ not administered Permax", "LBL": "0", "ID": "DDI-DrugBank.d650.s0.p10", "DRUGA": ["neuroleptics", "group", "34-45"], "DRUGB": ["metoclopramide", "drug", "99-112"]}
{"TEXT1": "Dopamine antagonists @DRUG$ butyrophenones metoclopramide not administered @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d650.s0.p11", "DRUGA": ["neuroleptics", "group", "34-45"], "DRUGB": ["Permax", "brand", "171-176"]}
{"TEXT1": "Dopamine antagonists @DRUG$ butyrophenones metoclopramide not administered Permax", "LBL": "0", "ID": "DDI-DrugBank.d650.s0.p12", "DRUGA": ["neuroleptics", "group", "34-45"], "DRUGB": ["dopamine agonist", "group", "181-196"]}
{"TEXT1": "Dopamine antagonists neuroleptics @DRUG$ metoclopramide not administered Permax", "LBL": "0", "ID": "DDI-DrugBank.d650.s0.p13", "DRUGA": ["phenothiazines", "group", "48-61"], "DRUGB": ["butyrophenones", "group", "64-77"]}
{"TEXT1": "Dopamine antagonists neuroleptics butyrophenones @DRUG$ metoclopramide not administered Permax", "LBL": "0", "ID": "DDI-DrugBank.d650.s0.p14", "DRUGA": ["phenothiazines", "group", "48-61"], "DRUGB": ["thioxanthines", "group", "80-92"]}
{"TEXT1": "Dopamine antagonists neuroleptics butyrophenones @DRUG$ not administered Permax", "LBL": "0", "ID": "DDI-DrugBank.d650.s0.p15", "DRUGA": ["phenothiazines", "group", "48-61"], "DRUGB": ["metoclopramide", "drug", "99-112"]}
{"TEXT1": "Dopamine antagonists neuroleptics butyrophenones metoclopramide not administered @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d650.s0.p16", "DRUGA": ["phenothiazines", "group", "48-61"], "DRUGB": ["Permax", "brand", "171-176"]}
{"TEXT1": "Dopamine antagonists neuroleptics butyrophenones metoclopramide not administered Permax", "LBL": "0", "ID": "DDI-DrugBank.d650.s0.p17", "DRUGA": ["phenothiazines", "group", "48-61"], "DRUGB": ["dopamine agonist", "group", "181-196"]}
{"TEXT1": "Dopamine antagonists neuroleptics @DRUG$ @DRUG$ metoclopramide not administered Permax", "LBL": "0", "ID": "DDI-DrugBank.d650.s0.p18", "DRUGA": ["butyrophenones", "group", "64-77"], "DRUGB": ["thioxanthines", "group", "80-92"]}
{"TEXT1": "Dopamine antagonists neuroleptics @DRUG$ @DRUG$ not administered Permax", "LBL": "0", "ID": "DDI-DrugBank.d650.s0.p19", "DRUGA": ["butyrophenones", "group", "64-77"], "DRUGB": ["metoclopramide", "drug", "99-112"]}
{"TEXT1": "Dopamine antagonists neuroleptics @DRUG$ metoclopramide not administered @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d650.s0.p20", "DRUGA": ["butyrophenones", "group", "64-77"], "DRUGB": ["Permax", "brand", "171-176"]}
{"TEXT1": "Dopamine antagonists neuroleptics @DRUG$ metoclopramide not administered Permax", "LBL": "0", "ID": "DDI-DrugBank.d650.s0.p21", "DRUGA": ["butyrophenones", "group", "64-77"], "DRUGB": ["dopamine agonist", "group", "181-196"]}
{"TEXT1": "Dopamine antagonists neuroleptics butyrophenones @DRUG$ @DRUG$ not administered Permax", "LBL": "0", "ID": "DDI-DrugBank.d650.s0.p22", "DRUGA": ["thioxanthines", "group", "80-92"], "DRUGB": ["metoclopramide", "drug", "99-112"]}
{"TEXT1": "Dopamine antagonists neuroleptics butyrophenones @DRUG$ metoclopramide not administered @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d650.s0.p23", "DRUGA": ["thioxanthines", "group", "80-92"], "DRUGB": ["Permax", "brand", "171-176"]}
{"TEXT1": "Dopamine antagonists neuroleptics butyrophenones @DRUG$ metoclopramide not administered Permax", "LBL": "0", "ID": "DDI-DrugBank.d650.s0.p24", "DRUGA": ["thioxanthines", "group", "80-92"], "DRUGB": ["dopamine agonist", "group", "181-196"]}
{"TEXT1": "Dopamine antagonists neuroleptics butyrophenones @DRUG$ not administered @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d650.s0.p25", "DRUGA": ["metoclopramide", "drug", "99-112"], "DRUGB": ["Permax", "brand", "171-176"]}
{"TEXT1": "Dopamine antagonists neuroleptics butyrophenones @DRUG$ not administered Permax", "LBL": "0", "ID": "DDI-DrugBank.d650.s0.p26", "DRUGA": ["metoclopramide", "drug", "99-112"], "DRUGB": ["dopamine agonist", "group", "181-196"]}
{"TEXT1": "Dopamine antagonists neuroleptics butyrophenones metoclopramide not administered @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d650.s0.p27", "DRUGA": ["Permax", "brand", "171-176"], "DRUGB": ["dopamine agonist", "group", "181-196"]}
{"TEXT1": "@DRUG$ approximately bound to plasma proteins exercised @DRUG$ drugs known affect protein binding", "LBL": "0", "ID": "DDI-DrugBank.d650.s2.p0", "DRUGA": ["pergolide mesylate", "drug", "8-25"], "DRUGB": ["pergolide mesylate", "drug", "105-122"]}
{"TEXT1": "Co administration oral @DRUG$ twice daily @DRUG$ geometric mean Cmax topical application of ointment retapamulin abraded skin healthy adult males", "LBL": "0", "ID": "DDI-DrugBank.d654.s0.p0", "DRUGA": ["ketoconazole", "drug", "26-37"], "DRUGB": ["retapamulin", "drug", "68-78"]}
{"TEXT1": "Co administration oral @DRUG$ twice daily retapamulin geometric mean Cmax topical application of ointment @DRUG$ abraded skin healthy adult males", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d654.s0.p1", "DRUGA": ["ketoconazole", "drug", "26-37"], "DRUGB": ["retapamulin", "drug", "150-160"]}
{"TEXT1": "Co administration oral ketoconazole 200 mg twice daily @DRUG$ geometric mean Cmax topical application of ointment @DRUG$ abraded skin healthy adult males", "LBL": "0", "ID": "DDI-DrugBank.d654.s0.p2", "DRUGA": ["retapamulin", "drug", "68-78"], "DRUGB": ["retapamulin", "drug", "150-160"]}
{"TEXT1": "Due to low exposure systemic @DRUG$ following topical application patients dosage adjustments @DRUG$ co administered CYP3A4 inhibitors ketoconazole", "LBL": "0", "ID": "DDI-DrugBank.d654.s1.p0", "DRUGA": ["retapamulin", "drug", "32-42"], "DRUGB": ["retapamulin", "drug", "110-120"]}
{"TEXT1": "Due to low exposure systemic @DRUG$ following topical application patients dosage adjustments retapamulin co administered CYP3A4 inhibitors @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d654.s1.p1", "DRUGA": ["retapamulin", "drug", "32-42"], "DRUGB": ["ketoconazole", "drug", "191-202"]}
{"TEXT1": "Due to low exposure systemic retapamulin following topical application patients dosage adjustments @DRUG$ co administered CYP3A4 inhibitors @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d654.s1.p2", "DRUGA": ["retapamulin", "drug", "110-120"], "DRUGB": ["ketoconazole", "drug", "191-202"]}
{"TEXT1": "Based P450 inhibition low exposure systemic observed following topical application @DRUG$ @DRUG$ unlikely to affect metabolism substrates", "LBL": "0", "ID": "DDI-DrugBank.d654.s2.p0", "DRUGA": ["ALTABAX", "brand", "114-120"], "DRUGB": ["retapamulin", "drug", "123-133"]}
{"TEXT1": "multiple study @DRUG$ approximately doubled @DRUG$ paricalcitol metabolized CYP3A ketoconazole le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d726.s1.p0", "DRUGA": ["ketoconazole", "drug", "62-73"], "DRUGB": ["paricalcitol", "drug", "97-108"]}
{"TEXT1": "multiple study @DRUG$ approximately doubled paricalcitol @DRUG$ metabolized CYP3A ketoconazole le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p1", "DRUGA": ["ketoconazole", "drug", "62-73"], "DRUGB": ["paricalcitol", "drug", "126-137"]}
{"TEXT1": "multiple study @DRUG$ approximately doubled paricalcitol metabolized CYP3A @DRUG$ le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing ketoconazole inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p2", "DRUGA": ["ketoconazole", "drug", "62-73"], "DRUGB": ["ketoconazole", "drug", "177-188"]}
{"TEXT1": "multiple study @DRUG$ approximately doubled paricalcitol metabolized CYP3A ketoconazole le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing @DRUG$ inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p3", "DRUGA": ["ketoconazole", "drug", "62-73"], "DRUGB": ["paricalcitol", "drug", "291-302"]}
{"TEXT1": "multiple study @DRUG$ approximately doubled paricalcitol metabolized CYP3A ketoconazole le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing @DRUG$ inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p4", "DRUGA": ["ketoconazole", "drug", "62-73"], "DRUGB": ["ketoconazole", "drug", "309-320"]}
{"TEXT1": "multiple study @DRUG$ approximately doubled paricalcitol metabolized CYP3A ketoconazole le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including @DRUG$ clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p5", "DRUGA": ["ketoconazole", "drug", "62-73"], "DRUGB": ["atazanavir", "drug", "368-377"]}
{"TEXT1": "multiple study @DRUG$ approximately doubled paricalcitol metabolized CYP3A ketoconazole le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir @DRUG$ indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p6", "DRUGA": ["ketoconazole", "drug", "62-73"], "DRUGB": ["clarithromycin", "drug", "380-393"]}
{"TEXT1": "multiple study @DRUG$ approximately doubled paricalcitol metabolized CYP3A ketoconazole le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin @DRUG$ itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p7", "DRUGA": ["ketoconazole", "drug", "62-73"], "DRUGB": ["indinavir", "drug", "396-404"]}
{"TEXT1": "multiple study @DRUG$ approximately doubled paricalcitol metabolized CYP3A ketoconazole le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir @DRUG$ nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p8", "DRUGA": ["ketoconazole", "drug", "62-73"], "DRUGB": ["itraconazole", "drug", "407-418"]}
{"TEXT1": "multiple study @DRUG$ approximately doubled paricalcitol metabolized CYP3A ketoconazole le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole @DRUG$ nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p9", "DRUGA": ["ketoconazole", "drug", "62-73"], "DRUGB": ["nefazodone", "drug", "421-430"]}
{"TEXT1": "multiple study @DRUG$ approximately doubled paricalcitol metabolized CYP3A ketoconazole le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone @DRUG$ ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p10", "DRUGA": ["ketoconazole", "drug", "62-73"], "DRUGB": ["nelfinavir", "drug", "433-442"]}
{"TEXT1": "multiple study @DRUG$ approximately doubled paricalcitol metabolized CYP3A ketoconazole le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir @DRUG$ saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p11", "DRUGA": ["ketoconazole", "drug", "62-73"], "DRUGB": ["ritonavir", "drug", "445-453"]}
{"TEXT1": "multiple study @DRUG$ approximately doubled paricalcitol metabolized CYP3A ketoconazole le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir @DRUG$ telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p12", "DRUGA": ["ketoconazole", "drug", "62-73"], "DRUGB": ["saquinavir", "drug", "456-465"]}
{"TEXT1": "multiple study @DRUG$ approximately doubled paricalcitol metabolized CYP3A ketoconazole le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir @DRUG$ voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p13", "DRUGA": ["ketoconazole", "drug", "62-73"], "DRUGB": ["telithromycin", "drug", "468-480"]}
{"TEXT1": "multiple study @DRUG$ approximately doubled paricalcitol metabolized CYP3A ketoconazole le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p14", "DRUGA": ["ketoconazole", "drug", "62-73"], "DRUGB": ["voriconazole", "drug", "485-496"]}
{"TEXT1": "multiple study ketoconazole approximately doubled @DRUG$ @DRUG$ metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing paricalcitol inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p15", "DRUGA": ["paricalcitol", "drug", "97-108"], "DRUGB": ["paricalcitol", "drug", "126-137"]}
{"TEXT1": "multiple study ketoconazole approximately doubled @DRUG$ paricalcitol metabolized CYP3A @DRUG$ le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p16", "DRUGA": ["paricalcitol", "drug", "97-108"], "DRUGB": ["ketoconazole", "drug", "177-188"]}
{"TEXT1": "multiple study ketoconazole approximately doubled @DRUG$ paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing @DRUG$ inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p17", "DRUGA": ["paricalcitol", "drug", "97-108"], "DRUGB": ["paricalcitol", "drug", "291-302"]}
{"TEXT1": "multiple study ketoconazole approximately doubled @DRUG$ paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing @DRUG$ inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p18", "DRUGA": ["paricalcitol", "drug", "97-108"], "DRUGB": ["ketoconazole", "drug", "309-320"]}
{"TEXT1": "multiple study ketoconazole approximately doubled @DRUG$ paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including @DRUG$ clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p19", "DRUGA": ["paricalcitol", "drug", "97-108"], "DRUGB": ["atazanavir", "drug", "368-377"]}
{"TEXT1": "multiple study ketoconazole approximately doubled @DRUG$ paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir @DRUG$ indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p20", "DRUGA": ["paricalcitol", "drug", "97-108"], "DRUGB": ["clarithromycin", "drug", "380-393"]}
{"TEXT1": "multiple study ketoconazole approximately doubled @DRUG$ paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin @DRUG$ itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p21", "DRUGA": ["paricalcitol", "drug", "97-108"], "DRUGB": ["indinavir", "drug", "396-404"]}
{"TEXT1": "multiple study ketoconazole approximately doubled @DRUG$ paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir @DRUG$ nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p22", "DRUGA": ["paricalcitol", "drug", "97-108"], "DRUGB": ["itraconazole", "drug", "407-418"]}
{"TEXT1": "multiple study ketoconazole approximately doubled @DRUG$ paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole @DRUG$ nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p23", "DRUGA": ["paricalcitol", "drug", "97-108"], "DRUGB": ["nefazodone", "drug", "421-430"]}
{"TEXT1": "multiple study ketoconazole approximately doubled @DRUG$ paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone @DRUG$ ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p24", "DRUGA": ["paricalcitol", "drug", "97-108"], "DRUGB": ["nelfinavir", "drug", "433-442"]}
{"TEXT1": "multiple study ketoconazole approximately doubled @DRUG$ paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir @DRUG$ saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p25", "DRUGA": ["paricalcitol", "drug", "97-108"], "DRUGB": ["ritonavir", "drug", "445-453"]}
{"TEXT1": "multiple study ketoconazole approximately doubled @DRUG$ paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir @DRUG$ telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p26", "DRUGA": ["paricalcitol", "drug", "97-108"], "DRUGB": ["saquinavir", "drug", "456-465"]}
{"TEXT1": "multiple study ketoconazole approximately doubled @DRUG$ paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir @DRUG$ voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p27", "DRUGA": ["paricalcitol", "drug", "97-108"], "DRUGB": ["telithromycin", "drug", "468-480"]}
{"TEXT1": "multiple study ketoconazole approximately doubled @DRUG$ paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p28", "DRUGA": ["paricalcitol", "drug", "97-108"], "DRUGB": ["voriconazole", "drug", "485-496"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol @DRUG$ metabolized CYP3A @DRUG$ le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p29", "DRUGA": ["paricalcitol", "drug", "126-137"], "DRUGB": ["ketoconazole", "drug", "177-188"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol @DRUG$ metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing @DRUG$ inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p30", "DRUGA": ["paricalcitol", "drug", "126-137"], "DRUGB": ["paricalcitol", "drug", "291-302"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol @DRUG$ metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing @DRUG$ inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p31", "DRUGA": ["paricalcitol", "drug", "126-137"], "DRUGB": ["ketoconazole", "drug", "309-320"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol @DRUG$ metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including @DRUG$ clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p32", "DRUGA": ["paricalcitol", "drug", "126-137"], "DRUGB": ["atazanavir", "drug", "368-377"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol @DRUG$ metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir @DRUG$ indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p33", "DRUGA": ["paricalcitol", "drug", "126-137"], "DRUGB": ["clarithromycin", "drug", "380-393"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol @DRUG$ metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin @DRUG$ itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p34", "DRUGA": ["paricalcitol", "drug", "126-137"], "DRUGB": ["indinavir", "drug", "396-404"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol @DRUG$ metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir @DRUG$ nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p35", "DRUGA": ["paricalcitol", "drug", "126-137"], "DRUGB": ["itraconazole", "drug", "407-418"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol @DRUG$ metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole @DRUG$ nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p36", "DRUGA": ["paricalcitol", "drug", "126-137"], "DRUGB": ["nefazodone", "drug", "421-430"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol @DRUG$ metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone @DRUG$ ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p37", "DRUGA": ["paricalcitol", "drug", "126-137"], "DRUGB": ["nelfinavir", "drug", "433-442"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol @DRUG$ metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir @DRUG$ saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p38", "DRUGA": ["paricalcitol", "drug", "126-137"], "DRUGB": ["ritonavir", "drug", "445-453"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol @DRUG$ metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir @DRUG$ telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p39", "DRUGA": ["paricalcitol", "drug", "126-137"], "DRUGB": ["saquinavir", "drug", "456-465"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol @DRUG$ metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir @DRUG$ voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p40", "DRUGA": ["paricalcitol", "drug", "126-137"], "DRUGB": ["telithromycin", "drug", "468-480"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol @DRUG$ metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p41", "DRUGA": ["paricalcitol", "drug", "126-137"], "DRUGB": ["voriconazole", "drug", "485-496"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A @DRUG$ le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing @DRUG$ inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p42", "DRUGA": ["ketoconazole", "drug", "177-188"], "DRUGB": ["paricalcitol", "drug", "291-302"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A @DRUG$ le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing @DRUG$ inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p43", "DRUGA": ["ketoconazole", "drug", "177-188"], "DRUGB": ["ketoconazole", "drug", "309-320"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A @DRUG$ le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including @DRUG$ clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p44", "DRUGA": ["ketoconazole", "drug", "177-188"], "DRUGB": ["atazanavir", "drug", "368-377"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A @DRUG$ le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir @DRUG$ indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p45", "DRUGA": ["ketoconazole", "drug", "177-188"], "DRUGB": ["clarithromycin", "drug", "380-393"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A @DRUG$ le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin @DRUG$ itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p46", "DRUGA": ["ketoconazole", "drug", "177-188"], "DRUGB": ["indinavir", "drug", "396-404"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A @DRUG$ le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir @DRUG$ nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p47", "DRUGA": ["ketoconazole", "drug", "177-188"], "DRUGB": ["itraconazole", "drug", "407-418"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A @DRUG$ le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole @DRUG$ nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p48", "DRUGA": ["ketoconazole", "drug", "177-188"], "DRUGB": ["nefazodone", "drug", "421-430"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A @DRUG$ le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone @DRUG$ ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p49", "DRUGA": ["ketoconazole", "drug", "177-188"], "DRUGB": ["nelfinavir", "drug", "433-442"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A @DRUG$ le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir @DRUG$ saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p50", "DRUGA": ["ketoconazole", "drug", "177-188"], "DRUGB": ["ritonavir", "drug", "445-453"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A @DRUG$ le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir @DRUG$ telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p51", "DRUGA": ["ketoconazole", "drug", "177-188"], "DRUGB": ["saquinavir", "drug", "456-465"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A @DRUG$ le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir @DRUG$ voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p52", "DRUGA": ["ketoconazole", "drug", "177-188"], "DRUGB": ["telithromycin", "drug", "468-480"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A @DRUG$ le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p53", "DRUGA": ["ketoconazole", "drug", "177-188"], "DRUGB": ["voriconazole", "drug", "485-496"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing @DRUG$ @DRUG$ inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d726.s1.p54", "DRUGA": ["paricalcitol", "drug", "291-302"], "DRUGB": ["ketoconazole", "drug", "309-320"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing @DRUG$ inhibitors including @DRUG$ clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d726.s1.p55", "DRUGA": ["paricalcitol", "drug", "291-302"], "DRUGB": ["atazanavir", "drug", "368-377"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing @DRUG$ inhibitors including atazanavir @DRUG$ indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d726.s1.p56", "DRUGA": ["paricalcitol", "drug", "291-302"], "DRUGB": ["clarithromycin", "drug", "380-393"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing @DRUG$ inhibitors including atazanavir clarithromycin @DRUG$ itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d726.s1.p57", "DRUGA": ["paricalcitol", "drug", "291-302"], "DRUGB": ["indinavir", "drug", "396-404"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing @DRUG$ inhibitors including atazanavir clarithromycin indinavir @DRUG$ nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d726.s1.p58", "DRUGA": ["paricalcitol", "drug", "291-302"], "DRUGB": ["itraconazole", "drug", "407-418"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing @DRUG$ inhibitors including atazanavir clarithromycin indinavir itraconazole @DRUG$ nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d726.s1.p59", "DRUGA": ["paricalcitol", "drug", "291-302"], "DRUGB": ["nefazodone", "drug", "421-430"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing @DRUG$ inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone @DRUG$ ritonavir saquinavir telithromycin voriconazole", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d726.s1.p60", "DRUGA": ["paricalcitol", "drug", "291-302"], "DRUGB": ["nelfinavir", "drug", "433-442"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing @DRUG$ inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir @DRUG$ saquinavir telithromycin voriconazole", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d726.s1.p61", "DRUGA": ["paricalcitol", "drug", "291-302"], "DRUGB": ["ritonavir", "drug", "445-453"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing @DRUG$ inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir @DRUG$ telithromycin voriconazole", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d726.s1.p62", "DRUGA": ["paricalcitol", "drug", "291-302"], "DRUGB": ["saquinavir", "drug", "456-465"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing @DRUG$ inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir @DRUG$ voriconazole", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d726.s1.p63", "DRUGA": ["paricalcitol", "drug", "291-302"], "DRUGB": ["telithromycin", "drug", "468-480"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing @DRUG$ inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d726.s1.p64", "DRUGA": ["paricalcitol", "drug", "291-302"], "DRUGB": ["voriconazole", "drug", "485-496"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing @DRUG$ inhibitors including @DRUG$ clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p65", "DRUGA": ["ketoconazole", "drug", "309-320"], "DRUGB": ["atazanavir", "drug", "368-377"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing @DRUG$ inhibitors including atazanavir @DRUG$ indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p66", "DRUGA": ["ketoconazole", "drug", "309-320"], "DRUGB": ["clarithromycin", "drug", "380-393"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing @DRUG$ inhibitors including atazanavir clarithromycin @DRUG$ itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p67", "DRUGA": ["ketoconazole", "drug", "309-320"], "DRUGB": ["indinavir", "drug", "396-404"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing @DRUG$ inhibitors including atazanavir clarithromycin indinavir @DRUG$ nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p68", "DRUGA": ["ketoconazole", "drug", "309-320"], "DRUGB": ["itraconazole", "drug", "407-418"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing @DRUG$ inhibitors including atazanavir clarithromycin indinavir itraconazole @DRUG$ nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p69", "DRUGA": ["ketoconazole", "drug", "309-320"], "DRUGB": ["nefazodone", "drug", "421-430"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing @DRUG$ inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone @DRUG$ ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p70", "DRUGA": ["ketoconazole", "drug", "309-320"], "DRUGB": ["nelfinavir", "drug", "433-442"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing @DRUG$ inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir @DRUG$ saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p71", "DRUGA": ["ketoconazole", "drug", "309-320"], "DRUGB": ["ritonavir", "drug", "445-453"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing @DRUG$ inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir @DRUG$ telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p72", "DRUGA": ["ketoconazole", "drug", "309-320"], "DRUGB": ["saquinavir", "drug", "456-465"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing @DRUG$ inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir @DRUG$ voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p73", "DRUGA": ["ketoconazole", "drug", "309-320"], "DRUGB": ["telithromycin", "drug", "468-480"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing @DRUG$ inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p74", "DRUGA": ["ketoconazole", "drug", "309-320"], "DRUGB": ["voriconazole", "drug", "485-496"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including @DRUG$ @DRUG$ indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p75", "DRUGA": ["atazanavir", "drug", "368-377"], "DRUGB": ["clarithromycin", "drug", "380-393"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including @DRUG$ clarithromycin @DRUG$ itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p76", "DRUGA": ["atazanavir", "drug", "368-377"], "DRUGB": ["indinavir", "drug", "396-404"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including @DRUG$ clarithromycin indinavir @DRUG$ nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p77", "DRUGA": ["atazanavir", "drug", "368-377"], "DRUGB": ["itraconazole", "drug", "407-418"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including @DRUG$ clarithromycin indinavir itraconazole @DRUG$ nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p78", "DRUGA": ["atazanavir", "drug", "368-377"], "DRUGB": ["nefazodone", "drug", "421-430"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including @DRUG$ clarithromycin indinavir itraconazole nefazodone @DRUG$ ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p79", "DRUGA": ["atazanavir", "drug", "368-377"], "DRUGB": ["nelfinavir", "drug", "433-442"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including @DRUG$ clarithromycin indinavir itraconazole nefazodone nelfinavir @DRUG$ saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p80", "DRUGA": ["atazanavir", "drug", "368-377"], "DRUGB": ["ritonavir", "drug", "445-453"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including @DRUG$ clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir @DRUG$ telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p81", "DRUGA": ["atazanavir", "drug", "368-377"], "DRUGB": ["saquinavir", "drug", "456-465"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including @DRUG$ clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir @DRUG$ voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p82", "DRUGA": ["atazanavir", "drug", "368-377"], "DRUGB": ["telithromycin", "drug", "468-480"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including @DRUG$ clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p83", "DRUGA": ["atazanavir", "drug", "368-377"], "DRUGB": ["voriconazole", "drug", "485-496"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir @DRUG$ @DRUG$ itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p84", "DRUGA": ["clarithromycin", "drug", "380-393"], "DRUGB": ["indinavir", "drug", "396-404"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir @DRUG$ indinavir @DRUG$ nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p85", "DRUGA": ["clarithromycin", "drug", "380-393"], "DRUGB": ["itraconazole", "drug", "407-418"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir @DRUG$ indinavir itraconazole @DRUG$ nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p86", "DRUGA": ["clarithromycin", "drug", "380-393"], "DRUGB": ["nefazodone", "drug", "421-430"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir @DRUG$ indinavir itraconazole nefazodone @DRUG$ ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p87", "DRUGA": ["clarithromycin", "drug", "380-393"], "DRUGB": ["nelfinavir", "drug", "433-442"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir @DRUG$ indinavir itraconazole nefazodone nelfinavir @DRUG$ saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p88", "DRUGA": ["clarithromycin", "drug", "380-393"], "DRUGB": ["ritonavir", "drug", "445-453"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir @DRUG$ indinavir itraconazole nefazodone nelfinavir ritonavir @DRUG$ telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p89", "DRUGA": ["clarithromycin", "drug", "380-393"], "DRUGB": ["saquinavir", "drug", "456-465"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir @DRUG$ indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir @DRUG$ voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p90", "DRUGA": ["clarithromycin", "drug", "380-393"], "DRUGB": ["telithromycin", "drug", "468-480"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir @DRUG$ indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p91", "DRUGA": ["clarithromycin", "drug", "380-393"], "DRUGB": ["voriconazole", "drug", "485-496"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin @DRUG$ @DRUG$ nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p92", "DRUGA": ["indinavir", "drug", "396-404"], "DRUGB": ["itraconazole", "drug", "407-418"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin @DRUG$ itraconazole @DRUG$ nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p93", "DRUGA": ["indinavir", "drug", "396-404"], "DRUGB": ["nefazodone", "drug", "421-430"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin @DRUG$ itraconazole nefazodone @DRUG$ ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p94", "DRUGA": ["indinavir", "drug", "396-404"], "DRUGB": ["nelfinavir", "drug", "433-442"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin @DRUG$ itraconazole nefazodone nelfinavir @DRUG$ saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p95", "DRUGA": ["indinavir", "drug", "396-404"], "DRUGB": ["ritonavir", "drug", "445-453"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin @DRUG$ itraconazole nefazodone nelfinavir ritonavir @DRUG$ telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p96", "DRUGA": ["indinavir", "drug", "396-404"], "DRUGB": ["saquinavir", "drug", "456-465"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin @DRUG$ itraconazole nefazodone nelfinavir ritonavir saquinavir @DRUG$ voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p97", "DRUGA": ["indinavir", "drug", "396-404"], "DRUGB": ["telithromycin", "drug", "468-480"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin @DRUG$ itraconazole nefazodone nelfinavir ritonavir saquinavir telithromycin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p98", "DRUGA": ["indinavir", "drug", "396-404"], "DRUGB": ["voriconazole", "drug", "485-496"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir @DRUG$ @DRUG$ nelfinavir ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p99", "DRUGA": ["itraconazole", "drug", "407-418"], "DRUGB": ["nefazodone", "drug", "421-430"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir @DRUG$ nefazodone @DRUG$ ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p100", "DRUGA": ["itraconazole", "drug", "407-418"], "DRUGB": ["nelfinavir", "drug", "433-442"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir @DRUG$ nefazodone nelfinavir @DRUG$ saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p101", "DRUGA": ["itraconazole", "drug", "407-418"], "DRUGB": ["ritonavir", "drug", "445-453"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir @DRUG$ nefazodone nelfinavir ritonavir @DRUG$ telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p102", "DRUGA": ["itraconazole", "drug", "407-418"], "DRUGB": ["saquinavir", "drug", "456-465"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir @DRUG$ nefazodone nelfinavir ritonavir saquinavir @DRUG$ voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p103", "DRUGA": ["itraconazole", "drug", "407-418"], "DRUGB": ["telithromycin", "drug", "468-480"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir @DRUG$ nefazodone nelfinavir ritonavir saquinavir telithromycin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p104", "DRUGA": ["itraconazole", "drug", "407-418"], "DRUGB": ["voriconazole", "drug", "485-496"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole @DRUG$ @DRUG$ ritonavir saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p105", "DRUGA": ["nefazodone", "drug", "421-430"], "DRUGB": ["nelfinavir", "drug", "433-442"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole @DRUG$ nelfinavir @DRUG$ saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p106", "DRUGA": ["nefazodone", "drug", "421-430"], "DRUGB": ["ritonavir", "drug", "445-453"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole @DRUG$ nelfinavir ritonavir @DRUG$ telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p107", "DRUGA": ["nefazodone", "drug", "421-430"], "DRUGB": ["saquinavir", "drug", "456-465"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole @DRUG$ nelfinavir ritonavir saquinavir @DRUG$ voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p108", "DRUGA": ["nefazodone", "drug", "421-430"], "DRUGB": ["telithromycin", "drug", "468-480"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole @DRUG$ nelfinavir ritonavir saquinavir telithromycin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p109", "DRUGA": ["nefazodone", "drug", "421-430"], "DRUGB": ["voriconazole", "drug", "485-496"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone @DRUG$ @DRUG$ saquinavir telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p110", "DRUGA": ["nelfinavir", "drug", "433-442"], "DRUGB": ["ritonavir", "drug", "445-453"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone @DRUG$ ritonavir @DRUG$ telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p111", "DRUGA": ["nelfinavir", "drug", "433-442"], "DRUGB": ["saquinavir", "drug", "456-465"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone @DRUG$ ritonavir saquinavir @DRUG$ voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p112", "DRUGA": ["nelfinavir", "drug", "433-442"], "DRUGB": ["telithromycin", "drug", "468-480"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone @DRUG$ ritonavir saquinavir telithromycin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p113", "DRUGA": ["nelfinavir", "drug", "433-442"], "DRUGB": ["voriconazole", "drug", "485-496"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir @DRUG$ @DRUG$ telithromycin voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p114", "DRUGA": ["ritonavir", "drug", "445-453"], "DRUGB": ["saquinavir", "drug", "456-465"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir @DRUG$ saquinavir @DRUG$ voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p115", "DRUGA": ["ritonavir", "drug", "445-453"], "DRUGB": ["telithromycin", "drug", "468-480"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir @DRUG$ saquinavir telithromycin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p116", "DRUGA": ["ritonavir", "drug", "445-453"], "DRUGB": ["voriconazole", "drug", "485-496"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir @DRUG$ @DRUG$ voriconazole", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p117", "DRUGA": ["saquinavir", "drug", "456-465"], "DRUGB": ["telithromycin", "drug", "468-480"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir @DRUG$ telithromycin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p118", "DRUGA": ["saquinavir", "drug", "456-465"], "DRUGB": ["voriconazole", "drug", "485-496"]}
{"TEXT1": "multiple study ketoconazole approximately doubled paricalcitol metabolized CYP3A le known to strong inhibitor cytochrome P450 3A P450 enzyme care taken dosing inhibitors including atazanavir clarithromycin indinavir itraconazole nefazodone nelfinavir ritonavir saquinavir @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d726.s1.p119", "DRUGA": ["telithromycin", "drug", "468-480"], "DRUGB": ["voriconazole", "drug", "485-496"]}
{"TEXT1": "Dose adjustment @DRUG$ Capsules required serum calcium concentrations monitored patient initiates discontinues therapy strong CYP3A4 inhibitor @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d726.s2.p0", "DRUGA": ["Zemplar", "brand", "19-25"], "DRUGB": ["ketoconazole", "drug", "209-220"]}
{"TEXT1": "Drugs intestinal absorption @DRUG$ @DRUG$ interfere Zemplar Capsules", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d726.s3.p0", "DRUGA": ["fat-soluble vitamins", "group", "43-62"], "DRUGB": ["cholestyramine", "drug", "73-86"]}
{"TEXT1": "Drugs intestinal absorption @DRUG$ cholestyramine interfere @DRUG$ Capsules", "LBL": "0", "ID": "DDI-DrugBank.d726.s3.p1", "DRUGA": ["fat-soluble vitamins", "group", "43-62"], "DRUGB": ["Zemplar", "brand", "126-132"]}
{"TEXT1": "Drugs intestinal absorption @DRUG$ interfere @DRUG$ Capsules", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d726.s3.p2", "DRUGA": ["cholestyramine", "drug", "73-86"], "DRUGB": ["Zemplar", "brand", "126-132"]}
{"TEXT1": "patients receiving high @DRUG$ @DRUG$ anorexia tachypnea lethargy coma death reported concomitant use of aspirin carbonic anhydrase inhibitors", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d630.s1.p0", "DRUGA": ["aspirin", "brand", "52-58"], "DRUGB": ["methazolamide", "drug", "64-76"]}
{"TEXT1": "patients receiving high @DRUG$ methazolamide anorexia tachypnea lethargy coma death reported concomitant use of @DRUG$ carbonic anhydrase inhibitors", "LBL": "0", "ID": "DDI-DrugBank.d630.s1.p1", "DRUGA": ["aspirin", "brand", "52-58"], "DRUGB": ["aspirin", "brand", "195-201"]}
{"TEXT1": "patients receiving high @DRUG$ methazolamide anorexia tachypnea lethargy coma death reported concomitant use of aspirin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d630.s1.p2", "DRUGA": ["aspirin", "brand", "52-58"], "DRUGB": ["carbonic anhydrase inhibitors", "group", "207-235"]}
{"TEXT1": "patients receiving high dose aspirin @DRUG$ anorexia tachypnea lethargy coma death reported concomitant use of @DRUG$ carbonic anhydrase inhibitors", "LBL": "0", "ID": "DDI-DrugBank.d630.s1.p3", "DRUGA": ["methazolamide", "drug", "64-76"], "DRUGB": ["aspirin", "brand", "195-201"]}
{"TEXT1": "patients receiving high dose aspirin @DRUG$ anorexia tachypnea lethargy coma death reported concomitant use of @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d630.s1.p4", "DRUGA": ["methazolamide", "drug", "64-76"], "DRUGB": ["carbonic anhydrase inhibitors", "group", "207-235"]}
{"TEXT1": "patients receiving high dose aspirin methazolamide anorexia tachypnea lethargy coma death reported concomitant use of @DRUG$ @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d630.s1.p5", "DRUGA": ["aspirin", "brand", "195-201"], "DRUGB": ["carbonic anhydrase inhibitors", "group", "207-235"]}
{"TEXT1": "pharmacokinetic pharmacodynamic interactions @DRUG$ capsules @DRUG$ not determined", "LBL": "0", "ID": "DDI-DrugBank.d704.s0.p0", "DRUGA": ["FLOMAX", "brand", "85-90"], "DRUGB": ["alpha-adrenergic blocking agents", "group", "111-142"]}
{"TEXT1": "interactions expected @DRUG$ capsules NOT used combination @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d704.s1.p0", "DRUGA": ["FLOMAX", "brand", "42-47"], "DRUGB": ["alpha-adrenergic blocking agents", "group", "103-134"]}
{"TEXT1": "pharmacokinetic interaction @DRUG$ @DRUG$ capsules investigated", "LBL": "0", "ID": "DDI-DrugBank.d704.s2.p0", "DRUGA": ["cimetidine", "drug", "40-49"], "DRUGB": ["FLOMAX", "brand", "55-60"]}
{"TEXT1": "@DRUG$ capsules used with caution combination @DRUG$ doses higher mg", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d704.s4.p0", "DRUGA": ["FLOMAX", "brand", "11-16"], "DRUGB": ["cimetidine", "drug", "75-84"]}
{"TEXT1": "Results limited in vitro @DRUG$ @DRUG$ inconclusive", "LBL": "0", "ID": "DDI-DrugBank.d704.s5.p0", "DRUGA": ["tamsulosin HCI", "drug", "80-93"], "DRUGB": ["warfarin", "drug", "99-106"]}
{"TEXT1": "exercised concomitant @DRUG$ @DRUG$ capsules", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d704.s6.p0", "DRUGA": ["warfarin", "drug", "74-81"], "DRUGB": ["FLOMAX", "brand", "87-92"]}
{"TEXT1": "@DRUG$ replacement required @DRUG$ dose adjusted", "LBL": "0", "ID": "DDI-DrugBank.d599.s4.p0", "DRUGA": ["glucocorticoid", "group", "3-16"], "DRUGB": ["glucocorticoid", "group", "47-60"]}
{"TEXT1": "Limited published data @DRUG$ treatment increases cytochrome P450 mediated @DRUG$ clearance man", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d599.s6.p0", "DRUGA": ["GH", "drug", "37-38"], "DRUGB": ["antipyrine", "drug", "93-102"]}
{"TEXT1": "data suggest @DRUG$ administration alter clearance compounds known to metabolized liver enzymes @DRUG$ sex steroids anticonvulsants", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d599.s7.p0", "DRUGA": ["GH", "drug", "24-25"], "DRUGB": ["corticosteroids", "group", "133-147"]}
{"TEXT1": "data suggest @DRUG$ administration alter clearance compounds known to metabolized liver enzymes corticosteroids @DRUG$ anticonvulsants", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d599.s7.p1", "DRUGA": ["GH", "drug", "24-25"], "DRUGB": ["sex steroids", "group", "150-161"]}
{"TEXT1": "data suggest @DRUG$ administration alter clearance compounds known to metabolized liver enzymes corticosteroids sex steroids @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d599.s7.p2", "DRUGA": ["GH", "drug", "24-25"], "DRUGB": ["anticonvulsants", "group", "164-178"]}
{"TEXT1": "data suggest @DRUG$ administration alter clearance compounds known to metabolized liver enzymes corticosteroids sex steroids anticonvulsants", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d599.s7.p3", "DRUGA": ["GH", "drug", "24-25"], "DRUGB": ["cyclosporin", "drug", "181-191"]}
{"TEXT1": "data suggest GH administration alter clearance compounds known to metabolized liver enzymes @DRUG$ @DRUG$ anticonvulsants", "LBL": "0", "ID": "DDI-DrugBank.d599.s7.p4", "DRUGA": ["corticosteroids", "group", "133-147"], "DRUGB": ["sex steroids", "group", "150-161"]}
{"TEXT1": "data suggest GH administration alter clearance compounds known to metabolized liver enzymes @DRUG$ sex steroids @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d599.s7.p5", "DRUGA": ["corticosteroids", "group", "133-147"], "DRUGB": ["anticonvulsants", "group", "164-178"]}
{"TEXT1": "data suggest GH administration alter clearance compounds known to metabolized liver enzymes @DRUG$ sex steroids anticonvulsants", "LBL": "0", "ID": "DDI-DrugBank.d599.s7.p6", "DRUGA": ["corticosteroids", "group", "133-147"], "DRUGB": ["cyclosporin", "drug", "181-191"]}
{"TEXT1": "data suggest GH administration alter clearance compounds known to metabolized liver enzymes corticosteroids @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d599.s7.p7", "DRUGA": ["sex steroids", "group", "150-161"], "DRUGB": ["anticonvulsants", "group", "164-178"]}
{"TEXT1": "data suggest GH administration alter clearance compounds known to metabolized liver enzymes corticosteroids @DRUG$ anticonvulsants", "LBL": "0", "ID": "DDI-DrugBank.d599.s7.p8", "DRUGA": ["sex steroids", "group", "150-161"], "DRUGB": ["cyclosporin", "drug", "181-191"]}
{"TEXT1": "data suggest GH administration alter clearance compounds known to metabolized liver enzymes corticosteroids sex steroids @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d599.s7.p9", "DRUGA": ["anticonvulsants", "group", "164-178"], "DRUGB": ["cyclosporin", "drug", "181-191"]}
{"TEXT1": "effects @DRUG$ additive @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d758.s0.p0", "DRUGA": ["oxycodone hydrochloride", "drug", "30-52"], "DRUGB": ["CNS depressants", "group", "89-103"]}
{"TEXT1": "Use effects @DRUG$ presence alcohol sedatives antihistaminics psychotropic drugs", "LBL": "0", "ID": "DDI-DrugBank.d637.s0.p0", "DRUGA": ["Central Nervous System Depressants", "group", "15-48"], "DRUGB": ["morphine", "drug", "77-84"]}
{"TEXT1": "Use effects morphine presence @DRUG$ alcohol sedatives antihistaminics psychotropic drugs", "LBL": "0", "ID": "DDI-DrugBank.d637.s0.p1", "DRUGA": ["Central Nervous System Depressants", "group", "15-48"], "DRUGB": ["CNS depressants", "group", "127-141"]}
{"TEXT1": "Use effects morphine presence @DRUG$ sedatives antihistaminics psychotropic drugs", "LBL": "0", "ID": "DDI-DrugBank.d637.s0.p2", "DRUGA": ["Central Nervous System Depressants", "group", "15-48"], "DRUGB": ["alcohol", "drug", "151-157"]}
{"TEXT1": "Use effects morphine presence alcohol @DRUG$ antihistaminics psychotropic drugs", "LBL": "0", "ID": "DDI-DrugBank.d637.s0.p3", "DRUGA": ["Central Nervous System Depressants", "group", "15-48"], "DRUGB": ["sedatives", "group", "160-168"]}
{"TEXT1": "Use effects morphine presence alcohol sedatives @DRUG$ psychotropic drugs", "LBL": "0", "ID": "DDI-DrugBank.d637.s0.p4", "DRUGA": ["Central Nervous System Depressants", "group", "15-48"], "DRUGB": ["antihistaminics", "group", "171-185"]}
{"TEXT1": "Use effects morphine presence alcohol sedatives antihistaminics @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d637.s0.p5", "DRUGA": ["Central Nervous System Depressants", "group", "15-48"], "DRUGB": ["psychotropic drugs", "group", "191-208"]}
{"TEXT1": "Use effects @DRUG$ presence @DRUG$ alcohol sedatives antihistaminics psychotropic drugs", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d637.s0.p6", "DRUGA": ["morphine", "drug", "77-84"], "DRUGB": ["CNS depressants", "group", "127-141"]}
{"TEXT1": "Use effects @DRUG$ presence @DRUG$ sedatives antihistaminics psychotropic drugs", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d637.s0.p7", "DRUGA": ["morphine", "drug", "77-84"], "DRUGB": ["alcohol", "drug", "151-157"]}
{"TEXT1": "Use effects @DRUG$ presence alcohol @DRUG$ antihistaminics psychotropic drugs", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d637.s0.p8", "DRUGA": ["morphine", "drug", "77-84"], "DRUGB": ["sedatives", "group", "160-168"]}
{"TEXT1": "Use effects @DRUG$ presence alcohol sedatives @DRUG$ psychotropic drugs", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d637.s0.p9", "DRUGA": ["morphine", "drug", "77-84"], "DRUGB": ["antihistaminics", "group", "171-185"]}
{"TEXT1": "Use effects @DRUG$ presence alcohol sedatives antihistaminics @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d637.s0.p10", "DRUGA": ["morphine", "drug", "77-84"], "DRUGB": ["psychotropic drugs", "group", "191-208"]}
{"TEXT1": "Use effects morphine presence @DRUG$ @DRUG$ sedatives antihistaminics psychotropic drugs", "LBL": "0", "ID": "DDI-DrugBank.d637.s0.p11", "DRUGA": ["CNS depressants", "group", "127-141"], "DRUGB": ["alcohol", "drug", "151-157"]}
{"TEXT1": "Use effects morphine presence @DRUG$ alcohol @DRUG$ antihistaminics psychotropic drugs", "LBL": "0", "ID": "DDI-DrugBank.d637.s0.p12", "DRUGA": ["CNS depressants", "group", "127-141"], "DRUGB": ["sedatives", "group", "160-168"]}
{"TEXT1": "Use effects morphine presence @DRUG$ alcohol sedatives @DRUG$ psychotropic drugs", "LBL": "0", "ID": "DDI-DrugBank.d637.s0.p13", "DRUGA": ["CNS depressants", "group", "127-141"], "DRUGB": ["antihistaminics", "group", "171-185"]}
{"TEXT1": "Use effects morphine presence @DRUG$ alcohol sedatives antihistaminics @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d637.s0.p14", "DRUGA": ["CNS depressants", "group", "127-141"], "DRUGB": ["psychotropic drugs", "group", "191-208"]}
{"TEXT1": "Use effects morphine presence @DRUG$ @DRUG$ antihistaminics psychotropic drugs", "LBL": "0", "ID": "DDI-DrugBank.d637.s0.p15", "DRUGA": ["alcohol", "drug", "151-157"], "DRUGB": ["sedatives", "group", "160-168"]}
{"TEXT1": "Use effects morphine presence @DRUG$ sedatives @DRUG$ psychotropic drugs", "LBL": "0", "ID": "DDI-DrugBank.d637.s0.p16", "DRUGA": ["alcohol", "drug", "151-157"], "DRUGB": ["antihistaminics", "group", "171-185"]}
{"TEXT1": "Use effects morphine presence @DRUG$ sedatives antihistaminics @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d637.s0.p17", "DRUGA": ["alcohol", "drug", "151-157"], "DRUGB": ["psychotropic drugs", "group", "191-208"]}
{"TEXT1": "Use effects morphine presence alcohol @DRUG$ @DRUG$ psychotropic drugs", "LBL": "0", "ID": "DDI-DrugBank.d637.s0.p18", "DRUGA": ["sedatives", "group", "160-168"], "DRUGB": ["antihistaminics", "group", "171-185"]}
{"TEXT1": "Use effects morphine presence alcohol @DRUG$ antihistaminics @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d637.s0.p19", "DRUGA": ["sedatives", "group", "160-168"], "DRUGB": ["psychotropic drugs", "group", "191-208"]}
{"TEXT1": "Use effects morphine presence alcohol sedatives @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d637.s0.p20", "DRUGA": ["antihistaminics", "group", "171-185"], "DRUGB": ["psychotropic drugs", "group", "191-208"]}
{"TEXT1": "Use of @DRUG$ @DRUG$ increase risk respiratory depression hypotension profound sedation coma", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d637.s1.p0", "DRUGA": ["neuroleptics", "group", "7-18"], "DRUGB": ["morphine", "drug", "45-52"]}
{"TEXT1": "Interaction @DRUG$ pentazocine nalbuphine butorphanol NOT administered patients receiving course therapy proof opioid agonist opioid analgesic agonist analgesic", "LBL": "0", "ID": "DDI-DrugBank.d637.s2.p0", "DRUGA": ["Mixed Agonist/Antagonist Opioid Analgesics", "group", "17-58"], "DRUGB": ["Agonist/antagonist analgesics", "group", "61-89"]}
{"TEXT1": "Interaction Agonist/antagonist @DRUG$ nalbuphine butorphanol NOT administered patients receiving course therapy proof opioid agonist opioid analgesic agonist analgesic", "LBL": "0", "ID": "DDI-DrugBank.d637.s2.p1", "DRUGA": ["Mixed Agonist/Antagonist Opioid Analgesics", "group", "17-58"], "DRUGB": ["pentazocine", "drug", "98-108"]}
{"TEXT1": "Interaction Agonist/antagonist pentazocine @DRUG$ butorphanol NOT administered patients receiving course therapy proof opioid agonist opioid analgesic agonist analgesic", "LBL": "0", "ID": "DDI-DrugBank.d637.s2.p2", "DRUGA": ["Mixed Agonist/Antagonist Opioid Analgesics", "group", "17-58"], "DRUGB": ["nalbuphine", "drug", "111-120"]}
{"TEXT1": "Interaction Agonist/antagonist pentazocine nalbuphine @DRUG$ NOT administered patients receiving course therapy proof opioid agonist opioid analgesic agonist analgesic", "LBL": "0", "ID": "DDI-DrugBank.d637.s2.p3", "DRUGA": ["Mixed Agonist/Antagonist Opioid Analgesics", "group", "17-58"], "DRUGB": ["butorphanol", "drug", "123-133"]}
{"TEXT1": "Interaction Agonist/antagonist pentazocine nalbuphine butorphanol NOT administered patients receiving course therapy proof opioid agonist opioid analgesic agonist analgesic", "LBL": "0", "ID": "DDI-DrugBank.d637.s2.p4", "DRUGA": ["Mixed Agonist/Antagonist Opioid Analgesics", "group", "17-58"], "DRUGB": ["buprenorphine", "drug", "139-151"]}
{"TEXT1": "Interaction Agonist/antagonist pentazocine nalbuphine butorphanol NOT administered patients receiving course therapy proof @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d637.s2.p5", "DRUGA": ["Mixed Agonist/Antagonist Opioid Analgesics", "group", "17-58"], "DRUGB": ["opioid agonist analgesic", "group", "261-284"]}
{"TEXT1": "Interaction Mixed Agonist/Antagonist Opioid @DRUG$ @DRUG$ nalbuphine butorphanol NOT administered patients receiving course therapy proof opioid agonist opioid analgesic agonist analgesic", "LBL": "0", "ID": "DDI-DrugBank.d637.s2.p6", "DRUGA": ["Agonist/antagonist analgesics", "group", "61-89"], "DRUGB": ["pentazocine", "drug", "98-108"]}
{"TEXT1": "Interaction Mixed Agonist/Antagonist Opioid @DRUG$ pentazocine @DRUG$ butorphanol NOT administered patients receiving course therapy proof opioid agonist opioid analgesic agonist analgesic", "LBL": "0", "ID": "DDI-DrugBank.d637.s2.p7", "DRUGA": ["Agonist/antagonist analgesics", "group", "61-89"], "DRUGB": ["nalbuphine", "drug", "111-120"]}
{"TEXT1": "Interaction Mixed Agonist/Antagonist Opioid @DRUG$ pentazocine nalbuphine @DRUG$ NOT administered patients receiving course therapy proof opioid agonist opioid analgesic agonist analgesic", "LBL": "0", "ID": "DDI-DrugBank.d637.s2.p8", "DRUGA": ["Agonist/antagonist analgesics", "group", "61-89"], "DRUGB": ["butorphanol", "drug", "123-133"]}
{"TEXT1": "Interaction Mixed Agonist/Antagonist Opioid @DRUG$ pentazocine nalbuphine butorphanol NOT administered patients receiving course therapy proof opioid agonist opioid analgesic agonist analgesic", "LBL": "0", "ID": "DDI-DrugBank.d637.s2.p9", "DRUGA": ["Agonist/antagonist analgesics", "group", "61-89"], "DRUGB": ["buprenorphine", "drug", "139-151"]}
{"TEXT1": "Interaction Mixed Agonist/Antagonist Opioid @DRUG$ pentazocine nalbuphine butorphanol NOT administered patients receiving course therapy proof @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d637.s2.p10", "DRUGA": ["Agonist/antagonist analgesics", "group", "61-89"], "DRUGB": ["opioid agonist analgesic", "group", "261-284"]}
{"TEXT1": "Interaction Mixed Agonist/Antagonist Opioid Agonist/antagonist @DRUG$ @DRUG$ butorphanol NOT administered patients receiving course therapy proof opioid agonist opioid analgesic agonist analgesic", "LBL": "0", "ID": "DDI-DrugBank.d637.s2.p11", "DRUGA": ["pentazocine", "drug", "98-108"], "DRUGB": ["nalbuphine", "drug", "111-120"]}
{"TEXT1": "Interaction Mixed Agonist/Antagonist Opioid Agonist/antagonist @DRUG$ nalbuphine @DRUG$ NOT administered patients receiving course therapy proof opioid agonist opioid analgesic agonist analgesic", "LBL": "0", "ID": "DDI-DrugBank.d637.s2.p12", "DRUGA": ["pentazocine", "drug", "98-108"], "DRUGB": ["butorphanol", "drug", "123-133"]}
{"TEXT1": "Interaction Mixed Agonist/Antagonist Opioid Agonist/antagonist @DRUG$ nalbuphine butorphanol NOT administered patients receiving course therapy proof opioid agonist opioid analgesic agonist analgesic", "LBL": "0", "ID": "DDI-DrugBank.d637.s2.p13", "DRUGA": ["pentazocine", "drug", "98-108"], "DRUGB": ["buprenorphine", "drug", "139-151"]}
{"TEXT1": "Interaction Mixed Agonist/Antagonist Opioid Agonist/antagonist @DRUG$ nalbuphine butorphanol NOT administered patients receiving course therapy proof @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d637.s2.p14", "DRUGA": ["pentazocine", "drug", "98-108"], "DRUGB": ["opioid agonist analgesic", "group", "261-284"]}
{"TEXT1": "Interaction Mixed Agonist/Antagonist Opioid Agonist/antagonist pentazocine @DRUG$ @DRUG$ NOT administered patients receiving course therapy proof opioid agonist opioid analgesic agonist analgesic", "LBL": "0", "ID": "DDI-DrugBank.d637.s2.p15", "DRUGA": ["nalbuphine", "drug", "111-120"], "DRUGB": ["butorphanol", "drug", "123-133"]}
{"TEXT1": "Interaction Mixed Agonist/Antagonist Opioid Agonist/antagonist pentazocine @DRUG$ butorphanol NOT administered patients receiving course therapy proof opioid agonist opioid analgesic agonist analgesic", "LBL": "0", "ID": "DDI-DrugBank.d637.s2.p16", "DRUGA": ["nalbuphine", "drug", "111-120"], "DRUGB": ["buprenorphine", "drug", "139-151"]}
{"TEXT1": "Interaction Mixed Agonist/Antagonist Opioid Agonist/antagonist pentazocine @DRUG$ butorphanol NOT administered patients receiving course therapy proof @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d637.s2.p17", "DRUGA": ["nalbuphine", "drug", "111-120"], "DRUGB": ["opioid agonist analgesic", "group", "261-284"]}
{"TEXT1": "Interaction Mixed Agonist/Antagonist Opioid Agonist/antagonist pentazocine nalbuphine @DRUG$ NOT administered patients receiving course therapy proof opioid agonist opioid analgesic agonist analgesic", "LBL": "0", "ID": "DDI-DrugBank.d637.s2.p18", "DRUGA": ["butorphanol", "drug", "123-133"], "DRUGB": ["buprenorphine", "drug", "139-151"]}
{"TEXT1": "Interaction Mixed Agonist/Antagonist Opioid Agonist/antagonist pentazocine nalbuphine @DRUG$ NOT administered patients receiving course therapy proof @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d637.s2.p19", "DRUGA": ["butorphanol", "drug", "123-133"], "DRUGB": ["opioid agonist analgesic", "group", "261-284"]}
{"TEXT1": "Interaction Mixed Agonist/Antagonist Opioid Agonist/antagonist pentazocine nalbuphine butorphanol NOT administered patients receiving course therapy proof @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d637.s2.p20", "DRUGA": ["buprenorphine", "drug", "139-151"], "DRUGB": ["opioid agonist analgesic", "group", "261-284"]}
{"TEXT1": "theoretical basis effects additive use of @DRUG$ containing @DRUG$ dihydroergotamine sumatriptan 24 hours", "LBL": "0", "ID": "DDI-DrugBank.d720.s1.p0", "DRUGA": ["ergotamine", "drug", "80-89"], "DRUGB": ["ergot-type medications", "group", "105-126"]}
{"TEXT1": "theoretical basis effects additive use of @DRUG$ containing ergot type medications @DRUG$ sumatriptan 24 hours", "LBL": "0", "ID": "DDI-DrugBank.d720.s1.p1", "DRUGA": ["ergotamine", "drug", "80-89"], "DRUGB": ["dihydroergotamine", "drug", "134-150"]}
{"TEXT1": "theoretical basis effects additive use of @DRUG$ containing ergot type medications dihydroergotamine sumatriptan 24 hours", "LBL": "0", "ID": "DDI-DrugBank.d720.s1.p2", "DRUGA": ["ergotamine", "drug", "80-89"], "DRUGB": ["methysergide", "drug", "155-166"]}
{"TEXT1": "theoretical basis effects additive use of @DRUG$ containing ergot type medications dihydroergotamine @DRUG$ 24 hours", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d720.s1.p3", "DRUGA": ["ergotamine", "drug", "80-89"], "DRUGB": ["sumatriptan", "drug", "173-183"]}
{"TEXT1": "theoretical basis effects additive use of ergotamine containing @DRUG$ @DRUG$ sumatriptan 24 hours", "LBL": "0", "ID": "DDI-DrugBank.d720.s1.p4", "DRUGA": ["ergot-type medications", "group", "105-126"], "DRUGB": ["dihydroergotamine", "drug", "134-150"]}
{"TEXT1": "theoretical basis effects additive use of ergotamine containing @DRUG$ dihydroergotamine sumatriptan 24 hours", "LBL": "0", "ID": "DDI-DrugBank.d720.s1.p5", "DRUGA": ["ergot-type medications", "group", "105-126"], "DRUGB": ["methysergide", "drug", "155-166"]}
{"TEXT1": "theoretical basis effects additive use of ergotamine containing @DRUG$ dihydroergotamine @DRUG$ 24 hours", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d720.s1.p6", "DRUGA": ["ergot-type medications", "group", "105-126"], "DRUGB": ["sumatriptan", "drug", "173-183"]}
{"TEXT1": "theoretical basis effects additive use of ergotamine containing ergot type medications @DRUG$ sumatriptan 24 hours", "LBL": "0", "ID": "DDI-DrugBank.d720.s1.p7", "DRUGA": ["dihydroergotamine", "drug", "134-150"], "DRUGB": ["methysergide", "drug", "155-166"]}
{"TEXT1": "theoretical basis effects additive use of ergotamine containing ergot type medications @DRUG$ @DRUG$ 24 hours", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d720.s1.p8", "DRUGA": ["dihydroergotamine", "drug", "134-150"], "DRUGB": ["sumatriptan", "drug", "173-183"]}
{"TEXT1": "theoretical basis effects additive use of ergotamine containing ergot type medications dihydroergotamine @DRUG$ 24 hours", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d720.s1.p9", "DRUGA": ["methysergide", "drug", "155-166"], "DRUGB": ["sumatriptan", "drug", "173-183"]}
{"TEXT1": "@DRUG$ @DRUG$ clearance increasing systemic exposure", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d720.s2.p0", "DRUGA": ["MAO-A inhibitors", "group", "0-15"], "DRUGB": ["sumatriptan", "drug", "24-34"]}
{"TEXT1": "use of @DRUG$ tablets patients receiving @DRUG$ contraindicated Selective serotonin reuptake inhibitors fluoxetine fluvoxamine paroxetine reported rarely to cause weakness hyperreflexia incoordination sumatriptan", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d720.s3.p0", "DRUGA": ["sumatriptan succinate", "drug", "22-42"], "DRUGB": ["MAO-A inhibitors", "group", "74-89"]}
{"TEXT1": "use of @DRUG$ tablets patients receiving contraindicated @DRUG$ fluoxetine fluvoxamine paroxetine reported rarely to cause weakness hyperreflexia incoordination sumatriptan", "LBL": "0", "ID": "DDI-DrugBank.d720.s3.p1", "DRUGA": ["sumatriptan succinate", "drug", "22-42"], "DRUGB": ["Selective serotonin reuptake inhibitors", "group", "112-150"]}
{"TEXT1": "use of @DRUG$ tablets patients receiving contraindicated fluoxetine fluvoxamine paroxetine reported rarely to cause weakness hyperreflexia incoordination sumatriptan", "LBL": "0", "ID": "DDI-DrugBank.d720.s3.p2", "DRUGA": ["sumatriptan succinate", "drug", "22-42"], "DRUGB": ["SSRIs", "group", "153-157"]}
{"TEXT1": "use of @DRUG$ tablets patients receiving contraindicated @DRUG$ fluvoxamine paroxetine reported rarely to cause weakness hyperreflexia incoordination sumatriptan", "LBL": "0", "ID": "DDI-DrugBank.d720.s3.p3", "DRUGA": ["sumatriptan succinate", "drug", "22-42"], "DRUGB": ["fluoxetine", "drug", "167-176"]}
{"TEXT1": "use of @DRUG$ tablets patients receiving contraindicated fluoxetine @DRUG$ paroxetine reported rarely to cause weakness hyperreflexia incoordination sumatriptan", "LBL": "0", "ID": "DDI-DrugBank.d720.s3.p4", "DRUGA": ["sumatriptan succinate", "drug", "22-42"], "DRUGB": ["fluvoxamine", "drug", "179-189"]}
{"TEXT1": "use of @DRUG$ tablets patients receiving contraindicated fluoxetine fluvoxamine @DRUG$ reported rarely to cause weakness hyperreflexia incoordination sumatriptan", "LBL": "0", "ID": "DDI-DrugBank.d720.s3.p5", "DRUGA": ["sumatriptan succinate", "drug", "22-42"], "DRUGB": ["paroxetine", "drug", "192-201"]}
{"TEXT1": "use of @DRUG$ tablets patients receiving contraindicated fluoxetine fluvoxamine paroxetine reported rarely to cause weakness hyperreflexia incoordination sumatriptan", "LBL": "0", "ID": "DDI-DrugBank.d720.s3.p6", "DRUGA": ["sumatriptan succinate", "drug", "22-42"], "DRUGB": ["sertraline", "drug", "204-213"]}
{"TEXT1": "use of @DRUG$ tablets patients receiving contraindicated fluoxetine fluvoxamine paroxetine reported rarely to cause weakness hyperreflexia incoordination @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d720.s3.p7", "DRUGA": ["sumatriptan succinate", "drug", "22-42"], "DRUGB": ["sumatriptan", "drug", "322-332"]}
{"TEXT1": "use of sumatriptan succinate sumatriptan tablets succinate tablets patients receiving @DRUG$ contraindicated @DRUG$ fluoxetine fluvoxamine paroxetine reported rarely to cause weakness hyperreflexia incoordination", "LBL": "0", "ID": "DDI-DrugBank.d720.s3.p8", "DRUGA": ["MAO-A inhibitors", "group", "74-89"], "DRUGB": ["Selective serotonin reuptake inhibitors", "group", "112-150"]}
{"TEXT1": "use of sumatriptan succinate sumatriptan tablets succinate tablets patients receiving @DRUG$ contraindicated Selective serotonin reuptake inhibitors fluoxetine fluvoxamine paroxetine reported rarely to cause weakness hyperreflexia incoordination", "LBL": "0", "ID": "DDI-DrugBank.d720.s3.p9", "DRUGA": ["MAO-A inhibitors", "group", "74-89"], "DRUGB": ["SSRIs", "group", "153-157"]}
{"TEXT1": "use of sumatriptan succinate sumatriptan tablets succinate tablets patients receiving @DRUG$ contraindicated Selective serotonin reuptake inhibitors @DRUG$ fluvoxamine paroxetine reported rarely to cause weakness hyperreflexia incoordination", "LBL": "0", "ID": "DDI-DrugBank.d720.s3.p10", "DRUGA": ["MAO-A inhibitors", "group", "74-89"], "DRUGB": ["fluoxetine", "drug", "167-176"]}
{"TEXT1": "use of sumatriptan succinate sumatriptan tablets succinate tablets patients receiving @DRUG$ contraindicated Selective serotonin reuptake inhibitors fluoxetine @DRUG$ paroxetine reported rarely to cause weakness hyperreflexia incoordination", "LBL": "0", "ID": "DDI-DrugBank.d720.s3.p11", "DRUGA": ["MAO-A inhibitors", "group", "74-89"], "DRUGB": ["fluvoxamine", "drug", "179-189"]}
{"TEXT1": "use of sumatriptan succinate sumatriptan tablets succinate tablets patients receiving @DRUG$ contraindicated Selective serotonin reuptake inhibitors fluoxetine fluvoxamine @DRUG$ reported rarely to cause weakness hyperreflexia incoordination", "LBL": "0", "ID": "DDI-DrugBank.d720.s3.p12", "DRUGA": ["MAO-A inhibitors", "group", "74-89"], "DRUGB": ["paroxetine", "drug", "192-201"]}
{"TEXT1": "use of sumatriptan succinate sumatriptan tablets succinate tablets patients receiving @DRUG$ contraindicated Selective serotonin reuptake inhibitors fluoxetine fluvoxamine paroxetine reported rarely to cause weakness hyperreflexia incoordination", "LBL": "0", "ID": "DDI-DrugBank.d720.s3.p13", "DRUGA": ["MAO-A inhibitors", "group", "74-89"], "DRUGB": ["sertraline", "drug", "204-213"]}
{"TEXT1": "use of sumatriptan succinate sumatriptan tablets succinate tablets patients receiving @DRUG$ contraindicated Selective serotonin reuptake inhibitors fluoxetine fluvoxamine paroxetine reported rarely to cause weakness hyperreflexia incoordination @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d720.s3.p14", "DRUGA": ["MAO-A inhibitors", "group", "74-89"], "DRUGB": ["sumatriptan", "drug", "322-332"]}
{"TEXT1": "use of sumatriptan succinate sumatriptan tablets succinate tablets patients receiving contraindicated @DRUG$ fluoxetine fluvoxamine paroxetine reported rarely to cause weakness hyperreflexia incoordination", "LBL": "0", "ID": "DDI-DrugBank.d720.s3.p15", "DRUGA": ["Selective serotonin reuptake inhibitors", "group", "112-150"], "DRUGB": ["SSRIs", "group", "153-157"]}
{"TEXT1": "use of sumatriptan succinate sumatriptan tablets succinate tablets patients receiving contraindicated @DRUG$ @DRUG$ fluvoxamine paroxetine reported rarely to cause weakness hyperreflexia incoordination", "LBL": "0", "ID": "DDI-DrugBank.d720.s3.p16", "DRUGA": ["Selective serotonin reuptake inhibitors", "group", "112-150"], "DRUGB": ["fluoxetine", "drug", "167-176"]}
{"TEXT1": "use of sumatriptan succinate sumatriptan tablets succinate tablets patients receiving contraindicated @DRUG$ fluoxetine @DRUG$ paroxetine reported rarely to cause weakness hyperreflexia incoordination", "LBL": "0", "ID": "DDI-DrugBank.d720.s3.p17", "DRUGA": ["Selective serotonin reuptake inhibitors", "group", "112-150"], "DRUGB": ["fluvoxamine", "drug", "179-189"]}
{"TEXT1": "use of sumatriptan succinate sumatriptan tablets succinate tablets patients receiving contraindicated @DRUG$ fluoxetine fluvoxamine @DRUG$ reported rarely to cause weakness hyperreflexia incoordination", "LBL": "0", "ID": "DDI-DrugBank.d720.s3.p18", "DRUGA": ["Selective serotonin reuptake inhibitors", "group", "112-150"], "DRUGB": ["paroxetine", "drug", "192-201"]}
{"TEXT1": "use of sumatriptan succinate sumatriptan tablets succinate tablets patients receiving contraindicated @DRUG$ fluoxetine fluvoxamine paroxetine reported rarely to cause weakness hyperreflexia incoordination", "LBL": "0", "ID": "DDI-DrugBank.d720.s3.p19", "DRUGA": ["Selective serotonin reuptake inhibitors", "group", "112-150"], "DRUGB": ["sertraline", "drug", "204-213"]}
{"TEXT1": "use of sumatriptan succinate sumatriptan tablets succinate tablets patients receiving contraindicated @DRUG$ fluoxetine fluvoxamine paroxetine reported rarely to cause weakness hyperreflexia incoordination @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d720.s3.p20", "DRUGA": ["Selective serotonin reuptake inhibitors", "group", "112-150"], "DRUGB": ["sumatriptan", "drug", "322-332"]}
{"TEXT1": "use of sumatriptan succinate sumatriptan tablets succinate tablets patients receiving contraindicated @DRUG$ fluvoxamine paroxetine reported rarely to cause weakness hyperreflexia incoordination", "LBL": "0", "ID": "DDI-DrugBank.d720.s3.p21", "DRUGA": ["SSRIs", "group", "153-157"], "DRUGB": ["fluoxetine", "drug", "167-176"]}
{"TEXT1": "use of sumatriptan succinate sumatriptan tablets succinate tablets patients receiving contraindicated fluoxetine @DRUG$ paroxetine reported rarely to cause weakness hyperreflexia incoordination", "LBL": "0", "ID": "DDI-DrugBank.d720.s3.p22", "DRUGA": ["SSRIs", "group", "153-157"], "DRUGB": ["fluvoxamine", "drug", "179-189"]}
{"TEXT1": "use of sumatriptan succinate sumatriptan tablets succinate tablets patients receiving contraindicated fluoxetine fluvoxamine @DRUG$ reported rarely to cause weakness hyperreflexia incoordination", "LBL": "0", "ID": "DDI-DrugBank.d720.s3.p23", "DRUGA": ["SSRIs", "group", "153-157"], "DRUGB": ["paroxetine", "drug", "192-201"]}
{"TEXT1": "use of sumatriptan succinate sumatriptan tablets succinate tablets patients receiving contraindicated fluoxetine fluvoxamine paroxetine reported rarely to cause weakness hyperreflexia incoordination", "LBL": "0", "ID": "DDI-DrugBank.d720.s3.p24", "DRUGA": ["SSRIs", "group", "153-157"], "DRUGB": ["sertraline", "drug", "204-213"]}
{"TEXT1": "use of sumatriptan succinate sumatriptan tablets succinate tablets patients receiving contraindicated fluoxetine fluvoxamine paroxetine reported rarely to cause weakness hyperreflexia incoordination @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d720.s3.p25", "DRUGA": ["SSRIs", "group", "153-157"], "DRUGB": ["sumatriptan", "drug", "322-332"]}
{"TEXT1": "use of sumatriptan succinate sumatriptan tablets succinate tablets patients receiving contraindicated @DRUG$ @DRUG$ paroxetine reported rarely to cause weakness hyperreflexia incoordination", "LBL": "0", "ID": "DDI-DrugBank.d720.s3.p26", "DRUGA": ["fluoxetine", "drug", "167-176"], "DRUGB": ["fluvoxamine", "drug", "179-189"]}
{"TEXT1": "use of sumatriptan succinate sumatriptan tablets succinate tablets patients receiving contraindicated @DRUG$ fluvoxamine @DRUG$ reported rarely to cause weakness hyperreflexia incoordination", "LBL": "0", "ID": "DDI-DrugBank.d720.s3.p27", "DRUGA": ["fluoxetine", "drug", "167-176"], "DRUGB": ["paroxetine", "drug", "192-201"]}
{"TEXT1": "use of sumatriptan succinate sumatriptan tablets succinate tablets patients receiving contraindicated @DRUG$ fluvoxamine paroxetine reported rarely to cause weakness hyperreflexia incoordination", "LBL": "0", "ID": "DDI-DrugBank.d720.s3.p28", "DRUGA": ["fluoxetine", "drug", "167-176"], "DRUGB": ["sertraline", "drug", "204-213"]}
{"TEXT1": "use of sumatriptan succinate sumatriptan tablets succinate tablets patients receiving contraindicated @DRUG$ fluvoxamine paroxetine reported rarely to cause weakness hyperreflexia incoordination @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d720.s3.p29", "DRUGA": ["fluoxetine", "drug", "167-176"], "DRUGB": ["sumatriptan", "drug", "322-332"]}
{"TEXT1": "use of sumatriptan succinate sumatriptan tablets succinate tablets patients receiving contraindicated fluoxetine @DRUG$ @DRUG$ reported rarely to cause weakness hyperreflexia incoordination", "LBL": "0", "ID": "DDI-DrugBank.d720.s3.p30", "DRUGA": ["fluvoxamine", "drug", "179-189"], "DRUGB": ["paroxetine", "drug", "192-201"]}
{"TEXT1": "use of sumatriptan succinate sumatriptan tablets succinate tablets patients receiving contraindicated fluoxetine @DRUG$ paroxetine reported rarely to cause weakness hyperreflexia incoordination", "LBL": "0", "ID": "DDI-DrugBank.d720.s3.p31", "DRUGA": ["fluvoxamine", "drug", "179-189"], "DRUGB": ["sertraline", "drug", "204-213"]}
{"TEXT1": "use of sumatriptan succinate sumatriptan tablets succinate tablets patients receiving contraindicated fluoxetine @DRUG$ paroxetine reported rarely to cause weakness hyperreflexia incoordination @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d720.s3.p32", "DRUGA": ["fluvoxamine", "drug", "179-189"], "DRUGB": ["sumatriptan", "drug", "322-332"]}
{"TEXT1": "use of sumatriptan succinate sumatriptan tablets succinate tablets patients receiving contraindicated fluoxetine fluvoxamine @DRUG$ reported rarely to cause weakness hyperreflexia incoordination", "LBL": "0", "ID": "DDI-DrugBank.d720.s3.p33", "DRUGA": ["paroxetine", "drug", "192-201"], "DRUGB": ["sertraline", "drug", "204-213"]}
{"TEXT1": "use of sumatriptan succinate sumatriptan tablets succinate tablets patients receiving contraindicated fluoxetine fluvoxamine @DRUG$ reported rarely to cause weakness hyperreflexia incoordination @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d720.s3.p34", "DRUGA": ["paroxetine", "drug", "192-201"], "DRUGB": ["sumatriptan", "drug", "322-332"]}
{"TEXT1": "use of sumatriptan succinate sumatriptan tablets succinate tablets patients receiving contraindicated fluoxetine fluvoxamine paroxetine reported rarely to cause weakness hyperreflexia incoordination @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d720.s3.p35", "DRUGA": ["sertraline", "drug", "204-213"], "DRUGB": ["sumatriptan", "drug", "322-332"]}
{"TEXT1": "concomitant treatment @DRUG$ @DRUG$ appropriate observation patient", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d720.s4.p0", "DRUGA": ["sumatriptan", "drug", "30-40"], "DRUGB": ["SSRI", "group", "49-52"]}
{"TEXT1": "Absorption single dose @DRUG$ decreased administered stable renal transplant patients taking magnesium containing antacids aluminum containing antacids mean Cmax values lower Myfortic alone fasting conditions", "LBL": "0", "ID": "DDI-DrugBank.d700.s0.p0", "DRUGA": ["Antacids", "group", "0-7"], "DRUGB": ["Myfortic", "brand", "41-48"]}
{"TEXT1": "Absorption single dose Myfortic decreased administered stable renal transplant patients taking @DRUG$ aluminum containing antacids mean Cmax values lower alone fasting conditions", "LBL": "0", "ID": "DDI-DrugBank.d700.s0.p1", "DRUGA": ["Antacids", "group", "0-7"], "DRUGB": ["magnesium", "drug", "133-141"]}
{"TEXT1": "Absorption single dose Myfortic decreased administered stable renal transplant patients taking magnesium containing antacids @DRUG$ mean Cmax values lower alone fasting conditions", "LBL": "0", "ID": "DDI-DrugBank.d700.s0.p2", "DRUGA": ["Antacids", "group", "0-7"], "DRUGB": ["aluminum", "drug", "143-150"]}
{"TEXT1": "Absorption single dose Myfortic decreased administered stable renal transplant patients taking magnesium aluminum @DRUG$ mean Cmax values lower alone fasting conditions", "LBL": "0", "ID": "DDI-DrugBank.d700.s0.p3", "DRUGA": ["Antacids", "group", "0-7"], "DRUGB": ["antacids", "group", "163-170"]}
{"TEXT1": "Absorption single dose Myfortic decreased administered stable renal transplant patients taking magnesium containing antacids aluminum containing antacids mean Cmax values lower @DRUG$ alone fasting conditions", "LBL": "0", "ID": "DDI-DrugBank.d700.s0.p4", "DRUGA": ["Antacids", "group", "0-7"], "DRUGB": ["Myfortic", "brand", "271-278"]}
{"TEXT1": "Absorption single dose @DRUG$ decreased administered stable renal transplant patients taking @DRUG$ aluminum containing antacids mean Cmax values lower Myfortic alone fasting conditions", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d700.s0.p5", "DRUGA": ["Myfortic", "brand", "41-48"], "DRUGB": ["magnesium", "drug", "133-141"]}
{"TEXT1": "Absorption single dose @DRUG$ decreased administered stable renal transplant patients taking magnesium containing antacids @DRUG$ mean Cmax values lower Myfortic alone fasting conditions", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d700.s0.p6", "DRUGA": ["Myfortic", "brand", "41-48"], "DRUGB": ["aluminum", "drug", "143-150"]}
{"TEXT1": "Absorption single dose @DRUG$ decreased administered stable renal transplant patients taking magnesium aluminum @DRUG$ mean Cmax values lower Myfortic alone fasting conditions", "LBL": "0", "ID": "DDI-DrugBank.d700.s0.p7", "DRUGA": ["Myfortic", "brand", "41-48"], "DRUGB": ["antacids", "group", "163-170"]}
{"TEXT1": "Absorption single dose @DRUG$ decreased administered stable renal transplant patients taking magnesium containing antacids aluminum containing antacids mean Cmax values lower @DRUG$ alone fasting conditions", "LBL": "0", "ID": "DDI-DrugBank.d700.s0.p8", "DRUGA": ["Myfortic", "brand", "41-48"], "DRUGB": ["Myfortic", "brand", "271-278"]}
{"TEXT1": "Absorption single dose Myfortic decreased administered stable renal transplant patients taking @DRUG$ @DRUG$ mean Cmax values lower alone fasting conditions", "LBL": "0", "ID": "DDI-DrugBank.d700.s0.p9", "DRUGA": ["magnesium", "drug", "133-141"], "DRUGB": ["aluminum", "drug", "143-150"]}
{"TEXT1": "Absorption single dose Myfortic decreased administered stable renal transplant patients taking @DRUG$ aluminum @DRUG$ mean Cmax values lower alone fasting conditions", "LBL": "0", "ID": "DDI-DrugBank.d700.s0.p10", "DRUGA": ["magnesium", "drug", "133-141"], "DRUGB": ["antacids", "group", "163-170"]}
{"TEXT1": "Absorption single dose Myfortic decreased administered stable renal transplant patients taking @DRUG$ aluminum containing antacids mean Cmax values lower @DRUG$ alone fasting conditions", "LBL": "0", "ID": "DDI-DrugBank.d700.s0.p11", "DRUGA": ["magnesium", "drug", "133-141"], "DRUGB": ["Myfortic", "brand", "271-278"]}
{"TEXT1": "Absorption single dose Myfortic decreased administered stable renal transplant patients taking magnesium @DRUG$ @DRUG$ mean Cmax values lower alone fasting conditions", "LBL": "0", "ID": "DDI-DrugBank.d700.s0.p12", "DRUGA": ["aluminum", "drug", "143-150"], "DRUGB": ["antacids", "group", "163-170"]}
{"TEXT1": "Absorption single dose Myfortic decreased administered stable renal transplant patients taking magnesium containing antacids @DRUG$ mean Cmax values lower @DRUG$ alone fasting conditions", "LBL": "0", "ID": "DDI-DrugBank.d700.s0.p13", "DRUGA": ["aluminum", "drug", "143-150"], "DRUGB": ["Myfortic", "brand", "271-278"]}
{"TEXT1": "Absorption single dose Myfortic decreased administered stable renal transplant patients taking magnesium aluminum @DRUG$ mean Cmax values lower @DRUG$ alone fasting conditions", "LBL": "0", "ID": "DDI-DrugBank.d700.s0.p14", "DRUGA": ["antacids", "group", "163-170"], "DRUGB": ["Myfortic", "brand", "271-278"]}
{"TEXT1": "recommended @DRUG$ @DRUG$ not administered simultaneously", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d700.s1.p0", "DRUGA": ["Myfortic", "drug", "23-30"], "DRUGB": ["antacids", "group", "36-43"]}
{"TEXT1": "studied renal stable transplant patients @DRUG$ USP pharmacokinetics unaffected steady state Myfortic", "LBL": "0", "ID": "DDI-DrugBank.d700.s2.p0", "DRUGA": ["Cyclosporine", "drug", "0-11"], "DRUGB": ["cyclosporine", "drug", "64-75"]}
{"TEXT1": "studied renal stable transplant patients cyclosporine USP pharmacokinetics unaffected steady state @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d700.s2.p1", "DRUGA": ["Cyclosporine", "drug", "0-11"], "DRUGB": ["Myfortic", "brand", "152-159"]}
{"TEXT1": "studied renal stable transplant patients @DRUG$ USP pharmacokinetics unaffected steady state @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d700.s2.p2", "DRUGA": ["cyclosporine", "drug", "64-75"], "DRUGB": ["Myfortic", "brand", "152-159"]}
{"TEXT1": "taken", "LBL": "0", "ID": "DDI-DrugBank.d700.s3.p0", "DRUGA": ["Acyclovir", "drug", "0-8"], "DRUGB": ["Ganciclovir", "drug", "10-20"]}
{"TEXT1": "taken", "LBL": "0", "ID": "DDI-DrugBank.d700.s3.p1", "DRUGA": ["Acyclovir", "drug", "0-8"], "DRUGB": ["Myfortic", "brand", "41-48"]}
{"TEXT1": "taken", "LBL": "0", "ID": "DDI-DrugBank.d700.s3.p2", "DRUGA": ["Ganciclovir", "drug", "10-20"], "DRUGB": ["Myfortic", "brand", "41-48"]}
{"TEXT1": "concentrations increased presence renal impairment tubular secretion further two", "LBL": "0", "ID": "DDI-DrugBank.d700.s5.p0", "DRUGA": ["acyclovir", "drug", "5-13"], "DRUGB": ["ganciclovir", "drug", "15-25"]}
{"TEXT1": "@DRUG$ concentrations increased presence renal impairment tubular secretion further two", "LBL": "0", "ID": "DDI-DrugBank.d700.s5.p1", "DRUGA": ["acyclovir", "drug", "5-13"], "DRUGB": ["MPAG", "drug_n", "31-34"]}
{"TEXT1": "@DRUG$ concentrations increased presence renal impairment tubular secretion further two", "LBL": "0", "ID": "DDI-DrugBank.d700.s5.p2", "DRUGA": ["ganciclovir", "drug", "15-25"], "DRUGB": ["MPAG", "drug_n", "31-34"]}
{"TEXT1": "Given azathioprine mycophenolate mofetil inhibit purine metabolism recommended Myfortic not administered", "LBL": "0", "ID": "DDI-DrugBank.d700.s6.p0", "DRUGA": ["Azathioprine", "drug", "0-11"], "DRUGB": ["Mycophenolate Mofetil", "drug", "13-33"]}
{"TEXT1": "Given @DRUG$ mycophenolate mofetil inhibit purine metabolism recommended Myfortic not administered azathioprine", "LBL": "0", "ID": "DDI-DrugBank.d700.s6.p1", "DRUGA": ["Azathioprine", "drug", "0-11"], "DRUGB": ["azathioprine", "drug", "47-58"]}
{"TEXT1": "Given azathioprine @DRUG$ inhibit purine metabolism recommended Myfortic not administered mycophenolate mofetil", "LBL": "0", "ID": "DDI-DrugBank.d700.s6.p2", "DRUGA": ["Azathioprine", "drug", "0-11"], "DRUGB": ["mycophenolate mofetil", "drug", "64-84"]}
{"TEXT1": "Given azathioprine mycophenolate mofetil inhibit purine metabolism recommended @DRUG$ not administered", "LBL": "0", "ID": "DDI-DrugBank.d700.s6.p3", "DRUGA": ["Azathioprine", "drug", "0-11"], "DRUGB": ["Myfortic", "brand", "136-143"]}
{"TEXT1": "Given azathioprine mycophenolate mofetil inhibit purine metabolism recommended Myfortic not administered @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d700.s6.p4", "DRUGA": ["Azathioprine", "drug", "0-11"], "DRUGB": ["azathioprine", "drug", "184-195"]}
{"TEXT1": "Given azathioprine mycophenolate mofetil inhibit purine metabolism recommended Myfortic not administered @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d700.s6.p5", "DRUGA": ["Azathioprine", "drug", "0-11"], "DRUGB": ["mycophenolate mofetil", "drug", "200-220"]}
{"TEXT1": "Given @DRUG$ mycophenolate mofetil inhibit purine metabolism recommended Myfortic not administered azathioprine", "LBL": "0", "ID": "DDI-DrugBank.d700.s6.p6", "DRUGA": ["Mycophenolate Mofetil", "drug", "13-33"], "DRUGB": ["azathioprine", "drug", "47-58"]}
{"TEXT1": "Given azathioprine @DRUG$ inhibit purine metabolism recommended Myfortic not administered mycophenolate mofetil", "LBL": "0", "ID": "DDI-DrugBank.d700.s6.p7", "DRUGA": ["Mycophenolate Mofetil", "drug", "13-33"], "DRUGB": ["mycophenolate mofetil", "drug", "64-84"]}
{"TEXT1": "Given azathioprine mycophenolate mofetil inhibit purine metabolism recommended @DRUG$ not administered", "LBL": "0", "ID": "DDI-DrugBank.d700.s6.p8", "DRUGA": ["Mycophenolate Mofetil", "drug", "13-33"], "DRUGB": ["Myfortic", "brand", "136-143"]}
{"TEXT1": "Given azathioprine mycophenolate mofetil inhibit purine metabolism recommended Myfortic not administered @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d700.s6.p9", "DRUGA": ["Mycophenolate Mofetil", "drug", "13-33"], "DRUGB": ["azathioprine", "drug", "184-195"]}
{"TEXT1": "Given azathioprine mycophenolate mofetil inhibit purine metabolism recommended Myfortic not administered @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d700.s6.p10", "DRUGA": ["Mycophenolate Mofetil", "drug", "13-33"], "DRUGB": ["mycophenolate mofetil", "drug", "200-220"]}
{"TEXT1": "Given @DRUG$ @DRUG$ inhibit purine metabolism recommended Myfortic not administered azathioprine mycophenolate mofetil", "LBL": "0", "ID": "DDI-DrugBank.d700.s6.p11", "DRUGA": ["azathioprine", "drug", "47-58"], "DRUGB": ["mycophenolate mofetil", "drug", "64-84"]}
{"TEXT1": "Given @DRUG$ mycophenolate mofetil inhibit purine metabolism recommended @DRUG$ not administered azathioprine", "LBL": "0", "ID": "DDI-DrugBank.d700.s6.p12", "DRUGA": ["azathioprine", "drug", "47-58"], "DRUGB": ["Myfortic", "brand", "136-143"]}
{"TEXT1": "Given @DRUG$ mycophenolate mofetil inhibit purine metabolism recommended Myfortic not administered @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d700.s6.p13", "DRUGA": ["azathioprine", "drug", "47-58"], "DRUGB": ["azathioprine", "drug", "184-195"]}
{"TEXT1": "Given @DRUG$ mycophenolate mofetil inhibit purine metabolism recommended Myfortic not administered azathioprine @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d700.s6.p14", "DRUGA": ["azathioprine", "drug", "47-58"], "DRUGB": ["mycophenolate mofetil", "drug", "200-220"]}
{"TEXT1": "Given azathioprine @DRUG$ inhibit purine metabolism recommended @DRUG$ not administered mycophenolate mofetil", "LBL": "0", "ID": "DDI-DrugBank.d700.s6.p15", "DRUGA": ["mycophenolate mofetil", "drug", "64-84"], "DRUGB": ["Myfortic", "brand", "136-143"]}
{"TEXT1": "Given azathioprine @DRUG$ inhibit purine metabolism recommended Myfortic not administered @DRUG$ mycophenolate mofetil", "LBL": "0", "ID": "DDI-DrugBank.d700.s6.p16", "DRUGA": ["mycophenolate mofetil", "drug", "64-84"], "DRUGB": ["azathioprine", "drug", "184-195"]}
{"TEXT1": "Given azathioprine @DRUG$ inhibit purine metabolism recommended Myfortic not administered @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d700.s6.p17", "DRUGA": ["mycophenolate mofetil", "drug", "64-84"], "DRUGB": ["mycophenolate mofetil", "drug", "200-220"]}
{"TEXT1": "Given azathioprine mycophenolate mofetil inhibit purine metabolism recommended @DRUG$ not administered @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d700.s6.p18", "DRUGA": ["Myfortic", "brand", "136-143"], "DRUGB": ["azathioprine", "drug", "184-195"]}
{"TEXT1": "Given azathioprine mycophenolate mofetil inhibit purine metabolism recommended @DRUG$ not administered @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d700.s6.p19", "DRUGA": ["Myfortic", "brand", "136-143"], "DRUGB": ["mycophenolate mofetil", "drug", "200-220"]}
{"TEXT1": "Given azathioprine mycophenolate mofetil inhibit purine metabolism recommended Myfortic not administered @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d700.s6.p20", "DRUGA": ["azathioprine", "drug", "184-195"], "DRUGB": ["mycophenolate mofetil", "drug", "200-220"]}
{"TEXT1": "@DRUG$ Bind drugs interrupt @DRUG$ exposure mycophenolate mofetil", "LBL": "0", "ID": "DDI-DrugBank.d700.s7.p0", "DRUGA": ["Cholestyramine", "drug", "0-13"], "DRUGB": ["MPA", "drug_n", "108-110"]}
{"TEXT1": "@DRUG$ Bind drugs interrupt exposure @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d700.s7.p1", "DRUGA": ["Cholestyramine", "drug", "0-13"], "DRUGB": ["mycophenolate mofetil", "drug", "146-166"]}
{"TEXT1": "Cholestyramine Bind drugs interrupt @DRUG$ exposure @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d700.s7.p2", "DRUGA": ["MPA", "drug_n", "108-110"], "DRUGB": ["mycophenolate mofetil", "drug", "146-166"]}
{"TEXT1": "not administer @DRUG$ @DRUG$ agents interfere drugs bind bile acids example oral activated charcoal potential to efficacy Myfortic", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d700.s8.p0", "DRUGA": ["Myfortic", "drug", "29-36"], "DRUGB": ["cholestyramine", "drug", "43-56"]}
{"TEXT1": "not administer @DRUG$ cholestyramine agents interfere drugs bind bile acids example oral @DRUG$ potential to efficacy Myfortic", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d700.s8.p1", "DRUGA": ["Myfortic", "drug", "29-36"], "DRUGB": ["activated charcoal", "drug", "204-221"]}
{"TEXT1": "not administer @DRUG$ cholestyramine agents interfere drugs bind bile acids example oral activated charcoal potential to efficacy @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d700.s8.p2", "DRUGA": ["Myfortic", "drug", "29-36"], "DRUGB": ["Myfortic", "brand", "275-282"]}
{"TEXT1": "not administer Myfortic @DRUG$ agents interfere drugs bind bile acids example oral @DRUG$ potential to efficacy", "LBL": "0", "ID": "DDI-DrugBank.d700.s8.p3", "DRUGA": ["cholestyramine", "drug", "43-56"], "DRUGB": ["activated charcoal", "drug", "204-221"]}
{"TEXT1": "not administer Myfortic @DRUG$ agents interfere drugs bind bile acids example oral activated charcoal potential to efficacy @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d700.s8.p4", "DRUGA": ["cholestyramine", "drug", "43-56"], "DRUGB": ["Myfortic", "brand", "275-282"]}
{"TEXT1": "not administer Myfortic cholestyramine agents interfere drugs bind bile acids example oral @DRUG$ potential to efficacy @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d700.s8.p5", "DRUGA": ["activated charcoal", "drug", "204-221"], "DRUGB": ["Myfortic", "brand", "275-282"]}
{"TEXT1": "Given different metabolism @DRUG$ oral contraceptives no two classes expected", "LBL": "0", "ID": "DDI-DrugBank.d700.s9.p0", "DRUGA": ["Contraceptives", "group", "5-18"], "DRUGB": ["Myfortic", "brand", "55-62"]}
{"TEXT1": "Given different metabolism Myfortic @DRUG$ no two classes expected", "LBL": "0", "ID": "DDI-DrugBank.d700.s9.p1", "DRUGA": ["Contraceptives", "group", "5-18"], "DRUGB": ["contraceptives", "group", "73-86"]}
{"TEXT1": "Given different metabolism @DRUG$ @DRUG$ no two classes expected", "LBL": "0", "ID": "DDI-DrugBank.d700.s9.p2", "DRUGA": ["Myfortic", "brand", "55-62"], "DRUGB": ["contraceptives", "group", "73-86"]}
{"TEXT1": "study mean @DRUG$ AUC decreased @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d700.s10.p0", "DRUGA": ["levonorgesterol", "drug", "48-62"], "DRUGB": ["mycophenolate mofetil", "drug", "114-134"]}
{"TEXT1": "recommended @DRUG$ co administered @DRUG$ additional birth control methods considered", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d700.s11.p0", "DRUGA": ["contraceptives", "group", "39-52"], "DRUGB": ["Myfortic", "brand", "80-87"]}
{"TEXT1": "treatment @DRUG$ use of patients vaccinations less effective", "LBL": "0", "ID": "DDI-DrugBank.d700.s12.p0", "DRUGA": ["Live Vaccines", "group", "0-12"], "DRUGB": ["Myfortic", "drug", "37-44"]}
{"TEXT1": "treatment Myfortic use of @DRUG$ patients vaccinations less effective", "LBL": "0", "ID": "DDI-DrugBank.d700.s12.p1", "DRUGA": ["Live Vaccines", "group", "0-12"], "DRUGB": ["live attenuated vaccines", "group", "58-81"]}
{"TEXT1": "treatment @DRUG$ use of @DRUG$ patients vaccinations less effective", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d700.s12.p2", "DRUGA": ["Myfortic", "drug", "37-44"], "DRUGB": ["live attenuated vaccines", "group", "58-81"]}
{"TEXT1": "Interference @DRUG$ hydrolysis lead to @DRUG$ available absorption", "LBL": "0", "ID": "DDI-DrugBank.d700.s16.p0", "DRUGA": ["MPAG", "drug_n", "16-19"], "DRUGB": ["MPA", "drug_n", "49-51"]}
{"TEXT1": "not occurred in vitro studies @DRUG$ interactions @DRUG$ reported FELDENE marketing physicians monitor patients change dosage requirements administering coumarin anticoagulants type highly drugs", "LBL": "0", "ID": "DDI-DrugBank.d656.s1.p0", "DRUGA": ["coumarin-type anticoagulants", "group", "56-83"], "DRUGB": ["coumarin-type anticoagulants", "group", "104-131"]}
{"TEXT1": "not occurred in vitro studies @DRUG$ interactions coumarin anticoagulants type reported @DRUG$ marketing physicians monitor patients change dosage requirements administering FELDENE highly drugs", "LBL": "0", "ID": "DDI-DrugBank.d656.s1.p1", "DRUGA": ["coumarin-type anticoagulants", "group", "56-83"], "DRUGB": ["FELDENE", "brand", "157-163"]}
{"TEXT1": "not occurred in vitro studies @DRUG$ interactions coumarin anticoagulants type reported FELDENE marketing physicians monitor patients change dosage requirements administering @DRUG$ highly drugs", "LBL": "0", "ID": "DDI-DrugBank.d656.s1.p2", "DRUGA": ["coumarin-type anticoagulants", "group", "56-83"], "DRUGB": ["FELDENE", "brand", "291-297"]}
{"TEXT1": "not occurred in vitro studies @DRUG$ interactions coumarin anticoagulants type reported FELDENE marketing physicians monitor patients change dosage requirements administering @DRUG$ highly drugs", "LBL": "0", "ID": "DDI-DrugBank.d656.s1.p3", "DRUGA": ["coumarin-type anticoagulants", "group", "56-83"], "DRUGB": ["coumarin-type anticoagulants", "group", "314-341"]}
{"TEXT1": "not occurred in vitro studies coumarin anticoagulants type interactions @DRUG$ reported @DRUG$ marketing physicians monitor patients change dosage requirements administering FELDENE highly drugs", "LBL": "DDI-int", "ID": "DDI-DrugBank.d656.s1.p4", "DRUGA": ["coumarin-type anticoagulants", "group", "104-131"], "DRUGB": ["FELDENE", "brand", "157-163"]}
{"TEXT1": "not occurred in vitro studies coumarin anticoagulants type interactions @DRUG$ reported FELDENE marketing physicians monitor patients change dosage requirements administering @DRUG$ highly drugs", "LBL": "0", "ID": "DDI-DrugBank.d656.s1.p5", "DRUGA": ["coumarin-type anticoagulants", "group", "104-131"], "DRUGB": ["FELDENE", "brand", "291-297"]}
{"TEXT1": "not occurred in vitro studies coumarin anticoagulants type interactions @DRUG$ reported FELDENE marketing physicians monitor patients change dosage requirements administering @DRUG$ highly drugs", "LBL": "0", "ID": "DDI-DrugBank.d656.s1.p6", "DRUGA": ["coumarin-type anticoagulants", "group", "104-131"], "DRUGB": ["coumarin-type anticoagulants", "group", "314-341"]}
{"TEXT1": "not occurred in vitro studies coumarin anticoagulants type interactions reported @DRUG$ marketing physicians monitor patients change dosage requirements administering @DRUG$ highly drugs", "LBL": "0", "ID": "DDI-DrugBank.d656.s1.p7", "DRUGA": ["FELDENE", "brand", "157-163"], "DRUGB": ["FELDENE", "brand", "291-297"]}
{"TEXT1": "not occurred in vitro studies coumarin anticoagulants type interactions reported @DRUG$ marketing physicians monitor patients change dosage requirements administering FELDENE @DRUG$ highly drugs", "LBL": "0", "ID": "DDI-DrugBank.d656.s1.p8", "DRUGA": ["FELDENE", "brand", "157-163"], "DRUGB": ["coumarin-type anticoagulants", "group", "314-341"]}
{"TEXT1": "not occurred in vitro studies coumarin anticoagulants type interactions reported FELDENE marketing physicians monitor patients change dosage requirements administering @DRUG$ @DRUG$ highly drugs", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d656.s1.p9", "DRUGA": ["FELDENE", "brand", "291-297"], "DRUGB": ["coumarin-type anticoagulants", "group", "314-341"]}
{"TEXT1": "levels @DRUG$ depressed to approximately rmal values @DRUG$ administered conjunction aspirin concomitant administration antacids no no effect piroxicam plasma including FELDENE reported increase steady state", "LBL": "0", "ID": "DDI-DrugBank.d656.s2.p0", "DRUGA": ["piroxicam", "drug", "17-25"], "DRUGB": ["FELDENE", "brand", "90-96"]}
{"TEXT1": "levels @DRUG$ depressed to approximately rmal values FELDENE administered conjunction @DRUG$ concomitant administration antacids no no effect piroxicam plasma including reported increase steady state", "LBL": "0", "ID": "DDI-DrugBank.d656.s2.p1", "DRUGA": ["piroxicam", "drug", "17-25"], "DRUGB": ["aspirin", "brand", "134-140"]}
{"TEXT1": "levels @DRUG$ depressed to approximately rmal values FELDENE administered conjunction aspirin concomitant administration @DRUG$ no no effect piroxicam plasma including reported increase steady state", "LBL": "0", "ID": "DDI-DrugBank.d656.s2.p2", "DRUGA": ["piroxicam", "drug", "17-25"], "DRUGB": ["antacids", "group", "191-198"]}
{"TEXT1": "levels @DRUG$ depressed to approximately rmal values FELDENE administered conjunction aspirin concomitant administration antacids no no effect @DRUG$ plasma including reported increase steady state", "LBL": "0", "ID": "DDI-DrugBank.d656.s2.p3", "DRUGA": ["piroxicam", "drug", "17-25"], "DRUGB": ["piroxicam", "drug", "217-225"]}
{"TEXT1": "levels @DRUG$ depressed to approximately rmal values FELDENE administered conjunction aspirin concomitant administration antacids no no effect piroxicam plasma @DRUG$ including reported increase steady state", "LBL": "0", "ID": "DDI-DrugBank.d656.s2.p4", "DRUGA": ["piroxicam", "drug", "17-25"], "DRUGB": ["Nonsteroidal anti-inflammatory agents", "group", "243-279"]}
{"TEXT1": "levels @DRUG$ depressed to approximately rmal values FELDENE administered conjunction aspirin concomitant administration antacids no no effect piroxicam plasma including @DRUG$ reported increase steady state", "LBL": "0", "ID": "DDI-DrugBank.d656.s2.p5", "DRUGA": ["piroxicam", "drug", "17-25"], "DRUGB": ["FELDENE", "brand", "292-298"]}
{"TEXT1": "levels @DRUG$ depressed to approximately rmal values FELDENE administered conjunction aspirin concomitant administration antacids no no effect piroxicam plasma including reported increase steady state @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d656.s2.p6", "DRUGA": ["piroxicam", "drug", "17-25"], "DRUGB": ["lithium", "drug", "352-358"]}
{"TEXT1": "levels piroxicam depressed to approximately rmal values @DRUG$ administered conjunction @DRUG$ concomitant administration antacids no no effect plasma including FELDENE reported increase steady state", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d656.s2.p7", "DRUGA": ["FELDENE", "brand", "90-96"], "DRUGB": ["aspirin", "brand", "134-140"]}
{"TEXT1": "levels piroxicam depressed to approximately rmal values @DRUG$ administered conjunction aspirin concomitant administration @DRUG$ no no effect plasma including FELDENE reported increase steady state", "LBL": "0", "ID": "DDI-DrugBank.d656.s2.p8", "DRUGA": ["FELDENE", "brand", "90-96"], "DRUGB": ["antacids", "group", "191-198"]}
{"TEXT1": "levels piroxicam depressed to approximately rmal values @DRUG$ administered conjunction aspirin concomitant administration antacids no no effect @DRUG$ plasma including FELDENE reported increase steady state", "LBL": "0", "ID": "DDI-DrugBank.d656.s2.p9", "DRUGA": ["FELDENE", "brand", "90-96"], "DRUGB": ["piroxicam", "drug", "217-225"]}
{"TEXT1": "levels piroxicam depressed to approximately rmal values @DRUG$ administered conjunction aspirin concomitant administration antacids no no effect plasma @DRUG$ including FELDENE reported increase steady state", "LBL": "0", "ID": "DDI-DrugBank.d656.s2.p10", "DRUGA": ["FELDENE", "brand", "90-96"], "DRUGB": ["Nonsteroidal anti-inflammatory agents", "group", "243-279"]}
{"TEXT1": "levels piroxicam depressed to approximately rmal values @DRUG$ administered conjunction aspirin concomitant administration antacids no no effect plasma including @DRUG$ reported increase steady state", "LBL": "0", "ID": "DDI-DrugBank.d656.s2.p11", "DRUGA": ["FELDENE", "brand", "90-96"], "DRUGB": ["FELDENE", "brand", "292-298"]}
{"TEXT1": "levels piroxicam depressed to approximately rmal values @DRUG$ administered conjunction aspirin concomitant administration antacids no no effect plasma including FELDENE reported increase steady state @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d656.s2.p12", "DRUGA": ["FELDENE", "brand", "90-96"], "DRUGB": ["lithium", "drug", "352-358"]}
{"TEXT1": "levels piroxicam depressed to approximately rmal values FELDENE administered conjunction @DRUG$ concomitant administration @DRUG$ no no effect plasma including reported increase steady state", "LBL": "0", "ID": "DDI-DrugBank.d656.s2.p13", "DRUGA": ["aspirin", "brand", "134-140"], "DRUGB": ["antacids", "group", "191-198"]}
{"TEXT1": "levels piroxicam depressed to approximately rmal values FELDENE administered conjunction @DRUG$ concomitant administration antacids no no effect @DRUG$ plasma including reported increase steady state", "LBL": "0", "ID": "DDI-DrugBank.d656.s2.p14", "DRUGA": ["aspirin", "brand", "134-140"], "DRUGB": ["piroxicam", "drug", "217-225"]}
{"TEXT1": "levels piroxicam depressed to approximately rmal values FELDENE administered conjunction @DRUG$ concomitant administration antacids no no effect plasma @DRUG$ including reported increase steady state", "LBL": "0", "ID": "DDI-DrugBank.d656.s2.p15", "DRUGA": ["aspirin", "brand", "134-140"], "DRUGB": ["Nonsteroidal anti-inflammatory agents", "group", "243-279"]}
{"TEXT1": "levels piroxicam depressed to approximately rmal values FELDENE administered conjunction @DRUG$ concomitant administration antacids no no effect plasma including @DRUG$ reported increase steady state", "LBL": "0", "ID": "DDI-DrugBank.d656.s2.p16", "DRUGA": ["aspirin", "brand", "134-140"], "DRUGB": ["FELDENE", "brand", "292-298"]}
{"TEXT1": "levels piroxicam depressed to approximately rmal values FELDENE administered conjunction @DRUG$ concomitant administration antacids no no effect plasma including reported increase steady state @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d656.s2.p17", "DRUGA": ["aspirin", "brand", "134-140"], "DRUGB": ["lithium", "drug", "352-358"]}
{"TEXT1": "levels piroxicam depressed to approximately rmal values FELDENE administered conjunction aspirin concomitant administration @DRUG$ no no effect @DRUG$ plasma including reported increase steady state", "LBL": "0", "ID": "DDI-DrugBank.d656.s2.p18", "DRUGA": ["antacids", "group", "191-198"], "DRUGB": ["piroxicam", "drug", "217-225"]}
{"TEXT1": "levels piroxicam depressed to approximately rmal values FELDENE administered conjunction aspirin concomitant administration @DRUG$ no no effect plasma @DRUG$ including reported increase steady state", "LBL": "0", "ID": "DDI-DrugBank.d656.s2.p19", "DRUGA": ["antacids", "group", "191-198"], "DRUGB": ["Nonsteroidal anti-inflammatory agents", "group", "243-279"]}
{"TEXT1": "levels piroxicam depressed to approximately rmal values FELDENE administered conjunction aspirin concomitant administration @DRUG$ no no effect plasma including @DRUG$ reported increase steady state", "LBL": "0", "ID": "DDI-DrugBank.d656.s2.p20", "DRUGA": ["antacids", "group", "191-198"], "DRUGB": ["FELDENE", "brand", "292-298"]}
{"TEXT1": "levels piroxicam depressed to approximately rmal values FELDENE administered conjunction aspirin concomitant administration @DRUG$ no no effect plasma including reported increase steady state @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d656.s2.p21", "DRUGA": ["antacids", "group", "191-198"], "DRUGB": ["lithium", "drug", "352-358"]}
{"TEXT1": "levels piroxicam depressed to approximately rmal values FELDENE administered conjunction aspirin concomitant administration antacids no no effect @DRUG$ plasma @DRUG$ including reported increase steady state", "LBL": "0", "ID": "DDI-DrugBank.d656.s2.p22", "DRUGA": ["piroxicam", "drug", "217-225"], "DRUGB": ["Nonsteroidal anti-inflammatory agents", "group", "243-279"]}
{"TEXT1": "levels piroxicam depressed to approximately rmal values FELDENE administered conjunction aspirin concomitant administration antacids no no effect @DRUG$ plasma including @DRUG$ reported increase steady state", "LBL": "0", "ID": "DDI-DrugBank.d656.s2.p23", "DRUGA": ["piroxicam", "drug", "217-225"], "DRUGB": ["FELDENE", "brand", "292-298"]}
{"TEXT1": "levels piroxicam depressed to approximately rmal values FELDENE administered conjunction aspirin concomitant administration antacids no no effect @DRUG$ plasma including reported increase steady state @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d656.s2.p24", "DRUGA": ["piroxicam", "drug", "217-225"], "DRUGB": ["lithium", "drug", "352-358"]}
{"TEXT1": "levels piroxicam depressed to approximately rmal values FELDENE administered conjunction aspirin concomitant administration antacids no no effect plasma @DRUG$ including @DRUG$ reported increase steady state", "LBL": "0", "ID": "DDI-DrugBank.d656.s2.p25", "DRUGA": ["Nonsteroidal anti-inflammatory agents", "group", "243-279"], "DRUGB": ["FELDENE", "brand", "292-298"]}
{"TEXT1": "levels piroxicam depressed to approximately rmal values FELDENE administered conjunction aspirin concomitant administration antacids no no effect plasma @DRUG$ including reported increase steady state @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d656.s2.p26", "DRUGA": ["Nonsteroidal anti-inflammatory agents", "group", "243-279"], "DRUGB": ["lithium", "drug", "352-358"]}
{"TEXT1": "levels piroxicam depressed to approximately rmal values FELDENE administered conjunction aspirin concomitant administration antacids no no effect plasma including @DRUG$ reported increase steady state @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d656.s2.p27", "DRUGA": ["FELDENE", "brand", "292-298"], "DRUGB": ["lithium", "drug", "352-358"]}
{"TEXT1": "recommended plasma @DRUG$ monitored initiating discontinuing @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d656.s3.p0", "DRUGA": ["lithium", "drug", "30-36"], "DRUGB": ["FELDENE", "brand", "103-109"]}
{"TEXT1": "@DRUG$ @DRUG$ cause serious cardiac arrhythmias halothane anesthesia used only great not at all", "LBL": "0", "ID": "DDI-DrugBank.d689.s0.p0", "DRUGA": ["Vasopressors", "group", "0-11"], "DRUGB": ["metaraminol", "drug", "27-37"]}
{"TEXT1": "@DRUG$ metaraminol cause serious cardiac arrhythmias @DRUG$ anesthesia used only great not at all", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d689.s0.p1", "DRUGA": ["Vasopressors", "group", "0-11"], "DRUGB": ["halothane", "drug", "85-93"]}
{"TEXT1": "Vasopressors @DRUG$ cause serious cardiac arrhythmias @DRUG$ anesthesia used only great not at all", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d689.s0.p2", "DRUGA": ["metaraminol", "drug", "27-37"], "DRUGB": ["halothane", "drug", "85-93"]}
{"TEXT1": "@DRUG$ pressor effect @DRUG$ markedly patients receiving monoamine oxidase inhibitors", "LBL": "0", "ID": "DDI-DrugBank.d689.s1.p0", "DRUGA": ["MAO Inhibitors", "group", "0-13"], "DRUGB": ["sympathomimetic pressor amines", "group", "39-68"]}
{"TEXT1": "@DRUG$ pressor effect sympathomimetic amines markedly patients receiving @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d689.s1.p1", "DRUGA": ["MAO Inhibitors", "group", "0-13"], "DRUGB": ["monoamine oxidase inhibitors", "group", "116-143"]}
{"TEXT1": "@DRUG$ pressor effect sympathomimetic amines markedly patients receiving monoamine oxidase inhibitors", "LBL": "0", "ID": "DDI-DrugBank.d689.s1.p2", "DRUGA": ["MAO Inhibitors", "group", "0-13"], "DRUGB": ["MAOI", "group", "146-149"]}
{"TEXT1": "MAO Inhibitors pressor effect @DRUG$ markedly patients receiving @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d689.s1.p3", "DRUGA": ["sympathomimetic pressor amines", "group", "39-68"], "DRUGB": ["monoamine oxidase inhibitors", "group", "116-143"]}
{"TEXT1": "MAO Inhibitors pressor effect @DRUG$ markedly patients receiving monoamine oxidase inhibitors", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d689.s1.p4", "DRUGA": ["sympathomimetic pressor amines", "group", "39-68"], "DRUGB": ["MAOI", "group", "146-149"]}
{"TEXT1": "MAO Inhibitors pressor effect sympathomimetic amines markedly patients receiving @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d689.s1.p5", "DRUGA": ["monoamine oxidase inhibitors", "group", "116-143"], "DRUGB": ["MAOI", "group", "146-149"]}
{"TEXT1": "pressor response @DRUG$ @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d689.s3.p0", "DRUGA": ["adrenergic agents", "group", "24-40"], "DRUGB": ["tricyclic antidepressants", "group", "69-93"]}
{"TEXT1": "patients diabetes mellitus @DRUG$ @DRUG$ dose reductions initiation therapy SOMAVERT", "LBL": "0", "ID": "DDI-DrugBank.d744.s0.p0", "DRUGA": ["insulin", "drug", "63-69"], "DRUGB": ["hypoglycemic", "group", "83-94"]}
{"TEXT1": "patients diabetes mellitus @DRUG$ oral hypoglycemic agents dose reductions initiation therapy @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d744.s0.p1", "DRUGA": ["insulin", "drug", "63-69"], "DRUGB": ["SOMAVERT", "brand", "196-203"]}
{"TEXT1": "patients diabetes mellitus insulin @DRUG$ dose reductions initiation therapy @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d744.s0.p2", "DRUGA": ["hypoglycemic", "group", "83-94"], "DRUGB": ["SOMAVERT", "brand", "196-203"]}
{"TEXT1": "clinical studies patients @DRUG$ often needed higher serum concentrations @DRUG$ to appropriate suppression compared not receiving opioids", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d744.s1.p0", "DRUGA": ["opioids", "group", "33-39"], "DRUGB": ["pegvisomant", "drug", "67-77"]}
{"TEXT1": "clinical studies patients @DRUG$ often needed higher serum concentrations pegvisomant to appropriate suppression compared not receiving @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d744.s1.p1", "DRUGA": ["opioids", "group", "33-39"], "DRUGB": ["opioids", "group", "172-178"]}
{"TEXT1": "clinical studies patients opioids often needed higher serum concentrations @DRUG$ to appropriate suppression compared not receiving @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d744.s1.p2", "DRUGA": ["pegvisomant", "drug", "67-77"], "DRUGB": ["opioids", "group", "172-178"]}
{"TEXT1": "slight increase area curve mean peak concentration drug concentration @DRUG$ co 100 mg sitagliptin 10 days", "LBL": "0", "ID": "DDI-DrugBank.d694.s0.p0", "DRUGA": ["Digoxin", "drug", "0-6"], "DRUGB": ["digoxin", "drug", "124-130"]}
{"TEXT1": "slight increase area curve mean peak concentration drug concentration digoxin administration co @DRUG$ 10 days", "LBL": "0", "ID": "DDI-DrugBank.d694.s0.p1", "DRUGA": ["Digoxin", "drug", "0-6"], "DRUGB": ["sitagliptin", "drug", "169-179"]}
{"TEXT1": "slight increase area curve mean peak concentration drug concentration @DRUG$ co @DRUG$ 10 days", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d694.s0.p2", "DRUGA": ["digoxin", "drug", "124-130"], "DRUGB": ["sitagliptin", "drug", "169-179"]}
{"TEXT1": "dosage adjustment @DRUG$ @DRUG$ recommended", "LBL": "0", "ID": "DDI-DrugBank.d694.s2.p0", "DRUGA": ["digoxin", "drug", "24-30"], "DRUGB": ["JANUVIA", "brand", "35-41"]}
{"TEXT1": "Limited evidence suggests @DRUG$ intensity duration action @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d759.s0.p0", "DRUGA": ["ascorbic acid", "drug", "31-43"], "DRUGB": ["bishydroxycoumarin", "drug", "99-116"]}
{"TEXT1": "@DRUG$ drugs following cause Bone marrow predictable dose related Neurotoxic neurologic toxicity increase seizure activity virus vaccine side effects vaccination decrease patient's response shortness of breath bronchospasm", "LBL": "DDI-int", "ID": "DDI-DrugBank.d782.s0.p0", "DRUGA": ["Vindesine", "drug", "0-8"], "DRUGB": ["Phenytoin", "drug", "310-318"]}
{"TEXT1": "@DRUG$ drugs following cause Bone marrow predictable dose related Neurotoxic neurologic toxicity increase seizure activity vaccine virus side effects vaccination decrease patient's response shortness of breath bronchospasm", "LBL": "DDI-int", "ID": "DDI-DrugBank.d782.s0.p1", "DRUGA": ["Vindesine", "drug", "0-8"], "DRUGB": ["Live virus vaccines", "group", "353-371"]}
{"TEXT1": "@DRUG$ drugs following cause Bone marrow predictable dose related Neurotoxic neurologic toxicity increase seizure activity virus @DRUG$ side effects vaccination decrease patient's response vaccine shortness of breath bronchospasm", "LBL": "0", "ID": "DDI-DrugBank.d782.s0.p2", "DRUGA": ["Vindesine", "drug", "0-8"], "DRUGB": ["vaccine", "drug", "412-418"]}
{"TEXT1": "@DRUG$ drugs following cause Bone marrow predictable dose related Neurotoxic neurologic toxicity increase seizure activity virus vaccine side effects vaccination decrease patient's response shortness of breath bronchospasm", "LBL": "DDI-int", "ID": "DDI-DrugBank.d782.s0.p3", "DRUGA": ["Vindesine", "drug", "0-8"], "DRUGB": ["Mitomycin-C", "drug", "526-536"]}
{"TEXT1": "@DRUG$ drugs following cause Bone marrow predictable dose related Neurotoxic neurologic toxicity increase seizure activity virus vaccine side effects vaccination decrease patient's response shortness of breath bronchospasm", "LBL": "DDI-int", "ID": "DDI-DrugBank.d782.s0.p4", "DRUGA": ["Vindesine", "drug", "0-8"], "DRUGB": ["Killed virus vaccines", "group", "588-608"]}
{"TEXT1": "@DRUG$ drugs following cause Bone marrow predictable dose related Neurotoxic neurologic toxicity increase seizure activity virus vaccine side effects vaccination decrease patient's response shortness of breath bronchospasm @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d782.s0.p5", "DRUGA": ["Vindesine", "drug", "0-8"], "DRUGB": ["vaccine", "group", "650-656"]}
{"TEXT1": "Vindesine drugs following cause Bone marrow predictable dose related Neurotoxic neurologic toxicity increase seizure activity vaccine virus side effects vaccination decrease patient's response shortness of breath bronchospasm", "LBL": "0", "ID": "DDI-DrugBank.d782.s0.p6", "DRUGA": ["Phenytoin", "drug", "310-318"], "DRUGB": ["Live virus vaccines", "group", "353-371"]}
{"TEXT1": "Vindesine drugs following cause Bone marrow predictable dose related Neurotoxic neurologic toxicity increase seizure activity virus @DRUG$ side effects vaccination decrease patient's response vaccine shortness of breath bronchospasm", "LBL": "0", "ID": "DDI-DrugBank.d782.s0.p7", "DRUGA": ["Phenytoin", "drug", "310-318"], "DRUGB": ["vaccine", "drug", "412-418"]}
{"TEXT1": "Vindesine drugs following cause Bone marrow predictable dose related Neurotoxic neurologic toxicity increase seizure activity virus vaccine side effects vaccination decrease patient's response shortness of breath bronchospasm", "LBL": "0", "ID": "DDI-DrugBank.d782.s0.p8", "DRUGA": ["Phenytoin", "drug", "310-318"], "DRUGB": ["Mitomycin-C", "drug", "526-536"]}
{"TEXT1": "Vindesine drugs following cause Bone marrow predictable dose related Neurotoxic neurologic toxicity increase seizure activity virus vaccine side effects vaccination decrease patient's response shortness of breath bronchospasm", "LBL": "0", "ID": "DDI-DrugBank.d782.s0.p9", "DRUGA": ["Phenytoin", "drug", "310-318"], "DRUGB": ["Killed virus vaccines", "group", "588-608"]}
{"TEXT1": "Vindesine drugs following cause Bone marrow predictable dose related Neurotoxic neurologic toxicity increase seizure activity virus vaccine side effects vaccination decrease patient's response shortness of breath bronchospasm @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d782.s0.p10", "DRUGA": ["Phenytoin", "drug", "310-318"], "DRUGB": ["vaccine", "group", "650-656"]}
{"TEXT1": "Vindesine drugs following cause Bone marrow predictable dose related Neurotoxic neurologic toxicity increase seizure activity replication virus @DRUG$ virus side effects vaccination decrease patient's response vaccine shortness of breath bronchospasm", "LBL": "0", "ID": "DDI-DrugBank.d782.s0.p11", "DRUGA": ["Live virus vaccines", "group", "353-371"], "DRUGB": ["vaccine", "drug", "412-418"]}
{"TEXT1": "Vindesine drugs following cause Bone marrow predictable dose related Neurotoxic neurologic toxicity increase seizure activity vaccine virus side effects vaccination decrease patient's response shortness of breath bronchospasm", "LBL": "0", "ID": "DDI-DrugBank.d782.s0.p12", "DRUGA": ["Live virus vaccines", "group", "353-371"], "DRUGB": ["Mitomycin-C", "drug", "526-536"]}
{"TEXT1": "Vindesine drugs following cause Bone marrow predictable dose related Neurotoxic neurologic toxicity increase seizure activity vaccine virus side effects vaccination decrease patient's response shortness of breath bronchospasm", "LBL": "0", "ID": "DDI-DrugBank.d782.s0.p13", "DRUGA": ["Live virus vaccines", "group", "353-371"], "DRUGB": ["Killed virus vaccines", "group", "588-608"]}
{"TEXT1": "Vindesine drugs following cause Bone marrow predictable dose related Neurotoxic neurologic toxicity increase seizure activity vaccine virus side effects vaccination decrease patient's response shortness of breath bronchospasm @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d782.s0.p14", "DRUGA": ["Live virus vaccines", "group", "353-371"], "DRUGB": ["vaccine", "group", "650-656"]}
{"TEXT1": "Vindesine drugs following cause Bone marrow predictable dose related Neurotoxic neurologic toxicity increase seizure activity virus @DRUG$ side effects vaccination decrease patient's response vaccine shortness of breath bronchospasm", "LBL": "0", "ID": "DDI-DrugBank.d782.s0.p15", "DRUGA": ["vaccine", "drug", "412-418"], "DRUGB": ["Mitomycin-C", "drug", "526-536"]}
{"TEXT1": "Vindesine drugs following cause Bone marrow predictable dose related Neurotoxic neurologic toxicity increase seizure activity virus @DRUG$ side effects vaccination decrease patient's response vaccine shortness of breath bronchospasm", "LBL": "0", "ID": "DDI-DrugBank.d782.s0.p16", "DRUGA": ["vaccine", "drug", "412-418"], "DRUGB": ["Killed virus vaccines", "group", "588-608"]}
{"TEXT1": "Vindesine drugs following cause Bone marrow predictable dose related Neurotoxic neurologic toxicity increase seizure activity virus @DRUG$ side effects vaccination decrease patient's response vaccine shortness of breath bronchospasm @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d782.s0.p17", "DRUGA": ["vaccine", "drug", "412-418"], "DRUGB": ["vaccine", "group", "650-656"]}
{"TEXT1": "Vindesine drugs following cause Bone marrow predictable dose related Neurotoxic neurologic toxicity increase seizure activity virus vaccine side effects vaccination decrease patient's response shortness of breath bronchospasm", "LBL": "0", "ID": "DDI-DrugBank.d782.s0.p18", "DRUGA": ["Mitomycin-C", "drug", "526-536"], "DRUGB": ["Killed virus vaccines", "group", "588-608"]}
{"TEXT1": "Vindesine drugs following cause Bone marrow predictable dose related Neurotoxic neurologic toxicity increase seizure activity virus vaccine side effects vaccination decrease patient's response shortness of breath bronchospasm @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d782.s0.p19", "DRUGA": ["Mitomycin-C", "drug", "526-536"], "DRUGB": ["vaccine", "group", "650-656"]}
{"TEXT1": "Vindesine drugs following cause Bone marrow predictable dose related Neurotoxic neurologic toxicity increase seizure activity virus vaccine side effects vaccination decrease patient's response shortness of breath bronchospasm @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d782.s0.p20", "DRUGA": ["Killed virus vaccines", "group", "588-608"], "DRUGB": ["vaccine", "group", "650-656"]}
{"TEXT1": "Excessive reductions blood pressure occur patients diuretic therapy @DRUG$ started", "LBL": "0", "ID": "DDI-DrugBank.d640.s0.p0", "DRUGA": ["Diuretics", "group", "0-8"], "DRUGB": ["ACE inhibitors", "group", "97-110"]}
{"TEXT1": "hypotensive effects @DRUG$ discontinuing diuretic therapy several days increasing salt intake initiation treatment @DRUG$ not possible starting dose reduced", "LBL": "0", "ID": "DDI-DrugBank.d640.s1.p0", "DRUGA": ["UNIVASC", "brand", "44-50"], "DRUGB": ["UNIVASC", "brand", "196-202"]}
{"TEXT1": "hypotensive effects @DRUG$ discontinuing diuretic therapy several days increasing salt intake initiation treatment UNIVASC not possible starting dose @DRUG$ reduced", "LBL": "0", "ID": "DDI-DrugBank.d640.s1.p1", "DRUGA": ["UNIVASC", "brand", "44-50"], "DRUGB": ["moexpril", "drug", "254-261"]}
{"TEXT1": "hypotensive effects UNIVASC discontinuing diuretic therapy several days increasing salt intake initiation treatment @DRUG$ not possible starting dose @DRUG$ reduced", "LBL": "0", "ID": "DDI-DrugBank.d640.s1.p2", "DRUGA": ["UNIVASC", "brand", "196-202"], "DRUGB": ["moexpril", "drug", "254-261"]}
{"TEXT1": "@DRUG$ UNIVASC increase serum potassium decreases aldosterone secretion", "LBL": "0", "ID": "DDI-DrugBank.d640.s2.p0", "DRUGA": ["Potassium", "drug", "0-8"], "DRUGB": ["Potassium-Sparing Diuretics", "group", "26-52"]}
{"TEXT1": "@DRUG$ @DRUG$ increase serum potassium decreases aldosterone secretion", "LBL": "0", "ID": "DDI-DrugBank.d640.s2.p1", "DRUGA": ["Potassium", "drug", "0-8"], "DRUGB": ["UNIVASC", "brand", "55-61"]}
{"TEXT1": "Potassium Supplements @DRUG$ increase serum potassium decreases aldosterone secretion", "LBL": "0", "ID": "DDI-DrugBank.d640.s2.p2", "DRUGA": ["Potassium-Sparing Diuretics", "group", "26-52"], "DRUGB": ["UNIVASC", "brand", "55-61"]}
{"TEXT1": "Use of @DRUG$ triamterene potassium supplements ACE inhibitors increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d640.s3.p0", "DRUGA": ["potassium-sparing diuretics", "group", "7-33"], "DRUGB": ["spironolactone", "drug", "36-49"]}
{"TEXT1": "Use of @DRUG$ @DRUG$ potassium supplements ACE inhibitors increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d640.s3.p1", "DRUGA": ["potassium-sparing diuretics", "group", "7-33"], "DRUGB": ["triamterene", "drug", "52-62"]}
{"TEXT1": "Use of @DRUG$ triamterene potassium supplements ACE inhibitors increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d640.s3.p2", "DRUGA": ["potassium-sparing diuretics", "group", "7-33"], "DRUGB": ["amiloride", "drug", "65-73"]}
{"TEXT1": "Use of @DRUG$ triamterene @DRUG$ supplements ACE inhibitors increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d640.s3.p3", "DRUGA": ["potassium-sparing diuretics", "group", "7-33"], "DRUGB": ["potassium", "drug", "79-87"]}
{"TEXT1": "Use of @DRUG$ triamterene potassium supplements @DRUG$ increase risk hyperkalemia", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d640.s3.p4", "DRUGA": ["potassium-sparing diuretics", "group", "7-33"], "DRUGB": ["ACE inhibitors", "group", "120-133"]}
{"TEXT1": "Use of potassium @DRUG$ supplements ACE inhibitors increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d640.s3.p5", "DRUGA": ["spironolactone", "drug", "36-49"], "DRUGB": ["triamterene", "drug", "52-62"]}
{"TEXT1": "Use of potassium triamterene supplements ACE inhibitors increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d640.s3.p6", "DRUGA": ["spironolactone", "drug", "36-49"], "DRUGB": ["amiloride", "drug", "65-73"]}
{"TEXT1": "Use of potassium triamterene @DRUG$ supplements ACE inhibitors increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d640.s3.p7", "DRUGA": ["spironolactone", "drug", "36-49"], "DRUGB": ["potassium", "drug", "79-87"]}
{"TEXT1": "Use of potassium triamterene supplements @DRUG$ increase risk hyperkalemia", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d640.s3.p8", "DRUGA": ["spironolactone", "drug", "36-49"], "DRUGB": ["ACE inhibitors", "group", "120-133"]}
{"TEXT1": "Use of potassium @DRUG$ supplements ACE inhibitors increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d640.s3.p9", "DRUGA": ["triamterene", "drug", "52-62"], "DRUGB": ["amiloride", "drug", "65-73"]}
{"TEXT1": "Use of potassium @DRUG$ @DRUG$ supplements ACE inhibitors increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d640.s3.p10", "DRUGA": ["triamterene", "drug", "52-62"], "DRUGB": ["potassium", "drug", "79-87"]}
{"TEXT1": "Use of potassium @DRUG$ supplements @DRUG$ increase risk hyperkalemia", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d640.s3.p11", "DRUGA": ["triamterene", "drug", "52-62"], "DRUGB": ["ACE inhibitors", "group", "120-133"]}
{"TEXT1": "Use of potassium triamterene @DRUG$ supplements ACE inhibitors increase risk hyperkalemia", "LBL": "0", "ID": "DDI-DrugBank.d640.s3.p12", "DRUGA": ["amiloride", "drug", "65-73"], "DRUGB": ["potassium", "drug", "79-87"]}
{"TEXT1": "Use of potassium triamterene supplements @DRUG$ increase risk hyperkalemia", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d640.s3.p13", "DRUGA": ["amiloride", "drug", "65-73"], "DRUGB": ["ACE inhibitors", "group", "120-133"]}
{"TEXT1": "Use of potassium triamterene @DRUG$ supplements @DRUG$ increase risk hyperkalemia", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d640.s3.p14", "DRUGA": ["potassium", "drug", "79-87"], "DRUGB": ["ACE inhibitors", "group", "120-133"]}
{"TEXT1": "Interaction studies @DRUG$ failed to important serum concentrations", "LBL": "0", "ID": "DDI-DrugBank.d640.s5.p0", "DRUGA": ["Anticoagulants", "group", "5-18"], "DRUGB": ["warfarin", "drug", "46-53"]}
{"TEXT1": "Interaction studies warfarin failed to important serum concentrations @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d640.s5.p1", "DRUGA": ["Anticoagulants", "group", "5-18"], "DRUGB": ["anticoagulant", "group", "141-153"]}
{"TEXT1": "Interaction studies @DRUG$ failed to important serum concentrations @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d640.s5.p2", "DRUGA": ["warfarin", "drug", "46-53"], "DRUGB": ["anticoagulant", "group", "141-153"]}
{"TEXT1": "Increased @DRUG$ symptoms lithium toxicity reported patients receiving ACE inhibitors therapy", "LBL": "0", "ID": "DDI-DrugBank.d640.s6.p0", "DRUGA": ["Lithium", "drug", "0-6"], "DRUGB": ["lithium", "drug", "25-31"]}
{"TEXT1": "Increased serum lithium levels lithium symptoms @DRUG$ reported patients receiving ACE inhibitors therapy", "LBL": "0", "ID": "DDI-DrugBank.d640.s6.p1", "DRUGA": ["Lithium", "drug", "0-6"], "DRUGB": ["lithium", "drug", "56-62"]}
{"TEXT1": "Increased serum lithium levels lithium symptoms reported patients receiving @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d640.s6.p2", "DRUGA": ["Lithium", "drug", "0-6"], "DRUGB": ["ACE inhibitors", "group", "114-127"]}
{"TEXT1": "Increased serum lithium levels lithium symptoms reported patients receiving ACE inhibitors therapy @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d640.s6.p3", "DRUGA": ["Lithium", "drug", "0-6"], "DRUGB": ["lithium", "drug", "149-155"]}
{"TEXT1": "Increased @DRUG$ symptoms @DRUG$ reported patients receiving ACE inhibitors therapy lithium", "LBL": "0", "ID": "DDI-DrugBank.d640.s6.p4", "DRUGA": ["lithium", "drug", "25-31"], "DRUGB": ["lithium", "drug", "56-62"]}
{"TEXT1": "Increased @DRUG$ symptoms lithium toxicity reported patients receiving @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d640.s6.p5", "DRUGA": ["lithium", "drug", "25-31"], "DRUGB": ["ACE inhibitors", "group", "114-127"]}
{"TEXT1": "Increased @DRUG$ symptoms lithium toxicity reported patients receiving ACE inhibitors therapy @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d640.s6.p6", "DRUGA": ["lithium", "drug", "25-31"], "DRUGB": ["lithium", "drug", "149-155"]}
{"TEXT1": "Increased serum lithium levels lithium symptoms @DRUG$ reported patients receiving @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d640.s6.p7", "DRUGA": ["lithium", "drug", "56-62"], "DRUGB": ["ACE inhibitors", "group", "114-127"]}
{"TEXT1": "Increased serum lithium levels lithium symptoms @DRUG$ reported patients receiving ACE inhibitors therapy @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d640.s6.p8", "DRUGA": ["lithium", "drug", "56-62"], "DRUGB": ["lithium", "drug", "149-155"]}
{"TEXT1": "Increased serum lithium levels lithium symptoms reported patients receiving @DRUG$ @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d640.s6.p9", "DRUGA": ["ACE inhibitors", "group", "114-127"], "DRUGB": ["lithium", "drug", "149-155"]}
{"TEXT1": "@DRUG$ used risk @DRUG$ increased", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d640.s8.p0", "DRUGA": ["diuretic", "group", "5-12"], "DRUGB": ["lithium", "drug", "40-46"]}
{"TEXT1": "important pharmacokinetic interactions occurred @DRUG$ administered @DRUG$ digoxin cimetidine", "LBL": "0", "ID": "DDI-DrugBank.d640.s9.p0", "DRUGA": ["UNIVASC", "brand", "81-87"], "DRUGB": ["hydrochlorothiazide", "drug", "128-146"]}
{"TEXT1": "important pharmacokinetic interactions occurred @DRUG$ administered hydrochlorothiazide @DRUG$ cimetidine", "LBL": "0", "ID": "DDI-DrugBank.d640.s9.p1", "DRUGA": ["UNIVASC", "brand", "81-87"], "DRUGB": ["digoxin", "drug", "149-155"]}
{"TEXT1": "important pharmacokinetic interactions occurred @DRUG$ administered hydrochlorothiazide digoxin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d640.s9.p2", "DRUGA": ["UNIVASC", "brand", "81-87"], "DRUGB": ["cimetidine", "drug", "161-170"]}
{"TEXT1": "important pharmacokinetic interactions occurred UNIVASC administered @DRUG$ @DRUG$ cimetidine", "LBL": "0", "ID": "DDI-DrugBank.d640.s9.p3", "DRUGA": ["hydrochlorothiazide", "drug", "128-146"], "DRUGB": ["digoxin", "drug", "149-155"]}
{"TEXT1": "important pharmacokinetic interactions occurred UNIVASC administered @DRUG$ digoxin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d640.s9.p4", "DRUGA": ["hydrochlorothiazide", "drug", "128-146"], "DRUGB": ["cimetidine", "drug", "161-170"]}
{"TEXT1": "important pharmacokinetic interactions occurred UNIVASC administered hydrochlorothiazide @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d640.s9.p5", "DRUGA": ["digoxin", "drug", "149-155"], "DRUGB": ["cimetidine", "drug", "161-170"]}
{"TEXT1": "@DRUG$ used clinical trials @DRUG$ diuretics H2 blockers digoxin oral hypoglycemic agents cholesterol lowering", "LBL": "0", "ID": "DDI-DrugBank.d640.s10.p0", "DRUGA": ["UNIVASC", "brand", "0-6"], "DRUGB": ["calcium-channel-blocking agents", "group", "63-93"]}
{"TEXT1": "@DRUG$ used clinical trials agents @DRUG$ H2 blockers digoxin cholesterol lowering", "LBL": "0", "ID": "DDI-DrugBank.d640.s10.p1", "DRUGA": ["UNIVASC", "brand", "0-6"], "DRUGB": ["diuretics", "group", "96-104"]}
{"TEXT1": "@DRUG$ used clinical trials agents diuretics @DRUG$ digoxin cholesterol lowering", "LBL": "0", "ID": "DDI-DrugBank.d640.s10.p2", "DRUGA": ["UNIVASC", "brand", "0-6"], "DRUGB": ["H2 blockers", "group", "107-117"]}
{"TEXT1": "@DRUG$ used clinical trials agents diuretics H2 blockers @DRUG$ cholesterol lowering", "LBL": "0", "ID": "DDI-DrugBank.d640.s10.p3", "DRUGA": ["UNIVASC", "brand", "0-6"], "DRUGB": ["digoxin", "drug", "120-126"]}
{"TEXT1": "@DRUG$ used clinical trials agents diuretics H2 blockers digoxin @DRUG$ cholesterol lowering", "LBL": "0", "ID": "DDI-DrugBank.d640.s10.p4", "DRUGA": ["UNIVASC", "brand", "0-6"], "DRUGB": ["hypoglycemic agents", "group", "134-152"]}
{"TEXT1": "UNIVASC used clinical trials @DRUG$ @DRUG$ H2 blockers digoxin oral hypoglycemic agents cholesterol lowering", "LBL": "0", "ID": "DDI-DrugBank.d640.s10.p5", "DRUGA": ["calcium-channel-blocking agents", "group", "63-93"], "DRUGB": ["diuretics", "group", "96-104"]}
{"TEXT1": "UNIVASC used clinical trials @DRUG$ diuretics @DRUG$ digoxin oral hypoglycemic agents cholesterol lowering", "LBL": "0", "ID": "DDI-DrugBank.d640.s10.p6", "DRUGA": ["calcium-channel-blocking agents", "group", "63-93"], "DRUGB": ["H2 blockers", "group", "107-117"]}
{"TEXT1": "UNIVASC used clinical trials @DRUG$ diuretics H2 blockers @DRUG$ oral hypoglycemic agents cholesterol lowering", "LBL": "0", "ID": "DDI-DrugBank.d640.s10.p7", "DRUGA": ["calcium-channel-blocking agents", "group", "63-93"], "DRUGB": ["digoxin", "drug", "120-126"]}
{"TEXT1": "UNIVASC used clinical trials @DRUG$ diuretics H2 blockers digoxin @DRUG$ cholesterol lowering agents", "LBL": "0", "ID": "DDI-DrugBank.d640.s10.p8", "DRUGA": ["calcium-channel-blocking agents", "group", "63-93"], "DRUGB": ["hypoglycemic agents", "group", "134-152"]}
{"TEXT1": "UNIVASC used clinical trials agents @DRUG$ @DRUG$ digoxin cholesterol lowering", "LBL": "0", "ID": "DDI-DrugBank.d640.s10.p9", "DRUGA": ["diuretics", "group", "96-104"], "DRUGB": ["H2 blockers", "group", "107-117"]}
{"TEXT1": "UNIVASC used clinical trials agents @DRUG$ H2 blockers @DRUG$ cholesterol lowering", "LBL": "0", "ID": "DDI-DrugBank.d640.s10.p10", "DRUGA": ["diuretics", "group", "96-104"], "DRUGB": ["digoxin", "drug", "120-126"]}
{"TEXT1": "UNIVASC used clinical trials agents @DRUG$ H2 blockers digoxin @DRUG$ cholesterol lowering", "LBL": "0", "ID": "DDI-DrugBank.d640.s10.p11", "DRUGA": ["diuretics", "group", "96-104"], "DRUGB": ["hypoglycemic agents", "group", "134-152"]}
{"TEXT1": "UNIVASC used clinical trials agents diuretics @DRUG$ @DRUG$ cholesterol lowering", "LBL": "0", "ID": "DDI-DrugBank.d640.s10.p12", "DRUGA": ["H2 blockers", "group", "107-117"], "DRUGB": ["digoxin", "drug", "120-126"]}
{"TEXT1": "UNIVASC used clinical trials agents diuretics @DRUG$ digoxin @DRUG$ cholesterol lowering", "LBL": "0", "ID": "DDI-DrugBank.d640.s10.p13", "DRUGA": ["H2 blockers", "group", "107-117"], "DRUGB": ["hypoglycemic agents", "group", "134-152"]}
{"TEXT1": "UNIVASC used clinical trials agents diuretics H2 blockers @DRUG$ @DRUG$ cholesterol lowering", "LBL": "0", "ID": "DDI-DrugBank.d640.s10.p14", "DRUGA": ["digoxin", "drug", "120-126"], "DRUGB": ["hypoglycemic agents", "group", "134-152"]}
{"TEXT1": "@DRUG$ following @DRUG$ NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "DDI-int", "ID": "DDI-DrugBank.d643.s0.p0", "DRUGA": ["Melatonin", "drug", "0-8"], "DRUGB": ["aspirin", "brand", "49-55"]}
{"TEXT1": "@DRUG$ following aspirin @DRUG$ lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "DDI-int", "ID": "DDI-DrugBank.d643.s0.p1", "DRUGA": ["Melatonin", "drug", "0-8"], "DRUGB": ["NSAIDs", "group", "67-72"]}
{"TEXT1": "@DRUG$ following aspirin NSAIDs lower @DRUG$ fluvoxamine oral melatonin increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p2", "DRUGA": ["Melatonin", "drug", "0-8"], "DRUGB": ["melatonin", "drug", "85-93"]}
{"TEXT1": "@DRUG$ following aspirin NSAIDs lower melatonin @DRUG$ oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "DDI-int", "ID": "DDI-DrugBank.d643.s0.p3", "DRUGA": ["Melatonin", "drug", "0-8"], "DRUGB": ["fluvoxamine", "drug", "104-114"]}
{"TEXT1": "@DRUG$ following aspirin NSAIDs lower melatonin fluvoxamine oral @DRUG$ increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p4", "DRUGA": ["Melatonin", "drug", "0-8"], "DRUGB": ["melatonin", "drug", "141-149"]}
{"TEXT1": "@DRUG$ following aspirin NSAIDs lower melatonin fluvoxamine oral increased @DRUG$ decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "DDI-int", "ID": "DDI-DrugBank.d643.s0.p5", "DRUGA": ["Melatonin", "drug", "0-8"], "DRUGB": ["beta blockers", "group", "188-200"]}
{"TEXT1": "@DRUG$ following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease @DRUG$ fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p6", "DRUGA": ["Melatonin", "drug", "0-8"], "DRUGB": ["melatonin", "drug", "216-224"]}
{"TEXT1": "@DRUG$ following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease @DRUG$ psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "DDI-int", "ID": "DDI-DrugBank.d643.s0.p7", "DRUGA": ["Melatonin", "drug", "0-8"], "DRUGB": ["fluoxetine", "drug", "235-244"]}
{"TEXT1": "@DRUG$ following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic @DRUG$ progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "DDI-int", "ID": "DDI-DrugBank.d643.s0.p8", "DRUGA": ["Melatonin", "drug", "0-8"], "DRUGB": ["progestin", "group", "299-307"]}
{"TEXT1": "@DRUG$ following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin @DRUG$ inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p9", "DRUGA": ["Melatonin", "drug", "0-8"], "DRUGB": ["melatonin", "drug", "330-338"]}
{"TEXT1": "@DRUG$ following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin @DRUG$ inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p10", "DRUGA": ["Melatonin", "drug", "0-8"], "DRUGB": ["progestin", "group", "345-353"]}
{"TEXT1": "@DRUG$ following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function @DRUG$ sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "DDI-int", "ID": "DDI-DrugBank.d643.s0.p11", "DRUGA": ["Melatonin", "drug", "0-8"], "DRUGB": ["benzodiazepenes", "group", "395-409"]}
{"TEXT1": "@DRUG$ following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence @DRUG$ corticosteroids interfere efficacy", "LBL": "DDI-int", "ID": "DDI-DrugBank.d643.s0.p12", "DRUGA": ["Melatonin", "drug", "0-8"], "DRUGB": ["corticosteroids", "group", "521-535"]}
{"TEXT1": "@DRUG$ following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids @DRUG$ interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p13", "DRUGA": ["Melatonin", "drug", "0-8"], "DRUGB": ["melatonin", "drug", "558-566"]}
{"TEXT1": "@DRUG$ following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids @DRUG$ interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p14", "DRUGA": ["Melatonin", "drug", "0-8"], "DRUGB": ["corticosteroids", "group", "572-586"]}
{"TEXT1": "@DRUG$ following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p15", "DRUGA": ["Melatonin", "drug", "0-8"], "DRUGB": ["corticosteroids", "group", "627-641"]}
{"TEXT1": "following @DRUG$ @DRUG$ lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p16", "DRUGA": ["aspirin", "brand", "49-55"], "DRUGB": ["NSAIDs", "group", "67-72"]}
{"TEXT1": "following @DRUG$ NSAIDs lower @DRUG$ fluvoxamine oral melatonin increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p17", "DRUGA": ["aspirin", "brand", "49-55"], "DRUGB": ["melatonin", "drug", "85-93"]}
{"TEXT1": "following @DRUG$ NSAIDs lower melatonin @DRUG$ oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p18", "DRUGA": ["aspirin", "brand", "49-55"], "DRUGB": ["fluvoxamine", "drug", "104-114"]}
{"TEXT1": "following @DRUG$ NSAIDs lower melatonin fluvoxamine oral @DRUG$ increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p19", "DRUGA": ["aspirin", "brand", "49-55"], "DRUGB": ["melatonin", "drug", "141-149"]}
{"TEXT1": "following @DRUG$ NSAIDs lower melatonin fluvoxamine oral increased @DRUG$ decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p20", "DRUGA": ["aspirin", "brand", "49-55"], "DRUGB": ["beta blockers", "group", "188-200"]}
{"TEXT1": "following @DRUG$ NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease @DRUG$ fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p21", "DRUGA": ["aspirin", "brand", "49-55"], "DRUGB": ["melatonin", "drug", "216-224"]}
{"TEXT1": "following @DRUG$ NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease @DRUG$ psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p22", "DRUGA": ["aspirin", "brand", "49-55"], "DRUGB": ["fluoxetine", "drug", "235-244"]}
{"TEXT1": "following @DRUG$ NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic @DRUG$ progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p23", "DRUGA": ["aspirin", "brand", "49-55"], "DRUGB": ["progestin", "group", "299-307"]}
{"TEXT1": "following @DRUG$ NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin @DRUG$ inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p24", "DRUGA": ["aspirin", "brand", "49-55"], "DRUGB": ["melatonin", "drug", "330-338"]}
{"TEXT1": "following @DRUG$ NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin @DRUG$ inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p25", "DRUGA": ["aspirin", "brand", "49-55"], "DRUGB": ["progestin", "group", "345-353"]}
{"TEXT1": "following @DRUG$ NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function @DRUG$ sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p26", "DRUGA": ["aspirin", "brand", "49-55"], "DRUGB": ["benzodiazepenes", "group", "395-409"]}
{"TEXT1": "following @DRUG$ NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence @DRUG$ corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p27", "DRUGA": ["aspirin", "brand", "49-55"], "DRUGB": ["corticosteroids", "group", "521-535"]}
{"TEXT1": "following @DRUG$ NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids @DRUG$ interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p28", "DRUGA": ["aspirin", "brand", "49-55"], "DRUGB": ["melatonin", "drug", "558-566"]}
{"TEXT1": "following @DRUG$ NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids @DRUG$ interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p29", "DRUGA": ["aspirin", "brand", "49-55"], "DRUGB": ["corticosteroids", "group", "572-586"]}
{"TEXT1": "following @DRUG$ NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p30", "DRUGA": ["aspirin", "brand", "49-55"], "DRUGB": ["corticosteroids", "group", "627-641"]}
{"TEXT1": "following aspirin @DRUG$ lower @DRUG$ fluvoxamine oral melatonin increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p31", "DRUGA": ["NSAIDs", "group", "67-72"], "DRUGB": ["melatonin", "drug", "85-93"]}
{"TEXT1": "following aspirin @DRUG$ lower melatonin @DRUG$ oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p32", "DRUGA": ["NSAIDs", "group", "67-72"], "DRUGB": ["fluvoxamine", "drug", "104-114"]}
{"TEXT1": "following aspirin @DRUG$ lower melatonin fluvoxamine oral @DRUG$ increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p33", "DRUGA": ["NSAIDs", "group", "67-72"], "DRUGB": ["melatonin", "drug", "141-149"]}
{"TEXT1": "following aspirin @DRUG$ lower melatonin fluvoxamine oral increased @DRUG$ decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p34", "DRUGA": ["NSAIDs", "group", "67-72"], "DRUGB": ["beta blockers", "group", "188-200"]}
{"TEXT1": "following aspirin @DRUG$ lower melatonin fluvoxamine oral increased beta blockers decrease @DRUG$ fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p35", "DRUGA": ["NSAIDs", "group", "67-72"], "DRUGB": ["melatonin", "drug", "216-224"]}
{"TEXT1": "following aspirin @DRUG$ lower melatonin fluvoxamine oral increased beta blockers decrease @DRUG$ psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p36", "DRUGA": ["NSAIDs", "group", "67-72"], "DRUGB": ["fluoxetine", "drug", "235-244"]}
{"TEXT1": "following aspirin @DRUG$ lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic @DRUG$ progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p37", "DRUGA": ["NSAIDs", "group", "67-72"], "DRUGB": ["progestin", "group", "299-307"]}
{"TEXT1": "following aspirin @DRUG$ lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin @DRUG$ inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p38", "DRUGA": ["NSAIDs", "group", "67-72"], "DRUGB": ["melatonin", "drug", "330-338"]}
{"TEXT1": "following aspirin @DRUG$ lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin @DRUG$ inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p39", "DRUGA": ["NSAIDs", "group", "67-72"], "DRUGB": ["progestin", "group", "345-353"]}
{"TEXT1": "following aspirin @DRUG$ lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function @DRUG$ sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p40", "DRUGA": ["NSAIDs", "group", "67-72"], "DRUGB": ["benzodiazepenes", "group", "395-409"]}
{"TEXT1": "following aspirin @DRUG$ lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence @DRUG$ corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p41", "DRUGA": ["NSAIDs", "group", "67-72"], "DRUGB": ["corticosteroids", "group", "521-535"]}
{"TEXT1": "following aspirin @DRUG$ lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids @DRUG$ interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p42", "DRUGA": ["NSAIDs", "group", "67-72"], "DRUGB": ["melatonin", "drug", "558-566"]}
{"TEXT1": "following aspirin @DRUG$ lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids @DRUG$ interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p43", "DRUGA": ["NSAIDs", "group", "67-72"], "DRUGB": ["corticosteroids", "group", "572-586"]}
{"TEXT1": "following aspirin @DRUG$ lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p44", "DRUGA": ["NSAIDs", "group", "67-72"], "DRUGB": ["corticosteroids", "group", "627-641"]}
{"TEXT1": "following aspirin NSAIDs lower @DRUG$ @DRUG$ oral melatonin increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p45", "DRUGA": ["melatonin", "drug", "85-93"], "DRUGB": ["fluvoxamine", "drug", "104-114"]}
{"TEXT1": "following aspirin NSAIDs lower @DRUG$ fluvoxamine oral @DRUG$ increased beta blockers decrease melatonin fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p46", "DRUGA": ["melatonin", "drug", "85-93"], "DRUGB": ["melatonin", "drug", "141-149"]}
{"TEXT1": "following aspirin NSAIDs lower @DRUG$ fluvoxamine oral melatonin increased @DRUG$ decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p47", "DRUGA": ["melatonin", "drug", "85-93"], "DRUGB": ["beta blockers", "group", "188-200"]}
{"TEXT1": "following aspirin NSAIDs lower @DRUG$ fluvoxamine oral melatonin increased beta blockers decrease @DRUG$ fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p48", "DRUGA": ["melatonin", "drug", "85-93"], "DRUGB": ["melatonin", "drug", "216-224"]}
{"TEXT1": "following aspirin NSAIDs lower @DRUG$ fluvoxamine oral melatonin increased beta blockers decrease @DRUG$ psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p49", "DRUGA": ["melatonin", "drug", "85-93"], "DRUGB": ["fluoxetine", "drug", "235-244"]}
{"TEXT1": "following aspirin NSAIDs lower @DRUG$ fluvoxamine oral melatonin increased beta blockers decrease fluoxetine psychotic @DRUG$ progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p50", "DRUGA": ["melatonin", "drug", "85-93"], "DRUGB": ["progestin", "group", "299-307"]}
{"TEXT1": "following aspirin NSAIDs lower @DRUG$ fluvoxamine oral melatonin increased beta blockers decrease fluoxetine psychotic progestin @DRUG$ inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p51", "DRUGA": ["melatonin", "drug", "85-93"], "DRUGB": ["melatonin", "drug", "330-338"]}
{"TEXT1": "following aspirin NSAIDs lower @DRUG$ fluvoxamine oral melatonin increased beta blockers decrease fluoxetine psychotic progestin @DRUG$ inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p52", "DRUGA": ["melatonin", "drug", "85-93"], "DRUGB": ["progestin", "group", "345-353"]}
{"TEXT1": "following aspirin NSAIDs lower @DRUG$ fluvoxamine oral melatonin increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function @DRUG$ sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p53", "DRUGA": ["melatonin", "drug", "85-93"], "DRUGB": ["benzodiazepenes", "group", "395-409"]}
{"TEXT1": "following aspirin NSAIDs lower @DRUG$ fluvoxamine oral melatonin increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence @DRUG$ corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p54", "DRUGA": ["melatonin", "drug", "85-93"], "DRUGB": ["corticosteroids", "group", "521-535"]}
{"TEXT1": "following aspirin NSAIDs lower @DRUG$ fluvoxamine oral melatonin increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids @DRUG$ interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p55", "DRUGA": ["melatonin", "drug", "85-93"], "DRUGB": ["melatonin", "drug", "558-566"]}
{"TEXT1": "following aspirin NSAIDs lower @DRUG$ fluvoxamine oral melatonin increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids @DRUG$ interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p56", "DRUGA": ["melatonin", "drug", "85-93"], "DRUGB": ["corticosteroids", "group", "572-586"]}
{"TEXT1": "following aspirin NSAIDs lower @DRUG$ fluvoxamine oral melatonin increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p57", "DRUGA": ["melatonin", "drug", "85-93"], "DRUGB": ["corticosteroids", "group", "627-641"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin @DRUG$ oral @DRUG$ increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p58", "DRUGA": ["fluvoxamine", "drug", "104-114"], "DRUGB": ["melatonin", "drug", "141-149"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin @DRUG$ oral increased @DRUG$ decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p59", "DRUGA": ["fluvoxamine", "drug", "104-114"], "DRUGB": ["beta blockers", "group", "188-200"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin @DRUG$ oral increased beta blockers decrease @DRUG$ fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p60", "DRUGA": ["fluvoxamine", "drug", "104-114"], "DRUGB": ["melatonin", "drug", "216-224"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin @DRUG$ oral increased beta blockers decrease @DRUG$ psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p61", "DRUGA": ["fluvoxamine", "drug", "104-114"], "DRUGB": ["fluoxetine", "drug", "235-244"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin @DRUG$ oral increased beta blockers decrease fluoxetine psychotic @DRUG$ progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p62", "DRUGA": ["fluvoxamine", "drug", "104-114"], "DRUGB": ["progestin", "group", "299-307"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin @DRUG$ oral increased beta blockers decrease fluoxetine psychotic progestin @DRUG$ inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p63", "DRUGA": ["fluvoxamine", "drug", "104-114"], "DRUGB": ["melatonin", "drug", "330-338"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin @DRUG$ oral increased beta blockers decrease fluoxetine psychotic progestin @DRUG$ inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p64", "DRUGA": ["fluvoxamine", "drug", "104-114"], "DRUGB": ["progestin", "group", "345-353"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin @DRUG$ oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function @DRUG$ sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p65", "DRUGA": ["fluvoxamine", "drug", "104-114"], "DRUGB": ["benzodiazepenes", "group", "395-409"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin @DRUG$ oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence @DRUG$ corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p66", "DRUGA": ["fluvoxamine", "drug", "104-114"], "DRUGB": ["corticosteroids", "group", "521-535"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin @DRUG$ oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids @DRUG$ interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p67", "DRUGA": ["fluvoxamine", "drug", "104-114"], "DRUGB": ["melatonin", "drug", "558-566"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin @DRUG$ oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids @DRUG$ interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p68", "DRUGA": ["fluvoxamine", "drug", "104-114"], "DRUGB": ["corticosteroids", "group", "572-586"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin @DRUG$ oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p69", "DRUGA": ["fluvoxamine", "drug", "104-114"], "DRUGB": ["corticosteroids", "group", "627-641"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral @DRUG$ increased @DRUG$ decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p70", "DRUGA": ["melatonin", "drug", "141-149"], "DRUGB": ["beta blockers", "group", "188-200"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral @DRUG$ increased beta blockers decrease @DRUG$ fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p71", "DRUGA": ["melatonin", "drug", "141-149"], "DRUGB": ["melatonin", "drug", "216-224"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral @DRUG$ increased beta blockers decrease @DRUG$ psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p72", "DRUGA": ["melatonin", "drug", "141-149"], "DRUGB": ["fluoxetine", "drug", "235-244"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral @DRUG$ increased beta blockers decrease fluoxetine psychotic @DRUG$ progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p73", "DRUGA": ["melatonin", "drug", "141-149"], "DRUGB": ["progestin", "group", "299-307"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral @DRUG$ increased beta blockers decrease fluoxetine psychotic progestin @DRUG$ inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p74", "DRUGA": ["melatonin", "drug", "141-149"], "DRUGB": ["melatonin", "drug", "330-338"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral @DRUG$ increased beta blockers decrease fluoxetine psychotic progestin @DRUG$ inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p75", "DRUGA": ["melatonin", "drug", "141-149"], "DRUGB": ["progestin", "group", "345-353"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral @DRUG$ increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function @DRUG$ sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p76", "DRUGA": ["melatonin", "drug", "141-149"], "DRUGB": ["benzodiazepenes", "group", "395-409"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral @DRUG$ increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence @DRUG$ corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p77", "DRUGA": ["melatonin", "drug", "141-149"], "DRUGB": ["corticosteroids", "group", "521-535"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral @DRUG$ increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids @DRUG$ interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p78", "DRUGA": ["melatonin", "drug", "141-149"], "DRUGB": ["melatonin", "drug", "558-566"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral @DRUG$ increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids @DRUG$ interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p79", "DRUGA": ["melatonin", "drug", "141-149"], "DRUGB": ["corticosteroids", "group", "572-586"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral @DRUG$ increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p80", "DRUGA": ["melatonin", "drug", "141-149"], "DRUGB": ["corticosteroids", "group", "627-641"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased @DRUG$ decrease @DRUG$ fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p81", "DRUGA": ["beta blockers", "group", "188-200"], "DRUGB": ["melatonin", "drug", "216-224"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased @DRUG$ decrease @DRUG$ psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p82", "DRUGA": ["beta blockers", "group", "188-200"], "DRUGB": ["fluoxetine", "drug", "235-244"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased @DRUG$ decrease fluoxetine psychotic @DRUG$ progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p83", "DRUGA": ["beta blockers", "group", "188-200"], "DRUGB": ["progestin", "group", "299-307"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased @DRUG$ decrease fluoxetine psychotic progestin @DRUG$ inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p84", "DRUGA": ["beta blockers", "group", "188-200"], "DRUGB": ["melatonin", "drug", "330-338"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased @DRUG$ decrease fluoxetine psychotic progestin @DRUG$ inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p85", "DRUGA": ["beta blockers", "group", "188-200"], "DRUGB": ["progestin", "group", "345-353"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased @DRUG$ decrease fluoxetine psychotic progestin inhibit ovarian function @DRUG$ sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p86", "DRUGA": ["beta blockers", "group", "188-200"], "DRUGB": ["benzodiazepenes", "group", "395-409"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased @DRUG$ decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence @DRUG$ corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p87", "DRUGA": ["beta blockers", "group", "188-200"], "DRUGB": ["corticosteroids", "group", "521-535"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased @DRUG$ decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids @DRUG$ interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p88", "DRUGA": ["beta blockers", "group", "188-200"], "DRUGB": ["melatonin", "drug", "558-566"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased @DRUG$ decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids @DRUG$ interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p89", "DRUGA": ["beta blockers", "group", "188-200"], "DRUGB": ["corticosteroids", "group", "572-586"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased @DRUG$ decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p90", "DRUGA": ["beta blockers", "group", "188-200"], "DRUGB": ["corticosteroids", "group", "627-641"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease @DRUG$ @DRUG$ psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p91", "DRUGA": ["melatonin", "drug", "216-224"], "DRUGB": ["fluoxetine", "drug", "235-244"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease @DRUG$ fluoxetine psychotic @DRUG$ progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p92", "DRUGA": ["melatonin", "drug", "216-224"], "DRUGB": ["progestin", "group", "299-307"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease @DRUG$ fluoxetine psychotic progestin @DRUG$ inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p93", "DRUGA": ["melatonin", "drug", "216-224"], "DRUGB": ["melatonin", "drug", "330-338"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease @DRUG$ fluoxetine psychotic progestin @DRUG$ inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p94", "DRUGA": ["melatonin", "drug", "216-224"], "DRUGB": ["progestin", "group", "345-353"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease @DRUG$ fluoxetine psychotic progestin inhibit ovarian function @DRUG$ sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p95", "DRUGA": ["melatonin", "drug", "216-224"], "DRUGB": ["benzodiazepenes", "group", "395-409"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease @DRUG$ fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence @DRUG$ corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p96", "DRUGA": ["melatonin", "drug", "216-224"], "DRUGB": ["corticosteroids", "group", "521-535"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease @DRUG$ fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids @DRUG$ interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p97", "DRUGA": ["melatonin", "drug", "216-224"], "DRUGB": ["melatonin", "drug", "558-566"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease @DRUG$ fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids @DRUG$ interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p98", "DRUGA": ["melatonin", "drug", "216-224"], "DRUGB": ["corticosteroids", "group", "572-586"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease @DRUG$ fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p99", "DRUGA": ["melatonin", "drug", "216-224"], "DRUGB": ["corticosteroids", "group", "627-641"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease @DRUG$ psychotic @DRUG$ progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p100", "DRUGA": ["fluoxetine", "drug", "235-244"], "DRUGB": ["progestin", "group", "299-307"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease @DRUG$ psychotic progestin @DRUG$ inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p101", "DRUGA": ["fluoxetine", "drug", "235-244"], "DRUGB": ["melatonin", "drug", "330-338"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease @DRUG$ psychotic progestin @DRUG$ inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p102", "DRUGA": ["fluoxetine", "drug", "235-244"], "DRUGB": ["progestin", "group", "345-353"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease @DRUG$ psychotic progestin inhibit ovarian function @DRUG$ sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p103", "DRUGA": ["fluoxetine", "drug", "235-244"], "DRUGB": ["benzodiazepenes", "group", "395-409"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease @DRUG$ psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence @DRUG$ corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p104", "DRUGA": ["fluoxetine", "drug", "235-244"], "DRUGB": ["corticosteroids", "group", "521-535"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease @DRUG$ psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids @DRUG$ interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p105", "DRUGA": ["fluoxetine", "drug", "235-244"], "DRUGB": ["melatonin", "drug", "558-566"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease @DRUG$ psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids @DRUG$ interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p106", "DRUGA": ["fluoxetine", "drug", "235-244"], "DRUGB": ["corticosteroids", "group", "572-586"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease @DRUG$ psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p107", "DRUGA": ["fluoxetine", "drug", "235-244"], "DRUGB": ["corticosteroids", "group", "627-641"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic @DRUG$ @DRUG$ progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p108", "DRUGA": ["progestin", "group", "299-307"], "DRUGB": ["melatonin", "drug", "330-338"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic @DRUG$ @DRUG$ inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p109", "DRUGA": ["progestin", "group", "299-307"], "DRUGB": ["progestin", "group", "345-353"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic @DRUG$ progestin inhibit ovarian function @DRUG$ sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p110", "DRUGA": ["progestin", "group", "299-307"], "DRUGB": ["benzodiazepenes", "group", "395-409"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic @DRUG$ progestin inhibit ovarian function sedating drugs result additive sedation incidence @DRUG$ corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p111", "DRUGA": ["progestin", "group", "299-307"], "DRUGB": ["corticosteroids", "group", "521-535"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic @DRUG$ progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids @DRUG$ interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p112", "DRUGA": ["progestin", "group", "299-307"], "DRUGB": ["melatonin", "drug", "558-566"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic @DRUG$ progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids @DRUG$ interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p113", "DRUGA": ["progestin", "group", "299-307"], "DRUGB": ["corticosteroids", "group", "572-586"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic @DRUG$ progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p114", "DRUGA": ["progestin", "group", "299-307"], "DRUGB": ["corticosteroids", "group", "627-641"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin @DRUG$ @DRUG$ inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d643.s0.p115", "DRUGA": ["melatonin", "drug", "330-338"], "DRUGB": ["progestin", "group", "345-353"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin @DRUG$ inhibit ovarian function @DRUG$ sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p116", "DRUGA": ["melatonin", "drug", "330-338"], "DRUGB": ["benzodiazepenes", "group", "395-409"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin @DRUG$ inhibit ovarian function sedating drugs result additive sedation incidence @DRUG$ corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p117", "DRUGA": ["melatonin", "drug", "330-338"], "DRUGB": ["corticosteroids", "group", "521-535"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin @DRUG$ inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids @DRUG$ interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p118", "DRUGA": ["melatonin", "drug", "330-338"], "DRUGB": ["melatonin", "drug", "558-566"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin @DRUG$ inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids @DRUG$ interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p119", "DRUGA": ["melatonin", "drug", "330-338"], "DRUGB": ["corticosteroids", "group", "572-586"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin @DRUG$ inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p120", "DRUGA": ["melatonin", "drug", "330-338"], "DRUGB": ["corticosteroids", "group", "627-641"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin @DRUG$ inhibit ovarian function @DRUG$ sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p121", "DRUGA": ["progestin", "group", "345-353"], "DRUGB": ["benzodiazepenes", "group", "395-409"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin @DRUG$ inhibit ovarian function sedating drugs result additive sedation incidence @DRUG$ corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p122", "DRUGA": ["progestin", "group", "345-353"], "DRUGB": ["corticosteroids", "group", "521-535"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin @DRUG$ inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids @DRUG$ interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p123", "DRUGA": ["progestin", "group", "345-353"], "DRUGB": ["melatonin", "drug", "558-566"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin @DRUG$ inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids @DRUG$ interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p124", "DRUGA": ["progestin", "group", "345-353"], "DRUGB": ["corticosteroids", "group", "572-586"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin @DRUG$ inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p125", "DRUGA": ["progestin", "group", "345-353"], "DRUGB": ["corticosteroids", "group", "627-641"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function @DRUG$ sedating drugs result additive sedation incidence @DRUG$ corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p126", "DRUGA": ["benzodiazepenes", "group", "395-409"], "DRUGB": ["corticosteroids", "group", "521-535"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function @DRUG$ sedating drugs result additive sedation incidence corticosteroids @DRUG$ interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p127", "DRUGA": ["benzodiazepenes", "group", "395-409"], "DRUGB": ["melatonin", "drug", "558-566"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function @DRUG$ sedating drugs result additive sedation incidence corticosteroids @DRUG$ interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p128", "DRUGA": ["benzodiazepenes", "group", "395-409"], "DRUGB": ["corticosteroids", "group", "572-586"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function @DRUG$ sedating drugs result additive sedation incidence corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p129", "DRUGA": ["benzodiazepenes", "group", "395-409"], "DRUGB": ["corticosteroids", "group", "627-641"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence @DRUG$ @DRUG$ corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p130", "DRUGA": ["corticosteroids", "group", "521-535"], "DRUGB": ["melatonin", "drug", "558-566"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence @DRUG$ @DRUG$ interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p131", "DRUGA": ["corticosteroids", "group", "521-535"], "DRUGB": ["corticosteroids", "group", "572-586"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence @DRUG$ corticosteroids interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p132", "DRUGA": ["corticosteroids", "group", "521-535"], "DRUGB": ["corticosteroids", "group", "627-641"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids @DRUG$ @DRUG$ interfere efficacy", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d643.s0.p133", "DRUGA": ["melatonin", "drug", "558-566"], "DRUGB": ["corticosteroids", "group", "572-586"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids @DRUG$ interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p134", "DRUGA": ["melatonin", "drug", "558-566"], "DRUGB": ["corticosteroids", "group", "627-641"]}
{"TEXT1": "following aspirin NSAIDs lower melatonin fluvoxamine oral increased beta blockers decrease fluoxetine psychotic progestin inhibit ovarian function sedating drugs result additive sedation incidence corticosteroids @DRUG$ interfere efficacy", "LBL": "0", "ID": "DDI-DrugBank.d643.s0.p135", "DRUGA": ["corticosteroids", "group", "572-586"], "DRUGB": ["corticosteroids", "group", "627-641"]}
{"TEXT1": "Drugs Affecting Hepatic Metabolism metabolism pharmacokinetics @DRUG$ Orally Disintegrating Tablets induction drug", "LBL": "0", "ID": "DDI-DrugBank.d742.s2.p0", "DRUGA": ["REMERON SolTab", "brand", "74-87"], "DRUGB": ["mirtazapine", "drug", "93-103"]}
{"TEXT1": "in vitro studies shown @DRUG$ not potent enzymes indication @DRUG$ likely to significant inhibitory metabolism drugs substrates concomitant REMERON SolTab metabolized studied", "LBL": "0", "ID": "DDI-DrugBank.d742.s5.p0", "DRUGA": ["mirtazapine", "drug", "39-49"], "DRUGB": ["mirtazapine", "drug", "121-131"]}
{"TEXT1": "in vitro studies shown @DRUG$ not potent enzymes indication mirtazapine likely to significant inhibitory metabolism drugs substrates concomitant @DRUG$ metabolized studied", "LBL": "0", "ID": "DDI-DrugBank.d742.s5.p1", "DRUGA": ["mirtazapine", "drug", "39-49"], "DRUGB": ["REMERON SolTab", "brand", "309-322"]}
{"TEXT1": "in vitro studies shown mirtazapine not potent enzymes indication @DRUG$ likely to significant inhibitory metabolism drugs substrates concomitant @DRUG$ metabolized studied", "LBL": "0", "ID": "DDI-DrugBank.d742.s5.p2", "DRUGA": ["mirtazapine", "drug", "121-131"], "DRUGB": ["REMERON SolTab", "brand", "309-322"]}
{"TEXT1": "Concomitant administration @DRUG$ 60 minimal effect plasma levels mirtazapine healthy subjects male", "LBL": "0", "ID": "DDI-DrugBank.d742.s7.p0", "DRUGA": ["Alcohol", "drug", "0-6"], "DRUGB": ["alcohol", "drug", "39-45"]}
{"TEXT1": "Concomitant administration alcohol 60 minimal effect plasma levels @DRUG$ healthy subjects male", "LBL": "0", "ID": "DDI-DrugBank.d742.s7.p1", "DRUGA": ["Alcohol", "drug", "0-6"], "DRUGB": ["mirtazapine", "drug", "109-119"]}
{"TEXT1": "Concomitant administration @DRUG$ 60 minimal effect plasma levels @DRUG$ healthy subjects male", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d742.s7.p2", "DRUGA": ["alcohol", "drug", "39-45"], "DRUGB": ["mirtazapine", "drug", "109-119"]}
{"TEXT1": "impairment cognitive motor skills @DRUG$ shown to additive @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d742.s8.p0", "DRUGA": ["REMERON", "brand", "66-72"], "DRUGB": ["alcohol", "drug", "126-132"]}
{"TEXT1": "patients to @DRUG$ taking @DRUG$ Concomitant administration diazepam minimal effect plasma levels mirtazapine healthy subjects", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d742.s9.p0", "DRUGA": ["alcohol", "drug", "49-55"], "DRUGB": ["REMERON SolTab", "brand", "70-83"]}
{"TEXT1": "patients to @DRUG$ taking REMERON SolTab Concomitant administration diazepam minimal effect plasma levels mirtazapine healthy subjects", "LBL": "0", "ID": "DDI-DrugBank.d742.s9.p1", "DRUGA": ["alcohol", "drug", "49-55"], "DRUGB": ["Diazepam", "drug", "86-93"]}
{"TEXT1": "patients to @DRUG$ taking REMERON SolTab Concomitant @DRUG$ minimal effect plasma levels mirtazapine healthy subjects", "LBL": "0", "ID": "DDI-DrugBank.d742.s9.p2", "DRUGA": ["alcohol", "drug", "49-55"], "DRUGB": ["diazepam", "drug", "126-133"]}
{"TEXT1": "patients to @DRUG$ taking REMERON SolTab Concomitant administration diazepam minimal effect plasma levels @DRUG$ healthy subjects", "LBL": "0", "ID": "DDI-DrugBank.d742.s9.p3", "DRUGA": ["alcohol", "drug", "49-55"], "DRUGB": ["mirtazapine", "drug", "184-194"]}
{"TEXT1": "patients to alcohol taking @DRUG$ Concomitant administration diazepam minimal effect plasma levels mirtazapine healthy subjects", "LBL": "0", "ID": "DDI-DrugBank.d742.s9.p4", "DRUGA": ["REMERON SolTab", "brand", "70-83"], "DRUGB": ["Diazepam", "drug", "86-93"]}
{"TEXT1": "patients to alcohol taking @DRUG$ Concomitant @DRUG$ minimal effect plasma levels mirtazapine healthy subjects", "LBL": "0", "ID": "DDI-DrugBank.d742.s9.p5", "DRUGA": ["REMERON SolTab", "brand", "70-83"], "DRUGB": ["diazepam", "drug", "126-133"]}
{"TEXT1": "patients to alcohol taking @DRUG$ Concomitant administration diazepam minimal effect plasma levels @DRUG$ healthy subjects", "LBL": "0", "ID": "DDI-DrugBank.d742.s9.p6", "DRUGA": ["REMERON SolTab", "brand", "70-83"], "DRUGB": ["mirtazapine", "drug", "184-194"]}
{"TEXT1": "patients to alcohol taking REMERON SolTab Concomitant @DRUG$ minimal effect plasma levels mirtazapine healthy subjects", "LBL": "0", "ID": "DDI-DrugBank.d742.s9.p7", "DRUGA": ["Diazepam", "drug", "86-93"], "DRUGB": ["diazepam", "drug", "126-133"]}
{"TEXT1": "patients to alcohol taking REMERON SolTab Concomitant administration diazepam minimal effect plasma levels @DRUG$ healthy subjects", "LBL": "0", "ID": "DDI-DrugBank.d742.s9.p8", "DRUGA": ["Diazepam", "drug", "86-93"], "DRUGB": ["mirtazapine", "drug", "184-194"]}
{"TEXT1": "patients to alcohol taking REMERON SolTab Concomitant @DRUG$ minimal effect plasma levels @DRUG$ healthy subjects", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d742.s9.p9", "DRUGA": ["diazepam", "drug", "126-133"], "DRUGB": ["mirtazapine", "drug", "184-194"]}
{"TEXT1": "impairment motor skills @DRUG$ shown to additive caused @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d742.s10.p0", "DRUGA": ["REMERON", "brand", "52-58"], "DRUGB": ["diazepam", "drug", "111-118"]}
{"TEXT1": "patients to @DRUG$ similar drugs taking @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d742.s11.p0", "DRUGA": ["diazepam", "drug", "49-56"], "DRUGB": ["REMERON SolTab", "brand", "95-108"]}
{"TEXT1": "Interaction @DRUG$ USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS PHENOTHIAZINES TRANQUILIZERS TRICYCLIC ANTIDEPRESSANTS", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p0", "DRUGA": ["Central Nervous System Depressants", "group", "23-56"], "DRUGB": ["MEPERIDINE", "drug", "59-68"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING @DRUG$ GENERAL ANESTHETICS PHENOTHIAZINES TRANQUILIZERS TRICYCLIC ANTIDEPRESSANTS", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p1", "DRUGA": ["Central Nervous System Depressants", "group", "23-56"], "DRUGB": ["NARCOTIC ANALGESICS", "group", "175-193"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS @DRUG$ PHENOTHIAZINES TRANQUILIZERS TRICYCLIC ANTIDEPRESSANTS", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p2", "DRUGA": ["Central Nervous System Depressants", "group", "23-56"], "DRUGB": ["ANESTHETICS", "group", "204-214"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS @DRUG$ TRANQUILIZERS TRICYCLIC ANTIDEPRESSANTS", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p3", "DRUGA": ["Central Nervous System Depressants", "group", "23-56"], "DRUGB": ["PHENOTHIAZINES", "group", "217-230"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS PHENOTHIAZINES @DRUG$ TRICYCLIC ANTIDEPRESSANTS", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p4", "DRUGA": ["Central Nervous System Depressants", "group", "23-56"], "DRUGB": ["TRANQUILIZERS", "group", "239-251"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS PHENOTHIAZINES TRANQUILIZERS @DRUG$ TRICYCLIC ANTIDEPRESSANTS", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p5", "DRUGA": ["Central Nervous System Depressants", "group", "23-56"], "DRUGB": ["SEDATIVE-HYPNOTICS", "group", "254-271"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS PHENOTHIAZINES TRANQUILIZERS TRICYCLIC ANTIDEPRESSANTS", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p6", "DRUGA": ["Central Nervous System Depressants", "group", "23-56"], "DRUGB": ["BARBITURATES", "group", "284-295"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS PHENOTHIAZINES TRANQUILIZERS @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p7", "DRUGA": ["Central Nervous System Depressants", "group", "23-56"], "DRUGB": ["TRICYCLIC ANTIDEPRESSANTS", "group", "299-323"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS PHENOTHIAZINES TRANQUILIZERS TRICYCLIC ANTIDEPRESSANTS @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p8", "DRUGA": ["Central Nervous System Depressants", "group", "23-56"], "DRUGB": ["CNS DEPRESSANTS", "group", "335-349"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS PHENOTHIAZINES TRANQUILIZERS TRICYCLIC ANTIDEPRESSANTS", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p9", "DRUGA": ["Central Nervous System Depressants", "group", "23-56"], "DRUGB": ["ALCOHOL", "drug", "362-368"]}
{"TEXT1": "Interaction @DRUG$ USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING @DRUG$ GENERAL ANESTHETICS PHENOTHIAZINES TRANQUILIZERS TRICYCLIC ANTIDEPRESSANTS", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d703.s0.p10", "DRUGA": ["MEPERIDINE", "drug", "59-68"], "DRUGB": ["NARCOTIC ANALGESICS", "group", "175-193"]}
{"TEXT1": "Interaction @DRUG$ USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS @DRUG$ PHENOTHIAZINES TRANQUILIZERS TRICYCLIC ANTIDEPRESSANTS", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d703.s0.p11", "DRUGA": ["MEPERIDINE", "drug", "59-68"], "DRUGB": ["ANESTHETICS", "group", "204-214"]}
{"TEXT1": "Interaction @DRUG$ USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS @DRUG$ TRANQUILIZERS TRICYCLIC ANTIDEPRESSANTS", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d703.s0.p12", "DRUGA": ["MEPERIDINE", "drug", "59-68"], "DRUGB": ["PHENOTHIAZINES", "group", "217-230"]}
{"TEXT1": "Interaction @DRUG$ USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS PHENOTHIAZINES @DRUG$ TRICYCLIC ANTIDEPRESSANTS", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d703.s0.p13", "DRUGA": ["MEPERIDINE", "drug", "59-68"], "DRUGB": ["TRANQUILIZERS", "group", "239-251"]}
{"TEXT1": "Interaction @DRUG$ USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS PHENOTHIAZINES TRANQUILIZERS @DRUG$ TRICYCLIC ANTIDEPRESSANTS", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d703.s0.p14", "DRUGA": ["MEPERIDINE", "drug", "59-68"], "DRUGB": ["SEDATIVE-HYPNOTICS", "group", "254-271"]}
{"TEXT1": "Interaction @DRUG$ USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS PHENOTHIAZINES TRANQUILIZERS TRICYCLIC ANTIDEPRESSANTS", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d703.s0.p15", "DRUGA": ["MEPERIDINE", "drug", "59-68"], "DRUGB": ["BARBITURATES", "group", "284-295"]}
{"TEXT1": "Interaction @DRUG$ USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS PHENOTHIAZINES TRANQUILIZERS @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d703.s0.p16", "DRUGA": ["MEPERIDINE", "drug", "59-68"], "DRUGB": ["TRICYCLIC ANTIDEPRESSANTS", "group", "299-323"]}
{"TEXT1": "Interaction @DRUG$ USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS PHENOTHIAZINES TRANQUILIZERS TRICYCLIC ANTIDEPRESSANTS @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d703.s0.p17", "DRUGA": ["MEPERIDINE", "drug", "59-68"], "DRUGB": ["CNS DEPRESSANTS", "group", "335-349"]}
{"TEXT1": "Interaction @DRUG$ USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS PHENOTHIAZINES TRANQUILIZERS TRICYCLIC ANTIDEPRESSANTS", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d703.s0.p18", "DRUGA": ["MEPERIDINE", "drug", "59-68"], "DRUGB": ["ALCOHOL", "drug", "362-368"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING @DRUG$ @DRUG$ PHENOTHIAZINES TRANQUILIZERS TRICYCLIC ANTIDEPRESSANTS", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p19", "DRUGA": ["NARCOTIC ANALGESICS", "group", "175-193"], "DRUGB": ["ANESTHETICS", "group", "204-214"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING @DRUG$ GENERAL ANESTHETICS @DRUG$ TRANQUILIZERS TRICYCLIC ANTIDEPRESSANTS", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p20", "DRUGA": ["NARCOTIC ANALGESICS", "group", "175-193"], "DRUGB": ["PHENOTHIAZINES", "group", "217-230"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING @DRUG$ GENERAL ANESTHETICS PHENOTHIAZINES @DRUG$ TRICYCLIC ANTIDEPRESSANTS", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p21", "DRUGA": ["NARCOTIC ANALGESICS", "group", "175-193"], "DRUGB": ["TRANQUILIZERS", "group", "239-251"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING @DRUG$ GENERAL ANESTHETICS PHENOTHIAZINES TRANQUILIZERS @DRUG$ TRICYCLIC ANTIDEPRESSANTS", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p22", "DRUGA": ["NARCOTIC ANALGESICS", "group", "175-193"], "DRUGB": ["SEDATIVE-HYPNOTICS", "group", "254-271"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING @DRUG$ GENERAL ANESTHETICS PHENOTHIAZINES TRANQUILIZERS TRICYCLIC ANTIDEPRESSANTS", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p23", "DRUGA": ["NARCOTIC ANALGESICS", "group", "175-193"], "DRUGB": ["BARBITURATES", "group", "284-295"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING @DRUG$ GENERAL ANESTHETICS PHENOTHIAZINES TRANQUILIZERS @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p24", "DRUGA": ["NARCOTIC ANALGESICS", "group", "175-193"], "DRUGB": ["TRICYCLIC ANTIDEPRESSANTS", "group", "299-323"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING @DRUG$ GENERAL ANESTHETICS PHENOTHIAZINES TRANQUILIZERS TRICYCLIC ANTIDEPRESSANTS @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p25", "DRUGA": ["NARCOTIC ANALGESICS", "group", "175-193"], "DRUGB": ["CNS DEPRESSANTS", "group", "335-349"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING @DRUG$ GENERAL ANESTHETICS PHENOTHIAZINES TRANQUILIZERS TRICYCLIC ANTIDEPRESSANTS", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p26", "DRUGA": ["NARCOTIC ANALGESICS", "group", "175-193"], "DRUGB": ["ALCOHOL", "drug", "362-368"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS @DRUG$ @DRUG$ TRANQUILIZERS TRICYCLIC ANTIDEPRESSANTS", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p27", "DRUGA": ["ANESTHETICS", "group", "204-214"], "DRUGB": ["PHENOTHIAZINES", "group", "217-230"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS @DRUG$ PHENOTHIAZINES @DRUG$ TRICYCLIC ANTIDEPRESSANTS", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p28", "DRUGA": ["ANESTHETICS", "group", "204-214"], "DRUGB": ["TRANQUILIZERS", "group", "239-251"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS @DRUG$ PHENOTHIAZINES TRANQUILIZERS @DRUG$ TRICYCLIC ANTIDEPRESSANTS", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p29", "DRUGA": ["ANESTHETICS", "group", "204-214"], "DRUGB": ["SEDATIVE-HYPNOTICS", "group", "254-271"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS @DRUG$ PHENOTHIAZINES TRANQUILIZERS TRICYCLIC ANTIDEPRESSANTS", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p30", "DRUGA": ["ANESTHETICS", "group", "204-214"], "DRUGB": ["BARBITURATES", "group", "284-295"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS @DRUG$ PHENOTHIAZINES TRANQUILIZERS @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p31", "DRUGA": ["ANESTHETICS", "group", "204-214"], "DRUGB": ["TRICYCLIC ANTIDEPRESSANTS", "group", "299-323"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS @DRUG$ PHENOTHIAZINES TRANQUILIZERS TRICYCLIC ANTIDEPRESSANTS @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p32", "DRUGA": ["ANESTHETICS", "group", "204-214"], "DRUGB": ["CNS DEPRESSANTS", "group", "335-349"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS @DRUG$ PHENOTHIAZINES TRANQUILIZERS TRICYCLIC ANTIDEPRESSANTS", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p33", "DRUGA": ["ANESTHETICS", "group", "204-214"], "DRUGB": ["ALCOHOL", "drug", "362-368"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS @DRUG$ @DRUG$ TRICYCLIC ANTIDEPRESSANTS", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p34", "DRUGA": ["PHENOTHIAZINES", "group", "217-230"], "DRUGB": ["TRANQUILIZERS", "group", "239-251"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS @DRUG$ TRANQUILIZERS @DRUG$ TRICYCLIC ANTIDEPRESSANTS", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p35", "DRUGA": ["PHENOTHIAZINES", "group", "217-230"], "DRUGB": ["SEDATIVE-HYPNOTICS", "group", "254-271"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS @DRUG$ TRANQUILIZERS TRICYCLIC ANTIDEPRESSANTS", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p36", "DRUGA": ["PHENOTHIAZINES", "group", "217-230"], "DRUGB": ["BARBITURATES", "group", "284-295"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS @DRUG$ TRANQUILIZERS @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p37", "DRUGA": ["PHENOTHIAZINES", "group", "217-230"], "DRUGB": ["TRICYCLIC ANTIDEPRESSANTS", "group", "299-323"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS @DRUG$ TRANQUILIZERS TRICYCLIC ANTIDEPRESSANTS @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p38", "DRUGA": ["PHENOTHIAZINES", "group", "217-230"], "DRUGB": ["CNS DEPRESSANTS", "group", "335-349"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS @DRUG$ TRANQUILIZERS TRICYCLIC ANTIDEPRESSANTS", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p39", "DRUGA": ["PHENOTHIAZINES", "group", "217-230"], "DRUGB": ["ALCOHOL", "drug", "362-368"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS PHENOTHIAZINES @DRUG$ @DRUG$ TRICYCLIC ANTIDEPRESSANTS", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p40", "DRUGA": ["TRANQUILIZERS", "group", "239-251"], "DRUGB": ["SEDATIVE-HYPNOTICS", "group", "254-271"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS PHENOTHIAZINES @DRUG$ TRICYCLIC ANTIDEPRESSANTS", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p41", "DRUGA": ["TRANQUILIZERS", "group", "239-251"], "DRUGB": ["BARBITURATES", "group", "284-295"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS PHENOTHIAZINES @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p42", "DRUGA": ["TRANQUILIZERS", "group", "239-251"], "DRUGB": ["TRICYCLIC ANTIDEPRESSANTS", "group", "299-323"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS PHENOTHIAZINES @DRUG$ TRICYCLIC ANTIDEPRESSANTS @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p43", "DRUGA": ["TRANQUILIZERS", "group", "239-251"], "DRUGB": ["CNS DEPRESSANTS", "group", "335-349"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS PHENOTHIAZINES @DRUG$ TRICYCLIC ANTIDEPRESSANTS", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p44", "DRUGA": ["TRANQUILIZERS", "group", "239-251"], "DRUGB": ["ALCOHOL", "drug", "362-368"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS PHENOTHIAZINES TRANQUILIZERS @DRUG$ TRICYCLIC ANTIDEPRESSANTS", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p45", "DRUGA": ["SEDATIVE-HYPNOTICS", "group", "254-271"], "DRUGB": ["BARBITURATES", "group", "284-295"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS PHENOTHIAZINES TRANQUILIZERS @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p46", "DRUGA": ["SEDATIVE-HYPNOTICS", "group", "254-271"], "DRUGB": ["TRICYCLIC ANTIDEPRESSANTS", "group", "299-323"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS PHENOTHIAZINES TRANQUILIZERS @DRUG$ TRICYCLIC ANTIDEPRESSANTS @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p47", "DRUGA": ["SEDATIVE-HYPNOTICS", "group", "254-271"], "DRUGB": ["CNS DEPRESSANTS", "group", "335-349"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS PHENOTHIAZINES TRANQUILIZERS @DRUG$ TRICYCLIC ANTIDEPRESSANTS", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p48", "DRUGA": ["SEDATIVE-HYPNOTICS", "group", "254-271"], "DRUGB": ["ALCOHOL", "drug", "362-368"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS PHENOTHIAZINES TRANQUILIZERS @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p49", "DRUGA": ["BARBITURATES", "group", "284-295"], "DRUGB": ["TRICYCLIC ANTIDEPRESSANTS", "group", "299-323"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS PHENOTHIAZINES TRANQUILIZERS TRICYCLIC ANTIDEPRESSANTS @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p50", "DRUGA": ["BARBITURATES", "group", "284-295"], "DRUGB": ["CNS DEPRESSANTS", "group", "335-349"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS PHENOTHIAZINES TRANQUILIZERS TRICYCLIC ANTIDEPRESSANTS", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p51", "DRUGA": ["BARBITURATES", "group", "284-295"], "DRUGB": ["ALCOHOL", "drug", "362-368"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS PHENOTHIAZINES TRANQUILIZERS @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p52", "DRUGA": ["TRICYCLIC ANTIDEPRESSANTS", "group", "299-323"], "DRUGB": ["CNS DEPRESSANTS", "group", "335-349"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS PHENOTHIAZINES TRANQUILIZERS @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p53", "DRUGA": ["TRICYCLIC ANTIDEPRESSANTS", "group", "299-323"], "DRUGB": ["ALCOHOL", "drug", "362-368"]}
{"TEXT1": "Interaction MEPERIDINE USED WITH CAUTION GREAT REDUCED DOSAGE PATIENTS RECEIVING NARCOTIC ANALGESICS GENERAL ANESTHETICS PHENOTHIAZINES TRANQUILIZERS TRICYCLIC ANTIDEPRESSANTS @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d703.s0.p54", "DRUGA": ["CNS DEPRESSANTS", "group", "335-349"], "DRUGB": ["ALCOHOL", "drug", "362-368"]}
{"TEXT1": "Concurrent @DRUG$ @DRUG$ diminish bactericidal effects penicillins slowing rate bacterial growth", "LBL": "0", "ID": "DDI-DrugBank.d665.s0.p0", "DRUGA": ["bacteriostatic antibiotics", "group", "29-54"], "DRUGB": ["erythromycin", "drug", "63-74"]}
{"TEXT1": "Concurrent @DRUG$ erythromycin diminish bactericidal effects penicillins slowing rate bacterial growth", "LBL": "0", "ID": "DDI-DrugBank.d665.s0.p1", "DRUGA": ["bacteriostatic antibiotics", "group", "29-54"], "DRUGB": ["tetracycline", "drug", "77-88"]}
{"TEXT1": "Concurrent @DRUG$ erythromycin diminish bactericidal effects @DRUG$ slowing rate bacterial growth", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d665.s0.p2", "DRUGA": ["bacteriostatic antibiotics", "group", "29-54"], "DRUGB": ["penicillins", "group", "132-142"]}
{"TEXT1": "Concurrent administration of antibiotics @DRUG$ diminish bactericidal effects penicillins slowing rate bacterial growth", "LBL": "0", "ID": "DDI-DrugBank.d665.s0.p3", "DRUGA": ["erythromycin", "drug", "63-74"], "DRUGB": ["tetracycline", "drug", "77-88"]}
{"TEXT1": "Concurrent administration of antibiotics @DRUG$ diminish bactericidal effects @DRUG$ slowing rate bacterial growth", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d665.s0.p4", "DRUGA": ["erythromycin", "drug", "63-74"], "DRUGB": ["penicillins", "group", "132-142"]}
{"TEXT1": "Concurrent administration of antibiotics erythromycin diminish bactericidal effects @DRUG$ slowing rate bacterial growth", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d665.s0.p5", "DRUGA": ["tetracycline", "drug", "77-88"], "DRUGB": ["penicillins", "group", "132-142"]}
{"TEXT1": "@DRUG$ blood levels prolonged concurrent administration @DRUG$ blocks renal tubular secretion", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d665.s6.p0", "DRUGA": ["Penicillin", "group", "0-9"], "DRUGB": ["probenecid", "drug", "73-82"]}
{"TEXT1": "@DRUG$ blood levels prolonged concurrent administration probenecid blocks renal tubular secretion @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d665.s6.p1", "DRUGA": ["Penicillin", "group", "0-9"], "DRUGB": ["penicillins", "group", "128-138"]}
{"TEXT1": "Penicillin blood levels prolonged concurrent administration @DRUG$ blocks renal tubular secretion @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d665.s6.p2", "DRUGA": ["probenecid", "drug", "73-82"], "DRUGB": ["penicillins", "group", "128-138"]}
{"TEXT1": "Displacement @DRUG$ plasma protein binding sites elevate level free @DRUG$ serum", "LBL": "0", "ID": "DDI-DrugBank.d665.s7.p0", "DRUGA": ["penicillin", "group", "16-25"], "DRUGB": ["penicillin", "group", "92-101"]}
{"TEXT1": "Women @DRUG$ shown significant increase plasma @DRUG$ levels", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d651.s0.p0", "DRUGA": ["contraceptives", "group", "33-46"], "DRUGB": ["vitamin A", "group", "92-100"]}
{"TEXT1": "@DRUG$ not known to drugs including @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d732.s0.p0", "DRUGA": ["CHEMET", "brand", "0-5"], "DRUGB": ["iron", "drug", "59-62"]}
{"TEXT1": "Concomitant administration @DRUG$ chelation therapy @DRUG$ not recommended", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d732.s2.p0", "DRUGA": ["CHEMET", "brand", "30-35"], "DRUGB": ["CaNa 2 EDTA", "drug", "75-85"]}
{"TEXT1": "@DRUG$ used @DRUG$ potentiation antihypertensive effect occur", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d779.s0.p0", "DRUGA": ["methyldopa", "drug", "5-14"], "DRUGB": ["antihypertensive drugs", "group", "35-56"]}
{"TEXT1": "Patients reduced doses @DRUG$ @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d779.s2.p0", "DRUGA": ["anesthetics", "group", "38-48"], "DRUGB": ["methyldopa", "drug", "58-67"]}
{"TEXT1": "@DRUG$ @DRUG$ given patient monitored symptoms lithium toxicity", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d779.s5.p0", "DRUGA": ["methyldopa", "drug", "5-14"], "DRUGB": ["lithium", "drug", "20-26"]}
{"TEXT1": "@DRUG$ lithium given patient monitored symptoms @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d779.s5.p1", "DRUGA": ["methyldopa", "drug", "5-14"], "DRUGB": ["lithium", "drug", "110-116"]}
{"TEXT1": "methyldopa @DRUG$ given patient monitored symptoms @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d779.s5.p2", "DRUGA": ["lithium", "drug", "20-26"], "DRUGB": ["lithium", "drug", "110-116"]}
{"TEXT1": "studies decrease bioavailability @DRUG$ ingested @DRUG$ ferrous gluconate", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d779.s7.p0", "DRUGA": ["methyldopa", "drug", "65-74"], "DRUGB": ["ferrous sulfate", "drug", "101-115"]}
{"TEXT1": "studies decrease bioavailability @DRUG$ ingested ferrous sulfate @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d779.s7.p1", "DRUGA": ["methyldopa", "drug", "65-74"], "DRUGB": ["ferrous gluconate", "drug", "120-136"]}
{"TEXT1": "studies decrease bioavailability methyldopa ingested @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d779.s7.p2", "DRUGA": ["ferrous sulfate", "drug", "101-115"], "DRUGB": ["ferrous gluconate", "drug", "120-136"]}
{"TEXT1": "Coadministration @DRUG$ @DRUG$ ferrous gluconate not recommended", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d779.s9.p0", "DRUGA": ["methyldopa", "drug", "20-29"], "DRUGB": ["ferrous sulfate", "drug", "36-50"]}
{"TEXT1": "Coadministration @DRUG$ ferrous sulfate @DRUG$ not recommended", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d779.s9.p1", "DRUGA": ["methyldopa", "drug", "20-29"], "DRUGB": ["ferrous gluconate", "drug", "55-71"]}
{"TEXT1": "Coadministration methyldopa @DRUG$ @DRUG$ not recommended", "LBL": "0", "ID": "DDI-DrugBank.d779.s9.p2", "DRUGA": ["ferrous sulfate", "drug", "36-50"], "DRUGB": ["ferrous gluconate", "drug", "55-71"]}
{"TEXT1": "@DRUG$ not interfere @DRUG$ test pheochromocytoma methods VMA vanillin", "LBL": "0", "ID": "DDI-DrugBank.d779.s16.p0", "DRUGA": ["Methyldopa", "drug", "0-9"], "DRUGB": ["VMA", "drug_n", "50-52"]}
{"TEXT1": "@DRUG$ not interfere measurement VMA test pheochromocytoma methods vanillin", "LBL": "0", "ID": "DDI-DrugBank.d779.s16.p1", "DRUGA": ["Methyldopa", "drug", "0-9"], "DRUGB": ["vanillylmandelic acid", "drug_n", "55-75"]}
{"TEXT1": "@DRUG$ not interfere measurement VMA test pheochromocytoma methods @DRUG$ vanillin", "LBL": "0", "ID": "DDI-DrugBank.d779.s16.p2", "DRUGA": ["Methyldopa", "drug", "0-9"], "DRUGB": ["VMA", "drug_n", "139-141"]}
{"TEXT1": "@DRUG$ not interfere measurement VMA test pheochromocytoma methods @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d779.s16.p3", "DRUGA": ["Methyldopa", "drug", "0-9"], "DRUGB": ["vanillin", "drug_n", "146-153"]}
{"TEXT1": "Methyldopa not interfere @DRUG$ test pheochromocytoma methods VMA vanillin", "LBL": "0", "ID": "DDI-DrugBank.d779.s16.p4", "DRUGA": ["VMA", "drug_n", "50-52"], "DRUGB": ["vanillylmandelic acid", "drug_n", "55-75"]}
{"TEXT1": "Methyldopa not interfere @DRUG$ test pheochromocytoma methods @DRUG$ vanillin", "LBL": "0", "ID": "DDI-DrugBank.d779.s16.p5", "DRUGA": ["VMA", "drug_n", "50-52"], "DRUGB": ["VMA", "drug_n", "139-141"]}
{"TEXT1": "Methyldopa not interfere @DRUG$ test pheochromocytoma methods VMA @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d779.s16.p6", "DRUGA": ["VMA", "drug_n", "50-52"], "DRUGB": ["vanillin", "drug_n", "146-153"]}
{"TEXT1": "Methyldopa not interfere measurement VMA test pheochromocytoma methods @DRUG$ vanillin", "LBL": "0", "ID": "DDI-DrugBank.d779.s16.p7", "DRUGA": ["vanillylmandelic acid", "drug_n", "55-75"], "DRUGB": ["VMA", "drug_n", "139-141"]}
{"TEXT1": "Methyldopa not interfere measurement VMA test pheochromocytoma methods @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d779.s16.p8", "DRUGA": ["vanillylmandelic acid", "drug_n", "55-75"], "DRUGB": ["vanillin", "drug_n", "146-153"]}
{"TEXT1": "Methyldopa not interfere measurement VMA test pheochromocytoma methods @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d779.s16.p9", "DRUGA": ["VMA", "drug_n", "139-141"], "DRUGB": ["vanillin", "drug_n", "146-153"]}
{"TEXT1": "@DRUG$ @DRUG$ incompatible sodium bicarbonate solution", "LBL": "0", "ID": "DDI-DrugBank.d595.s1.p0", "DRUGA": ["norepinephrine", "drug", "0-13"], "DRUGB": ["dobutamine", "drug", "19-28"]}
{"TEXT1": "@DRUG$ dobutamine incompatible @DRUG$", "LBL": "DDI-int", "ID": "DDI-DrugBank.d595.s1.p1", "DRUGA": ["norepinephrine", "drug", "0-13"], "DRUGB": ["sodium bicarbonate", "drug", "52-69"]}
{"TEXT1": "norepinephrine @DRUG$ incompatible @DRUG$", "LBL": "DDI-int", "ID": "DDI-DrugBank.d595.s1.p2", "DRUGA": ["dobutamine", "drug", "19-28"], "DRUGB": ["sodium bicarbonate", "drug", "52-69"]}
{"TEXT1": "addition @DRUG$ parenteral solutions containing @DRUG$ compatibility established", "LBL": "0", "ID": "DDI-DrugBank.d595.s2.p0", "DRUGA": ["sodium bicarbonate", "drug", "16-33"], "DRUGB": ["calcium", "drug", "70-76"]}
{"TEXT1": "bioavailability @DRUG$ decreased @DRUG$ calcium SKELID administered same time aluminum 1 hour", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d721.s0.p0", "DRUGA": ["SKELID", "brand", "23-28"], "DRUGB": ["calcium", "drug", "50-56"]}
{"TEXT1": "bioavailability @DRUG$ decreased calcium @DRUG$ SKELID administered same time aluminum 1 hour", "LBL": "0", "ID": "DDI-DrugBank.d721.s0.p1", "DRUGA": ["SKELID", "brand", "23-28"], "DRUGB": ["calcium", "drug", "64-70"]}
{"TEXT1": "bioavailability @DRUG$ decreased calcium @DRUG$ administered same time aluminum 1 hour SKELID", "LBL": "0", "ID": "DDI-DrugBank.d721.s0.p2", "DRUGA": ["SKELID", "brand", "23-28"], "DRUGB": ["SKELID", "brand", "76-81"]}
{"TEXT1": "bioavailability @DRUG$ decreased calcium SKELID administered same time @DRUG$ 1 hour", "LBL": "0", "ID": "DDI-DrugBank.d721.s0.p3", "DRUGA": ["SKELID", "brand", "23-28"], "DRUGB": ["aluminum", "drug", "134-141"]}
{"TEXT1": "bioavailability @DRUG$ decreased calcium SKELID administered same time aluminum @DRUG$ 1 hour", "LBL": "0", "ID": "DDI-DrugBank.d721.s0.p4", "DRUGA": ["SKELID", "brand", "23-28"], "DRUGB": ["magnesium", "drug", "147-155"]}
{"TEXT1": "bioavailability @DRUG$ decreased calcium SKELID administered same time aluminum @DRUG$ 1 hour", "LBL": "0", "ID": "DDI-DrugBank.d721.s0.p5", "DRUGA": ["SKELID", "brand", "23-28"], "DRUGB": ["antacids", "drug", "168-175"]}
{"TEXT1": "bioavailability @DRUG$ decreased calcium SKELID administered same time aluminum 1 hour @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d721.s0.p6", "DRUGA": ["SKELID", "brand", "23-28"], "DRUGB": ["SKELID", "brand", "210-215"]}
{"TEXT1": "bioavailability SKELID decreased @DRUG$ @DRUG$ administered same time aluminum 1 hour", "LBL": "0", "ID": "DDI-DrugBank.d721.s0.p7", "DRUGA": ["calcium", "drug", "50-56"], "DRUGB": ["calcium", "drug", "64-70"]}
{"TEXT1": "bioavailability SKELID decreased @DRUG$ calcium @DRUG$ administered same time aluminum 1 hour", "LBL": "0", "ID": "DDI-DrugBank.d721.s0.p8", "DRUGA": ["calcium", "drug", "50-56"], "DRUGB": ["SKELID", "brand", "76-81"]}
{"TEXT1": "bioavailability SKELID decreased @DRUG$ calcium administered same time @DRUG$ 1 hour", "LBL": "0", "ID": "DDI-DrugBank.d721.s0.p9", "DRUGA": ["calcium", "drug", "50-56"], "DRUGB": ["aluminum", "drug", "134-141"]}
{"TEXT1": "bioavailability SKELID decreased @DRUG$ calcium administered same time aluminum @DRUG$ 1 hour", "LBL": "0", "ID": "DDI-DrugBank.d721.s0.p10", "DRUGA": ["calcium", "drug", "50-56"], "DRUGB": ["magnesium", "drug", "147-155"]}
{"TEXT1": "bioavailability SKELID decreased @DRUG$ calcium administered same time aluminum @DRUG$ 1 hour", "LBL": "0", "ID": "DDI-DrugBank.d721.s0.p11", "DRUGA": ["calcium", "drug", "50-56"], "DRUGB": ["antacids", "drug", "168-175"]}
{"TEXT1": "bioavailability SKELID decreased @DRUG$ calcium administered same time aluminum 1 hour @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d721.s0.p12", "DRUGA": ["calcium", "drug", "50-56"], "DRUGB": ["SKELID", "brand", "210-215"]}
{"TEXT1": "bioavailability SKELID decreased calcium @DRUG$ @DRUG$ administered same time aluminum 1 hour", "LBL": "0", "ID": "DDI-DrugBank.d721.s0.p13", "DRUGA": ["calcium", "drug", "64-70"], "DRUGB": ["SKELID", "brand", "76-81"]}
{"TEXT1": "bioavailability SKELID decreased calcium @DRUG$ administered same time @DRUG$ 1 hour", "LBL": "0", "ID": "DDI-DrugBank.d721.s0.p14", "DRUGA": ["calcium", "drug", "64-70"], "DRUGB": ["aluminum", "drug", "134-141"]}
{"TEXT1": "bioavailability SKELID decreased calcium @DRUG$ administered same time aluminum @DRUG$ 1 hour", "LBL": "0", "ID": "DDI-DrugBank.d721.s0.p15", "DRUGA": ["calcium", "drug", "64-70"], "DRUGB": ["magnesium", "drug", "147-155"]}
{"TEXT1": "bioavailability SKELID decreased calcium @DRUG$ administered same time aluminum @DRUG$ 1 hour", "LBL": "0", "ID": "DDI-DrugBank.d721.s0.p16", "DRUGA": ["calcium", "drug", "64-70"], "DRUGB": ["antacids", "drug", "168-175"]}
{"TEXT1": "bioavailability SKELID decreased calcium @DRUG$ administered same time aluminum 1 hour @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d721.s0.p17", "DRUGA": ["calcium", "drug", "64-70"], "DRUGB": ["SKELID", "brand", "210-215"]}
{"TEXT1": "bioavailability SKELID decreased calcium @DRUG$ administered same time @DRUG$ 1 hour", "LBL": "0", "ID": "DDI-DrugBank.d721.s0.p18", "DRUGA": ["SKELID", "brand", "76-81"], "DRUGB": ["aluminum", "drug", "134-141"]}
{"TEXT1": "bioavailability SKELID decreased calcium @DRUG$ administered same time aluminum @DRUG$ 1 hour", "LBL": "0", "ID": "DDI-DrugBank.d721.s0.p19", "DRUGA": ["SKELID", "brand", "76-81"], "DRUGB": ["magnesium", "drug", "147-155"]}
{"TEXT1": "bioavailability SKELID decreased calcium @DRUG$ administered same time aluminum @DRUG$ 1 hour", "LBL": "0", "ID": "DDI-DrugBank.d721.s0.p20", "DRUGA": ["SKELID", "brand", "76-81"], "DRUGB": ["antacids", "drug", "168-175"]}
{"TEXT1": "bioavailability SKELID decreased calcium @DRUG$ administered same time aluminum 1 hour @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d721.s0.p21", "DRUGA": ["SKELID", "brand", "76-81"], "DRUGB": ["SKELID", "brand", "210-215"]}
{"TEXT1": "bioavailability SKELID decreased calcium administered same time @DRUG$ @DRUG$ 1 hour", "LBL": "0", "ID": "DDI-DrugBank.d721.s0.p22", "DRUGA": ["aluminum", "drug", "134-141"], "DRUGB": ["magnesium", "drug", "147-155"]}
{"TEXT1": "bioavailability SKELID decreased calcium administered same time @DRUG$ @DRUG$ 1 hour", "LBL": "0", "ID": "DDI-DrugBank.d721.s0.p23", "DRUGA": ["aluminum", "drug", "134-141"], "DRUGB": ["antacids", "drug", "168-175"]}
{"TEXT1": "bioavailability SKELID decreased calcium administered same time @DRUG$ 1 hour @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d721.s0.p24", "DRUGA": ["aluminum", "drug", "134-141"], "DRUGB": ["SKELID", "brand", "210-215"]}
{"TEXT1": "bioavailability SKELID decreased calcium administered same time aluminum @DRUG$ @DRUG$ 1 hour", "LBL": "0", "ID": "DDI-DrugBank.d721.s0.p25", "DRUGA": ["magnesium", "drug", "147-155"], "DRUGB": ["antacids", "drug", "168-175"]}
{"TEXT1": "bioavailability SKELID decreased calcium administered same time aluminum @DRUG$ 1 hour @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d721.s0.p26", "DRUGA": ["magnesium", "drug", "147-155"], "DRUGB": ["SKELID", "brand", "210-215"]}
{"TEXT1": "bioavailability SKELID decreased calcium administered same time aluminum @DRUG$ 1 hour @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d721.s0.p27", "DRUGA": ["antacids", "drug", "168-175"], "DRUGB": ["SKELID", "brand", "210-215"]}
{"TEXT1": "@DRUG$ decrease bioavailability @DRUG$ up to taken 2 hours SKELID", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d721.s1.p0", "DRUGA": ["Aspirin", "brand", "0-6"], "DRUGB": ["SKELID", "brand", "40-45"]}
{"TEXT1": "@DRUG$ decrease bioavailability SKELID up to taken 2 hours @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d721.s1.p1", "DRUGA": ["Aspirin", "brand", "0-6"], "DRUGB": ["SKELID", "brand", "85-90"]}
{"TEXT1": "Aspirin decrease bioavailability @DRUG$ up to taken 2 hours @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d721.s1.p2", "DRUGA": ["SKELID", "brand", "40-45"], "DRUGB": ["SKELID", "brand", "85-90"]}
{"TEXT1": "bioavailability @DRUG$ increased fold @DRUG$ not altered coadministration diclofenac", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d721.s2.p0", "DRUGA": ["SKELID", "brand", "23-28"], "DRUGB": ["indomethacin", "drug", "55-66"]}
{"TEXT1": "bioavailability @DRUG$ increased fold indomethacin not altered coadministration @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d721.s2.p1", "DRUGA": ["SKELID", "brand", "23-28"], "DRUGB": ["diclofenac", "drug", "124-133"]}
{"TEXT1": "bioavailability SKELID increased fold @DRUG$ not altered coadministration @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d721.s2.p2", "DRUGA": ["indomethacin", "drug", "55-66"], "DRUGB": ["diclofenac", "drug", "124-133"]}
{"TEXT1": "pharmacokinetic parameters @DRUG$ not modified by @DRUG$ coadministration", "LBL": "0", "ID": "DDI-DrugBank.d721.s3.p0", "DRUGA": ["digoxin", "drug", "34-40"], "DRUGB": ["SKELID", "brand", "76-81"]}
{"TEXT1": "In vitro studies show @DRUG$ not @DRUG$ binding site protein", "LBL": "0", "ID": "DDI-DrugBank.d721.s4.p0", "DRUGA": ["tiludronate", "drug", "27-37"], "DRUGB": ["warfarin", "drug", "57-64"]}
{"TEXT1": "@DRUG$ @DRUG$ bactericidal effect penicillin concurrent drugs", "LBL": "0", "ID": "DDI-DrugBank.d747.s0.p0", "DRUGA": ["Tetracycline", "group", "0-11"], "DRUGB": ["antibiotic", "group", "31-40"]}
{"TEXT1": "@DRUG$ antibiotic bactericidal effect @DRUG$ concurrent drugs", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d747.s0.p1", "DRUGA": ["Tetracycline", "group", "0-11"], "DRUGB": ["penicillin", "drug", "85-94"]}
{"TEXT1": "Tetracycline @DRUG$ bactericidal effect @DRUG$ concurrent drugs", "LBL": "0", "ID": "DDI-DrugBank.d747.s0.p2", "DRUGA": ["antibiotic", "group", "31-40"], "DRUGB": ["penicillin", "drug", "85-94"]}
{"TEXT1": "@DRUG$ used care patients taking drugs capable causing CNS effects @DRUG$ tranquilizers alcohol", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d771.s1.p0", "DRUGA": ["Scopolamine", "drug", "0-10"], "DRUGB": ["sedatives", "group", "116-124"]}
{"TEXT1": "@DRUG$ used care patients taking drugs capable causing CNS effects sedatives @DRUG$ alcohol", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d771.s1.p1", "DRUGA": ["Scopolamine", "drug", "0-10"], "DRUGB": ["tranquilizers", "group", "127-139"]}
{"TEXT1": "@DRUG$ used care patients taking drugs capable causing CNS effects sedatives tranquilizers @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d771.s1.p2", "DRUGA": ["Scopolamine", "drug", "0-10"], "DRUGB": ["alcohol", "drug", "145-151"]}
{"TEXT1": "Scopolamine used care patients taking drugs capable causing CNS effects @DRUG$ @DRUG$ alcohol", "LBL": "0", "ID": "DDI-DrugBank.d771.s1.p3", "DRUGA": ["sedatives", "group", "116-124"], "DRUGB": ["tranquilizers", "group", "127-139"]}
{"TEXT1": "Scopolamine used care patients taking drugs capable causing CNS effects @DRUG$ tranquilizers @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d771.s1.p4", "DRUGA": ["sedatives", "group", "116-124"], "DRUGB": ["alcohol", "drug", "145-151"]}
{"TEXT1": "Scopolamine used care patients taking drugs capable causing CNS effects sedatives @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d771.s1.p5", "DRUGA": ["tranquilizers", "group", "127-139"], "DRUGB": ["alcohol", "drug", "145-151"]}
{"TEXT1": "@DRUG$ @DRUG$ tricyclic antidepressants muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d771.s3.p0", "DRUGA": ["belladonna alkaloids", "group", "12-31"], "DRUGB": ["antihistamines", "group", "34-47"]}
{"TEXT1": "@DRUG$ antihistamines tricyclic antidepressants muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d771.s3.p1", "DRUGA": ["belladonna alkaloids", "group", "12-31"], "DRUGB": ["meclizine", "drug", "60-68"]}
{"TEXT1": "@DRUG$ antihistamines @DRUG$ muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d771.s3.p2", "DRUGA": ["belladonna alkaloids", "group", "12-31"], "DRUGB": ["tricyclic antidepressants", "group", "72-96"]}
{"TEXT1": "@DRUG$ antihistamines tricyclic antidepressants @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d771.s3.p3", "DRUGA": ["belladonna alkaloids", "group", "12-31"], "DRUGB": ["muscle relaxants", "group", "103-118"]}
{"TEXT1": "belladonna alkaloids @DRUG$ tricyclic antidepressants muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d771.s3.p4", "DRUGA": ["antihistamines", "group", "34-47"], "DRUGB": ["meclizine", "drug", "60-68"]}
{"TEXT1": "belladonna alkaloids @DRUG$ @DRUG$ muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d771.s3.p5", "DRUGA": ["antihistamines", "group", "34-47"], "DRUGB": ["tricyclic antidepressants", "group", "72-96"]}
{"TEXT1": "belladonna alkaloids @DRUG$ tricyclic antidepressants @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d771.s3.p6", "DRUGA": ["antihistamines", "group", "34-47"], "DRUGB": ["muscle relaxants", "group", "103-118"]}
{"TEXT1": "belladonna alkaloids antihistamines @DRUG$ muscle relaxants", "LBL": "0", "ID": "DDI-DrugBank.d771.s3.p7", "DRUGA": ["meclizine", "drug", "60-68"], "DRUGB": ["tricyclic antidepressants", "group", "72-96"]}
{"TEXT1": "belladonna alkaloids antihistamines tricyclic antidepressants @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d771.s3.p8", "DRUGA": ["meclizine", "drug", "60-68"], "DRUGB": ["muscle relaxants", "group", "103-118"]}
{"TEXT1": "belladonna alkaloids antihistamines @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d771.s3.p9", "DRUGA": ["tricyclic antidepressants", "group", "72-96"], "DRUGB": ["muscle relaxants", "group", "103-118"]}
{"TEXT1": "induction dose requirements @DRUG$ Injectable Emulsion reduced patients intramuscular intravenous premedication @DRUG$ morphine meperidine fentanyl etc", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d628.s0.p0", "DRUGA": ["DIPRIVAN", "brand", "35-42"], "DRUGB": ["narcotics", "group", "158-166"]}
{"TEXT1": "induction dose requirements @DRUG$ Injectable Emulsion reduced patients intramuscular intravenous premedication narcotics @DRUG$ meperidine fentanyl etc", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d628.s0.p1", "DRUGA": ["DIPRIVAN", "brand", "35-42"], "DRUGB": ["morphine", "drug", "173-180"]}
{"TEXT1": "induction dose requirements @DRUG$ Injectable Emulsion reduced patients intramuscular intravenous premedication narcotics morphine @DRUG$ fentanyl etc", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d628.s0.p2", "DRUGA": ["DIPRIVAN", "brand", "35-42"], "DRUGB": ["meperidine", "drug", "183-192"]}
{"TEXT1": "induction dose requirements @DRUG$ Injectable Emulsion reduced patients intramuscular intravenous premedication narcotics morphine meperidine @DRUG$ etc", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d628.s0.p3", "DRUGA": ["DIPRIVAN", "brand", "35-42"], "DRUGB": ["fentanyl", "drug", "199-206"]}
{"TEXT1": "induction dose requirements DIPRIVAN Injectable Emulsion reduced patients intramuscular intravenous premedication @DRUG$ @DRUG$ meperidine fentanyl etc", "LBL": "0", "ID": "DDI-DrugBank.d628.s0.p4", "DRUGA": ["narcotics", "group", "158-166"], "DRUGB": ["morphine", "drug", "173-180"]}
{"TEXT1": "induction dose requirements DIPRIVAN Injectable Emulsion reduced patients intramuscular intravenous premedication @DRUG$ morphine @DRUG$ fentanyl etc", "LBL": "0", "ID": "DDI-DrugBank.d628.s0.p5", "DRUGA": ["narcotics", "group", "158-166"], "DRUGB": ["meperidine", "drug", "183-192"]}
{"TEXT1": "induction dose requirements DIPRIVAN Injectable Emulsion reduced patients intramuscular intravenous premedication @DRUG$ morphine meperidine @DRUG$ etc", "LBL": "0", "ID": "DDI-DrugBank.d628.s0.p6", "DRUGA": ["narcotics", "group", "158-166"], "DRUGB": ["fentanyl", "drug", "199-206"]}
{"TEXT1": "induction dose requirements DIPRIVAN Injectable Emulsion reduced patients intramuscular intravenous premedication narcotics @DRUG$ @DRUG$ fentanyl etc", "LBL": "0", "ID": "DDI-DrugBank.d628.s0.p7", "DRUGA": ["morphine", "drug", "173-180"], "DRUGB": ["meperidine", "drug", "183-192"]}
{"TEXT1": "induction dose requirements DIPRIVAN Injectable Emulsion reduced patients intramuscular intravenous premedication narcotics @DRUG$ meperidine @DRUG$ etc", "LBL": "0", "ID": "DDI-DrugBank.d628.s0.p8", "DRUGA": ["morphine", "drug", "173-180"], "DRUGB": ["fentanyl", "drug", "199-206"]}
{"TEXT1": "induction dose requirements DIPRIVAN Injectable Emulsion reduced patients intramuscular intravenous premedication narcotics morphine @DRUG$ @DRUG$ etc", "LBL": "0", "ID": "DDI-DrugBank.d628.s0.p9", "DRUGA": ["meperidine", "drug", "183-192"], "DRUGB": ["fentanyl", "drug", "199-206"]}
{"TEXT1": "combinations @DRUG$ @DRUG$ benzodiazepines barbiturates chloral hydrate droperidol etc", "LBL": "0", "ID": "DDI-DrugBank.d628.s1.p0", "DRUGA": ["opioids", "group", "20-26"], "DRUGB": ["sedatives", "group", "32-40"]}
{"TEXT1": "combinations @DRUG$ sedatives @DRUG$ barbiturates chloral hydrate droperidol etc", "LBL": "0", "ID": "DDI-DrugBank.d628.s1.p1", "DRUGA": ["opioids", "group", "20-26"], "DRUGB": ["benzodiazepines", "group", "47-61"]}
{"TEXT1": "combinations @DRUG$ sedatives benzodiazepines @DRUG$ chloral hydrate droperidol etc", "LBL": "0", "ID": "DDI-DrugBank.d628.s1.p2", "DRUGA": ["opioids", "group", "20-26"], "DRUGB": ["barbiturates", "group", "64-75"]}
{"TEXT1": "combinations @DRUG$ sedatives benzodiazepines barbiturates @DRUG$ droperidol etc", "LBL": "0", "ID": "DDI-DrugBank.d628.s1.p3", "DRUGA": ["opioids", "group", "20-26"], "DRUGB": ["chloral hydrate", "drug", "78-92"]}
{"TEXT1": "combinations @DRUG$ sedatives benzodiazepines barbiturates chloral hydrate @DRUG$ etc", "LBL": "0", "ID": "DDI-DrugBank.d628.s1.p4", "DRUGA": ["opioids", "group", "20-26"], "DRUGB": ["droperidol", "drug", "95-104"]}
{"TEXT1": "combinations opioids @DRUG$ @DRUG$ barbiturates chloral hydrate droperidol etc", "LBL": "0", "ID": "DDI-DrugBank.d628.s1.p5", "DRUGA": ["sedatives", "group", "32-40"], "DRUGB": ["benzodiazepines", "group", "47-61"]}
{"TEXT1": "combinations opioids @DRUG$ benzodiazepines @DRUG$ chloral hydrate droperidol etc", "LBL": "0", "ID": "DDI-DrugBank.d628.s1.p6", "DRUGA": ["sedatives", "group", "32-40"], "DRUGB": ["barbiturates", "group", "64-75"]}
{"TEXT1": "combinations opioids @DRUG$ benzodiazepines barbiturates @DRUG$ droperidol etc", "LBL": "0", "ID": "DDI-DrugBank.d628.s1.p7", "DRUGA": ["sedatives", "group", "32-40"], "DRUGB": ["chloral hydrate", "drug", "78-92"]}
{"TEXT1": "combinations opioids @DRUG$ benzodiazepines barbiturates chloral hydrate @DRUG$ etc", "LBL": "0", "ID": "DDI-DrugBank.d628.s1.p8", "DRUGA": ["sedatives", "group", "32-40"], "DRUGB": ["droperidol", "drug", "95-104"]}
{"TEXT1": "combinations opioids sedatives @DRUG$ @DRUG$ chloral hydrate droperidol etc", "LBL": "0", "ID": "DDI-DrugBank.d628.s1.p9", "DRUGA": ["benzodiazepines", "group", "47-61"], "DRUGB": ["barbiturates", "group", "64-75"]}
{"TEXT1": "combinations opioids sedatives @DRUG$ barbiturates @DRUG$ droperidol etc", "LBL": "0", "ID": "DDI-DrugBank.d628.s1.p10", "DRUGA": ["benzodiazepines", "group", "47-61"], "DRUGB": ["chloral hydrate", "drug", "78-92"]}
{"TEXT1": "combinations opioids sedatives @DRUG$ barbiturates chloral hydrate @DRUG$ etc", "LBL": "0", "ID": "DDI-DrugBank.d628.s1.p11", "DRUGA": ["benzodiazepines", "group", "47-61"], "DRUGB": ["droperidol", "drug", "95-104"]}
{"TEXT1": "combinations opioids sedatives benzodiazepines @DRUG$ @DRUG$ droperidol etc", "LBL": "0", "ID": "DDI-DrugBank.d628.s1.p12", "DRUGA": ["barbiturates", "group", "64-75"], "DRUGB": ["chloral hydrate", "drug", "78-92"]}
{"TEXT1": "combinations opioids sedatives benzodiazepines @DRUG$ chloral hydrate @DRUG$ etc", "LBL": "0", "ID": "DDI-DrugBank.d628.s1.p13", "DRUGA": ["barbiturates", "group", "64-75"], "DRUGB": ["droperidol", "drug", "95-104"]}
{"TEXT1": "combinations opioids sedatives benzodiazepines barbiturates @DRUG$ @DRUG$ etc", "LBL": "0", "ID": "DDI-DrugBank.d628.s1.p14", "DRUGA": ["chloral hydrate", "drug", "78-92"], "DRUGB": ["droperidol", "drug", "95-104"]}
{"TEXT1": "maintenance anesthesia sedation @DRUG$ Injectable Emulsion adjusted according desired level reduced presence supplemental @DRUG$ nitrous oxide", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d628.s3.p0", "DRUGA": ["DIPRIVAN", "brand", "58-65"], "DRUGB": ["analgesic agents", "group", "229-244"]}
{"TEXT1": "maintenance anesthesia sedation @DRUG$ Injectable Emulsion adjusted according desired level reduced presence supplemental analgesic agents @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d628.s3.p1", "DRUGA": ["DIPRIVAN", "brand", "58-65"], "DRUGB": ["nitrous oxide", "drug", "251-263"]}
{"TEXT1": "maintenance anesthesia sedation @DRUG$ Injectable Emulsion adjusted according desired level reduced presence supplemental analgesic agents nitrous oxide", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d628.s3.p2", "DRUGA": ["DIPRIVAN", "brand", "58-65"], "DRUGB": ["opioids", "group", "268-274"]}
{"TEXT1": "maintenance anesthesia sedation DIPRIVAN Injectable Emulsion adjusted according desired level reduced presence supplemental @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d628.s3.p3", "DRUGA": ["analgesic agents", "group", "229-244"], "DRUGB": ["nitrous oxide", "drug", "251-263"]}
{"TEXT1": "maintenance anesthesia sedation DIPRIVAN Injectable Emulsion adjusted according desired level reduced presence supplemental @DRUG$ nitrous oxide", "LBL": "0", "ID": "DDI-DrugBank.d628.s3.p4", "DRUGA": ["analgesic agents", "group", "229-244"], "DRUGB": ["opioids", "group", "268-274"]}
{"TEXT1": "maintenance anesthesia sedation DIPRIVAN Injectable Emulsion adjusted according desired level reduced presence supplemental analgesic agents @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d628.s3.p5", "DRUGA": ["nitrous oxide", "drug", "251-263"], "DRUGB": ["opioids", "group", "268-274"]}
{"TEXT1": "concurrent administration inhalational potent inhalational agents @DRUG$ @DRUG$ maintenance DIPRIVAN Injectable Emulsion not evaluated", "LBL": "0", "ID": "DDI-DrugBank.d628.s4.p0", "DRUGA": ["isoflurane", "drug", "65-74"], "DRUGB": ["enflurane", "drug", "77-85"]}
{"TEXT1": "concurrent administration inhalational potent inhalational agents @DRUG$ enflurane maintenance DIPRIVAN Injectable Emulsion not evaluated", "LBL": "0", "ID": "DDI-DrugBank.d628.s4.p1", "DRUGA": ["isoflurane", "drug", "65-74"], "DRUGB": ["halothane", "drug", "92-100"]}
{"TEXT1": "concurrent administration inhalational potent inhalational agents @DRUG$ enflurane maintenance @DRUG$ Injectable Emulsion not evaluated", "LBL": "0", "ID": "DDI-DrugBank.d628.s4.p2", "DRUGA": ["isoflurane", "drug", "65-74"], "DRUGB": ["DIPRIVAN", "brand", "127-134"]}
{"TEXT1": "concurrent administration inhalational potent inhalational agents isoflurane @DRUG$ maintenance DIPRIVAN Injectable Emulsion not evaluated", "LBL": "0", "ID": "DDI-DrugBank.d628.s4.p3", "DRUGA": ["enflurane", "drug", "77-85"], "DRUGB": ["halothane", "drug", "92-100"]}
{"TEXT1": "concurrent administration inhalational potent inhalational agents isoflurane @DRUG$ maintenance @DRUG$ Injectable Emulsion not evaluated", "LBL": "0", "ID": "DDI-DrugBank.d628.s4.p4", "DRUGA": ["enflurane", "drug", "77-85"], "DRUGB": ["DIPRIVAN", "brand", "127-134"]}
{"TEXT1": "concurrent administration inhalational potent inhalational agents isoflurane enflurane maintenance @DRUG$ Injectable Emulsion not evaluated", "LBL": "0", "ID": "DDI-DrugBank.d628.s4.p5", "DRUGA": ["halothane", "drug", "92-100"], "DRUGB": ["DIPRIVAN", "brand", "127-134"]}
{"TEXT1": "@DRUG$ Injectable Emulsion not cause significant change onset intensity duration action used @DRUG$ succinylcholine", "LBL": "0", "ID": "DDI-DrugBank.d628.s6.p0", "DRUGA": ["DIPRIVAN", "brand", "0-7"], "DRUGB": ["neuromuscular blocking agents", "group", "140-168"]}
{"TEXT1": "@DRUG$ Injectable Emulsion not cause significant change onset intensity duration action used neuromuscular blocking agents @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d628.s6.p1", "DRUGA": ["DIPRIVAN", "brand", "0-7"], "DRUGB": ["succinylcholine", "drug", "175-189"]}
{"TEXT1": "@DRUG$ Injectable Emulsion not cause significant change onset intensity duration action used neuromuscular blocking agents succinylcholine", "LBL": "0", "ID": "DDI-DrugBank.d628.s6.p2", "DRUGA": ["DIPRIVAN", "brand", "0-7"], "DRUGB": ["nondepolarizing muscle relaxants", "group", "195-226"]}
{"TEXT1": "DIPRIVAN Injectable Emulsion not cause significant change onset intensity duration action used @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d628.s6.p3", "DRUGA": ["neuromuscular blocking agents", "group", "140-168"], "DRUGB": ["succinylcholine", "drug", "175-189"]}
{"TEXT1": "DIPRIVAN Injectable Emulsion not cause significant change onset intensity duration action used @DRUG$ succinylcholine", "LBL": "0", "ID": "DDI-DrugBank.d628.s6.p4", "DRUGA": ["neuromuscular blocking agents", "group", "140-168"], "DRUGB": ["nondepolarizing muscle relaxants", "group", "195-226"]}
{"TEXT1": "DIPRIVAN Injectable Emulsion not cause significant change onset intensity duration action used neuromuscular blocking agents @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d628.s6.p5", "DRUGA": ["succinylcholine", "drug", "175-189"], "DRUGB": ["nondepolarizing muscle relaxants", "group", "195-226"]}
{"TEXT1": "significant adverse interactions used premedications drugs anesthesia sedation range @DRUG$ inhalational agents @DRUG$ observed", "LBL": "0", "ID": "DDI-DrugBank.d628.s7.p0", "DRUGA": ["muscle relaxants", "group", "136-151"], "DRUGB": ["analgesic agents", "group", "175-190"]}
{"TEXT1": "significant adverse interactions used premedications drugs anesthesia sedation range @DRUG$ inhalational agents observed", "LBL": "0", "ID": "DDI-DrugBank.d628.s7.p1", "DRUGA": ["muscle relaxants", "group", "136-151"], "DRUGB": ["anesthetic agents", "group", "203-219"]}
{"TEXT1": "significant adverse interactions used premedications drugs anesthesia sedation range muscle relaxants inhalational agents @DRUG$ observed", "LBL": "0", "ID": "DDI-DrugBank.d628.s7.p2", "DRUGA": ["analgesic agents", "group", "175-190"], "DRUGB": ["anesthetic agents", "group", "203-219"]}
{"TEXT1": "in vitro binding @DRUG$ human plasma proteins unaffected @DRUG$ tolmetin not alter prothrombin time normal volunteers", "LBL": "0", "ID": "DDI-DrugBank.d608.s0.p0", "DRUGA": ["warfarin", "drug", "24-31"], "DRUGB": ["tolmetin", "drug", "75-82"]}
{"TEXT1": "in vitro binding @DRUG$ human plasma proteins unaffected tolmetin @DRUG$ not alter prothrombin time normal volunteers", "LBL": "0", "ID": "DDI-DrugBank.d608.s0.p1", "DRUGA": ["warfarin", "drug", "24-31"], "DRUGB": ["tolmetin", "drug", "89-96"]}
{"TEXT1": "in vitro binding warfarin human plasma proteins unaffected @DRUG$ @DRUG$ not alter prothrombin time normal volunteers", "LBL": "0", "ID": "DDI-DrugBank.d608.s0.p2", "DRUGA": ["tolmetin", "drug", "75-82"], "DRUGB": ["tolmetin", "drug", "89-96"]}
{"TEXT1": "increased prothrombin time bleeding reported patients concomitant @DRUG$ @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d608.s1.p0", "DRUGA": ["TOLECTIN", "brand", "95-102"], "DRUGB": ["warfarin", "drug", "108-115"]}
{"TEXT1": "exercised administering @DRUG$ patients @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d608.s2.p0", "DRUGA": ["TOLECTIN", "brand", "58-65"], "DRUGB": ["anticoagulants", "group", "82-95"]}
{"TEXT1": "adult diabetic patients treatment either @DRUG$ @DRUG$ no change clinical effects TOLECTIN hypoglycemic agents", "LBL": "0", "ID": "DDI-DrugBank.d608.s3.p0", "DRUGA": ["sulfonylureas", "group", "55-67"], "DRUGB": ["insulin", "drug", "72-78"]}
{"TEXT1": "adult diabetic patients treatment either @DRUG$ insulin no change clinical effects @DRUG$ hypoglycemic agents", "LBL": "0", "ID": "DDI-DrugBank.d608.s3.p1", "DRUGA": ["sulfonylureas", "group", "55-67"], "DRUGB": ["TOLECTIN", "brand", "133-140"]}
{"TEXT1": "adult diabetic patients treatment either @DRUG$ insulin no change clinical effects TOLECTIN @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d608.s3.p2", "DRUGA": ["sulfonylureas", "group", "55-67"], "DRUGB": ["hypoglycemic agents", "group", "149-167"]}
{"TEXT1": "adult diabetic patients treatment either sulfonylureas @DRUG$ no change clinical effects @DRUG$ hypoglycemic agents", "LBL": "0", "ID": "DDI-DrugBank.d608.s3.p3", "DRUGA": ["insulin", "drug", "72-78"], "DRUGB": ["TOLECTIN", "brand", "133-140"]}
{"TEXT1": "adult diabetic patients treatment either sulfonylureas @DRUG$ no change clinical effects TOLECTIN @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d608.s3.p4", "DRUGA": ["insulin", "drug", "72-78"], "DRUGB": ["hypoglycemic agents", "group", "149-167"]}
{"TEXT1": "adult diabetic patients treatment either sulfonylureas insulin no change clinical effects @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d608.s3.p5", "DRUGA": ["TOLECTIN", "brand", "133-140"], "DRUGB": ["hypoglycemic agents", "group", "149-167"]}
{"TEXT1": "used @DRUG$ administered @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d608.s4.p0", "DRUGA": ["TOLECTIN", "brand", "26-33"], "DRUGB": ["methotrexate", "drug", "70-81"]}
{"TEXT1": "@DRUG$ @DRUG$ reported to tubular secretion methotrexate animal model possibly enhancing", "LBL": "0", "ID": "DDI-DrugBank.d608.s5.p0", "DRUGA": ["TOLECTIN", "brand", "0-7"], "DRUGB": ["nonsteroidal anti-inflammatory drugs", "group", "19-54"]}
{"TEXT1": "@DRUG$ reported to tubular secretion @DRUG$ animal model possibly enhancing toxicity methotrexate", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d608.s5.p1", "DRUGA": ["TOLECTIN", "brand", "0-7"], "DRUGB": ["methotrexate", "drug", "110-121"]}
{"TEXT1": "@DRUG$ reported to tubular secretion methotrexate animal model possibly enhancing @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d608.s5.p2", "DRUGA": ["TOLECTIN", "brand", "0-7"], "DRUGB": ["methotrexate", "drug", "178-189"]}
{"TEXT1": "TOLECTIN @DRUG$ reported to tubular secretion @DRUG$ animal model possibly enhancing toxicity methotrexate", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d608.s5.p3", "DRUGA": ["nonsteroidal anti-inflammatory drugs", "group", "19-54"], "DRUGB": ["methotrexate", "drug", "110-121"]}
{"TEXT1": "TOLECTIN @DRUG$ reported to tubular secretion methotrexate animal model possibly enhancing @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d608.s5.p4", "DRUGA": ["nonsteroidal anti-inflammatory drugs", "group", "19-54"], "DRUGB": ["methotrexate", "drug", "178-189"]}
{"TEXT1": "TOLECTIN reported to tubular secretion @DRUG$ animal model possibly enhancing @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d608.s5.p5", "DRUGA": ["methotrexate", "drug", "110-121"], "DRUGB": ["methotrexate", "drug", "178-189"]}
{"TEXT1": "@DRUG$ orthostatic hypotension occur @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d734.s0.p0", "DRUGA": ["Thiazide diuretics", "group", "0-17"], "DRUGB": ["phenothiazines", "group", "82-95"]}
{"TEXT1": "Antihypertensive effects @DRUG$ related compounds @DRUG$ used", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d734.s1.p0", "DRUGA": ["guanethidine", "drug", "28-39"], "DRUGB": ["phenothiazines", "group", "88-101"]}
{"TEXT1": "Concomitant @DRUG$ @DRUG$ results increased levels drugs plasma", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d734.s2.p0", "DRUGA": ["propranolol", "drug", "30-40"], "DRUGB": ["phenothiazines", "group", "47-60"]}
{"TEXT1": "clinical studies @DRUG$ patients taking @DRUG$ dornase alfa agonists inhaled corticosteroids pseudomonal antibiotics parenteral aminoglycosides adverse experience profiles similar study population whole", "LBL": "0", "ID": "DDI-DrugBank.d624.s0.p0", "DRUGA": ["TOBI", "brand", "23-26"], "DRUGB": ["TOBI", "brand", "45-48"]}
{"TEXT1": "clinical studies @DRUG$ patients taking TOBI @DRUG$ agonists inhaled corticosteroids pseudomonal antibiotics parenteral aminoglycosides adverse experience profiles similar study population whole", "LBL": "0", "ID": "DDI-DrugBank.d624.s0.p1", "DRUGA": ["TOBI", "brand", "23-26"], "DRUGB": ["dornase alfa", "drug", "69-80"]}
{"TEXT1": "clinical studies @DRUG$ patients taking TOBI dornase alfa agonists inhaled corticosteroids pseudomonal antibiotics parenteral aminoglycosides adverse experience profiles similar study population whole", "LBL": "0", "ID": "DDI-DrugBank.d624.s0.p2", "DRUGA": ["TOBI", "brand", "23-26"], "DRUGB": ["PULMOZYME", "brand", "83-91"]}
{"TEXT1": "clinical studies @DRUG$ patients taking TOBI dornase alfa @DRUG$ inhaled corticosteroids pseudomonal antibiotics parenteral aminoglycosides adverse experience profiles similar study population whole", "LBL": "0", "ID": "DDI-DrugBank.d624.s0.p3", "DRUGA": ["TOBI", "brand", "23-26"], "DRUGB": ["(beta)-agonists", "group", "109-123"]}
{"TEXT1": "clinical studies @DRUG$ patients taking TOBI dornase alfa agonists inhaled @DRUG$ pseudomonal antibiotics parenteral aminoglycosides adverse experience profiles similar study population whole", "LBL": "0", "ID": "DDI-DrugBank.d624.s0.p4", "DRUGA": ["TOBI", "brand", "23-26"], "DRUGB": ["corticosteroids", "group", "134-148"]}
{"TEXT1": "clinical studies @DRUG$ patients taking TOBI dornase alfa agonists inhaled corticosteroids @DRUG$ parenteral aminoglycosides adverse experience profiles similar study population whole", "LBL": "0", "ID": "DDI-DrugBank.d624.s0.p5", "DRUGA": ["TOBI", "brand", "23-26"], "DRUGB": ["anti-pseudomonal antibiotics", "group", "157-184"]}
{"TEXT1": "clinical studies @DRUG$ patients taking TOBI dornase alfa agonists inhaled corticosteroids pseudomonal antibiotics parenteral @DRUG$ adverse experience profiles similar study population whole", "LBL": "0", "ID": "DDI-DrugBank.d624.s0.p6", "DRUGA": ["TOBI", "brand", "23-26"], "DRUGB": ["aminoglycosides", "group", "201-215"]}
{"TEXT1": "clinical studies TOBI patients taking @DRUG$ @DRUG$ agonists inhaled corticosteroids pseudomonal antibiotics parenteral aminoglycosides adverse experience profiles similar study population whole", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d624.s0.p7", "DRUGA": ["TOBI", "brand", "45-48"], "DRUGB": ["dornase alfa", "drug", "69-80"]}
{"TEXT1": "clinical studies TOBI patients taking @DRUG$ dornase alfa agonists inhaled corticosteroids pseudomonal antibiotics parenteral aminoglycosides adverse experience profiles similar study population whole", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d624.s0.p8", "DRUGA": ["TOBI", "brand", "45-48"], "DRUGB": ["PULMOZYME", "brand", "83-91"]}
{"TEXT1": "clinical studies TOBI patients taking @DRUG$ dornase alfa @DRUG$ inhaled corticosteroids pseudomonal antibiotics parenteral aminoglycosides adverse experience profiles similar study population whole", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d624.s0.p9", "DRUGA": ["TOBI", "brand", "45-48"], "DRUGB": ["(beta)-agonists", "group", "109-123"]}
{"TEXT1": "clinical studies TOBI patients taking @DRUG$ dornase alfa agonists inhaled @DRUG$ pseudomonal antibiotics parenteral aminoglycosides adverse experience profiles similar study population whole", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d624.s0.p10", "DRUGA": ["TOBI", "brand", "45-48"], "DRUGB": ["corticosteroids", "group", "134-148"]}
{"TEXT1": "clinical studies TOBI patients taking @DRUG$ dornase alfa agonists inhaled corticosteroids @DRUG$ parenteral aminoglycosides adverse experience profiles similar study population whole", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d624.s0.p11", "DRUGA": ["TOBI", "brand", "45-48"], "DRUGB": ["anti-pseudomonal antibiotics", "group", "157-184"]}
{"TEXT1": "clinical studies TOBI patients taking @DRUG$ dornase alfa agonists inhaled corticosteroids pseudomonal antibiotics parenteral @DRUG$ adverse experience profiles similar study population whole", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d624.s0.p12", "DRUGA": ["TOBI", "brand", "45-48"], "DRUGB": ["aminoglycosides", "group", "201-215"]}
{"TEXT1": "clinical studies TOBI patients taking @DRUG$ agonists inhaled corticosteroids pseudomonal antibiotics parenteral aminoglycosides adverse experience profiles similar study population whole", "LBL": "0", "ID": "DDI-DrugBank.d624.s0.p13", "DRUGA": ["dornase alfa", "drug", "69-80"], "DRUGB": ["PULMOZYME", "brand", "83-91"]}
{"TEXT1": "clinical studies TOBI patients taking @DRUG$ @DRUG$ inhaled corticosteroids pseudomonal antibiotics parenteral aminoglycosides adverse experience profiles similar study population whole", "LBL": "0", "ID": "DDI-DrugBank.d624.s0.p14", "DRUGA": ["dornase alfa", "drug", "69-80"], "DRUGB": ["(beta)-agonists", "group", "109-123"]}
{"TEXT1": "clinical studies TOBI patients taking @DRUG$ agonists inhaled @DRUG$ pseudomonal antibiotics parenteral aminoglycosides adverse experience profiles similar study population whole", "LBL": "0", "ID": "DDI-DrugBank.d624.s0.p15", "DRUGA": ["dornase alfa", "drug", "69-80"], "DRUGB": ["corticosteroids", "group", "134-148"]}
{"TEXT1": "clinical studies TOBI patients taking @DRUG$ agonists inhaled corticosteroids @DRUG$ parenteral aminoglycosides adverse experience profiles similar study population whole", "LBL": "0", "ID": "DDI-DrugBank.d624.s0.p16", "DRUGA": ["dornase alfa", "drug", "69-80"], "DRUGB": ["anti-pseudomonal antibiotics", "group", "157-184"]}
{"TEXT1": "clinical studies TOBI patients taking @DRUG$ agonists inhaled corticosteroids pseudomonal antibiotics parenteral @DRUG$ adverse experience profiles similar study population whole", "LBL": "0", "ID": "DDI-DrugBank.d624.s0.p17", "DRUGA": ["dornase alfa", "drug", "69-80"], "DRUGB": ["aminoglycosides", "group", "201-215"]}
{"TEXT1": "clinical studies TOBI patients taking dornase alfa @DRUG$ inhaled corticosteroids pseudomonal antibiotics parenteral aminoglycosides adverse experience profiles similar study population whole", "LBL": "0", "ID": "DDI-DrugBank.d624.s0.p18", "DRUGA": ["PULMOZYME", "brand", "83-91"], "DRUGB": ["(beta)-agonists", "group", "109-123"]}
{"TEXT1": "clinical studies TOBI patients taking dornase alfa agonists inhaled @DRUG$ pseudomonal antibiotics parenteral aminoglycosides adverse experience profiles similar study population whole", "LBL": "0", "ID": "DDI-DrugBank.d624.s0.p19", "DRUGA": ["PULMOZYME", "brand", "83-91"], "DRUGB": ["corticosteroids", "group", "134-148"]}
{"TEXT1": "clinical studies TOBI patients taking dornase alfa agonists inhaled corticosteroids @DRUG$ parenteral aminoglycosides adverse experience profiles similar study population whole", "LBL": "0", "ID": "DDI-DrugBank.d624.s0.p20", "DRUGA": ["PULMOZYME", "brand", "83-91"], "DRUGB": ["anti-pseudomonal antibiotics", "group", "157-184"]}
{"TEXT1": "clinical studies TOBI patients taking dornase alfa agonists inhaled corticosteroids pseudomonal antibiotics parenteral @DRUG$ adverse experience profiles similar study population whole", "LBL": "0", "ID": "DDI-DrugBank.d624.s0.p21", "DRUGA": ["PULMOZYME", "brand", "83-91"], "DRUGB": ["aminoglycosides", "group", "201-215"]}
{"TEXT1": "clinical studies TOBI patients taking dornase alfa @DRUG$ inhaled @DRUG$ pseudomonal antibiotics parenteral aminoglycosides adverse experience profiles similar study population whole", "LBL": "0", "ID": "DDI-DrugBank.d624.s0.p22", "DRUGA": ["(beta)-agonists", "group", "109-123"], "DRUGB": ["corticosteroids", "group", "134-148"]}
{"TEXT1": "clinical studies TOBI patients taking dornase alfa @DRUG$ inhaled corticosteroids @DRUG$ parenteral aminoglycosides adverse experience profiles similar study population whole", "LBL": "0", "ID": "DDI-DrugBank.d624.s0.p23", "DRUGA": ["(beta)-agonists", "group", "109-123"], "DRUGB": ["anti-pseudomonal antibiotics", "group", "157-184"]}
{"TEXT1": "clinical studies TOBI patients taking dornase alfa @DRUG$ inhaled corticosteroids pseudomonal antibiotics parenteral @DRUG$ adverse experience profiles similar study population whole", "LBL": "0", "ID": "DDI-DrugBank.d624.s0.p24", "DRUGA": ["(beta)-agonists", "group", "109-123"], "DRUGB": ["aminoglycosides", "group", "201-215"]}
{"TEXT1": "clinical studies TOBI patients taking dornase alfa agonists inhaled @DRUG$ @DRUG$ parenteral aminoglycosides adverse experience profiles similar study population whole", "LBL": "0", "ID": "DDI-DrugBank.d624.s0.p25", "DRUGA": ["corticosteroids", "group", "134-148"], "DRUGB": ["anti-pseudomonal antibiotics", "group", "157-184"]}
{"TEXT1": "clinical studies TOBI patients taking dornase alfa agonists inhaled @DRUG$ pseudomonal antibiotics parenteral @DRUG$ adverse experience profiles similar study population whole", "LBL": "0", "ID": "DDI-DrugBank.d624.s0.p26", "DRUGA": ["corticosteroids", "group", "134-148"], "DRUGB": ["aminoglycosides", "group", "201-215"]}
{"TEXT1": "clinical studies TOBI patients taking dornase alfa agonists inhaled corticosteroids @DRUG$ parenteral @DRUG$ adverse experience profiles similar study population whole", "LBL": "0", "ID": "DDI-DrugBank.d624.s0.p27", "DRUGA": ["anti-pseudomonal antibiotics", "group", "157-184"], "DRUGB": ["aminoglycosides", "group", "201-215"]}
{"TEXT1": "@DRUG$ enhance @DRUG$ toxicity altering concentrations serum tissue", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d624.s2.p0", "DRUGA": ["diuretics", "group", "5-13"], "DRUGB": ["aminoglycoside", "group", "27-40"]}
{"TEXT1": "@DRUG$ enhance toxicity altering @DRUG$ concentrations serum tissue", "LBL": "0", "ID": "DDI-DrugBank.d624.s2.p1", "DRUGA": ["diuretics", "group", "5-13"], "DRUGB": ["antibiotic", "group", "63-72"]}
{"TEXT1": "diuretics enhance @DRUG$ toxicity altering @DRUG$ concentrations serum tissue", "LBL": "0", "ID": "DDI-DrugBank.d624.s2.p2", "DRUGA": ["aminoglycoside", "group", "27-40"], "DRUGB": ["antibiotic", "group", "63-72"]}
{"TEXT1": "@DRUG$ not administered @DRUG$ furosemide urea mannitol", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d624.s3.p0", "DRUGA": ["TOBI", "brand", "0-3"], "DRUGB": ["ethacrynic acid", "drug", "51-65"]}
{"TEXT1": "@DRUG$ not administered ethacrynic acid @DRUG$ urea mannitol", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d624.s3.p1", "DRUGA": ["TOBI", "brand", "0-3"], "DRUGB": ["furosemide", "drug", "68-77"]}
{"TEXT1": "@DRUG$ not administered ethacrynic acid furosemide @DRUG$ mannitol", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d624.s3.p2", "DRUGA": ["TOBI", "brand", "0-3"], "DRUGB": ["urea", "drug", "80-83"]}
{"TEXT1": "@DRUG$ not administered ethacrynic acid furosemide urea @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d624.s3.p3", "DRUGA": ["TOBI", "brand", "0-3"], "DRUGB": ["mannitol", "drug", "89-96"]}
{"TEXT1": "TOBI not administered @DRUG$ @DRUG$ urea mannitol", "LBL": "0", "ID": "DDI-DrugBank.d624.s3.p4", "DRUGA": ["ethacrynic acid", "drug", "51-65"], "DRUGB": ["furosemide", "drug", "68-77"]}
{"TEXT1": "TOBI not administered @DRUG$ furosemide @DRUG$ mannitol", "LBL": "0", "ID": "DDI-DrugBank.d624.s3.p5", "DRUGA": ["ethacrynic acid", "drug", "51-65"], "DRUGB": ["urea", "drug", "80-83"]}
{"TEXT1": "TOBI not administered @DRUG$ furosemide urea @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d624.s3.p6", "DRUGA": ["ethacrynic acid", "drug", "51-65"], "DRUGB": ["mannitol", "drug", "89-96"]}
{"TEXT1": "TOBI not administered ethacrynic acid @DRUG$ @DRUG$ mannitol", "LBL": "0", "ID": "DDI-DrugBank.d624.s3.p7", "DRUGA": ["furosemide", "drug", "68-77"], "DRUGB": ["urea", "drug", "80-83"]}
{"TEXT1": "TOBI not administered ethacrynic acid @DRUG$ urea @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d624.s3.p8", "DRUGA": ["furosemide", "drug", "68-77"], "DRUGB": ["mannitol", "drug", "89-96"]}
{"TEXT1": "TOBI not administered ethacrynic acid furosemide @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d624.s3.p9", "DRUGA": ["urea", "drug", "80-83"], "DRUGB": ["mannitol", "drug", "89-96"]}
{"TEXT1": "inhibitor CYP2C8 increase AUC @DRUG$ inducer decrease rosiglitazone", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d609.s0.p0", "DRUGA": ["gemfibrozil", "drug", "32-42"], "DRUGB": ["rosiglitazone", "drug", "69-81"]}
{"TEXT1": "inhibitor CYP2C8 increase AUC rosiglitazone inducer decrease", "LBL": "0", "ID": "DDI-DrugBank.d609.s0.p1", "DRUGA": ["gemfibrozil", "drug", "32-42"], "DRUGB": ["rifampin", "drug", "117-124"]}
{"TEXT1": "inhibitor CYP2C8 increase AUC rosiglitazone inducer decrease @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d609.s0.p2", "DRUGA": ["gemfibrozil", "drug", "32-42"], "DRUGB": ["rosiglitazone", "drug", "151-163"]}
{"TEXT1": "inhibitor CYP2C8 increase AUC @DRUG$ inducer decrease rosiglitazone", "LBL": "0", "ID": "DDI-DrugBank.d609.s0.p3", "DRUGA": ["rosiglitazone", "drug", "69-81"], "DRUGB": ["rifampin", "drug", "117-124"]}
{"TEXT1": "inhibitor CYP2C8 increase AUC @DRUG$ inducer decrease @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d609.s0.p4", "DRUGA": ["rosiglitazone", "drug", "69-81"], "DRUGB": ["rosiglitazone", "drug", "151-163"]}
{"TEXT1": "inhibitor CYP2C8 increase AUC rosiglitazone inducer decrease @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d609.s0.p5", "DRUGA": ["rifampin", "drug", "117-124"], "DRUGB": ["rosiglitazone", "drug", "151-163"]}
{"TEXT1": "@DRUG$ causes reduction absorption cycling raloxifene not EVISTA", "LBL": "0", "ID": "DDI-DrugBank.d648.s0.p0", "DRUGA": ["Cholestyramine", "drug", "0-13"], "DRUGB": ["Cholestyramine", "drug", "16-29"]}
{"TEXT1": "Cholestyramine causes reduction absorption cycling @DRUG$ not EVISTA", "LBL": "0", "ID": "DDI-DrugBank.d648.s0.p1", "DRUGA": ["Cholestyramine", "drug", "0-13"], "DRUGB": ["raloxifene", "drug", "101-110"]}
{"TEXT1": "Cholestyramine causes reduction absorption cycling raloxifene not @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d648.s0.p2", "DRUGA": ["Cholestyramine", "drug", "0-13"], "DRUGB": ["EVISTA", "brand", "150-155"]}
{"TEXT1": "@DRUG$ causes reduction absorption cycling @DRUG$ not EVISTA", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d648.s0.p3", "DRUGA": ["Cholestyramine", "drug", "16-29"], "DRUGB": ["raloxifene", "drug", "101-110"]}
{"TEXT1": "@DRUG$ causes reduction absorption cycling raloxifene not @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d648.s0.p4", "DRUGA": ["Cholestyramine", "drug", "16-29"], "DRUGB": ["EVISTA", "brand", "150-155"]}
{"TEXT1": "Cholestyramine causes reduction absorption cycling @DRUG$ not @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d648.s0.p5", "DRUGA": ["raloxifene", "drug", "101-110"], "DRUGB": ["EVISTA", "brand", "150-155"]}
{"TEXT1": "coadministration @DRUG$ warfarin not assessed chronic conditions", "LBL": "0", "ID": "DDI-DrugBank.d648.s1.p0", "DRUGA": ["Warfarin", "drug", "0-7"], "DRUGB": ["EVISTA", "brand", "34-39"]}
{"TEXT1": "coadministration EVISTA @DRUG$ not assessed chronic conditions", "LBL": "0", "ID": "DDI-DrugBank.d648.s1.p1", "DRUGA": ["Warfarin", "drug", "0-7"], "DRUGB": ["warfarin", "drug", "45-52"]}
{"TEXT1": "coadministration @DRUG$ @DRUG$ not assessed chronic conditions", "LBL": "0", "ID": "DDI-DrugBank.d648.s1.p2", "DRUGA": ["EVISTA", "brand", "34-39"], "DRUGB": ["warfarin", "drug", "45-52"]}
{"TEXT1": "@DRUG$ given @DRUG$ prothrombin time monitored", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d648.s3.p0", "DRUGA": ["EVISTA", "brand", "3-8"], "DRUGB": ["warfarin", "drug", "37-44"]}
{"TEXT1": "In vitro @DRUG$ not affect binding @DRUG$ phenytoin tamoxifen", "LBL": "0", "ID": "DDI-DrugBank.d648.s5.p0", "DRUGA": ["raloxifene", "drug", "10-19"], "DRUGB": ["warfarin", "drug", "51-58"]}
{"TEXT1": "In vitro @DRUG$ not affect binding warfarin @DRUG$ tamoxifen", "LBL": "0", "ID": "DDI-DrugBank.d648.s5.p1", "DRUGA": ["raloxifene", "drug", "10-19"], "DRUGB": ["phenytoin", "drug", "61-69"]}
{"TEXT1": "In vitro @DRUG$ not affect binding warfarin phenytoin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d648.s5.p2", "DRUGA": ["raloxifene", "drug", "10-19"], "DRUGB": ["tamoxifen", "drug", "75-83"]}
{"TEXT1": "In vitro raloxifene not affect binding @DRUG$ @DRUG$ tamoxifen", "LBL": "0", "ID": "DDI-DrugBank.d648.s5.p3", "DRUGA": ["warfarin", "drug", "51-58"], "DRUGB": ["phenytoin", "drug", "61-69"]}
{"TEXT1": "In vitro raloxifene not affect binding @DRUG$ phenytoin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d648.s5.p4", "DRUGA": ["warfarin", "drug", "51-58"], "DRUGB": ["tamoxifen", "drug", "75-83"]}
{"TEXT1": "In vitro raloxifene not affect binding warfarin @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d648.s5.p5", "DRUGA": ["phenytoin", "drug", "61-69"], "DRUGB": ["tamoxifen", "drug", "75-83"]}
{"TEXT1": "used @DRUG$ highly protein bound drugs @DRUG$ indomethacin naproxen ibuprofen diazepam diazoxide", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d648.s6.p0", "DRUGA": ["EVISTA", "brand", "28-33"], "DRUGB": ["clofibrate", "drug", "100-109"]}
{"TEXT1": "used @DRUG$ highly protein bound drugs clofibrate @DRUG$ naproxen ibuprofen diazepam diazoxide", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d648.s6.p1", "DRUGA": ["EVISTA", "brand", "28-33"], "DRUGB": ["indomethacin", "drug", "112-123"]}
{"TEXT1": "used @DRUG$ highly protein bound drugs clofibrate indomethacin @DRUG$ ibuprofen diazepam diazoxide", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d648.s6.p2", "DRUGA": ["EVISTA", "brand", "28-33"], "DRUGB": ["naproxen", "drug", "126-133"]}
{"TEXT1": "used @DRUG$ highly protein bound drugs clofibrate indomethacin naproxen @DRUG$ diazepam diazoxide", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d648.s6.p3", "DRUGA": ["EVISTA", "brand", "28-33"], "DRUGB": ["ibuprofen", "drug", "136-144"]}
{"TEXT1": "used @DRUG$ highly protein bound drugs clofibrate indomethacin naproxen ibuprofen @DRUG$ diazoxide", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d648.s6.p4", "DRUGA": ["EVISTA", "brand", "28-33"], "DRUGB": ["diazepam", "drug", "147-154"]}
{"TEXT1": "used @DRUG$ highly protein bound drugs clofibrate indomethacin naproxen ibuprofen diazepam @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d648.s6.p5", "DRUGA": ["EVISTA", "brand", "28-33"], "DRUGB": ["diazoxide", "drug", "161-169"]}
{"TEXT1": "used EVISTA highly protein bound drugs @DRUG$ @DRUG$ naproxen ibuprofen diazepam diazoxide", "LBL": "0", "ID": "DDI-DrugBank.d648.s6.p6", "DRUGA": ["clofibrate", "drug", "100-109"], "DRUGB": ["indomethacin", "drug", "112-123"]}
{"TEXT1": "used EVISTA highly protein bound drugs @DRUG$ indomethacin @DRUG$ ibuprofen diazepam diazoxide", "LBL": "0", "ID": "DDI-DrugBank.d648.s6.p7", "DRUGA": ["clofibrate", "drug", "100-109"], "DRUGB": ["naproxen", "drug", "126-133"]}
{"TEXT1": "used EVISTA highly protein bound drugs @DRUG$ indomethacin naproxen @DRUG$ diazepam diazoxide", "LBL": "0", "ID": "DDI-DrugBank.d648.s6.p8", "DRUGA": ["clofibrate", "drug", "100-109"], "DRUGB": ["ibuprofen", "drug", "136-144"]}
{"TEXT1": "used EVISTA highly protein bound drugs @DRUG$ indomethacin naproxen ibuprofen @DRUG$ diazoxide", "LBL": "0", "ID": "DDI-DrugBank.d648.s6.p9", "DRUGA": ["clofibrate", "drug", "100-109"], "DRUGB": ["diazepam", "drug", "147-154"]}
{"TEXT1": "used EVISTA highly protein bound drugs @DRUG$ indomethacin naproxen ibuprofen diazepam @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d648.s6.p10", "DRUGA": ["clofibrate", "drug", "100-109"], "DRUGB": ["diazoxide", "drug", "161-169"]}
{"TEXT1": "used EVISTA highly protein bound drugs clofibrate @DRUG$ @DRUG$ ibuprofen diazepam diazoxide", "LBL": "0", "ID": "DDI-DrugBank.d648.s6.p11", "DRUGA": ["indomethacin", "drug", "112-123"], "DRUGB": ["naproxen", "drug", "126-133"]}
{"TEXT1": "used EVISTA highly protein bound drugs clofibrate @DRUG$ naproxen @DRUG$ diazepam diazoxide", "LBL": "0", "ID": "DDI-DrugBank.d648.s6.p12", "DRUGA": ["indomethacin", "drug", "112-123"], "DRUGB": ["ibuprofen", "drug", "136-144"]}
{"TEXT1": "used EVISTA highly protein bound drugs clofibrate @DRUG$ naproxen ibuprofen @DRUG$ diazoxide", "LBL": "0", "ID": "DDI-DrugBank.d648.s6.p13", "DRUGA": ["indomethacin", "drug", "112-123"], "DRUGB": ["diazepam", "drug", "147-154"]}
{"TEXT1": "used EVISTA highly protein bound drugs clofibrate @DRUG$ naproxen ibuprofen diazepam @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d648.s6.p14", "DRUGA": ["indomethacin", "drug", "112-123"], "DRUGB": ["diazoxide", "drug", "161-169"]}
{"TEXT1": "used EVISTA highly protein bound drugs clofibrate indomethacin @DRUG$ @DRUG$ diazepam diazoxide", "LBL": "0", "ID": "DDI-DrugBank.d648.s6.p15", "DRUGA": ["naproxen", "drug", "126-133"], "DRUGB": ["ibuprofen", "drug", "136-144"]}
{"TEXT1": "used EVISTA highly protein bound drugs clofibrate indomethacin @DRUG$ ibuprofen @DRUG$ diazoxide", "LBL": "0", "ID": "DDI-DrugBank.d648.s6.p16", "DRUGA": ["naproxen", "drug", "126-133"], "DRUGB": ["diazepam", "drug", "147-154"]}
{"TEXT1": "used EVISTA highly protein bound drugs clofibrate indomethacin @DRUG$ ibuprofen diazepam @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d648.s6.p17", "DRUGA": ["naproxen", "drug", "126-133"], "DRUGB": ["diazoxide", "drug", "161-169"]}
{"TEXT1": "used EVISTA highly protein bound drugs clofibrate indomethacin naproxen @DRUG$ @DRUG$ diazoxide", "LBL": "0", "ID": "DDI-DrugBank.d648.s6.p18", "DRUGA": ["ibuprofen", "drug", "136-144"], "DRUGB": ["diazepam", "drug", "147-154"]}
{"TEXT1": "used EVISTA highly protein bound drugs clofibrate indomethacin naproxen @DRUG$ diazepam @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d648.s6.p19", "DRUGA": ["ibuprofen", "drug", "136-144"], "DRUGB": ["diazoxide", "drug", "161-169"]}
{"TEXT1": "used EVISTA highly protein bound drugs clofibrate indomethacin naproxen ibuprofen @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d648.s6.p20", "DRUGA": ["diazepam", "drug", "147-154"], "DRUGB": ["diazoxide", "drug", "161-169"]}
{"TEXT1": "@DRUG$ @DRUG$ active tubular secretion inhibits renal excretion meropenem", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d762.s0.p0", "DRUGA": ["Probenecid", "drug", "0-9"], "DRUGB": ["meropenem", "drug", "25-33"]}
{"TEXT1": "@DRUG$ meropenem active tubular secretion inhibits renal excretion @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d762.s0.p1", "DRUGA": ["Probenecid", "drug", "0-9"], "DRUGB": ["meropenem", "drug", "105-113"]}
{"TEXT1": "Probenecid @DRUG$ active tubular secretion inhibits renal excretion @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d762.s0.p2", "DRUGA": ["meropenem", "drug", "25-33"], "DRUGB": ["meropenem", "drug", "105-113"]}
{"TEXT1": "coadministration @DRUG$ @DRUG$ not recommended", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d762.s2.p0", "DRUGA": ["probenecid", "drug", "35-44"], "DRUGB": ["meropenem", "drug", "51-59"]}
{"TEXT1": "evidence @DRUG$ serum levels @DRUG$ to considered 50 100 g/mL", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d762.s3.p0", "DRUGA": ["meropenem", "drug", "23-31"], "DRUGB": ["valproic acid", "drug", "60-72"]}
{"TEXT1": "evidence @DRUG$ serum levels valproic acid to considered 50 100 g/mL", "LBL": "0", "ID": "DDI-DrugBank.d762.s3.p1", "DRUGA": ["meropenem", "drug", "23-31"], "DRUGB": ["valproate", "drug", "159-167"]}
{"TEXT1": "evidence meropenem serum levels @DRUG$ to considered 50 100 g/mL", "LBL": "0", "ID": "DDI-DrugBank.d762.s3.p2", "DRUGA": ["valproic acid", "drug", "60-72"], "DRUGB": ["valproate", "drug", "159-167"]}
{"TEXT1": "@DRUG$ not used @DRUG$ additive effects", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d611.s0.p0", "DRUGA": ["beta adrenergic aerosol bronchodilators", "group", "6-44"], "DRUGB": ["Alupent", "brand", "84-90"]}
{"TEXT1": "@DRUG$ not used Alupent additive effects", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d611.s0.p1", "DRUGA": ["beta adrenergic aerosol bronchodilators", "group", "6-44"], "DRUGB": ["metaproterenol sulfate", "drug", "96-117"]}
{"TEXT1": "beta adrenergic aerosol bronchodilators not used @DRUG$ additive effects", "LBL": "0", "ID": "DDI-DrugBank.d611.s0.p2", "DRUGA": ["Alupent", "brand", "84-90"], "DRUGB": ["metaproterenol sulfate", "drug", "96-117"]}
{"TEXT1": "@DRUG$ administered patients @DRUG$ tricyclic antidepressants action beta adrenergic agonists vascular system", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d611.s1.p0", "DRUGA": ["Beta adrenergic agonists", "group", "0-23"], "DRUGB": ["monoamine oxidase inhibitors", "group", "92-119"]}
{"TEXT1": "@DRUG$ administered patients monoamine oxidase inhibitors @DRUG$ action beta adrenergic agonists vascular system", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d611.s1.p1", "DRUGA": ["Beta adrenergic agonists", "group", "0-23"], "DRUGB": ["tricyclic antidepressants", "group", "124-148"]}
{"TEXT1": "@DRUG$ administered patients monoamine oxidase inhibitors tricyclic antidepressants action @DRUG$ vascular system", "LBL": "0", "ID": "DDI-DrugBank.d611.s1.p2", "DRUGA": ["Beta adrenergic agonists", "group", "0-23"], "DRUGB": ["beta adrenergic agonists", "group", "171-194"]}
{"TEXT1": "administered patients @DRUG$ @DRUG$ action vascular system", "LBL": "0", "ID": "DDI-DrugBank.d611.s1.p3", "DRUGA": ["monoamine oxidase inhibitors", "group", "92-119"], "DRUGB": ["tricyclic antidepressants", "group", "124-148"]}
{"TEXT1": "administered patients @DRUG$ tricyclic antidepressants action @DRUG$ vascular system", "LBL": "0", "ID": "DDI-DrugBank.d611.s1.p4", "DRUGA": ["monoamine oxidase inhibitors", "group", "92-119"], "DRUGB": ["beta adrenergic agonists", "group", "171-194"]}
{"TEXT1": "administered patients monoamine oxidase inhibitors @DRUG$ action @DRUG$ vascular system", "LBL": "0", "ID": "DDI-DrugBank.d611.s1.p5", "DRUGA": ["tricyclic antidepressants", "group", "124-148"], "DRUGB": ["beta adrenergic agonists", "group", "171-194"]}
{"TEXT1": "use of @DRUG$ Injection succinylcholine purpose attenuating side effects not studied", "LBL": "0", "ID": "DDI-DrugBank.d661.s0.p0", "DRUGA": ["ZEMURON", "brand", "30-36"], "DRUGB": ["rocuronium bromide", "drug", "42-59"]}
{"TEXT1": "use of @DRUG$ Injection @DRUG$ purpose attenuating side effects succinylcholine not studied", "LBL": "0", "ID": "DDI-DrugBank.d661.s0.p1", "DRUGA": ["ZEMURON", "brand", "30-36"], "DRUGB": ["succinylcholine", "drug", "79-93"]}
{"TEXT1": "use of @DRUG$ Injection succinylcholine purpose attenuating side effects @DRUG$ not studied", "LBL": "0", "ID": "DDI-DrugBank.d661.s0.p2", "DRUGA": ["ZEMURON", "brand", "30-36"], "DRUGB": ["succinylcholine", "drug", "155-169"]}
{"TEXT1": "use of ZEMURON Injection @DRUG$ purpose attenuating side effects succinylcholine not studied", "LBL": "0", "ID": "DDI-DrugBank.d661.s0.p3", "DRUGA": ["rocuronium bromide", "drug", "42-59"], "DRUGB": ["succinylcholine", "drug", "79-93"]}
{"TEXT1": "use of ZEMURON Injection succinylcholine purpose attenuating side effects @DRUG$ not studied", "LBL": "0", "ID": "DDI-DrugBank.d661.s0.p4", "DRUGA": ["rocuronium bromide", "drug", "42-59"], "DRUGB": ["succinylcholine", "drug", "155-169"]}
{"TEXT1": "use of ZEMURON Injection @DRUG$ purpose attenuating side effects @DRUG$ not studied", "LBL": "0", "ID": "DDI-DrugBank.d661.s0.p5", "DRUGA": ["succinylcholine", "drug", "79-93"], "DRUGB": ["succinylcholine", "drug", "155-169"]}
{"TEXT1": "@DRUG$ administered following administration @DRUG$ not given recovery succinylcholine observed", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d661.s1.p0", "DRUGA": ["ZEMURON", "brand", "3-9"], "DRUGB": ["succinylcholine", "drug", "58-72"]}
{"TEXT1": "@DRUG$ administered following administration succinylcholine not given recovery @DRUG$ observed", "LBL": "0", "ID": "DDI-DrugBank.d661.s1.p1", "DRUGA": ["ZEMURON", "brand", "3-9"], "DRUGB": ["succinylcholine", "drug", "118-132"]}
{"TEXT1": "ZEMURON administered following administration @DRUG$ not given recovery @DRUG$ observed", "LBL": "0", "ID": "DDI-DrugBank.d661.s1.p2", "DRUGA": ["succinylcholine", "drug", "58-72"], "DRUGB": ["succinylcholine", "drug", "118-132"]}
{"TEXT1": "median duration action @DRUG$ mg/kg administered @DRUG$ T returned control 36 minutes 57 vs", "LBL": "0", "ID": "DDI-DrugBank.d661.s2.p0", "DRUGA": ["ZEMURON", "brand", "33-39"], "DRUGB": ["succinylcholine", "drug", "91-105"]}
{"TEXT1": "no controlled studies documenting use of @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d661.s4.p0", "DRUGA": ["ZEMURON", "brand", "55-61"], "DRUGB": ["nondepolarizing muscle relaxants", "group", "88-119"]}
{"TEXT1": "@DRUG$ metabolized hepatic drug CYP2D6 inducers change clearance @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d763.s1.p0", "DRUGA": ["ondansetron", "drug", "8-18"], "DRUGB": ["ondansetron", "drug", "209-219"]}
{"TEXT1": "@DRUG$ @DRUG$ patients treated with potent inducers CYP3A4 phenytoin carbamazepine clearance ondansetron increased blood concentrations decreased", "LBL": "0", "ID": "DDI-DrugBank.d763.s3.p0", "DRUGA": ["Phenytoin", "drug", "0-8"], "DRUGB": ["Carbamazepine", "drug", "11-23"]}
{"TEXT1": "@DRUG$ patients treated with potent inducers CYP3A4 phenytoin carbamazepine clearance ondansetron increased blood concentrations decreased", "LBL": "0", "ID": "DDI-DrugBank.d763.s3.p1", "DRUGA": ["Phenytoin", "drug", "0-8"], "DRUGB": ["Rifampicin", "drug", "30-39"]}
{"TEXT1": "@DRUG$ patients treated with potent inducers CYP3A4 @DRUG$ carbamazepine clearance ondansetron increased blood concentrations decreased", "LBL": "0", "ID": "DDI-DrugBank.d763.s3.p2", "DRUGA": ["Phenytoin", "drug", "0-8"], "DRUGB": ["phenytoin", "drug", "100-108"]}
{"TEXT1": "@DRUG$ patients treated with potent inducers CYP3A4 phenytoin @DRUG$ clearance ondansetron increased blood concentrations decreased", "LBL": "0", "ID": "DDI-DrugBank.d763.s3.p3", "DRUGA": ["Phenytoin", "drug", "0-8"], "DRUGB": ["carbamazepine", "drug", "111-123"]}
{"TEXT1": "@DRUG$ patients treated with potent inducers CYP3A4 phenytoin carbamazepine clearance ondansetron increased blood concentrations decreased", "LBL": "0", "ID": "DDI-DrugBank.d763.s3.p4", "DRUGA": ["Phenytoin", "drug", "0-8"], "DRUGB": ["rifampicin", "drug", "130-139"]}
{"TEXT1": "@DRUG$ patients treated with potent inducers CYP3A4 phenytoin carbamazepine clearance @DRUG$ increased ondansetron blood concentrations decreased", "LBL": "0", "ID": "DDI-DrugBank.d763.s3.p5", "DRUGA": ["Phenytoin", "drug", "0-8"], "DRUGB": ["ondansetron", "drug", "160-170"]}
{"TEXT1": "@DRUG$ patients treated with potent inducers CYP3A4 phenytoin carbamazepine clearance ondansetron increased @DRUG$ blood concentrations decreased", "LBL": "0", "ID": "DDI-DrugBank.d763.s3.p6", "DRUGA": ["Phenytoin", "drug", "0-8"], "DRUGB": ["ondansetron", "drug", "204-214"]}
{"TEXT1": "@DRUG$ patients treated with potent inducers CYP3A4 phenytoin carbamazepine clearance ondansetron increased blood concentrations decreased", "LBL": "0", "ID": "DDI-DrugBank.d763.s3.p7", "DRUGA": ["Carbamazepine", "drug", "11-23"], "DRUGB": ["Rifampicin", "drug", "30-39"]}
{"TEXT1": "@DRUG$ patients treated with potent inducers CYP3A4 @DRUG$ carbamazepine clearance ondansetron increased blood concentrations decreased", "LBL": "0", "ID": "DDI-DrugBank.d763.s3.p8", "DRUGA": ["Carbamazepine", "drug", "11-23"], "DRUGB": ["phenytoin", "drug", "100-108"]}
{"TEXT1": "@DRUG$ patients treated with potent inducers CYP3A4 phenytoin @DRUG$ clearance ondansetron increased blood concentrations decreased", "LBL": "0", "ID": "DDI-DrugBank.d763.s3.p9", "DRUGA": ["Carbamazepine", "drug", "11-23"], "DRUGB": ["carbamazepine", "drug", "111-123"]}
{"TEXT1": "@DRUG$ patients treated with potent inducers CYP3A4 phenytoin carbamazepine clearance ondansetron increased blood concentrations decreased", "LBL": "0", "ID": "DDI-DrugBank.d763.s3.p10", "DRUGA": ["Carbamazepine", "drug", "11-23"], "DRUGB": ["rifampicin", "drug", "130-139"]}
{"TEXT1": "@DRUG$ patients treated with potent inducers CYP3A4 phenytoin carbamazepine clearance @DRUG$ increased ondansetron blood concentrations decreased", "LBL": "0", "ID": "DDI-DrugBank.d763.s3.p11", "DRUGA": ["Carbamazepine", "drug", "11-23"], "DRUGB": ["ondansetron", "drug", "160-170"]}
{"TEXT1": "@DRUG$ patients treated with potent inducers CYP3A4 phenytoin carbamazepine clearance ondansetron increased @DRUG$ blood concentrations decreased", "LBL": "0", "ID": "DDI-DrugBank.d763.s3.p12", "DRUGA": ["Carbamazepine", "drug", "11-23"], "DRUGB": ["ondansetron", "drug", "204-214"]}
{"TEXT1": "patients treated with potent inducers CYP3A4 @DRUG$ carbamazepine clearance ondansetron increased blood concentrations decreased", "LBL": "0", "ID": "DDI-DrugBank.d763.s3.p13", "DRUGA": ["Rifampicin", "drug", "30-39"], "DRUGB": ["phenytoin", "drug", "100-108"]}
{"TEXT1": "patients treated with potent inducers CYP3A4 phenytoin @DRUG$ clearance ondansetron increased blood concentrations decreased", "LBL": "0", "ID": "DDI-DrugBank.d763.s3.p14", "DRUGA": ["Rifampicin", "drug", "30-39"], "DRUGB": ["carbamazepine", "drug", "111-123"]}
{"TEXT1": "patients treated with potent inducers CYP3A4 phenytoin carbamazepine clearance ondansetron increased blood concentrations decreased", "LBL": "0", "ID": "DDI-DrugBank.d763.s3.p15", "DRUGA": ["Rifampicin", "drug", "30-39"], "DRUGB": ["rifampicin", "drug", "130-139"]}
{"TEXT1": "patients treated with potent inducers CYP3A4 phenytoin carbamazepine clearance @DRUG$ increased ondansetron blood concentrations decreased", "LBL": "0", "ID": "DDI-DrugBank.d763.s3.p16", "DRUGA": ["Rifampicin", "drug", "30-39"], "DRUGB": ["ondansetron", "drug", "160-170"]}
{"TEXT1": "patients treated with potent inducers CYP3A4 phenytoin carbamazepine clearance ondansetron increased @DRUG$ blood concentrations decreased", "LBL": "0", "ID": "DDI-DrugBank.d763.s3.p17", "DRUGA": ["Rifampicin", "drug", "30-39"], "DRUGB": ["ondansetron", "drug", "204-214"]}
{"TEXT1": "patients treated with potent inducers CYP3A4 @DRUG$ @DRUG$ clearance ondansetron increased blood concentrations decreased", "LBL": "0", "ID": "DDI-DrugBank.d763.s3.p18", "DRUGA": ["phenytoin", "drug", "100-108"], "DRUGB": ["carbamazepine", "drug", "111-123"]}
{"TEXT1": "patients treated with potent inducers CYP3A4 @DRUG$ carbamazepine clearance ondansetron increased blood concentrations decreased", "LBL": "0", "ID": "DDI-DrugBank.d763.s3.p19", "DRUGA": ["phenytoin", "drug", "100-108"], "DRUGB": ["rifampicin", "drug", "130-139"]}
{"TEXT1": "patients treated with potent inducers CYP3A4 @DRUG$ carbamazepine clearance @DRUG$ increased ondansetron blood concentrations decreased", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d763.s3.p20", "DRUGA": ["phenytoin", "drug", "100-108"], "DRUGB": ["ondansetron", "drug", "160-170"]}
{"TEXT1": "patients treated with potent inducers CYP3A4 @DRUG$ carbamazepine clearance ondansetron increased @DRUG$ blood concentrations decreased", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d763.s3.p21", "DRUGA": ["phenytoin", "drug", "100-108"], "DRUGB": ["ondansetron", "drug", "204-214"]}
{"TEXT1": "patients treated with potent inducers CYP3A4 phenytoin @DRUG$ clearance ondansetron increased blood concentrations decreased", "LBL": "0", "ID": "DDI-DrugBank.d763.s3.p22", "DRUGA": ["carbamazepine", "drug", "111-123"], "DRUGB": ["rifampicin", "drug", "130-139"]}
{"TEXT1": "patients treated with potent inducers CYP3A4 phenytoin @DRUG$ clearance @DRUG$ increased ondansetron blood concentrations decreased", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d763.s3.p23", "DRUGA": ["carbamazepine", "drug", "111-123"], "DRUGB": ["ondansetron", "drug", "160-170"]}
{"TEXT1": "patients treated with potent inducers CYP3A4 phenytoin @DRUG$ clearance ondansetron increased @DRUG$ blood concentrations decreased", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d763.s3.p24", "DRUGA": ["carbamazepine", "drug", "111-123"], "DRUGB": ["ondansetron", "drug", "204-214"]}
{"TEXT1": "patients treated with potent inducers CYP3A4 phenytoin carbamazepine clearance @DRUG$ increased ondansetron blood concentrations decreased", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d763.s3.p25", "DRUGA": ["rifampicin", "drug", "130-139"], "DRUGB": ["ondansetron", "drug", "160-170"]}
{"TEXT1": "patients treated with potent inducers CYP3A4 phenytoin carbamazepine clearance ondansetron increased @DRUG$ blood concentrations decreased", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d763.s3.p26", "DRUGA": ["rifampicin", "drug", "130-139"], "DRUGB": ["ondansetron", "drug", "204-214"]}
{"TEXT1": "patients treated with potent inducers CYP3A4 phenytoin carbamazepine clearance @DRUG$ increased @DRUG$ blood concentrations decreased", "LBL": "0", "ID": "DDI-DrugBank.d763.s3.p27", "DRUGA": ["ondansetron", "drug", "160-170"], "DRUGB": ["ondansetron", "drug", "204-214"]}
{"TEXT1": "available data no dosage adjustment @DRUG$ recommended patients 3 pharmacokinetic drug interaction ondansetron tramadol observed small associated with increase controlled administration 5 Tumor response chemotherapy P mouse leukemia mouse model leukemia model not affected", "LBL": "0", "ID": "DDI-DrugBank.d763.s4.p0", "DRUGA": ["ondansetron", "drug", "66-76"], "DRUGB": ["Tramadol", "drug", "126-133"]}
{"TEXT1": "available data no dosage adjustment @DRUG$ recommended patients 3 pharmacokinetic drug interaction @DRUG$ tramadol observed small ondansetron associated with increase controlled administration 5 Tumor response chemotherapy P mouse leukemia mouse model leukemia model not affected", "LBL": "0", "ID": "DDI-DrugBank.d763.s4.p1", "DRUGA": ["ondansetron", "drug", "66-76"], "DRUGB": ["ondansetron", "drug", "189-199"]}
{"TEXT1": "available data no dosage adjustment @DRUG$ recommended patients 3 pharmacokinetic drug interaction ondansetron @DRUG$ observed small associated with increase controlled administration tramadol 5 Tumor response chemotherapy P mouse leukemia mouse model leukemia model not affected", "LBL": "0", "ID": "DDI-DrugBank.d763.s4.p2", "DRUGA": ["ondansetron", "drug", "66-76"], "DRUGB": ["tramadol", "drug", "205-212"]}
{"TEXT1": "available data no dosage adjustment @DRUG$ recommended patients 3 pharmacokinetic drug interaction ondansetron tramadol observed small @DRUG$ associated with increase controlled administration 5 Tumor response chemotherapy P mouse leukemia mouse model leukemia model not affected", "LBL": "0", "ID": "DDI-DrugBank.d763.s4.p3", "DRUGA": ["ondansetron", "drug", "66-76"], "DRUGB": ["ondansetron", "drug", "273-283"]}
{"TEXT1": "available data no dosage adjustment @DRUG$ recommended patients 3 pharmacokinetic drug interaction ondansetron tramadol observed small associated with increase controlled administration @DRUG$ 5 Tumor response chemotherapy P mouse leukemia mouse model leukemia model not affected", "LBL": "0", "ID": "DDI-DrugBank.d763.s4.p4", "DRUGA": ["ondansetron", "drug", "66-76"], "DRUGB": ["tramadol", "drug", "360-367"]}
{"TEXT1": "available data no dosage adjustment @DRUG$ recommended patients 3 pharmacokinetic drug interaction ondansetron tramadol observed small associated with increase controlled administration 5 Tumor response chemotherapy P mouse leukemia mouse model leukemia model not affected @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d763.s4.p5", "DRUGA": ["ondansetron", "drug", "66-76"], "DRUGB": ["ondansetron", "drug", "472-482"]}
{"TEXT1": "available data no dosage adjustment ondansetron recommended patients 3 pharmacokinetic drug interaction @DRUG$ tramadol observed small associated with increase controlled administration 5 Tumor response chemotherapy P mouse leukemia mouse model leukemia model not affected", "LBL": "0", "ID": "DDI-DrugBank.d763.s4.p6", "DRUGA": ["Tramadol", "drug", "126-133"], "DRUGB": ["ondansetron", "drug", "189-199"]}
{"TEXT1": "available data no dosage adjustment ondansetron recommended patients 3 pharmacokinetic drug interaction @DRUG$ observed small associated with increase controlled administration tramadol 5 Tumor response chemotherapy P mouse leukemia mouse model leukemia model not affected", "LBL": "0", "ID": "DDI-DrugBank.d763.s4.p7", "DRUGA": ["Tramadol", "drug", "126-133"], "DRUGB": ["tramadol", "drug", "205-212"]}
{"TEXT1": "available data no dosage adjustment ondansetron recommended patients 3 pharmacokinetic drug interaction tramadol observed small @DRUG$ associated with increase controlled administration 5 Tumor response chemotherapy P mouse leukemia mouse model leukemia model not affected", "LBL": "0", "ID": "DDI-DrugBank.d763.s4.p8", "DRUGA": ["Tramadol", "drug", "126-133"], "DRUGB": ["ondansetron", "drug", "273-283"]}
{"TEXT1": "available data no dosage adjustment ondansetron recommended patients 3 pharmacokinetic drug interaction tramadol observed small associated with increase controlled administration @DRUG$ 5 Tumor response chemotherapy P mouse leukemia mouse model leukemia model not affected", "LBL": "0", "ID": "DDI-DrugBank.d763.s4.p9", "DRUGA": ["Tramadol", "drug", "126-133"], "DRUGB": ["tramadol", "drug", "360-367"]}
{"TEXT1": "available data no dosage adjustment ondansetron recommended patients 3 pharmacokinetic drug interaction tramadol observed small associated with increase controlled administration 5 Tumor response chemotherapy P mouse leukemia mouse model leukemia model not affected @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d763.s4.p10", "DRUGA": ["Tramadol", "drug", "126-133"], "DRUGB": ["ondansetron", "drug", "472-482"]}
{"TEXT1": "available data no dosage adjustment ondansetron recommended patients 3 pharmacokinetic drug interaction @DRUG$ @DRUG$ observed small associated with increase controlled administration tramadol 5 Tumor response chemotherapy P mouse leukemia mouse model leukemia model not affected", "LBL": "0", "ID": "DDI-DrugBank.d763.s4.p11", "DRUGA": ["ondansetron", "drug", "189-199"], "DRUGB": ["tramadol", "drug", "205-212"]}
{"TEXT1": "available data no dosage adjustment ondansetron recommended patients 3 pharmacokinetic drug interaction @DRUG$ tramadol observed small @DRUG$ associated with increase controlled administration 5 Tumor response chemotherapy P mouse leukemia mouse model leukemia model not affected", "LBL": "0", "ID": "DDI-DrugBank.d763.s4.p12", "DRUGA": ["ondansetron", "drug", "189-199"], "DRUGB": ["ondansetron", "drug", "273-283"]}
{"TEXT1": "available data no dosage adjustment ondansetron recommended patients 3 pharmacokinetic drug interaction @DRUG$ tramadol observed small associated with increase controlled administration @DRUG$ 5 Tumor response chemotherapy P mouse leukemia mouse model leukemia model not affected", "LBL": "0", "ID": "DDI-DrugBank.d763.s4.p13", "DRUGA": ["ondansetron", "drug", "189-199"], "DRUGB": ["tramadol", "drug", "360-367"]}
{"TEXT1": "available data no dosage adjustment ondansetron recommended patients 3 pharmacokinetic drug interaction @DRUG$ tramadol observed small associated with increase controlled administration 5 Tumor response chemotherapy P mouse leukemia mouse model leukemia model not affected @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d763.s4.p14", "DRUGA": ["ondansetron", "drug", "189-199"], "DRUGB": ["ondansetron", "drug", "472-482"]}
{"TEXT1": "available data no dosage adjustment ondansetron recommended patients 3 pharmacokinetic drug interaction @DRUG$ observed small @DRUG$ associated with increase controlled administration tramadol 5 Tumor response chemotherapy P mouse leukemia mouse model leukemia model not affected", "LBL": "0", "ID": "DDI-DrugBank.d763.s4.p15", "DRUGA": ["tramadol", "drug", "205-212"], "DRUGB": ["ondansetron", "drug", "273-283"]}
{"TEXT1": "available data no dosage adjustment ondansetron recommended patients 3 pharmacokinetic drug interaction @DRUG$ observed small associated with increase controlled administration @DRUG$ 5 Tumor response chemotherapy P mouse leukemia mouse model leukemia model not affected", "LBL": "0", "ID": "DDI-DrugBank.d763.s4.p16", "DRUGA": ["tramadol", "drug", "205-212"], "DRUGB": ["tramadol", "drug", "360-367"]}
{"TEXT1": "available data no dosage adjustment ondansetron recommended patients 3 pharmacokinetic drug interaction @DRUG$ observed small associated with increase controlled administration tramadol 5 Tumor response chemotherapy P mouse leukemia mouse model leukemia model not affected @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d763.s4.p17", "DRUGA": ["tramadol", "drug", "205-212"], "DRUGB": ["ondansetron", "drug", "472-482"]}
{"TEXT1": "available data no dosage adjustment ondansetron recommended patients 3 pharmacokinetic drug interaction tramadol observed small @DRUG$ associated with increase controlled administration @DRUG$ 5 Tumor response chemotherapy P mouse leukemia mouse model leukemia model not affected", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d763.s4.p18", "DRUGA": ["ondansetron", "drug", "273-283"], "DRUGB": ["tramadol", "drug", "360-367"]}
{"TEXT1": "available data no dosage adjustment ondansetron recommended patients 3 pharmacokinetic drug interaction tramadol observed small @DRUG$ associated with increase controlled administration 5 Tumor response chemotherapy P mouse leukemia mouse model leukemia model not affected @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d763.s4.p19", "DRUGA": ["ondansetron", "drug", "273-283"], "DRUGB": ["ondansetron", "drug", "472-482"]}
{"TEXT1": "available data no dosage adjustment ondansetron recommended patients 3 pharmacokinetic drug interaction tramadol observed small associated with increase controlled administration @DRUG$ 5 Tumor response chemotherapy P mouse leukemia mouse model leukemia model not affected @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d763.s4.p20", "DRUGA": ["tramadol", "drug", "360-367"], "DRUGB": ["ondansetron", "drug", "472-482"]}
{"TEXT1": "humans @DRUG$ @DRUG$ cisplatin not affect pharmacokinetics ondansetron", "LBL": "0", "ID": "DDI-DrugBank.d763.s5.p0", "DRUGA": ["carmustine", "drug", "11-20"], "DRUGB": ["etoposide", "drug", "23-31"]}
{"TEXT1": "humans @DRUG$ etoposide @DRUG$ not affect pharmacokinetics ondansetron", "LBL": "0", "ID": "DDI-DrugBank.d763.s5.p1", "DRUGA": ["carmustine", "drug", "11-20"], "DRUGB": ["cisplatin", "drug", "38-46"]}
{"TEXT1": "humans @DRUG$ etoposide cisplatin not affect pharmacokinetics @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d763.s5.p2", "DRUGA": ["carmustine", "drug", "11-20"], "DRUGB": ["ondansetron", "drug", "86-96"]}
{"TEXT1": "humans carmustine @DRUG$ @DRUG$ not affect pharmacokinetics ondansetron", "LBL": "0", "ID": "DDI-DrugBank.d763.s5.p3", "DRUGA": ["etoposide", "drug", "23-31"], "DRUGB": ["cisplatin", "drug", "38-46"]}
{"TEXT1": "humans carmustine @DRUG$ cisplatin not affect pharmacokinetics @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d763.s5.p4", "DRUGA": ["etoposide", "drug", "23-31"], "DRUGB": ["ondansetron", "drug", "86-96"]}
{"TEXT1": "humans carmustine etoposide @DRUG$ not affect pharmacokinetics @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d763.s5.p5", "DRUGA": ["cisplatin", "drug", "38-46"], "DRUGB": ["ondansetron", "drug", "86-96"]}
{"TEXT1": "@DRUG$ not increase blood @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d763.s7.p0", "DRUGA": ["ondansetron", "drug", "0-10"], "DRUGB": ["methotrexate", "drug", "55-66"]}
{"TEXT1": "Administration @DRUG$ combination @DRUG$ resulted two fold decrease HERCEPTIN clearance non human study primate increase serum levels clinical studies", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d712.s1.p0", "DRUGA": ["paclitaxel", "drug", "18-27"], "DRUGB": ["HERCEPTIN", "brand", "49-57"]}
{"TEXT1": "Administration @DRUG$ combination HERCEPTIN resulted two fold decrease @DRUG$ clearance non human study primate increase serum levels clinical studies", "LBL": "0", "ID": "DDI-DrugBank.d712.s1.p1", "DRUGA": ["paclitaxel", "drug", "18-27"], "DRUGB": ["HERCEPTIN", "brand", "94-102"]}
{"TEXT1": "Administration @DRUG$ combination HERCEPTIN resulted two fold decrease clearance non human study primate increase @DRUG$ serum levels clinical studies", "LBL": "0", "ID": "DDI-DrugBank.d712.s1.p2", "DRUGA": ["paclitaxel", "drug", "18-27"], "DRUGB": ["HERCEPTIN", "brand", "173-181"]}
{"TEXT1": "Administration paclitaxel combination @DRUG$ resulted two fold decrease @DRUG$ clearance non human study primate increase HERCEPTIN serum levels clinical studies", "LBL": "0", "ID": "DDI-DrugBank.d712.s1.p3", "DRUGA": ["HERCEPTIN", "brand", "49-57"], "DRUGB": ["HERCEPTIN", "brand", "94-102"]}
{"TEXT1": "Administration paclitaxel combination @DRUG$ resulted two fold decrease HERCEPTIN clearance non human study primate increase @DRUG$ serum levels clinical studies", "LBL": "0", "ID": "DDI-DrugBank.d712.s1.p4", "DRUGA": ["HERCEPTIN", "brand", "49-57"], "DRUGB": ["HERCEPTIN", "brand", "173-181"]}
{"TEXT1": "Administration paclitaxel combination HERCEPTIN resulted two fold decrease @DRUG$ clearance non human study primate increase @DRUG$ serum levels clinical studies", "LBL": "0", "ID": "DDI-DrugBank.d712.s1.p5", "DRUGA": ["HERCEPTIN", "brand", "94-102"], "DRUGB": ["HERCEPTIN", "brand", "173-181"]}
{"TEXT1": "Concomitant administrations not @DRUG$ Certain macrolides terfenadine astemizole leading increased serum concentrations", "LBL": "0", "ID": "DDI-DrugBank.d709.s1.p0", "DRUGA": ["Terfenadine", "drug", "48-58"], "DRUGB": ["astemizole", "drug", "64-73"]}
{"TEXT1": "Concomitant administrations not @DRUG$ Certain @DRUG$ terfenadine astemizole leading increased serum concentrations", "LBL": "0", "ID": "DDI-DrugBank.d709.s1.p1", "DRUGA": ["Terfenadine", "drug", "48-58"], "DRUGB": ["macrolides", "group", "84-93"]}
{"TEXT1": "Concomitant administrations not @DRUG$ Certain macrolides @DRUG$ astemizole leading increased serum concentrations", "LBL": "0", "ID": "DDI-DrugBank.d709.s1.p2", "DRUGA": ["Terfenadine", "drug", "48-58"], "DRUGB": ["terfenadine", "drug", "109-119"]}
{"TEXT1": "Concomitant administrations not @DRUG$ Certain macrolides terfenadine @DRUG$ leading increased serum concentrations", "LBL": "0", "ID": "DDI-DrugBank.d709.s1.p3", "DRUGA": ["Terfenadine", "drug", "48-58"], "DRUGB": ["astemizole", "drug", "125-134"]}
{"TEXT1": "Concomitant administrations not Certain @DRUG$ terfenadine astemizole leading increased serum concentrations", "LBL": "0", "ID": "DDI-DrugBank.d709.s1.p4", "DRUGA": ["astemizole", "drug", "64-73"], "DRUGB": ["macrolides", "group", "84-93"]}
{"TEXT1": "Concomitant administrations not Certain macrolides @DRUG$ astemizole leading increased serum concentrations", "LBL": "0", "ID": "DDI-DrugBank.d709.s1.p5", "DRUGA": ["astemizole", "drug", "64-73"], "DRUGB": ["terfenadine", "drug", "109-119"]}
{"TEXT1": "Concomitant administrations not Certain macrolides terfenadine @DRUG$ leading increased serum concentrations", "LBL": "0", "ID": "DDI-DrugBank.d709.s1.p6", "DRUGA": ["astemizole", "drug", "64-73"], "DRUGB": ["astemizole", "drug", "125-134"]}
{"TEXT1": "Concomitant administrations not Certain @DRUG$ @DRUG$ astemizole leading increased serum concentrations", "LBL": "DDI-int", "ID": "DDI-DrugBank.d709.s1.p7", "DRUGA": ["macrolides", "group", "84-93"], "DRUGB": ["terfenadine", "drug", "109-119"]}
{"TEXT1": "Concomitant administrations not Certain @DRUG$ terfenadine @DRUG$ leading increased serum concentrations", "LBL": "DDI-int", "ID": "DDI-DrugBank.d709.s1.p8", "DRUGA": ["macrolides", "group", "84-93"], "DRUGB": ["astemizole", "drug", "125-134"]}
{"TEXT1": "Concomitant administrations not Certain macrolides @DRUG$ @DRUG$ leading increased serum concentrations", "LBL": "0", "ID": "DDI-DrugBank.d709.s1.p9", "DRUGA": ["terfenadine", "drug", "109-119"], "DRUGB": ["astemizole", "drug", "125-134"]}
{"TEXT1": "reaction not @DRUG$ concomitant administration @DRUG$ terfenadine astemizole recommended", "LBL": "0", "ID": "DDI-DrugBank.d709.s3.p0", "DRUGA": ["roxithromycin", "drug", "56-68"], "DRUGB": ["roxithromycin", "drug", "101-113"]}
{"TEXT1": "reaction not @DRUG$ concomitant administration roxithromycin @DRUG$ astemizole recommended", "LBL": "0", "ID": "DDI-DrugBank.d709.s3.p1", "DRUGA": ["roxithromycin", "drug", "56-68"], "DRUGB": ["terfenadine", "drug", "120-130"]}
{"TEXT1": "reaction not @DRUG$ concomitant administration roxithromycin terfenadine @DRUG$ recommended", "LBL": "0", "ID": "DDI-DrugBank.d709.s3.p2", "DRUGA": ["roxithromycin", "drug", "56-68"], "DRUGB": ["astemizole", "drug", "135-144"]}
{"TEXT1": "reaction not roxithromycin concomitant administration @DRUG$ @DRUG$ astemizole recommended", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d709.s3.p3", "DRUGA": ["roxithromycin", "drug", "101-113"], "DRUGB": ["terfenadine", "drug", "120-130"]}
{"TEXT1": "reaction not roxithromycin concomitant administration @DRUG$ terfenadine @DRUG$ recommended", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d709.s3.p4", "DRUGA": ["roxithromycin", "drug", "101-113"], "DRUGB": ["astemizole", "drug", "135-144"]}
{"TEXT1": "reaction not roxithromycin concomitant administration @DRUG$ @DRUG$ recommended", "LBL": "0", "ID": "DDI-DrugBank.d709.s3.p5", "DRUGA": ["terfenadine", "drug", "120-130"], "DRUGB": ["astemizole", "drug", "135-144"]}
{"TEXT1": "@DRUG$ drugs cisapride pimozide hepatic CYP3A isozymes associated with QT interval prolongation cardiac arrythmias result increase serum level subsequent interaction significant inhibitors including macrolide antibacterials", "LBL": "0", "ID": "DDI-DrugBank.d709.s4.p0", "DRUGA": ["Cisapride", "drug", "2-10"], "DRUGB": ["pimozide", "drug", "13-20"]}
{"TEXT1": "@DRUG$ drugs @DRUG$ pimozide hepatic CYP3A isozymes associated with QT interval prolongation cardiac arrythmias result increase serum level subsequent interaction significant inhibitors including macrolide antibacterials", "LBL": "0", "ID": "DDI-DrugBank.d709.s4.p1", "DRUGA": ["Cisapride", "drug", "2-10"], "DRUGB": ["cisapride", "drug", "43-51"]}
{"TEXT1": "@DRUG$ drugs cisapride @DRUG$ hepatic CYP3A isozymes associated with QT interval prolongation cardiac arrythmias result increase serum level subsequent interaction significant inhibitors including macrolide antibacterials", "LBL": "0", "ID": "DDI-DrugBank.d709.s4.p2", "DRUGA": ["Cisapride", "drug", "2-10"], "DRUGB": ["pimozide", "drug", "56-63"]}
{"TEXT1": "@DRUG$ drugs cisapride pimozide hepatic CYP3A isozymes associated with QT interval prolongation cardiac arrythmias result increase serum level subsequent interaction significant inhibitors including @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d709.s4.p3", "DRUGA": ["Cisapride", "drug", "2-10"], "DRUGB": ["macrolide antibacterials", "group", "352-375"]}
{"TEXT1": "drugs @DRUG$ pimozide hepatic CYP3A isozymes associated with QT interval prolongation cardiac arrythmias result increase serum level subsequent interaction significant inhibitors including macrolide antibacterials", "LBL": "0", "ID": "DDI-DrugBank.d709.s4.p4", "DRUGA": ["pimozide", "drug", "13-20"], "DRUGB": ["cisapride", "drug", "43-51"]}
{"TEXT1": "drugs cisapride @DRUG$ hepatic CYP3A isozymes associated with QT interval prolongation cardiac arrythmias result increase serum level subsequent interaction significant inhibitors including macrolide antibacterials", "LBL": "0", "ID": "DDI-DrugBank.d709.s4.p5", "DRUGA": ["pimozide", "drug", "13-20"], "DRUGB": ["pimozide", "drug", "56-63"]}
{"TEXT1": "drugs cisapride pimozide hepatic CYP3A isozymes associated with QT interval prolongation cardiac arrythmias result increase serum level subsequent interaction significant inhibitors including @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d709.s4.p6", "DRUGA": ["pimozide", "drug", "13-20"], "DRUGB": ["macrolide antibacterials", "group", "352-375"]}
{"TEXT1": "drugs @DRUG$ @DRUG$ hepatic CYP3A isozymes associated with QT interval prolongation cardiac arrythmias result increase serum level subsequent interaction significant inhibitors including macrolide antibacterials", "LBL": "0", "ID": "DDI-DrugBank.d709.s4.p7", "DRUGA": ["cisapride", "drug", "43-51"], "DRUGB": ["pimozide", "drug", "56-63"]}
{"TEXT1": "drugs @DRUG$ pimozide hepatic CYP3A isozymes associated with QT interval prolongation cardiac arrythmias result increase serum level subsequent interaction significant inhibitors including @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d709.s4.p8", "DRUGA": ["cisapride", "drug", "43-51"], "DRUGB": ["macrolide antibacterials", "group", "352-375"]}
{"TEXT1": "drugs cisapride @DRUG$ hepatic CYP3A isozymes associated with QT interval prolongation cardiac arrythmias result increase serum level subsequent interaction significant inhibitors including @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d709.s4.p9", "DRUGA": ["pimozide", "drug", "56-63"], "DRUGB": ["macrolide antibacterials", "group", "352-375"]}
{"TEXT1": "risk not verified @DRUG$ combination @DRUG$ drugs recommended", "LBL": "0", "ID": "DDI-DrugBank.d709.s5.p0", "DRUGA": ["roxithromycin", "drug", "41-53"], "DRUGB": ["roxithromycin", "drug", "71-83"]}
{"TEXT1": "@DRUG$ @DRUG$", "LBL": "DDI-int", "ID": "DDI-DrugBank.d636.s0.p0", "DRUGA": ["anticonvulsants", "group", "5-19"], "DRUGB": ["Mephenytoin", "drug", "39-49"]}
{"TEXT1": "@DRUG$ include @DRUG$ valproic acid phenobarbital", "LBL": "0", "ID": "DDI-DrugBank.d636.s2.p0", "DRUGA": ["anticonvulsants", "group", "6-20"], "DRUGB": ["divalproex sodium", "drug", "30-46"]}
{"TEXT1": "@DRUG$ include divalproex sodium @DRUG$ phenobarbital", "LBL": "0", "ID": "DDI-DrugBank.d636.s2.p1", "DRUGA": ["anticonvulsants", "group", "6-20"], "DRUGB": ["valproic acid", "drug", "49-61"]}
{"TEXT1": "@DRUG$ include divalproex sodium valproic acid @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d636.s2.p2", "DRUGA": ["anticonvulsants", "group", "6-20"], "DRUGB": ["phenobarbital", "drug", "68-80"]}
{"TEXT1": "anticonvulsants include @DRUG$ @DRUG$ phenobarbital", "LBL": "0", "ID": "DDI-DrugBank.d636.s2.p3", "DRUGA": ["divalproex sodium", "drug", "30-46"], "DRUGB": ["valproic acid", "drug", "49-61"]}
{"TEXT1": "anticonvulsants include @DRUG$ valproic acid @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d636.s2.p4", "DRUGA": ["divalproex sodium", "drug", "30-46"], "DRUGB": ["phenobarbital", "drug", "68-80"]}
{"TEXT1": "anticonvulsants include divalproex sodium @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d636.s2.p5", "DRUGA": ["valproic acid", "drug", "49-61"], "DRUGB": ["phenobarbital", "drug", "68-80"]}
{"TEXT1": "@DRUG$ affect effects of drugs include @DRUG$ warfarin certain heart medicines birth control pills furosemide theophylline e Mephenytoin not not listed", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d636.s3.p0", "DRUGA": ["Mephenytoin", "drug", "0-10"], "DRUGB": ["steroid medications", "group", "75-93"]}
{"TEXT1": "@DRUG$ affect effects of drugs include steroid medications @DRUG$ certain heart medicines birth control pills furosemide theophylline e Mephenytoin not not listed", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d636.s3.p1", "DRUGA": ["Mephenytoin", "drug", "0-10"], "DRUGB": ["warfarin", "drug", "96-103"]}
{"TEXT1": "@DRUG$ affect effects of drugs include steroid medications warfarin certain heart medicines birth control pills @DRUG$ furosemide theophylline e Mephenytoin not not listed", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d636.s3.p2", "DRUGA": ["Mephenytoin", "drug", "0-10"], "DRUGB": ["anti-infective medicines", "group", "152-175"]}
{"TEXT1": "@DRUG$ affect effects of drugs include steroid medications warfarin certain heart medicines birth control pills @DRUG$ theophylline e Mephenytoin not not listed", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d636.s3.p3", "DRUGA": ["Mephenytoin", "drug", "0-10"], "DRUGB": ["furosemide", "drug", "178-187"]}
{"TEXT1": "@DRUG$ affect effects of drugs include steroid medications warfarin certain heart medicines birth control pills furosemide @DRUG$ e Mephenytoin not not listed", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d636.s3.p4", "DRUGA": ["Mephenytoin", "drug", "0-10"], "DRUGB": ["theophylline", "drug", "193-204"]}
{"TEXT1": "@DRUG$ affect effects of drugs include steroid medications warfarin certain heart medicines birth control pills furosemide theophylline e @DRUG$ not not listed", "LBL": "0", "ID": "DDI-DrugBank.d636.s3.p5", "DRUGA": ["Mephenytoin", "drug", "0-10"], "DRUGB": ["Mephenytoin", "drug", "223-233"]}
{"TEXT1": "Mephenytoin affect effects of drugs include @DRUG$ @DRUG$ certain heart medicines birth control pills furosemide theophylline e not not listed", "LBL": "0", "ID": "DDI-DrugBank.d636.s3.p6", "DRUGA": ["steroid medications", "group", "75-93"], "DRUGB": ["warfarin", "drug", "96-103"]}
{"TEXT1": "Mephenytoin affect effects of drugs include @DRUG$ warfarin certain heart medicines birth control pills @DRUG$ furosemide theophylline e not not listed", "LBL": "0", "ID": "DDI-DrugBank.d636.s3.p7", "DRUGA": ["steroid medications", "group", "75-93"], "DRUGB": ["anti-infective medicines", "group", "152-175"]}
{"TEXT1": "Mephenytoin affect effects of drugs include @DRUG$ warfarin certain heart medicines birth control pills @DRUG$ theophylline e not not listed", "LBL": "0", "ID": "DDI-DrugBank.d636.s3.p8", "DRUGA": ["steroid medications", "group", "75-93"], "DRUGB": ["furosemide", "drug", "178-187"]}
{"TEXT1": "Mephenytoin affect effects of drugs include @DRUG$ warfarin certain heart medicines birth control pills furosemide @DRUG$ e not not listed", "LBL": "0", "ID": "DDI-DrugBank.d636.s3.p9", "DRUGA": ["steroid medications", "group", "75-93"], "DRUGB": ["theophylline", "drug", "193-204"]}
{"TEXT1": "Mephenytoin affect effects of drugs include @DRUG$ warfarin certain heart medicines birth control pills furosemide theophylline e @DRUG$ not not listed", "LBL": "0", "ID": "DDI-DrugBank.d636.s3.p10", "DRUGA": ["steroid medications", "group", "75-93"], "DRUGB": ["Mephenytoin", "drug", "223-233"]}
{"TEXT1": "Mephenytoin affect effects of drugs include steroid medications @DRUG$ certain heart medicines birth control pills @DRUG$ furosemide theophylline e not not listed", "LBL": "0", "ID": "DDI-DrugBank.d636.s3.p11", "DRUGA": ["warfarin", "drug", "96-103"], "DRUGB": ["anti-infective medicines", "group", "152-175"]}
{"TEXT1": "Mephenytoin affect effects of drugs include steroid medications @DRUG$ certain heart medicines birth control pills @DRUG$ theophylline e not not listed", "LBL": "0", "ID": "DDI-DrugBank.d636.s3.p12", "DRUGA": ["warfarin", "drug", "96-103"], "DRUGB": ["furosemide", "drug", "178-187"]}
{"TEXT1": "Mephenytoin affect effects of drugs include steroid medications @DRUG$ certain heart medicines birth control pills furosemide @DRUG$ e not not listed", "LBL": "0", "ID": "DDI-DrugBank.d636.s3.p13", "DRUGA": ["warfarin", "drug", "96-103"], "DRUGB": ["theophylline", "drug", "193-204"]}
{"TEXT1": "Mephenytoin affect effects of drugs include steroid medications @DRUG$ certain heart medicines birth control pills furosemide theophylline e @DRUG$ not not listed", "LBL": "0", "ID": "DDI-DrugBank.d636.s3.p14", "DRUGA": ["warfarin", "drug", "96-103"], "DRUGB": ["Mephenytoin", "drug", "223-233"]}
{"TEXT1": "Mephenytoin affect effects of drugs include steroid medications warfarin certain heart medicines birth control pills @DRUG$ @DRUG$ theophylline e not not listed", "LBL": "0", "ID": "DDI-DrugBank.d636.s3.p15", "DRUGA": ["anti-infective medicines", "group", "152-175"], "DRUGB": ["furosemide", "drug", "178-187"]}
{"TEXT1": "Mephenytoin affect effects of drugs include steroid medications warfarin certain heart medicines birth control pills @DRUG$ furosemide @DRUG$ e not not listed", "LBL": "0", "ID": "DDI-DrugBank.d636.s3.p16", "DRUGA": ["anti-infective medicines", "group", "152-175"], "DRUGB": ["theophylline", "drug", "193-204"]}
{"TEXT1": "Mephenytoin affect effects of drugs include steroid medications warfarin certain heart medicines birth control pills @DRUG$ furosemide theophylline e @DRUG$ not not listed", "LBL": "0", "ID": "DDI-DrugBank.d636.s3.p17", "DRUGA": ["anti-infective medicines", "group", "152-175"], "DRUGB": ["Mephenytoin", "drug", "223-233"]}
{"TEXT1": "Mephenytoin affect effects of drugs include steroid medications warfarin certain heart medicines birth control pills @DRUG$ @DRUG$ e not not listed", "LBL": "0", "ID": "DDI-DrugBank.d636.s3.p18", "DRUGA": ["furosemide", "drug", "178-187"], "DRUGB": ["theophylline", "drug", "193-204"]}
{"TEXT1": "Mephenytoin affect effects of drugs include steroid medications warfarin certain heart medicines birth control pills @DRUG$ theophylline e @DRUG$ not not listed", "LBL": "0", "ID": "DDI-DrugBank.d636.s3.p19", "DRUGA": ["furosemide", "drug", "178-187"], "DRUGB": ["Mephenytoin", "drug", "223-233"]}
{"TEXT1": "Mephenytoin affect effects of drugs include steroid medications warfarin certain heart medicines birth control pills furosemide @DRUG$ e @DRUG$ not not listed", "LBL": "0", "ID": "DDI-DrugBank.d636.s3.p20", "DRUGA": ["theophylline", "drug", "193-204"], "DRUGB": ["Mephenytoin", "drug", "223-233"]}
{"TEXT1": "interaction @DRUG$ @DRUG$ drugs not well studied", "LBL": "0", "ID": "DDI-DrugBank.d777.s0.p0", "DRUGA": ["Streptase", "brand", "19-27"], "DRUGB": ["Streptokinase", "drug", "30-42"]}
{"TEXT1": "Use of @DRUG$ @DRUG$ Streptase Streptokinase alone combination antiplatelet agents anticoagulants cause bleeding complications", "LBL": "0", "ID": "DDI-DrugBank.d777.s1.p0", "DRUGA": ["Anticoagulants", "group", "7-20"], "DRUGB": ["Antiplatelet Agents", "group", "26-44"]}
{"TEXT1": "Use of @DRUG$ @DRUG$ Streptokinase alone combination antiplatelet agents anticoagulants cause bleeding complications", "LBL": "0", "ID": "DDI-DrugBank.d777.s1.p1", "DRUGA": ["Anticoagulants", "group", "7-20"], "DRUGB": ["Streptase", "brand", "49-57"]}
{"TEXT1": "Use of @DRUG$ Streptase @DRUG$ alone combination antiplatelet agents anticoagulants cause bleeding complications", "LBL": "0", "ID": "DDI-DrugBank.d777.s1.p2", "DRUGA": ["Anticoagulants", "group", "7-20"], "DRUGB": ["Streptokinase", "drug", "60-72"]}
{"TEXT1": "Use of @DRUG$ Streptase Streptokinase alone combination @DRUG$ anticoagulants cause bleeding complications", "LBL": "0", "ID": "DDI-DrugBank.d777.s1.p3", "DRUGA": ["Anticoagulants", "group", "7-20"], "DRUGB": ["antiplatelet agents", "group", "104-122"]}
{"TEXT1": "Use of @DRUG$ Streptase Streptokinase alone combination antiplatelet agents @DRUG$ cause bleeding complications", "LBL": "0", "ID": "DDI-DrugBank.d777.s1.p4", "DRUGA": ["Anticoagulants", "group", "7-20"], "DRUGB": ["anticoagulants", "group", "128-141"]}
{"TEXT1": "Use of @DRUG$ @DRUG$ Streptokinase alone combination antiplatelet agents anticoagulants cause bleeding complications", "LBL": "0", "ID": "DDI-DrugBank.d777.s1.p5", "DRUGA": ["Antiplatelet Agents", "group", "26-44"], "DRUGB": ["Streptase", "brand", "49-57"]}
{"TEXT1": "Use of @DRUG$ Streptase @DRUG$ alone combination antiplatelet agents anticoagulants cause bleeding complications", "LBL": "0", "ID": "DDI-DrugBank.d777.s1.p6", "DRUGA": ["Antiplatelet Agents", "group", "26-44"], "DRUGB": ["Streptokinase", "drug", "60-72"]}
{"TEXT1": "Use of @DRUG$ Streptase Streptokinase alone combination @DRUG$ anticoagulants cause bleeding complications", "LBL": "0", "ID": "DDI-DrugBank.d777.s1.p7", "DRUGA": ["Antiplatelet Agents", "group", "26-44"], "DRUGB": ["antiplatelet agents", "group", "104-122"]}
{"TEXT1": "Use of @DRUG$ Streptase Streptokinase alone combination antiplatelet agents @DRUG$ cause bleeding complications", "LBL": "0", "ID": "DDI-DrugBank.d777.s1.p8", "DRUGA": ["Antiplatelet Agents", "group", "26-44"], "DRUGB": ["anticoagulants", "group", "128-141"]}
{"TEXT1": "Use of @DRUG$ @DRUG$ alone combination antiplatelet agents anticoagulants cause bleeding complications", "LBL": "0", "ID": "DDI-DrugBank.d777.s1.p9", "DRUGA": ["Streptase", "brand", "49-57"], "DRUGB": ["Streptokinase", "drug", "60-72"]}
{"TEXT1": "Use of @DRUG$ Streptokinase alone combination @DRUG$ anticoagulants cause bleeding complications", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d777.s1.p10", "DRUGA": ["Streptase", "brand", "49-57"], "DRUGB": ["antiplatelet agents", "group", "104-122"]}
{"TEXT1": "Use of @DRUG$ Streptokinase alone combination antiplatelet agents @DRUG$ cause bleeding complications", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d777.s1.p11", "DRUGA": ["Streptase", "brand", "49-57"], "DRUGB": ["anticoagulants", "group", "128-141"]}
{"TEXT1": "Use of Streptase @DRUG$ alone combination @DRUG$ anticoagulants cause bleeding complications", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d777.s1.p12", "DRUGA": ["Streptokinase", "drug", "60-72"], "DRUGB": ["antiplatelet agents", "group", "104-122"]}
{"TEXT1": "Use of Streptase @DRUG$ alone combination antiplatelet agents @DRUG$ cause bleeding complications", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d777.s1.p13", "DRUGA": ["Streptokinase", "drug", "60-72"], "DRUGB": ["anticoagulants", "group", "128-141"]}
{"TEXT1": "Use of Streptase Streptokinase alone combination @DRUG$ @DRUG$ cause bleeding complications", "LBL": "0", "ID": "DDI-DrugBank.d777.s1.p14", "DRUGA": ["antiplatelet agents", "group", "104-122"], "DRUGB": ["anticoagulants", "group", "128-141"]}
{"TEXT1": "treatment acute MI @DRUG$ not contraindicated administered @DRUG$ see", "LBL": "0", "ID": "DDI-DrugBank.d777.s3.p0", "DRUGA": ["aspirin", "brand", "30-36"], "DRUGB": ["Streptokinase", "drug", "103-115"]}
{"TEXT1": "Anticoagulation @DRUG$ After Treatment Myocardial Infarction treatment acute myocardial infarction @DRUG$ shown to incidence stroke", "LBL": "0", "ID": "DDI-DrugBank.d777.s4.p0", "DRUGA": ["Antiplatelets", "group", "20-32"], "DRUGB": ["aspirin", "brand", "139-145"]}
{"TEXT1": "addition @DRUG$ to @DRUG$ causes minimal increase risk bleeding minor bleeding not appear incidence major", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d777.s5.p0", "DRUGA": ["aspirin", "brand", "16-22"], "DRUGB": ["Streptokinase", "drug", "27-39"]}
{"TEXT1": "@DRUG$ @DRUG$ increase effects pseudoephedrine", "LBL": "0", "ID": "DDI-DrugBank.d606.s0.p0", "DRUGA": ["MAO inhibitors", "group", "0-13"], "DRUGB": ["beta adrenergic blockers", "group", "19-42"]}
{"TEXT1": "@DRUG$ beta adrenergic blockers increase effects @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d606.s0.p1", "DRUGA": ["MAO inhibitors", "group", "0-13"], "DRUGB": ["pseudoephedrine", "drug", "68-82"]}
{"TEXT1": "MAO inhibitors @DRUG$ increase effects @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d606.s0.p2", "DRUGA": ["beta adrenergic blockers", "group", "19-42"], "DRUGB": ["pseudoephedrine", "drug", "68-82"]}
{"TEXT1": "@DRUG$ antihypertensive effects @DRUG$ mecamylamine reserpine veratrum alkaloids", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d606.s1.p0", "DRUGA": ["Sympathomimetics", "group", "0-15"], "DRUGB": ["methyldopa", "drug", "60-69"]}
{"TEXT1": "@DRUG$ antihypertensive effects methyldopa @DRUG$ reserpine veratrum alkaloids", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d606.s1.p1", "DRUGA": ["Sympathomimetics", "group", "0-15"], "DRUGB": ["mecamylamine", "drug", "72-83"]}
{"TEXT1": "@DRUG$ antihypertensive effects methyldopa mecamylamine @DRUG$ veratrum alkaloids", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d606.s1.p2", "DRUGA": ["Sympathomimetics", "group", "0-15"], "DRUGB": ["reserpine", "drug", "86-94"]}
{"TEXT1": "@DRUG$ antihypertensive effects methyldopa mecamylamine reserpine @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d606.s1.p3", "DRUGA": ["Sympathomimetics", "group", "0-15"], "DRUGB": ["veratrum alkaloids", "group", "100-117"]}
{"TEXT1": "Sympathomimetics antihypertensive effects @DRUG$ @DRUG$ reserpine veratrum alkaloids", "LBL": "0", "ID": "DDI-DrugBank.d606.s1.p4", "DRUGA": ["methyldopa", "drug", "60-69"], "DRUGB": ["mecamylamine", "drug", "72-83"]}
{"TEXT1": "Sympathomimetics antihypertensive effects @DRUG$ mecamylamine @DRUG$ veratrum alkaloids", "LBL": "0", "ID": "DDI-DrugBank.d606.s1.p5", "DRUGA": ["methyldopa", "drug", "60-69"], "DRUGB": ["reserpine", "drug", "86-94"]}
{"TEXT1": "Sympathomimetics antihypertensive effects @DRUG$ mecamylamine reserpine @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d606.s1.p6", "DRUGA": ["methyldopa", "drug", "60-69"], "DRUGB": ["veratrum alkaloids", "group", "100-117"]}
{"TEXT1": "Sympathomimetics antihypertensive effects methyldopa @DRUG$ @DRUG$ veratrum alkaloids", "LBL": "0", "ID": "DDI-DrugBank.d606.s1.p7", "DRUGA": ["mecamylamine", "drug", "72-83"], "DRUGB": ["reserpine", "drug", "86-94"]}
{"TEXT1": "Sympathomimetics antihypertensive effects methyldopa @DRUG$ reserpine @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d606.s1.p8", "DRUGA": ["mecamylamine", "drug", "72-83"], "DRUGB": ["veratrum alkaloids", "group", "100-117"]}
{"TEXT1": "Sympathomimetics antihypertensive effects methyldopa mecamylamine @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d606.s1.p9", "DRUGA": ["reserpine", "drug", "86-94"], "DRUGB": ["veratrum alkaloids", "group", "100-117"]}
{"TEXT1": "@DRUG$ shown to plasma prothrombin activity patients @DRUG$ downward adjustment anticoagulant dosage", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d711.s0.p0", "DRUGA": ["tetracyclines", "group", "8-20"], "DRUGB": ["anticoagulant", "group", "98-110"]}
{"TEXT1": "@DRUG$ shown to plasma prothrombin activity patients anticoagulant therapy downward adjustment @DRUG$ dosage", "LBL": "0", "ID": "DDI-DrugBank.d711.s0.p1", "DRUGA": ["tetracyclines", "group", "8-20"], "DRUGB": ["anticoagulant", "group", "161-173"]}
{"TEXT1": "tetracyclines shown to plasma prothrombin activity patients @DRUG$ downward adjustment @DRUG$ dosage", "LBL": "0", "ID": "DDI-DrugBank.d711.s0.p2", "DRUGA": ["anticoagulant", "group", "98-110"], "DRUGB": ["anticoagulant", "group", "161-173"]}
{"TEXT1": "drugs interfere bactericidal action @DRUG$ to giving @DRUG$ conjunction penicillin", "LBL": "0", "ID": "DDI-DrugBank.d711.s1.p0", "DRUGA": ["penicillin", "drug", "73-82"], "DRUGB": ["tetracycline class drugs", "group", "117-140"]}
{"TEXT1": "drugs interfere bactericidal action @DRUG$ to giving conjunction @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d711.s1.p1", "DRUGA": ["penicillin", "drug", "73-82"], "DRUGB": ["penicillin", "drug", "162-171"]}
{"TEXT1": "drugs interfere bactericidal action penicillin to giving @DRUG$ conjunction @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d711.s1.p2", "DRUGA": ["tetracycline class drugs", "group", "117-140"], "DRUGB": ["penicillin", "drug", "162-171"]}
{"TEXT1": "Absorption @DRUG$ impaired @DRUG$ containing aluminum calcium magnesium iron preparations", "LBL": "0", "ID": "DDI-DrugBank.d711.s2.p0", "DRUGA": ["tetracyclines", "group", "14-26"], "DRUGB": ["antacids", "group", "43-50"]}
{"TEXT1": "Absorption @DRUG$ impaired antacids containing @DRUG$ calcium magnesium iron preparations", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d711.s2.p1", "DRUGA": ["tetracyclines", "group", "14-26"], "DRUGB": ["aluminum", "drug", "63-70"]}
{"TEXT1": "Absorption @DRUG$ impaired antacids containing aluminum @DRUG$ magnesium iron preparations", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d711.s2.p2", "DRUGA": ["tetracyclines", "group", "14-26"], "DRUGB": ["calcium", "drug", "73-79"]}
{"TEXT1": "Absorption @DRUG$ impaired antacids containing aluminum calcium @DRUG$ iron preparations", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d711.s2.p3", "DRUGA": ["tetracyclines", "group", "14-26"], "DRUGB": ["magnesium", "drug", "84-92"]}
{"TEXT1": "Absorption @DRUG$ impaired antacids containing aluminum calcium magnesium @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d711.s2.p4", "DRUGA": ["tetracyclines", "group", "14-26"], "DRUGB": ["iron", "drug", "99-102"]}
{"TEXT1": "Absorption tetracyclines impaired @DRUG$ containing @DRUG$ calcium magnesium iron preparations", "LBL": "0", "ID": "DDI-DrugBank.d711.s2.p5", "DRUGA": ["antacids", "group", "43-50"], "DRUGB": ["aluminum", "drug", "63-70"]}
{"TEXT1": "Absorption tetracyclines impaired @DRUG$ containing aluminum @DRUG$ magnesium iron preparations", "LBL": "0", "ID": "DDI-DrugBank.d711.s2.p6", "DRUGA": ["antacids", "group", "43-50"], "DRUGB": ["calcium", "drug", "73-79"]}
{"TEXT1": "Absorption tetracyclines impaired @DRUG$ containing aluminum calcium @DRUG$ iron preparations", "LBL": "0", "ID": "DDI-DrugBank.d711.s2.p7", "DRUGA": ["antacids", "group", "43-50"], "DRUGB": ["magnesium", "drug", "84-92"]}
{"TEXT1": "Absorption tetracyclines impaired @DRUG$ containing aluminum calcium magnesium @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d711.s2.p8", "DRUGA": ["antacids", "group", "43-50"], "DRUGB": ["iron", "drug", "99-102"]}
{"TEXT1": "Absorption tetracyclines impaired antacids containing @DRUG$ @DRUG$ magnesium iron preparations", "LBL": "0", "ID": "DDI-DrugBank.d711.s2.p9", "DRUGA": ["aluminum", "drug", "63-70"], "DRUGB": ["calcium", "drug", "73-79"]}
{"TEXT1": "Absorption tetracyclines impaired antacids containing @DRUG$ calcium @DRUG$ iron preparations", "LBL": "0", "ID": "DDI-DrugBank.d711.s2.p10", "DRUGA": ["aluminum", "drug", "63-70"], "DRUGB": ["magnesium", "drug", "84-92"]}
{"TEXT1": "Absorption tetracyclines impaired antacids containing @DRUG$ calcium magnesium @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d711.s2.p11", "DRUGA": ["aluminum", "drug", "63-70"], "DRUGB": ["iron", "drug", "99-102"]}
{"TEXT1": "Absorption tetracyclines impaired antacids containing aluminum @DRUG$ @DRUG$ iron preparations", "LBL": "0", "ID": "DDI-DrugBank.d711.s2.p12", "DRUGA": ["calcium", "drug", "73-79"], "DRUGB": ["magnesium", "drug", "84-92"]}
{"TEXT1": "Absorption tetracyclines impaired antacids containing aluminum @DRUG$ magnesium @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d711.s2.p13", "DRUGA": ["calcium", "drug", "73-79"], "DRUGB": ["iron", "drug", "99-102"]}
{"TEXT1": "Absorption tetracyclines impaired antacids containing aluminum calcium @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d711.s2.p14", "DRUGA": ["magnesium", "drug", "84-92"], "DRUGB": ["iron", "drug", "99-102"]}
{"TEXT1": "concurrent use of @DRUG$ @DRUG$ reported to result fatal renal toxicity", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d711.s3.p0", "DRUGA": ["tetracycline", "group", "22-33"], "DRUGB": ["methoxyflurane", "drug", "39-52"]}
{"TEXT1": "Concurrent use of @DRUG$ @DRUG$ less effective", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d711.s4.p0", "DRUGA": ["tetracyclines", "group", "18-30"], "DRUGB": ["contraceptives", "group", "42-55"]}
{"TEXT1": "Concurrent use of @DRUG$ oral contraceptives @DRUG$ less effective", "LBL": "0", "ID": "DDI-DrugBank.d711.s4.p1", "DRUGA": ["tetracyclines", "group", "18-30"], "DRUGB": ["contraceptives", "group", "73-86"]}
{"TEXT1": "Concurrent use of tetracyclines @DRUG$ @DRUG$ less effective", "LBL": "0", "ID": "DDI-DrugBank.d711.s4.p2", "DRUGA": ["contraceptives", "group", "42-55"], "DRUGB": ["contraceptives", "group", "73-86"]}
{"TEXT1": "concomitant use of @DRUG$ @DRUG$ dry mouth constipation anticholinergic pharmacological effects increase frequency severity", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d713.s0.p0", "DRUGA": ["Sanctura", "brand", "23-30"], "DRUGB": ["anticholinergic agents", "group", "43-64"]}
{"TEXT1": "studies to assess @DRUG$ not conducted @DRUG$ potential drugs eliminated active tubular secretion digoxin procainamide pancuronium morphine vancomycin metformin", "LBL": "0", "ID": "DDI-DrugBank.d713.s2.p0", "DRUGA": ["Sanctura", "brand", "101-108"], "DRUGB": ["Sanctura", "brand", "135-142"]}
{"TEXT1": "studies to assess @DRUG$ not conducted Sanctura potential drugs eliminated active tubular secretion @DRUG$ procainamide pancuronium morphine vancomycin metformin", "LBL": "0", "ID": "DDI-DrugBank.d713.s2.p1", "DRUGA": ["Sanctura", "brand", "101-108"], "DRUGB": ["digoxin", "drug", "266-272"]}
{"TEXT1": "studies to assess @DRUG$ not conducted Sanctura potential drugs eliminated active tubular secretion digoxin @DRUG$ pancuronium morphine vancomycin metformin", "LBL": "0", "ID": "DDI-DrugBank.d713.s2.p2", "DRUGA": ["Sanctura", "brand", "101-108"], "DRUGB": ["procainamide", "drug", "275-286"]}
{"TEXT1": "studies to assess @DRUG$ not conducted Sanctura potential drugs eliminated active tubular secretion digoxin procainamide @DRUG$ morphine vancomycin metformin", "LBL": "0", "ID": "DDI-DrugBank.d713.s2.p3", "DRUGA": ["Sanctura", "brand", "101-108"], "DRUGB": ["pancuronium", "drug", "289-299"]}
{"TEXT1": "studies to assess @DRUG$ not conducted Sanctura potential drugs eliminated active tubular secretion digoxin procainamide pancuronium @DRUG$ vancomycin metformin", "LBL": "0", "ID": "DDI-DrugBank.d713.s2.p4", "DRUGA": ["Sanctura", "brand", "101-108"], "DRUGB": ["morphine", "drug", "302-309"]}
{"TEXT1": "studies to assess @DRUG$ not conducted Sanctura potential drugs eliminated active tubular secretion digoxin procainamide pancuronium morphine @DRUG$ metformin", "LBL": "0", "ID": "DDI-DrugBank.d713.s2.p5", "DRUGA": ["Sanctura", "brand", "101-108"], "DRUGB": ["vancomycin", "drug", "312-321"]}
{"TEXT1": "studies to assess @DRUG$ not conducted Sanctura potential drugs eliminated active tubular secretion digoxin procainamide pancuronium morphine vancomycin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d713.s2.p6", "DRUGA": ["Sanctura", "brand", "101-108"], "DRUGB": ["metformin", "drug", "324-332"]}
{"TEXT1": "studies to assess @DRUG$ not conducted Sanctura potential drugs eliminated active tubular secretion digoxin procainamide pancuronium morphine vancomycin metformin", "LBL": "0", "ID": "DDI-DrugBank.d713.s2.p7", "DRUGA": ["Sanctura", "brand", "101-108"], "DRUGB": ["tenofovir", "drug", "338-346"]}
{"TEXT1": "studies to assess Sanctura not conducted @DRUG$ potential drugs eliminated active tubular secretion @DRUG$ procainamide pancuronium morphine vancomycin metformin", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d713.s2.p8", "DRUGA": ["Sanctura", "brand", "135-142"], "DRUGB": ["digoxin", "drug", "266-272"]}
{"TEXT1": "studies to assess Sanctura not conducted @DRUG$ potential drugs eliminated active tubular secretion digoxin @DRUG$ pancuronium morphine vancomycin metformin", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d713.s2.p9", "DRUGA": ["Sanctura", "brand", "135-142"], "DRUGB": ["procainamide", "drug", "275-286"]}
{"TEXT1": "studies to assess Sanctura not conducted @DRUG$ potential drugs eliminated active tubular secretion digoxin procainamide @DRUG$ morphine vancomycin metformin", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d713.s2.p10", "DRUGA": ["Sanctura", "brand", "135-142"], "DRUGB": ["pancuronium", "drug", "289-299"]}
{"TEXT1": "studies to assess Sanctura not conducted @DRUG$ potential drugs eliminated active tubular secretion digoxin procainamide pancuronium @DRUG$ vancomycin metformin", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d713.s2.p11", "DRUGA": ["Sanctura", "brand", "135-142"], "DRUGB": ["morphine", "drug", "302-309"]}
{"TEXT1": "studies to assess Sanctura not conducted @DRUG$ potential drugs eliminated active tubular secretion digoxin procainamide pancuronium morphine @DRUG$ metformin", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d713.s2.p12", "DRUGA": ["Sanctura", "brand", "135-142"], "DRUGB": ["vancomycin", "drug", "312-321"]}
{"TEXT1": "studies to assess Sanctura not conducted @DRUG$ potential drugs eliminated active tubular secretion digoxin procainamide pancuronium morphine vancomycin @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d713.s2.p13", "DRUGA": ["Sanctura", "brand", "135-142"], "DRUGB": ["metformin", "drug", "324-332"]}
{"TEXT1": "studies to assess Sanctura not conducted @DRUG$ potential drugs eliminated active tubular secretion digoxin procainamide pancuronium morphine vancomycin metformin", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d713.s2.p14", "DRUGA": ["Sanctura", "brand", "135-142"], "DRUGB": ["tenofovir", "drug", "338-346"]}
{"TEXT1": "studies to assess Sanctura not conducted potential drugs eliminated active tubular secretion @DRUG$ @DRUG$ pancuronium morphine vancomycin metformin", "LBL": "0", "ID": "DDI-DrugBank.d713.s2.p15", "DRUGA": ["digoxin", "drug", "266-272"], "DRUGB": ["procainamide", "drug", "275-286"]}
{"TEXT1": "studies to assess Sanctura not conducted potential drugs eliminated active tubular secretion @DRUG$ procainamide @DRUG$ morphine vancomycin metformin", "LBL": "0", "ID": "DDI-DrugBank.d713.s2.p16", "DRUGA": ["digoxin", "drug", "266-272"], "DRUGB": ["pancuronium", "drug", "289-299"]}
{"TEXT1": "studies to assess Sanctura not conducted potential drugs eliminated active tubular secretion @DRUG$ procainamide pancuronium @DRUG$ vancomycin metformin", "LBL": "0", "ID": "DDI-DrugBank.d713.s2.p17", "DRUGA": ["digoxin", "drug", "266-272"], "DRUGB": ["morphine", "drug", "302-309"]}
{"TEXT1": "studies to assess Sanctura not conducted potential drugs eliminated active tubular secretion @DRUG$ procainamide pancuronium morphine @DRUG$ metformin", "LBL": "0", "ID": "DDI-DrugBank.d713.s2.p18", "DRUGA": ["digoxin", "drug", "266-272"], "DRUGB": ["vancomycin", "drug", "312-321"]}
{"TEXT1": "studies to assess Sanctura not conducted potential drugs eliminated active tubular secretion @DRUG$ procainamide pancuronium morphine vancomycin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d713.s2.p19", "DRUGA": ["digoxin", "drug", "266-272"], "DRUGB": ["metformin", "drug", "324-332"]}
{"TEXT1": "studies to assess Sanctura not conducted potential drugs eliminated active tubular secretion @DRUG$ procainamide pancuronium morphine vancomycin metformin", "LBL": "0", "ID": "DDI-DrugBank.d713.s2.p20", "DRUGA": ["digoxin", "drug", "266-272"], "DRUGB": ["tenofovir", "drug", "338-346"]}
{"TEXT1": "studies to assess Sanctura not conducted potential drugs eliminated active tubular secretion digoxin @DRUG$ @DRUG$ morphine vancomycin metformin", "LBL": "0", "ID": "DDI-DrugBank.d713.s2.p21", "DRUGA": ["procainamide", "drug", "275-286"], "DRUGB": ["pancuronium", "drug", "289-299"]}
{"TEXT1": "studies to assess Sanctura not conducted potential drugs eliminated active tubular secretion digoxin @DRUG$ pancuronium @DRUG$ vancomycin metformin", "LBL": "0", "ID": "DDI-DrugBank.d713.s2.p22", "DRUGA": ["procainamide", "drug", "275-286"], "DRUGB": ["morphine", "drug", "302-309"]}
{"TEXT1": "studies to assess Sanctura not conducted potential drugs eliminated active tubular secretion digoxin @DRUG$ pancuronium morphine @DRUG$ metformin", "LBL": "0", "ID": "DDI-DrugBank.d713.s2.p23", "DRUGA": ["procainamide", "drug", "275-286"], "DRUGB": ["vancomycin", "drug", "312-321"]}
{"TEXT1": "studies to assess Sanctura not conducted potential drugs eliminated active tubular secretion digoxin @DRUG$ pancuronium morphine vancomycin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d713.s2.p24", "DRUGA": ["procainamide", "drug", "275-286"], "DRUGB": ["metformin", "drug", "324-332"]}
{"TEXT1": "studies to assess Sanctura not conducted potential drugs eliminated active tubular secretion digoxin @DRUG$ pancuronium morphine vancomycin metformin", "LBL": "0", "ID": "DDI-DrugBank.d713.s2.p25", "DRUGA": ["procainamide", "drug", "275-286"], "DRUGB": ["tenofovir", "drug", "338-346"]}
{"TEXT1": "studies to assess Sanctura not conducted potential drugs eliminated active tubular secretion digoxin procainamide @DRUG$ @DRUG$ vancomycin metformin", "LBL": "0", "ID": "DDI-DrugBank.d713.s2.p26", "DRUGA": ["pancuronium", "drug", "289-299"], "DRUGB": ["morphine", "drug", "302-309"]}
{"TEXT1": "studies to assess Sanctura not conducted potential drugs eliminated active tubular secretion digoxin procainamide @DRUG$ morphine @DRUG$ metformin", "LBL": "0", "ID": "DDI-DrugBank.d713.s2.p27", "DRUGA": ["pancuronium", "drug", "289-299"], "DRUGB": ["vancomycin", "drug", "312-321"]}
{"TEXT1": "studies to assess Sanctura not conducted potential drugs eliminated active tubular secretion digoxin procainamide @DRUG$ morphine vancomycin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d713.s2.p28", "DRUGA": ["pancuronium", "drug", "289-299"], "DRUGB": ["metformin", "drug", "324-332"]}
{"TEXT1": "studies to assess Sanctura not conducted potential drugs eliminated active tubular secretion digoxin procainamide @DRUG$ morphine vancomycin metformin", "LBL": "0", "ID": "DDI-DrugBank.d713.s2.p29", "DRUGA": ["pancuronium", "drug", "289-299"], "DRUGB": ["tenofovir", "drug", "338-346"]}
{"TEXT1": "studies to assess Sanctura not conducted potential drugs eliminated active tubular secretion digoxin procainamide pancuronium @DRUG$ @DRUG$ metformin", "LBL": "0", "ID": "DDI-DrugBank.d713.s2.p30", "DRUGA": ["morphine", "drug", "302-309"], "DRUGB": ["vancomycin", "drug", "312-321"]}
{"TEXT1": "studies to assess Sanctura not conducted potential drugs eliminated active tubular secretion digoxin procainamide pancuronium @DRUG$ vancomycin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d713.s2.p31", "DRUGA": ["morphine", "drug", "302-309"], "DRUGB": ["metformin", "drug", "324-332"]}
{"TEXT1": "studies to assess Sanctura not conducted potential drugs eliminated active tubular secretion digoxin procainamide pancuronium @DRUG$ vancomycin metformin", "LBL": "0", "ID": "DDI-DrugBank.d713.s2.p32", "DRUGA": ["morphine", "drug", "302-309"], "DRUGB": ["tenofovir", "drug", "338-346"]}
{"TEXT1": "studies to assess Sanctura not conducted potential drugs eliminated active tubular secretion digoxin procainamide pancuronium morphine @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d713.s2.p33", "DRUGA": ["vancomycin", "drug", "312-321"], "DRUGB": ["metformin", "drug", "324-332"]}
{"TEXT1": "studies to assess Sanctura not conducted potential drugs eliminated active tubular secretion digoxin procainamide pancuronium morphine @DRUG$ metformin", "LBL": "0", "ID": "DDI-DrugBank.d713.s2.p34", "DRUGA": ["vancomycin", "drug", "312-321"], "DRUGB": ["tenofovir", "drug", "338-346"]}
{"TEXT1": "studies to assess Sanctura not conducted potential drugs eliminated active tubular secretion digoxin procainamide pancuronium morphine vancomycin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d713.s2.p35", "DRUGA": ["metformin", "drug", "324-332"], "DRUGB": ["tenofovir", "drug", "338-346"]}
{"TEXT1": "Coadministration @DRUG$ drugs eliminated active renal tubular secretion increase serum concentration @DRUG$ drug due to competition elimination pathway", "LBL": "0", "ID": "DDI-DrugBank.d713.s3.p0", "DRUGA": ["Sanctura", "brand", "20-27"], "DRUGB": ["Sanctura", "brand", "134-141"]}
{"TEXT1": "no known drug/drug interactions with oral @DRUG$ Vaccinations @DRUG$ not recommended immunocompromised individuals Nalidixic acid intravenous melphalan caused deaths children haemorrhagic enterocolitis", "LBL": "0", "ID": "DDI-DrugBank.d625.s0.p0", "DRUGA": ["ALKERAN", "brand", "71-77"], "DRUGB": ["live organism vaccines", "group", "98-119"]}
{"TEXT1": "no known drug/drug interactions with oral @DRUG$ Vaccinations live vaccines organism not recommended immunocompromised individuals @DRUG$ intravenous melphalan caused deaths children haemorrhagic enterocolitis", "LBL": "0", "ID": "DDI-DrugBank.d625.s0.p1", "DRUGA": ["ALKERAN", "brand", "71-77"], "DRUGB": ["Nalidixic acid", "drug", "175-188"]}
{"TEXT1": "no known drug/drug interactions with oral @DRUG$ Vaccinations live vaccines organism not recommended immunocompromised individuals Nalidixic acid intravenous @DRUG$ caused deaths children haemorrhagic enterocolitis", "LBL": "0", "ID": "DDI-DrugBank.d625.s0.p2", "DRUGA": ["ALKERAN", "brand", "71-77"], "DRUGB": ["melphalan", "drug", "226-234"]}
{"TEXT1": "no known drug/drug interactions with oral ALKERAN Vaccinations @DRUG$ not recommended immunocompromised individuals @DRUG$ intravenous melphalan caused deaths children haemorrhagic enterocolitis", "LBL": "0", "ID": "DDI-DrugBank.d625.s0.p3", "DRUGA": ["live organism vaccines", "group", "98-119"], "DRUGB": ["Nalidixic acid", "drug", "175-188"]}
{"TEXT1": "no known drug/drug interactions with oral ALKERAN Vaccinations @DRUG$ not recommended immunocompromised individuals Nalidixic acid intravenous @DRUG$ caused deaths children haemorrhagic enterocolitis", "LBL": "0", "ID": "DDI-DrugBank.d625.s0.p4", "DRUGA": ["live organism vaccines", "group", "98-119"], "DRUGB": ["melphalan", "drug", "226-234"]}
{"TEXT1": "no known drug/drug interactions with oral ALKERAN Vaccinations live vaccines organism not recommended immunocompromised individuals @DRUG$ intravenous @DRUG$ caused deaths children haemorrhagic enterocolitis", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d625.s0.p5", "DRUGA": ["Nalidixic acid", "drug", "175-188"], "DRUGB": ["melphalan", "drug", "226-234"]}
{"TEXT1": "Impaired renal function described bone marrow transplant patients conditioned intravenous @DRUG$ received @DRUG$ to prevent", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d625.s1.p0", "DRUGA": ["melphalan", "drug", "126-134"], "DRUGB": ["cyclosporin", "drug", "166-176"]}
{"TEXT1": "Inhibitors CYP3A4 @DRUG$ administered drugs known to inhibit cytochrome P450 enzyme system classes @DRUG$ protease inhibitors calcium channel antagonists", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d752.s0.p0", "DRUGA": ["midazolam", "drug", "74-82"], "DRUGB": ["azole antimycotics", "group", "228-245"]}
{"TEXT1": "Inhibitors CYP3A4 @DRUG$ administered drugs known to inhibit cytochrome P450 enzyme system classes azole @DRUG$ calcium channel antagonists", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d752.s0.p1", "DRUGA": ["midazolam", "drug", "74-82"], "DRUGB": ["protease inhibitors", "group", "248-266"]}
{"TEXT1": "Inhibitors CYP3A4 @DRUG$ administered drugs known to inhibit cytochrome P450 enzyme system classes azole protease inhibitors @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d752.s0.p2", "DRUGA": ["midazolam", "drug", "74-82"], "DRUGB": ["calcium channel antagonists", "group", "269-295"]}
{"TEXT1": "Inhibitors CYP3A4 @DRUG$ administered drugs known to inhibit cytochrome P450 enzyme system classes azole protease inhibitors calcium channel antagonists", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d752.s0.p3", "DRUGA": ["midazolam", "drug", "74-82"], "DRUGB": ["macrolide antibiotics", "group", "302-322"]}
{"TEXT1": "Inhibitors CYP3A4 midazolam administered drugs known to inhibit cytochrome P450 enzyme system classes @DRUG$ @DRUG$ calcium channel antagonists", "LBL": "0", "ID": "DDI-DrugBank.d752.s0.p4", "DRUGA": ["azole antimycotics", "group", "228-245"], "DRUGB": ["protease inhibitors", "group", "248-266"]}
{"TEXT1": "Inhibitors CYP3A4 midazolam administered drugs known to inhibit cytochrome P450 enzyme system classes @DRUG$ protease inhibitors @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d752.s0.p5", "DRUGA": ["azole antimycotics", "group", "228-245"], "DRUGB": ["calcium channel antagonists", "group", "269-295"]}
{"TEXT1": "Inhibitors CYP3A4 midazolam administered drugs known to inhibit cytochrome P450 enzyme system classes @DRUG$ protease inhibitors calcium channel antagonists", "LBL": "0", "ID": "DDI-DrugBank.d752.s0.p6", "DRUGA": ["azole antimycotics", "group", "228-245"], "DRUGB": ["macrolide antibiotics", "group", "302-322"]}
{"TEXT1": "Inhibitors CYP3A4 midazolam administered drugs known to inhibit cytochrome P450 enzyme system classes azole @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d752.s0.p7", "DRUGA": ["protease inhibitors", "group", "248-266"], "DRUGB": ["calcium channel antagonists", "group", "269-295"]}
{"TEXT1": "Inhibitors CYP3A4 midazolam administered drugs known to inhibit cytochrome P450 enzyme system classes azole @DRUG$ calcium channel antagonists", "LBL": "0", "ID": "DDI-DrugBank.d752.s0.p8", "DRUGA": ["protease inhibitors", "group", "248-266"], "DRUGB": ["macrolide antibiotics", "group", "302-322"]}
{"TEXT1": "Inhibitors CYP3A4 midazolam administered drugs known to inhibit cytochrome P450 enzyme system classes azole protease inhibitors @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d752.s0.p9", "DRUGA": ["calcium channel antagonists", "group", "269-295"], "DRUGB": ["macrolide antibiotics", "group", "302-322"]}
{"TEXT1": "Drugs @DRUG$ @DRUG$ verapamil ketoconazole fluconazole itraconazole shown to increase C max AUC orally administered midazolam", "LBL": "0", "ID": "DDI-DrugBank.d752.s1.p0", "DRUGA": ["erythromycin", "drug", "14-25"], "DRUGB": ["diltiazem", "drug", "28-36"]}
{"TEXT1": "Drugs @DRUG$ diltiazem @DRUG$ ketoconazole fluconazole itraconazole shown to increase C max AUC orally administered midazolam", "LBL": "0", "ID": "DDI-DrugBank.d752.s1.p1", "DRUGA": ["erythromycin", "drug", "14-25"], "DRUGB": ["verapamil", "drug", "39-47"]}
{"TEXT1": "Drugs @DRUG$ diltiazem verapamil @DRUG$ fluconazole itraconazole shown to increase C max AUC orally administered midazolam", "LBL": "0", "ID": "DDI-DrugBank.d752.s1.p2", "DRUGA": ["erythromycin", "drug", "14-25"], "DRUGB": ["ketoconazole", "drug", "50-61"]}
{"TEXT1": "Drugs @DRUG$ diltiazem verapamil ketoconazole @DRUG$ itraconazole shown to increase C max AUC orally administered midazolam", "LBL": "0", "ID": "DDI-DrugBank.d752.s1.p3", "DRUGA": ["erythromycin", "drug", "14-25"], "DRUGB": ["fluconazole", "drug", "64-74"]}
{"TEXT1": "Drugs @DRUG$ diltiazem verapamil ketoconazole fluconazole @DRUG$ shown to increase C max AUC orally administered midazolam", "LBL": "0", "ID": "DDI-DrugBank.d752.s1.p4", "DRUGA": ["erythromycin", "drug", "14-25"], "DRUGB": ["itraconazole", "drug", "80-91"]}
{"TEXT1": "Drugs @DRUG$ diltiazem verapamil ketoconazole fluconazole itraconazole shown to increase C max AUC orally administered @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d752.s1.p5", "DRUGA": ["erythromycin", "drug", "14-25"], "DRUGB": ["midazolam", "drug", "171-179"]}
{"TEXT1": "Drugs @DRUG$ @DRUG$ ketoconazole fluconazole itraconazole shown to increase C max AUC orally administered midazolam", "LBL": "0", "ID": "DDI-DrugBank.d752.s1.p6", "DRUGA": ["diltiazem", "drug", "28-36"], "DRUGB": ["verapamil", "drug", "39-47"]}
{"TEXT1": "Drugs @DRUG$ verapamil @DRUG$ fluconazole itraconazole shown to increase C max AUC orally administered midazolam", "LBL": "0", "ID": "DDI-DrugBank.d752.s1.p7", "DRUGA": ["diltiazem", "drug", "28-36"], "DRUGB": ["ketoconazole", "drug", "50-61"]}
{"TEXT1": "Drugs @DRUG$ verapamil ketoconazole @DRUG$ itraconazole shown to increase C max AUC orally administered midazolam", "LBL": "0", "ID": "DDI-DrugBank.d752.s1.p8", "DRUGA": ["diltiazem", "drug", "28-36"], "DRUGB": ["fluconazole", "drug", "64-74"]}
{"TEXT1": "Drugs @DRUG$ verapamil ketoconazole fluconazole @DRUG$ shown to increase C max AUC orally administered midazolam", "LBL": "0", "ID": "DDI-DrugBank.d752.s1.p9", "DRUGA": ["diltiazem", "drug", "28-36"], "DRUGB": ["itraconazole", "drug", "80-91"]}
{"TEXT1": "Drugs @DRUG$ verapamil ketoconazole fluconazole itraconazole shown to increase C max AUC orally administered @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d752.s1.p10", "DRUGA": ["diltiazem", "drug", "28-36"], "DRUGB": ["midazolam", "drug", "171-179"]}
{"TEXT1": "Drugs diltiazem @DRUG$ @DRUG$ fluconazole itraconazole shown to increase C max AUC orally administered midazolam", "LBL": "0", "ID": "DDI-DrugBank.d752.s1.p11", "DRUGA": ["verapamil", "drug", "39-47"], "DRUGB": ["ketoconazole", "drug", "50-61"]}
{"TEXT1": "Drugs diltiazem @DRUG$ ketoconazole @DRUG$ itraconazole shown to increase C max AUC orally administered midazolam", "LBL": "0", "ID": "DDI-DrugBank.d752.s1.p12", "DRUGA": ["verapamil", "drug", "39-47"], "DRUGB": ["fluconazole", "drug", "64-74"]}
{"TEXT1": "Drugs diltiazem @DRUG$ ketoconazole fluconazole @DRUG$ shown to increase C max AUC orally administered midazolam", "LBL": "0", "ID": "DDI-DrugBank.d752.s1.p13", "DRUGA": ["verapamil", "drug", "39-47"], "DRUGB": ["itraconazole", "drug", "80-91"]}
{"TEXT1": "Drugs diltiazem @DRUG$ ketoconazole fluconazole itraconazole shown to increase C max AUC orally administered @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d752.s1.p14", "DRUGA": ["verapamil", "drug", "39-47"], "DRUGB": ["midazolam", "drug", "171-179"]}
{"TEXT1": "Drugs diltiazem verapamil @DRUG$ @DRUG$ itraconazole shown to increase C max AUC orally administered midazolam", "LBL": "0", "ID": "DDI-DrugBank.d752.s1.p15", "DRUGA": ["ketoconazole", "drug", "50-61"], "DRUGB": ["fluconazole", "drug", "64-74"]}
{"TEXT1": "Drugs diltiazem verapamil @DRUG$ fluconazole @DRUG$ shown to increase C max AUC orally administered midazolam", "LBL": "0", "ID": "DDI-DrugBank.d752.s1.p16", "DRUGA": ["ketoconazole", "drug", "50-61"], "DRUGB": ["itraconazole", "drug", "80-91"]}
{"TEXT1": "Drugs diltiazem verapamil @DRUG$ fluconazole itraconazole shown to increase C max AUC orally administered @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d752.s1.p17", "DRUGA": ["ketoconazole", "drug", "50-61"], "DRUGB": ["midazolam", "drug", "171-179"]}
{"TEXT1": "Drugs diltiazem verapamil ketoconazole @DRUG$ @DRUG$ shown to increase C max AUC orally administered midazolam", "LBL": "0", "ID": "DDI-DrugBank.d752.s1.p18", "DRUGA": ["fluconazole", "drug", "64-74"], "DRUGB": ["itraconazole", "drug", "80-91"]}
{"TEXT1": "Drugs diltiazem verapamil ketoconazole @DRUG$ itraconazole shown to increase C max AUC orally administered @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d752.s1.p19", "DRUGA": ["fluconazole", "drug", "64-74"], "DRUGB": ["midazolam", "drug", "171-179"]}
{"TEXT1": "Drugs diltiazem verapamil ketoconazole fluconazole @DRUG$ shown to increase C max AUC orally administered @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d752.s1.p20", "DRUGA": ["itraconazole", "drug", "80-91"], "DRUGB": ["midazolam", "drug", "171-179"]}
{"TEXT1": "not studied potent cytochrome P450 3A4 inhibitors @DRUG$ @DRUG$ cause intense prolonged sedation respiratory depression due to decrease plasma clearance midazolam", "LBL": "0", "ID": "DDI-DrugBank.d752.s3.p0", "DRUGA": ["ritonavir", "drug", "64-72"], "DRUGB": ["nelfinavir", "drug", "78-87"]}
{"TEXT1": "not studied potent cytochrome P450 3A4 inhibitors @DRUG$ nelfinavir cause intense prolonged sedation respiratory depression due to decrease plasma clearance @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d752.s3.p1", "DRUGA": ["ritonavir", "drug", "64-72"], "DRUGB": ["midazolam", "drug", "198-206"]}
{"TEXT1": "not studied potent cytochrome P450 3A4 inhibitors ritonavir @DRUG$ cause intense prolonged sedation respiratory depression due to decrease plasma clearance @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d752.s3.p2", "DRUGA": ["nelfinavir", "drug", "78-87"], "DRUGB": ["midazolam", "drug", "198-206"]}
{"TEXT1": "Inducers CYP3A4 Cytochrome P450 inducers @DRUG$ @DRUG$ phenytoin induce metabolism caused markedly decreased C max AUC oral midazolam adult studies", "LBL": "0", "ID": "DDI-DrugBank.d752.s6.p0", "DRUGA": ["rifampin", "drug", "63-70"], "DRUGB": ["carbamazepine", "drug", "73-85"]}
{"TEXT1": "Inducers CYP3A4 Cytochrome P450 inducers @DRUG$ carbamazepine @DRUG$ induce metabolism caused markedly decreased C max AUC oral midazolam adult studies", "LBL": "0", "ID": "DDI-DrugBank.d752.s6.p1", "DRUGA": ["rifampin", "drug", "63-70"], "DRUGB": ["phenytoin", "drug", "92-100"]}
{"TEXT1": "Inducers CYP3A4 Cytochrome P450 inducers @DRUG$ carbamazepine phenytoin induce metabolism caused markedly decreased C max AUC oral @DRUG$ adult studies", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d752.s6.p2", "DRUGA": ["rifampin", "drug", "63-70"], "DRUGB": ["midazolam", "drug", "175-183"]}
{"TEXT1": "Inducers CYP3A4 Cytochrome P450 inducers rifampin @DRUG$ @DRUG$ induce metabolism caused markedly decreased C max AUC oral midazolam adult studies", "LBL": "0", "ID": "DDI-DrugBank.d752.s6.p3", "DRUGA": ["carbamazepine", "drug", "73-85"], "DRUGB": ["phenytoin", "drug", "92-100"]}
{"TEXT1": "Inducers CYP3A4 Cytochrome P450 inducers rifampin @DRUG$ phenytoin induce metabolism caused markedly decreased C max AUC oral @DRUG$ adult studies", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d752.s6.p4", "DRUGA": ["carbamazepine", "drug", "73-85"], "DRUGB": ["midazolam", "drug", "175-183"]}
{"TEXT1": "Inducers CYP3A4 Cytochrome P450 inducers rifampin carbamazepine @DRUG$ induce metabolism caused markedly decreased C max AUC oral @DRUG$ adult studies", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d752.s6.p5", "DRUGA": ["phenytoin", "drug", "92-100"], "DRUGB": ["midazolam", "drug", "175-183"]}
{"TEXT1": "difficulty adequate sedation result decreased absorption @DRUG$ gastrointestinal effects stimulant @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d752.s9.p0", "DRUGA": ["sedatives", "group", "102-110"], "DRUGB": ["methylphenidate", "drug", "178-192"]}
{"TEXT1": "sedative effect @DRUG$ accentuated administered medication central nervous system @DRUG$ morphine meperidine propofol ketamine nitrous oxide secobarbital droperidol", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d752.s10.p0", "DRUGA": ["VERSED Syrup", "brand", "23-34"], "DRUGB": ["narcotics", "group", "153-161"]}
{"TEXT1": "sedative effect @DRUG$ accentuated administered medication central nervous system narcotics @DRUG$ meperidine propofol ketamine nitrous oxide secobarbital droperidol", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d752.s10.p1", "DRUGA": ["VERSED Syrup", "brand", "23-34"], "DRUGB": ["morphine", "drug", "168-175"]}
{"TEXT1": "sedative effect @DRUG$ accentuated administered medication central nervous system narcotics morphine @DRUG$ propofol ketamine nitrous oxide secobarbital droperidol", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d752.s10.p2", "DRUGA": ["VERSED Syrup", "brand", "23-34"], "DRUGB": ["meperidine", "drug", "178-187"]}
{"TEXT1": "sedative effect @DRUG$ accentuated administered medication central nervous system narcotics morphine meperidine propofol ketamine nitrous oxide secobarbital droperidol", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d752.s10.p3", "DRUGA": ["VERSED Syrup", "brand", "23-34"], "DRUGB": ["fentanyl", "drug", "193-200"]}
{"TEXT1": "sedative effect @DRUG$ accentuated administered medication central nervous system narcotics morphine meperidine @DRUG$ ketamine nitrous oxide secobarbital droperidol", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d752.s10.p4", "DRUGA": ["VERSED Syrup", "brand", "23-34"], "DRUGB": ["propofol", "drug", "204-211"]}
{"TEXT1": "sedative effect @DRUG$ accentuated administered medication central nervous system narcotics morphine meperidine propofol @DRUG$ nitrous oxide secobarbital droperidol", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d752.s10.p5", "DRUGA": ["VERSED Syrup", "brand", "23-34"], "DRUGB": ["ketamine", "drug", "214-221"]}
{"TEXT1": "sedative effect @DRUG$ accentuated administered medication central nervous system narcotics morphine meperidine propofol ketamine @DRUG$ secobarbital droperidol", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d752.s10.p6", "DRUGA": ["VERSED Syrup", "brand", "23-34"], "DRUGB": ["nitrous oxide", "drug", "224-236"]}
{"TEXT1": "sedative effect @DRUG$ accentuated administered medication central nervous system narcotics morphine meperidine propofol ketamine nitrous oxide @DRUG$ droperidol", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d752.s10.p7", "DRUGA": ["VERSED Syrup", "brand", "23-34"], "DRUGB": ["secobarbital", "drug", "239-250"]}
{"TEXT1": "sedative effect @DRUG$ accentuated administered medication central nervous system narcotics morphine meperidine propofol ketamine nitrous oxide secobarbital @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d752.s10.p8", "DRUGA": ["VERSED Syrup", "brand", "23-34"], "DRUGB": ["droperidol", "drug", "256-265"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system @DRUG$ @DRUG$ meperidine propofol ketamine nitrous oxide secobarbital droperidol", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p9", "DRUGA": ["narcotics", "group", "153-161"], "DRUGB": ["morphine", "drug", "168-175"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system @DRUG$ morphine @DRUG$ propofol ketamine nitrous oxide secobarbital droperidol", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p10", "DRUGA": ["narcotics", "group", "153-161"], "DRUGB": ["meperidine", "drug", "178-187"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system @DRUG$ morphine meperidine propofol ketamine nitrous oxide secobarbital droperidol", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p11", "DRUGA": ["narcotics", "group", "153-161"], "DRUGB": ["fentanyl", "drug", "193-200"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system @DRUG$ morphine meperidine @DRUG$ ketamine nitrous oxide secobarbital droperidol", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p12", "DRUGA": ["narcotics", "group", "153-161"], "DRUGB": ["propofol", "drug", "204-211"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system @DRUG$ morphine meperidine propofol @DRUG$ nitrous oxide secobarbital droperidol", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p13", "DRUGA": ["narcotics", "group", "153-161"], "DRUGB": ["ketamine", "drug", "214-221"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system @DRUG$ morphine meperidine propofol ketamine @DRUG$ secobarbital droperidol", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p14", "DRUGA": ["narcotics", "group", "153-161"], "DRUGB": ["nitrous oxide", "drug", "224-236"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system @DRUG$ morphine meperidine propofol ketamine nitrous oxide @DRUG$ droperidol", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p15", "DRUGA": ["narcotics", "group", "153-161"], "DRUGB": ["secobarbital", "drug", "239-250"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system @DRUG$ morphine meperidine propofol ketamine nitrous oxide secobarbital @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p16", "DRUGA": ["narcotics", "group", "153-161"], "DRUGB": ["droperidol", "drug", "256-265"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system narcotics @DRUG$ @DRUG$ propofol ketamine nitrous oxide secobarbital droperidol", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p17", "DRUGA": ["morphine", "drug", "168-175"], "DRUGB": ["meperidine", "drug", "178-187"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system narcotics @DRUG$ meperidine propofol ketamine nitrous oxide secobarbital droperidol", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p18", "DRUGA": ["morphine", "drug", "168-175"], "DRUGB": ["fentanyl", "drug", "193-200"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system narcotics @DRUG$ meperidine @DRUG$ ketamine nitrous oxide secobarbital droperidol", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p19", "DRUGA": ["morphine", "drug", "168-175"], "DRUGB": ["propofol", "drug", "204-211"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system narcotics @DRUG$ meperidine propofol @DRUG$ nitrous oxide secobarbital droperidol", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p20", "DRUGA": ["morphine", "drug", "168-175"], "DRUGB": ["ketamine", "drug", "214-221"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system narcotics @DRUG$ meperidine propofol ketamine @DRUG$ secobarbital droperidol", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p21", "DRUGA": ["morphine", "drug", "168-175"], "DRUGB": ["nitrous oxide", "drug", "224-236"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system narcotics @DRUG$ meperidine propofol ketamine nitrous oxide @DRUG$ droperidol", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p22", "DRUGA": ["morphine", "drug", "168-175"], "DRUGB": ["secobarbital", "drug", "239-250"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system narcotics @DRUG$ meperidine propofol ketamine nitrous oxide secobarbital @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p23", "DRUGA": ["morphine", "drug", "168-175"], "DRUGB": ["droperidol", "drug", "256-265"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system narcotics morphine @DRUG$ propofol ketamine nitrous oxide secobarbital droperidol", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p24", "DRUGA": ["meperidine", "drug", "178-187"], "DRUGB": ["fentanyl", "drug", "193-200"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system narcotics morphine @DRUG$ @DRUG$ ketamine nitrous oxide secobarbital droperidol", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p25", "DRUGA": ["meperidine", "drug", "178-187"], "DRUGB": ["propofol", "drug", "204-211"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system narcotics morphine @DRUG$ propofol @DRUG$ nitrous oxide secobarbital droperidol", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p26", "DRUGA": ["meperidine", "drug", "178-187"], "DRUGB": ["ketamine", "drug", "214-221"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system narcotics morphine @DRUG$ propofol ketamine @DRUG$ secobarbital droperidol", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p27", "DRUGA": ["meperidine", "drug", "178-187"], "DRUGB": ["nitrous oxide", "drug", "224-236"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system narcotics morphine @DRUG$ propofol ketamine nitrous oxide @DRUG$ droperidol", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p28", "DRUGA": ["meperidine", "drug", "178-187"], "DRUGB": ["secobarbital", "drug", "239-250"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system narcotics morphine @DRUG$ propofol ketamine nitrous oxide secobarbital @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p29", "DRUGA": ["meperidine", "drug", "178-187"], "DRUGB": ["droperidol", "drug", "256-265"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system narcotics morphine meperidine @DRUG$ ketamine nitrous oxide secobarbital droperidol", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p30", "DRUGA": ["fentanyl", "drug", "193-200"], "DRUGB": ["propofol", "drug", "204-211"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system narcotics morphine meperidine propofol @DRUG$ nitrous oxide secobarbital droperidol", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p31", "DRUGA": ["fentanyl", "drug", "193-200"], "DRUGB": ["ketamine", "drug", "214-221"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system narcotics morphine meperidine propofol ketamine @DRUG$ secobarbital droperidol", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p32", "DRUGA": ["fentanyl", "drug", "193-200"], "DRUGB": ["nitrous oxide", "drug", "224-236"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system narcotics morphine meperidine propofol ketamine nitrous oxide @DRUG$ droperidol", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p33", "DRUGA": ["fentanyl", "drug", "193-200"], "DRUGB": ["secobarbital", "drug", "239-250"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system narcotics morphine meperidine propofol ketamine nitrous oxide secobarbital @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p34", "DRUGA": ["fentanyl", "drug", "193-200"], "DRUGB": ["droperidol", "drug", "256-265"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system narcotics morphine meperidine @DRUG$ @DRUG$ nitrous oxide secobarbital droperidol", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p35", "DRUGA": ["propofol", "drug", "204-211"], "DRUGB": ["ketamine", "drug", "214-221"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system narcotics morphine meperidine @DRUG$ ketamine @DRUG$ secobarbital droperidol", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p36", "DRUGA": ["propofol", "drug", "204-211"], "DRUGB": ["nitrous oxide", "drug", "224-236"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system narcotics morphine meperidine @DRUG$ ketamine nitrous oxide @DRUG$ droperidol", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p37", "DRUGA": ["propofol", "drug", "204-211"], "DRUGB": ["secobarbital", "drug", "239-250"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system narcotics morphine meperidine @DRUG$ ketamine nitrous oxide secobarbital @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p38", "DRUGA": ["propofol", "drug", "204-211"], "DRUGB": ["droperidol", "drug", "256-265"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system narcotics morphine meperidine propofol @DRUG$ @DRUG$ secobarbital droperidol", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p39", "DRUGA": ["ketamine", "drug", "214-221"], "DRUGB": ["nitrous oxide", "drug", "224-236"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system narcotics morphine meperidine propofol @DRUG$ nitrous oxide @DRUG$ droperidol", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p40", "DRUGA": ["ketamine", "drug", "214-221"], "DRUGB": ["secobarbital", "drug", "239-250"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system narcotics morphine meperidine propofol @DRUG$ nitrous oxide secobarbital @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p41", "DRUGA": ["ketamine", "drug", "214-221"], "DRUGB": ["droperidol", "drug", "256-265"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system narcotics morphine meperidine propofol ketamine @DRUG$ @DRUG$ droperidol", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p42", "DRUGA": ["nitrous oxide", "drug", "224-236"], "DRUGB": ["secobarbital", "drug", "239-250"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system narcotics morphine meperidine propofol ketamine @DRUG$ secobarbital @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p43", "DRUGA": ["nitrous oxide", "drug", "224-236"], "DRUGB": ["droperidol", "drug", "256-265"]}
{"TEXT1": "sedative effect VERSED Syrup accentuated administered medication central nervous system narcotics morphine meperidine propofol ketamine nitrous oxide @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d752.s10.p44", "DRUGA": ["secobarbital", "drug", "239-250"], "DRUGB": ["droperidol", "drug", "256-265"]}
{"TEXT1": "significant adverse interactions common premedications @DRUG$ @DRUG$ glycopyrrolate diazepam hydroxyzine local anesthetics observed", "LBL": "0", "ID": "DDI-DrugBank.d752.s12.p0", "DRUGA": ["atropine", "drug", "72-79"], "DRUGB": ["scopolamine", "drug", "82-92"]}
{"TEXT1": "significant adverse interactions common premedications @DRUG$ scopolamine @DRUG$ diazepam hydroxyzine local anesthetics observed", "LBL": "0", "ID": "DDI-DrugBank.d752.s12.p1", "DRUGA": ["atropine", "drug", "72-79"], "DRUGB": ["glycopyrrolate", "drug", "95-108"]}
{"TEXT1": "significant adverse interactions common premedications @DRUG$ scopolamine glycopyrrolate @DRUG$ hydroxyzine local anesthetics observed", "LBL": "0", "ID": "DDI-DrugBank.d752.s12.p2", "DRUGA": ["atropine", "drug", "72-79"], "DRUGB": ["diazepam", "drug", "111-118"]}
{"TEXT1": "significant adverse interactions common premedications @DRUG$ scopolamine glycopyrrolate diazepam @DRUG$ local anesthetics observed", "LBL": "0", "ID": "DDI-DrugBank.d752.s12.p3", "DRUGA": ["atropine", "drug", "72-79"], "DRUGB": ["hydroxyzine", "drug", "121-131"]}
{"TEXT1": "significant adverse interactions common premedications @DRUG$ scopolamine glycopyrrolate diazepam hydroxyzine local anesthetics observed", "LBL": "0", "ID": "DDI-DrugBank.d752.s12.p4", "DRUGA": ["atropine", "drug", "72-79"], "DRUGB": ["muscle relaxants", "group", "144-159"]}
{"TEXT1": "significant adverse interactions common premedications @DRUG$ scopolamine glycopyrrolate diazepam hydroxyzine @DRUG$ observed", "LBL": "0", "ID": "DDI-DrugBank.d752.s12.p5", "DRUGA": ["atropine", "drug", "72-79"], "DRUGB": ["anesthetics", "group", "171-181"]}
{"TEXT1": "significant adverse interactions common premedications atropine @DRUG$ @DRUG$ diazepam hydroxyzine local anesthetics observed", "LBL": "0", "ID": "DDI-DrugBank.d752.s12.p6", "DRUGA": ["scopolamine", "drug", "82-92"], "DRUGB": ["glycopyrrolate", "drug", "95-108"]}
{"TEXT1": "significant adverse interactions common premedications atropine @DRUG$ glycopyrrolate @DRUG$ hydroxyzine local anesthetics observed", "LBL": "0", "ID": "DDI-DrugBank.d752.s12.p7", "DRUGA": ["scopolamine", "drug", "82-92"], "DRUGB": ["diazepam", "drug", "111-118"]}
{"TEXT1": "significant adverse interactions common premedications atropine @DRUG$ glycopyrrolate diazepam @DRUG$ local anesthetics observed", "LBL": "0", "ID": "DDI-DrugBank.d752.s12.p8", "DRUGA": ["scopolamine", "drug", "82-92"], "DRUGB": ["hydroxyzine", "drug", "121-131"]}
{"TEXT1": "significant adverse interactions common premedications atropine @DRUG$ glycopyrrolate diazepam hydroxyzine local anesthetics observed", "LBL": "0", "ID": "DDI-DrugBank.d752.s12.p9", "DRUGA": ["scopolamine", "drug", "82-92"], "DRUGB": ["muscle relaxants", "group", "144-159"]}
{"TEXT1": "significant adverse interactions common premedications atropine @DRUG$ glycopyrrolate diazepam hydroxyzine @DRUG$ observed", "LBL": "0", "ID": "DDI-DrugBank.d752.s12.p10", "DRUGA": ["scopolamine", "drug", "82-92"], "DRUGB": ["anesthetics", "group", "171-181"]}
{"TEXT1": "significant adverse interactions common premedications atropine scopolamine @DRUG$ @DRUG$ hydroxyzine local anesthetics observed", "LBL": "0", "ID": "DDI-DrugBank.d752.s12.p11", "DRUGA": ["glycopyrrolate", "drug", "95-108"], "DRUGB": ["diazepam", "drug", "111-118"]}
{"TEXT1": "significant adverse interactions common premedications atropine scopolamine @DRUG$ diazepam @DRUG$ local anesthetics observed", "LBL": "0", "ID": "DDI-DrugBank.d752.s12.p12", "DRUGA": ["glycopyrrolate", "drug", "95-108"], "DRUGB": ["hydroxyzine", "drug", "121-131"]}
{"TEXT1": "significant adverse interactions common premedications atropine scopolamine @DRUG$ diazepam hydroxyzine local anesthetics observed", "LBL": "0", "ID": "DDI-DrugBank.d752.s12.p13", "DRUGA": ["glycopyrrolate", "drug", "95-108"], "DRUGB": ["muscle relaxants", "group", "144-159"]}
{"TEXT1": "significant adverse interactions common premedications atropine scopolamine @DRUG$ diazepam hydroxyzine @DRUG$ observed", "LBL": "0", "ID": "DDI-DrugBank.d752.s12.p14", "DRUGA": ["glycopyrrolate", "drug", "95-108"], "DRUGB": ["anesthetics", "group", "171-181"]}
{"TEXT1": "significant adverse interactions common premedications atropine scopolamine glycopyrrolate @DRUG$ @DRUG$ local anesthetics observed", "LBL": "0", "ID": "DDI-DrugBank.d752.s12.p15", "DRUGA": ["diazepam", "drug", "111-118"], "DRUGB": ["hydroxyzine", "drug", "121-131"]}
{"TEXT1": "significant adverse interactions common premedications atropine scopolamine glycopyrrolate @DRUG$ hydroxyzine local anesthetics observed", "LBL": "0", "ID": "DDI-DrugBank.d752.s12.p16", "DRUGA": ["diazepam", "drug", "111-118"], "DRUGB": ["muscle relaxants", "group", "144-159"]}
{"TEXT1": "significant adverse interactions common premedications atropine scopolamine glycopyrrolate @DRUG$ hydroxyzine @DRUG$ observed", "LBL": "0", "ID": "DDI-DrugBank.d752.s12.p17", "DRUGA": ["diazepam", "drug", "111-118"], "DRUGB": ["anesthetics", "group", "171-181"]}
{"TEXT1": "significant adverse interactions common premedications atropine scopolamine glycopyrrolate diazepam @DRUG$ local anesthetics observed", "LBL": "0", "ID": "DDI-DrugBank.d752.s12.p18", "DRUGA": ["hydroxyzine", "drug", "121-131"], "DRUGB": ["muscle relaxants", "group", "144-159"]}
{"TEXT1": "significant adverse interactions common premedications atropine scopolamine glycopyrrolate diazepam @DRUG$ @DRUG$ observed", "LBL": "0", "ID": "DDI-DrugBank.d752.s12.p19", "DRUGA": ["hydroxyzine", "drug", "121-131"], "DRUGB": ["anesthetics", "group", "171-181"]}
{"TEXT1": "significant adverse interactions common premedications atropine scopolamine glycopyrrolate diazepam hydroxyzine @DRUG$ observed", "LBL": "0", "ID": "DDI-DrugBank.d752.s12.p20", "DRUGA": ["muscle relaxants", "group", "144-159"], "DRUGB": ["anesthetics", "group", "171-181"]}
{"TEXT1": "Drugs myeloproliferative effects @DRUG$ @DRUG$ corticosteroids used with caution", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d607.s1.p0", "DRUGA": ["Leukine", "brand", "61-67"], "DRUGB": ["lithium", "drug", "78-84"]}
{"TEXT1": "Drugs myeloproliferative effects @DRUG$ lithium @DRUG$ used with caution", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d607.s1.p1", "DRUGA": ["Leukine", "brand", "61-67"], "DRUGB": ["corticosteroids", "group", "90-104"]}
{"TEXT1": "Drugs myeloproliferative effects Leukine @DRUG$ @DRUG$ used with caution", "LBL": "0", "ID": "DDI-DrugBank.d607.s1.p2", "DRUGA": ["lithium", "drug", "78-84"], "DRUGB": ["corticosteroids", "group", "90-104"]}
{"TEXT1": "described greater detail @DRUG$ @DRUG$ Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p0", "DRUGA": ["hypoglycemics", "group", "51-63"], "DRUGB": ["Coumarin-type anticoagulants", "group", "66-93"]}
{"TEXT1": "described greater detail @DRUG$ Coumarin anticoagulants type @DRUG$ Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p1", "DRUGA": ["hypoglycemics", "group", "51-63"], "DRUGB": ["Phenytoin", "drug", "96-104"]}
{"TEXT1": "described greater detail @DRUG$ Coumarin anticoagulants type Phenytoin @DRUG$ Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p2", "DRUGA": ["hypoglycemics", "group", "51-63"], "DRUGB": ["Cyclosporine", "drug", "107-118"]}
{"TEXT1": "described greater detail @DRUG$ Coumarin anticoagulants type Phenytoin Cyclosporine @DRUG$ Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p3", "DRUGA": ["hypoglycemics", "group", "51-63"], "DRUGB": ["Rifampin", "drug", "121-128"]}
{"TEXT1": "described greater detail @DRUG$ Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin @DRUG$ Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p4", "DRUGA": ["hypoglycemics", "group", "51-63"], "DRUGB": ["Theophylline", "drug", "131-142"]}
{"TEXT1": "described greater detail @DRUG$ Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline @DRUG$ Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p5", "DRUGA": ["hypoglycemics", "group", "51-63"], "DRUGB": ["Terfenadine", "drug", "145-155"]}
{"TEXT1": "described greater detail @DRUG$ Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine @DRUG$ Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p6", "DRUGA": ["hypoglycemics", "group", "51-63"], "DRUGB": ["Cisapride", "drug", "158-166"]}
{"TEXT1": "described greater detail @DRUG$ Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride @DRUG$ Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p7", "DRUGA": ["hypoglycemics", "group", "51-63"], "DRUGB": ["Astemizole", "drug", "169-178"]}
{"TEXT1": "described greater detail @DRUG$ Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole @DRUG$ Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p8", "DRUGA": ["hypoglycemics", "group", "51-63"], "DRUGB": ["Rifabutin", "drug", "181-189"]}
{"TEXT1": "described greater detail @DRUG$ Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin @DRUG$ significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p9", "DRUGA": ["hypoglycemics", "group", "51-63"], "DRUGB": ["Tacrolimus", "drug", "192-201"]}
{"TEXT1": "described greater detail @DRUG$ Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus @DRUG$ significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p10", "DRUGA": ["hypoglycemics", "group", "51-63"], "DRUGB": ["Short-acting benzodiazepines", "group", "204-231"]}
{"TEXT1": "described greater detail @DRUG$ Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p11", "DRUGA": ["hypoglycemics", "group", "51-63"], "DRUGB": ["hypoglycemics", "group", "240-252"]}
{"TEXT1": "described greater detail @DRUG$ Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p12", "DRUGA": ["hypoglycemics", "group", "51-63"], "DRUGB": ["DIFLUCAN", "brand", "325-332"]}
{"TEXT1": "described greater detail @DRUG$ Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p13", "DRUGA": ["hypoglycemics", "group", "51-63"], "DRUGB": ["hypoglycemic agents", "group", "344-362"]}
{"TEXT1": "described greater detail @DRUG$ @DRUG$ Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p14", "DRUGA": ["Coumarin-type anticoagulants", "group", "66-93"], "DRUGB": ["Phenytoin", "drug", "96-104"]}
{"TEXT1": "described greater detail @DRUG$ Phenytoin @DRUG$ Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p15", "DRUGA": ["Coumarin-type anticoagulants", "group", "66-93"], "DRUGB": ["Cyclosporine", "drug", "107-118"]}
{"TEXT1": "described greater detail @DRUG$ Phenytoin Cyclosporine @DRUG$ Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p16", "DRUGA": ["Coumarin-type anticoagulants", "group", "66-93"], "DRUGB": ["Rifampin", "drug", "121-128"]}
{"TEXT1": "described greater detail @DRUG$ Phenytoin Cyclosporine Rifampin @DRUG$ Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p17", "DRUGA": ["Coumarin-type anticoagulants", "group", "66-93"], "DRUGB": ["Theophylline", "drug", "131-142"]}
{"TEXT1": "described greater detail @DRUG$ Phenytoin Cyclosporine Rifampin Theophylline @DRUG$ Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p18", "DRUGA": ["Coumarin-type anticoagulants", "group", "66-93"], "DRUGB": ["Terfenadine", "drug", "145-155"]}
{"TEXT1": "described greater detail @DRUG$ Phenytoin Cyclosporine Rifampin Theophylline Terfenadine @DRUG$ Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p19", "DRUGA": ["Coumarin-type anticoagulants", "group", "66-93"], "DRUGB": ["Cisapride", "drug", "158-166"]}
{"TEXT1": "described greater detail @DRUG$ Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride @DRUG$ Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p20", "DRUGA": ["Coumarin-type anticoagulants", "group", "66-93"], "DRUGB": ["Astemizole", "drug", "169-178"]}
{"TEXT1": "described greater detail @DRUG$ Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole @DRUG$ Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p21", "DRUGA": ["Coumarin-type anticoagulants", "group", "66-93"], "DRUGB": ["Rifabutin", "drug", "181-189"]}
{"TEXT1": "described greater detail @DRUG$ Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin @DRUG$ significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p22", "DRUGA": ["Coumarin-type anticoagulants", "group", "66-93"], "DRUGB": ["Tacrolimus", "drug", "192-201"]}
{"TEXT1": "described greater detail @DRUG$ Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus @DRUG$ significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p23", "DRUGA": ["Coumarin-type anticoagulants", "group", "66-93"], "DRUGB": ["Short-acting benzodiazepines", "group", "204-231"]}
{"TEXT1": "described greater detail @DRUG$ Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p24", "DRUGA": ["Coumarin-type anticoagulants", "group", "66-93"], "DRUGB": ["hypoglycemics", "group", "240-252"]}
{"TEXT1": "described greater detail @DRUG$ Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p25", "DRUGA": ["Coumarin-type anticoagulants", "group", "66-93"], "DRUGB": ["DIFLUCAN", "brand", "325-332"]}
{"TEXT1": "described greater detail @DRUG$ Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p26", "DRUGA": ["Coumarin-type anticoagulants", "group", "66-93"], "DRUGB": ["hypoglycemic agents", "group", "344-362"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type @DRUG$ @DRUG$ Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p27", "DRUGA": ["Phenytoin", "drug", "96-104"], "DRUGB": ["Cyclosporine", "drug", "107-118"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type @DRUG$ Cyclosporine @DRUG$ Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p28", "DRUGA": ["Phenytoin", "drug", "96-104"], "DRUGB": ["Rifampin", "drug", "121-128"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type @DRUG$ Cyclosporine Rifampin @DRUG$ Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p29", "DRUGA": ["Phenytoin", "drug", "96-104"], "DRUGB": ["Theophylline", "drug", "131-142"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type @DRUG$ Cyclosporine Rifampin Theophylline @DRUG$ Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p30", "DRUGA": ["Phenytoin", "drug", "96-104"], "DRUGB": ["Terfenadine", "drug", "145-155"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type @DRUG$ Cyclosporine Rifampin Theophylline Terfenadine @DRUG$ Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p31", "DRUGA": ["Phenytoin", "drug", "96-104"], "DRUGB": ["Cisapride", "drug", "158-166"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type @DRUG$ Cyclosporine Rifampin Theophylline Terfenadine Cisapride @DRUG$ Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p32", "DRUGA": ["Phenytoin", "drug", "96-104"], "DRUGB": ["Astemizole", "drug", "169-178"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type @DRUG$ Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole @DRUG$ Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p33", "DRUGA": ["Phenytoin", "drug", "96-104"], "DRUGB": ["Rifabutin", "drug", "181-189"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type @DRUG$ Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin @DRUG$ significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p34", "DRUGA": ["Phenytoin", "drug", "96-104"], "DRUGB": ["Tacrolimus", "drug", "192-201"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type @DRUG$ Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus @DRUG$ significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p35", "DRUGA": ["Phenytoin", "drug", "96-104"], "DRUGB": ["Short-acting benzodiazepines", "group", "204-231"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type @DRUG$ Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p36", "DRUGA": ["Phenytoin", "drug", "96-104"], "DRUGB": ["hypoglycemics", "group", "240-252"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type @DRUG$ Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p37", "DRUGA": ["Phenytoin", "drug", "96-104"], "DRUGB": ["DIFLUCAN", "brand", "325-332"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type @DRUG$ Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p38", "DRUGA": ["Phenytoin", "drug", "96-104"], "DRUGB": ["hypoglycemic agents", "group", "344-362"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin @DRUG$ @DRUG$ Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p39", "DRUGA": ["Cyclosporine", "drug", "107-118"], "DRUGB": ["Rifampin", "drug", "121-128"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin @DRUG$ Rifampin @DRUG$ Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p40", "DRUGA": ["Cyclosporine", "drug", "107-118"], "DRUGB": ["Theophylline", "drug", "131-142"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin @DRUG$ Rifampin Theophylline @DRUG$ Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p41", "DRUGA": ["Cyclosporine", "drug", "107-118"], "DRUGB": ["Terfenadine", "drug", "145-155"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin @DRUG$ Rifampin Theophylline Terfenadine @DRUG$ Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p42", "DRUGA": ["Cyclosporine", "drug", "107-118"], "DRUGB": ["Cisapride", "drug", "158-166"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin @DRUG$ Rifampin Theophylline Terfenadine Cisapride @DRUG$ Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p43", "DRUGA": ["Cyclosporine", "drug", "107-118"], "DRUGB": ["Astemizole", "drug", "169-178"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin @DRUG$ Rifampin Theophylline Terfenadine Cisapride Astemizole @DRUG$ Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p44", "DRUGA": ["Cyclosporine", "drug", "107-118"], "DRUGB": ["Rifabutin", "drug", "181-189"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin @DRUG$ Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin @DRUG$ significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p45", "DRUGA": ["Cyclosporine", "drug", "107-118"], "DRUGB": ["Tacrolimus", "drug", "192-201"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin @DRUG$ Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus @DRUG$ significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p46", "DRUGA": ["Cyclosporine", "drug", "107-118"], "DRUGB": ["Short-acting benzodiazepines", "group", "204-231"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin @DRUG$ Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p47", "DRUGA": ["Cyclosporine", "drug", "107-118"], "DRUGB": ["hypoglycemics", "group", "240-252"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin @DRUG$ Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p48", "DRUGA": ["Cyclosporine", "drug", "107-118"], "DRUGB": ["DIFLUCAN", "brand", "325-332"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin @DRUG$ Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p49", "DRUGA": ["Cyclosporine", "drug", "107-118"], "DRUGB": ["hypoglycemic agents", "group", "344-362"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine @DRUG$ @DRUG$ Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p50", "DRUGA": ["Rifampin", "drug", "121-128"], "DRUGB": ["Theophylline", "drug", "131-142"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine @DRUG$ Theophylline @DRUG$ Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p51", "DRUGA": ["Rifampin", "drug", "121-128"], "DRUGB": ["Terfenadine", "drug", "145-155"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine @DRUG$ Theophylline Terfenadine @DRUG$ Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p52", "DRUGA": ["Rifampin", "drug", "121-128"], "DRUGB": ["Cisapride", "drug", "158-166"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine @DRUG$ Theophylline Terfenadine Cisapride @DRUG$ Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p53", "DRUGA": ["Rifampin", "drug", "121-128"], "DRUGB": ["Astemizole", "drug", "169-178"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine @DRUG$ Theophylline Terfenadine Cisapride Astemizole @DRUG$ Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p54", "DRUGA": ["Rifampin", "drug", "121-128"], "DRUGB": ["Rifabutin", "drug", "181-189"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine @DRUG$ Theophylline Terfenadine Cisapride Astemizole Rifabutin @DRUG$ significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p55", "DRUGA": ["Rifampin", "drug", "121-128"], "DRUGB": ["Tacrolimus", "drug", "192-201"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine @DRUG$ Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus @DRUG$ significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p56", "DRUGA": ["Rifampin", "drug", "121-128"], "DRUGB": ["Short-acting benzodiazepines", "group", "204-231"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine @DRUG$ Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p57", "DRUGA": ["Rifampin", "drug", "121-128"], "DRUGB": ["hypoglycemics", "group", "240-252"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine @DRUG$ Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p58", "DRUGA": ["Rifampin", "drug", "121-128"], "DRUGB": ["DIFLUCAN", "brand", "325-332"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine @DRUG$ Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p59", "DRUGA": ["Rifampin", "drug", "121-128"], "DRUGB": ["hypoglycemic agents", "group", "344-362"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin @DRUG$ @DRUG$ Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p60", "DRUGA": ["Theophylline", "drug", "131-142"], "DRUGB": ["Terfenadine", "drug", "145-155"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin @DRUG$ Terfenadine @DRUG$ Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p61", "DRUGA": ["Theophylline", "drug", "131-142"], "DRUGB": ["Cisapride", "drug", "158-166"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin @DRUG$ Terfenadine Cisapride @DRUG$ Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p62", "DRUGA": ["Theophylline", "drug", "131-142"], "DRUGB": ["Astemizole", "drug", "169-178"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin @DRUG$ Terfenadine Cisapride Astemizole @DRUG$ Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p63", "DRUGA": ["Theophylline", "drug", "131-142"], "DRUGB": ["Rifabutin", "drug", "181-189"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin @DRUG$ Terfenadine Cisapride Astemizole Rifabutin @DRUG$ significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p64", "DRUGA": ["Theophylline", "drug", "131-142"], "DRUGB": ["Tacrolimus", "drug", "192-201"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin @DRUG$ Terfenadine Cisapride Astemizole Rifabutin Tacrolimus @DRUG$ significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p65", "DRUGA": ["Theophylline", "drug", "131-142"], "DRUGB": ["Short-acting benzodiazepines", "group", "204-231"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin @DRUG$ Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p66", "DRUGA": ["Theophylline", "drug", "131-142"], "DRUGB": ["hypoglycemics", "group", "240-252"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin @DRUG$ Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p67", "DRUGA": ["Theophylline", "drug", "131-142"], "DRUGB": ["DIFLUCAN", "brand", "325-332"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin @DRUG$ Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p68", "DRUGA": ["Theophylline", "drug", "131-142"], "DRUGB": ["hypoglycemic agents", "group", "344-362"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline @DRUG$ @DRUG$ Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p69", "DRUGA": ["Terfenadine", "drug", "145-155"], "DRUGB": ["Cisapride", "drug", "158-166"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline @DRUG$ Cisapride @DRUG$ Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p70", "DRUGA": ["Terfenadine", "drug", "145-155"], "DRUGB": ["Astemizole", "drug", "169-178"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline @DRUG$ Cisapride Astemizole @DRUG$ Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p71", "DRUGA": ["Terfenadine", "drug", "145-155"], "DRUGB": ["Rifabutin", "drug", "181-189"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline @DRUG$ Cisapride Astemizole Rifabutin @DRUG$ significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p72", "DRUGA": ["Terfenadine", "drug", "145-155"], "DRUGB": ["Tacrolimus", "drug", "192-201"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline @DRUG$ Cisapride Astemizole Rifabutin Tacrolimus @DRUG$ significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p73", "DRUGA": ["Terfenadine", "drug", "145-155"], "DRUGB": ["Short-acting benzodiazepines", "group", "204-231"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline @DRUG$ Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p74", "DRUGA": ["Terfenadine", "drug", "145-155"], "DRUGB": ["hypoglycemics", "group", "240-252"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline @DRUG$ Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p75", "DRUGA": ["Terfenadine", "drug", "145-155"], "DRUGB": ["DIFLUCAN", "brand", "325-332"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline @DRUG$ Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p76", "DRUGA": ["Terfenadine", "drug", "145-155"], "DRUGB": ["hypoglycemic agents", "group", "344-362"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine @DRUG$ @DRUG$ Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p77", "DRUGA": ["Cisapride", "drug", "158-166"], "DRUGB": ["Astemizole", "drug", "169-178"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine @DRUG$ Astemizole @DRUG$ Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p78", "DRUGA": ["Cisapride", "drug", "158-166"], "DRUGB": ["Rifabutin", "drug", "181-189"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine @DRUG$ Astemizole Rifabutin @DRUG$ significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p79", "DRUGA": ["Cisapride", "drug", "158-166"], "DRUGB": ["Tacrolimus", "drug", "192-201"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine @DRUG$ Astemizole Rifabutin Tacrolimus @DRUG$ significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p80", "DRUGA": ["Cisapride", "drug", "158-166"], "DRUGB": ["Short-acting benzodiazepines", "group", "204-231"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine @DRUG$ Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p81", "DRUGA": ["Cisapride", "drug", "158-166"], "DRUGB": ["hypoglycemics", "group", "240-252"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine @DRUG$ Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p82", "DRUGA": ["Cisapride", "drug", "158-166"], "DRUGB": ["DIFLUCAN", "brand", "325-332"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine @DRUG$ Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p83", "DRUGA": ["Cisapride", "drug", "158-166"], "DRUGB": ["hypoglycemic agents", "group", "344-362"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride @DRUG$ @DRUG$ Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p84", "DRUGA": ["Astemizole", "drug", "169-178"], "DRUGB": ["Rifabutin", "drug", "181-189"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride @DRUG$ Rifabutin @DRUG$ significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p85", "DRUGA": ["Astemizole", "drug", "169-178"], "DRUGB": ["Tacrolimus", "drug", "192-201"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride @DRUG$ Rifabutin Tacrolimus @DRUG$ significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p86", "DRUGA": ["Astemizole", "drug", "169-178"], "DRUGB": ["Short-acting benzodiazepines", "group", "204-231"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride @DRUG$ Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p87", "DRUGA": ["Astemizole", "drug", "169-178"], "DRUGB": ["hypoglycemics", "group", "240-252"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride @DRUG$ Rifabutin Tacrolimus significant hypoglycemia precipitated use of @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p88", "DRUGA": ["Astemizole", "drug", "169-178"], "DRUGB": ["DIFLUCAN", "brand", "325-332"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride @DRUG$ Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p89", "DRUGA": ["Astemizole", "drug", "169-178"], "DRUGB": ["hypoglycemic agents", "group", "344-362"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole @DRUG$ @DRUG$ significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p90", "DRUGA": ["Rifabutin", "drug", "181-189"], "DRUGB": ["Tacrolimus", "drug", "192-201"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole @DRUG$ Tacrolimus @DRUG$ significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p91", "DRUGA": ["Rifabutin", "drug", "181-189"], "DRUGB": ["Short-acting benzodiazepines", "group", "204-231"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole @DRUG$ Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p92", "DRUGA": ["Rifabutin", "drug", "181-189"], "DRUGB": ["hypoglycemics", "group", "240-252"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole @DRUG$ Tacrolimus significant hypoglycemia precipitated use of @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p93", "DRUGA": ["Rifabutin", "drug", "181-189"], "DRUGB": ["DIFLUCAN", "brand", "325-332"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole @DRUG$ Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p94", "DRUGA": ["Rifabutin", "drug", "181-189"], "DRUGB": ["hypoglycemic agents", "group", "344-362"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin @DRUG$ @DRUG$ significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p95", "DRUGA": ["Tacrolimus", "drug", "192-201"], "DRUGB": ["Short-acting benzodiazepines", "group", "204-231"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin @DRUG$ significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p96", "DRUGA": ["Tacrolimus", "drug", "192-201"], "DRUGB": ["hypoglycemics", "group", "240-252"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin @DRUG$ significant hypoglycemia precipitated use of @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p97", "DRUGA": ["Tacrolimus", "drug", "192-201"], "DRUGB": ["DIFLUCAN", "brand", "325-332"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin @DRUG$ significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p98", "DRUGA": ["Tacrolimus", "drug", "192-201"], "DRUGB": ["hypoglycemic agents", "group", "344-362"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus @DRUG$ significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p99", "DRUGA": ["Short-acting benzodiazepines", "group", "204-231"], "DRUGB": ["hypoglycemics", "group", "240-252"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus @DRUG$ significant hypoglycemia precipitated use of @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p100", "DRUGA": ["Short-acting benzodiazepines", "group", "204-231"], "DRUGB": ["DIFLUCAN", "brand", "325-332"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus @DRUG$ significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p101", "DRUGA": ["Short-acting benzodiazepines", "group", "204-231"], "DRUGB": ["hypoglycemic agents", "group", "344-362"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p102", "DRUGA": ["hypoglycemics", "group", "240-252"], "DRUGB": ["DIFLUCAN", "brand", "325-332"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s2.p103", "DRUGA": ["hypoglycemics", "group", "240-252"], "DRUGB": ["hypoglycemic agents", "group", "344-362"]}
{"TEXT1": "described greater detail Coumarin anticoagulants type Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Tacrolimus significant hypoglycemia precipitated use of @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d776.s2.p104", "DRUGA": ["DIFLUCAN", "brand", "325-332"], "DRUGB": ["hypoglycemic agents", "group", "344-362"]}
{"TEXT1": "one fatality reported hypoglycemia association combined @DRUG$ @DRUG$ use", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d776.s3.p0", "DRUGA": ["DIFLUCAN", "brand", "78-85"], "DRUGB": ["glyburide", "drug", "91-99"]}
{"TEXT1": "@DRUG$ metabolism @DRUG$ glyburide glipizide increases plasma concentration agents", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d776.s4.p0", "DRUGA": ["DIFLUCAN", "brand", "0-7"], "DRUGB": ["tolbutamide", "drug", "35-45"]}
{"TEXT1": "@DRUG$ metabolism tolbutamide @DRUG$ glipizide increases plasma concentration agents", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d776.s4.p1", "DRUGA": ["DIFLUCAN", "brand", "0-7"], "DRUGB": ["glyburide", "drug", "48-56"]}
{"TEXT1": "@DRUG$ metabolism tolbutamide glyburide @DRUG$ increases plasma concentration agents", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d776.s4.p2", "DRUGA": ["DIFLUCAN", "brand", "0-7"], "DRUGB": ["glipizide", "drug", "63-71"]}
{"TEXT1": "DIFLUCAN metabolism @DRUG$ @DRUG$ glipizide increases plasma concentration agents", "LBL": "0", "ID": "DDI-DrugBank.d776.s4.p3", "DRUGA": ["tolbutamide", "drug", "35-45"], "DRUGB": ["glyburide", "drug", "48-56"]}
{"TEXT1": "DIFLUCAN metabolism @DRUG$ glyburide @DRUG$ increases plasma concentration agents", "LBL": "0", "ID": "DDI-DrugBank.d776.s4.p4", "DRUGA": ["tolbutamide", "drug", "35-45"], "DRUGB": ["glipizide", "drug", "63-71"]}
{"TEXT1": "DIFLUCAN metabolism tolbutamide @DRUG$ @DRUG$ increases plasma concentration agents", "LBL": "0", "ID": "DDI-DrugBank.d776.s4.p5", "DRUGA": ["glyburide", "drug", "48-56"], "DRUGB": ["glipizide", "drug", "63-71"]}
{"TEXT1": "@DRUG$ used @DRUG$ blood glucose concentrations monitored dose sulfonylurea adjusted", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d776.s5.p0", "DRUGA": ["DIFLUCAN", "brand", "5-12"], "DRUGB": ["sulfonylurea oral hypoglycemic agents", "group", "56-92"]}
{"TEXT1": "@DRUG$ used sulfonylurea oral hypoglycemic agents blood glucose concentrations monitored dose @DRUG$ adjusted", "LBL": "0", "ID": "DDI-DrugBank.d776.s5.p1", "DRUGA": ["DIFLUCAN", "brand", "5-12"], "DRUGB": ["sulfonylurea", "group", "174-185"]}
{"TEXT1": "DIFLUCAN used @DRUG$ blood glucose concentrations monitored dose @DRUG$ adjusted", "LBL": "0", "ID": "DDI-DrugBank.d776.s5.p2", "DRUGA": ["sulfonylurea oral hypoglycemic agents", "group", "56-92"], "DRUGB": ["sulfonylurea", "group", "174-185"]}
{"TEXT1": "Prothrombin time increased patients receiving concomitant @DRUG$ coumarin anticoagulants type", "LBL": "0", "ID": "DDI-DrugBank.d776.s6.p0", "DRUGA": ["Coumarin-type anticoagulants", "group", "0-27"], "DRUGB": ["DIFLUCAN", "brand", "98-105"]}
{"TEXT1": "Prothrombin time increased patients receiving concomitant DIFLUCAN @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s6.p1", "DRUGA": ["Coumarin-type anticoagulants", "group", "0-27"], "DRUGB": ["coumarin-type anticoagulants", "group", "111-138"]}
{"TEXT1": "type Prothrombin time increased patients receiving concomitant @DRUG$ @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d776.s6.p2", "DRUGA": ["DIFLUCAN", "brand", "98-105"], "DRUGB": ["coumarin-type anticoagulants", "group", "111-138"]}
{"TEXT1": "post marketing experience @DRUG$ bleeding events epistaxis hematuria reported association increases prothrombin time patients receiving @DRUG$ warfarin", "LBL": "0", "ID": "DDI-DrugBank.d776.s7.p0", "DRUGA": ["azole antifungals", "group", "44-60"], "DRUGB": ["fluconazole", "drug", "242-252"]}
{"TEXT1": "post marketing experience @DRUG$ bleeding events epistaxis hematuria reported association increases prothrombin time patients receiving fluconazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s7.p1", "DRUGA": ["azole antifungals", "group", "44-60"], "DRUGB": ["warfarin", "drug", "272-279"]}
{"TEXT1": "post marketing experience azole antifungals bleeding events epistaxis hematuria reported association increases prothrombin time patients receiving @DRUG$ @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d776.s7.p2", "DRUGA": ["fluconazole", "drug", "242-252"], "DRUGB": ["warfarin", "drug", "272-279"]}
{"TEXT1": "Careful monitoring prothrombin time patients receiving @DRUG$ @DRUG$ recommended", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d776.s8.p0", "DRUGA": ["DIFLUCAN", "brand", "61-68"], "DRUGB": ["coumarin-type anticoagulants", "group", "74-101"]}
{"TEXT1": "@DRUG$ increases plasma concentrations phenytoin", "LBL": "0", "ID": "DDI-DrugBank.d776.s10.p0", "DRUGA": ["Phenytoin", "drug", "0-8"], "DRUGB": ["DIFLUCAN", "brand", "11-18"]}
{"TEXT1": "DIFLUCAN increases plasma concentrations @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s10.p1", "DRUGA": ["Phenytoin", "drug", "0-8"], "DRUGB": ["phenytoin", "drug", "59-67"]}
{"TEXT1": "@DRUG$ increases plasma concentrations @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d776.s10.p2", "DRUGA": ["DIFLUCAN", "brand", "11-18"], "DRUGB": ["phenytoin", "drug", "59-67"]}
{"TEXT1": "Careful monitoring @DRUG$ concentrations patients receiving @DRUG$ phenytoin recommended", "LBL": "0", "ID": "DDI-DrugBank.d776.s11.p0", "DRUGA": ["phenytoin", "drug", "22-30"], "DRUGB": ["DIFLUCAN", "brand", "69-76"]}
{"TEXT1": "Careful monitoring @DRUG$ concentrations patients receiving DIFLUCAN @DRUG$ recommended", "LBL": "0", "ID": "DDI-DrugBank.d776.s11.p1", "DRUGA": ["phenytoin", "drug", "22-30"], "DRUGB": ["phenytoin", "drug", "82-90"]}
{"TEXT1": "Careful monitoring phenytoin concentrations patients receiving @DRUG$ @DRUG$ recommended", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d776.s11.p2", "DRUGA": ["DIFLUCAN", "brand", "69-76"], "DRUGB": ["phenytoin", "drug", "82-90"]}
{"TEXT1": "@DRUG$ increase cyclosporine levels renal transplant patients", "LBL": "0", "ID": "DDI-DrugBank.d776.s13.p0", "DRUGA": ["Cyclosporine", "drug", "0-11"], "DRUGB": ["DIFLUCAN", "brand", "14-21"]}
{"TEXT1": "DIFLUCAN increase @DRUG$ levels renal transplant patients", "LBL": "0", "ID": "DDI-DrugBank.d776.s13.p1", "DRUGA": ["Cyclosporine", "drug", "0-11"], "DRUGB": ["cyclosporine", "drug", "50-61"]}
{"TEXT1": "@DRUG$ increase @DRUG$ levels renal transplant patients", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d776.s13.p2", "DRUGA": ["DIFLUCAN", "brand", "14-21"], "DRUGB": ["cyclosporine", "drug", "50-61"]}
{"TEXT1": "Careful monitoring @DRUG$ concentrations serum creatinine recommended patients receiving @DRUG$ cyclosporine", "LBL": "0", "ID": "DDI-DrugBank.d776.s14.p0", "DRUGA": ["cyclosporine", "drug", "22-33"], "DRUGB": ["DIFLUCAN", "brand", "108-115"]}
{"TEXT1": "Careful monitoring @DRUG$ concentrations serum creatinine recommended patients receiving DIFLUCAN @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s14.p1", "DRUGA": ["cyclosporine", "drug", "22-33"], "DRUGB": ["cyclosporine", "drug", "121-132"]}
{"TEXT1": "Careful monitoring cyclosporine concentrations serum creatinine recommended patients receiving @DRUG$ @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d776.s14.p2", "DRUGA": ["DIFLUCAN", "brand", "108-115"], "DRUGB": ["cyclosporine", "drug", "121-132"]}
{"TEXT1": "@DRUG$ enhances metabolism administered DIFLUCAN", "LBL": "0", "ID": "DDI-DrugBank.d776.s16.p0", "DRUGA": ["Rifampin", "drug", "0-7"], "DRUGB": ["Rifampin", "drug", "10-17"]}
{"TEXT1": "Rifampin enhances metabolism administered @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s16.p1", "DRUGA": ["Rifampin", "drug", "0-7"], "DRUGB": ["DIFLUCAN", "brand", "72-79"]}
{"TEXT1": "@DRUG$ enhances metabolism administered @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d776.s16.p2", "DRUGA": ["Rifampin", "drug", "10-17"], "DRUGB": ["DIFLUCAN", "brand", "72-79"]}
{"TEXT1": "Depending clinical consideration given increasing dose @DRUG$ administered @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d776.s17.p0", "DRUGA": ["DIFLUCAN", "brand", "93-100"], "DRUGB": ["rifampin", "drug", "131-138"]}
{"TEXT1": "@DRUG$ increases serum concentrations theophylline", "LBL": "0", "ID": "DDI-DrugBank.d776.s18.p0", "DRUGA": ["Theophylline", "drug", "0-11"], "DRUGB": ["DIFLUCAN", "brand", "14-21"]}
{"TEXT1": "DIFLUCAN increases serum concentrations @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s18.p1", "DRUGA": ["Theophylline", "drug", "0-11"], "DRUGB": ["theophylline", "drug", "61-72"]}
{"TEXT1": "@DRUG$ increases serum concentrations @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d776.s18.p2", "DRUGA": ["DIFLUCAN", "brand", "14-21"], "DRUGB": ["theophylline", "drug", "61-72"]}
{"TEXT1": "Careful monitoring serum concentrations @DRUG$ patients receiving @DRUG$ theophylline recommended", "LBL": "0", "ID": "DDI-DrugBank.d776.s19.p0", "DRUGA": ["theophylline", "drug", "28-39"], "DRUGB": ["DIFLUCAN", "brand", "78-85"]}
{"TEXT1": "Careful monitoring serum concentrations @DRUG$ patients receiving DIFLUCAN @DRUG$ recommended", "LBL": "0", "ID": "DDI-DrugBank.d776.s19.p1", "DRUGA": ["theophylline", "drug", "28-39"], "DRUGB": ["theophylline", "drug", "91-102"]}
{"TEXT1": "Careful monitoring serum concentrations theophylline patients receiving @DRUG$ @DRUG$ recommended", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d776.s19.p2", "DRUGA": ["DIFLUCAN", "brand", "78-85"], "DRUGB": ["theophylline", "drug", "91-102"]}
{"TEXT1": "occurrence cardiac serious cardiac dysrhythmias secondary to prolongation QTc interval patients receiving @DRUG$ conjunction terfenadine interaction studies performed", "LBL": "0", "ID": "DDI-DrugBank.d776.s20.p0", "DRUGA": ["Terfenadine", "drug", "0-10"], "DRUGB": ["azole antifungals", "group", "139-155"]}
{"TEXT1": "occurrence cardiac serious cardiac dysrhythmias secondary to prolongation QTc interval patients receiving azole antifungals conjunction @DRUG$ interaction studies performed", "LBL": "0", "ID": "DDI-DrugBank.d776.s20.p1", "DRUGA": ["Terfenadine", "drug", "0-10"], "DRUGB": ["terfenadine", "drug", "177-187"]}
{"TEXT1": "occurrence cardiac serious cardiac dysrhythmias secondary to prolongation QTc interval patients receiving @DRUG$ conjunction @DRUG$ interaction studies performed", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d776.s20.p2", "DRUGA": ["azole antifungals", "group", "139-155"], "DRUGB": ["terfenadine", "drug", "177-187"]}
{"TEXT1": "study 400 mg 800 daily dose @DRUG$ @DRUG$ taken day greater increases plasma levels terfenadine", "LBL": "0", "ID": "DDI-DrugBank.d776.s22.p0", "DRUGA": ["fluconazole", "drug", "51-61"], "DRUGB": ["DIFLUCAN", "brand", "81-88"]}
{"TEXT1": "study 400 mg 800 daily dose @DRUG$ DIFLUCAN taken day greater increases plasma levels @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s22.p1", "DRUGA": ["fluconazole", "drug", "51-61"], "DRUGB": ["terfenadine", "drug", "175-185"]}
{"TEXT1": "study 400 mg 800 daily dose fluconazole @DRUG$ taken day greater increases plasma levels @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d776.s22.p2", "DRUGA": ["DIFLUCAN", "brand", "81-88"], "DRUGB": ["terfenadine", "drug", "175-185"]}
{"TEXT1": "combined use of @DRUG$ 400 greater @DRUG$ contraindicated", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d776.s23.p0", "DRUGA": ["fluconazole", "drug", "20-30"], "DRUGB": ["terfenadine", "drug", "67-77"]}
{"TEXT1": "coadministration @DRUG$ doses lower 400 mg/day @DRUG$ monitored", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d776.s24.p0", "DRUGA": ["fluconazole", "drug", "24-34"], "DRUGB": ["terfenadine", "drug", "72-82"]}
{"TEXT1": "reports cardiac events including torsade de pointes patients @DRUG$ cisapride", "LBL": "0", "ID": "DDI-DrugBank.d776.s25.p0", "DRUGA": ["Cisapride", "drug", "0-8"], "DRUGB": ["fluconazole", "drug", "103-113"]}
{"TEXT1": "reports cardiac events including torsade de pointes patients fluconazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s25.p1", "DRUGA": ["Cisapride", "drug", "0-8"], "DRUGB": ["cisapride", "drug", "119-127"]}
{"TEXT1": "reports cardiac events including torsade de pointes patients @DRUG$ @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d776.s25.p2", "DRUGA": ["fluconazole", "drug", "103-113"], "DRUGB": ["cisapride", "drug", "119-127"]}
{"TEXT1": "controlled study found concomitant @DRUG$ once daily @DRUG$ four times day increase cisapride plasma prolongation QTc interval", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d776.s26.p0", "DRUGA": ["fluconazole", "drug", "42-52"], "DRUGB": ["cisapride", "drug", "76-84"]}
{"TEXT1": "controlled study found concomitant @DRUG$ once daily cisapride four times day increase @DRUG$ plasma prolongation QTc interval", "LBL": "0", "ID": "DDI-DrugBank.d776.s26.p1", "DRUGA": ["fluconazole", "drug", "42-52"], "DRUGB": ["cisapride", "drug", "143-151"]}
{"TEXT1": "controlled study found concomitant fluconazole 200 mg once daily @DRUG$ four times day increase @DRUG$ plasma prolongation QTc interval", "LBL": "0", "ID": "DDI-DrugBank.d776.s26.p2", "DRUGA": ["cisapride", "drug", "76-84"], "DRUGB": ["cisapride", "drug", "143-151"]}
{"TEXT1": "combined use of @DRUG$ @DRUG$ contraindicated", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d776.s27.p0", "DRUGA": ["fluconazole", "drug", "20-30"], "DRUGB": ["cisapride", "drug", "37-45"]}
{"TEXT1": "use of @DRUG$ patients taking astemizole drugs metabolized cytochrome P450 system associated with elevations serum", "LBL": "0", "ID": "DDI-DrugBank.d776.s28.p0", "DRUGA": ["Astemizole", "drug", "0-9"], "DRUGB": ["fluconazole", "drug", "23-33"]}
{"TEXT1": "use of fluconazole patients taking @DRUG$ drugs metabolized cytochrome P450 system associated with elevations serum", "LBL": "0", "ID": "DDI-DrugBank.d776.s28.p1", "DRUGA": ["Astemizole", "drug", "0-9"], "DRUGB": ["astemizole", "drug", "67-76"]}
{"TEXT1": "use of @DRUG$ patients taking @DRUG$ drugs metabolized cytochrome P450 system associated with elevations serum", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d776.s28.p2", "DRUGA": ["fluconazole", "drug", "23-33"], "DRUGB": ["astemizole", "drug", "67-76"]}
{"TEXT1": "reports uveitis patients @DRUG$ rifabutin", "LBL": "0", "ID": "DDI-DrugBank.d776.s31.p0", "DRUGA": ["Rifabutin", "drug", "0-8"], "DRUGB": ["fluconazole", "drug", "66-76"]}
{"TEXT1": "reports uveitis patients fluconazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s31.p1", "DRUGA": ["Rifabutin", "drug", "0-8"], "DRUGB": ["rifabutin", "drug", "82-90"]}
{"TEXT1": "reports uveitis patients @DRUG$ @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d776.s31.p2", "DRUGA": ["fluconazole", "drug", "66-76"], "DRUGB": ["rifabutin", "drug", "82-90"]}
{"TEXT1": "Patients receiving @DRUG$ @DRUG$ monitored", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d776.s32.p0", "DRUGA": ["rifabutin", "drug", "19-27"], "DRUGB": ["fluconazole", "drug", "33-43"]}
{"TEXT1": "reports nephrotoxicity patients @DRUG$ tacrolimus", "LBL": "0", "ID": "DDI-DrugBank.d776.s33.p0", "DRUGA": ["Tacrolimus", "drug", "0-9"], "DRUGB": ["fluconazole", "drug", "74-84"]}
{"TEXT1": "reports nephrotoxicity patients fluconazole @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s33.p1", "DRUGA": ["Tacrolimus", "drug", "0-9"], "DRUGB": ["tacrolimus", "drug", "90-99"]}
{"TEXT1": "reports nephrotoxicity patients @DRUG$ @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d776.s33.p2", "DRUGA": ["fluconazole", "drug", "74-84"], "DRUGB": ["tacrolimus", "drug", "90-99"]}
{"TEXT1": "Patients receiving @DRUG$ @DRUG$ monitored", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d776.s34.p0", "DRUGA": ["tacrolimus", "drug", "19-28"], "DRUGB": ["fluconazole", "drug", "34-44"]}
{"TEXT1": "Following oral administration @DRUG$ fluconazole resulted increases midazolam concentrations effects", "LBL": "0", "ID": "DDI-DrugBank.d776.s35.p0", "DRUGA": ["Short-acting Benzodiazepines", "group", "0-27"], "DRUGB": ["midazolam", "drug", "63-71"]}
{"TEXT1": "Following oral administration midazolam @DRUG$ resulted increases concentrations effects", "LBL": "0", "ID": "DDI-DrugBank.d776.s35.p1", "DRUGA": ["Short-acting Benzodiazepines", "group", "0-27"], "DRUGB": ["fluconazole", "drug", "74-84"]}
{"TEXT1": "Following oral administration midazolam fluconazole resulted increases @DRUG$ concentrations effects", "LBL": "0", "ID": "DDI-DrugBank.d776.s35.p2", "DRUGA": ["Short-acting Benzodiazepines", "group", "0-27"], "DRUGB": ["midazolam", "drug", "123-131"]}
{"TEXT1": "Following oral administration @DRUG$ @DRUG$ resulted increases midazolam concentrations effects", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d776.s35.p3", "DRUGA": ["midazolam", "drug", "63-71"], "DRUGB": ["fluconazole", "drug", "74-84"]}
{"TEXT1": "Following oral administration @DRUG$ fluconazole resulted increases @DRUG$ concentrations effects", "LBL": "0", "ID": "DDI-DrugBank.d776.s35.p4", "DRUGA": ["midazolam", "drug", "63-71"], "DRUGB": ["midazolam", "drug", "123-131"]}
{"TEXT1": "Following oral administration midazolam @DRUG$ resulted increases @DRUG$ concentrations effects", "LBL": "0", "ID": "DDI-DrugBank.d776.s35.p5", "DRUGA": ["fluconazole", "drug", "74-84"], "DRUGB": ["midazolam", "drug", "123-131"]}
{"TEXT1": "effect @DRUG$ appears to more following oral administration @DRUG$ fluconazole administered", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d776.s36.p0", "DRUGA": ["midazolam", "drug", "15-23"], "DRUGB": ["fluconazole", "drug", "88-98"]}
{"TEXT1": "effect @DRUG$ appears to more following oral administration fluconazole @DRUG$ administered", "LBL": "0", "ID": "DDI-DrugBank.d776.s36.p1", "DRUGA": ["midazolam", "drug", "15-23"], "DRUGB": ["fluconazole", "drug", "110-120"]}
{"TEXT1": "effect midazolam appears to more following oral administration @DRUG$ @DRUG$ administered", "LBL": "0", "ID": "DDI-DrugBank.d776.s36.p2", "DRUGA": ["fluconazole", "drug", "88-98"], "DRUGB": ["fluconazole", "drug", "110-120"]}
{"TEXT1": "@DRUG$ metabolized cytochrome P450 system administered @DRUG$ consideration given decreasing benzodiazepine dosage patients monitored", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d776.s37.p0", "DRUGA": ["short-acting benzodiazepines", "group", "3-30"], "DRUGB": ["fluconazole", "drug", "122-132"]}
{"TEXT1": "@DRUG$ metabolized cytochrome P450 system administered fluconazole consideration given decreasing @DRUG$ dosage patients monitored", "LBL": "0", "ID": "DDI-DrugBank.d776.s37.p1", "DRUGA": ["short-acting benzodiazepines", "group", "3-30"], "DRUGB": ["benzodiazepine", "group", "183-196"]}
{"TEXT1": "metabolized cytochrome P450 system administered @DRUG$ consideration given decreasing @DRUG$ dosage patients monitored", "LBL": "0", "ID": "DDI-DrugBank.d776.s37.p2", "DRUGA": ["fluconazole", "drug", "122-132"], "DRUGB": ["benzodiazepine", "group", "183-196"]}
{"TEXT1": "@DRUG$ @DRUG$ levonorgestrel containing oral contraceptives overall mean increase ethinyl estradiol", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d776.s38.p0", "DRUGA": ["Fluconazole", "drug", "0-10"], "DRUGB": ["ethinyl estradiol", "drug", "40-56"]}
{"TEXT1": "@DRUG$ ethinyl estradiol @DRUG$ containing oral contraceptives overall mean increase levonorgestrel", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d776.s38.p1", "DRUGA": ["Fluconazole", "drug", "0-10"], "DRUGB": ["levonorgestrel", "drug", "63-76"]}
{"TEXT1": "@DRUG$ ethinyl estradiol levonorgestrel containing @DRUG$ overall mean increase", "LBL": "0", "ID": "DDI-DrugBank.d776.s38.p2", "DRUGA": ["Fluconazole", "drug", "0-10"], "DRUGB": ["contraceptives", "group", "94-107"]}
{"TEXT1": "@DRUG$ ethinyl estradiol levonorgestrel containing oral contraceptives overall mean increase @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s38.p3", "DRUGA": ["Fluconazole", "drug", "0-10"], "DRUGB": ["ethinyl estradiol", "drug", "146-162"]}
{"TEXT1": "@DRUG$ ethinyl estradiol levonorgestrel containing oral contraceptives overall mean increase @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s38.p4", "DRUGA": ["Fluconazole", "drug", "0-10"], "DRUGB": ["levonorgestrel", "drug", "168-181"]}
{"TEXT1": "Fluconazole tablets @DRUG$ @DRUG$ containing oral contraceptives overall mean increase ethinyl estradiol levonorgestrel", "LBL": "0", "ID": "DDI-DrugBank.d776.s38.p5", "DRUGA": ["ethinyl estradiol", "drug", "40-56"], "DRUGB": ["levonorgestrel", "drug", "63-76"]}
{"TEXT1": "Fluconazole tablets @DRUG$ levonorgestrel containing @DRUG$ overall mean increase ethinyl estradiol", "LBL": "0", "ID": "DDI-DrugBank.d776.s38.p6", "DRUGA": ["ethinyl estradiol", "drug", "40-56"], "DRUGB": ["contraceptives", "group", "94-107"]}
{"TEXT1": "Fluconazole tablets @DRUG$ levonorgestrel containing oral contraceptives overall mean increase @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s38.p7", "DRUGA": ["ethinyl estradiol", "drug", "40-56"], "DRUGB": ["ethinyl estradiol", "drug", "146-162"]}
{"TEXT1": "Fluconazole tablets @DRUG$ levonorgestrel containing oral contraceptives overall mean increase ethinyl estradiol @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s38.p8", "DRUGA": ["ethinyl estradiol", "drug", "40-56"], "DRUGB": ["levonorgestrel", "drug", "168-181"]}
{"TEXT1": "Fluconazole tablets ethinyl estradiol @DRUG$ containing @DRUG$ overall mean increase levonorgestrel", "LBL": "0", "ID": "DDI-DrugBank.d776.s38.p9", "DRUGA": ["levonorgestrel", "drug", "63-76"], "DRUGB": ["contraceptives", "group", "94-107"]}
{"TEXT1": "Fluconazole tablets ethinyl estradiol @DRUG$ containing oral contraceptives overall mean increase @DRUG$ levonorgestrel", "LBL": "0", "ID": "DDI-DrugBank.d776.s38.p10", "DRUGA": ["levonorgestrel", "drug", "63-76"], "DRUGB": ["ethinyl estradiol", "drug", "146-162"]}
{"TEXT1": "Fluconazole tablets ethinyl estradiol @DRUG$ containing oral contraceptives overall mean increase @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s38.p11", "DRUGA": ["levonorgestrel", "drug", "63-76"], "DRUGB": ["levonorgestrel", "drug", "168-181"]}
{"TEXT1": "Fluconazole tablets ethinyl estradiol levonorgestrel containing @DRUG$ overall mean increase @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s38.p12", "DRUGA": ["contraceptives", "group", "94-107"], "DRUGB": ["ethinyl estradiol", "drug", "146-162"]}
{"TEXT1": "Fluconazole tablets ethinyl estradiol levonorgestrel containing @DRUG$ overall mean increase @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s38.p13", "DRUGA": ["contraceptives", "group", "94-107"], "DRUGB": ["levonorgestrel", "drug", "168-181"]}
{"TEXT1": "Fluconazole tablets ethinyl estradiol levonorgestrel containing oral contraceptives overall mean increase @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s38.p14", "DRUGA": ["ethinyl estradiol", "drug", "146-162"], "DRUGB": ["levonorgestrel", "drug", "168-181"]}
{"TEXT1": "patients decreases @DRUG$ @DRUG$ levels", "LBL": "0", "ID": "DDI-DrugBank.d776.s39.p0", "DRUGA": ["ethinyl estradiol", "drug", "68-84"], "DRUGB": ["levonorgestrel", "drug", "90-103"]}
{"TEXT1": "data presently available decreases individual @DRUG$ @DRUG$ AUC values fluconazole treatment likely result random variation", "LBL": "0", "ID": "DDI-DrugBank.d776.s40.p0", "DRUGA": ["ethinyl estradiol", "drug", "76-92"], "DRUGB": ["levonorgestrel", "drug", "98-111"]}
{"TEXT1": "data presently available decreases individual @DRUG$ levonorgestrel AUC values @DRUG$ treatment likely result random variation", "LBL": "0", "ID": "DDI-DrugBank.d776.s40.p1", "DRUGA": ["ethinyl estradiol", "drug", "76-92"], "DRUGB": ["fluconazole", "drug", "129-139"]}
{"TEXT1": "data presently available decreases individual ethinyl estradiol @DRUG$ AUC values @DRUG$ treatment likely result random variation", "LBL": "0", "ID": "DDI-DrugBank.d776.s40.p2", "DRUGA": ["levonorgestrel", "drug", "98-111"], "DRUGB": ["fluconazole", "drug", "129-139"]}
{"TEXT1": "evidence @DRUG$ inhibit metabolism @DRUG$ levonorgestrel no fluconazole net inducer ethinyl estradiol", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d776.s41.p0", "DRUGA": ["fluconazole", "drug", "29-39"], "DRUGB": ["ethinyl estradiol", "drug", "71-87"]}
{"TEXT1": "evidence @DRUG$ inhibit metabolism ethinyl estradiol @DRUG$ no fluconazole net inducer levonorgestrel", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d776.s41.p1", "DRUGA": ["fluconazole", "drug", "29-39"], "DRUGB": ["levonorgestrel", "drug", "93-106"]}
{"TEXT1": "evidence @DRUG$ inhibit metabolism ethinyl estradiol levonorgestrel no @DRUG$ net inducer", "LBL": "0", "ID": "DDI-DrugBank.d776.s41.p2", "DRUGA": ["fluconazole", "drug", "29-39"], "DRUGB": ["fluconazole", "drug", "135-145"]}
{"TEXT1": "evidence @DRUG$ inhibit metabolism ethinyl estradiol levonorgestrel no fluconazole net inducer @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s41.p3", "DRUGA": ["fluconazole", "drug", "29-39"], "DRUGB": ["ethinyl estradiol", "drug", "167-183"]}
{"TEXT1": "evidence @DRUG$ inhibit metabolism ethinyl estradiol levonorgestrel no fluconazole net inducer @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s41.p4", "DRUGA": ["fluconazole", "drug", "29-39"], "DRUGB": ["levonorgestrel", "drug", "188-201"]}
{"TEXT1": "evidence fluconazole inhibit metabolism @DRUG$ @DRUG$ no net inducer ethinyl estradiol levonorgestrel", "LBL": "0", "ID": "DDI-DrugBank.d776.s41.p5", "DRUGA": ["ethinyl estradiol", "drug", "71-87"], "DRUGB": ["levonorgestrel", "drug", "93-106"]}
{"TEXT1": "evidence fluconazole inhibit metabolism @DRUG$ levonorgestrel no @DRUG$ net inducer ethinyl estradiol", "LBL": "0", "ID": "DDI-DrugBank.d776.s41.p6", "DRUGA": ["ethinyl estradiol", "drug", "71-87"], "DRUGB": ["fluconazole", "drug", "135-145"]}
{"TEXT1": "evidence fluconazole inhibit metabolism @DRUG$ levonorgestrel no net inducer @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s41.p7", "DRUGA": ["ethinyl estradiol", "drug", "71-87"], "DRUGB": ["ethinyl estradiol", "drug", "167-183"]}
{"TEXT1": "evidence fluconazole inhibit metabolism @DRUG$ levonorgestrel no net inducer ethinyl estradiol @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s41.p8", "DRUGA": ["ethinyl estradiol", "drug", "71-87"], "DRUGB": ["levonorgestrel", "drug", "188-201"]}
{"TEXT1": "evidence fluconazole inhibit metabolism ethinyl estradiol @DRUG$ no @DRUG$ net inducer levonorgestrel", "LBL": "0", "ID": "DDI-DrugBank.d776.s41.p9", "DRUGA": ["levonorgestrel", "drug", "93-106"], "DRUGB": ["fluconazole", "drug", "135-145"]}
{"TEXT1": "evidence fluconazole inhibit metabolism ethinyl estradiol @DRUG$ no net inducer @DRUG$ levonorgestrel", "LBL": "0", "ID": "DDI-DrugBank.d776.s41.p10", "DRUGA": ["levonorgestrel", "drug", "93-106"], "DRUGB": ["ethinyl estradiol", "drug", "167-183"]}
{"TEXT1": "evidence fluconazole inhibit metabolism ethinyl estradiol @DRUG$ no net inducer @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s41.p11", "DRUGA": ["levonorgestrel", "drug", "93-106"], "DRUGB": ["levonorgestrel", "drug", "188-201"]}
{"TEXT1": "evidence fluconazole inhibit metabolism ethinyl estradiol levonorgestrel no @DRUG$ net inducer @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s41.p12", "DRUGA": ["fluconazole", "drug", "135-145"], "DRUGB": ["ethinyl estradiol", "drug", "167-183"]}
{"TEXT1": "evidence fluconazole inhibit metabolism ethinyl estradiol levonorgestrel no @DRUG$ net inducer @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s41.p13", "DRUGA": ["fluconazole", "drug", "135-145"], "DRUGB": ["levonorgestrel", "drug", "188-201"]}
{"TEXT1": "evidence fluconazole inhibit metabolism ethinyl estradiol levonorgestrel no net inducer @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d776.s41.p14", "DRUGA": ["ethinyl estradiol", "drug", "167-183"], "DRUGB": ["levonorgestrel", "drug", "188-201"]}
{"TEXT1": "causal relationship not established reports bleeding prolonged prothrombin time patients treated with @DRUG$ @DRUG$ platelet aggregation inhibitors", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d659.s0.p0", "DRUGA": ["TRENTAL", "brand", "152-158"], "DRUGB": ["anticoagulants", "group", "177-190"]}
{"TEXT1": "causal relationship not established reports bleeding prolonged prothrombin time patients treated with @DRUG$ anticoagulants @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d659.s0.p1", "DRUGA": ["TRENTAL", "brand", "152-158"], "DRUGB": ["platelet aggregation inhibitors", "group", "195-225"]}
{"TEXT1": "causal relationship not established reports bleeding prolonged prothrombin time patients treated with TRENTAL @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d659.s0.p2", "DRUGA": ["anticoagulants", "group", "177-190"], "DRUGB": ["platelet aggregation inhibitors", "group", "195-225"]}
{"TEXT1": "Concomitant administration @DRUG$ @DRUG$ containing drugs leads increased levels theophylline individuals", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d659.s2.p0", "DRUGA": ["TRENTAL", "brand", "30-36"], "DRUGB": ["theophylline", "drug", "42-53"]}
{"TEXT1": "Concomitant administration @DRUG$ theophylline containing drugs leads increased levels @DRUG$ individuals", "LBL": "0", "ID": "DDI-DrugBank.d659.s2.p1", "DRUGA": ["TRENTAL", "brand", "30-36"], "DRUGB": ["theophylline", "drug", "91-102"]}
{"TEXT1": "Concomitant administration @DRUG$ theophylline containing drugs leads increased levels @DRUG$ individuals", "LBL": "0", "ID": "DDI-DrugBank.d659.s2.p2", "DRUGA": ["TRENTAL", "brand", "30-36"], "DRUGB": ["theophylline", "drug", "115-126"]}
{"TEXT1": "Concomitant administration TRENTAL @DRUG$ containing drugs leads increased levels @DRUG$ theophylline toxicity individuals", "LBL": "0", "ID": "DDI-DrugBank.d659.s2.p3", "DRUGA": ["theophylline", "drug", "42-53"], "DRUGB": ["theophylline", "drug", "91-102"]}
{"TEXT1": "Concomitant administration TRENTAL @DRUG$ containing drugs leads increased levels theophylline toxicity @DRUG$ individuals", "LBL": "0", "ID": "DDI-DrugBank.d659.s2.p4", "DRUGA": ["theophylline", "drug", "42-53"], "DRUGB": ["theophylline", "drug", "115-126"]}
{"TEXT1": "Concomitant administration TRENTAL theophylline containing drugs leads increased levels @DRUG$ @DRUG$ individuals", "LBL": "0", "ID": "DDI-DrugBank.d659.s2.p5", "DRUGA": ["theophylline", "drug", "91-102"], "DRUGB": ["theophylline", "drug", "115-126"]}
{"TEXT1": "@DRUG$ used @DRUG$ beta blockers digitalis diuretics antidiabetic agents antiarrhythmics observed problems", "LBL": "0", "ID": "DDI-DrugBank.d659.s4.p0", "DRUGA": ["TRENTAL", "brand", "0-6"], "DRUGB": ["antihypertensive drugs", "group", "40-61"]}
{"TEXT1": "@DRUG$ used antihypertensive drugs @DRUG$ digitalis diuretics antidiabetic agents antiarrhythmics observed problems", "LBL": "0", "ID": "DDI-DrugBank.d659.s4.p1", "DRUGA": ["TRENTAL", "brand", "0-6"], "DRUGB": ["beta blockers", "group", "64-76"]}
{"TEXT1": "@DRUG$ used antihypertensive drugs beta blockers @DRUG$ diuretics antidiabetic agents antiarrhythmics observed problems", "LBL": "0", "ID": "DDI-DrugBank.d659.s4.p2", "DRUGA": ["TRENTAL", "brand", "0-6"], "DRUGB": ["digitalis", "group", "79-87"]}
{"TEXT1": "@DRUG$ used antihypertensive drugs beta blockers digitalis @DRUG$ antidiabetic agents antiarrhythmics observed problems", "LBL": "0", "ID": "DDI-DrugBank.d659.s4.p3", "DRUGA": ["TRENTAL", "brand", "0-6"], "DRUGB": ["diuretics", "group", "90-98"]}
{"TEXT1": "@DRUG$ used antihypertensive drugs beta blockers digitalis diuretics @DRUG$ antiarrhythmics observed problems", "LBL": "0", "ID": "DDI-DrugBank.d659.s4.p4", "DRUGA": ["TRENTAL", "brand", "0-6"], "DRUGB": ["antidiabetic agents", "group", "101-119"]}
{"TEXT1": "@DRUG$ used antihypertensive drugs beta blockers digitalis diuretics antidiabetic agents @DRUG$ observed problems", "LBL": "0", "ID": "DDI-DrugBank.d659.s4.p5", "DRUGA": ["TRENTAL", "brand", "0-6"], "DRUGB": ["antiarrhythmics", "group", "126-140"]}
{"TEXT1": "TRENTAL used @DRUG$ @DRUG$ digitalis diuretics antidiabetic agents antiarrhythmics observed problems", "LBL": "0", "ID": "DDI-DrugBank.d659.s4.p6", "DRUGA": ["antihypertensive drugs", "group", "40-61"], "DRUGB": ["beta blockers", "group", "64-76"]}
{"TEXT1": "TRENTAL used @DRUG$ beta blockers @DRUG$ diuretics antidiabetic agents antiarrhythmics observed problems", "LBL": "0", "ID": "DDI-DrugBank.d659.s4.p7", "DRUGA": ["antihypertensive drugs", "group", "40-61"], "DRUGB": ["digitalis", "group", "79-87"]}
{"TEXT1": "TRENTAL used @DRUG$ beta blockers digitalis @DRUG$ antidiabetic agents antiarrhythmics observed problems", "LBL": "0", "ID": "DDI-DrugBank.d659.s4.p8", "DRUGA": ["antihypertensive drugs", "group", "40-61"], "DRUGB": ["diuretics", "group", "90-98"]}
{"TEXT1": "TRENTAL used @DRUG$ beta blockers digitalis diuretics @DRUG$ antiarrhythmics observed problems", "LBL": "0", "ID": "DDI-DrugBank.d659.s4.p9", "DRUGA": ["antihypertensive drugs", "group", "40-61"], "DRUGB": ["antidiabetic agents", "group", "101-119"]}
{"TEXT1": "TRENTAL used @DRUG$ beta blockers digitalis diuretics antidiabetic agents @DRUG$ observed problems", "LBL": "0", "ID": "DDI-DrugBank.d659.s4.p10", "DRUGA": ["antihypertensive drugs", "group", "40-61"], "DRUGB": ["antiarrhythmics", "group", "126-140"]}
{"TEXT1": "TRENTAL used antihypertensive drugs @DRUG$ @DRUG$ diuretics antidiabetic agents antiarrhythmics observed problems", "LBL": "0", "ID": "DDI-DrugBank.d659.s4.p11", "DRUGA": ["beta blockers", "group", "64-76"], "DRUGB": ["digitalis", "group", "79-87"]}
{"TEXT1": "TRENTAL used antihypertensive drugs @DRUG$ digitalis @DRUG$ antidiabetic agents antiarrhythmics observed problems", "LBL": "0", "ID": "DDI-DrugBank.d659.s4.p12", "DRUGA": ["beta blockers", "group", "64-76"], "DRUGB": ["diuretics", "group", "90-98"]}
{"TEXT1": "TRENTAL used antihypertensive drugs @DRUG$ digitalis diuretics @DRUG$ antiarrhythmics observed problems", "LBL": "0", "ID": "DDI-DrugBank.d659.s4.p13", "DRUGA": ["beta blockers", "group", "64-76"], "DRUGB": ["antidiabetic agents", "group", "101-119"]}
{"TEXT1": "TRENTAL used antihypertensive drugs @DRUG$ digitalis diuretics antidiabetic agents @DRUG$ observed problems", "LBL": "0", "ID": "DDI-DrugBank.d659.s4.p14", "DRUGA": ["beta blockers", "group", "64-76"], "DRUGB": ["antiarrhythmics", "group", "126-140"]}
{"TEXT1": "TRENTAL used antihypertensive drugs beta blockers @DRUG$ @DRUG$ antidiabetic agents antiarrhythmics observed problems", "LBL": "0", "ID": "DDI-DrugBank.d659.s4.p15", "DRUGA": ["digitalis", "group", "79-87"], "DRUGB": ["diuretics", "group", "90-98"]}
{"TEXT1": "TRENTAL used antihypertensive drugs beta blockers @DRUG$ diuretics @DRUG$ antiarrhythmics observed problems", "LBL": "0", "ID": "DDI-DrugBank.d659.s4.p16", "DRUGA": ["digitalis", "group", "79-87"], "DRUGB": ["antidiabetic agents", "group", "101-119"]}
{"TEXT1": "TRENTAL used antihypertensive drugs beta blockers @DRUG$ diuretics antidiabetic agents @DRUG$ observed problems", "LBL": "0", "ID": "DDI-DrugBank.d659.s4.p17", "DRUGA": ["digitalis", "group", "79-87"], "DRUGB": ["antiarrhythmics", "group", "126-140"]}
{"TEXT1": "TRENTAL used antihypertensive drugs beta blockers digitalis @DRUG$ @DRUG$ antiarrhythmics observed problems", "LBL": "0", "ID": "DDI-DrugBank.d659.s4.p18", "DRUGA": ["diuretics", "group", "90-98"], "DRUGB": ["antidiabetic agents", "group", "101-119"]}
{"TEXT1": "TRENTAL used antihypertensive drugs beta blockers digitalis @DRUG$ antidiabetic agents @DRUG$ observed problems", "LBL": "0", "ID": "DDI-DrugBank.d659.s4.p19", "DRUGA": ["diuretics", "group", "90-98"], "DRUGB": ["antiarrhythmics", "group", "126-140"]}
{"TEXT1": "TRENTAL used antihypertensive drugs beta blockers digitalis diuretics @DRUG$ @DRUG$ observed problems", "LBL": "0", "ID": "DDI-DrugBank.d659.s4.p20", "DRUGA": ["antidiabetic agents", "group", "101-119"], "DRUGB": ["antiarrhythmics", "group", "126-140"]}
{"TEXT1": "@DRUG$ Reports suggest @DRUG$ diminish antihypertensive effect", "LBL": "0", "ID": "DDI-DrugBank.d597.s0.p0", "DRUGA": ["ACE inhibitors", "group", "0-13"], "DRUGB": ["NSAIDs", "group", "36-41"]}
{"TEXT1": "@DRUG$ Reports suggest NSAIDs diminish antihypertensive effect @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d597.s0.p1", "DRUGA": ["ACE inhibitors", "group", "0-13"], "DRUGB": ["angiotensin-converting enzyme (ACE) inhibitors", "group", "87-132"]}
{"TEXT1": "Reports suggest @DRUG$ diminish antihypertensive effect @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d597.s0.p2", "DRUGA": ["NSAIDs", "group", "36-41"], "DRUGB": ["angiotensin-converting enzyme (ACE) inhibitors", "group", "87-132"]}
{"TEXT1": "interaction given consideration patients taking @DRUG$ @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d597.s1.p0", "DRUGA": ["NSAIDs", "group", "66-71"], "DRUGB": ["ACE inhibitors", "group", "92-105"]}
{"TEXT1": "Concomitant @DRUG$ mg to healthy volunteers increase AUC Cmax meloxicam", "LBL": "0", "ID": "DDI-DrugBank.d597.s2.p0", "DRUGA": ["Aspirin", "brand", "0-6"], "DRUGB": ["aspirin", "brand", "39-45"]}
{"TEXT1": "Concomitant administration of aspirin mg to healthy volunteers increase AUC Cmax @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d597.s2.p1", "DRUGA": ["Aspirin", "brand", "0-6"], "DRUGB": ["meloxicam", "drug", "134-142"]}
{"TEXT1": "Concomitant @DRUG$ mg to healthy volunteers increase AUC Cmax @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d597.s2.p2", "DRUGA": ["aspirin", "brand", "39-45"], "DRUGB": ["meloxicam", "drug", "134-142"]}
{"TEXT1": "@DRUG$ concomitant administration @DRUG$ aspirin not recommended potential increased adverse effects", "LBL": "0", "ID": "DDI-DrugBank.d597.s4.p0", "DRUGA": ["NSAIDs", "group", "23-28"], "DRUGB": ["meloxicam", "drug", "61-69"]}
{"TEXT1": "@DRUG$ concomitant administration meloxicam @DRUG$ not recommended potential increased adverse effects", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d597.s4.p1", "DRUGA": ["NSAIDs", "group", "23-28"], "DRUGB": ["aspirin", "brand", "75-81"]}
{"TEXT1": "NSAIDs concomitant administration @DRUG$ @DRUG$ not recommended potential increased adverse effects", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d597.s4.p2", "DRUGA": ["meloxicam", "drug", "61-69"], "DRUGB": ["aspirin", "brand", "75-81"]}
{"TEXT1": "Concomitant @DRUG$ @DRUG$ result increased rate GI ulceration complications compared to MOBIC alone", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d597.s5.p0", "DRUGA": ["aspirin", "brand", "39-45"], "DRUGB": ["MOBIC", "brand", "52-56"]}
{"TEXT1": "Concomitant @DRUG$ MOBIC result increased rate GI ulceration complications compared to @DRUG$ alone", "LBL": "0", "ID": "DDI-DrugBank.d597.s5.p1", "DRUGA": ["aspirin", "brand", "39-45"], "DRUGB": ["MOBIC", "brand", "150-154"]}
{"TEXT1": "Concomitant administration of aspirin @DRUG$ result increased rate GI ulceration complications compared to @DRUG$ alone", "LBL": "0", "ID": "DDI-DrugBank.d597.s5.p2", "DRUGA": ["MOBIC", "brand", "52-56"], "DRUGB": ["MOBIC", "brand", "150-154"]}
{"TEXT1": "@DRUG$ not @DRUG$ cardiovascular prophylaxis", "LBL": "0", "ID": "DDI-DrugBank.d597.s6.p0", "DRUGA": ["MOBIC", "brand", "0-4"], "DRUGB": ["aspirin", "brand", "30-36"]}
{"TEXT1": "Pretreatment four days @DRUG$ increased clearance meloxicam", "LBL": "0", "ID": "DDI-DrugBank.d597.s7.p0", "DRUGA": ["Cholestyramine", "drug", "0-13"], "DRUGB": ["cholestyramine", "drug", "48-61"]}
{"TEXT1": "Pretreatment four days cholestyramine increased clearance @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d597.s7.p1", "DRUGA": ["Cholestyramine", "drug", "0-13"], "DRUGB": ["meloxicam", "drug", "104-112"]}
{"TEXT1": "Pretreatment four days @DRUG$ increased clearance @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d597.s7.p2", "DRUGA": ["cholestyramine", "drug", "48-61"], "DRUGB": ["meloxicam", "drug", "104-112"]}
{"TEXT1": "Concomitant administration @DRUG$ QID not alter single pharmacokinetics 30 meloxicam", "LBL": "0", "ID": "DDI-DrugBank.d597.s11.p0", "DRUGA": ["Cimetidine", "drug", "0-9"], "DRUGB": ["cimetidine", "drug", "49-58"]}
{"TEXT1": "Concomitant administration 200 mg cimetidine QID not alter single pharmacokinetics 30 @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d597.s11.p1", "DRUGA": ["Cimetidine", "drug", "0-9"], "DRUGB": ["meloxicam", "drug", "120-128"]}
{"TEXT1": "Concomitant administration @DRUG$ QID not alter single pharmacokinetics 30 @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d597.s11.p2", "DRUGA": ["cimetidine", "drug", "49-58"], "DRUGB": ["meloxicam", "drug", "120-128"]}
{"TEXT1": "@DRUG$ once daily 7 days not alter plasma concentration profile digoxin acetyldigoxin administration clinical doses", "LBL": "0", "ID": "DDI-DrugBank.d597.s12.p0", "DRUGA": ["Digoxin", "drug", "0-6"], "DRUGB": ["Meloxicam", "drug", "9-17"]}
{"TEXT1": "Meloxicam 15 mg once daily 7 days not alter plasma concentration profile @DRUG$ acetyldigoxin administration clinical doses", "LBL": "0", "ID": "DDI-DrugBank.d597.s12.p1", "DRUGA": ["Digoxin", "drug", "0-6"], "DRUGB": ["digoxin", "drug", "97-103"]}
{"TEXT1": "@DRUG$ once daily 7 days not alter plasma concentration profile @DRUG$ acetyldigoxin administration clinical doses", "LBL": "0", "ID": "DDI-DrugBank.d597.s12.p2", "DRUGA": ["Meloxicam", "drug", "9-17"], "DRUGB": ["digoxin", "drug", "97-103"]}
{"TEXT1": "In vitro testing found no protein binding protein interaction binding drug interaction @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d597.s13.p0", "DRUGA": ["digoxin", "drug", "67-73"], "DRUGB": ["meloxicam", "drug", "79-87"]}
{"TEXT1": "Clinical studies post marketing observations shown @DRUG$ natriuretic effect furosemide thiazide diuretics patients", "LBL": "0", "ID": "DDI-DrugBank.d597.s14.p0", "DRUGA": ["Furosemide", "drug", "0-9"], "DRUGB": ["NSAIDs", "group", "86-91"]}
{"TEXT1": "Clinical studies post marketing observations shown NSAIDs natriuretic effect @DRUG$ thiazide diuretics patients", "LBL": "0", "ID": "DDI-DrugBank.d597.s14.p1", "DRUGA": ["Furosemide", "drug", "0-9"], "DRUGB": ["furosemide", "drug", "130-139"]}
{"TEXT1": "Clinical studies post marketing observations shown NSAIDs natriuretic effect furosemide @DRUG$ patients", "LBL": "0", "ID": "DDI-DrugBank.d597.s14.p2", "DRUGA": ["Furosemide", "drug", "0-9"], "DRUGB": ["thiazide diuretics", "group", "145-162"]}
{"TEXT1": "Clinical studies post marketing observations shown @DRUG$ natriuretic effect @DRUG$ thiazide diuretics patients", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d597.s14.p3", "DRUGA": ["NSAIDs", "group", "86-91"], "DRUGB": ["furosemide", "drug", "130-139"]}
{"TEXT1": "Clinical studies post marketing observations shown @DRUG$ natriuretic effect furosemide @DRUG$ patients", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d597.s14.p4", "DRUGA": ["NSAIDs", "group", "86-91"], "DRUGB": ["thiazide diuretics", "group", "145-162"]}
{"TEXT1": "Clinical studies post marketing observations shown NSAIDs natriuretic effect @DRUG$ @DRUG$ patients", "LBL": "0", "ID": "DDI-DrugBank.d597.s14.p5", "DRUGA": ["furosemide", "drug", "130-139"], "DRUGB": ["thiazide diuretics", "group", "145-162"]}
{"TEXT1": "Studies agents @DRUG$ @DRUG$ not reduction natriuretic effect", "LBL": "0", "ID": "DDI-DrugBank.d597.s16.p0", "DRUGA": ["furosemide", "drug", "13-22"], "DRUGB": ["meloxicam", "drug", "35-43"]}
{"TEXT1": "single multiple dose pharmacodynamics pharmacokinetics not affected doses @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d597.s17.p0", "DRUGA": ["Furosemide", "drug", "0-9"], "DRUGB": ["meloxicam", "drug", "113-121"]}
{"TEXT1": "concomitant therapy @DRUG$ @DRUG$ patients observed signs declining renal function to diuretic efficacy", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d597.s18.p0", "DRUGA": ["furosemide", "drug", "46-55"], "DRUGB": ["MOBIC", "brand", "61-65"]}
{"TEXT1": "clinical trials @DRUG$ elevation plasma lithium levels reduction renal lithium clearance", "LBL": "0", "ID": "DDI-DrugBank.d597.s19.p0", "DRUGA": ["Lithium", "drug", "0-6"], "DRUGB": ["NSAIDs", "group", "29-34"]}
{"TEXT1": "clinical trials NSAIDs elevation plasma @DRUG$ levels reduction renal lithium clearance", "LBL": "0", "ID": "DDI-DrugBank.d597.s19.p1", "DRUGA": ["Lithium", "drug", "0-6"], "DRUGB": ["lithium", "drug", "73-79"]}
{"TEXT1": "clinical trials NSAIDs elevation plasma lithium levels reduction renal lithium clearance @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d597.s19.p2", "DRUGA": ["Lithium", "drug", "0-6"], "DRUGB": ["lithium", "drug", "113-119"]}
{"TEXT1": "clinical trials @DRUG$ elevation plasma @DRUG$ levels reduction renal lithium clearance", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d597.s19.p3", "DRUGA": ["NSAIDs", "group", "29-34"], "DRUGB": ["lithium", "drug", "73-79"]}
{"TEXT1": "clinical trials @DRUG$ elevation plasma lithium levels reduction renal lithium clearance @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d597.s19.p4", "DRUGA": ["NSAIDs", "group", "29-34"], "DRUGB": ["lithium", "drug", "113-119"]}
{"TEXT1": "clinical trials NSAIDs elevation plasma @DRUG$ levels reduction renal lithium clearance @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d597.s19.p5", "DRUGA": ["lithium", "drug", "73-79"], "DRUGB": ["lithium", "drug", "113-119"]}
{"TEXT1": "study conducted healthy subjects mean pre @DRUG$ concentration AUC increased receiving @DRUG$ ranging mg meloxicam 15 QD compared lithium alone", "LBL": "0", "ID": "DDI-DrugBank.d597.s20.p0", "DRUGA": ["lithium", "drug", "56-62"], "DRUGB": ["lithium", "drug", "130-136"]}
{"TEXT1": "study conducted healthy subjects mean pre @DRUG$ concentration AUC increased receiving lithium doses ranging @DRUG$ QD compared alone", "LBL": "0", "ID": "DDI-DrugBank.d597.s20.p1", "DRUGA": ["lithium", "drug", "56-62"], "DRUGB": ["meloxicam", "drug", "181-189"]}
{"TEXT1": "study conducted healthy subjects mean pre @DRUG$ concentration AUC increased receiving lithium doses ranging mg meloxicam 15 QD compared @DRUG$ alone", "LBL": "0", "ID": "DDI-DrugBank.d597.s20.p2", "DRUGA": ["lithium", "drug", "56-62"], "DRUGB": ["lithium", "drug", "234-240"]}
{"TEXT1": "study conducted healthy subjects mean pre lithium concentration AUC increased receiving @DRUG$ ranging @DRUG$ QD compared alone", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d597.s20.p3", "DRUGA": ["lithium", "drug", "130-136"], "DRUGB": ["meloxicam", "drug", "181-189"]}
{"TEXT1": "study conducted healthy subjects mean pre lithium concentration AUC increased receiving @DRUG$ ranging mg meloxicam 15 QD compared @DRUG$ alone", "LBL": "0", "ID": "DDI-DrugBank.d597.s20.p4", "DRUGA": ["lithium", "drug", "130-136"], "DRUGB": ["lithium", "drug", "234-240"]}
{"TEXT1": "study conducted healthy subjects mean pre lithium concentration AUC increased receiving ranging @DRUG$ QD compared @DRUG$ alone", "LBL": "0", "ID": "DDI-DrugBank.d597.s20.p5", "DRUGA": ["meloxicam", "drug", "181-189"], "DRUGB": ["lithium", "drug", "234-240"]}
{"TEXT1": "Patients treatment @DRUG$ monitored @DRUG$ introduced withdrawn", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d597.s22.p0", "DRUGA": ["lithium", "drug", "12-18"], "DRUGB": ["MOBIC", "brand", "63-67"]}
{"TEXT1": "study rheumatoid arthritis patients evaluated effects multiple doses @DRUG$ pharmacokinetics methotrexate taken once weekly", "LBL": "0", "ID": "DDI-DrugBank.d597.s23.p0", "DRUGA": ["Methotrexate", "drug", "0-11"], "DRUGB": ["meloxicam", "drug", "106-114"]}
{"TEXT1": "study rheumatoid arthritis patients evaluated effects multiple doses meloxicam pharmacokinetics @DRUG$ taken once weekly", "LBL": "0", "ID": "DDI-DrugBank.d597.s23.p1", "DRUGA": ["Methotrexate", "drug", "0-11"], "DRUGB": ["methotrexate", "drug", "143-154"]}
{"TEXT1": "study rheumatoid arthritis patients evaluated effects multiple doses @DRUG$ pharmacokinetics @DRUG$ taken once weekly", "LBL": "0", "ID": "DDI-DrugBank.d597.s23.p2", "DRUGA": ["meloxicam", "drug", "106-114"], "DRUGB": ["methotrexate", "drug", "143-154"]}
{"TEXT1": "@DRUG$ not significant effect pharmacokinetics single doses @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d597.s24.p0", "DRUGA": ["Meloxicam", "drug", "0-8"], "DRUGB": ["methotrexate", "drug", "87-98"]}
{"TEXT1": "In vitro @DRUG$ not @DRUG$ human serum binding sites", "LBL": "0", "ID": "DDI-DrugBank.d597.s25.p0", "DRUGA": ["methotrexate", "drug", "10-21"], "DRUGB": ["meloxicam", "drug", "40-48"]}
{"TEXT1": "Anticoagulant activity monitored first days initiating changing @DRUG$ therapy patients receiving warfarin similar agents increased risk bleeding", "LBL": "0", "ID": "DDI-DrugBank.d597.s26.p0", "DRUGA": ["Warfarin", "drug", "0-7"], "DRUGB": ["MOBIC", "brand", "118-122"]}
{"TEXT1": "Anticoagulant activity monitored first days initiating changing MOBIC therapy patients receiving @DRUG$ similar agents increased risk bleeding", "LBL": "0", "ID": "DDI-DrugBank.d597.s26.p1", "DRUGA": ["Warfarin", "drug", "0-7"], "DRUGB": ["warfarin", "drug", "154-161"]}
{"TEXT1": "Anticoagulant activity monitored first days initiating changing @DRUG$ therapy patients receiving @DRUG$ similar agents increased risk bleeding", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d597.s26.p2", "DRUGA": ["MOBIC", "brand", "118-122"], "DRUGB": ["warfarin", "drug", "154-161"]}
{"TEXT1": "effect @DRUG$ @DRUG$ studied a group healthy subjects receiving daily doses warfarin INR", "LBL": "0", "ID": "DDI-DrugBank.d597.s27.p0", "DRUGA": ["meloxicam", "drug", "14-22"], "DRUGB": ["warfarin", "drug", "55-62"]}
{"TEXT1": "effect @DRUG$ warfarin studied a group healthy subjects receiving daily @DRUG$ INR", "LBL": "0", "ID": "DDI-DrugBank.d597.s27.p1", "DRUGA": ["meloxicam", "drug", "14-22"], "DRUGB": ["warfarin", "drug", "132-139"]}
{"TEXT1": "effect meloxicam @DRUG$ studied a group healthy subjects receiving daily @DRUG$ INR", "LBL": "0", "ID": "DDI-DrugBank.d597.s27.p2", "DRUGA": ["warfarin", "drug", "55-62"], "DRUGB": ["warfarin", "drug", "132-139"]}
{"TEXT1": "subjects @DRUG$ not alter @DRUG$ pharmacokinetics average anticoagulant effect warfarin determined by prothrombin time", "LBL": "0", "ID": "DDI-DrugBank.d597.s28.p0", "DRUGA": ["meloxicam", "drug", "19-27"], "DRUGB": ["warfarin", "drug", "43-50"]}
{"TEXT1": "subjects @DRUG$ not alter warfarin pharmacokinetics average anticoagulant effect @DRUG$ determined by prothrombin time", "LBL": "0", "ID": "DDI-DrugBank.d597.s28.p1", "DRUGA": ["meloxicam", "drug", "19-27"], "DRUGB": ["warfarin", "drug", "109-116"]}
{"TEXT1": "subjects meloxicam not alter @DRUG$ pharmacokinetics average anticoagulant effect @DRUG$ determined by prothrombin time", "LBL": "0", "ID": "DDI-DrugBank.d597.s28.p2", "DRUGA": ["warfarin", "drug", "43-50"], "DRUGB": ["warfarin", "drug", "109-116"]}
{"TEXT1": "used administering @DRUG$ @DRUG$ patients warfarin experience changes INR increased risk bleeding complications new medication introduced", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d597.s30.p0", "DRUGA": ["MOBIC", "brand", "42-46"], "DRUGB": ["warfarin", "drug", "53-60"]}
{"TEXT1": "used administering @DRUG$ warfarin patients @DRUG$ experience changes INR increased risk bleeding complications new medication introduced", "LBL": "0", "ID": "DDI-DrugBank.d597.s30.p1", "DRUGA": ["MOBIC", "brand", "42-46"], "DRUGB": ["warfarin", "drug", "80-87"]}
{"TEXT1": "used administering MOBIC @DRUG$ patients @DRUG$ experience changes INR increased risk bleeding complications new medication introduced", "LBL": "0", "ID": "DDI-DrugBank.d597.s30.p2", "DRUGA": ["warfarin", "drug", "53-60"], "DRUGB": ["warfarin", "drug", "80-87"]}
{"TEXT1": "administered @DRUG$ @DRUG$ enhance precipitate bradycardia", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d603.s0.p0", "DRUGA": ["ProAmatine", "brand", "37-46"], "DRUGB": ["cardiac glycosides", "group", "52-69"]}
{"TEXT1": "use drugs @DRUG$ @DRUG$ ephedrine phenylpropanolamine enhance pressor effects ProAmatine used administered agents cause vasoconstriction", "LBL": "0", "ID": "DDI-DrugBank.d603.s2.p0", "DRUGA": ["phenylephrine", "drug", "66-78"], "DRUGB": ["pseudoephedrine", "drug", "81-95"]}
{"TEXT1": "use drugs @DRUG$ pseudoephedrine @DRUG$ phenylpropanolamine enhance pressor effects ProAmatine used administered agents cause vasoconstriction", "LBL": "0", "ID": "DDI-DrugBank.d603.s2.p1", "DRUGA": ["phenylephrine", "drug", "66-78"], "DRUGB": ["ephedrine", "drug", "98-106"]}
{"TEXT1": "use drugs @DRUG$ pseudoephedrine ephedrine @DRUG$ enhance pressor effects ProAmatine used administered agents cause vasoconstriction", "LBL": "0", "ID": "DDI-DrugBank.d603.s2.p2", "DRUGA": ["phenylephrine", "drug", "66-78"], "DRUGB": ["phenylpropanolamine", "drug", "109-127"]}
{"TEXT1": "use drugs @DRUG$ pseudoephedrine ephedrine phenylpropanolamine enhance pressor effects ProAmatine used administered agents cause vasoconstriction", "LBL": "0", "ID": "DDI-DrugBank.d603.s2.p3", "DRUGA": ["phenylephrine", "drug", "66-78"], "DRUGB": ["dihydroergotamine", "drug", "132-148"]}
{"TEXT1": "use drugs @DRUG$ pseudoephedrine ephedrine phenylpropanolamine enhance pressor effects @DRUG$ used ProAmatine administered agents cause vasoconstriction", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d603.s2.p4", "DRUGA": ["phenylephrine", "drug", "66-78"], "DRUGB": ["ProAmatine", "brand", "200-209"]}
{"TEXT1": "use drugs @DRUG$ pseudoephedrine ephedrine phenylpropanolamine enhance pressor effects ProAmatine used @DRUG$ administered agents cause vasoconstriction", "LBL": "0", "ID": "DDI-DrugBank.d603.s2.p5", "DRUGA": ["phenylephrine", "drug", "66-78"], "DRUGB": ["ProAmatine", "brand", "254-263"]}
{"TEXT1": "use drugs phenylephrine @DRUG$ @DRUG$ phenylpropanolamine enhance pressor effects ProAmatine used administered agents cause vasoconstriction", "LBL": "0", "ID": "DDI-DrugBank.d603.s2.p6", "DRUGA": ["pseudoephedrine", "drug", "81-95"], "DRUGB": ["ephedrine", "drug", "98-106"]}
{"TEXT1": "use drugs phenylephrine @DRUG$ ephedrine @DRUG$ enhance pressor effects ProAmatine used administered agents cause vasoconstriction", "LBL": "0", "ID": "DDI-DrugBank.d603.s2.p7", "DRUGA": ["pseudoephedrine", "drug", "81-95"], "DRUGB": ["phenylpropanolamine", "drug", "109-127"]}
{"TEXT1": "use drugs phenylephrine @DRUG$ ephedrine phenylpropanolamine enhance pressor effects ProAmatine used administered agents cause vasoconstriction", "LBL": "0", "ID": "DDI-DrugBank.d603.s2.p8", "DRUGA": ["pseudoephedrine", "drug", "81-95"], "DRUGB": ["dihydroergotamine", "drug", "132-148"]}
{"TEXT1": "use drugs phenylephrine @DRUG$ ephedrine phenylpropanolamine enhance pressor effects @DRUG$ used ProAmatine administered agents cause vasoconstriction", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d603.s2.p9", "DRUGA": ["pseudoephedrine", "drug", "81-95"], "DRUGB": ["ProAmatine", "brand", "200-209"]}
{"TEXT1": "use drugs phenylephrine @DRUG$ ephedrine phenylpropanolamine enhance pressor effects ProAmatine used @DRUG$ administered agents cause vasoconstriction", "LBL": "0", "ID": "DDI-DrugBank.d603.s2.p10", "DRUGA": ["pseudoephedrine", "drug", "81-95"], "DRUGB": ["ProAmatine", "brand", "254-263"]}
{"TEXT1": "use drugs phenylephrine pseudoephedrine @DRUG$ @DRUG$ enhance pressor effects ProAmatine used administered agents cause vasoconstriction", "LBL": "0", "ID": "DDI-DrugBank.d603.s2.p11", "DRUGA": ["ephedrine", "drug", "98-106"], "DRUGB": ["phenylpropanolamine", "drug", "109-127"]}
{"TEXT1": "use drugs phenylephrine pseudoephedrine @DRUG$ phenylpropanolamine enhance pressor effects ProAmatine used administered agents cause vasoconstriction", "LBL": "0", "ID": "DDI-DrugBank.d603.s2.p12", "DRUGA": ["ephedrine", "drug", "98-106"], "DRUGB": ["dihydroergotamine", "drug", "132-148"]}
{"TEXT1": "use drugs phenylephrine pseudoephedrine @DRUG$ phenylpropanolamine enhance pressor effects @DRUG$ used ProAmatine administered agents cause vasoconstriction", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d603.s2.p13", "DRUGA": ["ephedrine", "drug", "98-106"], "DRUGB": ["ProAmatine", "brand", "200-209"]}
{"TEXT1": "use drugs phenylephrine pseudoephedrine @DRUG$ phenylpropanolamine enhance pressor effects ProAmatine used @DRUG$ administered agents cause vasoconstriction", "LBL": "0", "ID": "DDI-DrugBank.d603.s2.p14", "DRUGA": ["ephedrine", "drug", "98-106"], "DRUGB": ["ProAmatine", "brand", "254-263"]}
{"TEXT1": "use drugs phenylephrine pseudoephedrine ephedrine @DRUG$ enhance pressor effects ProAmatine used administered agents cause vasoconstriction", "LBL": "0", "ID": "DDI-DrugBank.d603.s2.p15", "DRUGA": ["phenylpropanolamine", "drug", "109-127"], "DRUGB": ["dihydroergotamine", "drug", "132-148"]}
{"TEXT1": "use drugs phenylephrine pseudoephedrine ephedrine @DRUG$ enhance pressor effects @DRUG$ used ProAmatine administered agents cause vasoconstriction", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d603.s2.p16", "DRUGA": ["phenylpropanolamine", "drug", "109-127"], "DRUGB": ["ProAmatine", "brand", "200-209"]}
{"TEXT1": "use drugs phenylephrine pseudoephedrine ephedrine @DRUG$ enhance pressor effects ProAmatine used @DRUG$ administered agents cause vasoconstriction", "LBL": "0", "ID": "DDI-DrugBank.d603.s2.p17", "DRUGA": ["phenylpropanolamine", "drug", "109-127"], "DRUGB": ["ProAmatine", "brand", "254-263"]}
{"TEXT1": "use drugs phenylephrine pseudoephedrine ephedrine phenylpropanolamine enhance pressor effects @DRUG$ used ProAmatine administered agents cause vasoconstriction", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d603.s2.p18", "DRUGA": ["dihydroergotamine", "drug", "132-148"], "DRUGB": ["ProAmatine", "brand", "200-209"]}
{"TEXT1": "use drugs phenylephrine pseudoephedrine ephedrine phenylpropanolamine enhance pressor effects ProAmatine used @DRUG$ administered agents cause vasoconstriction", "LBL": "0", "ID": "DDI-DrugBank.d603.s2.p19", "DRUGA": ["dihydroergotamine", "drug", "132-148"], "DRUGB": ["ProAmatine", "brand", "254-263"]}
{"TEXT1": "use drugs phenylephrine pseudoephedrine ephedrine phenylpropanolamine enhance pressor effects @DRUG$ used @DRUG$ administered agents cause vasoconstriction", "LBL": "0", "ID": "DDI-DrugBank.d603.s2.p20", "DRUGA": ["ProAmatine", "brand", "200-209"], "DRUGB": ["ProAmatine", "brand", "254-263"]}
{"TEXT1": "@DRUG$ used patients treated with salt retaining steroid therapy supplementation", "LBL": "0", "ID": "DDI-DrugBank.d603.s3.p0", "DRUGA": ["ProAmatine", "brand", "0-9"], "DRUGB": ["fludrocortisone acetate", "drug", "105-127"]}
{"TEXT1": "@DRUG$ @DRUG$ prazosin terazosin doxazosin effects ProAmatine appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p0", "DRUGA": ["ProAmatine", "brand", "0-9"], "DRUGB": ["Alpha-adrenergic blocking agents", "group", "12-43"]}
{"TEXT1": "@DRUG$ @DRUG$ terazosin doxazosin effects ProAmatine appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p1", "DRUGA": ["ProAmatine", "brand", "0-9"], "DRUGB": ["prazosin", "drug", "54-61"]}
{"TEXT1": "@DRUG$ prazosin @DRUG$ doxazosin effects ProAmatine appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p2", "DRUGA": ["ProAmatine", "brand", "0-9"], "DRUGB": ["terazosin", "drug", "64-72"]}
{"TEXT1": "@DRUG$ prazosin terazosin @DRUG$ effects ProAmatine appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p3", "DRUGA": ["ProAmatine", "brand", "0-9"], "DRUGB": ["doxazosin", "drug", "79-87"]}
{"TEXT1": "@DRUG$ prazosin terazosin doxazosin effects @DRUG$ appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p4", "DRUGA": ["ProAmatine", "brand", "0-9"], "DRUGB": ["ProAmatine", "brand", "120-129"]}
{"TEXT1": "@DRUG$ prazosin terazosin doxazosin effects ProAmatine appears possible no supporting experimental evidence high renal clearance @DRUG$ due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p5", "DRUGA": ["ProAmatine", "brand", "0-9"], "DRUGB": ["desglymidodrine", "drug_n", "274-288"]}
{"TEXT1": "@DRUG$ prazosin terazosin doxazosin effects ProAmatine appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs @DRUG$ cimetidine ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p6", "DRUGA": ["ProAmatine", "brand", "0-9"], "DRUGB": ["metformin", "drug", "415-423"]}
{"TEXT1": "@DRUG$ prazosin terazosin doxazosin effects ProAmatine appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin @DRUG$ ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p7", "DRUGA": ["ProAmatine", "brand", "0-9"], "DRUGB": ["cimetidine", "drug", "426-435"]}
{"TEXT1": "@DRUG$ prazosin terazosin doxazosin effects ProAmatine appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine @DRUG$ procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p8", "DRUGA": ["ProAmatine", "brand", "0-9"], "DRUGB": ["ranitidine", "drug", "438-447"]}
{"TEXT1": "@DRUG$ prazosin terazosin doxazosin effects ProAmatine appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine @DRUG$ triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p9", "DRUGA": ["ProAmatine", "brand", "0-9"], "DRUGB": ["procainamide", "drug", "450-461"]}
{"TEXT1": "@DRUG$ prazosin terazosin doxazosin effects ProAmatine appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide @DRUG$ flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p10", "DRUGA": ["ProAmatine", "brand", "0-9"], "DRUGB": ["triamterene", "drug", "464-474"]}
{"TEXT1": "@DRUG$ prazosin terazosin doxazosin effects ProAmatine appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene @DRUG$ quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p11", "DRUGA": ["ProAmatine", "brand", "0-9"], "DRUGB": ["flecainide", "drug", "477-486"]}
{"TEXT1": "@DRUG$ prazosin terazosin doxazosin effects ProAmatine appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene flecainide @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p12", "DRUGA": ["ProAmatine", "brand", "0-9"], "DRUGB": ["quinidine", "drug", "493-501"]}
{"TEXT1": "ProAmatine @DRUG$ @DRUG$ terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p13", "DRUGA": ["Alpha-adrenergic blocking agents", "group", "12-43"], "DRUGB": ["prazosin", "drug", "54-61"]}
{"TEXT1": "ProAmatine @DRUG$ prazosin @DRUG$ doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p14", "DRUGA": ["Alpha-adrenergic blocking agents", "group", "12-43"], "DRUGB": ["terazosin", "drug", "64-72"]}
{"TEXT1": "ProAmatine @DRUG$ prazosin terazosin @DRUG$ effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p15", "DRUGA": ["Alpha-adrenergic blocking agents", "group", "12-43"], "DRUGB": ["doxazosin", "drug", "79-87"]}
{"TEXT1": "ProAmatine @DRUG$ prazosin terazosin doxazosin effects @DRUG$ appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene flecainide quinidine", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d603.s5.p16", "DRUGA": ["Alpha-adrenergic blocking agents", "group", "12-43"], "DRUGB": ["ProAmatine", "brand", "120-129"]}
{"TEXT1": "ProAmatine @DRUG$ prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance @DRUG$ due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p17", "DRUGA": ["Alpha-adrenergic blocking agents", "group", "12-43"], "DRUGB": ["desglymidodrine", "drug_n", "274-288"]}
{"TEXT1": "ProAmatine @DRUG$ prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs @DRUG$ cimetidine ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p18", "DRUGA": ["Alpha-adrenergic blocking agents", "group", "12-43"], "DRUGB": ["metformin", "drug", "415-423"]}
{"TEXT1": "ProAmatine @DRUG$ prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin @DRUG$ ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p19", "DRUGA": ["Alpha-adrenergic blocking agents", "group", "12-43"], "DRUGB": ["cimetidine", "drug", "426-435"]}
{"TEXT1": "ProAmatine @DRUG$ prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine @DRUG$ procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p20", "DRUGA": ["Alpha-adrenergic blocking agents", "group", "12-43"], "DRUGB": ["ranitidine", "drug", "438-447"]}
{"TEXT1": "ProAmatine @DRUG$ prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine @DRUG$ triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p21", "DRUGA": ["Alpha-adrenergic blocking agents", "group", "12-43"], "DRUGB": ["procainamide", "drug", "450-461"]}
{"TEXT1": "ProAmatine @DRUG$ prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide @DRUG$ flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p22", "DRUGA": ["Alpha-adrenergic blocking agents", "group", "12-43"], "DRUGB": ["triamterene", "drug", "464-474"]}
{"TEXT1": "ProAmatine @DRUG$ prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene @DRUG$ quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p23", "DRUGA": ["Alpha-adrenergic blocking agents", "group", "12-43"], "DRUGB": ["flecainide", "drug", "477-486"]}
{"TEXT1": "ProAmatine @DRUG$ prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene flecainide @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p24", "DRUGA": ["Alpha-adrenergic blocking agents", "group", "12-43"], "DRUGB": ["quinidine", "drug", "493-501"]}
{"TEXT1": "ProAmatine @DRUG$ @DRUG$ doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p25", "DRUGA": ["prazosin", "drug", "54-61"], "DRUGB": ["terazosin", "drug", "64-72"]}
{"TEXT1": "ProAmatine @DRUG$ terazosin @DRUG$ effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p26", "DRUGA": ["prazosin", "drug", "54-61"], "DRUGB": ["doxazosin", "drug", "79-87"]}
{"TEXT1": "ProAmatine @DRUG$ terazosin doxazosin effects @DRUG$ appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene flecainide quinidine", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d603.s5.p27", "DRUGA": ["prazosin", "drug", "54-61"], "DRUGB": ["ProAmatine", "brand", "120-129"]}
{"TEXT1": "ProAmatine @DRUG$ terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance @DRUG$ due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p28", "DRUGA": ["prazosin", "drug", "54-61"], "DRUGB": ["desglymidodrine", "drug_n", "274-288"]}
{"TEXT1": "ProAmatine @DRUG$ terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs @DRUG$ cimetidine ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p29", "DRUGA": ["prazosin", "drug", "54-61"], "DRUGB": ["metformin", "drug", "415-423"]}
{"TEXT1": "ProAmatine @DRUG$ terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin @DRUG$ ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p30", "DRUGA": ["prazosin", "drug", "54-61"], "DRUGB": ["cimetidine", "drug", "426-435"]}
{"TEXT1": "ProAmatine @DRUG$ terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine @DRUG$ procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p31", "DRUGA": ["prazosin", "drug", "54-61"], "DRUGB": ["ranitidine", "drug", "438-447"]}
{"TEXT1": "ProAmatine @DRUG$ terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine @DRUG$ triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p32", "DRUGA": ["prazosin", "drug", "54-61"], "DRUGB": ["procainamide", "drug", "450-461"]}
{"TEXT1": "ProAmatine @DRUG$ terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide @DRUG$ flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p33", "DRUGA": ["prazosin", "drug", "54-61"], "DRUGB": ["triamterene", "drug", "464-474"]}
{"TEXT1": "ProAmatine @DRUG$ terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene @DRUG$ quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p34", "DRUGA": ["prazosin", "drug", "54-61"], "DRUGB": ["flecainide", "drug", "477-486"]}
{"TEXT1": "ProAmatine @DRUG$ terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene flecainide @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p35", "DRUGA": ["prazosin", "drug", "54-61"], "DRUGB": ["quinidine", "drug", "493-501"]}
{"TEXT1": "ProAmatine prazosin @DRUG$ @DRUG$ effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p36", "DRUGA": ["terazosin", "drug", "64-72"], "DRUGB": ["doxazosin", "drug", "79-87"]}
{"TEXT1": "ProAmatine prazosin @DRUG$ doxazosin effects @DRUG$ appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene flecainide quinidine", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d603.s5.p37", "DRUGA": ["terazosin", "drug", "64-72"], "DRUGB": ["ProAmatine", "brand", "120-129"]}
{"TEXT1": "ProAmatine prazosin @DRUG$ doxazosin effects appears possible no supporting experimental evidence high renal clearance @DRUG$ due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p38", "DRUGA": ["terazosin", "drug", "64-72"], "DRUGB": ["desglymidodrine", "drug_n", "274-288"]}
{"TEXT1": "ProAmatine prazosin @DRUG$ doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs @DRUG$ cimetidine ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p39", "DRUGA": ["terazosin", "drug", "64-72"], "DRUGB": ["metformin", "drug", "415-423"]}
{"TEXT1": "ProAmatine prazosin @DRUG$ doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin @DRUG$ ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p40", "DRUGA": ["terazosin", "drug", "64-72"], "DRUGB": ["cimetidine", "drug", "426-435"]}
{"TEXT1": "ProAmatine prazosin @DRUG$ doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine @DRUG$ procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p41", "DRUGA": ["terazosin", "drug", "64-72"], "DRUGB": ["ranitidine", "drug", "438-447"]}
{"TEXT1": "ProAmatine prazosin @DRUG$ doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine @DRUG$ triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p42", "DRUGA": ["terazosin", "drug", "64-72"], "DRUGB": ["procainamide", "drug", "450-461"]}
{"TEXT1": "ProAmatine prazosin @DRUG$ doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide @DRUG$ flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p43", "DRUGA": ["terazosin", "drug", "64-72"], "DRUGB": ["triamterene", "drug", "464-474"]}
{"TEXT1": "ProAmatine prazosin @DRUG$ doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene @DRUG$ quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p44", "DRUGA": ["terazosin", "drug", "64-72"], "DRUGB": ["flecainide", "drug", "477-486"]}
{"TEXT1": "ProAmatine prazosin @DRUG$ doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene flecainide @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p45", "DRUGA": ["terazosin", "drug", "64-72"], "DRUGB": ["quinidine", "drug", "493-501"]}
{"TEXT1": "ProAmatine prazosin terazosin @DRUG$ effects @DRUG$ appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene flecainide quinidine", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d603.s5.p46", "DRUGA": ["doxazosin", "drug", "79-87"], "DRUGB": ["ProAmatine", "brand", "120-129"]}
{"TEXT1": "ProAmatine prazosin terazosin @DRUG$ effects appears possible no supporting experimental evidence high renal clearance @DRUG$ due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p47", "DRUGA": ["doxazosin", "drug", "79-87"], "DRUGB": ["desglymidodrine", "drug_n", "274-288"]}
{"TEXT1": "ProAmatine prazosin terazosin @DRUG$ effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs @DRUG$ cimetidine ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p48", "DRUGA": ["doxazosin", "drug", "79-87"], "DRUGB": ["metformin", "drug", "415-423"]}
{"TEXT1": "ProAmatine prazosin terazosin @DRUG$ effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin @DRUG$ ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p49", "DRUGA": ["doxazosin", "drug", "79-87"], "DRUGB": ["cimetidine", "drug", "426-435"]}
{"TEXT1": "ProAmatine prazosin terazosin @DRUG$ effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine @DRUG$ procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p50", "DRUGA": ["doxazosin", "drug", "79-87"], "DRUGB": ["ranitidine", "drug", "438-447"]}
{"TEXT1": "ProAmatine prazosin terazosin @DRUG$ effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine @DRUG$ triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p51", "DRUGA": ["doxazosin", "drug", "79-87"], "DRUGB": ["procainamide", "drug", "450-461"]}
{"TEXT1": "ProAmatine prazosin terazosin @DRUG$ effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide @DRUG$ flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p52", "DRUGA": ["doxazosin", "drug", "79-87"], "DRUGB": ["triamterene", "drug", "464-474"]}
{"TEXT1": "ProAmatine prazosin terazosin @DRUG$ effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene @DRUG$ quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p53", "DRUGA": ["doxazosin", "drug", "79-87"], "DRUGB": ["flecainide", "drug", "477-486"]}
{"TEXT1": "ProAmatine prazosin terazosin @DRUG$ effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene flecainide @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p54", "DRUGA": ["doxazosin", "drug", "79-87"], "DRUGB": ["quinidine", "drug", "493-501"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects @DRUG$ appears possible no supporting experimental evidence high renal clearance @DRUG$ due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p55", "DRUGA": ["ProAmatine", "brand", "120-129"], "DRUGB": ["desglymidodrine", "drug_n", "274-288"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects @DRUG$ appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs @DRUG$ cimetidine ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p56", "DRUGA": ["ProAmatine", "brand", "120-129"], "DRUGB": ["metformin", "drug", "415-423"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects @DRUG$ appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin @DRUG$ ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p57", "DRUGA": ["ProAmatine", "brand", "120-129"], "DRUGB": ["cimetidine", "drug", "426-435"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects @DRUG$ appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine @DRUG$ procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p58", "DRUGA": ["ProAmatine", "brand", "120-129"], "DRUGB": ["ranitidine", "drug", "438-447"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects @DRUG$ appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine @DRUG$ triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p59", "DRUGA": ["ProAmatine", "brand", "120-129"], "DRUGB": ["procainamide", "drug", "450-461"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects @DRUG$ appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide @DRUG$ flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p60", "DRUGA": ["ProAmatine", "brand", "120-129"], "DRUGB": ["triamterene", "drug", "464-474"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects @DRUG$ appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene @DRUG$ quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p61", "DRUGA": ["ProAmatine", "brand", "120-129"], "DRUGB": ["flecainide", "drug", "477-486"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects @DRUG$ appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene flecainide @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p62", "DRUGA": ["ProAmatine", "brand", "120-129"], "DRUGB": ["quinidine", "drug", "493-501"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance @DRUG$ due to active tubular secretion base secreting system responsible drugs @DRUG$ cimetidine ranitidine procainamide triamterene flecainide quinidine", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d603.s5.p63", "DRUGA": ["desglymidodrine", "drug_n", "274-288"], "DRUGB": ["metformin", "drug", "415-423"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance @DRUG$ due to active tubular secretion base secreting system responsible drugs metformin @DRUG$ ranitidine procainamide triamterene flecainide quinidine", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d603.s5.p64", "DRUGA": ["desglymidodrine", "drug_n", "274-288"], "DRUGB": ["cimetidine", "drug", "426-435"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance @DRUG$ due to active tubular secretion base secreting system responsible drugs metformin cimetidine @DRUG$ procainamide triamterene flecainide quinidine", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d603.s5.p65", "DRUGA": ["desglymidodrine", "drug_n", "274-288"], "DRUGB": ["ranitidine", "drug", "438-447"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance @DRUG$ due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine @DRUG$ triamterene flecainide quinidine", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d603.s5.p66", "DRUGA": ["desglymidodrine", "drug_n", "274-288"], "DRUGB": ["procainamide", "drug", "450-461"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance @DRUG$ due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide @DRUG$ flecainide quinidine", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d603.s5.p67", "DRUGA": ["desglymidodrine", "drug_n", "274-288"], "DRUGB": ["triamterene", "drug", "464-474"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance @DRUG$ due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene @DRUG$ quinidine", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d603.s5.p68", "DRUGA": ["desglymidodrine", "drug_n", "274-288"], "DRUGB": ["flecainide", "drug", "477-486"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance @DRUG$ due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene flecainide @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d603.s5.p69", "DRUGA": ["desglymidodrine", "drug_n", "274-288"], "DRUGB": ["quinidine", "drug", "493-501"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs @DRUG$ @DRUG$ ranitidine procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p70", "DRUGA": ["metformin", "drug", "415-423"], "DRUGB": ["cimetidine", "drug", "426-435"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs @DRUG$ cimetidine @DRUG$ procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p71", "DRUGA": ["metformin", "drug", "415-423"], "DRUGB": ["ranitidine", "drug", "438-447"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs @DRUG$ cimetidine ranitidine @DRUG$ triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p72", "DRUGA": ["metformin", "drug", "415-423"], "DRUGB": ["procainamide", "drug", "450-461"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs @DRUG$ cimetidine ranitidine procainamide @DRUG$ flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p73", "DRUGA": ["metformin", "drug", "415-423"], "DRUGB": ["triamterene", "drug", "464-474"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs @DRUG$ cimetidine ranitidine procainamide triamterene @DRUG$ quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p74", "DRUGA": ["metformin", "drug", "415-423"], "DRUGB": ["flecainide", "drug", "477-486"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs @DRUG$ cimetidine ranitidine procainamide triamterene flecainide @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p75", "DRUGA": ["metformin", "drug", "415-423"], "DRUGB": ["quinidine", "drug", "493-501"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin @DRUG$ @DRUG$ procainamide triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p76", "DRUGA": ["cimetidine", "drug", "426-435"], "DRUGB": ["ranitidine", "drug", "438-447"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin @DRUG$ ranitidine @DRUG$ triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p77", "DRUGA": ["cimetidine", "drug", "426-435"], "DRUGB": ["procainamide", "drug", "450-461"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin @DRUG$ ranitidine procainamide @DRUG$ flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p78", "DRUGA": ["cimetidine", "drug", "426-435"], "DRUGB": ["triamterene", "drug", "464-474"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin @DRUG$ ranitidine procainamide triamterene @DRUG$ quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p79", "DRUGA": ["cimetidine", "drug", "426-435"], "DRUGB": ["flecainide", "drug", "477-486"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin @DRUG$ ranitidine procainamide triamterene flecainide @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p80", "DRUGA": ["cimetidine", "drug", "426-435"], "DRUGB": ["quinidine", "drug", "493-501"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine @DRUG$ @DRUG$ triamterene flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p81", "DRUGA": ["ranitidine", "drug", "438-447"], "DRUGB": ["procainamide", "drug", "450-461"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine @DRUG$ procainamide @DRUG$ flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p82", "DRUGA": ["ranitidine", "drug", "438-447"], "DRUGB": ["triamterene", "drug", "464-474"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine @DRUG$ procainamide triamterene @DRUG$ quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p83", "DRUGA": ["ranitidine", "drug", "438-447"], "DRUGB": ["flecainide", "drug", "477-486"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine @DRUG$ procainamide triamterene flecainide @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p84", "DRUGA": ["ranitidine", "drug", "438-447"], "DRUGB": ["quinidine", "drug", "493-501"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine @DRUG$ @DRUG$ flecainide quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p85", "DRUGA": ["procainamide", "drug", "450-461"], "DRUGB": ["triamterene", "drug", "464-474"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine @DRUG$ triamterene @DRUG$ quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p86", "DRUGA": ["procainamide", "drug", "450-461"], "DRUGB": ["flecainide", "drug", "477-486"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine @DRUG$ triamterene flecainide @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p87", "DRUGA": ["procainamide", "drug", "450-461"], "DRUGB": ["quinidine", "drug", "493-501"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide @DRUG$ @DRUG$ quinidine", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p88", "DRUGA": ["triamterene", "drug", "464-474"], "DRUGB": ["flecainide", "drug", "477-486"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide @DRUG$ flecainide @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p89", "DRUGA": ["triamterene", "drug", "464-474"], "DRUGB": ["quinidine", "drug", "493-501"]}
{"TEXT1": "ProAmatine prazosin terazosin doxazosin effects appears possible no supporting experimental evidence high renal clearance desglymidodrine due to active tubular secretion base secreting system responsible drugs metformin cimetidine ranitidine procainamide triamterene @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d603.s5.p90", "DRUGA": ["flecainide", "drug", "477-486"], "DRUGB": ["quinidine", "drug", "493-501"]}
{"TEXT1": "Preliminary evidence suggests @DRUG$ inhibits @DRUG$ metabolism result increase plasma concentrations mebendazole", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d679.s0.p0", "DRUGA": ["cimetidine", "drug", "35-44"], "DRUGB": ["mebendazole", "drug", "55-65"]}
{"TEXT1": "Preliminary evidence suggests @DRUG$ inhibits mebendazole metabolism result increase plasma concentrations @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d679.s0.p1", "DRUGA": ["cimetidine", "drug", "35-44"], "DRUGB": ["mebendazole", "drug", "136-146"]}
{"TEXT1": "Preliminary evidence suggests cimetidine inhibits @DRUG$ metabolism result increase plasma concentrations @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d679.s0.p2", "DRUGA": ["mebendazole", "drug", "55-65"], "DRUGB": ["mebendazole", "drug", "136-146"]}
{"TEXT1": "Interactions @DRUG$ Alcohol intestinal absorption riboflavin", "LBL": "0", "ID": "DDI-DrugBank.d698.s0.p0", "DRUGA": ["Vitamin B2", "drug", "17-26"], "DRUGB": ["Riboflavin", "drug", "29-38"]}
{"TEXT1": "Interactions @DRUG$ @DRUG$ intestinal absorption riboflavin", "LBL": "0", "ID": "DDI-DrugBank.d698.s0.p1", "DRUGA": ["Vitamin B2", "drug", "17-26"], "DRUGB": ["Alcohol", "drug", "43-49"]}
{"TEXT1": "Interactions @DRUG$ Alcohol intestinal absorption @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d698.s0.p2", "DRUGA": ["Vitamin B2", "drug", "17-26"], "DRUGB": ["riboflavin", "drug", "90-99"]}
{"TEXT1": "Interactions Vitamin B2 @DRUG$ intestinal absorption riboflavin", "LBL": "0", "ID": "DDI-DrugBank.d698.s0.p3", "DRUGA": ["Riboflavin", "drug", "29-38"], "DRUGB": ["Alcohol", "drug", "43-49"]}
{"TEXT1": "Interactions Vitamin B2 Alcohol intestinal absorption @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d698.s0.p4", "DRUGA": ["Riboflavin", "drug", "29-38"], "DRUGB": ["riboflavin", "drug", "90-99"]}
{"TEXT1": "Interactions Vitamin B2 @DRUG$ intestinal absorption @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d698.s0.p5", "DRUGA": ["Alcohol", "drug", "43-49"], "DRUGB": ["riboflavin", "drug", "90-99"]}
{"TEXT1": "@DRUG$ concurrent use decreases gastrointestinal absorption", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d698.s1.p0", "DRUGA": ["Probenecid", "drug", "0-9"], "DRUGB": ["riboflavin", "drug", "69-78"]}
{"TEXT1": "requirements @DRUG$ increased patients receiving @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d698.s2.p0", "DRUGA": ["riboflavin", "drug", "17-26"], "DRUGB": ["probenecid", "drug", "67-76"]}
{"TEXT1": "concomitant use of @DRUG$ including @DRUG$ hypnotics tranquilizers general anesthetics phenothiazines opioids tricyclic antidepressants monoamine oxidase inhibitors alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p0", "DRUGA": ["CNS depressants", "group", "29-43"], "DRUGB": ["sedatives", "group", "55-63"]}
{"TEXT1": "concomitant use of @DRUG$ including sedatives @DRUG$ tranquilizers general anesthetics phenothiazines opioids tricyclic antidepressants monoamine oxidase inhibitors alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p1", "DRUGA": ["CNS depressants", "group", "29-43"], "DRUGB": ["hypnotics", "group", "66-74"]}
{"TEXT1": "concomitant use of @DRUG$ including sedatives hypnotics @DRUG$ general anesthetics phenothiazines opioids tricyclic antidepressants monoamine oxidase inhibitors alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p2", "DRUGA": ["CNS depressants", "group", "29-43"], "DRUGB": ["tranquilizers", "group", "77-89"]}
{"TEXT1": "concomitant use of @DRUG$ including sedatives hypnotics tranquilizers @DRUG$ phenothiazines opioids tricyclic antidepressants monoamine oxidase inhibitors alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p3", "DRUGA": ["CNS depressants", "group", "29-43"], "DRUGB": ["anesthetics", "group", "100-110"]}
{"TEXT1": "concomitant use of @DRUG$ including sedatives hypnotics tranquilizers general anesthetics @DRUG$ opioids tricyclic antidepressants monoamine oxidase inhibitors alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p4", "DRUGA": ["CNS depressants", "group", "29-43"], "DRUGB": ["phenothiazines", "group", "113-126"]}
{"TEXT1": "concomitant use of @DRUG$ including sedatives hypnotics tranquilizers general anesthetics phenothiazines @DRUG$ tricyclic antidepressants monoamine oxidase inhibitors alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p5", "DRUGA": ["CNS depressants", "group", "29-43"], "DRUGB": ["opioids", "group", "135-141"]}
{"TEXT1": "concomitant use of @DRUG$ including sedatives hypnotics tranquilizers general anesthetics phenothiazines opioids @DRUG$ monoamine oxidase inhibitors alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p6", "DRUGA": ["CNS depressants", "group", "29-43"], "DRUGB": ["tricyclic antidepressants", "group", "144-168"]}
{"TEXT1": "concomitant use of @DRUG$ including sedatives hypnotics tranquilizers general anesthetics phenothiazines opioids tricyclic antidepressants @DRUG$ alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p7", "DRUGA": ["CNS depressants", "group", "29-43"], "DRUGB": ["monoamine oxidase (MAO) inhibitors", "group", "171-204"]}
{"TEXT1": "concomitant use of @DRUG$ including sedatives hypnotics tranquilizers general anesthetics phenothiazines opioids tricyclic antidepressants monoamine oxidase inhibitors @DRUG$ additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p8", "DRUGA": ["CNS depressants", "group", "29-43"], "DRUGB": ["alcohol", "drug", "211-217"]}
{"TEXT1": "concomitant use of CNS depressants including @DRUG$ @DRUG$ tranquilizers general anesthetics phenothiazines opioids tricyclic antidepressants monoamine oxidase inhibitors alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p9", "DRUGA": ["sedatives", "group", "55-63"], "DRUGB": ["hypnotics", "group", "66-74"]}
{"TEXT1": "concomitant use of CNS depressants including @DRUG$ hypnotics @DRUG$ general anesthetics phenothiazines opioids tricyclic antidepressants monoamine oxidase inhibitors alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p10", "DRUGA": ["sedatives", "group", "55-63"], "DRUGB": ["tranquilizers", "group", "77-89"]}
{"TEXT1": "concomitant use of CNS depressants including @DRUG$ hypnotics tranquilizers @DRUG$ phenothiazines opioids tricyclic antidepressants monoamine oxidase inhibitors alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p11", "DRUGA": ["sedatives", "group", "55-63"], "DRUGB": ["anesthetics", "group", "100-110"]}
{"TEXT1": "concomitant use of CNS depressants including @DRUG$ hypnotics tranquilizers general anesthetics @DRUG$ opioids tricyclic antidepressants monoamine oxidase inhibitors alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p12", "DRUGA": ["sedatives", "group", "55-63"], "DRUGB": ["phenothiazines", "group", "113-126"]}
{"TEXT1": "concomitant use of CNS depressants including @DRUG$ hypnotics tranquilizers general anesthetics phenothiazines @DRUG$ tricyclic antidepressants monoamine oxidase inhibitors alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p13", "DRUGA": ["sedatives", "group", "55-63"], "DRUGB": ["opioids", "group", "135-141"]}
{"TEXT1": "concomitant use of CNS depressants including @DRUG$ hypnotics tranquilizers general anesthetics phenothiazines opioids @DRUG$ monoamine oxidase inhibitors alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p14", "DRUGA": ["sedatives", "group", "55-63"], "DRUGB": ["tricyclic antidepressants", "group", "144-168"]}
{"TEXT1": "concomitant use of CNS depressants including @DRUG$ hypnotics tranquilizers general anesthetics phenothiazines opioids tricyclic antidepressants @DRUG$ alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p15", "DRUGA": ["sedatives", "group", "55-63"], "DRUGB": ["monoamine oxidase (MAO) inhibitors", "group", "171-204"]}
{"TEXT1": "concomitant use of CNS depressants including @DRUG$ hypnotics tranquilizers general anesthetics phenothiazines opioids tricyclic antidepressants monoamine oxidase inhibitors @DRUG$ additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p16", "DRUGA": ["sedatives", "group", "55-63"], "DRUGB": ["alcohol", "drug", "211-217"]}
{"TEXT1": "concomitant use of CNS depressants including sedatives @DRUG$ @DRUG$ general anesthetics phenothiazines opioids tricyclic antidepressants monoamine oxidase inhibitors alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p17", "DRUGA": ["hypnotics", "group", "66-74"], "DRUGB": ["tranquilizers", "group", "77-89"]}
{"TEXT1": "concomitant use of CNS depressants including sedatives @DRUG$ tranquilizers @DRUG$ phenothiazines opioids tricyclic antidepressants monoamine oxidase inhibitors alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p18", "DRUGA": ["hypnotics", "group", "66-74"], "DRUGB": ["anesthetics", "group", "100-110"]}
{"TEXT1": "concomitant use of CNS depressants including sedatives @DRUG$ tranquilizers general anesthetics @DRUG$ opioids tricyclic antidepressants monoamine oxidase inhibitors alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p19", "DRUGA": ["hypnotics", "group", "66-74"], "DRUGB": ["phenothiazines", "group", "113-126"]}
{"TEXT1": "concomitant use of CNS depressants including sedatives @DRUG$ tranquilizers general anesthetics phenothiazines @DRUG$ tricyclic antidepressants monoamine oxidase inhibitors alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p20", "DRUGA": ["hypnotics", "group", "66-74"], "DRUGB": ["opioids", "group", "135-141"]}
{"TEXT1": "concomitant use of CNS depressants including sedatives @DRUG$ tranquilizers general anesthetics phenothiazines opioids @DRUG$ monoamine oxidase inhibitors alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p21", "DRUGA": ["hypnotics", "group", "66-74"], "DRUGB": ["tricyclic antidepressants", "group", "144-168"]}
{"TEXT1": "concomitant use of CNS depressants including sedatives @DRUG$ tranquilizers general anesthetics phenothiazines opioids tricyclic antidepressants @DRUG$ alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p22", "DRUGA": ["hypnotics", "group", "66-74"], "DRUGB": ["monoamine oxidase (MAO) inhibitors", "group", "171-204"]}
{"TEXT1": "concomitant use of CNS depressants including sedatives @DRUG$ tranquilizers general anesthetics phenothiazines opioids tricyclic antidepressants monoamine oxidase inhibitors @DRUG$ additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p23", "DRUGA": ["hypnotics", "group", "66-74"], "DRUGB": ["alcohol", "drug", "211-217"]}
{"TEXT1": "concomitant use of CNS depressants including sedatives hypnotics @DRUG$ @DRUG$ phenothiazines opioids tricyclic antidepressants monoamine oxidase inhibitors alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p24", "DRUGA": ["tranquilizers", "group", "77-89"], "DRUGB": ["anesthetics", "group", "100-110"]}
{"TEXT1": "concomitant use of CNS depressants including sedatives hypnotics @DRUG$ general anesthetics @DRUG$ opioids tricyclic antidepressants monoamine oxidase inhibitors alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p25", "DRUGA": ["tranquilizers", "group", "77-89"], "DRUGB": ["phenothiazines", "group", "113-126"]}
{"TEXT1": "concomitant use of CNS depressants including sedatives hypnotics @DRUG$ general anesthetics phenothiazines @DRUG$ tricyclic antidepressants monoamine oxidase inhibitors alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p26", "DRUGA": ["tranquilizers", "group", "77-89"], "DRUGB": ["opioids", "group", "135-141"]}
{"TEXT1": "concomitant use of CNS depressants including sedatives hypnotics @DRUG$ general anesthetics phenothiazines opioids @DRUG$ monoamine oxidase inhibitors alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p27", "DRUGA": ["tranquilizers", "group", "77-89"], "DRUGB": ["tricyclic antidepressants", "group", "144-168"]}
{"TEXT1": "concomitant use of CNS depressants including sedatives hypnotics @DRUG$ general anesthetics phenothiazines opioids tricyclic antidepressants @DRUG$ alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p28", "DRUGA": ["tranquilizers", "group", "77-89"], "DRUGB": ["monoamine oxidase (MAO) inhibitors", "group", "171-204"]}
{"TEXT1": "concomitant use of CNS depressants including sedatives hypnotics @DRUG$ general anesthetics phenothiazines opioids tricyclic antidepressants monoamine oxidase inhibitors @DRUG$ additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p29", "DRUGA": ["tranquilizers", "group", "77-89"], "DRUGB": ["alcohol", "drug", "211-217"]}
{"TEXT1": "concomitant use of CNS depressants including sedatives hypnotics tranquilizers @DRUG$ @DRUG$ opioids tricyclic antidepressants monoamine oxidase inhibitors alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p30", "DRUGA": ["anesthetics", "group", "100-110"], "DRUGB": ["phenothiazines", "group", "113-126"]}
{"TEXT1": "concomitant use of CNS depressants including sedatives hypnotics tranquilizers @DRUG$ phenothiazines @DRUG$ tricyclic antidepressants monoamine oxidase inhibitors alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p31", "DRUGA": ["anesthetics", "group", "100-110"], "DRUGB": ["opioids", "group", "135-141"]}
{"TEXT1": "concomitant use of CNS depressants including sedatives hypnotics tranquilizers @DRUG$ phenothiazines opioids @DRUG$ monoamine oxidase inhibitors alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p32", "DRUGA": ["anesthetics", "group", "100-110"], "DRUGB": ["tricyclic antidepressants", "group", "144-168"]}
{"TEXT1": "concomitant use of CNS depressants including sedatives hypnotics tranquilizers @DRUG$ phenothiazines opioids tricyclic antidepressants @DRUG$ alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p33", "DRUGA": ["anesthetics", "group", "100-110"], "DRUGB": ["monoamine oxidase (MAO) inhibitors", "group", "171-204"]}
{"TEXT1": "concomitant use of CNS depressants including sedatives hypnotics tranquilizers @DRUG$ phenothiazines opioids tricyclic antidepressants monoamine oxidase inhibitors @DRUG$ additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p34", "DRUGA": ["anesthetics", "group", "100-110"], "DRUGB": ["alcohol", "drug", "211-217"]}
{"TEXT1": "concomitant use of CNS depressants including sedatives hypnotics tranquilizers general anesthetics @DRUG$ @DRUG$ tricyclic antidepressants monoamine oxidase inhibitors alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p35", "DRUGA": ["phenothiazines", "group", "113-126"], "DRUGB": ["opioids", "group", "135-141"]}
{"TEXT1": "concomitant use of CNS depressants including sedatives hypnotics tranquilizers general anesthetics @DRUG$ opioids @DRUG$ monoamine oxidase inhibitors alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p36", "DRUGA": ["phenothiazines", "group", "113-126"], "DRUGB": ["tricyclic antidepressants", "group", "144-168"]}
{"TEXT1": "concomitant use of CNS depressants including sedatives hypnotics tranquilizers general anesthetics @DRUG$ opioids tricyclic antidepressants @DRUG$ alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p37", "DRUGA": ["phenothiazines", "group", "113-126"], "DRUGB": ["monoamine oxidase (MAO) inhibitors", "group", "171-204"]}
{"TEXT1": "concomitant use of CNS depressants including sedatives hypnotics tranquilizers general anesthetics @DRUG$ opioids tricyclic antidepressants monoamine oxidase inhibitors @DRUG$ additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p38", "DRUGA": ["phenothiazines", "group", "113-126"], "DRUGB": ["alcohol", "drug", "211-217"]}
{"TEXT1": "concomitant use of CNS depressants including sedatives hypnotics tranquilizers general anesthetics phenothiazines @DRUG$ @DRUG$ monoamine oxidase inhibitors alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p39", "DRUGA": ["opioids", "group", "135-141"], "DRUGB": ["tricyclic antidepressants", "group", "144-168"]}
{"TEXT1": "concomitant use of CNS depressants including sedatives hypnotics tranquilizers general anesthetics phenothiazines @DRUG$ tricyclic antidepressants @DRUG$ alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p40", "DRUGA": ["opioids", "group", "135-141"], "DRUGB": ["monoamine oxidase (MAO) inhibitors", "group", "171-204"]}
{"TEXT1": "concomitant use of CNS depressants including sedatives hypnotics tranquilizers general anesthetics phenothiazines @DRUG$ tricyclic antidepressants monoamine oxidase inhibitors @DRUG$ additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p41", "DRUGA": ["opioids", "group", "135-141"], "DRUGB": ["alcohol", "drug", "211-217"]}
{"TEXT1": "concomitant use of CNS depressants including sedatives hypnotics tranquilizers general anesthetics phenothiazines opioids @DRUG$ @DRUG$ alcohol additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p42", "DRUGA": ["tricyclic antidepressants", "group", "144-168"], "DRUGB": ["monoamine oxidase (MAO) inhibitors", "group", "171-204"]}
{"TEXT1": "concomitant use of CNS depressants including sedatives hypnotics tranquilizers general anesthetics phenothiazines opioids @DRUG$ monoamine oxidase inhibitors @DRUG$ additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p43", "DRUGA": ["tricyclic antidepressants", "group", "144-168"], "DRUGB": ["alcohol", "drug", "211-217"]}
{"TEXT1": "concomitant use of CNS depressants including sedatives hypnotics tranquilizers general anesthetics phenothiazines opioids tricyclic antidepressants @DRUG$ @DRUG$ additive effects", "LBL": "0", "ID": "DDI-DrugBank.d753.s0.p44", "DRUGA": ["monoamine oxidase (MAO) inhibitors", "group", "171-204"], "DRUGB": ["alcohol", "drug", "211-217"]}
{"TEXT1": "@DRUG$ activity used @DRUG$ result increased risk of urinary retention severe constipation lead paralytic ileus", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d753.s2.p0", "DRUGA": ["Anticholinergics", "group", "0-15"], "DRUGB": ["opioid analgesics", "group", "96-112"]}
{"TEXT1": "reported incidence bradycardia increased @DRUG$ combined @DRUG$ induction of anesthesia", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d753.s3.p0", "DRUGA": ["oxymorphone", "drug", "74-84"], "DRUGB": ["propofol", "drug", "104-111"]}
{"TEXT1": "addition CNS toxicity reported disorientation respiratory depression apnea following coadministration @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d753.s4.p0", "DRUGA": ["cimetidine", "drug", "143-152"], "DRUGB": ["opioid analgesics", "group", "159-175"]}
{"TEXT1": "@DRUG$ administered antiepileptic drugs periodic serum determinations methsuximide increase plasma concentrations phenytoin", "LBL": "0", "ID": "DDI-DrugBank.d587.s0.p0", "DRUGA": ["Celontin", "brand", "6-13"], "DRUGB": ["methsuximide", "drug", "16-27"]}
{"TEXT1": "@DRUG$ administered @DRUG$ periodic serum determinations methsuximide increase plasma concentrations phenytoin", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d587.s0.p1", "DRUGA": ["Celontin", "brand", "6-13"], "DRUGB": ["antiepileptic drugs", "group", "74-92"]}
{"TEXT1": "@DRUG$ administered antiepileptic drugs periodic serum determinations @DRUG$ increase plasma concentrations phenytoin", "LBL": "0", "ID": "DDI-DrugBank.d587.s0.p2", "DRUGA": ["Celontin", "brand", "6-13"], "DRUGB": ["methsuximide", "drug", "167-178"]}
{"TEXT1": "@DRUG$ administered antiepileptic drugs periodic serum determinations methsuximide increase plasma concentrations @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d587.s0.p3", "DRUGA": ["Celontin", "brand", "6-13"], "DRUGB": ["phenytoin", "drug", "222-230"]}
{"TEXT1": "@DRUG$ administered antiepileptic drugs periodic serum determinations methsuximide increase plasma concentrations phenytoin", "LBL": "0", "ID": "DDI-DrugBank.d587.s0.p4", "DRUGA": ["Celontin", "brand", "6-13"], "DRUGB": ["phenobarbital", "drug", "236-248"]}
{"TEXT1": "Celontin administered @DRUG$ periodic serum determinations methsuximide increase plasma concentrations phenytoin", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d587.s0.p5", "DRUGA": ["methsuximide", "drug", "16-27"], "DRUGB": ["antiepileptic drugs", "group", "74-92"]}
{"TEXT1": "Celontin administered antiepileptic drugs periodic serum determinations @DRUG$ increase plasma concentrations phenytoin", "LBL": "0", "ID": "DDI-DrugBank.d587.s0.p6", "DRUGA": ["methsuximide", "drug", "16-27"], "DRUGB": ["methsuximide", "drug", "167-178"]}
{"TEXT1": "Celontin administered antiepileptic drugs periodic serum determinations methsuximide increase plasma concentrations @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d587.s0.p7", "DRUGA": ["methsuximide", "drug", "16-27"], "DRUGB": ["phenytoin", "drug", "222-230"]}
{"TEXT1": "Celontin administered antiepileptic drugs periodic serum determinations methsuximide increase plasma concentrations phenytoin", "LBL": "0", "ID": "DDI-DrugBank.d587.s0.p8", "DRUGA": ["methsuximide", "drug", "16-27"], "DRUGB": ["phenobarbital", "drug", "236-248"]}
{"TEXT1": "Celontin administered @DRUG$ periodic serum determinations @DRUG$ increase plasma concentrations phenytoin", "LBL": "0", "ID": "DDI-DrugBank.d587.s0.p9", "DRUGA": ["antiepileptic drugs", "group", "74-92"], "DRUGB": ["methsuximide", "drug", "167-178"]}
{"TEXT1": "Celontin administered @DRUG$ periodic serum determinations methsuximide increase plasma concentrations @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d587.s0.p10", "DRUGA": ["antiepileptic drugs", "group", "74-92"], "DRUGB": ["phenytoin", "drug", "222-230"]}
{"TEXT1": "Celontin administered @DRUG$ periodic serum determinations methsuximide increase plasma concentrations phenytoin", "LBL": "0", "ID": "DDI-DrugBank.d587.s0.p11", "DRUGA": ["antiepileptic drugs", "group", "74-92"], "DRUGB": ["phenobarbital", "drug", "236-248"]}
{"TEXT1": "Celontin administered antiepileptic drugs periodic serum determinations @DRUG$ increase plasma concentrations @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d587.s0.p12", "DRUGA": ["methsuximide", "drug", "167-178"], "DRUGB": ["phenytoin", "drug", "222-230"]}
{"TEXT1": "Celontin administered antiepileptic drugs periodic serum determinations @DRUG$ increase plasma concentrations phenytoin", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d587.s0.p13", "DRUGA": ["methsuximide", "drug", "167-178"], "DRUGB": ["phenobarbital", "drug", "236-248"]}
{"TEXT1": "Celontin administered antiepileptic drugs periodic serum determinations methsuximide increase plasma concentrations @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d587.s0.p14", "DRUGA": ["phenytoin", "drug", "222-230"], "DRUGB": ["phenobarbital", "drug", "236-248"]}
{"TEXT1": "@DRUG$ @DRUG$ used together signs atropinization mydriasis tachycardia dryness mouth occur earlier expected atropine alone", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d622.s0.p0", "DRUGA": ["atropine", "drug", "5-12"], "DRUGB": ["pralidoxime", "drug", "18-28"]}
{"TEXT1": "@DRUG$ pralidoxime used together signs atropinization mydriasis tachycardia dryness mouth occur earlier expected @DRUG$ alone", "LBL": "0", "ID": "DDI-DrugBank.d622.s0.p1", "DRUGA": ["atropine", "drug", "5-12"], "DRUGB": ["atropine", "drug", "189-196"]}
{"TEXT1": "atropine @DRUG$ used together signs atropinization mydriasis tachycardia dryness mouth occur earlier expected @DRUG$ alone", "LBL": "0", "ID": "DDI-DrugBank.d622.s0.p2", "DRUGA": ["pralidoxime", "drug", "18-28"], "DRUGB": ["atropine", "drug", "189-196"]}
{"TEXT1": "true total dose @DRUG$ large administration @DRUG$ delayed", "LBL": "0", "ID": "DDI-DrugBank.d622.s1.p0", "DRUGA": ["atropine", "drug", "45-52"], "DRUGB": ["pralidoxime", "drug", "95-105"]}
{"TEXT1": "following precautions kept mind treatment anticholinesterase poisoning not bear directly @DRUG$ anticholinesterases used", "LBL": "0", "ID": "DDI-DrugBank.d622.s2.p0", "DRUGA": ["pralidoxime", "drug", "154-164"], "DRUGB": ["barbiturates", "group", "173-184"]}
{"TEXT1": "following precautions kept mind treatment anticholinesterase poisoning not bear directly barbiturates @DRUG$ used", "LBL": "0", "ID": "DDI-DrugBank.d622.s2.p1", "DRUGA": ["pralidoxime", "drug", "154-164"], "DRUGB": ["anticholinesterases", "group", "209-227"]}
{"TEXT1": "following precautions kept mind treatment anticholinesterase poisoning not bear directly @DRUG$ @DRUG$ used", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d622.s2.p2", "DRUGA": ["barbiturates", "group", "173-184"], "DRUGB": ["anticholinesterases", "group", "209-227"]}
{"TEXT1": "@DRUG$ @DRUG$ aminophylline succinylcholine reserpine phenothiazine tranquilizers type patients organophosphate poisoning", "LBL": "0", "ID": "DDI-DrugBank.d622.s3.p0", "DRUGA": ["morphine", "drug", "0-7"], "DRUGB": ["theophylline", "drug", "10-21"]}
{"TEXT1": "@DRUG$ theophylline @DRUG$ succinylcholine reserpine phenothiazine tranquilizers type patients organophosphate poisoning", "LBL": "0", "ID": "DDI-DrugBank.d622.s3.p1", "DRUGA": ["morphine", "drug", "0-7"], "DRUGB": ["aminophylline", "drug", "24-36"]}
{"TEXT1": "@DRUG$ theophylline aminophylline @DRUG$ reserpine phenothiazine tranquilizers type patients organophosphate poisoning", "LBL": "0", "ID": "DDI-DrugBank.d622.s3.p2", "DRUGA": ["morphine", "drug", "0-7"], "DRUGB": ["succinylcholine", "drug", "39-53"]}
{"TEXT1": "@DRUG$ theophylline aminophylline succinylcholine @DRUG$ phenothiazine tranquilizers type patients organophosphate poisoning", "LBL": "0", "ID": "DDI-DrugBank.d622.s3.p3", "DRUGA": ["morphine", "drug", "0-7"], "DRUGB": ["reserpine", "drug", "56-64"]}
{"TEXT1": "@DRUG$ theophylline aminophylline succinylcholine reserpine @DRUG$ patients organophosphate poisoning", "LBL": "0", "ID": "DDI-DrugBank.d622.s3.p4", "DRUGA": ["morphine", "drug", "0-7"], "DRUGB": ["phenothiazine-type tranquilizers", "group", "71-102"]}
{"TEXT1": "morphine @DRUG$ @DRUG$ succinylcholine reserpine phenothiazine tranquilizers type patients organophosphate poisoning", "LBL": "0", "ID": "DDI-DrugBank.d622.s3.p5", "DRUGA": ["theophylline", "drug", "10-21"], "DRUGB": ["aminophylline", "drug", "24-36"]}
{"TEXT1": "morphine @DRUG$ aminophylline @DRUG$ reserpine phenothiazine tranquilizers type patients organophosphate poisoning", "LBL": "0", "ID": "DDI-DrugBank.d622.s3.p6", "DRUGA": ["theophylline", "drug", "10-21"], "DRUGB": ["succinylcholine", "drug", "39-53"]}
{"TEXT1": "morphine @DRUG$ aminophylline succinylcholine @DRUG$ phenothiazine tranquilizers type patients organophosphate poisoning", "LBL": "0", "ID": "DDI-DrugBank.d622.s3.p7", "DRUGA": ["theophylline", "drug", "10-21"], "DRUGB": ["reserpine", "drug", "56-64"]}
{"TEXT1": "morphine @DRUG$ aminophylline succinylcholine reserpine @DRUG$ patients organophosphate poisoning", "LBL": "0", "ID": "DDI-DrugBank.d622.s3.p8", "DRUGA": ["theophylline", "drug", "10-21"], "DRUGB": ["phenothiazine-type tranquilizers", "group", "71-102"]}
{"TEXT1": "morphine theophylline @DRUG$ @DRUG$ reserpine phenothiazine tranquilizers type patients organophosphate poisoning", "LBL": "0", "ID": "DDI-DrugBank.d622.s3.p9", "DRUGA": ["aminophylline", "drug", "24-36"], "DRUGB": ["succinylcholine", "drug", "39-53"]}
{"TEXT1": "morphine theophylline @DRUG$ succinylcholine @DRUG$ phenothiazine tranquilizers type patients organophosphate poisoning", "LBL": "0", "ID": "DDI-DrugBank.d622.s3.p10", "DRUGA": ["aminophylline", "drug", "24-36"], "DRUGB": ["reserpine", "drug", "56-64"]}
{"TEXT1": "morphine theophylline @DRUG$ succinylcholine reserpine @DRUG$ patients organophosphate poisoning", "LBL": "0", "ID": "DDI-DrugBank.d622.s3.p11", "DRUGA": ["aminophylline", "drug", "24-36"], "DRUGB": ["phenothiazine-type tranquilizers", "group", "71-102"]}
{"TEXT1": "morphine theophylline aminophylline @DRUG$ @DRUG$ phenothiazine tranquilizers type patients organophosphate poisoning", "LBL": "0", "ID": "DDI-DrugBank.d622.s3.p12", "DRUGA": ["succinylcholine", "drug", "39-53"], "DRUGB": ["reserpine", "drug", "56-64"]}
{"TEXT1": "morphine theophylline aminophylline @DRUG$ reserpine @DRUG$ patients organophosphate poisoning", "LBL": "0", "ID": "DDI-DrugBank.d622.s3.p13", "DRUGA": ["succinylcholine", "drug", "39-53"], "DRUGB": ["phenothiazine-type tranquilizers", "group", "71-102"]}
{"TEXT1": "morphine theophylline aminophylline succinylcholine @DRUG$ @DRUG$ patients organophosphate poisoning", "LBL": "0", "ID": "DDI-DrugBank.d622.s3.p14", "DRUGA": ["reserpine", "drug", "56-64"], "DRUGB": ["phenothiazine-type tranquilizers", "group", "71-102"]}
{"TEXT1": "absorption @DRUG$ @DRUG$ reported agents administered sulfasalazine", "LBL": "0", "ID": "DDI-DrugBank.d693.s0.p0", "DRUGA": ["folic acid", "drug", "22-31"], "DRUGB": ["digoxin", "drug", "37-43"]}
{"TEXT1": "absorption @DRUG$ digoxin reported agents administered @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d693.s0.p1", "DRUGA": ["folic acid", "drug", "22-31"], "DRUGB": ["sulfasalazine", "drug", "119-131"]}
{"TEXT1": "Reduced folic acid absorption @DRUG$ reported agents administered @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d693.s0.p2", "DRUGA": ["digoxin", "drug", "37-43"], "DRUGB": ["sulfasalazine", "drug", "119-131"]}
{"TEXT1": "daily doses @DRUG$ g weekly @DRUG$ rheumatoid arthritis patients study pharmacokinetic disposition drugs not altered", "LBL": "0", "ID": "DDI-DrugBank.d693.s1.p0", "DRUGA": ["sulfasalazine", "drug", "20-32"], "DRUGB": ["methotrexate", "drug", "58-69"]}
{"TEXT1": "Daily doses @DRUG$ weekly @DRUG$ mg administered alone combination rheumatoid arthritis patients two controlled week clinical studies", "LBL": "0", "ID": "DDI-DrugBank.d693.s2.p0", "DRUGA": ["sulfasalazine", "drug", "15-27"], "DRUGB": ["methotrexate", "drug", "67-78"]}
{"TEXT1": "@DRUG$ @DRUG$ increase sensitivity to oral anticoagulants", "LBL": "0", "ID": "DDI-DrugBank.d584.s0.p0", "DRUGA": ["Anticoagulants", "group", "0-13"], "DRUGB": ["Anabolic steroids", "group", "15-31"]}
{"TEXT1": "@DRUG$ Anabolic steroids increase sensitivity to @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d584.s0.p1", "DRUGA": ["Anticoagulants", "group", "0-13"], "DRUGB": ["anticoagulants", "group", "66-79"]}
{"TEXT1": "Anticoagulants @DRUG$ increase sensitivity to @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d584.s0.p2", "DRUGA": ["Anabolic steroids", "group", "15-31"], "DRUGB": ["anticoagulants", "group", "66-79"]}
{"TEXT1": "study @DRUG$ given 10 mg healthy subjects treated with warfarin resulted half 48 hours AUC 55 similar increases R detected", "LBL": "0", "ID": "DDI-DrugBank.d584.s3.p0", "DRUGA": ["Warfarin", "drug", "0-7"], "DRUGB": ["oxandrolone", "drug", "31-41"]}
{"TEXT1": "study oxandrolone given 10 mg healthy subjects treated with @DRUG$ resulted warfarin half 48 hours AUC 55 similar increases R detected", "LBL": "0", "ID": "DDI-DrugBank.d584.s3.p1", "DRUGA": ["Warfarin", "drug", "0-7"], "DRUGB": ["warfarin", "drug", "117-124"]}
{"TEXT1": "study oxandrolone given 10 mg healthy subjects treated with warfarin resulted @DRUG$ half 48 hours AUC 55 similar increases R detected", "LBL": "0", "ID": "DDI-DrugBank.d584.s3.p2", "DRUGA": ["Warfarin", "drug", "0-7"], "DRUGB": ["S-warfarin", "drug", "158-167"]}
{"TEXT1": "study oxandrolone given 10 mg healthy subjects treated with warfarin resulted half 48 hours AUC 55 similar increases @DRUG$ detected", "LBL": "0", "ID": "DDI-DrugBank.d584.s3.p3", "DRUGA": ["Warfarin", "drug", "0-7"], "DRUGB": ["R-warfarin", "drug", "257-266"]}
{"TEXT1": "study @DRUG$ given 10 mg healthy subjects treated with @DRUG$ resulted warfarin half 48 hours AUC 55 similar increases R detected", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d584.s3.p4", "DRUGA": ["oxandrolone", "drug", "31-41"], "DRUGB": ["warfarin", "drug", "117-124"]}
{"TEXT1": "study @DRUG$ given 10 mg healthy subjects treated with warfarin resulted @DRUG$ half 48 hours AUC 55 similar increases R detected", "LBL": "0", "ID": "DDI-DrugBank.d584.s3.p5", "DRUGA": ["oxandrolone", "drug", "31-41"], "DRUGB": ["S-warfarin", "drug", "158-167"]}
{"TEXT1": "study @DRUG$ given 10 mg healthy subjects treated with warfarin resulted half 48 hours AUC 55 similar increases @DRUG$ detected", "LBL": "0", "ID": "DDI-DrugBank.d584.s3.p6", "DRUGA": ["oxandrolone", "drug", "31-41"], "DRUGB": ["R-warfarin", "drug", "257-266"]}
{"TEXT1": "study oxandrolone given 10 mg healthy subjects treated with @DRUG$ resulted @DRUG$ half 48 hours AUC 55 similar increases R warfarin detected", "LBL": "0", "ID": "DDI-DrugBank.d584.s3.p7", "DRUGA": ["warfarin", "drug", "117-124"], "DRUGB": ["S-warfarin", "drug", "158-167"]}
{"TEXT1": "study oxandrolone given 10 mg healthy subjects treated with @DRUG$ resulted warfarin half 48 hours AUC 55 similar increases @DRUG$ detected", "LBL": "0", "ID": "DDI-DrugBank.d584.s3.p8", "DRUGA": ["warfarin", "drug", "117-124"], "DRUGB": ["R-warfarin", "drug", "257-266"]}
{"TEXT1": "study oxandrolone given 10 mg healthy subjects treated with warfarin resulted @DRUG$ half 48 hours AUC 55 similar increases @DRUG$ detected", "LBL": "0", "ID": "DDI-DrugBank.d584.s3.p9", "DRUGA": ["S-warfarin", "drug", "158-167"], "DRUGB": ["R-warfarin", "drug", "257-266"]}
{"TEXT1": "fold decrease mean @DRUG$ to 80 reduction @DRUG$ maintain target INR", "LBL": "0", "ID": "DDI-DrugBank.d584.s5.p0", "DRUGA": ["warfarin", "drug", "32-39"], "DRUGB": ["warfarin", "drug", "113-120"]}
{"TEXT1": "@DRUG$ therapy initiated patient receiving @DRUG$ INR prothrombin time monitored dose warfarin adjusted stable target", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d584.s6.p0", "DRUGA": ["oxandrolone", "drug", "5-15"], "DRUGB": ["warfarin", "drug", "84-91"]}
{"TEXT1": "@DRUG$ therapy initiated patient receiving treatment warfarin INR prothrombin time monitored @DRUG$ adjusted stable target", "LBL": "0", "ID": "DDI-DrugBank.d584.s6.p1", "DRUGA": ["oxandrolone", "drug", "5-15"], "DRUGB": ["warfarin", "drug", "171-178"]}
{"TEXT1": "oxandrolone therapy initiated patient receiving @DRUG$ INR prothrombin time monitored @DRUG$ adjusted stable target", "LBL": "0", "ID": "DDI-DrugBank.d584.s6.p2", "DRUGA": ["warfarin", "drug", "84-91"], "DRUGB": ["warfarin", "drug", "171-178"]}
{"TEXT1": "patients receiving drugs careful monitoring INR PT adjustment @DRUG$ dosage indicated recommended @DRUG$ changed discontinued", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d584.s7.p0", "DRUGA": ["warfarin", "drug", "106-113"], "DRUGB": ["oxandrolone", "drug", "160-170"]}
{"TEXT1": "@DRUG$ @DRUG$ inhibit metabolism oral hypoglycemic agents", "LBL": "0", "ID": "DDI-DrugBank.d584.s9.p0", "DRUGA": ["hypoglycemic agents", "group", "5-23"], "DRUGB": ["Oxandrolone", "drug", "25-35"]}
{"TEXT1": "@DRUG$ Oxandrolone inhibit metabolism @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d584.s9.p1", "DRUGA": ["hypoglycemic agents", "group", "5-23"], "DRUGB": ["hypoglycemic agents", "group", "72-90"]}
{"TEXT1": "@DRUG$ inhibit metabolism @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d584.s9.p2", "DRUGA": ["Oxandrolone", "drug", "25-35"], "DRUGB": ["hypoglycemic agents", "group", "72-90"]}
{"TEXT1": "@DRUG$ @DRUG$ patients edema concomitant adrenal cortical steroids ACTH increase", "LBL": "0", "ID": "DDI-DrugBank.d584.s10.p0", "DRUGA": ["Adrenal steroids", "group", "0-15"], "DRUGB": ["ACTH", "drug", "20-23"]}
{"TEXT1": "@DRUG$ ACTH patients edema concomitant @DRUG$ increase", "LBL": "0", "ID": "DDI-DrugBank.d584.s10.p1", "DRUGA": ["Adrenal steroids", "group", "0-15"], "DRUGB": ["adrenal cortical steroids", "group", "81-105"]}
{"TEXT1": "@DRUG$ ACTH patients edema concomitant adrenal cortical steroids @DRUG$ increase", "LBL": "0", "ID": "DDI-DrugBank.d584.s10.p2", "DRUGA": ["Adrenal steroids", "group", "0-15"], "DRUGB": ["ACTH", "drug", "110-113"]}
{"TEXT1": "steroids @DRUG$ patients edema concomitant @DRUG$ ACTH increase", "LBL": "0", "ID": "DDI-DrugBank.d584.s10.p3", "DRUGA": ["ACTH", "drug", "20-23"], "DRUGB": ["adrenal cortical steroids", "group", "81-105"]}
{"TEXT1": "steroids @DRUG$ patients edema concomitant adrenal cortical @DRUG$ increase", "LBL": "0", "ID": "DDI-DrugBank.d584.s10.p4", "DRUGA": ["ACTH", "drug", "20-23"], "DRUGB": ["ACTH", "drug", "110-113"]}
{"TEXT1": "steroids ACTH patients edema concomitant @DRUG$ @DRUG$ increase", "LBL": "0", "ID": "DDI-DrugBank.d584.s10.p5", "DRUGA": ["adrenal cortical steroids", "group", "81-105"], "DRUGB": ["ACTH", "drug", "110-113"]}
{"TEXT1": "@DRUG$ reverse analgesic activity @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d696.s0.p0", "DRUGA": ["Methysergide", "drug", "0-11"], "DRUGB": ["narcotic analgesics", "group", "51-69"]}
{"TEXT1": "Concurrent use @DRUG$ including @DRUG$ sumatriptan nicotine result enhanced vasoconstriction", "LBL": "0", "ID": "DDI-DrugBank.d696.s1.p0", "DRUGA": ["vasoconstrictor agents", "group", "20-41"], "DRUGB": ["ergot alkaloids", "group", "53-67"]}
{"TEXT1": "Concurrent use @DRUG$ including ergot alkaloids @DRUG$ nicotine result enhanced vasoconstriction", "LBL": "0", "ID": "DDI-DrugBank.d696.s1.p1", "DRUGA": ["vasoconstrictor agents", "group", "20-41"], "DRUGB": ["sumatriptan", "drug", "70-80"]}
{"TEXT1": "Concurrent use @DRUG$ including ergot alkaloids sumatriptan @DRUG$ result enhanced vasoconstriction", "LBL": "0", "ID": "DDI-DrugBank.d696.s1.p2", "DRUGA": ["vasoconstrictor agents", "group", "20-41"], "DRUGB": ["nicotine", "drug", "87-94"]}
{"TEXT1": "Concurrent use vasoconstrictor agents including @DRUG$ @DRUG$ nicotine result enhanced vasoconstriction", "LBL": "0", "ID": "DDI-DrugBank.d696.s1.p3", "DRUGA": ["ergot alkaloids", "group", "53-67"], "DRUGB": ["sumatriptan", "drug", "70-80"]}
{"TEXT1": "Concurrent use vasoconstrictor agents including @DRUG$ sumatriptan @DRUG$ result enhanced vasoconstriction", "LBL": "0", "ID": "DDI-DrugBank.d696.s1.p4", "DRUGA": ["ergot alkaloids", "group", "53-67"], "DRUGB": ["nicotine", "drug", "87-94"]}
{"TEXT1": "Concurrent use vasoconstrictor agents including ergot alkaloids @DRUG$ @DRUG$ result enhanced vasoconstriction", "LBL": "0", "ID": "DDI-DrugBank.d696.s1.p5", "DRUGA": ["sumatriptan", "drug", "70-80"], "DRUGB": ["nicotine", "drug", "87-94"]}
{"TEXT1": "@DRUG$ inhibits intracellular phosphorylation @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d727.s0.p0", "DRUGA": ["Zidovudine", "drug", "0-9"], "DRUGB": ["stavudine", "drug", "71-79"]}
{"TEXT1": "use of @DRUG$ combination @DRUG$", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d727.s1.p0", "DRUGA": ["zidovudine", "drug", "18-27"], "DRUGB": ["ZERIT", "brand", "49-53"]}
{"TEXT1": "In vitro data phosphorylation @DRUG$ inhibited relevant concentrations @DRUG$ ribavirin", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d727.s2.p0", "DRUGA": ["stavudine", "drug", "51-59"], "DRUGB": ["doxorubicin", "drug", "109-119"]}
{"TEXT1": "In vitro data phosphorylation @DRUG$ inhibited relevant concentrations doxorubicin @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d727.s2.p1", "DRUGA": ["stavudine", "drug", "51-59"], "DRUGB": ["ribavirin", "drug", "125-133"]}
{"TEXT1": "In vitro data phosphorylation stavudine inhibited relevant concentrations @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d727.s2.p2", "DRUGA": ["doxorubicin", "drug", "109-119"], "DRUGB": ["ribavirin", "drug", "125-133"]}
{"TEXT1": "administered @DRUG$ increase effects oral", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d658.s0.p0", "DRUGA": ["testolactone", "drug", "32-43"], "DRUGB": ["anticoagulants", "group", "78-91"]}
{"TEXT1": "Concomitant @DRUG$ administration decreased mean AUC total ezetimibe approximately", "LBL": "0", "ID": "DDI-DrugBank.d572.s0.p0", "DRUGA": ["Cholestyramine", "drug", "0-13"], "DRUGB": ["cholestyramine", "drug", "28-41"]}
{"TEXT1": "Concomitant cholestyramine administration decreased mean AUC total @DRUG$ approximately", "LBL": "0", "ID": "DDI-DrugBank.d572.s0.p1", "DRUGA": ["Cholestyramine", "drug", "0-13"], "DRUGB": ["ezetimibe", "drug", "90-98"]}
{"TEXT1": "Concomitant @DRUG$ administration decreased mean AUC total @DRUG$ approximately", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d572.s0.p2", "DRUGA": ["cholestyramine", "drug", "28-41"], "DRUGB": ["ezetimibe", "drug", "90-98"]}
{"TEXT1": "incremental reduction due to adding @DRUG$ @DRUG$ interaction", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d572.s1.p0", "DRUGA": ["ezetimibe", "drug", "46-54"], "DRUGB": ["cholestyramine", "drug", "59-72"]}
{"TEXT1": "safety effectiveness @DRUG$ administered fibrates not established", "LBL": "0", "ID": "DDI-DrugBank.d572.s2.p0", "DRUGA": ["Fibrates", "group", "0-7"], "DRUGB": ["ezetimibe", "drug", "42-50"]}
{"TEXT1": "safety effectiveness ezetimibe administered @DRUG$ not established", "LBL": "0", "ID": "DDI-DrugBank.d572.s2.p1", "DRUGA": ["Fibrates", "group", "0-7"], "DRUGB": ["fibrates", "group", "70-77"]}
{"TEXT1": "safety effectiveness @DRUG$ administered @DRUG$ not established", "LBL": "0", "ID": "DDI-DrugBank.d572.s2.p2", "DRUGA": ["ezetimibe", "drug", "42-50"], "DRUGB": ["fibrates", "group", "70-77"]}
{"TEXT1": "@DRUG$ @DRUG$ not recommended use patients studied", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d572.s5.p0", "DRUGA": ["ZETIA", "brand", "21-25"], "DRUGB": ["fibrates", "group", "32-39"]}
{"TEXT1": "pharmacokinetic study concomitant @DRUG$ administration increased total ezetimibe concentrations approximately fold", "LBL": "0", "ID": "DDI-DrugBank.d572.s6.p0", "DRUGA": ["Fenofibrate", "drug", "0-10"], "DRUGB": ["fenofibrate", "drug", "53-63"]}
{"TEXT1": "pharmacokinetic study concomitant fenofibrate administration increased total @DRUG$ concentrations approximately fold", "LBL": "0", "ID": "DDI-DrugBank.d572.s6.p1", "DRUGA": ["Fenofibrate", "drug", "0-10"], "DRUGB": ["ezetimibe", "drug", "96-104"]}
{"TEXT1": "pharmacokinetic study concomitant @DRUG$ administration increased total @DRUG$ concentrations approximately fold", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d572.s6.p2", "DRUGA": ["fenofibrate", "drug", "53-63"], "DRUGB": ["ezetimibe", "drug", "96-104"]}
{"TEXT1": "pharmacokinetic study concomitant @DRUG$ administration increased total ezetimibe concentrations approximately fold", "LBL": "0", "ID": "DDI-DrugBank.d572.s7.p0", "DRUGA": ["Gemfibrozil", "drug", "0-10"], "DRUGB": ["gemfibrozil", "drug", "53-63"]}
{"TEXT1": "pharmacokinetic study concomitant gemfibrozil administration increased total @DRUG$ concentrations approximately fold", "LBL": "0", "ID": "DDI-DrugBank.d572.s7.p1", "DRUGA": ["Gemfibrozil", "drug", "0-10"], "DRUGB": ["ezetimibe", "drug", "96-104"]}
{"TEXT1": "pharmacokinetic study concomitant @DRUG$ administration increased total @DRUG$ concentrations approximately fold", "LBL": "0", "ID": "DDI-DrugBank.d572.s7.p2", "DRUGA": ["gemfibrozil", "drug", "53-63"], "DRUGB": ["ezetimibe", "drug", "96-104"]}
{"TEXT1": "significant pharmacokinetic interactions seen @DRUG$ co administered atorvastatin simvastatin pravastatin lovastatin fluvastatin", "LBL": "0", "ID": "DDI-DrugBank.d572.s8.p0", "DRUGA": ["HMG-CoA reductase inhibitors", "group", "0-27"], "DRUGB": ["ezetimibe", "drug", "100-108"]}
{"TEXT1": "significant pharmacokinetic interactions seen ezetimibe co administered @DRUG$ simvastatin pravastatin lovastatin fluvastatin", "LBL": "0", "ID": "DDI-DrugBank.d572.s8.p1", "DRUGA": ["HMG-CoA reductase inhibitors", "group", "0-27"], "DRUGB": ["atorvastatin", "drug", "135-146"]}
{"TEXT1": "significant pharmacokinetic interactions seen ezetimibe co administered atorvastatin @DRUG$ pravastatin lovastatin fluvastatin", "LBL": "0", "ID": "DDI-DrugBank.d572.s8.p2", "DRUGA": ["HMG-CoA reductase inhibitors", "group", "0-27"], "DRUGB": ["simvastatin", "drug", "149-159"]}
{"TEXT1": "significant pharmacokinetic interactions seen ezetimibe co administered atorvastatin simvastatin @DRUG$ lovastatin fluvastatin", "LBL": "0", "ID": "DDI-DrugBank.d572.s8.p3", "DRUGA": ["HMG-CoA reductase inhibitors", "group", "0-27"], "DRUGB": ["pravastatin", "drug", "162-172"]}
{"TEXT1": "significant pharmacokinetic interactions seen ezetimibe co administered atorvastatin simvastatin pravastatin @DRUG$ fluvastatin", "LBL": "0", "ID": "DDI-DrugBank.d572.s8.p4", "DRUGA": ["HMG-CoA reductase inhibitors", "group", "0-27"], "DRUGB": ["lovastatin", "drug", "175-184"]}
{"TEXT1": "significant pharmacokinetic interactions seen ezetimibe co administered atorvastatin simvastatin pravastatin lovastatin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d572.s8.p5", "DRUGA": ["HMG-CoA reductase inhibitors", "group", "0-27"], "DRUGB": ["fluvastatin", "drug", "190-200"]}
{"TEXT1": "significant pharmacokinetic interactions seen @DRUG$ co administered @DRUG$ simvastatin pravastatin lovastatin fluvastatin", "LBL": "0", "ID": "DDI-DrugBank.d572.s8.p6", "DRUGA": ["ezetimibe", "drug", "100-108"], "DRUGB": ["atorvastatin", "drug", "135-146"]}
{"TEXT1": "significant pharmacokinetic interactions seen @DRUG$ co administered atorvastatin @DRUG$ pravastatin lovastatin fluvastatin", "LBL": "0", "ID": "DDI-DrugBank.d572.s8.p7", "DRUGA": ["ezetimibe", "drug", "100-108"], "DRUGB": ["simvastatin", "drug", "149-159"]}
{"TEXT1": "significant pharmacokinetic interactions seen @DRUG$ co administered atorvastatin simvastatin @DRUG$ lovastatin fluvastatin", "LBL": "0", "ID": "DDI-DrugBank.d572.s8.p8", "DRUGA": ["ezetimibe", "drug", "100-108"], "DRUGB": ["pravastatin", "drug", "162-172"]}
{"TEXT1": "significant pharmacokinetic interactions seen @DRUG$ co administered atorvastatin simvastatin pravastatin @DRUG$ fluvastatin", "LBL": "0", "ID": "DDI-DrugBank.d572.s8.p9", "DRUGA": ["ezetimibe", "drug", "100-108"], "DRUGB": ["lovastatin", "drug", "175-184"]}
{"TEXT1": "significant pharmacokinetic interactions seen @DRUG$ co administered atorvastatin simvastatin pravastatin lovastatin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d572.s8.p10", "DRUGA": ["ezetimibe", "drug", "100-108"], "DRUGB": ["fluvastatin", "drug", "190-200"]}
{"TEXT1": "significant pharmacokinetic interactions seen ezetimibe co administered @DRUG$ @DRUG$ pravastatin lovastatin fluvastatin", "LBL": "0", "ID": "DDI-DrugBank.d572.s8.p11", "DRUGA": ["atorvastatin", "drug", "135-146"], "DRUGB": ["simvastatin", "drug", "149-159"]}
{"TEXT1": "significant pharmacokinetic interactions seen ezetimibe co administered @DRUG$ simvastatin @DRUG$ lovastatin fluvastatin", "LBL": "0", "ID": "DDI-DrugBank.d572.s8.p12", "DRUGA": ["atorvastatin", "drug", "135-146"], "DRUGB": ["pravastatin", "drug", "162-172"]}
{"TEXT1": "significant pharmacokinetic interactions seen ezetimibe co administered @DRUG$ simvastatin pravastatin @DRUG$ fluvastatin", "LBL": "0", "ID": "DDI-DrugBank.d572.s8.p13", "DRUGA": ["atorvastatin", "drug", "135-146"], "DRUGB": ["lovastatin", "drug", "175-184"]}
{"TEXT1": "significant pharmacokinetic interactions seen ezetimibe co administered @DRUG$ simvastatin pravastatin lovastatin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d572.s8.p14", "DRUGA": ["atorvastatin", "drug", "135-146"], "DRUGB": ["fluvastatin", "drug", "190-200"]}
{"TEXT1": "significant pharmacokinetic interactions seen ezetimibe co administered atorvastatin @DRUG$ @DRUG$ lovastatin fluvastatin", "LBL": "0", "ID": "DDI-DrugBank.d572.s8.p15", "DRUGA": ["simvastatin", "drug", "149-159"], "DRUGB": ["pravastatin", "drug", "162-172"]}
{"TEXT1": "significant pharmacokinetic interactions seen ezetimibe co administered atorvastatin @DRUG$ pravastatin @DRUG$ fluvastatin", "LBL": "0", "ID": "DDI-DrugBank.d572.s8.p16", "DRUGA": ["simvastatin", "drug", "149-159"], "DRUGB": ["lovastatin", "drug", "175-184"]}
{"TEXT1": "significant pharmacokinetic interactions seen ezetimibe co administered atorvastatin @DRUG$ pravastatin lovastatin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d572.s8.p17", "DRUGA": ["simvastatin", "drug", "149-159"], "DRUGB": ["fluvastatin", "drug", "190-200"]}
{"TEXT1": "significant pharmacokinetic interactions seen ezetimibe co administered atorvastatin simvastatin @DRUG$ @DRUG$ fluvastatin", "LBL": "0", "ID": "DDI-DrugBank.d572.s8.p18", "DRUGA": ["pravastatin", "drug", "162-172"], "DRUGB": ["lovastatin", "drug", "175-184"]}
{"TEXT1": "significant pharmacokinetic interactions seen ezetimibe co administered atorvastatin simvastatin @DRUG$ lovastatin @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d572.s8.p19", "DRUGA": ["pravastatin", "drug", "162-172"], "DRUGB": ["fluvastatin", "drug", "190-200"]}
{"TEXT1": "significant pharmacokinetic interactions seen ezetimibe co administered atorvastatin simvastatin pravastatin @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d572.s8.p20", "DRUGA": ["lovastatin", "drug", "175-184"], "DRUGB": ["fluvastatin", "drug", "190-200"]}
{"TEXT1": "total @DRUG$ level increased fold one renal transplant patient receiving multiple medications including cyclosporine", "LBL": "0", "ID": "DDI-DrugBank.d572.s9.p0", "DRUGA": ["Cyclosporine", "drug", "0-11"], "DRUGB": ["ezetimibe", "drug", "24-32"]}
{"TEXT1": "total ezetimibe level increased fold one renal transplant patient receiving multiple medications including @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d572.s9.p1", "DRUGA": ["Cyclosporine", "drug", "0-11"], "DRUGB": ["cyclosporine", "drug", "132-143"]}
{"TEXT1": "total @DRUG$ level increased fold one renal transplant patient receiving multiple medications including @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d572.s9.p2", "DRUGA": ["ezetimibe", "drug", "24-32"], "DRUGB": ["cyclosporine", "drug", "132-143"]}
{"TEXT1": "Patients take @DRUG$ @DRUG$ monitored", "LBL": "DDI-advise", "ID": "DDI-DrugBank.d572.s10.p0", "DRUGA": ["ezetimibe", "drug", "23-31"], "DRUGB": ["cyclosporine", "drug", "37-48"]}
{"TEXT1": "Carcinogenesis Mutagenesis Impairment Fertility week dietary carcinogenicity study @DRUG$ conducted rats doses 1500 mg/kg/day 500 times human exposure 10 mg daily based total", "LBL": "0", "ID": "DDI-DrugBank.d572.s11.p0", "DRUGA": ["ezetimibe", "drug", "99-107"], "DRUGB": ["ezetimibe", "drug", "271-279"]}
{"TEXT1": "week dietary carcinogenicity study @DRUG$ conducted mice doses 500 mg/kg/day times human exposure 10 mg daily based total", "LBL": "0", "ID": "DDI-DrugBank.d572.s12.p0", "DRUGA": ["ezetimibe", "drug", "46-54"], "DRUGB": ["ezetimibe", "drug", "187-195"]}
{"TEXT1": "oral fertility studies @DRUG$ conducted rats no evidence reproductive toxicity doses mg/kg/day male female times human exposure 10 mg daily based total", "LBL": "0", "ID": "DDI-DrugBank.d572.s17.p0", "DRUGA": ["ezetimibe", "drug", "38-46"], "DRUGB": ["ezetimibe", "drug", "240-248"]}
{"TEXT1": "rabbits treated with @DRUG$ increased incidence observed mg/kg/day times human exposure 10 mg daily based total", "LBL": "0", "ID": "DDI-DrugBank.d572.s22.p0", "DRUGA": ["ezetimibe", "drug", "24-32"], "DRUGB": ["ezetimibe", "drug", "186-194"]}
{"TEXT1": "Multiple dose studies @DRUG$ given combination @DRUG$ rats rabbits organogenesis result higher ezetimibe exposures", "LBL": "0", "ID": "DDI-DrugBank.d572.s24.p0", "DRUGA": ["ezetimibe", "drug", "25-33"], "DRUGB": ["HMG-CoA reductase inhibitors", "group", "61-88"]}
{"TEXT1": "Multiple dose studies @DRUG$ given combination rats rabbits organogenesis result higher ezetimibe exposures", "LBL": "0", "ID": "DDI-DrugBank.d572.s24.p1", "DRUGA": ["ezetimibe", "drug", "25-33"], "DRUGB": ["statins", "group", "91-97"]}
{"TEXT1": "Multiple dose studies @DRUG$ given combination rats rabbits organogenesis result higher @DRUG$ exposures", "LBL": "0", "ID": "DDI-DrugBank.d572.s24.p2", "DRUGA": ["ezetimibe", "drug", "25-33"], "DRUGB": ["ezetimibe", "drug", "158-166"]}
{"TEXT1": "Multiple dose studies ezetimibe given combination @DRUG$ rats rabbits organogenesis result higher exposures", "LBL": "0", "ID": "DDI-DrugBank.d572.s24.p3", "DRUGA": ["HMG-CoA reductase inhibitors", "group", "61-88"], "DRUGB": ["statins", "group", "91-97"]}
{"TEXT1": "Multiple dose studies ezetimibe given combination @DRUG$ rats rabbits organogenesis result higher @DRUG$ exposures", "LBL": "0", "ID": "DDI-DrugBank.d572.s24.p4", "DRUGA": ["HMG-CoA reductase inhibitors", "group", "61-88"], "DRUGB": ["ezetimibe", "drug", "158-166"]}
{"TEXT1": "Multiple dose studies ezetimibe given combination rats rabbits organogenesis result higher @DRUG$ exposures", "LBL": "0", "ID": "DDI-DrugBank.d572.s24.p5", "DRUGA": ["statins", "group", "91-97"], "DRUGB": ["ezetimibe", "drug", "158-166"]}
{"TEXT1": "@DRUG$ administered @DRUG$ woman childbearing potential refer pregnancy category package labeling", "LBL": "0", "ID": "DDI-DrugBank.d572.s27.p0", "DRUGA": ["ZETIA", "brand", "5-9"], "DRUGB": ["HMG-CoA reductase inhibitor", "group", "35-61"]}
{"TEXT1": "@DRUG$ administered woman childbearing potential refer pregnancy category package labeling @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d572.s27.p1", "DRUGA": ["ZETIA", "brand", "5-9"], "DRUGB": ["HMG-CoA reductase inhibitor", "drug", "162-188"]}
{"TEXT1": "ZETIA administered @DRUG$ woman childbearing potential refer pregnancy category package labeling @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d572.s27.p2", "DRUGA": ["HMG-CoA reductase inhibitor", "group", "35-61"], "DRUGB": ["HMG-CoA reductase inhibitor", "drug", "162-188"]}
{"TEXT1": "@DRUG$ potent inhibitor cytochrome P450 3A4 increase plasma levels @DRUG$ concomitant", "LBL": "DDI-mechanism", "ID": "DDI-DrugBank.d580.s1.p0", "DRUGA": ["ketoconazole", "drug", "9-20"], "DRUGB": ["mometasone furoate", "drug", "96-113"]}
{"TEXT1": "@DRUG$ enhance @DRUG$ barbiturates CNS depressants", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d605.s0.p0", "DRUGA": ["SKELAXIN", "brand", "0-7"], "DRUGB": ["alcohol", "drug", "36-42"]}
{"TEXT1": "@DRUG$ enhance effects alcohol @DRUG$ CNS depressants", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d605.s0.p1", "DRUGA": ["SKELAXIN", "brand", "0-7"], "DRUGB": ["barbiturates", "group", "45-56"]}
{"TEXT1": "@DRUG$ enhance effects alcohol barbiturates @DRUG$", "LBL": "DDI-effect", "ID": "DDI-DrugBank.d605.s0.p2", "DRUGA": ["SKELAXIN", "brand", "0-7"], "DRUGB": ["CNS depressants", "group", "68-82"]}
{"TEXT1": "SKELAXIN enhance @DRUG$ @DRUG$ CNS depressants", "LBL": "0", "ID": "DDI-DrugBank.d605.s0.p3", "DRUGA": ["alcohol", "drug", "36-42"], "DRUGB": ["barbiturates", "group", "45-56"]}
{"TEXT1": "SKELAXIN enhance @DRUG$ barbiturates @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d605.s0.p4", "DRUGA": ["alcohol", "drug", "36-42"], "DRUGB": ["CNS depressants", "group", "68-82"]}
{"TEXT1": "SKELAXIN enhance effects alcohol @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-DrugBank.d605.s0.p5", "DRUGA": ["barbiturates", "group", "45-56"], "DRUGB": ["CNS depressants", "group", "68-82"]}
{"TEXT1": "@DRUG$ one adenosylhomocysteine hydrolase inhibitors shown activities broad range solid tumors acute myeloid leukemia", "LBL": "0", "ID": "DDI-MedLine.d180.s1.p0", "DRUGA": ["3-Deazaneplanocin A", "drug_n", "4-22"], "DRUGB": ["DZNep", "drug_n", "25-29"]}
{"TEXT1": "found overexpressed @DRUG$ insensitive cells cotreatment @DRUG$ family inhibited growth induced apoptosis MM", "LBL": "0", "ID": "DDI-MedLine.d180.s10.p0", "DRUGA": ["DZNep", "drug_n", "46-50"], "DRUGB": ["DZNep", "drug_n", "92-96"]}
{"TEXT1": "found overexpressed @DRUG$ insensitive cells cotreatment @DRUG$ family inhibited growth induced apoptosis MM", "LBL": "0", "ID": "DDI-MedLine.d180.s10.p1", "DRUGA": ["DZNep", "drug_n", "46-50"], "DRUGB": ["ABT-737", "drug_n", "102-108"]}
{"TEXT1": "found overexpressed @DRUG$ insensitive cells cotreatment family inhibited growth induced apoptosis @DRUG$ MM", "LBL": "0", "ID": "DDI-MedLine.d180.s10.p2", "DRUGA": ["DZNep", "drug_n", "46-50"], "DRUGB": ["DZNep", "drug_n", "195-199"]}
{"TEXT1": "found overexpressed insensitive cells cotreatment @DRUG$ @DRUG$ family inhibited growth induced apoptosis MM", "LBL": "DDI-effect", "ID": "DDI-MedLine.d180.s10.p3", "DRUGA": ["DZNep", "drug_n", "92-96"], "DRUGB": ["ABT-737", "drug_n", "102-108"]}
{"TEXT1": "found overexpressed insensitive cells cotreatment @DRUG$ family inhibited growth induced apoptosis @DRUG$ MM", "LBL": "0", "ID": "DDI-MedLine.d180.s10.p4", "DRUGA": ["DZNep", "drug_n", "92-96"], "DRUGB": ["DZNep", "drug_n", "195-199"]}
{"TEXT1": "found overexpressed insensitive cells cotreatment @DRUG$ family inhibited growth induced apoptosis @DRUG$ MM", "LBL": "0", "ID": "DDI-MedLine.d180.s10.p5", "DRUGA": ["ABT-737", "drug_n", "102-108"], "DRUGB": ["DZNep", "drug_n", "195-199"]}
{"TEXT1": "addition @DRUG$ insensitivity associated with overexpression combination @DRUG$ induced apoptosis", "LBL": "0", "ID": "DDI-MedLine.d180.s12.p0", "DRUGA": ["DZNep", "drug_n", "13-17"], "DRUGB": ["ABT-737", "drug_n", "106-112"]}
{"TEXT1": "addition @DRUG$ insensitivity associated with overexpression combination @DRUG$ induced apoptosis", "LBL": "0", "ID": "DDI-MedLine.d180.s12.p1", "DRUGA": ["DZNep", "drug_n", "13-17"], "DRUGB": ["DZNep", "drug_n", "118-122"]}
{"TEXT1": "addition insensitivity associated with overexpression combination @DRUG$ @DRUG$ induced apoptosis", "LBL": "DDI-effect", "ID": "DDI-MedLine.d180.s12.p2", "DRUGA": ["ABT-737", "drug_n", "106-112"], "DRUGB": ["DZNep", "drug_n", "118-122"]}
{"TEXT1": "@DRUG$ enhances effect @DRUG$ mice", "LBL": "DDI-effect", "ID": "DDI-MedLine.d227.s0.p0", "DRUGA": ["Ephedrine", "drug", "0-8"], "DRUGB": ["dexmedetomidine", "drug", "49-63"]}
{"TEXT1": "purpose of study to evaluate psychostimulant drug @DRUG$ effect @DRUG$ induced locomotor activity inhibitor mice acute application", "LBL": "0", "ID": "DDI-MedLine.d227.s2.p0", "DRUGA": ["ephedrine", "drug", "75-83"], "DRUGB": ["dexmedetomidine", "drug", "103-117"]}
{"TEXT1": "saline @DRUG$ @DRUG$ ephedrine dexmedetomidine 30 min hot plate holed open field tests", "LBL": "0", "ID": "DDI-MedLine.d227.s6.p0", "DRUGA": ["ephedrine", "drug", "17-25"], "DRUGB": ["dexmedetomidine", "drug", "59-73"]}
{"TEXT1": "saline @DRUG$ dexmedetomidine @DRUG$ 30 min hot plate holed open field tests", "LBL": "0", "ID": "DDI-MedLine.d227.s6.p1", "DRUGA": ["ephedrine", "drug", "17-25"], "DRUGB": ["ephedrine", "drug", "93-101"]}
{"TEXT1": "saline @DRUG$ dexmedetomidine ephedrine @DRUG$ 30 min hot plate holed open field tests", "LBL": "0", "ID": "DDI-MedLine.d227.s6.p2", "DRUGA": ["ephedrine", "drug", "17-25"], "DRUGB": ["dexmedetomidine", "drug", "118-132"]}
{"TEXT1": "saline ephedrine @DRUG$ @DRUG$ dexmedetomidine 30 min hot plate holed open field tests", "LBL": "0", "ID": "DDI-MedLine.d227.s6.p3", "DRUGA": ["dexmedetomidine", "drug", "59-73"], "DRUGB": ["ephedrine", "drug", "93-101"]}
{"TEXT1": "saline ephedrine @DRUG$ @DRUG$ 30 min hot plate holed open field tests", "LBL": "0", "ID": "DDI-MedLine.d227.s6.p4", "DRUGA": ["dexmedetomidine", "drug", "59-73"], "DRUGB": ["dexmedetomidine", "drug", "118-132"]}
{"TEXT1": "saline ephedrine dexmedetomidine @DRUG$ @DRUG$ 30 min hot plate holed open field tests", "LBL": "0", "ID": "DDI-MedLine.d227.s6.p5", "DRUGA": ["ephedrine", "drug", "93-101"], "DRUGB": ["dexmedetomidine", "drug", "118-132"]}
{"TEXT1": "hot plate mice administration g/kg @DRUG$ 10 mg/kg @DRUG$ not only enhanced prolonged duration induced dexmedetomidine", "LBL": "DDI-effect", "ID": "DDI-MedLine.d227.s7.p0", "DRUGA": ["dexmedetomidine", "drug", "64-78"], "DRUGB": ["ephedrine", "drug", "96-104"]}
{"TEXT1": "hot plate mice administration g/kg @DRUG$ 10 mg/kg ephedrine not only enhanced prolonged duration induced @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d227.s7.p1", "DRUGA": ["dexmedetomidine", "drug", "64-78"], "DRUGB": ["dexmedetomidine", "drug", "205-219"]}
{"TEXT1": "hot plate mice administration g/kg dexmedetomidine 10 mg/kg @DRUG$ not only enhanced prolonged duration induced @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d227.s7.p2", "DRUGA": ["ephedrine", "drug", "96-104"], "DRUGB": ["dexmedetomidine", "drug", "205-219"]}
{"TEXT1": "same time inhibitory effect @DRUG$ @DRUG$", "LBL": "DDI-effect", "ID": "DDI-MedLine.d227.s8.p0", "DRUGA": ["dexmedetomidine", "drug", "53-67"], "DRUGB": ["ephedrine", "drug", "89-97"]}
{"TEXT1": "concluded combined administration @DRUG$ @DRUG$ effects treatment pain causing sedation limits dexmedetomidine analgesic humans", "LBL": "DDI-effect", "ID": "DDI-MedLine.d227.s9.p0", "DRUGA": ["dexmedetomidine", "drug", "49-63"], "DRUGB": ["ephedrine", "drug", "70-78"]}
{"TEXT1": "concluded combined administration @DRUG$ ephedrine effects treatment pain causing sedation limits @DRUG$ analgesic humans", "LBL": "0", "ID": "DDI-MedLine.d227.s9.p1", "DRUGA": ["dexmedetomidine", "drug", "49-63"], "DRUGB": ["dexmedetomidine", "drug", "183-197"]}
{"TEXT1": "concluded combined administration @DRUG$ ephedrine effects treatment pain causing sedation limits dexmedetomidine @DRUG$ humans", "LBL": "0", "ID": "DDI-MedLine.d227.s9.p2", "DRUGA": ["dexmedetomidine", "drug", "49-63"], "DRUGB": ["analgesic", "group", "205-213"]}
{"TEXT1": "concluded combined administration dexmedetomidine @DRUG$ effects treatment pain causing sedation limits @DRUG$ analgesic humans", "LBL": "0", "ID": "DDI-MedLine.d227.s9.p3", "DRUGA": ["ephedrine", "drug", "70-78"], "DRUGB": ["dexmedetomidine", "drug", "183-197"]}
{"TEXT1": "concluded combined administration dexmedetomidine @DRUG$ effects treatment pain causing sedation limits @DRUG$ humans", "LBL": "0", "ID": "DDI-MedLine.d227.s9.p4", "DRUGA": ["ephedrine", "drug", "70-78"], "DRUGB": ["analgesic", "group", "205-213"]}
{"TEXT1": "concluded combined administration dexmedetomidine ephedrine effects treatment pain causing sedation limits @DRUG$ @DRUG$ humans", "LBL": "0", "ID": "DDI-MedLine.d227.s9.p5", "DRUGA": ["dexmedetomidine", "drug", "183-197"], "DRUGB": ["analgesic", "group", "205-213"]}
{"TEXT1": "effect @DRUG$ @DRUG$ acute toxicity diepoxybutane human lymphocytes", "LBL": "0", "ID": "DDI-MedLine.d159.s0.p0", "DRUGA": ["acetyl-l-carnitine", "drug", "21-38"], "DRUGB": ["alpha lipoic acid", "drug_n", "45-61"]}
{"TEXT1": "@DRUG$ elicits significant effect DEB induced toxicity @DRUG$", "LBL": "DDI-effect", "ID": "DDI-MedLine.d159.s6.p0", "DRUGA": ["acetyl-l-carnitine", "drug", "5-22"], "DRUGB": ["alpha-lipoic acid", "drug", "115-131"]}
{"TEXT1": "role @DRUG$ enhanced @DRUG$ cytotoxicity ovarian cancer", "LBL": "DDI-effect", "ID": "DDI-MedLine.d194.s0.p0", "DRUGA": ["dasatinib", "drug", "25-33"], "DRUGB": ["paclitaxel", "drug", "44-53"]}
{"TEXT1": "effect @DRUG$ inhibitor Src Abl kinases @DRUG$ sensitivity measured ovarian cancer cells xenografts", "LBL": "0", "ID": "DDI-MedLine.d194.s4.p0", "DRUGA": ["dasatinib", "drug", "14-22"], "DRUGB": ["paclitaxel", "drug", "65-74"]}
{"TEXT1": "roles Cdk1 apoptosis induced @DRUG$ @DRUG$ assessed using mediated dUTP assay siRNA knockdown gene expression transfection flow cytometry", "LBL": "0", "ID": "DDI-MedLine.d194.s5.p0", "DRUGA": ["dasatinib", "drug", "64-72"], "DRUGB": ["paclitaxel", "drug", "78-87"]}
{"TEXT1": "cells treated with @DRUG$ plus @DRUG$ formed fewer colonies agent alone", "LBL": "DDI-effect", "ID": "DDI-MedLine.d194.s9.p0", "DRUGA": ["dasatinib", "drug", "23-31"], "DRUGB": ["paclitaxel", "drug", "38-47"]}
{"TEXT1": "xenograft bearing mice @DRUG$ plus @DRUG$ inhibited tumor growth treatment either agent alone mouse dasatinib paclitaxel 0 81 cm3 difference confidence interval 62 P", "LBL": "DDI-effect", "ID": "DDI-MedLine.d194.s10.p0", "DRUGA": ["dasatinib", "drug", "45-53"], "DRUGB": ["paclitaxel", "drug", "60-69"]}
{"TEXT1": "xenograft bearing mice @DRUG$ plus paclitaxel inhibited tumor growth treatment either agent alone mouse @DRUG$ 0 81 cm3 difference confidence interval 62 P", "LBL": "0", "ID": "DDI-MedLine.d194.s10.p1", "DRUGA": ["dasatinib", "drug", "45-53"], "DRUGB": ["dasatinib", "drug", "171-179"]}
{"TEXT1": "xenograft bearing mice @DRUG$ plus paclitaxel inhibited tumor growth treatment either agent alone mouse dasatinib @DRUG$ 0 81 cm3 difference confidence interval 62 P", "LBL": "0", "ID": "DDI-MedLine.d194.s10.p2", "DRUGA": ["dasatinib", "drug", "45-53"], "DRUGB": ["paclitaxel", "drug", "183-192"]}
{"TEXT1": "xenograft bearing mice @DRUG$ plus paclitaxel inhibited tumor growth treatment either agent alone mouse dasatinib 0 81 cm3 difference confidence interval 62 P", "LBL": "0", "ID": "DDI-MedLine.d194.s10.p3", "DRUGA": ["dasatinib", "drug", "45-53"], "DRUGB": ["paclitaxel", "drug", "197-206"]}
{"TEXT1": "xenograft bearing mice dasatinib plus @DRUG$ inhibited tumor growth treatment either agent alone mouse @DRUG$ paclitaxel 0 81 cm3 difference confidence interval 62 P", "LBL": "0", "ID": "DDI-MedLine.d194.s10.p4", "DRUGA": ["paclitaxel", "drug", "60-69"], "DRUGB": ["dasatinib", "drug", "171-179"]}
{"TEXT1": "xenograft bearing mice dasatinib plus @DRUG$ inhibited tumor growth treatment either agent alone mouse @DRUG$ 0 81 cm3 difference confidence interval 62 P", "LBL": "0", "ID": "DDI-MedLine.d194.s10.p5", "DRUGA": ["paclitaxel", "drug", "60-69"], "DRUGB": ["paclitaxel", "drug", "183-192"]}
{"TEXT1": "xenograft bearing mice dasatinib plus @DRUG$ inhibited tumor growth treatment either agent alone mouse paclitaxel 0 81 cm3 difference confidence interval 62 P", "LBL": "0", "ID": "DDI-MedLine.d194.s10.p6", "DRUGA": ["paclitaxel", "drug", "60-69"], "DRUGB": ["paclitaxel", "drug", "197-206"]}
{"TEXT1": "xenograft bearing mice dasatinib plus paclitaxel inhibited tumor growth treatment either agent alone mouse @DRUG$ @DRUG$ 0 81 cm3 difference confidence interval 62 P", "LBL": "0", "ID": "DDI-MedLine.d194.s10.p7", "DRUGA": ["dasatinib", "drug", "171-179"], "DRUGB": ["paclitaxel", "drug", "183-192"]}
{"TEXT1": "xenograft bearing mice dasatinib plus paclitaxel inhibited tumor growth treatment either agent alone mouse @DRUG$ 0 81 cm3 difference confidence interval 62 P", "LBL": "0", "ID": "DDI-MedLine.d194.s10.p8", "DRUGA": ["dasatinib", "drug", "171-179"], "DRUGB": ["paclitaxel", "drug", "197-206"]}
{"TEXT1": "xenograft bearing mice dasatinib plus paclitaxel inhibited tumor growth treatment either agent alone mouse @DRUG$ 0 81 cm3 difference confidence interval 62 P", "LBL": "0", "ID": "DDI-MedLine.d194.s10.p9", "DRUGA": ["paclitaxel", "drug", "183-192"], "DRUGB": ["paclitaxel", "drug", "197-206"]}
{"TEXT1": "@DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d194.s11.p0", "DRUGA": ["dasatinib", "drug", "0-8"], "DRUGB": ["paclitaxel", "drug", "12-21"]}
{"TEXT1": "siRNA decreased @DRUG$ @DRUG$ induced apoptosis compared negative control G1 fraction 20 difference CI P", "LBL": "0", "ID": "DDI-MedLine.d194.s15.p0", "DRUGA": ["dasatinib", "drug", "43-51"], "DRUGB": ["paclitaxel", "drug", "58-67"]}
{"TEXT1": "Studies forced expression siRNA Cdk1 suggest @DRUG$ mediated enhanced @DRUG$ induced", "LBL": "DDI-effect", "ID": "DDI-MedLine.d194.s16.p0", "DRUGA": ["dasatinib", "drug", "82-90"], "DRUGB": ["paclitaxel", "drug", "133-142"]}
{"TEXT1": "Inhibition Src family Abl kinases siRNAs @DRUG$ enhances @DRUG$ sensitivity cells mediated suppression Cdk1 expression", "LBL": "DDI-effect", "ID": "DDI-MedLine.d194.s17.p0", "DRUGA": ["dasatinib", "drug", "63-71"], "DRUGB": ["paclitaxel", "drug", "82-91"]}
{"TEXT1": "Interaction @DRUG$ different @DRUG$ antagonistic breast not other cancer cells", "LBL": "DDI-effect", "ID": "DDI-MedLine.d217.s0.p0", "DRUGA": ["celecoxib", "drug", "15-23"], "DRUGB": ["anti-cancer drugs", "group", "40-56"]}
{"TEXT1": "study investigates ability @DRUG$ to cells different origins several @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d217.s2.p0", "DRUGA": ["cyclooxygenase-2 inhibitors", "group", "39-65"], "DRUGB": ["chemotherapeutic agents", "group", "120-142"]}
{"TEXT1": "sensitivity cell cycle apoptosis DNA damage five different cancer lines HCT116 MCF7 @DRUG$ @DRUG$ doxorubicin etoposide celecoxib following schedules analyzed", "LBL": "0", "ID": "DDI-MedLine.d217.s4.p0", "DRUGA": ["5-FU", "drug", "130-133"], "DRUGB": ["cisplatin", "drug", "136-144"]}
{"TEXT1": "sensitivity cell cycle apoptosis DNA damage five different cancer lines HCT116 MCF7 @DRUG$ cisplatin @DRUG$ etoposide celecoxib following schedules analyzed", "LBL": "0", "ID": "DDI-MedLine.d217.s4.p1", "DRUGA": ["5-FU", "drug", "130-133"], "DRUGB": ["doxorubicin", "drug", "147-157"]}
{"TEXT1": "sensitivity cell cycle apoptosis DNA damage five different cancer lines HCT116 MCF7 @DRUG$ cisplatin doxorubicin @DRUG$ celecoxib following schedules analyzed", "LBL": "0", "ID": "DDI-MedLine.d217.s4.p2", "DRUGA": ["5-FU", "drug", "130-133"], "DRUGB": ["etoposide", "drug", "163-171"]}
{"TEXT1": "sensitivity cell cycle apoptosis DNA damage five different cancer lines HCT116 MCF7 @DRUG$ cisplatin doxorubicin etoposide @DRUG$ following schedules analyzed", "LBL": "0", "ID": "DDI-MedLine.d217.s4.p3", "DRUGA": ["5-FU", "drug", "130-133"], "DRUGB": ["celecoxib", "drug", "175-183"]}
{"TEXT1": "sensitivity cell cycle apoptosis DNA damage five different cancer lines HCT116 MCF7 @DRUG$ @DRUG$ etoposide celecoxib following schedules analyzed", "LBL": "0", "ID": "DDI-MedLine.d217.s4.p4", "DRUGA": ["cisplatin", "drug", "136-144"], "DRUGB": ["doxorubicin", "drug", "147-157"]}
{"TEXT1": "sensitivity cell cycle apoptosis DNA damage five different cancer lines HCT116 MCF7 @DRUG$ doxorubicin @DRUG$ celecoxib following schedules analyzed", "LBL": "0", "ID": "DDI-MedLine.d217.s4.p5", "DRUGA": ["cisplatin", "drug", "136-144"], "DRUGB": ["etoposide", "drug", "163-171"]}
{"TEXT1": "sensitivity cell cycle apoptosis DNA damage five different cancer lines HCT116 MCF7 @DRUG$ doxorubicin etoposide @DRUG$ following schedules analyzed", "LBL": "0", "ID": "DDI-MedLine.d217.s4.p6", "DRUGA": ["cisplatin", "drug", "136-144"], "DRUGB": ["celecoxib", "drug", "175-183"]}
{"TEXT1": "sensitivity cell cycle apoptosis DNA damage five different cancer lines HCT116 MCF7 cisplatin @DRUG$ @DRUG$ celecoxib following schedules analyzed", "LBL": "0", "ID": "DDI-MedLine.d217.s4.p7", "DRUGA": ["doxorubicin", "drug", "147-157"], "DRUGB": ["etoposide", "drug", "163-171"]}
{"TEXT1": "sensitivity cell cycle apoptosis DNA damage five different cancer lines HCT116 MCF7 cisplatin @DRUG$ etoposide @DRUG$ following schedules analyzed", "LBL": "0", "ID": "DDI-MedLine.d217.s4.p8", "DRUGA": ["doxorubicin", "drug", "147-157"], "DRUGB": ["celecoxib", "drug", "175-183"]}
{"TEXT1": "sensitivity cell cycle apoptosis DNA damage five different cancer lines HCT116 MCF7 cisplatin doxorubicin @DRUG$ @DRUG$ following schedules analyzed", "LBL": "0", "ID": "DDI-MedLine.d217.s4.p9", "DRUGA": ["etoposide", "drug", "163-171"], "DRUGB": ["celecoxib", "drug", "175-183"]}
{"TEXT1": "found antagonism @DRUG$ four drugs breast cancer cells MCF7 following schedules @DRUG$ doxorubicin cell lines except for two combinations", "LBL": "0", "ID": "DDI-MedLine.d217.s5.p0", "DRUGA": ["celecoxib", "drug", "28-36"], "DRUGB": ["celecoxib", "drug", "136-144"]}
{"TEXT1": "found antagonism @DRUG$ four drugs breast cancer cells MCF7 following schedules celecoxib @DRUG$ cell lines except for two combinations", "LBL": "0", "ID": "DDI-MedLine.d217.s5.p1", "DRUGA": ["celecoxib", "drug", "28-36"], "DRUGB": ["doxorubicin", "drug", "150-160"]}
{"TEXT1": "found antagonism celecoxib four drugs breast cancer cells MCF7 following schedules @DRUG$ @DRUG$ cell lines except for two combinations", "LBL": "DDI-effect", "ID": "DDI-MedLine.d217.s5.p2", "DRUGA": ["celecoxib", "drug", "136-144"], "DRUGB": ["doxorubicin", "drug", "150-160"]}
{"TEXT1": "results confirmed @DRUG$ not suitable chemosensitizer breast cancer @DRUG$ cancers", "LBL": "0", "ID": "DDI-MedLine.d217.s11.p0", "DRUGA": ["celecoxib", "drug", "51-59"], "DRUGB": ["doxorubicin", "drug", "121-131"]}
{"TEXT1": "authors report case infant confirmed congenital hypothyroidism @DRUG$ experienced possible drug interaction @DRUG$", "LBL": "DDI-int", "ID": "DDI-MedLine.d181.s4.p0", "DRUGA": ["levothyroxine", "drug", "85-97"], "DRUGB": ["simeticone", "drug", "148-157"]}
{"TEXT1": "Questioning revealed child taking @DRUG$ drops feeds @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d181.s6.p0", "DRUGA": ["Infacol", "brand", "42-48"], "DRUGB": ["levothyroxine", "drug", "78-90"]}
{"TEXT1": "Drug interaction @DRUG$ @DRUG$ not reported listed British National Formulary Children", "LBL": "0", "ID": "DDI-MedLine.d181.s8.p0", "DRUGA": ["thyroxine", "drug", "20-28"], "DRUGB": ["simeticone", "drug", "35-44"]}
{"TEXT1": "In vivo CYP3A activity lower @DRUG$ treated compared @DRUG$ renal allograft recipients", "LBL": "0", "ID": "DDI-MedLine.d213.s0.p0", "DRUGA": ["cyclosporine", "drug", "49-60"], "DRUGB": ["tacrolimus", "drug", "87-96"]}
{"TEXT1": "In vitro studies identified @DRUG$ @DRUG$ CYP3A inhibitors", "LBL": "0", "ID": "DDI-MedLine.d213.s1.p0", "DRUGA": ["cyclosporine", "drug", "33-44"], "DRUGB": ["tacrolimus", "drug", "50-59"]}
{"TEXT1": "Systemic apparent oral @DRUG$ clearance ml/min P 0 lower @DRUG$ treated patients matched tacrolimus", "LBL": "DDI-mechanism", "ID": "DDI-MedLine.d213.s3.p0", "DRUGA": ["midazolam", "drug", "27-35"], "DRUGB": ["cyclosporine", "drug", "181-192"]}
{"TEXT1": "Systemic apparent oral @DRUG$ clearance ml/min P 0 lower cyclosporine treated patients matched @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d213.s3.p1", "DRUGA": ["midazolam", "drug", "27-35"], "DRUGB": ["tacrolimus", "drug", "236-245"]}
{"TEXT1": "Systemic apparent oral midazolam clearance ml/min P 0 lower @DRUG$ treated patients matched @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d213.s3.p2", "DRUGA": ["cyclosporine", "drug", "181-192"], "DRUGB": ["tacrolimus", "drug", "236-245"]}
{"TEXT1": "displayed @DRUG$ clearances similar two larger cohorts @DRUG$ treated patients 58 n receiving calcineurin inhibitor free regimen", "LBL": "0", "ID": "DDI-MedLine.d213.s4.p0", "DRUGA": ["midazolam", "drug", "21-29"], "DRUGB": ["tacrolimus", "drug", "95-104"]}
{"TEXT1": "displayed @DRUG$ clearances similar two larger cohorts tacrolimus treated patients 58 n receiving @DRUG$ free regimen", "LBL": "0", "ID": "DDI-MedLine.d213.s4.p1", "DRUGA": ["midazolam", "drug", "21-29"], "DRUGB": ["calcineurin inhibitor", "group", "168-188"]}
{"TEXT1": "displayed midazolam clearances similar two larger cohorts @DRUG$ treated patients 58 n receiving @DRUG$ free regimen", "LBL": "0", "ID": "DDI-MedLine.d213.s4.p2", "DRUGA": ["tacrolimus", "drug", "95-104"], "DRUGB": ["calcineurin inhibitor", "group", "168-188"]}
{"TEXT1": "in vivo hepatic CYP3A activities lower patients receiving @DRUG$ @DRUG$ doses used clinical practice cyclosporine stronger two inhibition", "LBL": "0", "ID": "DDI-MedLine.d213.s5.p0", "DRUGA": ["cyclosporine", "drug", "112-123"], "DRUGB": ["tacrolimus", "drug", "149-158"]}
{"TEXT1": "in vivo hepatic CYP3A activities lower patients receiving @DRUG$ tacrolimus doses used clinical practice @DRUG$ stronger two inhibition", "LBL": "0", "ID": "DDI-MedLine.d213.s5.p1", "DRUGA": ["cyclosporine", "drug", "112-123"], "DRUGB": ["cyclosporine", "drug", "228-239"]}
{"TEXT1": "in vivo hepatic CYP3A activities lower patients receiving cyclosporine @DRUG$ doses used clinical practice @DRUG$ stronger two inhibition", "LBL": "0", "ID": "DDI-MedLine.d213.s5.p2", "DRUGA": ["tacrolimus", "drug", "149-158"], "DRUGB": ["cyclosporine", "drug", "228-239"]}
{"TEXT1": "@DRUG$ failure woman @DRUG$ two ectopic pregnancies", "LBL": "DDI-effect", "ID": "DDI-MedLine.d208.s0.p0", "DRUGA": ["Implanon", "brand", "0-7"], "DRUGB": ["antiretroviral", "group", "47-60"]}
{"TEXT1": "present interesting case woman @DRUG$ tubal pregnancies two separate occasions @DRUG$ place", "LBL": "DDI-effect", "ID": "DDI-MedLine.d208.s3.p0", "DRUGA": ["antiretroviral", "group", "59-72"], "DRUGB": ["Implanon", "brand", "138-145"]}
{"TEXT1": "Synergistic interaction @DRUG$ @DRUG$ sequence dependent human non small lung cancer", "LBL": "DDI-int", "ID": "DDI-MedLine.d179.s0.p0", "DRUGA": ["sunitinib", "drug", "32-40"], "DRUGB": ["docetaxel", "drug", "46-54"]}
{"TEXT1": "study aimed to investigate efficacy single @DRUG$ concurrent sequential administration @DRUG$ docetaxel NSCLC cell lines EGFR", "LBL": "0", "ID": "DDI-MedLine.d179.s2.p0", "DRUGA": ["sunitinib", "drug", "66-74"], "DRUGB": ["sunitinib", "drug", "131-139"]}
{"TEXT1": "study aimed to investigate efficacy single @DRUG$ concurrent sequential administration sunitinib @DRUG$ NSCLC cell lines EGFR", "LBL": "0", "ID": "DDI-MedLine.d179.s2.p1", "DRUGA": ["sunitinib", "drug", "66-74"], "DRUGB": ["docetaxel", "drug", "145-153"]}
{"TEXT1": "study aimed to investigate efficacy single sunitinib concurrent sequential administration @DRUG$ @DRUG$ NSCLC cell lines EGFR", "LBL": "0", "ID": "DDI-MedLine.d179.s2.p2", "DRUGA": ["sunitinib", "drug", "131-139"], "DRUGB": ["docetaxel", "drug", "145-153"]}
{"TEXT1": "NSCLC cell lines EGFR T790M mutation K exposed @DRUG$ @DRUG$ based various sequential administrations", "LBL": "0", "ID": "DDI-MedLine.d179.s3.p0", "DRUGA": ["sunitinib", "drug", "84-92"], "DRUGB": ["docetaxel", "drug", "97-105"]}
{"TEXT1": "@DRUG$ exhibited growth inhibition NSCLC cell lines arrested cell cycle G1 at phase @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d179.s5.p0", "DRUGA": ["Sunitinib", "drug", "0-8"], "DRUGB": ["docetaxel", "drug", "118-126"]}
{"TEXT1": "single concurrent use of @DRUG$ @DRUG$ proliferative effects sequential administrations drugs enhanced tumor activity", "LBL": "DDI-effect", "ID": "DDI-MedLine.d179.s6.p0", "DRUGA": ["sunitinib", "drug", "37-45"], "DRUGB": ["docetaxel", "drug", "51-59"]}
{"TEXT1": "cells exposed @DRUG$ followed by @DRUG$ synergism observed", "LBL": "DDI-effect", "ID": "DDI-MedLine.d179.s7.p0", "DRUGA": ["docetaxel", "drug", "27-35"], "DRUGB": ["sunitinib", "drug", "49-57"]}
{"TEXT1": "molecular basis synergism signaling pathways initially activated @DRUG$ exposure suppressed subsequent @DRUG$", "LBL": "DDI-effect", "ID": "DDI-MedLine.d179.s8.p0", "DRUGA": ["docetaxel", "drug", "102-110"], "DRUGB": ["sunitinib", "drug", "179-187"]}
{"TEXT1": "@DRUG$ single agent exhibits proliferative effects in vitro NSCLC cell lines EGFR T790M K ras mutations sequential administration @DRUG$ followed by sunitinib superior docetaxel concurrent", "LBL": "0", "ID": "DDI-MedLine.d179.s10.p0", "DRUGA": ["Sunitinib", "drug", "0-8"], "DRUGB": ["docetaxel", "drug", "166-174"]}
{"TEXT1": "@DRUG$ single agent exhibits proliferative effects in vitro NSCLC cell lines EGFR T790M K ras mutations sequential administration docetaxel followed by @DRUG$ superior sunitinib concurrent", "LBL": "0", "ID": "DDI-MedLine.d179.s10.p1", "DRUGA": ["Sunitinib", "drug", "0-8"], "DRUGB": ["sunitinib", "drug", "188-196"]}
{"TEXT1": "@DRUG$ single agent exhibits proliferative effects in vitro NSCLC cell lines EGFR T790M K ras mutations sequential administration docetaxel followed by sunitinib superior @DRUG$ concurrent", "LBL": "0", "ID": "DDI-MedLine.d179.s10.p2", "DRUGA": ["Sunitinib", "drug", "0-8"], "DRUGB": ["sunitinib", "drug", "213-221"]}
{"TEXT1": "@DRUG$ single agent exhibits proliferative effects in vitro NSCLC cell lines EGFR T790M K ras mutations sequential administration docetaxel followed by sunitinib superior @DRUG$ concurrent", "LBL": "0", "ID": "DDI-MedLine.d179.s10.p3", "DRUGA": ["Sunitinib", "drug", "0-8"], "DRUGB": ["docetaxel", "drug", "235-243"]}
{"TEXT1": "single agent exhibits proliferative effects in vitro NSCLC cell lines EGFR T790M K ras mutations sequential administration @DRUG$ followed by @DRUG$ superior sunitinib docetaxel concurrent", "LBL": "DDI-effect", "ID": "DDI-MedLine.d179.s10.p4", "DRUGA": ["docetaxel", "drug", "166-174"], "DRUGB": ["sunitinib", "drug", "188-196"]}
{"TEXT1": "single agent exhibits proliferative effects in vitro NSCLC cell lines EGFR T790M K ras mutations sequential administration @DRUG$ followed by sunitinib superior @DRUG$ docetaxel concurrent", "LBL": "0", "ID": "DDI-MedLine.d179.s10.p5", "DRUGA": ["docetaxel", "drug", "166-174"], "DRUGB": ["sunitinib", "drug", "213-221"]}
{"TEXT1": "single agent exhibits proliferative effects in vitro NSCLC cell lines EGFR T790M K ras mutations sequential administration @DRUG$ followed by sunitinib superior @DRUG$ concurrent", "LBL": "0", "ID": "DDI-MedLine.d179.s10.p6", "DRUGA": ["docetaxel", "drug", "166-174"], "DRUGB": ["docetaxel", "drug", "235-243"]}
{"TEXT1": "single agent exhibits proliferative effects in vitro NSCLC cell lines EGFR T790M K ras mutations sequential administration docetaxel followed by @DRUG$ superior @DRUG$ concurrent", "LBL": "0", "ID": "DDI-MedLine.d179.s10.p7", "DRUGA": ["sunitinib", "drug", "188-196"], "DRUGB": ["sunitinib", "drug", "213-221"]}
{"TEXT1": "single agent exhibits proliferative effects in vitro NSCLC cell lines EGFR T790M K ras mutations sequential administration docetaxel followed by @DRUG$ superior sunitinib @DRUG$ concurrent", "LBL": "0", "ID": "DDI-MedLine.d179.s10.p8", "DRUGA": ["sunitinib", "drug", "188-196"], "DRUGB": ["docetaxel", "drug", "235-243"]}
{"TEXT1": "single agent exhibits proliferative effects in vitro NSCLC cell lines EGFR T790M K ras mutations sequential administration docetaxel followed by sunitinib superior @DRUG$ @DRUG$ concurrent", "LBL": "0", "ID": "DDI-MedLine.d179.s10.p9", "DRUGA": ["sunitinib", "drug", "213-221"], "DRUGB": ["docetaxel", "drug", "235-243"]}
{"TEXT1": "present study tested highly specific metabotropic glutamate receptor 5 antagonist @DRUG$ dopaminergic noradrenergic neuronal loss monkeys chronic treatment low doses @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d161.s3.p0", "DRUGA": ["3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "drug_n", "106-153"], "DRUGB": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "281-324"]}
{"TEXT1": "Weekly intramuscular @DRUG$ injections 2 0 combination daily administration @DRUG$ vehicle performed development parkinsonian symptoms motor two experimental groups phenyl 3 pyridine", "LBL": "0", "ID": "DDI-MedLine.d161.s4.p0", "DRUGA": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "21-64"], "DRUGB": ["3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "drug_n", "150-197"]}
{"TEXT1": "Weekly intramuscular @DRUG$ injections 2 0 combination daily administration 3 pyridine vehicle performed development parkinsonian symptoms motor two experimental groups phenyl", "LBL": "0", "ID": "DDI-MedLine.d161.s4.p1", "DRUGA": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "21-64"], "DRUGB": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "321-364"]}
{"TEXT1": "Weekly intramuscular @DRUG$ injections 2 0 combination daily administration 3 pyridine vehicle performed development parkinsonian symptoms motor two experimental groups phenyl", "LBL": "0", "ID": "DDI-MedLine.d161.s4.p2", "DRUGA": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "21-64"], "DRUGB": ["3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "drug_n", "366-413"]}
{"TEXT1": "Weekly intramuscular @DRUG$ injections 2 0 combination daily administration 3 pyridine vehicle performed development parkinsonian symptoms motor two experimental groups phenyl", "LBL": "0", "ID": "DDI-MedLine.d161.s4.p3", "DRUGA": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "21-64"], "DRUGB": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "422-465"]}
{"TEXT1": "Weekly intramuscular phenyl 2 3 injections 0 combination daily administration @DRUG$ vehicle performed development parkinsonian symptoms motor two experimental groups pyridine", "LBL": "0", "ID": "DDI-MedLine.d161.s4.p4", "DRUGA": ["3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "drug_n", "150-197"], "DRUGB": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "321-364"]}
{"TEXT1": "Weekly intramuscular phenyl 2 3 injections 0 combination daily administration @DRUG$ vehicle performed development parkinsonian symptoms motor two experimental groups", "LBL": "0", "ID": "DDI-MedLine.d161.s4.p5", "DRUGA": ["3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "drug_n", "150-197"], "DRUGB": ["3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "drug_n", "366-413"]}
{"TEXT1": "Weekly intramuscular phenyl 2 3 injections 0 combination daily administration @DRUG$ vehicle performed development parkinsonian symptoms motor two experimental groups pyridine", "LBL": "0", "ID": "DDI-MedLine.d161.s4.p6", "DRUGA": ["3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "drug_n", "150-197"], "DRUGB": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "422-465"]}
{"TEXT1": "Weekly intramuscular phenyl 2 3 injections 0 combination daily administration pyridine vehicle performed development parkinsonian symptoms motor two experimental groups", "LBL": "0", "ID": "DDI-MedLine.d161.s4.p7", "DRUGA": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "321-364"], "DRUGB": ["3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "drug_n", "366-413"]}
{"TEXT1": "Weekly intramuscular phenyl 2 3 injections 0 combination daily administration pyridine vehicle performed development parkinsonian symptoms motor two experimental groups", "LBL": "0", "ID": "DDI-MedLine.d161.s4.p8", "DRUGA": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "321-364"], "DRUGB": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "422-465"]}
{"TEXT1": "Weekly intramuscular phenyl 2 3 injections 0 combination daily administration pyridine vehicle performed development parkinsonian symptoms motor two experimental groups", "LBL": "0", "ID": "DDI-MedLine.d161.s4.p9", "DRUGA": ["3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "drug_n", "366-413"], "DRUGB": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "422-465"]}
{"TEXT1": "@DRUG$ treatment animals displayed parkinsonian symptoms none phenyl 2 3 pyridine monkeys affected", "LBL": "0", "ID": "DDI-MedLine.d161.s5.p0", "DRUGA": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "18-61"], "DRUGB": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "78-121"]}
{"TEXT1": "@DRUG$ treatment phenyl 2 3 animals displayed parkinsonian symptoms none pyridine monkeys affected", "LBL": "0", "ID": "DDI-MedLine.d161.s5.p1", "DRUGA": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "18-61"], "DRUGB": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "200-243"]}
{"TEXT1": "@DRUG$ treatment phenyl 2 3 animals displayed parkinsonian symptoms none monkeys affected", "LBL": "0", "ID": "DDI-MedLine.d161.s5.p2", "DRUGA": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "18-61"], "DRUGB": ["3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "drug_n", "245-292"]}
{"TEXT1": "weeks 1 phenyl 2 3 treatment animals displayed parkinsonian symptoms none pyridine monkeys affected", "LBL": "0", "ID": "DDI-MedLine.d161.s5.p3", "DRUGA": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "78-121"], "DRUGB": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "200-243"]}
{"TEXT1": "weeks 1 phenyl 2 3 treatment animals displayed parkinsonian symptoms none monkeys affected", "LBL": "0", "ID": "DDI-MedLine.d161.s5.p4", "DRUGA": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "78-121"], "DRUGB": ["3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "drug_n", "245-292"]}
{"TEXT1": "weeks 1 phenyl 2 3 treatment animals displayed parkinsonian symptoms none monkeys affected", "LBL": "DDI-effect", "ID": "DDI-MedLine.d161.s5.p5", "DRUGA": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "200-243"], "DRUGB": ["3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "drug_n", "245-292"]}
{"TEXT1": "behavioural observations consistent with positron emission tomography dopamine transporter data counts midbrain dopaminergic neurons striatal intensity measurements tyrosine hydroxylase immunoreactivity significantly higher treated animals phenyl 2 3 monkeys", "LBL": "DDI-effect", "ID": "DDI-MedLine.d161.s6.p0", "DRUGA": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "349-392"], "DRUGB": ["3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "drug_n", "394-441"]}
{"TEXT1": "behavioural observations consistent with positron emission tomography dopamine transporter data counts midbrain dopaminergic neurons striatal intensity measurements tyrosine hydroxylase immunoreactivity significantly higher 3 pyridine treated animals monkeys", "LBL": "0", "ID": "DDI-MedLine.d161.s6.p1", "DRUGA": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "349-392"], "DRUGB": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "467-510"]}
{"TEXT1": "behavioural observations consistent with positron emission tomography dopamine transporter data counts midbrain dopaminergic neurons striatal intensity measurements tyrosine hydroxylase immunoreactivity significantly higher phenyl 2 3 treated animals monkeys", "LBL": "0", "ID": "DDI-MedLine.d161.s6.p2", "DRUGA": ["3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "drug_n", "394-441"], "DRUGB": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "467-510"]}
{"TEXT1": "@DRUG$ treatment significant effect @DRUG$ induced norepinephrine locus coeruleus A7 noradrenaline cell groups", "LBL": "DDI-effect", "ID": "DDI-MedLine.d161.s7.p0", "DRUGA": ["3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "drug_n", "4-51"], "DRUGB": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "100-143"]}
{"TEXT1": "treated animals almost tyrosine hydroxylase positive norepinephrine found noradrenaline cell groups extent lower control values 3 pyridine monkeys", "LBL": "0", "ID": "DDI-MedLine.d161.s8.p0", "DRUGA": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "3-46"], "DRUGB": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "283-326"]}
{"TEXT1": "treated animals almost tyrosine hydroxylase positive norepinephrine found noradrenaline cell groups extent lower control values phenyl 2 3 monkeys", "LBL": "0", "ID": "DDI-MedLine.d161.s8.p1", "DRUGA": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "3-46"], "DRUGB": ["3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "drug_n", "328-375"]}
{"TEXT1": "phenyl 2 3 treated animals almost tyrosine hydroxylase positive norepinephrine found noradrenaline cell groups extent lower control values monkeys", "LBL": "DDI-effect", "ID": "DDI-MedLine.d161.s8.p2", "DRUGA": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "283-326"], "DRUGB": ["3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "drug_n", "328-375"]}
{"TEXT1": "data chronic treatment metabotropic glutamate receptor 5 antagonist @DRUG$ @DRUG$ dopaminergic noradrenergic cell groups human non primates", "LBL": "DDI-effect", "ID": "DDI-MedLine.d161.s9.p0", "DRUGA": ["3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine", "drug_n", "99-146"], "DRUGB": ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "drug_n", "171-214"]}
{"TEXT1": "@DRUG$", "LBL": "0", "ID": "DDI-MedLine.d143.s0.p0", "DRUGA": ["clopidogrel", "drug", "21-31"], "DRUGB": ["proton pump inhibitors", "group", "37-58"]}
{"TEXT1": "drug interaction @DRUG$ @DRUG$ subject study recent years", "LBL": "0", "ID": "DDI-MedLine.d143.s1.p0", "DRUGA": ["proton pump inhibitors", "group", "29-50"], "DRUGB": ["clopidogrel", "drug", "56-66"]}
{"TEXT1": "results effect @DRUG$ platelet reactivity clinical @DRUG$ treated patients reported literature", "LBL": "0", "ID": "DDI-MedLine.d143.s2.p0", "DRUGA": ["proton pump inhibitors", "group", "46-67"], "DRUGB": ["clopidogrel", "drug", "119-129"]}
{"TEXT1": "Concomitant use of @DRUG$ @DRUG$ found to decrease exposure clopidogrel's active metabolite increase platelet reactivity result inhibition omeprazole CYP2C19 cytochrome P450 enzyme", "LBL": "DDI-mechanism", "ID": "DDI-MedLine.d143.s3.p0", "DRUGA": ["omeprazole", "drug", "19-28"], "DRUGB": ["clopidogrel", "drug", "34-44"]}
{"TEXT1": "Concomitant use of @DRUG$ found to decrease exposure clopidogrel's active metabolite increase platelet reactivity result inhibition @DRUG$ CYP2C19 cytochrome P450 enzyme", "LBL": "0", "ID": "DDI-MedLine.d143.s3.p1", "DRUGA": ["omeprazole", "drug", "19-28"], "DRUGB": ["omeprazole", "drug", "203-212"]}
{"TEXT1": "Concomitant use of omeprazole @DRUG$ found to decrease exposure clopidogrel's active metabolite increase platelet reactivity result inhibition @DRUG$ CYP2C19 cytochrome P450 enzyme", "LBL": "0", "ID": "DDI-MedLine.d143.s3.p2", "DRUGA": ["clopidogrel", "drug", "34-44"], "DRUGB": ["omeprazole", "drug", "203-212"]}
{"TEXT1": "@DRUG$ much weaker effect pharmacokinetics platelet reactivity concomitant use", "LBL": "DDI-mechanism", "ID": "DDI-MedLine.d143.s4.p0", "DRUGA": ["Pantoprazole", "drug", "0-11"], "DRUGB": ["clopidogrel", "drug", "41-51"]}
{"TEXT1": "influence @DRUG$ used simultaneously @DRUG$ not investigated randomized studies", "LBL": "0", "ID": "DDI-MedLine.d143.s5.p0", "DRUGA": ["proton pump inhibitors", "group", "27-48"], "DRUGB": ["clopidogrel", "drug", "80-90"]}
{"TEXT1": "Regulatory agencies state combination @DRUG$ CYP2C19 inhibitors @DRUG$ esomeprazole", "LBL": "DDI-advise", "ID": "DDI-MedLine.d143.s6.p0", "DRUGA": ["clopidogrel", "drug", "50-60"], "DRUGB": ["omeprazole", "drug", "89-98"]}
{"TEXT1": "Regulatory agencies state combination @DRUG$ CYP2C19 inhibitors omeprazole @DRUG$", "LBL": "DDI-advise", "ID": "DDI-MedLine.d143.s6.p1", "DRUGA": ["clopidogrel", "drug", "50-60"], "DRUGB": ["esomeprazole", "drug", "104-115"]}
{"TEXT1": "Regulatory agencies state combination clopidogrel CYP2C19 inhibitors @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d143.s6.p2", "DRUGA": ["omeprazole", "drug", "89-98"], "DRUGB": ["esomeprazole", "drug", "104-115"]}
{"TEXT1": "date no conclusive evidence relevant interaction @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d143.s7.p0", "DRUGA": ["proton pump inhibitors", "group", "97-118"], "DRUGB": ["clopidogrel", "drug", "124-134"]}
{"TEXT1": "Effect @DRUG$ mediated CYP3A4 inhibition clinical pharmacokinetics @DRUG$ orally active histone deacetylase inhibitor", "LBL": "0", "ID": "DDI-MedLine.d185.s0.p0", "DRUGA": ["ketoconazole", "drug", "10-21"], "DRUGB": ["panobinostat", "drug", "82-93"]}
{"TEXT1": "Effect @DRUG$ mediated CYP3A4 inhibition clinical pharmacokinetics panobinostat orally active histone deacetylase inhibitor", "LBL": "0", "ID": "DDI-MedLine.d185.s0.p1", "DRUGA": ["ketoconazole", "drug", "10-21"], "DRUGB": ["LBH589", "drug", "96-101"]}
{"TEXT1": "Effect @DRUG$ mediated CYP3A4 inhibition clinical pharmacokinetics panobinostat orally active @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d185.s0.p2", "DRUGA": ["ketoconazole", "drug", "10-21"], "DRUGB": ["histone deacetylase inhibitor", "group", "122-150"]}
{"TEXT1": "Effect ketoconazole mediated CYP3A4 inhibition clinical pharmacokinetics @DRUG$ orally active histone deacetylase inhibitor", "LBL": "0", "ID": "DDI-MedLine.d185.s0.p3", "DRUGA": ["panobinostat", "drug", "82-93"], "DRUGB": ["LBH589", "drug", "96-101"]}
{"TEXT1": "Effect ketoconazole mediated CYP3A4 inhibition clinical pharmacokinetics @DRUG$ orally active @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d185.s0.p4", "DRUGA": ["panobinostat", "drug", "82-93"], "DRUGB": ["histone deacetylase inhibitor", "group", "122-150"]}
{"TEXT1": "Effect ketoconazole mediated CYP3A4 inhibition clinical pharmacokinetics panobinostat orally active @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d185.s0.p5", "DRUGA": ["LBH589", "drug", "96-101"], "DRUGB": ["histone deacetylase inhibitor", "group", "122-150"]}
{"TEXT1": "study evaluated effect potent CYP3A inhibitor @DRUG$ pharmacokinetics safety @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d185.s2.p0", "DRUGA": ["ketoconazole", "drug", "61-72"], "DRUGB": ["panobinostat", "drug", "113-124"]}
{"TEXT1": "day single @DRUG$ dose co administered @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d185.s5.p0", "DRUGA": ["panobinostat", "drug", "19-30"], "DRUGB": ["ketoconazole", "drug", "62-73"]}
{"TEXT1": "presence @DRUG$ fold increase AUC @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-MedLine.d185.s7.p0", "DRUGA": ["ketoconazole", "drug", "19-30"], "DRUGB": ["panobinostat", "drug", "92-103"]}
{"TEXT1": "@DRUG$ CYP3A inhibitors observed increase @DRUG$ PK parameters not considered relevant", "LBL": "0", "ID": "DDI-MedLine.d185.s12.p0", "DRUGA": ["panobinostat", "drug", "21-32"], "DRUGB": ["panobinostat", "drug", "96-107"]}
{"TEXT1": "Considering variability exposure following enzyme inhibition chronic @DRUG$ not studied CYP3A inhibitors close monitoring @DRUG$ related adverse events", "LBL": "0", "ID": "DDI-MedLine.d185.s13.p0", "DRUGA": ["panobinostat", "drug", "104-115"], "DRUGB": ["panobinostat", "drug", "176-187"]}
{"TEXT1": "Phase I trial @DRUG$ @DRUG$ patients evidence lenalidomide interaction", "LBL": "0", "ID": "DDI-MedLine.d211.s0.p0", "DRUGA": ["lenalidomide", "drug", "17-28"], "DRUGB": ["CCI-779", "drug", "34-40"]}
{"TEXT1": "Phase I trial @DRUG$ patients evidence @DRUG$ interaction", "LBL": "0", "ID": "DDI-MedLine.d211.s0.p1", "DRUGA": ["lenalidomide", "drug", "17-28"], "DRUGB": ["lenalidomide", "drug", "99-110"]}
{"TEXT1": "Phase I trial @DRUG$ patients evidence lenalidomide @DRUG$ interaction", "LBL": "0", "ID": "DDI-MedLine.d211.s0.p2", "DRUGA": ["lenalidomide", "drug", "17-28"], "DRUGB": ["CCI-779", "drug", "112-118"]}
{"TEXT1": "Phase I trial lenalidomide @DRUG$ patients evidence @DRUG$ interaction", "LBL": "0", "ID": "DDI-MedLine.d211.s0.p3", "DRUGA": ["CCI-779", "drug", "34-40"], "DRUGB": ["lenalidomide", "drug", "99-110"]}
{"TEXT1": "Phase I trial lenalidomide @DRUG$ patients evidence @DRUG$ interaction", "LBL": "0", "ID": "DDI-MedLine.d211.s0.p4", "DRUGA": ["CCI-779", "drug", "34-40"], "DRUGB": ["CCI-779", "drug", "112-118"]}
{"TEXT1": "Phase I trial lenalidomide patients evidence @DRUG$ @DRUG$ interaction", "LBL": "0", "ID": "DDI-MedLine.d211.s0.p5", "DRUGA": ["lenalidomide", "drug", "99-110"], "DRUGB": ["CCI-779", "drug", "112-118"]}
{"TEXT1": "preclinical combination @DRUG$ mTOR inhibitor @DRUG$ displayed in vitro represents novel MM", "LBL": "DDI-effect", "ID": "DDI-MedLine.d211.s2.p0", "DRUGA": ["lenalidomide", "drug", "31-42"], "DRUGB": ["CCI-779", "drug", "68-74"]}
{"TEXT1": "@DRUG$ better clopidogrel", "LBL": "0", "ID": "DDI-MedLine.d193.s0.p0", "DRUGA": ["Ticagrelor", "drug", "0-9"], "DRUGB": ["Brilinta", "brand", "12-19"]}
{"TEXT1": "@DRUG$ better @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d193.s0.p1", "DRUGA": ["Ticagrelor", "drug", "0-9"], "DRUGB": ["clopidogrel", "drug", "35-45"]}
{"TEXT1": "@DRUG$ better clopidogrel", "LBL": "0", "ID": "DDI-MedLine.d193.s0.p2", "DRUGA": ["Ticagrelor", "drug", "0-9"], "DRUGB": ["Plavix", "brand", "48-53"]}
{"TEXT1": "Ticagrelor better @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d193.s0.p3", "DRUGA": ["Brilinta", "brand", "12-19"], "DRUGB": ["clopidogrel", "drug", "35-45"]}
{"TEXT1": "Ticagrelor better clopidogrel", "LBL": "0", "ID": "DDI-MedLine.d193.s0.p4", "DRUGA": ["Brilinta", "brand", "12-19"], "DRUGB": ["Plavix", "brand", "48-53"]}
{"TEXT1": "Ticagrelor better @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d193.s0.p5", "DRUGA": ["clopidogrel", "drug", "35-45"], "DRUGB": ["Plavix", "brand", "48-53"]}
{"TEXT1": "FDA approved @DRUG$ oral antiplatelet drug use to rate thrombotic cardiovascular events patients acute coronary syndrome", "LBL": "0", "ID": "DDI-MedLine.d193.s1.p0", "DRUGA": ["ticagrelor", "drug", "21-30"], "DRUGB": ["Brilinta", "brand", "33-40"]}
{"TEXT1": "FDA approved @DRUG$ oral @DRUG$ use to rate thrombotic cardiovascular events patients acute coronary syndrome", "LBL": "0", "ID": "DDI-MedLine.d193.s1.p1", "DRUGA": ["ticagrelor", "drug", "21-30"], "DRUGB": ["antiplatelet drug", "group", "64-80"]}
{"TEXT1": "FDA approved @DRUG$ oral antiplatelet drug use @DRUG$ to rate thrombotic cardiovascular events patients acute coronary syndrome", "LBL": "DDI-effect", "ID": "DDI-MedLine.d193.s1.p2", "DRUGA": ["ticagrelor", "drug", "21-30"], "DRUGB": ["aspirin", "brand", "105-111"]}
{"TEXT1": "FDA approved ticagrelor oral @DRUG$ use to rate thrombotic cardiovascular events patients acute coronary syndrome", "LBL": "0", "ID": "DDI-MedLine.d193.s1.p3", "DRUGA": ["Brilinta", "brand", "33-40"], "DRUGB": ["antiplatelet drug", "group", "64-80"]}
{"TEXT1": "FDA approved ticagrelor oral antiplatelet drug use @DRUG$ to rate thrombotic cardiovascular events patients acute coronary syndrome", "LBL": "DDI-effect", "ID": "DDI-MedLine.d193.s1.p4", "DRUGA": ["Brilinta", "brand", "33-40"], "DRUGB": ["aspirin", "brand", "105-111"]}
{"TEXT1": "FDA approved ticagrelor oral @DRUG$ use @DRUG$ to rate thrombotic cardiovascular events patients acute coronary syndrome", "LBL": "0", "ID": "DDI-MedLine.d193.s1.p5", "DRUGA": ["antiplatelet drug", "group", "64-80"], "DRUGB": ["aspirin", "brand", "105-111"]}
{"TEXT1": "@DRUG$ prasugrel use", "LBL": "0", "ID": "DDI-MedLine.d193.s2.p0", "DRUGA": ["clopidogrel", "drug", "21-31"], "DRUGB": ["Plavix", "brand", "34-39"]}
{"TEXT1": "@DRUG$ @DRUG$ use", "LBL": "0", "ID": "DDI-MedLine.d193.s2.p1", "DRUGA": ["clopidogrel", "drug", "21-31"], "DRUGB": ["prasugrel", "drug", "46-54"]}
{"TEXT1": "@DRUG$ prasugrel use", "LBL": "0", "ID": "DDI-MedLine.d193.s2.p2", "DRUGA": ["clopidogrel", "drug", "21-31"], "DRUGB": ["Effient", "brand", "57-63"]}
{"TEXT1": "clopidogrel @DRUG$ use", "LBL": "0", "ID": "DDI-MedLine.d193.s2.p3", "DRUGA": ["Plavix", "brand", "34-39"], "DRUGB": ["prasugrel", "drug", "46-54"]}
{"TEXT1": "clopidogrel prasugrel use", "LBL": "0", "ID": "DDI-MedLine.d193.s2.p4", "DRUGA": ["Plavix", "brand", "34-39"], "DRUGB": ["Effient", "brand", "57-63"]}
{"TEXT1": "clopidogrel @DRUG$ use", "LBL": "0", "ID": "DDI-MedLine.d193.s2.p5", "DRUGA": ["prasugrel", "drug", "46-54"], "DRUGB": ["Effient", "brand", "57-63"]}
{"TEXT1": "Exposure to oral @DRUG$ unaffected @DRUG$ greatly increased ticlopidine", "LBL": "0", "ID": "DDI-MedLine.d216.s0.p0", "DRUGA": ["S-ketamine", "drug", "17-26"], "DRUGB": ["itraconazole", "drug", "45-56"]}
{"TEXT1": "Exposure to oral @DRUG$ unaffected itraconazole greatly increased @DRUG$", "LBL": "DDI-effect", "ID": "DDI-MedLine.d216.s0.p1", "DRUGA": ["S-ketamine", "drug", "17-26"], "DRUGB": ["ticlopidine", "drug", "83-93"]}
{"TEXT1": "Exposure to oral ketamine unaffected @DRUG$ greatly increased @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d216.s0.p2", "DRUGA": ["itraconazole", "drug", "45-56"], "DRUGB": ["ticlopidine", "drug", "83-93"]}
{"TEXT1": "study examined oral @DRUG$ cytochrome P450 2B6 inhibitor @DRUG$ CYP3A itraconazole", "LBL": "0", "ID": "DDI-MedLine.d216.s1.p0", "DRUGA": ["S-ketamine", "drug", "51-60"], "DRUGB": ["ticlopidine", "drug", "107-117"]}
{"TEXT1": "study examined oral @DRUG$ cytochrome P450 2B6 inhibitor ticlopidine CYP3A @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d216.s1.p1", "DRUGA": ["S-ketamine", "drug", "51-60"], "DRUGB": ["itraconazole", "drug", "143-154"]}
{"TEXT1": "study examined oral ketamine cytochrome P450 2B6 inhibitor @DRUG$ CYP3A @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d216.s1.p2", "DRUGA": ["ticlopidine", "drug", "107-117"], "DRUGB": ["itraconazole", "drug", "143-154"]}
{"TEXT1": "randomized blinded crossover study healthy volunteers ingested mg/kg @DRUG$ pretreatments oral @DRUG$ mg itraconazole placebo treatment periods intervals weeks", "LBL": "0", "ID": "DDI-MedLine.d216.s2.p0", "DRUGA": ["S-ketamine", "drug", "87-96"], "DRUGB": ["ticlopidine", "drug", "128-138"]}
{"TEXT1": "randomized blinded crossover study healthy volunteers ingested mg/kg @DRUG$ pretreatments oral ticlopidine mg @DRUG$ placebo treatment periods intervals weeks", "LBL": "0", "ID": "DDI-MedLine.d216.s2.p1", "DRUGA": ["S-ketamine", "drug", "87-96"], "DRUGB": ["itraconazole", "drug", "162-173"]}
{"TEXT1": "randomized blinded crossover study healthy volunteers ingested mg/kg ketamine pretreatments oral @DRUG$ mg @DRUG$ placebo treatment periods intervals weeks", "LBL": "0", "ID": "DDI-MedLine.d216.s2.p2", "DRUGA": ["ticlopidine", "drug", "128-138"], "DRUGB": ["itraconazole", "drug", "162-173"]}
{"TEXT1": "@DRUG$ treatment increased mean plasma concentration time infinity oral @DRUG$ fold itraconazole not ketamine", "LBL": "DDI-mechanism", "ID": "DDI-MedLine.d216.s3.p0", "DRUGA": ["Ticlopidine", "drug", "0-10"], "DRUGB": ["ketamine", "drug", "134-141"]}
{"TEXT1": "@DRUG$ treatment increased mean plasma concentration time infinity oral ketamine fold @DRUG$ not", "LBL": "0", "ID": "DDI-MedLine.d216.s3.p1", "DRUGA": ["Ticlopidine", "drug", "0-10"], "DRUGB": ["itraconazole", "drug", "164-175"]}
{"TEXT1": "@DRUG$ treatment increased mean plasma concentration time infinity oral ketamine fold itraconazole not @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d216.s3.p2", "DRUGA": ["Ticlopidine", "drug", "0-10"], "DRUGB": ["S-ketamine", "drug", "220-229"]}
{"TEXT1": "Ticlopidine treatment increased mean plasma concentration time infinity oral @DRUG$ fold @DRUG$ not ketamine", "LBL": "0", "ID": "DDI-MedLine.d216.s3.p3", "DRUGA": ["ketamine", "drug", "134-141"], "DRUGB": ["itraconazole", "drug", "164-175"]}
{"TEXT1": "Ticlopidine treatment increased mean plasma concentration time infinity oral @DRUG$ fold itraconazole not @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d216.s3.p4", "DRUGA": ["ketamine", "drug", "134-141"], "DRUGB": ["S-ketamine", "drug", "220-229"]}
{"TEXT1": "Ticlopidine treatment increased mean plasma concentration time infinity oral ketamine fold @DRUG$ not @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d216.s3.p5", "DRUGA": ["itraconazole", "drug", "164-175"], "DRUGB": ["S-ketamine", "drug", "220-229"]}
{"TEXT1": "ratio @DRUG$ @DRUG$ decreased ticlopidine 0 itraconazole phases compared placebo", "LBL": "0", "ID": "DDI-MedLine.d216.s4.p0", "DRUGA": ["norketamine", "drug_n", "13-23"], "DRUGB": ["ketamine", "drug", "39-46"]}
{"TEXT1": "ratio @DRUG$ ketamine decreased @DRUG$ 0 itraconazole phases compared placebo", "LBL": "0", "ID": "DDI-MedLine.d216.s4.p1", "DRUGA": ["norketamine", "drug_n", "13-23"], "DRUGB": ["ticlopidine", "drug", "94-104"]}
{"TEXT1": "ratio @DRUG$ ketamine decreased ticlopidine 0 @DRUG$ phases compared placebo", "LBL": "0", "ID": "DDI-MedLine.d216.s4.p2", "DRUGA": ["norketamine", "drug_n", "13-23"], "DRUGB": ["itraconazole", "drug", "125-136"]}
{"TEXT1": "ratio norketamine @DRUG$ decreased @DRUG$ 0 itraconazole phases compared placebo", "LBL": "0", "ID": "DDI-MedLine.d216.s4.p3", "DRUGA": ["ketamine", "drug", "39-46"], "DRUGB": ["ticlopidine", "drug", "94-104"]}
{"TEXT1": "ratio norketamine @DRUG$ decreased ticlopidine 0 @DRUG$ phases compared placebo", "LBL": "0", "ID": "DDI-MedLine.d216.s4.p4", "DRUGA": ["ketamine", "drug", "39-46"], "DRUGB": ["itraconazole", "drug", "125-136"]}
{"TEXT1": "ratio norketamine ketamine decreased @DRUG$ 0 @DRUG$ phases compared placebo", "LBL": "0", "ID": "DDI-MedLine.d216.s4.p5", "DRUGA": ["ticlopidine", "drug", "94-104"], "DRUGB": ["itraconazole", "drug", "125-136"]}
{"TEXT1": "@DRUG$ @DRUG$ phases effect time drowsiness significantly higher placebo phase", "LBL": "0", "ID": "DDI-MedLine.d216.s5.p0", "DRUGA": ["ticlopidine", "drug", "7-17"], "DRUGB": ["itraconazole", "drug", "23-34"]}
{"TEXT1": "findings suggest dosage @DRUG$ reduced patients receiving @DRUG$", "LBL": "DDI-advise", "ID": "DDI-MedLine.d216.s6.p0", "DRUGA": ["S-ketamine", "drug", "40-49"], "DRUGB": ["ticlopidine", "drug", "91-101"]}
{"TEXT1": "Improved parathyroid hormone control @DRUG$ associated with reduction @DRUG$ requirement patients", "LBL": "0", "ID": "DDI-MedLine.d166.s0.p0", "DRUGA": ["cinacalcet", "drug", "40-49"], "DRUGB": ["darbepoetin", "drug", "83-93"]}
{"TEXT1": "Uncontrolled hy causes bone marrow fibrosis leading @DRUG$ resistance", "LBL": "0", "ID": "DDI-MedLine.d166.s1.p0", "DRUGA": ["erythropoietin", "drug", "75-88"], "DRUGB": ["EPO", "drug", "91-93"]}
{"TEXT1": "Medical treatment @DRUG$ effective reducing plasma parathyroid hormone levels effect @DRUG$ unknown", "LBL": "0", "ID": "DDI-MedLine.d166.s2.p0", "DRUGA": ["cinacalcet", "drug", "23-32"], "DRUGB": ["darbepoetin", "drug", "118-128"]}
{"TEXT1": "primary objective study to difference @DRUG$ responsiveness 12 months @DRUG$ therapy", "LBL": "0", "ID": "DDI-MedLine.d166.s6.p0", "DRUGA": ["darbepoetin", "drug", "70-80"], "DRUGB": ["cinacalcet", "drug", "127-136"]}
{"TEXT1": "Reduction @DRUG$ associated with decrease @DRUG$ requirement", "LBL": "DDI-effect", "ID": "DDI-MedLine.d166.s17.p0", "DRUGA": ["cinacalcet", "drug", "20-29"], "DRUGB": ["darbepoetin", "drug", "64-74"]}
{"TEXT1": "@DRUG$ @DRUG$ interaction associated gastrointestinal bleeding risk", "LBL": "0", "ID": "DDI-MedLine.d218.s0.p0", "DRUGA": ["Antidepressant", "group", "0-13"], "DRUGB": ["warfarin", "drug", "15-22"]}
{"TEXT1": "to evaluate initiation @DRUG$ increases risk hospitalization gastrointestinal bleeding @DRUG$ users", "LBL": "0", "ID": "DDI-MedLine.d218.s3.p0", "DRUGA": ["antidepressant", "group", "47-60"], "DRUGB": ["warfarin", "drug", "133-140"]}
{"TEXT1": "total @DRUG$ users contributed 370 person years of use @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d218.s5.p0", "DRUGA": ["warfarin", "drug", "18-25"], "DRUGB": ["warfarin", "drug", "69-76"]}
{"TEXT1": "@DRUG$ users increased odds ratio gastrointestinal bleeding initiation @DRUG$ 1 CI fluoxetine 63 paroxetine 27 amitriptyline", "LBL": "DDI-effect", "ID": "DDI-MedLine.d218.s8.p0", "DRUGA": ["Warfarin", "drug", "0-7"], "DRUGB": ["citalopram", "drug", "91-100"]}
{"TEXT1": "@DRUG$ users increased odds ratio gastrointestinal bleeding initiation citalopram 1 CI @DRUG$ 63 paroxetine 27 amitriptyline", "LBL": "DDI-effect", "ID": "DDI-MedLine.d218.s8.p1", "DRUGA": ["Warfarin", "drug", "0-7"], "DRUGB": ["fluoxetine", "drug", "139-148"]}
{"TEXT1": "@DRUG$ users increased odds ratio gastrointestinal bleeding initiation citalopram 1 CI fluoxetine 63 @DRUG$ 27 amitriptyline", "LBL": "DDI-effect", "ID": "DDI-MedLine.d218.s8.p2", "DRUGA": ["Warfarin", "drug", "0-7"], "DRUGB": ["paroxetine", "drug", "187-196"]}
{"TEXT1": "@DRUG$ users increased odds ratio gastrointestinal bleeding initiation citalopram 1 CI fluoxetine 63 paroxetine 27 @DRUG$", "LBL": "DDI-effect", "ID": "DDI-MedLine.d218.s8.p3", "DRUGA": ["Warfarin", "drug", "0-7"], "DRUGB": ["amitriptyline", "drug", "235-247"]}
{"TEXT1": "Warfarin users increased odds ratio gastrointestinal bleeding initiation @DRUG$ 1 CI @DRUG$ 63 paroxetine 27 amitriptyline", "LBL": "0", "ID": "DDI-MedLine.d218.s8.p4", "DRUGA": ["citalopram", "drug", "91-100"], "DRUGB": ["fluoxetine", "drug", "139-148"]}
{"TEXT1": "Warfarin users increased odds ratio gastrointestinal bleeding initiation @DRUG$ 1 CI fluoxetine 63 @DRUG$ 27 amitriptyline", "LBL": "0", "ID": "DDI-MedLine.d218.s8.p5", "DRUGA": ["citalopram", "drug", "91-100"], "DRUGB": ["paroxetine", "drug", "187-196"]}
{"TEXT1": "Warfarin users increased odds ratio gastrointestinal bleeding initiation @DRUG$ 1 CI fluoxetine 63 paroxetine 27 @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d218.s8.p6", "DRUGA": ["citalopram", "drug", "91-100"], "DRUGB": ["amitriptyline", "drug", "235-247"]}
{"TEXT1": "Warfarin users increased odds ratio gastrointestinal bleeding initiation citalopram 1 CI @DRUG$ 63 @DRUG$ 27 amitriptyline", "LBL": "0", "ID": "DDI-MedLine.d218.s8.p7", "DRUGA": ["fluoxetine", "drug", "139-148"], "DRUGB": ["paroxetine", "drug", "187-196"]}
{"TEXT1": "Warfarin users increased odds ratio gastrointestinal bleeding initiation citalopram 1 CI @DRUG$ 63 paroxetine 27 @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d218.s8.p8", "DRUGA": ["fluoxetine", "drug", "139-148"], "DRUGB": ["amitriptyline", "drug", "235-247"]}
{"TEXT1": "Warfarin users increased odds ratio gastrointestinal bleeding initiation citalopram 1 CI fluoxetine 63 @DRUG$ 27 @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d218.s8.p9", "DRUGA": ["paroxetine", "drug", "187-196"], "DRUGB": ["amitriptyline", "drug", "235-247"]}
{"TEXT1": "@DRUG$ not to @DRUG$ increased risk bleeding GI bleeding 1 75 CI 30", "LBL": "DDI-effect", "ID": "DDI-MedLine.d218.s9.p0", "DRUGA": ["mirtazapine", "drug", "5-15"], "DRUGB": ["warfarin", "drug", "57-64"]}
{"TEXT1": "@DRUG$ users initiated @DRUG$ fluoxetine paroxetine amitriptyline mirtazapine increased risk hospitalization gastrointestinal bleeding", "LBL": "DDI-effect", "ID": "DDI-MedLine.d218.s10.p0", "DRUGA": ["Warfarin", "drug", "0-7"], "DRUGB": ["citalopram", "drug", "29-38"]}
{"TEXT1": "@DRUG$ users initiated citalopram @DRUG$ paroxetine amitriptyline mirtazapine increased risk hospitalization gastrointestinal bleeding", "LBL": "DDI-effect", "ID": "DDI-MedLine.d218.s10.p1", "DRUGA": ["Warfarin", "drug", "0-7"], "DRUGB": ["fluoxetine", "drug", "41-50"]}
{"TEXT1": "@DRUG$ users initiated citalopram fluoxetine @DRUG$ amitriptyline mirtazapine increased risk hospitalization gastrointestinal bleeding", "LBL": "DDI-effect", "ID": "DDI-MedLine.d218.s10.p2", "DRUGA": ["Warfarin", "drug", "0-7"], "DRUGB": ["paroxetine", "drug", "53-62"]}
{"TEXT1": "@DRUG$ users initiated citalopram fluoxetine paroxetine @DRUG$ mirtazapine increased risk hospitalization gastrointestinal bleeding", "LBL": "DDI-effect", "ID": "DDI-MedLine.d218.s10.p3", "DRUGA": ["Warfarin", "drug", "0-7"], "DRUGB": ["amitriptyline", "drug", "65-77"]}
{"TEXT1": "@DRUG$ users initiated citalopram fluoxetine paroxetine amitriptyline @DRUG$ increased risk hospitalization gastrointestinal bleeding", "LBL": "DDI-effect", "ID": "DDI-MedLine.d218.s10.p4", "DRUGA": ["Warfarin", "drug", "0-7"], "DRUGB": ["mirtazapine", "drug", "83-93"]}
{"TEXT1": "Warfarin users initiated @DRUG$ @DRUG$ paroxetine amitriptyline mirtazapine increased risk hospitalization gastrointestinal bleeding", "LBL": "0", "ID": "DDI-MedLine.d218.s10.p5", "DRUGA": ["citalopram", "drug", "29-38"], "DRUGB": ["fluoxetine", "drug", "41-50"]}
{"TEXT1": "Warfarin users initiated @DRUG$ fluoxetine @DRUG$ amitriptyline mirtazapine increased risk hospitalization gastrointestinal bleeding", "LBL": "0", "ID": "DDI-MedLine.d218.s10.p6", "DRUGA": ["citalopram", "drug", "29-38"], "DRUGB": ["paroxetine", "drug", "53-62"]}
{"TEXT1": "Warfarin users initiated @DRUG$ fluoxetine paroxetine @DRUG$ mirtazapine increased risk hospitalization gastrointestinal bleeding", "LBL": "0", "ID": "DDI-MedLine.d218.s10.p7", "DRUGA": ["citalopram", "drug", "29-38"], "DRUGB": ["amitriptyline", "drug", "65-77"]}
{"TEXT1": "Warfarin users initiated @DRUG$ fluoxetine paroxetine amitriptyline @DRUG$ increased risk hospitalization gastrointestinal bleeding", "LBL": "0", "ID": "DDI-MedLine.d218.s10.p8", "DRUGA": ["citalopram", "drug", "29-38"], "DRUGB": ["mirtazapine", "drug", "83-93"]}
{"TEXT1": "Warfarin users initiated citalopram @DRUG$ @DRUG$ amitriptyline mirtazapine increased risk hospitalization gastrointestinal bleeding", "LBL": "0", "ID": "DDI-MedLine.d218.s10.p9", "DRUGA": ["fluoxetine", "drug", "41-50"], "DRUGB": ["paroxetine", "drug", "53-62"]}
{"TEXT1": "Warfarin users initiated citalopram @DRUG$ paroxetine @DRUG$ mirtazapine increased risk hospitalization gastrointestinal bleeding", "LBL": "0", "ID": "DDI-MedLine.d218.s10.p10", "DRUGA": ["fluoxetine", "drug", "41-50"], "DRUGB": ["amitriptyline", "drug", "65-77"]}
{"TEXT1": "Warfarin users initiated citalopram @DRUG$ paroxetine amitriptyline @DRUG$ increased risk hospitalization gastrointestinal bleeding", "LBL": "0", "ID": "DDI-MedLine.d218.s10.p11", "DRUGA": ["fluoxetine", "drug", "41-50"], "DRUGB": ["mirtazapine", "drug", "83-93"]}
{"TEXT1": "Warfarin users initiated citalopram fluoxetine @DRUG$ @DRUG$ mirtazapine increased risk hospitalization gastrointestinal bleeding", "LBL": "0", "ID": "DDI-MedLine.d218.s10.p12", "DRUGA": ["paroxetine", "drug", "53-62"], "DRUGB": ["amitriptyline", "drug", "65-77"]}
{"TEXT1": "Warfarin users initiated citalopram fluoxetine @DRUG$ amitriptyline @DRUG$ increased risk hospitalization gastrointestinal bleeding", "LBL": "0", "ID": "DDI-MedLine.d218.s10.p13", "DRUGA": ["paroxetine", "drug", "53-62"], "DRUGB": ["mirtazapine", "drug", "83-93"]}
{"TEXT1": "Warfarin users initiated citalopram fluoxetine paroxetine @DRUG$ @DRUG$ increased risk hospitalization gastrointestinal bleeding", "LBL": "0", "ID": "DDI-MedLine.d218.s10.p14", "DRUGA": ["amitriptyline", "drug", "65-77"], "DRUGB": ["mirtazapine", "drug", "83-93"]}
{"TEXT1": "Enhancement humoral immune responses Newcastle disease @DRUG$ oral administration @DRUG$ chickens", "LBL": "0", "ID": "DDI-MedLine.d154.s0.p0", "DRUGA": ["avian influenza vaccines", "group", "77-100"], "DRUGB": ["ginseng stem-and-leaf saponins", "drug_n", "128-157"]}
{"TEXT1": "objective study to evaluate effect oral administration @DRUG$ humoral immune responses chickens AI vaccines", "LBL": "0", "ID": "DDI-MedLine.d154.s2.p0", "DRUGA": ["ginseng stem-and-leaf saponins", "drug_n", "81-110"], "DRUGB": ["GSLS", "drug_n", "113-116"]}
{"TEXT1": "objective study to evaluate effect oral administration @DRUG$ humoral immune responses chickens @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d154.s2.p1", "DRUGA": ["ginseng stem-and-leaf saponins", "drug_n", "81-110"], "DRUGB": ["inactivated ND vaccines", "drug", "166-179;188-195"]}
{"TEXT1": "objective study to evaluate effect oral administration @DRUG$ humoral immune responses chickens @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d154.s2.p2", "DRUGA": ["ginseng stem-and-leaf saponins", "drug_n", "81-110"], "DRUGB": ["inactivated AI vaccines", "drug", "166-176;185-186;188-195"]}
{"TEXT1": "objective study to evaluate effect oral administration ginseng stem leaf saponins humoral immune responses chickens @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d154.s2.p3", "DRUGA": ["GSLS", "drug_n", "113-116"], "DRUGB": ["inactivated ND vaccines", "drug", "166-179;188-195"]}
{"TEXT1": "objective study to evaluate effect oral administration ginseng stem leaf saponins humoral immune responses chickens @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d154.s2.p4", "DRUGA": ["GSLS", "drug_n", "113-116"], "DRUGB": ["inactivated AI vaccines", "drug", "166-176;185-186;188-195"]}
{"TEXT1": "objective study to evaluate effect oral administration ginseng stem leaf saponins humoral immune responses chickens", "LBL": "0", "ID": "DDI-MedLine.d154.s2.p5", "DRUGA": ["inactivated ND vaccines", "drug", "166-179;188-195"], "DRUGB": ["inactivated AI vaccines", "drug", "166-176;185-186;188-195"]}
{"TEXT1": "experiment oral administration @DRUG$ dose mg/kg BW immune response chickens injected @DRUG$ evaluated", "LBL": "0", "ID": "DDI-MedLine.d154.s3.p0", "DRUGA": ["GSLS", "drug_n", "40-43"], "DRUGB": ["inactivated ND vaccine", "drug", "145-166"]}
{"TEXT1": "experiment same regimen @DRUG$ administered chickens inoculated @DRUG$ enhanced serum antibody response AI vaccination observed", "LBL": "DDI-effect", "ID": "DDI-MedLine.d154.s5.p0", "DRUGA": ["GSLS", "drug_n", "37-40"], "DRUGB": ["inactivated AI vaccines", "drug", "87-109"]}
{"TEXT1": "Considering safety @DRUG$ no adverse effect found experiments @DRUG$ promising oral adjuvant to immunization poultry", "LBL": "0", "ID": "DDI-MedLine.d154.s6.p0", "DRUGA": ["GSLS", "drug_n", "26-29"], "DRUGB": ["GSLS", "drug_n", "96-99"]}
{"TEXT1": "@DRUG$ not inhibit absorption milligrams @DRUG$ doses 800 women", "LBL": "0", "ID": "DDI-MedLine.d169.s0.p0", "DRUGA": ["Calcium", "drug", "0-6"], "DRUGB": ["nonheme iron", "drug", "59-65;75-78"]}
{"TEXT1": "@DRUG$ not inhibit absorption milligrams @DRUG$ doses 800 women", "LBL": "0", "ID": "DDI-MedLine.d169.s0.p1", "DRUGA": ["Calcium", "drug", "0-6"], "DRUGB": ["heme iron", "drug", "70-78"]}
{"TEXT1": "Calcium not inhibit absorption milligrams doses 800 women", "LBL": "0", "ID": "DDI-MedLine.d169.s0.p2", "DRUGA": ["nonheme iron", "drug", "59-65;75-78"], "DRUGB": ["heme iron", "drug", "70-78"]}
{"TEXT1": "@DRUG$ only known component diet affect absorption @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-MedLine.d169.s1.p0", "DRUGA": ["Calcium", "drug", "0-6"], "DRUGB": ["nonheme iron", "drug", "83-89;100-103"]}
{"TEXT1": "@DRUG$ only known component diet affect absorption @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-MedLine.d169.s1.p1", "DRUGA": ["Calcium", "drug", "0-6"], "DRUGB": ["heme iron", "drug", "95-103"]}
{"TEXT1": "Calcium only known component diet affect absorption", "LBL": "0", "ID": "DDI-MedLine.d169.s1.p2", "DRUGA": ["nonheme iron", "drug", "83-89;100-103"], "DRUGB": ["heme iron", "drug", "95-103"]}
{"TEXT1": "evidence @DRUG$ effect @DRUG$ studies not isolate calcium dietary components detected single meal", "LBL": "DDI-mechanism", "ID": "DDI-MedLine.d169.s2.p0", "DRUGA": ["calcium", "drug", "28-34"], "DRUGB": ["iron", "drug", "46-49"]}
{"TEXT1": "evidence @DRUG$ effect iron absorption studies not isolate @DRUG$ dietary components detected single meal", "LBL": "0", "ID": "DDI-MedLine.d169.s2.p1", "DRUGA": ["calcium", "drug", "28-34"], "DRUGB": ["calcium", "drug", "123-129"]}
{"TEXT1": "evidence calcium effect @DRUG$ studies not isolate @DRUG$ dietary components detected single meal", "LBL": "0", "ID": "DDI-MedLine.d169.s2.p2", "DRUGA": ["iron", "drug", "46-49"], "DRUGB": ["calcium", "drug", "123-129"]}
{"TEXT1": "objective to establish potential effects @DRUG$ absorption @DRUG$ dose response effect absence meal", "LBL": "0", "ID": "DDI-MedLine.d169.s3.p0", "DRUGA": ["calcium", "drug", "52-58"], "DRUGB": ["nonheme iron", "drug", "77-83;94-97"]}
{"TEXT1": "objective to establish potential effects @DRUG$ absorption @DRUG$ dose response effect absence meal", "LBL": "0", "ID": "DDI-MedLine.d169.s3.p1", "DRUGA": ["calcium", "drug", "52-58"], "DRUGB": ["heme iron", "drug", "89-97"]}
{"TEXT1": "objective to establish potential effects calcium absorption dose response effect absence meal", "LBL": "0", "ID": "DDI-MedLine.d169.s3.p2", "DRUGA": ["nonheme iron", "drug", "77-83;94-97"], "DRUGB": ["heme iron", "drug", "89-97"]}
{"TEXT1": "evaluated effects @DRUG$ doses 200 1500 absorption @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d169.s5.p0", "DRUGA": ["calcium", "drug", "28-34"], "DRUGB": ["nonheme iron", "drug", "88-99"]}
{"TEXT1": "evaluated effects @DRUG$ doses 200 1500 absorption iron", "LBL": "0", "ID": "DDI-MedLine.d169.s5.p1", "DRUGA": ["calcium", "drug", "28-34"], "DRUGB": ["ferrous sulfate", "drug", "105-119"]}
{"TEXT1": "evaluated effects calcium doses 200 1500 absorption @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d169.s5.p2", "DRUGA": ["nonheme iron", "drug", "88-99"], "DRUGB": ["ferrous sulfate", "drug", "105-119"]}
{"TEXT1": "evaluated effects @DRUG$ doses 200 800 absorption @DRUG$ concentrated RBC", "LBL": "0", "ID": "DDI-MedLine.d169.s6.p0", "DRUGA": ["calcium", "drug", "33-39"], "DRUGB": ["heme iron", "drug", "92-100"]}
{"TEXT1": "@DRUG$ administered @DRUG$ studies minerals ingested empty stomach", "LBL": "0", "ID": "DDI-MedLine.d169.s7.p0", "DRUGA": ["Calcium", "drug", "0-6"], "DRUGB": ["calcium chloride", "drug", "28-43"]}
{"TEXT1": "@DRUG$ administered calcium chloride studies @DRUG$ ingested empty stomach", "LBL": "0", "ID": "DDI-MedLine.d169.s7.p1", "DRUGA": ["Calcium", "drug", "0-6"], "DRUGB": ["minerals", "group", "64-71"]}
{"TEXT1": "Calcium administered @DRUG$ studies @DRUG$ ingested empty stomach", "LBL": "0", "ID": "DDI-MedLine.d169.s7.p2", "DRUGA": ["calcium chloride", "drug", "28-43"], "DRUGB": ["minerals", "group", "64-71"]}
{"TEXT1": "@DRUG$ doses mg diminished @DRUG$ average", "LBL": "DDI-mechanism", "ID": "DDI-MedLine.d169.s8.p0", "DRUGA": ["Calcium", "drug", "0-6"], "DRUGB": ["nonheme iron", "drug", "35-46"]}
{"TEXT1": "@DRUG$ 800 mg diminished absorption @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-MedLine.d169.s9.p0", "DRUGA": ["calcium", "drug", "2-8"], "DRUGB": ["heme iron", "drug", "55-63"]}
{"TEXT1": "conclusion isolated effect @DRUG$ absorption iron mg iron provided @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-MedLine.d169.s10.p0", "DRUGA": ["calcium", "drug", "53-59"], "DRUGB": ["nonheme iron", "drug", "117-123;157-160"]}
{"TEXT1": "conclusion isolated effect @DRUG$ absorption iron mg iron provided @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-MedLine.d169.s10.p1", "DRUGA": ["calcium", "drug", "53-59"], "DRUGB": ["heme iron", "drug", "142-145;157-160"]}
{"TEXT1": "conclusion isolated effect calcium absorption iron mg iron provided", "LBL": "0", "ID": "DDI-MedLine.d169.s10.p2", "DRUGA": ["nonheme iron", "drug", "117-123;157-160"], "DRUGB": ["heme iron", "drug", "142-145;157-160"]}
{"TEXT1": "@DRUG$ sensitization conditioned place preference adolescent male female rats treated with @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d184.s0.p0", "DRUGA": ["Amphetamine", "drug", "0-10"], "DRUGB": ["quinpirole", "drug_n", "128-137"]}
{"TEXT1": "objective to effects neonatal @DRUG$ treatment @DRUG$ adolescent rats using sensitization conditioned place preference procedures", "LBL": "0", "ID": "DDI-MedLine.d184.s2.p0", "DRUGA": ["quinpirole", "drug_n", "53-62"], "DRUGB": ["amphetamine", "drug", "88-98"]}
{"TEXT1": "female rats neonatal @DRUG$ treatment enhanced @DRUG$ sensitization compared quinpirole free controls amphetamine", "LBL": "DDI-effect", "ID": "DDI-MedLine.d184.s5.p0", "DRUGA": ["quinpirole", "drug_n", "25-34"], "DRUGB": ["amphetamine", "drug", "55-65"]}
{"TEXT1": "female rats neonatal @DRUG$ treatment enhanced amphetamine sensitization compared @DRUG$ free controls", "LBL": "0", "ID": "DDI-MedLine.d184.s5.p1", "DRUGA": ["quinpirole", "drug_n", "25-34"], "DRUGB": ["quinpirole", "drug_n", "105-114"]}
{"TEXT1": "female rats neonatal @DRUG$ treatment enhanced amphetamine sensitization compared quinpirole free controls @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d184.s5.p2", "DRUGA": ["quinpirole", "drug_n", "25-34"], "DRUGB": ["amphetamine", "drug", "144-154"]}
{"TEXT1": "female rats neonatal quinpirole treatment enhanced @DRUG$ sensitization compared @DRUG$ free controls amphetamine", "LBL": "0", "ID": "DDI-MedLine.d184.s5.p3", "DRUGA": ["amphetamine", "drug", "55-65"], "DRUGB": ["quinpirole", "drug_n", "105-114"]}
{"TEXT1": "female rats neonatal quinpirole treatment enhanced @DRUG$ sensitization compared free controls @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d184.s5.p4", "DRUGA": ["amphetamine", "drug", "55-65"], "DRUGB": ["amphetamine", "drug", "144-154"]}
{"TEXT1": "female rats neonatal quinpirole treatment enhanced amphetamine sensitization compared @DRUG$ free controls @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d184.s5.p5", "DRUGA": ["quinpirole", "drug_n", "105-114"], "DRUGB": ["amphetamine", "drug", "144-154"]}
{"TEXT1": "Male rats sensitization @DRUG$ muted compared female unaffected neonatal @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d184.s6.p0", "DRUGA": ["amphetamine", "drug", "40-50"], "DRUGB": ["quinpirole", "drug_n", "136-145"]}
{"TEXT1": "Rats neonatal @DRUG$ enhanced time spent @DRUG$ paired context compared quinpirole free controls conditioned amphetamine only female more drug saline", "LBL": "0", "ID": "DDI-MedLine.d184.s8.p0", "DRUGA": ["quinpirole", "drug_n", "27-36"], "DRUGB": ["amphetamine", "drug", "65-75"]}
{"TEXT1": "Rats neonatal @DRUG$ enhanced time spent amphetamine paired context compared @DRUG$ free controls conditioned only female more drug saline", "LBL": "0", "ID": "DDI-MedLine.d184.s8.p1", "DRUGA": ["quinpirole", "drug_n", "27-36"], "DRUGB": ["quinpirole", "drug_n", "106-115"]}
{"TEXT1": "Rats neonatal @DRUG$ enhanced time spent amphetamine paired context compared quinpirole free controls conditioned @DRUG$ only female more drug saline", "LBL": "0", "ID": "DDI-MedLine.d184.s8.p2", "DRUGA": ["quinpirole", "drug_n", "27-36"], "DRUGB": ["amphetamine", "drug", "148-158"]}
{"TEXT1": "Rats neonatal @DRUG$ enhanced time spent amphetamine paired context compared quinpirole free controls conditioned only female @DRUG$ more drug saline", "LBL": "0", "ID": "DDI-MedLine.d184.s8.p3", "DRUGA": ["quinpirole", "drug_n", "27-36"], "DRUGB": ["amphetamine", "drug", "203-213"]}
{"TEXT1": "Rats neonatal quinpirole enhanced time spent @DRUG$ paired context compared @DRUG$ free controls conditioned amphetamine only female more drug saline", "LBL": "0", "ID": "DDI-MedLine.d184.s8.p4", "DRUGA": ["amphetamine", "drug", "65-75"], "DRUGB": ["quinpirole", "drug_n", "106-115"]}
{"TEXT1": "Rats neonatal quinpirole enhanced time spent @DRUG$ paired context compared free controls conditioned @DRUG$ only female amphetamine more drug saline", "LBL": "0", "ID": "DDI-MedLine.d184.s8.p5", "DRUGA": ["amphetamine", "drug", "65-75"], "DRUGB": ["amphetamine", "drug", "148-158"]}
{"TEXT1": "Rats neonatal quinpirole enhanced time spent @DRUG$ paired context compared free controls conditioned amphetamine only female @DRUG$ more drug saline", "LBL": "0", "ID": "DDI-MedLine.d184.s8.p6", "DRUGA": ["amphetamine", "drug", "65-75"], "DRUGB": ["amphetamine", "drug", "203-213"]}
{"TEXT1": "Rats neonatal quinpirole enhanced time spent amphetamine paired context compared @DRUG$ free controls conditioned @DRUG$ only female more drug saline", "LBL": "0", "ID": "DDI-MedLine.d184.s8.p7", "DRUGA": ["quinpirole", "drug_n", "106-115"], "DRUGB": ["amphetamine", "drug", "148-158"]}
{"TEXT1": "Rats neonatal quinpirole enhanced time spent amphetamine paired context compared @DRUG$ free controls conditioned only female @DRUG$ more drug saline", "LBL": "0", "ID": "DDI-MedLine.d184.s8.p8", "DRUGA": ["quinpirole", "drug_n", "106-115"], "DRUGB": ["amphetamine", "drug", "203-213"]}
{"TEXT1": "Rats neonatal quinpirole enhanced time spent amphetamine paired context compared free controls conditioned @DRUG$ only female @DRUG$ more drug saline", "LBL": "0", "ID": "DDI-MedLine.d184.s8.p9", "DRUGA": ["amphetamine", "drug", "148-158"], "DRUGB": ["amphetamine", "drug", "203-213"]}
{"TEXT1": "In vitro activity @DRUG$ combined @DRUG$ clinical", "LBL": "0", "ID": "DDI-MedLine.d163.s0.p0", "DRUGA": ["minocycline", "drug", "21-31"], "DRUGB": ["fosfomycin", "drug", "47-56"]}
{"TEXT1": "In vitro activity @DRUG$ combined fosfomycin clinical @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d163.s0.p1", "DRUGA": ["minocycline", "drug", "21-31"], "DRUGB": ["methicillin", "drug", "87-97"]}
{"TEXT1": "In vitro activity minocycline combined @DRUG$ clinical @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d163.s0.p2", "DRUGA": ["fosfomycin", "drug", "47-56"], "DRUGB": ["methicillin", "drug", "87-97"]}
{"TEXT1": "study aimed to evaluate in vitro activity @DRUG$ combined @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d163.s1.p0", "DRUGA": ["minocycline", "drug", "54-64"], "DRUGB": ["fosfomycin", "drug", "80-89"]}
{"TEXT1": "study aimed to evaluate in vitro activity @DRUG$ combined fosfomycin @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d163.s1.p1", "DRUGA": ["minocycline", "drug", "54-64"], "DRUGB": ["methicillin", "drug", "111-121"]}
{"TEXT1": "study aimed to evaluate in vitro activity minocycline combined @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d163.s1.p2", "DRUGA": ["fosfomycin", "drug", "80-89"], "DRUGB": ["methicillin", "drug", "111-121"]}
{"TEXT1": "susceptibility results @DRUG$ @DRUG$ interpreted according relevant criteria", "LBL": "0", "ID": "DDI-MedLine.d163.s4.p0", "DRUGA": ["minocycline", "drug", "31-41"], "DRUGB": ["fosfomycin", "drug", "47-56"]}
{"TEXT1": "combination @DRUG$ @DRUG$ synergistic MRSA", "LBL": "DDI-effect", "ID": "DDI-MedLine.d163.s7.p0", "DRUGA": ["minocycline", "drug", "19-29"], "DRUGB": ["fosfomycin", "drug", "35-44"]}
{"TEXT1": "@DRUG$ enhances @DRUG$ mediated surface HER2 expression", "LBL": "DDI-effect", "ID": "DDI-MedLine.d164.s0.p0", "DRUGA": ["Lapatinib", "drug", "0-8"], "DRUGB": ["herceptin", "brand", "19-27"]}
{"TEXT1": "reported @DRUG$ combined @DRUG$ improved rate compared lapatinib alone patients Herceptin refractory mechanism to effect relating synergism two", "LBL": "DDI-effect", "ID": "DDI-MedLine.d164.s1.p0", "DRUGA": ["lapatinib", "drug", "41-49"], "DRUGB": ["Herceptin", "brand", "65-73"]}
{"TEXT1": "reported @DRUG$ combined Herceptin improved rate compared @DRUG$ alone patients refractory mechanism to effect relating synergism two", "LBL": "0", "ID": "DDI-MedLine.d164.s1.p1", "DRUGA": ["lapatinib", "drug", "41-49"], "DRUGB": ["lapatinib", "drug", "133-141"]}
{"TEXT1": "reported @DRUG$ combined Herceptin improved rate compared lapatinib alone patients @DRUG$ refractory mechanism to effect relating synergism two", "LBL": "0", "ID": "DDI-MedLine.d164.s1.p2", "DRUGA": ["lapatinib", "drug", "41-49"], "DRUGB": ["Herceptin", "brand", "167-175"]}
{"TEXT1": "reported lapatinib combined @DRUG$ improved rate compared @DRUG$ alone patients Herceptin refractory mechanism to effect relating synergism two", "LBL": "0", "ID": "DDI-MedLine.d164.s1.p3", "DRUGA": ["Herceptin", "brand", "65-73"], "DRUGB": ["lapatinib", "drug", "133-141"]}
{"TEXT1": "reported lapatinib combined @DRUG$ improved rate compared alone patients @DRUG$ refractory mechanism to effect relating synergism two", "LBL": "0", "ID": "DDI-MedLine.d164.s1.p4", "DRUGA": ["Herceptin", "brand", "65-73"], "DRUGB": ["Herceptin", "brand", "167-175"]}
{"TEXT1": "reported lapatinib combined Herceptin improved rate compared @DRUG$ alone patients @DRUG$ refractory mechanism to effect relating synergism two", "LBL": "0", "ID": "DDI-MedLine.d164.s1.p5", "DRUGA": ["lapatinib", "drug", "133-141"], "DRUGB": ["Herceptin", "brand", "167-175"]}
{"TEXT1": "evaluated @DRUG$ @DRUG$ focus Herceptin", "LBL": "0", "ID": "DDI-MedLine.d164.s2.p0", "DRUGA": ["lapatinib", "drug", "17-25"], "DRUGB": ["Herceptin", "brand", "42-50"]}
{"TEXT1": "evaluated @DRUG$ Herceptin focus @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d164.s2.p1", "DRUGA": ["lapatinib", "drug", "17-25"], "DRUGB": ["Herceptin", "brand", "111-119"]}
{"TEXT1": "evaluated lapatinib @DRUG$ focus @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d164.s2.p2", "DRUGA": ["Herceptin", "brand", "42-50"], "DRUGB": ["Herceptin", "brand", "111-119"]}
{"TEXT1": "In vitro assay @DRUG$ induced expression cell surface of lines leading enhancement @DRUG$ mediated ADCC", "LBL": "DDI-effect", "ID": "DDI-MedLine.d164.s3.p0", "DRUGA": ["lapatinib", "drug", "22-30"], "DRUGB": ["Herceptin", "brand", "149-157"]}
{"TEXT1": "present case report second @DRUG$ treatment following @DRUG$ resulted marked shrinkage multiple tumors metastatic tumors", "LBL": "DDI-effect", "ID": "DDI-MedLine.d164.s4.p0", "DRUGA": ["Herceptin", "brand", "56-64"], "DRUGB": ["lapatinib", "drug", "86-94"]}
{"TEXT1": "@DRUG$ potential to @DRUG$ Herceptin regulation cell surface expression", "LBL": "0", "ID": "DDI-MedLine.d164.s5.p0", "DRUGA": ["Lapatinib", "drug", "0-8"], "DRUGB": ["Herceptin", "brand", "44-52"]}
{"TEXT1": "@DRUG$ potential to Herceptin @DRUG$ regulation cell surface expression", "LBL": "0", "ID": "DDI-MedLine.d164.s5.p1", "DRUGA": ["Lapatinib", "drug", "0-8"], "DRUGB": ["Herceptin", "brand", "68-76"]}
{"TEXT1": "Lapatinib potential to @DRUG$ @DRUG$ regulation cell surface expression", "LBL": "0", "ID": "DDI-MedLine.d164.s5.p2", "DRUGA": ["Herceptin", "brand", "44-52"], "DRUGB": ["Herceptin", "brand", "68-76"]}
{"TEXT1": "Influence @DRUG$ @DRUG$ induced pharmacokinetics", "LBL": "0", "ID": "DDI-MedLine.d195.s0.p0", "DRUGA": ["piperine", "drug_n", "13-20"], "DRUGB": ["ibuprofen", "drug", "25-33"]}
{"TEXT1": "present study @DRUG$ increased dependent activity @DRUG$ evaluated acetic acid formalin test administered ibuprofen", "LBL": "DDI-effect", "ID": "DDI-MedLine.d195.s4.p0", "DRUGA": ["piperine", "drug_n", "21-28"], "DRUGB": ["ibuprofen", "drug", "112-120"]}
{"TEXT1": "present study @DRUG$ increased dependent activity ibuprofen evaluated @DRUG$ formalin test administered", "LBL": "0", "ID": "DDI-MedLine.d195.s4.p1", "DRUGA": ["piperine", "drug_n", "21-28"], "DRUGB": ["acetic acid", "drug", "140-150"]}
{"TEXT1": "present study @DRUG$ increased dependent activity ibuprofen evaluated acetic acid formalin test administered @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d195.s4.p2", "DRUGA": ["piperine", "drug_n", "21-28"], "DRUGB": ["ibuprofen", "drug", "210-218"]}
{"TEXT1": "present study piperine increased dependent activity @DRUG$ evaluated @DRUG$ formalin test administered ibuprofen", "LBL": "0", "ID": "DDI-MedLine.d195.s4.p3", "DRUGA": ["ibuprofen", "drug", "112-120"], "DRUGB": ["acetic acid", "drug", "140-150"]}
{"TEXT1": "present study piperine increased dependent activity @DRUG$ evaluated acetic acid formalin test administered @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d195.s4.p4", "DRUGA": ["ibuprofen", "drug", "112-120"], "DRUGB": ["ibuprofen", "drug", "210-218"]}
{"TEXT1": "present study piperine increased dependent activity ibuprofen evaluated @DRUG$ formalin test administered @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d195.s4.p5", "DRUGA": ["acetic acid", "drug", "140-150"], "DRUGB": ["ibuprofen", "drug", "210-218"]}
{"TEXT1": "@DRUG$ plasma concentration increased administered @DRUG$", "LBL": "DDI-mechanism", "ID": "DDI-MedLine.d195.s5.p0", "DRUGA": ["Ibuprofen", "drug", "0-8"], "DRUGB": ["piperine", "drug_n", "80-87"]}
{"TEXT1": "synergistic activity @DRUG$ administered @DRUG$ attributed increased plasma concentration ibuprofen", "LBL": "DDI-mechanism", "ID": "DDI-MedLine.d195.s6.p0", "DRUGA": ["ibuprofen", "drug", "44-52"], "DRUGB": ["piperine", "drug_n", "77-84"]}
{"TEXT1": "synergistic activity @DRUG$ administered piperine attributed increased plasma concentration @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d195.s6.p1", "DRUGA": ["ibuprofen", "drug", "44-52"], "DRUGB": ["ibuprofen", "drug", "141-149"]}
{"TEXT1": "synergistic activity ibuprofen administered @DRUG$ attributed increased plasma concentration @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d195.s6.p2", "DRUGA": ["piperine", "drug_n", "77-84"], "DRUGB": ["ibuprofen", "drug", "141-149"]}
{"TEXT1": "study concluded @DRUG$ used @DRUG$", "LBL": "DDI-effect", "ID": "DDI-MedLine.d195.s7.p0", "DRUGA": ["piperine", "drug_n", "41-48"], "DRUGB": ["ibuprofen", "drug", "90-98"]}
{"TEXT1": "To co injection extracellular matrix enzymes improves retinal transduction following delivery @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d190.s1.p0", "DRUGA": ["adeno-associated virus-2", "drug_n", "145-168"], "DRUGB": ["AAV2", "drug_n", "171-174"]}
{"TEXT1": "@DRUG$ containing cDNA encoding enhanced green fluorescent protein control chicken actin promoter delivered intravitreal injection adult mice conjunction enzymes including @DRUG$ hyaluronan lyase heparinase III", "LBL": "0", "ID": "DDI-MedLine.d190.s2.p0", "DRUGA": ["AAV2", "drug_n", "0-3"], "DRUGB": ["collagenase", "drug_n", "214-224"]}
{"TEXT1": "@DRUG$ containing cDNA encoding enhanced green fluorescent protein control chicken actin promoter delivered intravitreal injection adult mice conjunction enzymes including collagenase @DRUG$ heparinase III chondroitin ABC lyase", "LBL": "0", "ID": "DDI-MedLine.d190.s2.p1", "DRUGA": ["AAV2", "drug_n", "0-3"], "DRUGB": ["hyaluronan lyase", "drug_n", "227-242"]}
{"TEXT1": "@DRUG$ containing cDNA encoding enhanced green fluorescent protein control chicken actin promoter delivered intravitreal injection adult mice conjunction enzymes including collagenase hyaluronan lyase @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d190.s2.p2", "DRUGA": ["AAV2", "drug_n", "0-3"], "DRUGB": ["heparinase III", "drug_n", "245-258"]}
{"TEXT1": "@DRUG$ containing cDNA encoding enhanced green fluorescent protein control chicken actin promoter delivered intravitreal injection adult mice conjunction enzymes including collagenase hyaluronan lyase heparinase III @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d190.s2.p3", "DRUGA": ["AAV2", "drug_n", "0-3"], "DRUGB": ["chondroitin ABC lyase", "drug_n", "264-284"]}
{"TEXT1": "AAV2 containing cDNA encoding enhanced green fluorescent protein control chicken actin promoter delivered intravitreal injection adult mice conjunction enzymes including @DRUG$ @DRUG$ heparinase III chondroitin ABC lyase", "LBL": "0", "ID": "DDI-MedLine.d190.s2.p4", "DRUGA": ["collagenase", "drug_n", "214-224"], "DRUGB": ["hyaluronan lyase", "drug_n", "227-242"]}
{"TEXT1": "AAV2 containing cDNA encoding enhanced green fluorescent protein control chicken actin promoter delivered intravitreal injection adult mice conjunction enzymes including @DRUG$ hyaluronan lyase @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d190.s2.p5", "DRUGA": ["collagenase", "drug_n", "214-224"], "DRUGB": ["heparinase III", "drug_n", "245-258"]}
{"TEXT1": "AAV2 containing cDNA encoding enhanced green fluorescent protein control chicken actin promoter delivered intravitreal injection adult mice conjunction enzymes including @DRUG$ hyaluronan lyase heparinase III @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d190.s2.p6", "DRUGA": ["collagenase", "drug_n", "214-224"], "DRUGB": ["chondroitin ABC lyase", "drug_n", "264-284"]}
{"TEXT1": "AAV2 containing cDNA encoding enhanced green fluorescent protein control chicken actin promoter delivered intravitreal injection adult mice conjunction enzymes including collagenase @DRUG$ @DRUG$ chondroitin ABC lyase", "LBL": "0", "ID": "DDI-MedLine.d190.s2.p7", "DRUGA": ["hyaluronan lyase", "drug_n", "227-242"], "DRUGB": ["heparinase III", "drug_n", "245-258"]}
{"TEXT1": "AAV2 containing cDNA encoding enhanced green fluorescent protein control chicken actin promoter delivered intravitreal injection adult mice conjunction enzymes including collagenase @DRUG$ heparinase III @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d190.s2.p8", "DRUGA": ["hyaluronan lyase", "drug_n", "227-242"], "DRUGB": ["chondroitin ABC lyase", "drug_n", "264-284"]}
{"TEXT1": "AAV2 containing cDNA encoding enhanced green fluorescent protein control chicken actin promoter delivered intravitreal injection adult mice conjunction enzymes including collagenase hyaluronan lyase @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d190.s2.p9", "DRUGA": ["heparinase III", "drug_n", "245-258"], "DRUGB": ["chondroitin ABC lyase", "drug_n", "264-284"]}
{"TEXT1": "addition @DRUG$ @DRUG$ greatly enhanced transduction retinal ganglion cell layer increased depth outer", "LBL": "0", "ID": "DDI-MedLine.d190.s5.p0", "DRUGA": ["heparinase III", "drug_n", "16-29"], "DRUGB": ["chondroitin ABC lyase", "drug_n", "34-54"]}
{"TEXT1": "@DRUG$ limited effect @DRUG$ ineffective", "LBL": "0", "ID": "DDI-MedLine.d190.s6.p0", "DRUGA": ["Hyaluronan lyase", "drug_n", "0-15"], "DRUGB": ["collagenase", "drug_n", "42-52"]}
{"TEXT1": "Electroretinograms survived higher concentrations @DRUG$ @DRUG$ required optimal retinal transduction", "LBL": "0", "ID": "DDI-MedLine.d190.s7.p0", "DRUGA": ["heparinase III", "drug_n", "58-71"], "DRUGB": ["chondroitin ABC lyase", "drug_n", "77-97"]}
{"TEXT1": "@DRUG$ mediated retinal transduction improved co injection @DRUG$ chondroitin ABC lyase", "LBL": "DDI-effect", "ID": "DDI-MedLine.d190.s8.p0", "DRUGA": ["AAV2", "drug_n", "0-3"], "DRUGB": ["heparinase III", "drug_n", "66-79"]}
{"TEXT1": "@DRUG$ mediated retinal transduction improved co injection heparinase III @DRUG$", "LBL": "DDI-effect", "ID": "DDI-MedLine.d190.s8.p1", "DRUGA": ["AAV2", "drug_n", "0-3"], "DRUGB": ["chondroitin ABC lyase", "drug_n", "84-104"]}
{"TEXT1": "AAV2 mediated retinal transduction improved co injection @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d190.s8.p2", "DRUGA": ["heparinase III", "drug_n", "66-79"], "DRUGB": ["chondroitin ABC lyase", "drug_n", "84-104"]}
{"TEXT1": "aim present study to investigate therapeutic target further effects specific inhibitor @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d201.s4.p0", "DRUGA": ["cross-reacting material 197", "drug_n", "180-206"], "DRUGB": ["CRM197", "drug_n", "209-214"]}
{"TEXT1": "expression cell lines evaluated effect @DRUG$ cells alone combination @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d201.s5.p0", "DRUGA": ["CRM197", "drug_n", "88-93"], "DRUGB": ["anticancer agent", "group", "139-154"]}
{"TEXT1": "@DRUG$ induced apoptosis combination @DRUG$ plus doxorubicin enhanced cytotoxicity T cell line", "LBL": "0", "ID": "DDI-MedLine.d201.s9.p0", "DRUGA": ["CRM197", "drug_n", "0-5"], "DRUGB": ["CRM197", "drug_n", "62-67"]}
{"TEXT1": "@DRUG$ induced apoptosis combination CRM197 plus @DRUG$ enhanced cytotoxicity T cell line", "LBL": "0", "ID": "DDI-MedLine.d201.s9.p1", "DRUGA": ["CRM197", "drug_n", "0-5"], "DRUGB": ["doxorubicin", "drug", "74-84"]}
{"TEXT1": "CRM197 induced apoptosis combination @DRUG$ plus @DRUG$ enhanced cytotoxicity T cell line", "LBL": "DDI-effect", "ID": "DDI-MedLine.d201.s9.p2", "DRUGA": ["CRM197", "drug_n", "62-67"], "DRUGB": ["doxorubicin", "drug", "74-84"]}
{"TEXT1": "Prevention emergence agitation seven children receiving @DRUG$ @DRUG$ total intravenous anesthesia", "LBL": "0", "ID": "DDI-MedLine.d199.s0.p0", "DRUGA": ["ketamine", "drug", "71-78"], "DRUGB": ["propofol", "drug", "84-91"]}
{"TEXT1": "reviewed pediatric oncology received low @DRUG$ conjunction @DRUG$ total intravenous anesthesia repeatedly radiation therapy", "LBL": "0", "ID": "DDI-MedLine.d199.s2.p0", "DRUGA": ["ketamine", "drug", "95-102"], "DRUGB": ["propofol", "drug", "124-131"]}
{"TEXT1": "EA signs observed patients association @DRUG$ not recur subsequent anesthetics sessions @DRUG$ added propofol", "LBL": "0", "ID": "DDI-MedLine.d199.s3.p0", "DRUGA": ["propofol", "drug", "61-68"], "DRUGB": ["ketamine", "drug", "161-168"]}
{"TEXT1": "EA signs observed patients association @DRUG$ not recur subsequent anesthetics sessions ketamine added @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d199.s3.p1", "DRUGA": ["propofol", "drug", "61-68"], "DRUGB": ["propofol", "drug", "183-190"]}
{"TEXT1": "EA signs observed patients association propofol not recur subsequent anesthetics sessions @DRUG$ added @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d199.s3.p2", "DRUGA": ["ketamine", "drug", "161-168"], "DRUGB": ["propofol", "drug", "183-190"]}
{"TEXT1": "Based experience suggest @DRUG$ added @DRUG$ associated with prevention EA children history propofol", "LBL": "DDI-effect", "ID": "DDI-MedLine.d199.s4.p0", "DRUGA": ["ketamine", "drug", "51-58"], "DRUGB": ["propofol", "drug", "69-76"]}
{"TEXT1": "Based experience suggest @DRUG$ added propofol associated with prevention EA children history @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d199.s4.p1", "DRUGA": ["ketamine", "drug", "51-58"], "DRUGB": ["propofol", "drug", "156-163"]}
{"TEXT1": "Based experience suggest ketamine added @DRUG$ associated with prevention EA children history @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d199.s4.p2", "DRUGA": ["propofol", "drug", "69-76"], "DRUGB": ["propofol", "drug", "156-163"]}
{"TEXT1": "synergistic action @DRUG$ @DRUG$ Pseudomonas aeruginosa", "LBL": "0", "ID": "DDI-MedLine.d204.s0.p0", "DRUGA": ["piperacillin", "drug", "31-42"], "DRUGB": ["methylglyoxal", "drug_n", "48-60"]}
{"TEXT1": "Results revealed strains resistant to drugs high levels only @DRUG$ @DRUG$ amikacin ciprofloxacin showed resistances lower", "LBL": "0", "ID": "DDI-MedLine.d204.s7.p0", "DRUGA": ["piperacillin", "drug", "84-95"], "DRUGB": ["carbenicillin", "drug", "98-110"]}
{"TEXT1": "Results revealed strains resistant to drugs high levels only @DRUG$ carbenicillin @DRUG$ ciprofloxacin showed resistances lower", "LBL": "0", "ID": "DDI-MedLine.d204.s7.p1", "DRUGA": ["piperacillin", "drug", "84-95"], "DRUGB": ["amikacin", "drug", "113-120"]}
{"TEXT1": "Results revealed strains resistant to drugs high levels only @DRUG$ carbenicillin amikacin @DRUG$ showed resistances lower", "LBL": "0", "ID": "DDI-MedLine.d204.s7.p2", "DRUGA": ["piperacillin", "drug", "84-95"], "DRUGB": ["ciprofloxacin", "drug", "126-138"]}
{"TEXT1": "Results revealed strains resistant to drugs high levels only piperacillin @DRUG$ @DRUG$ ciprofloxacin showed resistances lower", "LBL": "0", "ID": "DDI-MedLine.d204.s7.p3", "DRUGA": ["carbenicillin", "drug", "98-110"], "DRUGB": ["amikacin", "drug", "113-120"]}
{"TEXT1": "Results revealed strains resistant to drugs high levels only piperacillin @DRUG$ amikacin @DRUG$ showed resistances lower", "LBL": "0", "ID": "DDI-MedLine.d204.s7.p4", "DRUGA": ["carbenicillin", "drug", "98-110"], "DRUGB": ["ciprofloxacin", "drug", "126-138"]}
{"TEXT1": "Results revealed strains resistant to drugs high levels only piperacillin carbenicillin @DRUG$ @DRUG$ showed resistances lower", "LBL": "0", "ID": "DDI-MedLine.d204.s7.p5", "DRUGA": ["amikacin", "drug", "113-120"], "DRUGB": ["ciprofloxacin", "drug", "126-138"]}
{"TEXT1": "statistically significant synergism observed @DRUG$ @DRUG$ disc diffusion tests compared individual effects", "LBL": "DDI-effect", "ID": "DDI-MedLine.d204.s9.p0", "DRUGA": ["methylglyoxal", "drug_n", "70-82"], "DRUGB": ["piperacillin", "drug", "88-99"]}
{"TEXT1": "Synergism noted @DRUG$ combined @DRUG$ amikacin", "LBL": "DDI-effect", "ID": "DDI-MedLine.d204.s11.p0", "DRUGA": ["methylglyoxal", "drug_n", "30-42"], "DRUGB": ["carbenicillin", "drug", "62-74"]}
{"TEXT1": "Synergism noted @DRUG$ combined carbenicillin @DRUG$", "LBL": "DDI-effect", "ID": "DDI-MedLine.d204.s11.p1", "DRUGA": ["methylglyoxal", "drug_n", "30-42"], "DRUGB": ["amikacin", "drug", "80-87"]}
{"TEXT1": "Synergism noted methylglyoxal combined @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d204.s11.p2", "DRUGA": ["carbenicillin", "drug", "62-74"], "DRUGB": ["amikacin", "drug", "80-87"]}
{"TEXT1": "Interaction study @DRUG$ @DRUG$ co administered drugs", "LBL": "0", "ID": "DDI-MedLine.d231.s0.p0", "DRUGA": ["moxifloxacin", "drug", "21-32"], "DRUGB": ["lomefloxacin", "drug", "38-49"]}
{"TEXT1": "@DRUG$ @DRUG$ fluoroquinolone antibiotics used treating urinary respiratory tract infections", "LBL": "0", "ID": "DDI-MedLine.d231.s1.p0", "DRUGA": ["Moxifloxacin", "drug", "0-11"], "DRUGB": ["lomefloxacin", "drug", "17-28"]}
{"TEXT1": "@DRUG$ lomefloxacin @DRUG$ used treating urinary respiratory tract infections", "LBL": "0", "ID": "DDI-MedLine.d231.s1.p1", "DRUGA": ["Moxifloxacin", "drug", "0-11"], "DRUGB": ["fluoroquinolone antibiotics", "group", "34-60"]}
{"TEXT1": "Moxifloxacin @DRUG$ @DRUG$ used treating urinary respiratory tract infections", "LBL": "0", "ID": "DDI-MedLine.d231.s1.p2", "DRUGA": ["lomefloxacin", "drug", "17-28"], "DRUGB": ["fluoroquinolone antibiotics", "group", "34-60"]}
{"TEXT1": "@DRUG$ lomefloxacin @DRUG$ interaction study carried out sucralfate gelusil erythromycin multi minerals", "LBL": "0", "ID": "DDI-MedLine.d231.s3.p0", "DRUGA": ["moxifloxacin", "drug", "6-17"], "DRUGB": ["fluoroquinolones", "group", "36-51"]}
{"TEXT1": "@DRUG$ lomefloxacin fluoroquinolones interaction study carried out @DRUG$ gelusil erythromycin multi minerals", "LBL": "0", "ID": "DDI-MedLine.d231.s3.p1", "DRUGA": ["moxifloxacin", "drug", "6-17"], "DRUGB": ["sucralfate", "drug", "99-108"]}
{"TEXT1": "@DRUG$ lomefloxacin fluoroquinolones interaction study carried out sucralfate @DRUG$ erythromycin multi minerals", "LBL": "0", "ID": "DDI-MedLine.d231.s3.p2", "DRUGA": ["moxifloxacin", "drug", "6-17"], "DRUGB": ["gelusil", "brand", "111-117"]}
{"TEXT1": "@DRUG$ lomefloxacin fluoroquinolones interaction study carried out sucralfate gelusil @DRUG$ multi minerals", "LBL": "0", "ID": "DDI-MedLine.d231.s3.p3", "DRUGA": ["moxifloxacin", "drug", "6-17"], "DRUGB": ["erythromycin", "drug", "120-131"]}
{"TEXT1": "@DRUG$ lomefloxacin fluoroquinolones interaction study carried out sucralfate gelusil erythromycin @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d231.s3.p4", "DRUGA": ["moxifloxacin", "drug", "6-17"], "DRUGB": ["multi minerals", "group", "137-150"]}
{"TEXT1": "moxifloxacin lomefloxacin @DRUG$ interaction study carried out @DRUG$ gelusil erythromycin multi minerals", "LBL": "0", "ID": "DDI-MedLine.d231.s3.p5", "DRUGA": ["fluoroquinolones", "group", "36-51"], "DRUGB": ["sucralfate", "drug", "99-108"]}
{"TEXT1": "moxifloxacin lomefloxacin @DRUG$ interaction study carried out sucralfate @DRUG$ erythromycin multi minerals", "LBL": "0", "ID": "DDI-MedLine.d231.s3.p6", "DRUGA": ["fluoroquinolones", "group", "36-51"], "DRUGB": ["gelusil", "brand", "111-117"]}
{"TEXT1": "moxifloxacin lomefloxacin @DRUG$ interaction study carried out sucralfate gelusil @DRUG$ multi minerals", "LBL": "0", "ID": "DDI-MedLine.d231.s3.p7", "DRUGA": ["fluoroquinolones", "group", "36-51"], "DRUGB": ["erythromycin", "drug", "120-131"]}
{"TEXT1": "moxifloxacin lomefloxacin @DRUG$ interaction study carried out sucralfate gelusil erythromycin @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d231.s3.p8", "DRUGA": ["fluoroquinolones", "group", "36-51"], "DRUGB": ["multi minerals", "group", "137-150"]}
{"TEXT1": "moxifloxacin lomefloxacin fluoroquinolones interaction study carried out @DRUG$ @DRUG$ erythromycin multi minerals", "LBL": "0", "ID": "DDI-MedLine.d231.s3.p9", "DRUGA": ["sucralfate", "drug", "99-108"], "DRUGB": ["gelusil", "brand", "111-117"]}
{"TEXT1": "moxifloxacin lomefloxacin fluoroquinolones interaction study carried out @DRUG$ gelusil @DRUG$ multi minerals", "LBL": "0", "ID": "DDI-MedLine.d231.s3.p10", "DRUGA": ["sucralfate", "drug", "99-108"], "DRUGB": ["erythromycin", "drug", "120-131"]}
{"TEXT1": "moxifloxacin lomefloxacin fluoroquinolones interaction study carried out @DRUG$ gelusil erythromycin @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d231.s3.p11", "DRUGA": ["sucralfate", "drug", "99-108"], "DRUGB": ["multi minerals", "group", "137-150"]}
{"TEXT1": "moxifloxacin lomefloxacin fluoroquinolones interaction study carried out sucralfate @DRUG$ @DRUG$ multi minerals", "LBL": "0", "ID": "DDI-MedLine.d231.s3.p12", "DRUGA": ["gelusil", "brand", "111-117"], "DRUGB": ["erythromycin", "drug", "120-131"]}
{"TEXT1": "moxifloxacin lomefloxacin fluoroquinolones interaction study carried out sucralfate @DRUG$ erythromycin @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d231.s3.p13", "DRUGA": ["gelusil", "brand", "111-117"], "DRUGB": ["multi minerals", "group", "137-150"]}
{"TEXT1": "moxifloxacin lomefloxacin fluoroquinolones interaction study carried out sucralfate gelusil @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d231.s3.p14", "DRUGA": ["erythromycin", "drug", "120-131"], "DRUGB": ["multi minerals", "group", "137-150"]}
{"TEXT1": "response @DRUG$ @DRUG$ interaction co administered drugs conditions different temperature noted using HPLC system PDA detector", "LBL": "0", "ID": "DDI-MedLine.d231.s6.p0", "DRUGA": ["moxifloxacin", "drug", "16-27"], "DRUGB": ["lomefloxacin", "drug", "33-44"]}
{"TEXT1": "@DRUG$ @DRUG$ reacts faster sucralfate gelusil acidic media erythromycin basic multi minerals neutral", "LBL": "0", "ID": "DDI-MedLine.d231.s8.p0", "DRUGA": ["Moxifloxacin", "drug", "0-11"], "DRUGB": ["Lomefloxacin", "drug", "17-28"]}
{"TEXT1": "@DRUG$ Lomefloxacin reacts faster @DRUG$ gelusil acidic media erythromycin basic multi minerals neutral", "LBL": "DDI-mechanism", "ID": "DDI-MedLine.d231.s8.p1", "DRUGA": ["Moxifloxacin", "drug", "0-11"], "DRUGB": ["sucralfate", "drug", "49-58"]}
{"TEXT1": "@DRUG$ Lomefloxacin reacts faster sucralfate @DRUG$ acidic media erythromycin basic multi minerals neutral", "LBL": "DDI-mechanism", "ID": "DDI-MedLine.d231.s8.p2", "DRUGA": ["Moxifloxacin", "drug", "0-11"], "DRUGB": ["gelusil", "brand", "64-70"]}
{"TEXT1": "@DRUG$ Lomefloxacin reacts faster sucralfate gelusil acidic media @DRUG$ basic multi minerals neutral", "LBL": "DDI-mechanism", "ID": "DDI-MedLine.d231.s8.p3", "DRUGA": ["Moxifloxacin", "drug", "0-11"], "DRUGB": ["erythromycin", "drug", "101-112"]}
{"TEXT1": "@DRUG$ Lomefloxacin reacts faster sucralfate gelusil acidic media erythromycin basic @DRUG$ neutral", "LBL": "DDI-mechanism", "ID": "DDI-MedLine.d231.s8.p4", "DRUGA": ["Moxifloxacin", "drug", "0-11"], "DRUGB": ["multi-minerals", "group", "133-146"]}
{"TEXT1": "Moxifloxacin @DRUG$ reacts faster @DRUG$ gelusil acidic media erythromycin basic multi minerals neutral", "LBL": "DDI-mechanism", "ID": "DDI-MedLine.d231.s8.p5", "DRUGA": ["Lomefloxacin", "drug", "17-28"], "DRUGB": ["sucralfate", "drug", "49-58"]}
{"TEXT1": "Moxifloxacin @DRUG$ reacts faster sucralfate @DRUG$ acidic media erythromycin basic multi minerals neutral", "LBL": "DDI-mechanism", "ID": "DDI-MedLine.d231.s8.p6", "DRUGA": ["Lomefloxacin", "drug", "17-28"], "DRUGB": ["gelusil", "brand", "64-70"]}
{"TEXT1": "Moxifloxacin @DRUG$ reacts faster sucralfate gelusil acidic media @DRUG$ basic multi minerals neutral", "LBL": "DDI-mechanism", "ID": "DDI-MedLine.d231.s8.p7", "DRUGA": ["Lomefloxacin", "drug", "17-28"], "DRUGB": ["erythromycin", "drug", "101-112"]}
{"TEXT1": "Moxifloxacin @DRUG$ reacts faster sucralfate gelusil acidic media erythromycin basic @DRUG$ neutral", "LBL": "DDI-mechanism", "ID": "DDI-MedLine.d231.s8.p8", "DRUGA": ["Lomefloxacin", "drug", "17-28"], "DRUGB": ["multi-minerals", "group", "133-146"]}
{"TEXT1": "Moxifloxacin Lomefloxacin reacts faster @DRUG$ @DRUG$ acidic media erythromycin basic multi minerals neutral", "LBL": "0", "ID": "DDI-MedLine.d231.s8.p9", "DRUGA": ["sucralfate", "drug", "49-58"], "DRUGB": ["gelusil", "brand", "64-70"]}
{"TEXT1": "Moxifloxacin Lomefloxacin reacts faster @DRUG$ gelusil acidic media @DRUG$ basic multi minerals neutral", "LBL": "0", "ID": "DDI-MedLine.d231.s8.p10", "DRUGA": ["sucralfate", "drug", "49-58"], "DRUGB": ["erythromycin", "drug", "101-112"]}
{"TEXT1": "Moxifloxacin Lomefloxacin reacts faster @DRUG$ gelusil acidic media erythromycin basic @DRUG$ neutral", "LBL": "0", "ID": "DDI-MedLine.d231.s8.p11", "DRUGA": ["sucralfate", "drug", "49-58"], "DRUGB": ["multi-minerals", "group", "133-146"]}
{"TEXT1": "Moxifloxacin Lomefloxacin reacts faster sucralfate @DRUG$ acidic media @DRUG$ basic multi minerals neutral", "LBL": "0", "ID": "DDI-MedLine.d231.s8.p12", "DRUGA": ["gelusil", "brand", "64-70"], "DRUGB": ["erythromycin", "drug", "101-112"]}
{"TEXT1": "Moxifloxacin Lomefloxacin reacts faster sucralfate @DRUG$ acidic media erythromycin basic @DRUG$ neutral", "LBL": "0", "ID": "DDI-MedLine.d231.s8.p13", "DRUGA": ["gelusil", "brand", "64-70"], "DRUGB": ["multi-minerals", "group", "133-146"]}
{"TEXT1": "Moxifloxacin Lomefloxacin reacts faster sucralfate gelusil acidic media @DRUG$ basic @DRUG$ neutral", "LBL": "0", "ID": "DDI-MedLine.d231.s8.p14", "DRUGA": ["erythromycin", "drug", "101-112"], "DRUGB": ["multi-minerals", "group", "133-146"]}
{"TEXT1": "@DRUG$ @DRUG$ standard hormone treatment cancer treatment breast cancer breast", "LBL": "0", "ID": "DDI-MedLine.d209.s1.p0", "DRUGA": ["Tamoxifen", "drug", "0-8"], "DRUGB": ["estrogen antagonist", "group", "14-32"]}
{"TEXT1": "@DRUG$ @DRUG$ plasma concentration endoxifen about", "LBL": "0", "ID": "DDI-MedLine.d209.s5.p0", "DRUGA": ["Paroxetine", "drug", "0-9"], "DRUGB": ["fluoxetine", "drug", "15-24"]}
{"TEXT1": "@DRUG$ fluoxetine plasma concentration @DRUG$ about", "LBL": "DDI-mechanism", "ID": "DDI-MedLine.d209.s5.p1", "DRUGA": ["Paroxetine", "drug", "0-9"], "DRUGB": ["endoxifen", "drug_n", "61-69"]}
{"TEXT1": "Paroxetine @DRUG$ plasma concentration @DRUG$ about", "LBL": "DDI-mechanism", "ID": "DDI-MedLine.d209.s5.p2", "DRUGA": ["fluoxetine", "drug", "15-24"], "DRUGB": ["endoxifen", "drug_n", "61-69"]}
{"TEXT1": "better to prescribing isoenzyme CYP 2D6 inhibitors women treated with @DRUG$ breast cancer @DRUG$ paroxetine fluoxetine", "LBL": "DDI-advise", "ID": "DDI-MedLine.d209.s9.p0", "DRUGA": ["tamoxifen", "drug", "85-93"], "DRUGB": ["SSRI antidepressants", "group", "125-144"]}
{"TEXT1": "better to prescribing isoenzyme CYP 2D6 inhibitors women treated with @DRUG$ breast cancer SSRI antidepressants @DRUG$ fluoxetine", "LBL": "DDI-advise", "ID": "DDI-MedLine.d209.s9.p1", "DRUGA": ["tamoxifen", "drug", "85-93"], "DRUGB": ["paroxetine", "drug", "154-163"]}
{"TEXT1": "better to prescribing isoenzyme CYP 2D6 inhibitors women treated with @DRUG$ breast cancer SSRI antidepressants paroxetine @DRUG$", "LBL": "DDI-advise", "ID": "DDI-MedLine.d209.s9.p2", "DRUGA": ["tamoxifen", "drug", "85-93"], "DRUGB": ["fluoxetine", "drug", "169-178"]}
{"TEXT1": "better to prescribing isoenzyme CYP 2D6 inhibitors women treated with tamoxifen breast cancer @DRUG$ @DRUG$ fluoxetine", "LBL": "0", "ID": "DDI-MedLine.d209.s9.p3", "DRUGA": ["SSRI antidepressants", "group", "125-144"], "DRUGB": ["paroxetine", "drug", "154-163"]}
{"TEXT1": "better to prescribing isoenzyme CYP 2D6 inhibitors women treated with tamoxifen breast cancer @DRUG$ paroxetine @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d209.s9.p4", "DRUGA": ["SSRI antidepressants", "group", "125-144"], "DRUGB": ["fluoxetine", "drug", "169-178"]}
{"TEXT1": "better to prescribing isoenzyme CYP 2D6 inhibitors women treated with tamoxifen breast cancer SSRI antidepressants @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d209.s9.p5", "DRUGA": ["paroxetine", "drug", "154-163"], "DRUGB": ["fluoxetine", "drug", "169-178"]}
{"TEXT1": "Depression not always @DRUG$ @DRUG$ no proven preventive impact hot flushes linked menopause", "LBL": "0", "ID": "DDI-MedLine.d209.s10.p0", "DRUGA": ["antidepressant drug", "group", "35-53"], "DRUGB": ["antidepressants", "group", "68-82"]}
{"TEXT1": "certain cases @DRUG$ considered to replace @DRUG$ anastrozole", "LBL": "DDI-advise", "ID": "DDI-MedLine.d209.s11.p0", "DRUGA": ["antidepressant", "group", "24-37"], "DRUGB": ["tamoxifen", "drug", "95-103"]}
{"TEXT1": "certain cases @DRUG$ considered to replace tamoxifen @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d209.s11.p1", "DRUGA": ["antidepressant", "group", "24-37"], "DRUGB": ["anastrozole", "drug", "110-120"]}
{"TEXT1": "certain cases antidepressant considered to replace @DRUG$ @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d209.s11.p2", "DRUGA": ["tamoxifen", "drug", "95-103"], "DRUGB": ["anastrozole", "drug", "110-120"]}
{"TEXT1": "fixed combination hospitalized patients", "LBL": "0", "ID": "DDI-MedLine.d200.s0.p0", "DRUGA": ["amlodipine", "drug", "31-40"], "DRUGB": ["valsartan", "drug", "42-50"]}
{"TEXT1": "Efficacy tolerability fixed combination studied patients hypertensive disease hospitalized departments general medicine internal cardiology", "LBL": "0", "ID": "DDI-MedLine.d200.s1.p0", "DRUGA": ["amlodipine", "drug", "35-44"], "DRUGB": ["valsartan", "drug", "46-54"]}
{"TEXT1": "patients indications antihypertensive therapy randomized either fixed combination hospital formulary", "LBL": "0", "ID": "DDI-MedLine.d200.s2.p0", "DRUGA": ["amlodipine", "drug", "106-115"], "DRUGB": ["valsartan", "drug", "117-125"]}
{"TEXT1": "Rate achievement target BP fixed combination traditional therapy", "LBL": "0", "ID": "DDI-MedLine.d200.s7.p0", "DRUGA": ["amlodipine", "drug", "56-65"], "DRUGB": ["valsartan", "drug", "67-75"]}
{"TEXT1": "use of fixed combination compared traditional therapy lower clinical self measured BP quicker achievement target days lesser number antihypertensive drugs rate concealed treatment", "LBL": "DDI-effect", "ID": "DDI-MedLine.d200.s8.p0", "DRUGA": ["amlodipine", "drug", "33-42"], "DRUGB": ["valsartan", "drug", "44-52"]}
{"TEXT1": "use of fixed combination compared traditional therapy lower clinical self measured BP quicker achievement target days lesser number @DRUG$ rate concealed treatment", "LBL": "0", "ID": "DDI-MedLine.d200.s8.p1", "DRUGA": ["amlodipine", "drug", "33-42"], "DRUGB": ["antihypertensive drugs", "group", "247-268"]}
{"TEXT1": "use of fixed combination compared traditional therapy lower clinical self measured BP quicker achievement target days lesser number @DRUG$ rate concealed treatment", "LBL": "0", "ID": "DDI-MedLine.d200.s8.p2", "DRUGA": ["valsartan", "drug", "44-52"], "DRUGB": ["antihypertensive drugs", "group", "247-268"]}
{"TEXT1": "appropriateness inhospital administration fixed combination approach allowing to target BP shorter time antihypertensive drugs diminishing concealed treatment", "LBL": "DDI-effect", "ID": "DDI-MedLine.d200.s10.p0", "DRUGA": ["amlodipine", "drug", "75-84"], "DRUGB": ["valsartan", "drug", "86-94"]}
{"TEXT1": "appropriateness inhospital administration fixed combination approach allowing to target BP shorter time @DRUG$ diminishing concealed treatment", "LBL": "0", "ID": "DDI-MedLine.d200.s10.p1", "DRUGA": ["amlodipine", "drug", "75-84"], "DRUGB": ["antihypertensive drugs", "group", "192-213"]}
{"TEXT1": "appropriateness inhospital administration fixed combination approach allowing to target BP shorter time @DRUG$ diminishing concealed treatment", "LBL": "0", "ID": "DDI-MedLine.d200.s10.p2", "DRUGA": ["valsartan", "drug", "86-94"], "DRUGB": ["antihypertensive drugs", "group", "192-213"]}
{"TEXT1": "Interaction @DRUG$ @DRUG$ in vitro melanoma", "LBL": "0", "ID": "DDI-MedLine.d147.s0.p0", "DRUGA": ["dacarbazine", "drug", "15-25"], "DRUGB": ["imexon", "drug_n", "31-36"]}
{"TEXT1": "evaluated mechanisms interaction agent @DRUG$ imexon melanoma", "LBL": "0", "ID": "DDI-MedLine.d147.s1.p0", "DRUGA": ["dacarbazine", "drug", "67-77"], "DRUGB": ["DTIC", "drug", "80-83"]}
{"TEXT1": "evaluated mechanisms interaction agent @DRUG$ @DRUG$ melanoma", "LBL": "0", "ID": "DDI-MedLine.d147.s1.p1", "DRUGA": ["dacarbazine", "drug", "67-77"], "DRUGB": ["imexon", "drug", "107-112"]}
{"TEXT1": "evaluated mechanisms interaction agent dacarbazine @DRUG$ melanoma", "LBL": "0", "ID": "DDI-MedLine.d147.s1.p2", "DRUGA": ["DTIC", "drug", "80-83"], "DRUGB": ["imexon", "drug", "107-112"]}
{"TEXT1": "effect @DRUG$ @DRUG$ alone combination evaluated growth inhibition radiolabeled drug uptake cellular thiol content DNA strand breaks", "LBL": "0", "ID": "DDI-MedLine.d147.s2.p0", "DRUGA": ["DTIC", "drug", "14-17"], "DRUGB": ["imexon", "drug", "23-28"]}
{"TEXT1": "reduction glutathione cellular cysteine @DRUG$ not @DRUG$", "LBL": "0", "ID": "DDI-MedLine.d147.s6.p0", "DRUGA": ["imexon", "drug", "69-74"], "DRUGB": ["DTIC", "drug", "84-87"]}
{"TEXT1": "@DRUG$ @DRUG$ show additive effects in vitro not melanoma", "LBL": "DDI-effect", "ID": "DDI-MedLine.d147.s8.p0", "DRUGA": ["Imexon", "drug", "0-5"], "DRUGB": ["dacarbazine", "drug", "11-21"]}
{"TEXT1": "@DRUG$ @DRUG$ MPTP evoked behavior", "LBL": "0", "ID": "DDI-MedLine.d214.s0.p0", "DRUGA": ["hemantane", "drug_n", "14-22"], "DRUGB": ["doxycycline", "drug", "28-38"]}
{"TEXT1": "@DRUG$ @DRUG$ mg/kg p", "LBL": "0", "ID": "DDI-MedLine.d214.s1.p0", "DRUGA": ["anti-parkinsonian drug", "group", "15-36"], "DRUGB": ["hemantane", "drug_n", "38-46"]}
{"TEXT1": "@DRUG$ hemantane mg/kg p", "LBL": "0", "ID": "DDI-MedLine.d214.s1.p1", "DRUGA": ["anti-parkinsonian drug", "group", "15-36"], "DRUGB": ["(2-adamantyl)hexamethylenimine", "drug_n", "49-78"]}
{"TEXT1": "@DRUG$ mg/kg p", "LBL": "0", "ID": "DDI-MedLine.d214.s1.p2", "DRUGA": ["hemantane", "drug_n", "38-46"], "DRUGB": ["(2-adamantyl)hexamethylenimine", "drug_n", "49-78"]}
{"TEXT1": "@DRUG$ @DRUG$ mg/kg p neurotoxin 4 phenyl 2 3 20 i", "LBL": "0", "ID": "DDI-MedLine.d214.s2.p0", "DRUGA": ["antibiotic drug", "group", "7-21"], "DRUGB": ["doxycycline", "drug", "23-33"]}
{"TEXT1": "@DRUG$ doxycycline mg/kg p neurotoxin @DRUG$ 20 i", "LBL": "0", "ID": "DDI-MedLine.d214.s2.p1", "DRUGA": ["antibiotic drug", "group", "7-21"], "DRUGB": ["1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine", "drug_n", "85-128"]}
{"TEXT1": "@DRUG$ doxycycline mg/kg p neurotoxin 4 phenyl 2 3 20 i", "LBL": "0", "ID": "DDI-MedLine.d214.s2.p2", "DRUGA": ["antibiotic drug", "group", "7-21"], "DRUGB": ["MPTP", "drug_n", "131-134"]}
{"TEXT1": "antibiotic drug @DRUG$ mg/kg p neurotoxin @DRUG$ 20 i", "LBL": "0", "ID": "DDI-MedLine.d214.s2.p3", "DRUGA": ["doxycycline", "drug", "23-33"], "DRUGB": ["1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine", "drug_n", "85-128"]}
{"TEXT1": "antibiotic drug @DRUG$ mg/kg p neurotoxin 4 phenyl 2 3 20 i", "LBL": "0", "ID": "DDI-MedLine.d214.s2.p4", "DRUGA": ["doxycycline", "drug", "23-33"], "DRUGB": ["MPTP", "drug_n", "131-134"]}
{"TEXT1": "antibiotic drug doxycycline mg/kg p neurotoxin @DRUG$ 20 i", "LBL": "0", "ID": "DDI-MedLine.d214.s2.p5", "DRUGA": ["1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine", "drug_n", "85-128"], "DRUGB": ["MPTP", "drug_n", "131-134"]}
{"TEXT1": "Acute administration @DRUG$ @DRUG$ failed to locomotion mice combination normalized motor activity", "LBL": "DDI-effect", "ID": "DDI-MedLine.d214.s5.p0", "DRUGA": ["hemantane", "drug_n", "24-32"], "DRUGB": ["doxycycline", "drug", "37-47"]}
{"TEXT1": "performed absence presence specific CYP inhibitor @DRUG$ isoform inhibitors", "LBL": "0", "ID": "DDI-MedLine.d189.s3.p0", "DRUGA": ["1-aminobenzotriazole", "drug_n", "94-113"], "DRUGB": ["ABT", "drug_n", "116-118"]}
{"TEXT1": "@DRUG$ decreased @DRUG$ increased exposure to parent compound metabolite levels", "LBL": "DDI-effect", "ID": "DDI-MedLine.d189.s7.p0", "DRUGA": ["ABT", "drug_n", "0-2"], "DRUGB": ["precocene I", "drug_n", "30-40"]}
{"TEXT1": "isoform specific inhibitors tested effect @DRUG$ metabolite profile only @DRUG$ effective role CYPs", "LBL": "0", "ID": "DDI-MedLine.d189.s8.p0", "DRUGA": ["precocene I", "drug_n", "67-77"], "DRUGB": ["tranylcypromine", "drug", "104-118"]}
{"TEXT1": "respect toxicity order CYP inhibitor effectiveness", "LBL": "0", "ID": "DDI-MedLine.d189.s9.p0", "DRUGA": ["ABT", "drug_n", "71-73"], "DRUGB": ["diethyldithiocarbamate", "drug_n", "75-96"]}
{"TEXT1": "respect toxicity order CYP inhibitor effectiveness", "LBL": "0", "ID": "DDI-MedLine.d189.s9.p1", "DRUGA": ["ABT", "drug_n", "71-73"], "DRUGB": ["tranylcypromine", "drug", "98-112"]}
{"TEXT1": "respect toxicity order CYP inhibitor effectiveness", "LBL": "0", "ID": "DDI-MedLine.d189.s9.p2", "DRUGA": ["ABT", "drug_n", "71-73"], "DRUGB": ["ketoconazole", "drug", "114-125"]}
{"TEXT1": "respect toxicity order CYP inhibitor effectiveness", "LBL": "0", "ID": "DDI-MedLine.d189.s9.p3", "DRUGA": ["diethyldithiocarbamate", "drug_n", "75-96"], "DRUGB": ["tranylcypromine", "drug", "98-112"]}
{"TEXT1": "respect toxicity order CYP inhibitor effectiveness", "LBL": "0", "ID": "DDI-MedLine.d189.s9.p4", "DRUGA": ["diethyldithiocarbamate", "drug_n", "75-96"], "DRUGB": ["ketoconazole", "drug", "114-125"]}
{"TEXT1": "respect toxicity order CYP inhibitor effectiveness", "LBL": "0", "ID": "DDI-MedLine.d189.s9.p5", "DRUGA": ["tranylcypromine", "drug", "98-112"], "DRUGB": ["ketoconazole", "drug", "114-125"]}
{"TEXT1": "@DRUG$ @DRUG$ no effect quinidine appeared to augment precocene I toxicity", "LBL": "0", "ID": "DDI-MedLine.d189.s10.p0", "DRUGA": ["Furafylline", "drug_n", "0-10"], "DRUGB": ["sulfaphenazole", "drug_n", "16-29"]}
{"TEXT1": "@DRUG$ sulfaphenazole no effect @DRUG$ appeared to augment precocene I toxicity", "LBL": "0", "ID": "DDI-MedLine.d189.s10.p1", "DRUGA": ["Furafylline", "drug_n", "0-10"], "DRUGB": ["quinidine", "drug", "52-60"]}
{"TEXT1": "@DRUG$ sulfaphenazole no effect quinidine appeared to augment @DRUG$ toxicity", "LBL": "0", "ID": "DDI-MedLine.d189.s10.p2", "DRUGA": ["Furafylline", "drug_n", "0-10"], "DRUGB": ["precocene I", "drug_n", "82-92"]}
{"TEXT1": "Furafylline @DRUG$ no effect @DRUG$ appeared to augment precocene I toxicity", "LBL": "0", "ID": "DDI-MedLine.d189.s10.p3", "DRUGA": ["sulfaphenazole", "drug_n", "16-29"], "DRUGB": ["quinidine", "drug", "52-60"]}
{"TEXT1": "Furafylline @DRUG$ no effect quinidine appeared to augment @DRUG$ toxicity", "LBL": "0", "ID": "DDI-MedLine.d189.s10.p4", "DRUGA": ["sulfaphenazole", "drug_n", "16-29"], "DRUGB": ["precocene I", "drug_n", "82-92"]}
{"TEXT1": "Furafylline sulfaphenazole no effect @DRUG$ appeared to augment @DRUG$ toxicity", "LBL": "DDI-effect", "ID": "DDI-MedLine.d189.s10.p5", "DRUGA": ["quinidine", "drug", "52-60"], "DRUGB": ["precocene I", "drug_n", "82-92"]}
{"TEXT1": "results suggest rat liver slices not reported in vivo biotransformation @DRUG$ appropriate model @DRUG$ metabolism", "LBL": "0", "ID": "DDI-MedLine.d189.s11.p0", "DRUGA": ["precocene I", "drug_n", "103-113"], "DRUGB": ["precocene I", "drug_n", "165-175"]}
